A B-O B-NP_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
antiinflammatory B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
corticosteroids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
the B-O B-S_NP_DT
glucocorticoid B-O B-NN
receptor B-O B-NN
" " B-O O-NP
regulates B-O B-VP_VBZ
leukocyte B-O B-NP_NP_NP_NN
adhesion B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
endothelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
endothelial-leukocyte B-O B-NP_NP_JJ
adhesion B-O B-NN
molecule B-O B-NN
1 B-O B-CD
" " B-O O-NP
and B-O B-CC
intercellular B-O B-NP_JJ
adhesion B-O B-NN
molecule B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
Corticosteroids B-O B-S_NP_NNS
" " B-O O-NP
are B-O B-VP_VBP
the B-O B-NP_DT
preeminent B-O B-JJ
antiinflammatory B-O B-JJ
agents B-O B-NNS
" " B-O O-NP
although B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
molecular B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
impart B-O B-S_NP_VP_VBP
their B-O B-NP_PRPP
efficacy B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
have B-O B-VP_VBP
not B-O B-RB
been B-O B-VP_VBN
defined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
endothelium B-O B-NN
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
critical B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
inflammation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
directing B-O B-S_NP_VP_VBG
circulating B-O B-NP_VBG
leukocytes B-O B-NNS
" " B-O O-NP
into B-O B-PP_IN
extravascular B-O B-NP_JJ
tissues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
expressing B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PRN_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
determined B-O B-VP_VBD
whether B-O B-SBAR_IN
corticosteroids B-O B-S_NP_NNS
" " B-O O-NP
suppress B-O B-VP_VBP
inflammation B-O B-NP_NN
" " B-O O-NP
by B-O B-PP_IN
inhibiting B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Preincubation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
endothelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
endotoxin B-O B-NP_NP_NN
" " B-O O-NP
[ B-O B-PRN_LRB
lipopolysaccharide B-O B-FRAG_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
LPS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
1 B-O B-NP_CD
microgram/ml B-O B-NN
" " B-O O-NP
" " B-O O-FRAG
] B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
led B-O B-VP_VBD
to B-O B-PP_TO
a B-O B-NP_NP_NP_DT
4-fold B-O B-ADJP_JJ
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
subsequent B-O B-NP_NP_JJ
adherence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
to B-O B-PP_TO
endothelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
markedly B-O B-ADVP_RB
" " B-O O-ADVP
attenuated B-O B-VP_VBN
" " B-O B-NP_SBAR_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_NP_DT
steroid B-O B-NN
receptor B-O B-NN
agonist B-O B-NN
cortisol B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
10 B-O B-FRAG_NP_CD
microM B-O B-NN
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
its B-O B-NP_NP_PRPP
inactive B-O B-JJ
metabolite B-O B-NN
tetrahydrocortisol B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
10 B-O B-FRAG_NP_CD
microM B-O B-NN
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
diminished B-O B-VP_VBD
LPS-induced B-O B-NP_JJ
endothelial B-O B-JJ
cell B-O B-NN
adhesiveness B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_NP_JJ
evidence B-O B-NN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
ligation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
was B-O B-VP_VBD
provided B-O B-VP_VBN
by B-O B-NP_PP_IN
experiments B-O B-NP_NP_NNS
" " B-O O-NP
utilizing B-O B-VP_VBG
the B-O B-NP_DT
steroid B-O B-NN
antagonist B-O B-NN
RU-486 B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
RU-486 B-O B-S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
10 B-O B-FRAG_NP_CD
microM B-O B-NN
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
prevents B-O B-S_NP_VP_VBZ
translocation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ligated B-O B-NP_VBN
hGR B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
inhibiting B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
completely B-O B-ADVP_RB
" " B-O O-ADVP
aborted B-O B-VP_VBD
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
adhesiveness B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
endothelial B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
, B-O B-S_S_COMMA
) B-O B-S_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
endothelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
LPS B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
1 B-O B-FRAG_NP_CD
microgram/ml B-O B-NN
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
stimulated B-O B-VP_VP_VBD
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ELAM-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_IN
shown B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
Northern B-O B-NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
expression B-O B-VP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
membrane-associated B-O B-NP_JJ
ELAM-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
ICAM-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_IN
shown B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
quantitative B-O B-NP_NP_JJ
immunofluorescence B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-S_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Dexamethasone B-O B-S_S_NP_NN
" " B-O O-NP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
LPS-stimulated B-O B-NP_NP_NP_JJ
accumulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mRNA B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
ELAM-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ELAM-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
ICAM-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
, B-O B-S_S_COMMA
, B-O B-S_COMMA
) B-O B-S_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
reversed B-O B-VP_VBN
by B-O B-NP_PP_IN
RU-486 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
, B-O B-S_S_NP_VP_COMMA
" " B-O B-S_NP_VP_O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
As B-O B-S_SBAR_IN
in B-O B-FRAG_PP_IN
the B-O B-NP_DT
adhesion B-O B-NN
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-SBAR
, B-O B-COMMA
cortisol B-O B-NP_NP_NN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
tetrahydrocortisol B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inhibited B-O B-VP_VBD
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ELAM-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
ICAM-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
both B-O B-S_S_NP_DT
P B-O B-NN
" " B-O O-NP
< B-O B-VP_VBG
" " B-O B-NP_O-S
, B-O B-COMMA
n B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
" " B-O B-NP_O-S
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
sodium B-O B-NP_NP_NN
salicylate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
1 B-O B-FRAG_NP_CD
mM B-O B-NN
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
inhibited B-O B-VP_VBD
neither B-O B-NP_NP_CC
adhesion B-O B-NP_NN
" " B-O O-NP
nor B-O B-CC
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
adhesion B-O B-NN
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
antagonism B-O B-S_NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
of B-O B-PP_IN
endotoxin-induced B-O B-NP_JJ
inflammation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
specific B-O B-JJ
instance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
general B-O B-JJ
biological B-O B-JJ
principle B-O B-NN
that B-O B-SBAR_IN
" " B-O B-S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Ablation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transplanted B-O B-NP_NP_VBN
HTLV-I B-O B-ADJP_NN
Tax-transformed B-O B-JJ
" " B-O O-ADJP
tumors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
mice B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
antisense B-O B-NP_NP_JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
[ B-O B-S_LRB
published B-O B-NP_VBN
erratum B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
in B-O B-PP_IN
Science B-O B-NP_NNP
1993 B-O B-CD
Mar B-O B-NNP
12 B-O B-CD
; B-O B-COLON
259 B-O B-CD
( B-O B-LRB
5101 B-O B-CD
) B-O B-RRB
: B-O B-COLON
1523 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-NP
  
Mice B-O B-S_NP_NP_NNS
" " B-O O-NP
transgenic B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_NP_JJ
T B-O B-NN
cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-I B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
Tax B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
develop B-O B-VP_VBP
fibroblastic B-O B-NP_NP_JJ
tumors B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
express B-O B-S_NP_VP_VBP
NF-kappa B-O B-NP_ADJP_NN
B-inducible B-O B-JJ
" " B-O O-ADJP
early B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
antisense B-O B-NP_JJ
oligodeoxynucleotides B-O B-NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
ODNs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibited B-O B-VP_VBD
growth B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_NP_DT
culture-adapted B-O B-JJ
Tax-transformed B-O B-JJ
fibroblasts B-O B-NNS
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
an B-O B-NP_DT
HTLV-I-transformed B-O B-JJ
human B-O B-JJ
lymphocyte B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
antisense B-O B-NP_NP_JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Tax B-O B-NP_NP_NN
" " B-O O-NP
itself B-O B-NP_PRP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
apparent B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
cell B-O B-NP_NN
growth B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mice B-O B-S_NP_NP_NNS
" " B-O O-NP
treated B-O B-VP_VBN
with B-O B-NP_PP_IN
antisense B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
NF-kappa B-O B-NP_NN
B B-O B-NN
ODNs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
showed B-O B-VP_VBD
rapid B-O B-NP_NP_JJ
regression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transplanted B-O B-NP_VBN
fibrosarcomas B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
suggests B-O B-VP_VP_VBZ
that B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NN
B B-O B-NN
expression B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
necessary B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
provides B-O B-VP_VBZ
a B-O B-NP_NP_DT
therapeutic B-O B-JJ
approach B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
HTLV-I-associated B-O B-NP_JJ
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_DT
cellular B-O B-JJ
oncogene B-O B-NN
c-myb B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
interact B-O B-VP_VB
synergistically B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
the B-O B-NP_DT
Epstein-Barr B-O B-JJ
virus B-O B-NN
BZLF1 B-O B-NN
transactivator B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Regulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
replicative B-O B-NP_NP_JJ
functions B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
Epstein-Barr B-O B-NP_NP_JJ
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EBV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
genome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
virally B-O B-ADJP_RB
encoded B-O B-VBN
" " B-O O-ADJP
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
Z B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
Z B-O B-NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
and B-O B-S_NP_VP_VP_CC
" " B-O B-VP_O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
can B-O B-VP_MD
efficiently B-O B-ADVP_RB
" " B-O O-ADVP
activate B-O B-VP_VB
the B-O B-NP_NP_DT
EBV B-O B-NN
early B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
, B-O B-COMMA
BMRF1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_CONJP_NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
c-myb B-O B-NN
proto-oncogene B-O B-NN
product B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-NP_NP_O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
can B-O B-VP_MD
interact B-O B-VP_VB
synergistically B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
Z B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
the B-O B-S_NP_NP_DT
c-myb B-O B-NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
itself B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
little B-O B-NP_JJ
effect B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
simian B-O B-JJ
virus B-O B-NN
40 B-O B-CD
early B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
synergistically B-O B-ADVP_RB
" " B-O O-ADVP
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
Z/c-myb B-O B-NN
combination B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Synergistic B-O B-S_NP_NP_JJ
transactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
BMRF1 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
Z/c-myb B-O B-NN
combination B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
involve B-O B-VP_VB
direct B-O B-NP_NP_JJ
binding B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
the B-O B-NP_NP_DT
Z B-O B-NN
protein B-O B-NN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
c-myb B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
30-bp B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
BMRF1 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contains B-O B-S_NP_VP_VBZ
a B-O B-NP_NP_DT
Z B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
sufficient B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
transfer B-O B-VP_VB
high-level B-O B-NP_NP_JJ
lymphoid-specific B-O B-JJ
responsiveness B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
Z/c-myb B-O B-NN
combination B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_DT
heterologous B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
That B-O B-S_SBAR_IN
the B-O B-S_NP_DT
c-myb B-O B-NN
oncogene B-O B-NN
product B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
interact B-O B-VP_VB
synergistically B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
an B-O B-NP_NP_DT
EBV-encoded B-O B-JJ
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
leucine B-O B-NN
zipper B-O B-NN
protein B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
suggests B-O B-VP_VBZ
c-myb B-O B-SBAR_WHNP_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
likely B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
engage B-O B-VP_VB
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cortisol B-O B-NP_NP_NP_NN
receptor B-O B-NN
resistance B-O B-NN
" " B-O O-NP
: B-O B-COLON
" " B-O O-NP
the B-O B-NP_NP_DT
variability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_PRPP
clinical B-O B-NP_NP_JJ
presentation B-O B-NN
" " B-O O-NP
and B-O B-CC
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
treatment B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Primary B-O B-S_NP_JJ
( B-O B-LRB
partial B-O B-JJ
) B-O B-RRB
cortisol B-O B-NN
receptor B-O B-NN
resistance B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
previously B-O B-ADVP_RB
" " B-O O-ADVP
reported B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
total B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
7 B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
and B-O B-CC
14 B-O B-NP_CD
asymptomatic B-O B-JJ
family B-O B-NN
members B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Its B-O B-S_NP_PRPP
occurrence B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
considered B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
extremely B-O B-ADJP_RB
rare B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
on B-O B-PP_IN
6 B-O B-NP_NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
2 B-O B-NP_NP_CD
males B-O B-NNS
" " B-O O-NP
and B-O B-CC
4 B-O B-NP_CD
females B-O B-NNS
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
first B-O B-JJ
male B-O B-JJ
patient B-O B-NN
" " B-O O-NP
presented B-O B-VP_VBD
with B-O B-PP_IN
mild B-O B-NP_JJ
hypertension B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Hydrochlorothiazide B-O B-S_NP_NN
therapy B-O B-NN
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
life-threatening B-O B-NP_JJ
hypokalemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
second B-O B-JJ
male B-O B-JJ
patient B-O B-NN
" " B-O O-NP
had B-O B-VP_VBD
slight B-O B-NP_NP_JJ
hypertension B-O B-NN
" " B-O O-NP
without B-O B-PP_IN
hypokalemia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_DT
four B-O B-CD
female B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
presented B-O B-VP_VBD
between B-O B-PP_IN
the B-O B-NP_NP_DT
age B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
20-30 B-O B-NP_QP_CD
" " B-O O-QP
yr B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
acne B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
hirsutism B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
irregular B-O B-NP_JJ
menstruations B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Low B-O B-S_NP_NP_JJ
dose B-O B-NN
dexamethasone B-O B-NN
therapy B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
1-1.5 B-O B-NP_QP_CD
" " B-O O-QP
mg/day B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
of B-O B-PP_IN
clinical B-O B-NP_JJ
benefit B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
these B-O B-NP_DT
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_DT
patients B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
insufficient B-O B-NP_NP_JJ
suppression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
serum B-O B-NP_NN
cortisol B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
overnight B-O B-JJ
1-mg B-O B-JJ
dexamethasone B-O B-NN
test B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
diurnal B-O B-JJ
rhythm B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ACTH B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
cortisol B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
intact B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
albeit B-O B-PP_IN
at B-O B-FRAG_PP_IN
an B-O B-NP_DT
elevated B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_NP_DT
normal B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
ACTH B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
cortisol B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
GH B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-LRB
except B-O B-PP_IN
in B-O B-FRAG_PP_IN
one B-O B-NP_CD
obese B-O B-JJ
patient B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
) B-O B-RRB
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
insulin-induced B-O B-NP_JJ
hypoglycemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
while B-O B-SBAR_IN
cortisol B-O B-S_NP_NN
production B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
elevated B-O B-VP_JJ
in B-O B-NP_PP_IN
three B-O B-NP_CD
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Circulating B-O B-S_NP_VBG
adrenal B-O B-JJ
androgen B-O B-NN
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
increased B-O B-VP_VBN
in B-O B-NP_PP_IN
all B-O B-NP_DT
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Glucocorticoid B-O B-S_NP_NN
receptors B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
investigated B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_DT
whole B-O B-JJ
cell B-O B-NN
dexamethasone B-O B-NN
binding B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
mononuclear B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
first B-O B-JJ
male B-O B-JJ
patient B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
receptors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
very B-O B-ADJP_RB
low B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
while B-O B-SBAR_IN
the B-O B-S_NP_DT
affinity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
lower B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
lowered B-O B-JJ
affinity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
in B-O B-NP_PP_IN
one B-O B-NP_CD
female B-O B-JJ
patient B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
while B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
lowered B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
receptors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
in B-O B-NP_PP_IN
three B-O B-NP_CD
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
second B-O B-JJ
male B-O B-JJ
patient B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
no B-O B-NP_DT
abnormalities B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_PP_IN
a B-O B-NP_NP_DT
bioassay B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
glucocorticoid B-O B-NP_NN
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
measured B-O B-VP_VBD
dexamethasone B-O B-NP_NP_NN
suppressibility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mitogen-stimulated B-O B-NP_NP_JJ
incorporation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
[3H]thymidine B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
mononuclear B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
male B-O B-JJ
patient B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
normal B-O B-NP_JJ
receptor B-O B-NN
status B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
dexamethasone B-O B-NP_NP_NN
suppressibility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
[3H]thymidine B-O B-NP_NN
incorporation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADJP_ADJP_RB
lower B-O B-JJR
" " B-O O-ADJP
than B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
in B-O B-PP_IN
healthy B-O B-NP_JJ
controls B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
with B-O B-PP_IN
respect B-O B-NN
to B-O B-TO
both B-O B-NP_CC
maximal B-O B-NP_JJ
suppression B-O B-NN
" " B-O O-NP
and B-O B-CC
IC50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Partial B-O B-S_NP_JJ
cortisol B-O B-NN
receptor B-O B-NN
resistance B-O B-NN
" " B-O O-NP
might B-O B-VP_MD
be B-O B-VP_VB
less B-O B-ADJP_ADJP_RBR
rare B-O B-JJ
" " B-O O-ADJP
than B-O B-SBAR_IN
previously B-O B-FRAG_VP_ADVP_RB
" " B-O O-ADVP
thought B-O B-VBN
" " B-O O-VP
" " B-O O-FRAG
" " B-O O-SBAR
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
six B-O B-CD
patients B-O B-NNS
" " B-O O-NP
presented B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
at B-O B-NP_QP_IN
least B-O B-JJS
three B-O B-CD
" " B-O O-QP
different B-O B-JJ
forms B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
recognized B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therapy B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
successful B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
female B-O B-NP_NP_JJ
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
acne B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
hirsutism B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
secondary B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
adrenal B-O B-NP_JJ
androgens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
effectively B-O B-ADVP_RB
" " B-O O-ADVP
controlled B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Structure B-O B-NP_NP_NN
function B-O B-NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
vitamin B-O B-NP_NP_NN
D B-O B-NN
analogs B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
C-ring B-O B-NP_NN
modifications B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Analogs B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
1 B-O B-NP_NP_CD
alpha,25-dihydroxyvitamin B-O B-NN
D3 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
1 B-O B-NP_CD
alpha,25-(OH)2D3 B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
substitutions B-O B-NP_NP_NNS
" " B-O O-NP
on B-O B-PP_IN
C-11 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
synthesized B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Small B-O B-S_S_NP_NP_JJ
apolar B-O B-JJ
substitutions B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
11 B-O B-NP_NP_CD
alpha-methyl B-O B-NN
" " B-O O-NP
, B-O B-COMMA
11 B-O B-NP_CD
alpha-fluoromethyl B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
markedly B-O B-ADVP_RB
" " B-O O-ADVP
decrease B-O B-VP_VB
the B-O B-NP_NP_DT
affinity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
vitamin B-O B-NN
D B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
larger B-O B-S_NP_NP_ADJP_ADJP_JJR
( B-O B-PRN_LRB
11 B-O B-NP_NP_CD
alpha-chloromethyl B-O B-NN
" " B-O O-NP
or B-O B-CC
or B-O B-NP_NP_CC
11 B-O B-CD
beta-phenyl B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
or B-O B-CC
more B-O B-ADJP_RBR
polar B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
substitutions B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
11 B-O B-NP_NP_CD
alpha-hydroxymethyl B-O B-NN
" " B-O O-NP
, B-O B-COMMA
11 B-O B-NP_CD
alpha-(2-hydroxyethyl B-O B-NN
" " B-O O-NP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
decreased B-O B-VP_VBD
the B-O B-NP_DT
affinity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
less B-O B-NP_NP_QP_JJR
than B-O B-IN
5 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
1 B-O B-NP_CD
alpha,25-OH)2D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Their B-O B-S_NP_NP_PRPP
affinity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
vitamin B-O B-ADJP_NN
D-binding B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
increased B-O B-VP_VBD
up B-O B-ADVP_RB
to B-O B-TO
4-fold B-O B-RB
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
biological B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
11 B-O B-NP_CD
alpha-methyl-1 B-O B-NN
alpha,25-(OH)2D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
closely B-O B-ADVP_RB
" " B-O O-ADVP
resembled B-O B-VP_VBD
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
natural B-O B-JJ
hormone B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
normal B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
leukemic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
cell B-O B-NP_NP_NN
proliferation B-O B-NN
" " B-O O-NP
and B-O B-CC
bone B-O B-NP_NN
resorption B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
its B-O B-S_NP_NP_PRPP
in B-O B-ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
calcium B-O B-NP_NP_NN
metabolism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
rachitic B-O B-JJ
chick B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
about B-O B-NP_NP_QP_IN
50 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
1 B-O B-NP_CD
alpha,25-(OH)2D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
11 B-O B-CD
beta-methyl B-O B-NN
analog B-O B-NN
" " B-O O-NP
had B-O B-VP_VBD
a B-O B-NP_DT
greater B-O B-ADJP_ADVP_JJR
than B-O B-IN
10-fold B-O B-RB
" " B-O O-ADVP
lower B-O B-JJR
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
differentiating B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
other B-O B-JJ
C-11 B-O B-NN
analogs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
human B-O B-NP_NP_JJ
promyeloid B-O B-JJ
leukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
HL-60 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
agreed B-O B-VP_VBD
well B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
their B-O B-NP_PRPP
bone-resorbing B-O B-NP_NP_JJ
activity B-O B-NN
" " B-O O-NP
and B-O B-CC
receptor B-O B-NP_NN
affinity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
they B-O B-S_NP_PRP
" " B-O O-NP
demonstrated B-O B-VP_VBD
lower B-O B-NP_JJR
calcemic B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Large B-O B-S_NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
polar B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
substitutions B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
C-11 B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
1 B-O B-NP_CD
alpha,25-(OH)2D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
thus B-O B-ADVP_RB
" " B-O O-ADVP
impair B-O B-VP_VP_VBP
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
vitamin B-O B-NN
D B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
but B-O B-CC
increase B-O B-VP_VBP
the B-O B-NP_NP_DT
affinity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
vitamin B-O B-NP_ADJP_NN
D-binding B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
many B-O B-NP_JJ
C-11-substituted B-O B-JJ
1 B-O B-CD
alpha,25-(OH)2D3 B-O B-NN
analogs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
HL-60 B-O B-NP_NN
cell B-O B-NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
exceeded B-O B-VP_VBD
their B-O B-NP_NP_PRPP
activity B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
calcium B-O B-NP_NN
metabolism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Mineralocorticoids B-O B-NP_NP_NP_NNPS
" " B-O O-NP
and B-O B-CC
mineralocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
pregnancy-induced B-O B-NP_JJ
hypertension B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
To B-O B-S_S_NP_VP_TO
examine B-O B-VP_VB
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mineralocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
pathophysiology B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
plasma B-O B-NP_NP_NP_NP_NN
aldosterone B-O B-NN
" " B-O O-NP
and B-O B-CC
18-hydroxycorticosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
25 B-O B-NP_NP_NP_CD
women B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
PIH B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
25 B-O B-NP_NP_CD
normal B-O B-JJ
pregnant B-O B-JJ
women B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
as B-O B-PP_IN
controls B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
evaluated B-O B-VP_VBD
the B-O B-NP_NP_NP_DT
mineralocorticoid B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
status B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
2 B-O B-CD
groups B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
MR B-O B-S_NP_NN
count B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
( B-O B-PRN_LRB
P B-O B-S_NP_NN
" " B-O O-NP
less B-O B-NP_QP_JJR
than B-O B-IN
0.0005 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
decreased B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
PIH B-O B-NN
group B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
148 B-O B-FRAG_NP_QP_CD
+/- B-O B-CC
9 B-O B-CD
" " B-O O-QP
binding B-O B-VBG
sites/cell B-O B-NNS
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
compared B-O B-PP_VBN
with B-O B-PP_IN
the B-O B-NP_NP_DT
control B-O B-NN
group B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
; B-O B-FRAG_NP_NP_COLON
" " B-O B-NP_O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Plasma B-O B-S_S_NP_NP_NN
aldosterone B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
women B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
PIH B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
281 B-O B-NP_QP_CD
+/- B-O B-CC
61 B-O B-CD
" " B-O O-QP
pmol/L B-O B-NN
" " B-O O-NP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
in B-O B-S_PP_IN
normal B-O B-NP_JJ
pregnant B-O B-JJ
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
it B-O B-NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
697 B-O B-NP_QP_CD
+/- B-O B-CC
172 B-O B-CD
" " B-O O-QP
pmol/L B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-S_NP_NN
" " B-O O-NP
less B-O B-NP_QP_JJR
than B-O B-IN
0.025 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Plasma B-O B-S_NP_NN
18-hydroxycorticosterone B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
significantly B-O B-ADJP_ADJP_RB
( B-O B-PRN_LRB
P B-O B-S_NP_NN
" " B-O O-NP
less B-O B-NP_QP_JJR
than B-O B-IN
0.025 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
lower B-O B-JJR
" " B-O O-ADJP
( B-O B-PRN_LRB
PIH B-O B-FRAG_FRAG_NP_NN
" " B-O O-NP
, B-O B-COMMA
1071 B-O B-NP_QP_CD
+/- B-O B-CC
149 B-O B-CD
" " B-O O-QP
pmol/L B-O B-NN
" " B-O O-NP
" " B-O O-FRAG
; B-O B-COLON
controls B-O B-FRAG_NP_NNS
" " B-O O-NP
, B-O B-COMMA
1907 B-O B-NP_QP_CD
+/- B-O B-CC
318 B-O B-CD
" " B-O O-QP
pmol/L B-O B-NN
" " B-O O-NP
" " B-O O-FRAG
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
values B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
determined B-O B-VP_VBN
at B-O B-NP_PP_IN
the B-O B-NP_NP_DT
onset B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
clinical B-O B-NP_NP_JJ
symptoms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
PIH B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_S_NP_DT
results B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
not B-O B-RB
be B-O B-VP_VB
explained B-O B-VP_VBN
by B-O B-NP_PP_IN
receptor B-O B-NP_NP_NN
down-regulation B-O B-NN
" " B-O O-NP
due B-O B-PP_JJ
to B-O B-TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
a B-O B-S_NP_DT
hitherto B-O B-ADJP_RB
unknown B-O B-JJ
" " B-O O-ADJP
mineralocorticoid B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
, B-O B-COMMA
thus B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
be B-O B-VP_VB
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_DT
hypertension B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
altered B-O B-NP_JJ
MR B-O B-NN
" " B-O O-NP
" " B-O O-NP
status B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
Mineralocorticoid B-O B-NP_NP_NN
effector B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
preeclampsia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Mineralocorticoid B-O B-S_NP_NN
effector B-O B-NN
mechanisms B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
evaluated B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
29 B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
preeclampsia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
25 B-O B-NP_CD
uncomplicated B-O B-JJ
pregnancies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
by B-O B-PP_IN
measurement B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
plasma B-O B-NP_NP_NN
aldosterone B-O B-NN
" " B-O O-NP
, B-O B-COMMA
levels B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
subtraction B-O B-NP_NP_NN
potential B-O B-NN
difference B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
; B-O B-NP_COLON
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mean B-O B-S_S_NP_NP_NN
values B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
plasma B-O B-NP_NN
aldosterone B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
different B-O B-ADJP_JJ
" " B-O O-ADJP
between B-O B-PP_IN
the B-O B-NP_DT
two B-O B-CD
groups B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
significant B-O B-S_NP_JJ
differences B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
observed B-O B-VP_VBN
for B-O B-NP_PP_IN
MR B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
; B-O B-NP_NP_COLON
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
SPD B-O B-NP_NN
( B-O B-PRN_LRB
; B-O B-NP_NP_COLON
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
six B-O B-NP_CD
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
determined B-O B-VP_VBD
MR B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
plasma B-O B-NP_NN
aldosterone B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
SPD B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
preeclampsia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
before B-O B-PP_PP_PP_IN
" " B-O B-NP_O-PP
and B-O B-CC
3 B-O B-PP_NP_CD
months B-O B-NNS
" " B-O O-NP
after B-O B-IN
" " B-O B-NP_O-PP
" " B-O O-PP
delivery B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
MR B-O B-S_S_S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
reduced B-O B-VP_VP_VBN
before B-O B-NP_PP_IN
delivery B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
( B-O B-PRN_LRB
96 B-O B-NP_QP_CD
+/- B-O B-CC
27 B-O B-CD
" " B-O O-QP
receptors/cell B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
SPD B-O B-S_NP_NN
" " B-O O-NP
increased B-O B-VP_VP_VBD
" " B-O O-VP
( B-O B-PRN_LRB
64 B-O B-NP_QP_CD
+/- B-O B-CC
8 B-O B-CD
" " B-O O-QP
mV B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-S
" " B-O O-S
, B-O B-COMMA
with B-O B-PP_IN
both B-O B-S_NP_DT
parameters B-O B-NNS
" " B-O O-NP
normalizing B-O B-VP_VP_VBG
after B-O B-PP_IN
delivery B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
( B-O B-PRN_LRB
MR B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
242 B-O B-NP_QP_CD
+/- B-O B-CC
79 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
SPD B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
14.0 B-O B-NP_QP_CD
+/- B-O B-CC
4 B-O B-CD
" " B-O O-QP
mV B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-S
  
Aldosterone B-O B-S_NP_NN
levels B-O B-NNS
" " B-O O-NP
returned B-O B-VP_VBD
to B-O B-PP_TO
normal B-O B-NP_JJ
nonpregnant B-O B-JJ
values B-O B-NNS
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
delivery B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VP_VBP
an B-O B-NP_NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
abnormalities B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
mineralocorticoid B-O B-NP_NN
effector B-O B-NN
mechanisms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
etiology B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
preeclampsia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
could B-O B-VP_MD
be B-O B-VP_VB
an B-O B-NP_NP_DT
useful B-O B-JJ
marker B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
diagnosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Leukotriene B-O B-S_NP_NN
B4 B-O B-NN
" " B-O O-NP
stimulates B-O B-VP_VBZ
c-fos B-O B-NP_NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
leukotriene B-O B-NP_NP_NP_NN
B4 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
LTB4 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
potent B-O B-JJ
lipid B-O B-NN
proinflammatory B-O B-JJ
mediator B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
proto-oncogenes B-O B-NNS
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
looked B-O B-VP_VBD
at B-O B-PP_IN
the B-O B-NP_NP_DT
modulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
binding B-O B-VP_VBG
specifically B-O B-PP_RB
to B-O B-TO
the B-O B-NP_DT
AP-1 B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
LTB4 B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LTB4 B-O B-S_NP_NN
" " B-O O-NP
increased B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
c-fos B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
time- B-O B-ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
concentration-dependent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
c-jun B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_JJ
peripheral-blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
relatively B-O B-NP_ADJP_RB
high B-O B-JJ
" " B-O O-ADJP
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
slightly B-O B-ADVP_RB
" " B-O O-ADVP
augmented B-O B-VP_JJ
by B-O B-NP_PP_IN
LTB4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
although B-O B-SBAR_IN
to B-O B-FRAG_PP_TO
a B-O B-NP_NP_DT
much B-O B-ADJP_RB
lower B-O B-JJR
" " B-O O-ADJP
extent B-O B-NN
" " B-O O-NP
than B-O B-PP_IN
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
kinetics B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
two B-O B-CD
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADJP_RB
slightly B-O B-RB
different B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
with B-O B-PP_IN
c-fos B-O B-S_S_NP_NN
mRNA B-O B-NN
" " B-O O-NP
reaching B-O B-VP_VBG
a B-O B-NP_DT
peak B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
15 B-O B-NP_NP_CD
min B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
c-jun B-O B-S_NP_NN
" " B-O O-NP
at B-O B-PP_IN
30 B-O B-NP_CD
min B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-S
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_DT
messages B-O B-NNS
" " B-O O-NP
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
declined B-O B-VP_VBD
thereafter B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Stability B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
c-fos B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
affected B-O B-VP_VBN
by B-O B-NP_PP_IN
LTB4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-SBAR_IN
assessed B-O B-S_NP_VP_VBN
after B-O B-NP_PP_IN
actinomycin B-O B-NP_NN
D B-O B-NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_NP_JJ
transcription B-O B-NN
studies B-O B-NNS
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
LTB4 B-O B-S_NP_NN
" " B-O O-NP
increased B-O B-VP_VP_VBD
the B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
c-fos B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
7-fold B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
and B-O B-CC
the B-O B-VP_NP_DT
c-jun B-O B-NN
gene B-O B-NN
" " B-O O-NP
1.4-fold B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Resting B-O B-S_S_NP_VBG
monocytes B-O B-NNS
" " B-O O-NP
contained B-O B-VP_VBD
nuclear B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
the B-O B-NP_DT
AP-1 B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
LTB4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induced B-O B-VP_VBD
greater B-O B-NP_NP_JJR
AP-1-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
LTB4 B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
regulate B-O B-VP_VB
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
different B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
modulating B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Kinetics B-O B-NP_NP_NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
translocation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
turnover B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
vitamin B-O B-NN
D B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
HL60 B-O B-NN
leukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
peripheral B-O B-NP_JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
-- B-O B-COLON
" " B-O O-NP
coincident B-O B-NP_NP_JJ
rise B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA-relaxing B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
High B-O B-S_NP_NP_NP_JJ
affinity B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
VDR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
for B-O B-PP_IN
1,25-dihydroxycholecalciferol B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
calcitriol B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
expressed B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
HL60 B-O B-NP_NN
human B-O B-JJ
leukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
low B-O B-NP_NP_JJ
numbers B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HL60 B-O B-S_NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
expressing B-O B-VP_VBG
some B-O B-NP_NP_DT
characteristics B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
promyelocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
induced B-O B-VP_VBN
to B-O B-NP_PP_TO
monocytoid B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
calcitriol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Specific B-O B-S_NP_NP_JJ
nuclear B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
[3H]calcitriol/VDR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
examined B-O B-VP_VBN
after B-O B-NP_PP_IN
exposure B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
whole B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
10(-9) B-O B-NP_ADJP_CD
M/l B-O B-NN
" " B-O O-ADJP
calcitriol B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
and B-O B-NP_NP_CC
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
subsequent B-O B-NP_NP_JJ
isolation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclei B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Specific B-O B-S_S_NP_NP_JJ
nuclear B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
[3H]calcitriol/VDR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
time B-O B-ADJP_NN
dependent B-O B-JJ
" " B-O O-ADJP
reaching B-O B-S_NP_VP_VBG
" " B-O B-NP_PP_O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
a B-O B-S_NP_NP_DT
maximum B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
approximately B-O B-NP_QP_RB
310 B-O B-CD
" " B-O O-QP
binding B-O B-VBG
sites/nucleus B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
after B-O B-NP_PP_IN
3 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
PBL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Pulse B-O B-S_NP_NP_NN
exposure B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HL60 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
radiolabeled B-O B-NP_VBN
hormone B-O B-NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
3 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
followed B-O B-VP_VBN
by B-O B-NP_PP_IN
culture B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
medium B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
without B-O B-PP_IN
serum B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
calcitriol B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
lead B-O B-VP_VBD
to B-O B-PP_TO
nuclear B-O B-NP_NP_NP_JJ
retention B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
approximately B-O B-NP_QP_RB
1600 B-O B-CD
" " B-O O-QP
radiolabeled B-O B-VBN
VDR B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
8 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
approximately B-O B-NP_NP_QP_RB
1000 B-O B-CD
" " B-O O-QP
VDR B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
24 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Radiolabeled B-O B-S_NP_VBN
VDR B-O B-NN
" " B-O O-NP
disappeared B-O B-VP_VBD
from B-O B-PP_IN
the B-O B-NP_DT
nuclear B-O B-JJ
compartment B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_DT
halflife B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
approximately B-O B-NP_QP_RB
30 B-O B-CD
" " B-O O-QP
min B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
if B-O B-SBAR_IN
cells B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
cultured B-O B-VP_VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
after B-O B-PP_IN
the B-O B-NP_DT
pulse B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
( B-O B-PRN_LRB
pulse/chase-experiments B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_NP_DT
difference B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
VDR B-O B-NP_NN
retention B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
pulse B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
pulse/chase-experiments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
PBL B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
VDR B-O B-S_NP_NN
halflife B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
min B-O B-NP_QP_NN
" " B-O O-NP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_NP_DT
specific B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
into B-O B-PP_IN
the B-O B-NP_DT
nuclear B-O B-JJ
compartment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
seen B-O B-VP_VBN
when B-O B-NP_SBAR_WHADVP_WRB
" " B-O O-WHADVP
isolated B-O B-S_NP_VBN
nuclei B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
incubated B-O B-VP_VBN
in B-O B-NP_PP_IN
[3H]calcitriol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Radiolabeled B-O B-S_NP_NP_VBN
hormone/receptor B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
nuclei B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
exposed B-O B-VP_VBN
for B-O B-NP_PP_IN
3 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
radiolabeled B-O B-NP_VBN
hormone B-O B-NN
" " B-O O-NP
" " B-O O-PP
-- B-O B-COLON
in B-O B-PP_IN
contrast B-O B-NN
to B-O B-TO
identical B-O B-NP_NP_JJ
experiments B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
-- B-O B-COLON
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
disappear B-O B-VP_VB
from B-O B-PP_IN
the B-O B-NP_DT
nuclear B-O B-JJ
compartment B-O B-NN
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_IN
incubation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
nuclei B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
identical B-O B-NP_NP_JJ
concentrations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
unlabeled B-O B-JJ
compound B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NP_NP_NN
relaxing B-O B-NN
enzymes B-O B-NNS
" " B-O O-NP
( B-O B-LRB
e.g. B-O B-ADVP_FW
topoisomerases B-O B-NP_NNS
I B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
II B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-ADVP
) B-O B-RRB
" " B-O O-NP
in B-O B-PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
measured B-O B-VP_VBN
using B-O B-NP_S_NP_VP_VBG
a B-O B-NP_DT
PBR B-O B-NN
322-relaxation-assay B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Enhanced B-O B-S_NP_VBN
overall B-O B-JJ
enzyme B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
in B-O B-NP_PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
1 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
incubation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
in B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
enhanced B-O B-VBN
activity B-O B-NN
" " B-O O-NP
disappeared B-O B-VP_VBD
after B-O B-PP_IN
2 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
PBL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
it B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
still B-O B-ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VBN
by B-O B-NP_PP_IN
4 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
HL60 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
ethanol B-O B-NP_ADJP_NN
treated B-O B-JJ
" " B-O O-ADJP
controls B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_DT
specific B-O B-JJ
nuclear B-O B-JJ
translocation B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
exists B-O B-VP_VBZ
for B-O B-PP_IN
calcitriol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
both B-O B-NP_NP_DT
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
most B-O B-PP_ADVP_RBS
likely B-O B-RB
" " B-O O-ADVP
due B-O B-IN
to B-O B-TO
translocation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
receptor B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
hormone B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Translocated B-O B-S_NP_VBN
hormone/receptor B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
compete B-O B-VP_VBP
for B-O B-PP_IN
a B-O B-NP_NP_DT
limited B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_JJ
nuclear B-O B-JJ
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Enhanced B-O B-S_NP_NP_VBN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
topoisomerases B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_IN
translocation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
VDR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
might B-O B-VP_MD
reflect B-O B-VP_VB
interaction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
the B-O B-NP_DT
nuclear B-O B-JJ
compartment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
thus B-O B-S_ADVP_RB
" " B-O O-ADVP
initiating B-O B-NP_VP_VBG
DNA-unwinding B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
prerequisite B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
initiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcription B-O B-NP_NP_NP_NN
factor B-O B-NN
activation B-O B-NN
" " B-O O-NP
and B-O B-CC
functional B-O B-NP_JJ
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Activation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
encoding B-O B-VP_VBG
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
c-fos B-O B-S_NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
formation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
AP1 B-O B-NP_NN
transcriptional B-O B-JJ
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
investigated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
It B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
that B-O B-SBAR_IN
lipopolysaccharide B-O B-S_NP_NN
" " B-O O-NP
induced B-O B-VP_VBD
strongly B-O B-ADVP_RB
" " B-O O-ADVP
both B-O B-NP_NP_NP_CC
and B-O B-NP_CC
expression B-O B-NP_NN
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
AP1 B-O B-NP_NN
formation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interferon B-O B-S_NP_NN
gamma B-O B-NN
" " B-O O-NP
activated B-O B-VP_VP_VBD
strongly B-O B-ADVP_RB
" " B-O O-ADVP
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
weakly B-O B-VP_ADVP_RB
" " B-O O-ADVP
c-jun B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
AP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tumor B-O B-S_NP_NN
necrosis B-O B-NN
factor B-O B-NN
" " B-O O-NP
induced B-O B-VP_VP_VBD
slightly B-O B-ADVP_RB
" " B-O O-ADVP
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
had B-O B-VP_VBD
almost B-O B-NP_QP_RB
no B-O B-DT
" " B-O O-QP
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
c-jun B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
AP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
differences B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
functional B-O B-NP_NP_JJ
responses B-O B-NNS
" " B-O O-NP
elicited B-O B-VP_VBN
in B-O B-NP_PP_IN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Interferon-gamma B-O B-S_NP_NN
" " B-O O-NP
potentiates B-O B-VP_VBZ
the B-O B-NP_NP_NP_DT
antiviral B-O B-JJ
activity B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
interferon-stimulated B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
interferon-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Binding B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
type B-O B-NP_NP_NN
I B-O B-CD
interferon B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IFN-alpha/beta B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
specific B-O B-NP_JJ
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_DT
rapid B-O B-JJ
transcriptional B-O B-JJ
activation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
independent B-O B-ADJP_JJ
of B-O B-PP_IN
protein B-O B-NP_NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
of B-O B-PP_IN
IFN-alpha-stimulated B-O B-NP_NP_NP_JJ
genes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
ISGs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
fibroblasts B-O B-NNS
" " B-O O-NP
and B-O B-CC
cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ISGF3 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IFN-stimulated B-O B-NP_JJ
gene B-O B-NN
factor B-O B-NN
3 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
conserved B-O B-VBN
IFN-stimulated B-O B-NP_JJ
response B-O B-NN
element B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ISRE B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
transcriptional B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
factor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
composed B-O B-VP_VBN
of B-O B-NP_PP_IN
a B-O B-NP_NP_NP_NP_DT
DNA-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ISGF3 B-O B-NP_NN
gamma B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
normally B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
is B-O B-VP_VBZ
" " B-O B-ADJP_O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
and B-O B-CC
other B-O B-NP_NP_JJ
IFN-alpha-activated B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
preexist B-O B-S_NP_VP_VBP
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
found B-O B-VP_VBN
that B-O B-SBAR_IN
ISG B-O B-S_NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
monocytic B-O B-JJ
U937 B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
differs B-O B-VP_VBZ
from B-O B-PP_IN
most B-O B-NP_NP_JJS
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
examined B-O B-VP_ADVP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
U937 B-O B-S_S_NP_NN
cells B-O B-NNS
" " B-O O-NP
express B-O B-VP_VBP
both B-O B-NP_NP_CC
type B-O B-NP_NN
I B-O B-CD
" " B-O O-NP
and B-O B-CC
type B-O B-NP_NN
II B-O B-CD
" " B-O O-NP
" " B-O O-NP
IFN B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
only B-O B-S_NP_RB
IFN-alpha B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
capable B-O B-ADJP_JJ
of B-O B-PP_IN
inducing B-O B-S_NP_VP_VBG
antiviral B-O B-NP_JJ
protection B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Pretreatment B-O B-S_S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
IFN-gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
potentiates B-O B-VP_VBZ
the B-O B-NP_DT
IFN-alpha-induced B-O B-JJ
protection B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
IFN-gamma B-O B-S_NP_NP_NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
have B-O B-VP_VB
any B-O B-NP_DT
antiviral B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
ISG15 B-O B-S_NP_NP_NN
mRNA B-O B-NN
accumulation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
not B-O B-RB
detectable B-O B-ADJP_JJ
" " B-O O-ADJP
before B-O B-PP_IN
6 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IFN-alpha B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
peaks B-O B-VP_VBZ
at B-O B-PP_IN
24 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
requires B-O B-VP_VBZ
protein B-O B-NP_NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
IFN-gamma B-O B-S_NP_NP_NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
induce B-O B-VP_VB
ISG B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
IFN-gamma B-O B-NP_NN
pretreatment B-O B-NN
" " B-O O-NP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
increases B-O B-VP_VP_VP_VBZ
" " B-O B-NP_O-VP
and B-O B-CC
hastens B-O B-VP_VBZ
" " B-O B-NP_O-VP
" " B-O O-VP
ISG B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
and B-O B-CC
transcriptional B-O B-NP_JJ
induction B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
assayed B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ISRE B-O B-NP_NN
binding B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
ISGF3 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
IFN-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
6 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
undetectable B-O B-NP_JJ
basal B-O B-JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
untreated B-O B-NP_JJ
U937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ISGF3 B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
latent B-O B-JJ
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ISGF3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurs B-O B-VP_VBZ
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
ISGF3 B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
ultimately B-O B-ADVP_RB
" " B-O O-ADVP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
the B-O B-NP_NP_DT
accumulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ISGF3 B-O B-NP_NN
gamma B-O B-NN
" " B-O O-NP
" " B-O O-PP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
IFN-alpha B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
IFN-gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LRB
ABSTRACT B-O B-NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-S
[ B-O B-NP_LRB
Effect B-O B-NP_NN
" " B-O O-NP
of B-O B-PP_IN
antihypertensive B-O B-NP_NP_JJ
therapy B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
captopril B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
gluco- B-O B-NP_NP_NP_NP_NP_JJ
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
mineralocorticoid B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
receptors B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
hypertensive B-O B-NP_NP_JJ
patients B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
various B-O B-NP_JJ
age B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
] B-O B-RRB
" " B-O O-NP
  
Binding B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
3H-dexamethasone B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
3H-aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
peripheral B-O B-NP_JJ
lymphocyte B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
investigated B-O B-VP_VBN
in B-O B-NP_PP_IN
healthy B-O B-NP_NP_JJ
persons B-O B-NNS
" " B-O O-NP
and B-O B-CC
hypertensive B-O B-NP_JJ
patients B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
before B-O B-PP_PP_PP_IN
" " B-O B-NP_O-PP
and B-O B-CC
after B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-PP
2-week B-O B-NP_ADJP_JJ
" " B-O O-ADJP
captopril B-O B-NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
mineralocorticoid B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
increased B-O B-VP_VBN
in B-O B-NP_PP_IN
hypertensives B-O B-NP_NP_NNS
" " B-O O-NP
vs B-O B-CC
normotensives B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
treatment B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
ACE B-O B-NN
inhibitor B-O B-NN
captopril B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
led B-O B-VP_VBD
to B-O B-PP_TO
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
hormone-receptor B-O B-NP_NN
interactions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_NP_DT
more B-O B-ADJP_RBR
marked B-O B-JJ
" " B-O O-ADJP
rise B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
receptors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
middle-aged B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
years B-O B-NP_QP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
hypertensives B-O B-NNS
" " B-O O-NP
vs B-O B-CC
elderly B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
years B-O B-NP_QP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
after B-O B-PP_IN
captopril B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Leukotriene B-O B-S_NP_NN
B4 B-O B-NN
" " B-O O-NP
transcriptionally B-O B-ADVP_RB
" " B-O O-ADVP
activates B-O B-VP_VBZ
interleukin-6 B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
involving B-O B-VP_VBG
NK-chi B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-IL6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Leukotriene B-O B-S_NP_NP_NN
B4 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
LTB4 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
notable B-O B-JJ
participant B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
inflammation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
chemotaxis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
still B-O B-ADJP_RB
unclear B-O B-JJ
" " B-O O-ADJP
whether B-O B-SBAR_IN
LTB4 B-O B-S_NP_NN
" " B-O O-NP
acts B-O B-VP_VBZ
in B-O B-PP_IN
this B-O B-NP_DT
regard B-O B-NN
" " B-O O-NP
" " B-O O-PP
directly B-O B-ADVP_ADVP_RB
" " B-O O-ADVP
or B-O B-CC
indirectly B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-ADVP
by B-O B-PP_IN
stimulating B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
LTB4 B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
synthesis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
-6 B-O B-NP_NP_NP_PRN_CD
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
human B-O B-NP_JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
through B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-6 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
furthermore B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
this B-O B-S_NP_DT
process B-O B-NN
" " B-O O-NP
involves B-O B-VP_VP_VP_VBZ
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
and B-O B-CC
, B-O B-VP_COMMA
to B-O B-PP_TO
a B-O B-NP_DT
lesser B-O B-JJR
extent B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
of B-O B-NP_NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
while B-O B-SBAR_IN
the B-O B-NP_NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
shown B-O B-VP_VBN
" " B-O B-S_NP_VP_O-VP
, B-O B-COMMA
" " B-O O-NP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Involvement B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-chi B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-IL6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL-6 B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
demonstrated B-O B-VP_VBN
using B-O B-NP_S_NP_VP_VBG
deleted B-O B-NP_NP_JJ
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-6 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-6 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
LTB4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VP_VBD
not B-O B-CONJP_RB
only B-O B-RB
" " B-O O-CONJP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
accumulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
respective B-O B-JJ
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
but B-O B-CC
resulted B-O B-VP_VBD
in B-O B-PP_IN
synthesis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
functional B-O B-NP_JJ
IL-6 B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_RB
well B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
LTB4 B-O B-NP_NN
" " B-O O-NP
mediated B-O B-VP_VBD
transactivation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
heterologous B-O B-JJ
promoter B-O B-NN
construct B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
or B-O B-NP_NP_NP_NP_CC
enhancer B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
AP-1 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
signaling B-O B-NN
events B-O B-NNS
" " B-O O-NP
mediating B-O B-VP_VBG
this B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
involve B-O B-VP_VB
the B-O B-NP_NP_DT
release B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
H2O2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
since B-O B-SBAR_IN
LTB4 B-O B-S_NP_NN
" " B-O O-NP
failed B-O B-VP_VBD
" " B-O B-S_NP_VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Characterization B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
new B-O B-JJ
tissue-specific B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
the B-O B-NP_DT
simian B-O B-JJ
virus B-O B-NN
40 B-O B-CD
enhancer B-O B-NN
TC-II B-O B-NN
( B-O B-LRB
NF-kappa B-O B-NN
B B-O B-NN
) B-O B-RRB
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
biochemically B-O B-ADVP_ADVP_RB
" " B-O O-ADVP
and B-O B-CC
functionally B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-ADVP
characterized B-O B-VP_VBN
a B-O B-NP_NP_NP_DT
new B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
NP-TCII B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VP_VBZ
present B-O B-ADJP_JJ
" " B-O B-PP_O-VP
but B-O B-CC
is B-O B-VP_VBZ
not B-O B-RB
found B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
factor B-O B-NN
" " B-O O-NP
has B-O B-VP_VP_VBZ
a B-O B-NP_NP_DT
DNA-binding B-O B-JJ
specificity B-O B-NN
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
but B-O B-CC
is B-O B-VP_VBZ
unrelated B-O B-ADJP_JJ
to B-O B-PP_TO
this B-O B-NP_ADJP_ADJP_DT
" " B-O O-ADJP
or B-O B-CC
other B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
Rel B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
functional B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
biochemical B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
criteria B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
can B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
distinguished B-O B-VP_VBN
from B-O B-NP_PP_IN
other B-O B-NP_JJ
previously B-O B-ADJP_RB
described B-O B-VBN
" " B-O O-ADJP
lymphocyte-specific B-O B-JJ
DNA-binding B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Reticuloendotheliosis B-O B-S_NP_NN
virus B-O B-NN
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
elements B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
efficient B-O B-NP_NP_JJ
promoters B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
various B-O B-NP_NP_JJ
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
origin B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
including B-O B-PP_VBG
human B-O B-NP_JJ
lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Promiscuous B-O B-S_S_S_NP_NP_JJ
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
reticuloendotheliosis B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
REV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
long B-O B-NP_NP_JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
LTR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
transient B-O B-NP_JJ
expression B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
using B-O B-S_NP_VP_VBG
LTR-chloramphenicol B-O B-NP_NP_NN
acetyltransferase-encoding B-O B-JJ
gene B-O B-NN
chimeras B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
levels B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
two B-O B-NP_CD
different B-O B-JJ
REV B-O B-NN
LTRs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlate B-O B-VP_VBP
with B-O B-PP_IN
reports B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
pathogenicity B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
" " B-O O-S
  
REVs B-O B-S_S_NP_NNS
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
encode B-O B-VP_VB
a B-O B-NP_NP_DT
transactivator B-O B-NN
" " B-O O-NP
targeted B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
viral B-O B-JJ
LTR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
cells B-O B-S_NP_NP_NNS
" " B-O O-NP
infected B-O B-VP_VBN
with B-O B-NP_PP_IN
Marek B-O B-NP_NP_NP_NN
's B-O B-POS
" " B-O O-NP
disease B-O B-NN
virus B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
herpesvirus B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
an B-O B-NP_DT
overlapping B-O B-VBG
host B-O B-NN
range B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
express B-O B-VP_VB
factors B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
preferentially B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
enhance B-O B-VP_VBP
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
REV B-O B-S_NP_NN
LTRs B-O B-NNS
" " B-O O-NP
work B-O B-VP_VP_VBP
efficiently B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
human B-O B-NP_JJ
lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
are B-O B-VP_VBP
viable B-O B-NP_NP_JJ
alternatives B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
promoters B-O B-NP_NP_NNS
" " B-O O-NP
commonly B-O B-VP_ADVP_RB
" " B-O O-ADVP
used B-O B-VBN
for B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
They B-O B-S_NP_PRP
" " B-O O-NP
may B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
prove B-O B-VP_VB
useful B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
the B-O B-NP_NP_DT
identification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
new B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
ubiquitous B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
cellular B-O B-JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
anti-CD3 B-O B-NP_ADJP_JJ
monoclonal B-O B-JJ
antibody-induced B-O B-JJ
" " B-O O-ADJP
T-cell B-O B-NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
dexamethasone B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
isoproterenol B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
prostaglandin B-O B-NP_NN
E2 B-O B-NN
" " B-O O-NP
" " B-O O-NP
either B-O B-UCP_CC
alone B-O B-ADVP_RB
" " B-O O-ADVP
or B-O B-CC
in B-O B-PP_IN
combination B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-UCP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
1 B-O B-S_LST_LS
. B-O B-PERIOD
" " B-O O-LST
The B-O B-NP_NP_DT
purpose B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
to B-O B-S_NP_VP_TO
investigate B-O B-VP_VB
the B-O B-NP_NP_DT
modulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
proliferation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
by B-O B-PP_IN
, B-O B-NP_NP_NP_PRN_COMMA
, B-O B-NP_NP_PRN_COMMA
and B-O B-CC
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
former B-O B-JJ
two B-O B-CD
substances B-O B-NNS
" " B-O O-NP
interact B-O B-VP_VBP
with B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
via B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-UCP_NP_NN
" " B-O O-NP
and B-O B-CC
beta-adrenergic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-UCP
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
occupied B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
their B-O B-NP_NP_PRPP
natural B-O B-JJ
ligands B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
glucocorticosteroids B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
catecholamines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O B-ADVP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
these B-O B-NP_DT
receptors B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
modulating B-O B-S_NP_VP_VBG
T-cell B-O B-NP_NN
function B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
stress B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
During B-O B-S_PP_IN
the B-O B-NP_DT
inflammatory B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
increased B-O B-NP_NP_VBN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
PGE2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
bind B-O B-VP_VP_VBP
to B-O B-PP_TO
their B-O B-NP_NP_PRPP
receptors B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
thus B-O B-RB
alter B-O B-VP_VBP
responsiveness B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Proliferation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
immobilized B-O B-NP_VBN
anti-CD3 B-O B-JJ
monoclonal B-O B-NP_NP_JJ
antibody B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
mAb B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
absence B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
additional B-O B-JJ
costimulatory B-O B-JJ
signal B-O B-NN
" " B-O O-NP
delivered B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
2 B-O B-S_LST_LS
. B-O B-PERIOD
" " B-O O-LST
Various B-O B-S_S_NP_NP_JJ
physiologic B-O B-JJ
concentrations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
DEX B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
ISO B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
PGE2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
added B-O B-VP_VBN
at B-O B-NP_PP_IN
the B-O B-NP_NP_DT
time B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
subsequent B-O B-S_NP_NP_JJ
proliferation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
unstimulated B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
determined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
physiologic B-O B-S_NP_NP_JJ
concentrations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
all B-O B-NP_NP_DT
three B-O B-CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibit B-O B-VP_VBP
the B-O B-NP_NP_DT
anti-CD3 B-O B-ADJP_JJ
mAb-induced B-O B-JJ
" " B-O O-ADJP
proliferation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
3 B-O B-S_LST_LS
. B-O B-PERIOD
" " B-O O-LST
Although B-O B-SBAR_IN
DEX B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
PGE2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
equipotent B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
suppressing B-O B-S_NP_VP_JJ
T-cell B-O B-NP_NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
ISO B-O B-NP_NN
" " B-O O-NP
was B-O B-VP_VBD
much B-O B-ADJP_ADVP_RB
less B-O B-RBR
" " B-O O-ADVP
effective B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
4 B-O B-S_LST_LS
. B-O B-PERIOD
" " B-O O-LST
Because B-O B-SBAR_IN
concomitant B-O B-S_NP_NP_JJ
elevations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
peripheral B-O B-JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
substances B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
occur B-O B-VP_VB
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
experiments B-O B-NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
performed B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
determine B-O B-VP_VB
the B-O B-NP_NP_DT
T-cell B-O B-NN
inhibitory B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
DEX B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
together B-O B-PP_RB
with B-O B-IN
either B-O B-NP_CC
or B-O B-NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Synergistic B-O B-S_NP_NP_JJ
suppression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T-cell B-O B-NP_NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
when B-O B-NP_SBAR_WHADVP_WRB
" " B-O O-WHADVP
various B-O B-S_NP_NP_JJ
concentrations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_NP_CC
, B-O B-NP_COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
and B-O B-NP_NP_CC
, B-O B-NP_COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
added B-O B-VP_VBN
to B-O B-NP_PP_TO
cultures B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
synergistic B-O B-JJ
suppression B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
not B-O B-RB
be B-O B-VP_VB
explained B-O B-VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cAMP B-O B-NP_NP_NN
accumulation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
5 B-O B-S_LST_LS
. B-O B-PERIOD
" " B-O O-LST
Finally B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
anti-CD28 B-O B-NP_JJ
mAb B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
anti-CD3 B-O B-NP_ADJP_JJ
mAb-stimulated B-O B-JJ
" " B-O O-ADJP
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
overcame B-O B-VP_VBD
much B-O B-NP_NP_JJ
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
suppression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
proliferation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
PGE2 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
ISO B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
but B-O B-CC
less B-O B-ADVP_ADVP_RBR
so B-O B-RB
" " B-O O-ADVP
than B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
DEX B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Calcitriol B-O B-NP_NP_NN
: B-O B-COLON
" " B-O O-NP
a B-O B-FRAG_NP_DT
hematolymphopoietrope B-O B-NN
" " B-O O-NP
? B-O B-PERIOD
" " B-O O-FRAG
[ B-O B-FRAG_LRB
editorial B-O B-NP_NN
" " B-O O-NP
] B-O B-RRB
" " B-O O-FRAG
" " B-O O-NP
  
A B-O B-S_NP_NP_DT
MEDLINE B-O B-NN
search B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
English-language B-O B-JJ
literature B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
conducted B-O B-VP_VBN
using B-O B-NP_S_NP_VP_VBG
the B-O B-NP_NP_DT
indexing B-O B-NN
terms B-O B-NNS
" " B-O O-NP
' B-O B-PRN_LQT
immunology B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
calcitriol B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
vitamin B-O B-NP_NN
D B-O B-NN
" " B-O O-NP
" " B-O O-NP
' B-O B-RQT
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
to B-O B-S_NP_VP_TO
identify B-O B-VP_VB
studies B-O B-NP_NP_NNS
" " B-O O-NP
indicating B-O B-VP_VBG
" " B-O B-NP_NP_PP_PP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Sixty-six B-O B-S_NP_NP_CD
papers B-O B-NNS
" " B-O O-NP
published B-O B-VP_VBN
between B-O B-PP_IN
January B-O B-NP_NP_NNP
1956 B-O B-CD
" " B-O O-NP
and B-O B-CC
June B-O B-NP_NNP
1991 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Forty-five B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
reports B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
cited B-O B-VP_VBN
in B-O B-NP_PP_IN
this B-O B-NP_DT
review B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
suggest B-O B-VP_VBP
an B-O B-NP_NP_NP_DT
endocrine B-O B-ADJP_ADJP_NN
" " B-O O-ADJP
, B-O B-COMMA
autocrine B-O B-ADJP_NN
" " B-O O-ADJP
and/or B-O B-CC
paracrine B-O B-ADJP_NN
" " B-O O-ADJP
" " B-O O-ADJP
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
calcitriol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
immune B-O B-NP_JJ
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_NP_DT
unifying B-O B-JJ
hypothesis B-O B-NN
" " B-O O-NP
" " B-O B-S_O-NP
has B-O B-VP_VBZ
yet B-O B-ADVP_RB
" " B-O O-ADVP
emerged B-O B-VP_VBN
explaining B-O B-S_NP_VP_VBG
this B-O B-NP_NP_DT
collection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
data B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
paper B-O B-NN
" " B-O O-NP
provides B-O B-VP_VBZ
a B-O B-NP_NP_DT
brief B-O B-JJ
review B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immune B-O B-NP_NP_JJ
properties B-O B-NNS
" " B-O O-NP
currently B-O B-VP_ADVP_RB
" " B-O O-ADVP
attributed B-O B-VBN
to B-O B-NP_PP_TO
calcitriol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-S_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
elevation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cAMP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
interact B-O B-VP_VBP
synergistically B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-S_NP_VP_TO
raise B-O B-VP_VB
c-Fos B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
earlier B-O B-ADVP_RBR
" " B-O O-ADVP
found B-O B-VP_VBN
that B-O B-SBAR_IN
in B-O B-S_PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
enhances B-O B-VP_VBZ
the B-O B-NP_NP_DT
accumulation B-O B-NP_NP_PRN_NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
phorbol B-O B-NN
ester B-O B-NN
PMA B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
stimulates B-O B-S_NP_VP_VBZ
" " B-O B-S_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
on B-O B-PP_PP_IN
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
on B-O B-PP_IN
the B-O B-NP_NP_DT
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PMA B-O B-S_NP_NN
treatment B-O B-NN
" " B-O O-NP
caused B-O B-VP_VBD
a B-O B-NP_NP_DT
concentration- B-O B-ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
time-dependent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_NP_CC
c-Fos B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
immunoreactivity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
contrast B-O B-NN
to B-O B-TO
cAMP B-O B-NP_NP_NN
elevation B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
had B-O B-S_NP_VP_VBD
only B-O B-NP_RB
a B-O B-DT
slight B-O B-JJ
effect B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
PMA B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NECA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
forskolin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
acted B-O B-VP_VBD
together B-O B-ADVP_RB
" " B-O O-ADVP
either B-O B-S_NP_VP_CC
to B-O B-VP_TO
increase B-O B-VP_VP_VP_VB
( B-O B-NP_LRB
) B-O B-NP_RRB
" " B-O B-NP_O-NP
" " B-O O-VP
or B-O B-CC
decrease B-O B-VP_VB
( B-O B-NP_LRB
) B-O B-NP_RRB
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
protein B-O B-NP_NN
levels B-O B-NNS
" " B-O O-NP
as B-O B-PP_RB
well B-O B-RB
as B-O B-IN
and B-O B-S_NP_VP_VP_CC
" " B-O B-VP_O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
there B-O B-NP_EX
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_DT
clear-cut B-O B-JJ
synergy B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
PKC B-O B-NN
stimulator B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
cAMP B-O B-NN
elevating B-O B-NN
agents B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
simultaneous B-O B-JJ
activation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
elevation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cAMP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
an B-O B-NP_NP_DT
enhanced B-O B-VBN
AP-1 B-O B-NN
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
T-leukemia B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Aldosterone-specific B-O B-NP_NP_NP_JJ
membrane B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
and B-O B-CC
rapid B-O B-NP_NP_JJ
non-genomic B-O B-JJ
actions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
mineralocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
Functional B-O B-S_NP_NP_JJ
studies B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
extrarenal B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
non-epithelial B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
smooth B-O B-NP_NP_JJ
muscle B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
more B-O B-NP_ADVP_RBR
recently B-O B-RB
" " B-O O-ADVP
circulating B-O B-VBG
human B-O B-JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
provided B-O B-VP_VBN
increasing B-O B-NP_VBG
evidence B-O B-NN
that B-O B-SBAR_IN
aldosterone B-O B-S_NP_NN
" " B-O O-NP
produces B-O B-VP_VBZ
, B-O B-NP_NP_CONJP_NP_COMMA
on B-O B-CONJP_NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
" " B-O O-NP
involve B-O B-VP_VBP
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
sodium/proton B-O B-NN
exchanger B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
membrane B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
very B-O B-NP_NP_ADJP_ADJP_RB
low B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
physiological B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
concentrations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
an B-O B-NP_NP_DT
acute B-O B-JJ
onset B-O B-NN
" " B-O O-NP
within B-O B-PP_IN
1-2 B-O B-NP_QP_CD
" " B-O O-QP
min B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
second B-O B-JJ
messenger B-O B-NN
cascade B-O B-NN
" " B-O O-NP
involved B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
inositol B-O B-NN
1,4,5-trisphosphate/calcium B-O B-NN
pathway B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
responds B-O B-S_NP_VP_VBZ
over B-O B-PP_IN
the B-O B-NP_DT
same B-O B-JJ
rapid B-O B-JJ
time B-O B-NN
course B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Such B-O B-S_NP_JJ
changes B-O B-NNS
" " B-O O-NP
clearly B-O B-ADVP_RB
" " B-O O-ADVP
can B-O B-VP_MD
not B-O B-RB
be B-O B-VP_VB
explained B-O B-VP_VBN
by B-O B-NP_PP_IN
genomic B-O B-NP_NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
underlying B-O B-VP_VBG
these B-O B-NP_NP_DT
rapid B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
electrolytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
extensively B-O B-ADVP_RB
" " B-O O-ADVP
studied B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
thus B-O B-S_ADVP_RB
" " B-O O-ADVP
may B-O B-NP_VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
unique B-O B-JJ
characteristics B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_NP_DT
new B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
steroid B-O B-NP_NN
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
include B-O B-VP_VBP
its B-O B-NP_NP_PRPP
rapid B-O B-JJ
time B-O B-NN
course B-O B-NN
" " B-O O-NP
, B-O B-COMMA
10,000-fold B-O B-NP_NP_JJ
selectivity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
over B-O B-PP_IN
cortisol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
ineffectiveness B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
spironolactones B-O B-NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
classical B-O B-NP_JJ
mineralocorticoid B-O B-NN
antagonists B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
antagonists B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Modulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
normal B-O B-NP_JJ
erythroid B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
endogenous B-O B-NP_NP_JJ
thyroid B-O B-NN
hormone B-O B-NN
" " B-O O-NP
and B-O B-CC
retinoic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-NP
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
a B-O B-NP_NP_DT
possible B-O B-JJ
target B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
v-erbA B-O B-NP_NN
oncogene B-O B-NN
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
v-erbA B-O B-NN
oncogene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
mutated B-O B-VBN
version B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
thyroid B-O B-NN
hormone B-O B-NN
receptor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
c-erbA/TR-alpha B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
inhibits B-O B-VP_VP_VP_VBZ
erythroid B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
constitutively B-O B-VP_ADVP_RB
" " B-O O-ADVP
represses B-O B-VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
certain B-O B-NP_JJ
erythrocyte B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
normal B-O B-JJ
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
proto-oncogene B-O B-NN
c-erbA B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
erythropoiesis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
endogenous B-O B-JJ
thyroid B-O B-NN
hormone B-O B-NN
receptor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
c-erbA/TR-alpha B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
closely B-O B-ADJP_RB
related B-O B-JJ
" " B-O O-ADJP
retinoic B-O B-NP_NP_JJ
acid B-O B-NN
receptor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RAR-alpha B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
play B-O B-VP_VBP
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
normal B-O B-NP_JJ
erythroid B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Retinoic B-O B-S_NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
distinctly B-O B-ADVP_RB
" " B-O O-ADVP
modulated B-O B-VP_VBD
the B-O B-NP_NP_DT
erythroid B-O B-JJ
differentiation B-O B-NN
program B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
normal B-O B-NP_NP_NP_JJ
erythroid B-O B-JJ
progenitors B-O B-NNS
" " B-O O-NP
and B-O B-CC
erythroblasts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
reversibly B-O B-VP_ADVP_RB
" " B-O O-ADVP
transformed B-O B-VBN
by B-O B-NP_PP_IN
a B-O B-NP_DT
conditional B-O B-JJ
tyrosine B-O B-NN
kinase B-O B-NN
oncogene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
added B-O B-S_NP_VP_VBN
pulsewise B-O B-NP_ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
immature B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
differentiation B-O B-NP_NN
" " B-O O-NP
was B-O B-VP_VBD
accelerated B-O B-VP_VBN
while B-O B-NP_SBAR_IN
more B-O B-S_NP_ADJP_RBR
mature B-O B-JJ
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
underwent B-O B-VP_VBD
premature B-O B-NP_JJ
cell B-O B-NN
death B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thyroid B-O B-S_NP_NP_NP_NN
hormone B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
T3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
caused B-O B-VP_VBD
similar B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
but B-O B-CC
weaker B-O B-ADJP_JJR
" " B-O O-ADJP
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
T3 B-O B-NP_NN
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VBD
the B-O B-NP_NP_DT
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
cooperative B-O B-NP_NP_JJ
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
two B-O B-CD
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
modulating B-O B-S_NP_VP_VBG
erythroid B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
RAR-alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
receptor-negative B-O B-NP_JJ
erythroblasts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
conferred B-O B-VP_VBD
RA-induced B-O B-NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
otherwise B-O B-ADJP_RB
unresponsive B-O B-JJ
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
thus B-O B-RB
showing B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_DT
RAR-alpha B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Likewise B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
enhanced B-O B-NP_NP_VBN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
exogenous B-O B-NP_JJ
c-erbA/TR-alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
erythroblasts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
rendered B-O B-VP_VBD
them B-O B-S_NP_PRP
" " B-O O-NP
susceptible B-O B-ADJP_JJ
to B-O B-PP_TO
modulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
T3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
similar B-O B-JJ
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Stable B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HB24 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
diverged B-O B-JJ
human B-O B-JJ
homeobox B-O B-NN
gene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
genes B-O B-NP_NP_NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
growth B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_NP_DT
diverged B-O B-JJ
homeobox B-O B-NN
gene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
HB24 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
introduced B-O B-VP_VBN
into B-O B-NP_PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
under B-O B-PP_IN
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
constitutive B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Stable B-O B-S_NP_NP_JJ
transfectants B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HB24 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-SBAR_O-NP
were B-O B-VP_VBD
established B-O B-VP_VBN
that B-O B-NP_SBAR_WHNP_WDT
" " B-O O-WHNP
expressed B-O B-S_NP_VP_VP_VBD
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
and B-O B-CC
possessed B-O B-VP_VBD
an B-O B-NP_NP_DT
altered B-O B-JJ
phenotype B-O B-NN
" " B-O O-NP
suggestive B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
known B-O B-VP_VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-VP
and B-O B-CC
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
cell B-O B-NP_NN
growth B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
increased B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
transfectants B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
c-fos B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
c-myc B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
c-myb B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
HLA-DR B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
lck B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
interleukin-2 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
interleukin-2 B-O B-NP_NP_NN
receptor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL-2R B-O B-NP_NP_NN
alpha B-O B-NN
expression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
transient B-O B-NP_NP_JJ
transfection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2R B-O B-NP_NN
alpha B-O B-NN
promoter B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
the B-O B-NP_DT
HB24 B-O B-NN
transfectants B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
constitutive B-O B-NP_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
about B-O B-FRAG_NP_NP_QP_RB
60 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Jurkat B-O B-NP_ADJP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
as B-O B-PP_IN
a B-O B-NP_NP_DT
consequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
increased B-O B-VBN
HB24 B-O B-NN
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
Jurkat B-O B-NN
HB24 B-O B-NN
transfectants B-O B-NNS
" " B-O O-NP
proliferated B-O B-VP_VBD
more B-O B-ADVP_ADVP_RBR
rapidly B-O B-RB
" " B-O O-ADVP
than B-O B-PP_IN
control B-O B-NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
stable B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HB24 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
confers B-O B-VP_VBZ
an B-O B-NP_DT
activation B-O B-NN
phenotype B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
a B-O B-NP_DT
human B-O B-JJ
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
implicating B-O B-S_NP_VP_VBG
this B-O B-NP_DT
gene B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
an B-O B-NP_NP_DT
important B-O B-JJ
transcriptional B-O B-JJ
factor B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Reduced B-O B-S_NP_NP_VBN
susceptibility B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
HIV-1 B-O B-NP_NP_NN
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ethyl-methanesulfonate-treated B-O B-NP_JJ
CEM B-O B-NN
subclones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
a B-O B-NP_NP_DT
blockade B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
their B-O B-NP_PRPP
protein B-O B-NN
kinase B-O B-NN
C B-O B-NN
signaling B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
described B-O B-VP_VBN
the B-O B-NP_NP_DT
isolation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
chemically B-O B-NP_NP_ADJP_RB
induced B-O B-VBN
" " B-O O-ADJP
CEM B-O B-NN
subclones B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
and B-O B-S_NP_VP_VP_CC
, B-O B-VP_COMMA
yet B-O B-RB
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_CD
subclones B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
an B-O B-NP_NP_DT
abnormal B-O B-JJ
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
activator B-O B-NP_NN
PMA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PMA B-O B-S_NP_NN
treatment B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBD
CD3 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
CD25 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-2R B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
receptors B-O B-NNS
" " B-O O-NP
on B-O B-PP_PP_IN
the B-O B-NP_DT
parental B-O B-JJ
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
on B-O B-PP_IN
other B-O B-NP_JJ
ethyl-methanesulfonate-derived B-O B-JJ
subclones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-PP_RB
on B-O B-IN
these B-O B-NP_DT
two B-O B-CD
mutants B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Direct B-O B-S_NP_NP_JJ
assays B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
conducted B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Total B-O B-S_NP_JJ
cellular B-O B-JJ
PKC B-O B-NN
enzymatic B-O B-JJ
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
normal B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
these B-O B-NP_DT
subclones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PMA-induced B-O B-S_NP_JJ
CD4 B-O B-NN
down-modulation B-O B-NN
" " B-O O-NP
occurred B-O B-VP_VBD
normally B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-raf B-O B-NP_NN
kinase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
normal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
HIV-1 B-O B-S_NP_NN
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
two B-O B-NP_CD
functional B-O B-JJ
nuclear B-O B-NP_NP_JJ
factor B-O B-NN
kB B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kB B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O B-S_O-NP
of B-O B-PP_IN
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
NF-kB B-O B-NP_NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
different B-O B-NP_JJ
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Chloramphenicol B-O B-S_NP_NP_NP_NP_NN
acetyl B-O B-NN
transferase B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CAT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
assays B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
the B-O B-NP_DT
HIV-1 B-O B-NN
( B-O B-ADJP_LRB
-139 B-O B-CD
) B-O B-RRB
long B-O B-JJ
terminal B-O B-JJ
repeat-CAT B-O B-JJ
" " B-O O-ADJP
construct B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
showed B-O B-VP_VBD
no B-O B-NP_NP_DT
PMA B-O B-NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CAT B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
subclones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
( B-O B-LRB
unlike B-O B-PP_IN
the B-O B-NP_NP_DT
parental B-O B-JJ
line B-O B-NN
" " B-O O-NP
and B-O B-CC
other B-O B-NP_JJ
subclones B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
) B-O B-RRB
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Okadaic B-O B-S_NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
phosphatases B-O B-NP_NNS
1 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
2A B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
overcome B-O B-VP_VB
the B-O B-NP_NP_DT
defect B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
subclones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Gel B-O B-S_NP_NP_NN
retardation B-O B-NN
assays B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
using B-O B-VP_VBG
a B-O B-NP_NP_DT
32P-probe B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_NP_DT
HIV-1 B-O B-NN
NF-kB B-O B-NN
probe B-O B-NN
" " B-O O-NP
and B-O B-CC
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
PMA-treated B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
showed B-O B-VP_VBD
significantly B-O B-NP_NP_ADJP_RB
reduced B-O B-VBN
" " B-O O-ADJP
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
NF-kB B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
two B-O B-CD
subclones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
compared B-O B-PP_VBN
with B-O B-PP_IN
wild B-O B-NP_NP_JJ
type B-O B-NN
CEM B-O B-NN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_DT
control B-O B-NN
subclone B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deoxycholate B-O B-S_NP_NP_JJ
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytoplasmic B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
these B-O B-NP_DT
subclones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
released B-O B-VP_VBD
much B-O B-NP_ADJP_JJ
reduced B-O B-VBN
" " B-O O-ADJP
NF-kB B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
their B-O B-NP_PRPP
cytoplasmic B-O B-JJ
pools B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
reduced B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
PKC-induced B-O B-NP_JJ
nuclear B-O B-JJ
NF-kB B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
two B-O B-NP_CD
T B-O B-NN
cell B-O B-NN
subclones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VP_VBD
not B-O B-RB
affect B-O B-VP_VB
their B-O B-NP_PRPP
normal B-O B-JJ
cell B-O B-NN
growth B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
correlated B-O B-VP_VBD
with B-O B-PP_IN
a B-O B-NP_NP_DT
pronounced B-O B-JJ
reduction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
their B-O B-NP_NP_PRPP
susceptibility B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
HIV-1 B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Functional B-O B-NP_NP_JJ
interaction B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
two B-O B-CD
zinc B-O B-NN
finger B-O B-NN
domains B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
v-erb B-O B-NN
A B-O B-NN
oncoprotein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
v-erb B-O B-NN
A B-O B-NN
oncogene B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
avian B-O B-NP_JJ
erythroblastosis B-O B-NN
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
mutated B-O B-ADJP_ADJP_VBN
" " B-O O-ADJP
and B-O B-CC
virally B-O B-ADJP_RB
transduced B-O B-VBN
" " B-O O-ADJP
" " B-O O-ADJP
copy B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
host B-O B-NN
cell B-O B-NN
gene B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
a B-O B-NP_DT
thyroid B-O B-NN
hormone B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
protein B-O B-NN
" " B-O O-NP
expressed B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
v-erb B-O B-NN
A B-O B-NN
oncogene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
binds B-O B-VP_VP_VBZ
to B-O B-PP_TO
DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
acts B-O B-VP_VBZ
as B-O B-PP_IN
a B-O B-NP_NP_DT
dominant B-O B-JJ
negative B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
the B-O B-NP_DT
thyroid B-O B-NN
hormone B-O B-NN
receptor B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
closely B-O B-ADJP_RB
related B-O B-JJ
" " B-O O-ADJP
retinoic B-O B-JJ
acid B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
v-erb B-O B-NN
A B-O B-NN
protein B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
sustained B-O B-VP_VBN
two B-O B-NP_CD
amino B-O B-NN
acid B-O B-NN
alterations B-O B-NNS
" " B-O O-NP
within B-O B-PP_IN
its B-O B-NP_PRPP
DNA-binding B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
relative B-O B-PP_JJ
to B-O B-TO
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
c-erb B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
, B-O B-COMMA
, B-O B-SBAR_WHNP_WHNP_COMMA
, B-O B-PP_COMMA
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
second B-O B-JJ
alteration B-O B-NN
" " B-O O-NP
, B-O B-COMMA
at B-O B-PP_IN
threonine B-O B-NP_NN
78 B-O B-CD
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
plays B-O B-VP_VBZ
an B-O B-NP_DT
important B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
although B-O B-IN
more B-O B-ADJP_RBR
indirect B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
" " B-O O-ADJP
role B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
alteration B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
threonine B-O B-NP_NN
78 B-O B-CD
" " B-O O-NP
" " B-O O-PP
such B-O B-SBAR_JJ
that B-O B-IN
it B-O B-S_NP_PRP
" " B-O O-NP
resembles B-O B-VP_VBZ
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
c-erb B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
can B-O B-VP_VP_MD
act B-O B-VP_VB
as B-O B-PP_IN
an B-O B-NP_DT
intragenic B-O B-JJ
suppressor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
can B-O B-VP_MD
partially B-O B-ADVP_RB
" " B-O O-ADVP
restore B-O B-VP_VB
function B-O B-NP_NN
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_NP_DT
v-erb B-O B-NN
A B-O B-NN
protein B-O B-NN
" " B-O O-NP
rendered B-O B-VP_VBN
due B-O B-S_NP_ADJP_PP_JJ
to B-O B-TO
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Threonine B-O B-S_NP_NN
78 B-O B-CD
" " B-O O-NP
lies B-O B-VP_VP_VBZ
within B-O B-PP_IN
the B-O B-NP_NP_DT
D-box B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
v-erb B-O B-NN
A B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
thought B-O B-VP_VBN
to B-O B-S_NP_VP_TO
mediate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
is B-O B-VP_VBZ
not B-O B-RB
in B-O B-PP_IN
physical B-O B-NP_NP_JJ
proximity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
serine B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
position B-O B-NP_NN
61 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
appears B-O B-VP_VBZ
that B-O B-SBAR_SBAR_IN
an B-O B-S_NP_DT
indirect B-O B-JJ
interaction B-O B-NN
" " B-O O-NP
occurs B-O B-VP_VBZ
between B-O B-PP_IN
these B-O B-NP_DT
two B-O B-CD
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
this B-O B-S_NP_DT
interaction B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
crucial B-O B-ADJP_JJ
for B-O B-PP_IN
v-erb B-O B-NP_NN
A B-O B-NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cellular B-O B-NP_NP_UCP_ADJP_JJ
immune B-O B-JJ
" " B-O O-ADJP
and B-O B-CC
cytokine B-O B-NP_NN
" " B-O O-NP
" " B-O O-UCP
pathways B-O B-NNS
" " B-O O-NP
resulting B-O B-VP_VBG
in B-O B-PP_IN
tissue B-O B-NP_NP_NN
factor B-O B-NN
expression B-O B-NN
" " B-O O-NP
and B-O B-CC
relevance B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
septic B-O B-NP_JJ
shock B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-NP
  
Cells B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
monocyte B-O B-NP_NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
serve B-O B-VP_VBP
as B-O B-PP_IN
effector B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
cellular B-O B-JJ
immune B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
they B-O B-NP_PRP
" " B-O O-NP
respond B-O B-VP_VBP
to B-O B-PP_TO
LPS B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
cytokines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
activation B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
inflammatory B-O B-NP_NP_JJ
effector B-O B-NN
gene B-O B-NN
products B-O B-NNS
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_VP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
antigen B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
proceeds B-O B-VP_VBZ
at B-O B-PP_IN
the B-O B-NP_DT
T B-O B-NN
helper B-O B-NN
cell B-O B-NN
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
two B-O B-NP_NP_NP_CD
independent B-O B-JJ
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
cellular B-O B-NP_JJ
collaboration B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
contact B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
lymphokine B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
review B-O B-VP_VBP
the B-O B-NP_NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
gene B-O B-NP_NP_PRN_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TF B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
enhanced B-O B-VBN
initiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TF B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
require B-O B-VP_VB
engagement B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
LPS B-O B-ADJP_NN
Response B-O B-NN
Element B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-NP_NP_SBAR_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Dissociation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
Ig B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
cytokine B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
stimulation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
possibly B-O B-NP_ADVP_RB
" " B-O O-ADVP
activated B-O B-VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
represent B-O B-VP_VB
a B-O B-NP_NP_DT
common B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
and B-O B-NP_NP_CC
genes B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Enhancement B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
TF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
observed B-O B-VP_VBN
upon B-O B-NP_PP_PP_IN
adhesion B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Mo B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
endothelial B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
extracellular B-O B-NP_JJ
matrix B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
upon B-O B-PP_IN
engagement B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
leukocyte B-O B-NP_NN
integrins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
biological B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
follow B-O B-S_NP_VP_VBP
from B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
TF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
vascular B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
resolved B-O B-VP_VBN
by B-O B-NP_PP_IN
analysis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
function B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
aided B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
rules B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
assembly B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
cognate B-O B-JJ
ligands B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
TF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
namely B-O B-RB
the B-O B-NP_NP_DT
zymogen B-O B-NN
plasma B-O B-NN
factors B-O B-NNS
VII B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
serine B-O B-NN
protease B-O B-NN
factor B-O B-NN
VIIa B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_NP_DT
soluble B-O B-JJ
surface B-O B-NN
domain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
free B-O B-NP_JJ
solution B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_PP_IN
phospholipid B-O B-NP_NP_JJ
surfaces B-O B-NNS
" " B-O O-NP
and B-O B-CC
cell B-O B-NP_NN
surface B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
of B-O B-PP_IN
the B-O B-NP_DT
anchored B-O B-VBN
TF B-O B-NN
molecule B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
described B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
evident B-O B-ADJP_JJ
" " B-O O-ADJP
that B-O B-SBAR_IN
assembly B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
surface B-O B-NN
domain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
VIIa B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-SBAR_WHNP_S_NP_VP_TO
form B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
induces B-O B-VP_VBZ
a B-O B-NP_NP_DT
significant B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
Kcat B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
provides B-O B-VP_VBZ
substantial B-O B-NP_NP_JJ
evidence B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
an B-O B-NP_NP_DT
allosteric B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
catalytic B-O B-JJ
cleft B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
also B-O B-ADJP_RB
evident B-O B-JJ
" " B-O O-ADJP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
TF.VIIa B-O B-NN
complex B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
proteolytically B-O B-ADJP_RB
active B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
can B-O B-VP_MD
activate B-O B-VP_VB
the B-O B-NP_DT
zymogen B-O B-NN
plasma B-O B-NN
factor B-O B-NN
X B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
inferring B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
extended B-O B-S_NP_NP_VBN
substrate B-O B-NN
recognition B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
are B-O B-VP_VBP
created B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_S_NP_VP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
also B-O B-ADJP_RB
evident B-O B-JJ
" " B-O O-ADJP
that B-O B-SBAR_IN
association B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
X B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
charged B-O B-NP_JJ
phospholipid B-O B-JJ
surfaces B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
enhances B-O B-VP_VBZ
the B-O B-NP_NP_DT
proteolytic B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
zymogen B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
increasing B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Gangliosides B-O B-S_NP_NN
" " B-O O-NP
suppress B-O B-VP_VBP
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
production B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_ADJP_CC
normal B-O B-ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
malignant B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
contain B-O B-VP_VBP
gangliosides B-O B-NP_NNS
" " B-O O-NP
as B-O B-PP_IN
important B-O B-NP_NP_JJ
cell B-O B-NN
membrane B-O B-NN
constituents B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
, B-O B-COMMA
after B-O B-S_PP_IN
being B-O B-S_NP_VP_VBG
" " B-O B-VP_O-S
" " B-O O-PP
, B-O B-COMMA
may B-O B-NP_VP_MD
influence B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
studied B-O B-VP_VBN
the B-O B-NP_NP_DT
impact B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gangliosides B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TNF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
blood B-O B-NP_NN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
the B-O B-NP_DT
monocytic B-O B-JJ
cell B-O B-NN
line B-O B-NN
Mono B-O B-NN
Mac B-O B-NN
6 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
under B-O B-S_PP_IN
standard B-O B-NP_JJ
culture B-O B-NN
conditions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
bovine B-O B-NP_NP_JJ
brain B-O B-NN
gangliosides B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
100 B-O B-FRAG_NP_CD
micrograms/ml B-O B-NNS
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
suppressed B-O B-VP_VP_VBD
LPS-stimulated B-O B-NP_JJ
TNF B-O B-NN
production B-O B-NN
" " B-O O-NP
5-fold B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
PBMC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
10-fold B-O B-VP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
Mono B-O B-NP_NN
Mac B-O B-NN
6 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
suppression B-O B-NP_NN
" " B-O O-NP
was B-O B-VP_VBD
more B-O B-ADJP_RBR
efficient B-O B-JJ
" " B-O O-ADJP
under B-O B-PP_IN
serum-free B-O B-NP_JJ
conditions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Looking B-O B-S_S_NP_VP_VBG
at B-O B-PP_IN
highly B-O B-NP_ADJP_RB
purified B-O B-VBN
" " B-O O-ADJP
gangliosides B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
GD3 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
GD1a B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
GM3 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
GM2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
GM1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
all B-O B-ADJP_DT
effective B-O B-JJ
" " B-O O-ADJP
in B-O B-PP_IN
reducing B-O B-S_NP_VP_VBG
TNF B-O B-NP_NP_NN
production B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
PBMC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
in B-O B-PP_IN
Mono B-O B-NP_NN
Mac B-O B-NN
6 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
by B-O B-PP_IN
factor B-O B-NP_NN
to B-O B-NP_NP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
suppressive B-O B-JJ
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
lost B-O B-VP_VBN
in B-O B-NP_PP_IN
molecules B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
lacking B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
sugar B-O B-NN
moiety B-O B-NN
" " B-O O-NP
or B-O B-CC
the B-O B-NP_DT
lipid B-O B-NN
moiety B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Gangliosides B-O B-S_NP_NNS
" " B-O O-NP
appear B-O B-VP_VBP
to B-O B-S_NP_VP_TO
act B-O B-VP_VB
at B-O B-PP_IN
an B-O B-NP_NP_DT
early B-O B-JJ
step B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-SBAR_WHPP_IN
and B-O B-WHNP_S_S_CC
" " B-O B-S_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
time B-O B-NP_NN
kinetics B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
gangliosides B-O B-NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
effective B-O B-ADJP_JJ
" " B-O O-ADJP
for B-O B-UCP_PP_IN
up B-O B-NP_NP_QP_RB
to B-O B-TO
30 B-O B-CD
" " B-O O-QP
min B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
addition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-ADVP_RB
thereafter B-O B-RB
" " B-O O-ADVP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
CD14 B-O B-NN
Ag B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
receptor B-O B-NN
molecule B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
LPS-LPS B-O B-NP_NN
binding B-O B-NN
protein B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
unaffected B-O B-VP_JJ
by B-O B-NP_PP_IN
gangliosides B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
using B-O B-S_NP_VP_VBG
Staphylococcus B-O B-NP_NP_FW
aureus B-O B-FW
" " B-O O-NP
or B-O B-CC
platelet B-O B-NP_NN
activating B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_DT
stimulus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
gangliosides B-O B-NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
suppress B-O B-VP_VB
TNF B-O B-NP_NP_NN
production B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Mono B-O B-NP_NN
Mac B-O B-NN
6 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
factor B-O B-NP_NN
to B-O B-NP_NP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-PP_RB
well B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-NP_DT
other B-O B-JJ
hand B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
phorbol B-O B-NP_NP_ADJP_NN
ester-induced B-O B-JJ
" " B-O O-ADJP
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
O2- B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
similar B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
treated B-O B-VP_VBN
with B-O B-NP_PP_PP_PP_IN
" " B-O B-NP_O-PP
and B-O B-CC
without B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-PP
gangliosides B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
our B-O B-NP_PRPP
data B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
TNF B-O B-S_NP_NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
different B-O B-NP_NP_JJ
types B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
gangliosides B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_NP_NP_DT
lymphoid B-O B-ADJP_JJ
cell-specific B-O B-JJ
" " B-O O-ADJP
nuclear B-O B-JJ
factor B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
c-Rel-like B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
preferentially B-O B-ADVP_RB
" " B-O O-ADVP
interacts B-O B-VP_VBZ
with B-O B-PP_IN
interleukin-6 B-O B-NP_NP_ADJP_NN
kappa B-O B-NN
B-related B-O B-JJ
" " B-O O-ADJP
motifs B-O B-NNS
" " B-O O-NP
whose B-O B-SBAR_WHNP_WPP
activities B-O B-NNS
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
repressed B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
proto-oncoprotein B-O B-NN
c-Rel B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
nuclear B-O B-JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
transcription B-O B-NN
factor B-O B-NN
family B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
includes B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
c-Rel B-O B-S_NP_NN
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
kappa B-O B-NP_NN
B B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
homodimers B-O B-NP_NP_NNS
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
heterodimers B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
homodimers B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
heterodimers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
show B-O B-VP_VBP
distinct B-O B-NP_NP_JJ
DNA-binding B-O B-JJ
specificities B-O B-NNS
" " B-O O-NP
and B-O B-CC
affinities B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
various B-O B-NP_JJ
kappa B-O B-NN
B B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
particular B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
c-Rel B-O B-NN
homodimer B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
a B-O B-NP_NP_DT
high B-O B-JJ
affinity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
interleukin-6 B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-6 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
beta B-O B-NP_NN
interferon B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
spite B-O B-NN
of B-O B-IN
its B-O B-NP_NP_PRPP
association B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
a B-O B-NP_NP_DT
lymphoid B-O B-ADJP_JJ
cell-specific B-O B-JJ
" " B-O O-ADJP
nuclear B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O B-SBAR_O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contains B-O B-S_NP_VP_VBZ
c-Rel B-O B-NP_NP_NP_NN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
epitopes B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
this B-O B-S_NP_NP_DT
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
termed B-O B-VP_VBN
IL-6 B-O B-S_NP_NP_NN
kappa B-O B-NN
B B-O B-NN
binding B-O B-NN
factor B-O B-NN
II B-O B-CD
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
appears B-O B-VP_VP_VBZ
to B-O B-S_NP_VP_TO
contain B-O B-VP_VB
the B-O B-NP_DT
c-Rel B-O B-NN
homodimer B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
and B-O B-CC
preferentially B-O B-VP_ADVP_RB
" " B-O O-ADVP
recognizes B-O B-VBZ
several B-O B-NP_JJ
IL-6 B-O B-ADJP_NN
kappa B-O B-NN
B-related B-O B-JJ
" " B-O O-ADJP
kappa B-O B-NN
B B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Although B-O B-S_SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
previously B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_DT
IL-6 B-O B-NN
kappa B-O B-NN
B B-O B-NN
motif B-O B-NN
" " B-O O-NP
functions B-O B-VP_VBZ
" " B-O B-PP_PP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
its B-O B-NP_PRPP
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
repressed B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
present B-O B-VP_VBP
evidence B-O B-NP_NN
that B-O B-SBAR_IN
IL-6 B-O B-S_NP_NN
kappa B-O B-NN
B B-O B-NN
binding B-O B-NN
factor B-O B-NN
II B-O B-CD
" " B-O O-NP
functions B-O B-VP_VBZ
as B-O B-PP_IN
a B-O B-NP_NP_DT
repressor B-O B-NN
" " B-O O-NP
specific B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-PP
in B-O B-PP_IN
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cyclosporin B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
CsA B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
powerful B-O B-NP_NP_JJ
suppressors B-O B-NNS
" " B-O O-NP
of B-O B-PP_PP_IN
the B-O B-NP_DT
immune B-O B-JJ
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
most B-O B-PP_ADVP_RBS
notably B-O B-RB
" " B-O O-ADVP
of B-O B-IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
They B-O B-S_NP_PRP
" " B-O O-NP
act B-O B-VP_VBP
at B-O B-PP_IN
a B-O B-NP_NP_DT
point B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
lies B-O B-S_NP_VP_VBZ
between B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
Stuart B-O B-NP_NP_NNP
Schreiber B-O B-NNP
" " B-O O-NP
and B-O B-CC
Gerald B-O B-NP_NNP
Crabtree B-O B-NNP
" " B-O O-NP
" " B-O O-NP
review B-O B-VP_VBP
recent B-O B-NP_NP_JJ
findings B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
indicate B-O B-S_NP_S_VBP
" " B-O B-SBAR_WHNP_S_NP_VP_O-SBAR
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
they B-O B-S_S_NP_PRP
" " B-O O-NP
bind B-O B-VP_VBP
endogenous B-O B-NP_NP_JJ
intracellular B-O B-JJ
receptors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
immunophilins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_DT
resulting B-O B-VBG
complex B-O B-NN
" " B-O O-NP
targets B-O B-VP_VBZ
the B-O B-NP_NP_DT
protein B-O B-NN
phosphatase B-O B-NN
" " B-O O-NP
, B-O B-COMMA
calcineurin B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
to B-O B-S_NP_VP_TO
exert B-O B-VP_VB
the B-O B-NP_DT
immunosuppressive B-O B-JJ
effect B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
The B-O B-S_NP_NP_DT
promoter B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD19 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
target B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
B-cell-specific B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
BSAP B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
CD19 B-O B-NN
protein B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
expressed B-O B-VP_VBN
on B-O B-NP_PP_IN
the B-O B-NP_NP_DT
surface B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
all B-O B-NP_DT
B-lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_NP_DT
exception B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
terminally B-O B-NP_ADJP_RB
differentiated B-O B-VBN
" " B-O O-ADJP
plasma B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
has B-O B-VP_VBZ
been B-O B-VP_VBN
implicated B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_DT
signal-transducing B-O B-JJ
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
complete B-O B-NP_NP_JJ
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_NP_DT
expression B-O B-NN
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD19 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
B-cell-specific B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
BSAP B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
large B-O B-JJ
panel B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
human B-O B-JJ
CD19 B-O B-NN
gene B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
cloned B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
several B-O B-S_NP_JJ
BSAP-binding B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
mapped B-O B-VP_VBN
by B-O B-NP_PP_IN
in B-O B-NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
protein-DNA B-O B-JJ
binding B-O B-NN
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
particular B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_NP_DT
high-affinity B-O B-JJ
BSAP-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
instead B-O B-CONJP_RB
of B-O B-IN
" " B-O O-CONJP
a B-O B-NP_DT
TATA B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
located B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_NP_DT
-30 B-O B-CD
promoter B-O B-NN
region B-O B-NN
" " B-O O-NP
upstream B-O B-ADJP_JJ
of B-O B-PP_IN
a B-O B-NP_NP_DT
cluster B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
this B-O B-NP_DT
site B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
occupied B-O B-VP_VBN
by B-O B-NP_PP_IN
BSAP B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
a B-O B-NP_DT
CD19-expressing B-O B-JJ
B-cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
plasma B-O B-NP_NP_NP_NN
" " B-O O-NP
or B-O B-CC
HeLa B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
high-affinity B-O B-JJ
site B-O B-NN
" " B-O O-NP
has B-O B-VP_VP_VBZ
been B-O B-VP_VBN
conserved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
promoters B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
CD19 B-O B-NP_UCP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
was B-O B-VP_VBD
furthermore B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
confer B-O B-VP_VB
B-cell B-O B-NP_NN
specificity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_DT
beta-globin B-O B-NN
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
transient B-O B-NP_JJ
transfection B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
BSAP B-O B-NP_NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
the B-O B-NP_NP_DT
only B-O B-RB
abundant B-O B-JJ
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B-cell B-O B-NP_NN
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Together B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
this B-O B-NP_DT
evidence B-O B-NN
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
implicates B-O B-VP_VBZ
BSAP B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD19 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
SRC-related B-O B-NP_NP_NP_NP_JJ
proto-oncogenes B-O B-NNS
" " B-O O-NP
and B-O B-CC
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
primary B-O B-NP_JJ
human B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
modulation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
cyclosporin B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
encoding B-O B-VP_VBG
for B-O B-PP_IN
lymphokines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interleukin-2 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
controlled B-O B-VP_VBN
transcriptionally B-O B-NP_ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
the B-O B-NP_NP_DT
cooperative B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_NP_JJ
trans-activating B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cyclosporin B-O B-S_NP_NP_NP_NN
A B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CsA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inhibit B-O B-VP_VBP
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
src B-O B-NN
gene B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
lymphocyte-specific B-O B-JJ
protein B-O B-NN
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
, B-O B-COMMA
p56lck B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
implicated B-O B-VP_VBN
in B-O B-NP_PP_IN
IL-2 B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CsA B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
not B-O B-S_NP_VP_RB
to B-O B-TO
inhibit B-O B-VP_VB
lck B-O B-NP_NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
, B-O B-COMMA
nor B-O B-CC
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
CsA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inhibit B-O B-VP_VBP
the B-O B-NP_NP_DT
appearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NP_NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
factors B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
the B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
same B-O B-JJ
stimuli B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
immunosuppressant B-O B-JJ
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CsA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
exerted B-O B-VP_VBN
at B-O B-NP_PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-NP_LRB
Age-related B-O B-NP_JJ
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
mineralocorticoid B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
healthy B-O B-NP_NP_JJ
persons B-O B-NNS
" " B-O O-NP
and B-O B-CC
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
] B-O B-RRB
" " B-O O-NP
  
It B-O B-S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
found B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
increases B-O B-VP_VBZ
, B-O B-COMMA
while B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
hormone-receptor B-O B-NP_NN
interactions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
hypertension B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
activated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
the B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
mineralocorticoid B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
grows B-O B-VP_VBZ
in B-O B-PP_IN
hypertensive B-O B-NP_JJ
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Still B-O B-S_ADVP_RB
" " B-O O-ADVP
a B-O B-NP_NP_DT
more B-O B-ADJP_RBR
essential B-O B-JJ
" " B-O O-ADJP
rise B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
receptors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O B-PP_O-NP
is B-O B-VP_VBZ
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
mid-age B-O B-NP_JJ
hypertensive B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
than B-O B-PP_IN
in B-O B-FRAG_PP_IN
elderly B-O B-NP_JJ
ones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_DT
development B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
functionally B-O B-NP_ADJP_RB
responsive B-O B-JJ
" " B-O O-ADJP
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
work B-O B-NN
" " B-O O-NP
reviewed B-O B-VP_VBN
in B-O B-NP_PP_IN
this B-O B-NP_DT
article B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
separates B-O B-VP_VBZ
T B-O B-NP_NN
cell B-O B-NN
development B-O B-NN
" " B-O O-NP
into B-O B-PP_IN
four B-O B-NP_CD
phases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
First B-O B-SINV_ADJP_JJ
" " B-O O-ADJP
is B-O B-VP_VBZ
" " B-O B-ADJP_O-VP
an B-O B-NP_NP_DT
expansion B-O B-NN
phase B-O B-NN
" " B-O O-NP
prior B-O B-PP_RB
to B-O B-TO
TCR B-O B-NP_NN
rearrangement B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
appears B-O B-S_NP_VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
correlated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-SINV
  
This B-O B-S_NP_DT
phase B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
occur B-O B-VP_VB
to B-O B-PP_TO
some B-O B-NP_DT
extent B-O B-NN
" " B-O O-NP
" " B-O O-PP
outside B-O B-ADVP_IN
of B-O B-PP_IN
the B-O B-NP_DT
thymus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
profound B-O B-JJ
T B-O B-NN
cell B-O B-NN
deficit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nude B-O B-NP_JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicates B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_DT
thymus B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
by B-O B-PP_IN
far B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-PP
the B-O B-NP_NP_DT
most B-O B-ADJP_RBS
potent B-O B-JJ
" " B-O O-ADJP
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
inducing B-O B-S_NP_VP_VBG
" " B-O B-NP_ADVP_O-S
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
even B-O B-SBAR_RB
if B-O B-IN
other B-O B-S_NP_JJ
sites B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
induce B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Second B-O B-SINV_ADJP_JJ
" " B-O O-ADJP
is B-O B-VP_VBZ
" " B-O B-ADJP_O-VP
a B-O B-NP_NP_DT
controlled B-O B-JJ
phase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TCR B-O B-NP_NN
gene B-O B-NN
rearrangement B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-SINV
  
The B-O B-S_NP_NP_DT
details B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
regulatory B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
selects B-O B-S_NP_VP_VBZ
particular B-O B-NP_NP_JJ
loci B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
still B-O B-ADVP_RB
" " B-O O-ADVP
not B-O B-RB
known B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_S_NP_PRP
" " B-O O-NP
seems B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
rearrangement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TCR B-O B-NN
gamma B-O B-NN
loci B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
gamma B-O B-NN
delta B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
not B-O B-RB
always B-O B-ADVP_RB
" " B-O O-ADVP
take B-O B-VP_VB
place B-O B-NP_NN
" " B-O O-NP
at B-O B-PP_IN
" " B-O B-NP_NP_ADJP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
it B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
not B-O B-RB
clear B-O B-ADJP_JJ
" " B-O O-ADJP
just B-O B-SBAR_WHADVP_RB
how B-O B-WRB
early B-O B-RB
" " B-O O-WHADVP
the B-O B-S_NP_DT
two B-O B-CD
lineages B-O B-NNS
" " B-O O-NP
diverge B-O B-VP_VBP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
TCR B-O B-NN
alpha B-O B-NN
beta B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
final B-O B-JJ
gene B-O B-NN
rearrangement B-O B-NN
events B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
rapid B-O B-NP_NP_JJ
proliferation B-O B-NN
" " B-O O-NP
and B-O B-CC
an B-O B-NP_NP_DT
interruption B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cellular B-O B-NP_JJ
response B-O B-NN
gene B-O B-NN
inducibility B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
conventional B-O B-NP_JJ
responsiveness B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
probably B-O B-ADVP_RB
" " B-O O-ADVP
caused B-O B-VP_VBN
by B-O B-NP_PP_IN
alterations B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
signaling B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
may B-O B-VP_MD
be B-O B-VP_VB
a B-O B-NP_NP_DT
manifestation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
physiological B-O B-JJ
state B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Third B-O B-SINV_ADJP_JJ
" " B-O O-ADJP
is B-O B-VP_VBZ
" " B-O B-ADJP_O-VP
the B-O B-NP_NP_DT
complex B-O B-JJ
process B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
selection B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-SINV
  
Whereas B-O B-S_SBAR_IN
peripheral B-O B-S_NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
undergo B-O B-VP_VB
forms B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
( B-O B-NP_NP_NP_LRB
) B-O B-PP_RRB
" " B-O O-NP
and B-O B-CC
( B-O B-NP_NP_LRB
) B-O B-PP_RRB
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
neither B-O B-S_NP_DT
" " B-O O-NP
is B-O B-VP_VBZ
exactly B-O B-NP_NP_ADJP_RB
the B-O B-DT
same B-O B-JJ
" " B-O O-ADJP
phenomenon B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
occurs B-O B-S_NP_VP_VBZ
in B-O B-PP_IN
the B-O B-NP_DT
thymic B-O B-JJ
cortex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Negative B-O B-S_S_NP_NP_JJ
selection B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
cortex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
a B-O B-NP_NP_DT
suicidal B-O B-JJ
inversion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
antigen B-O B-NP_NN
responsiveness B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
instead B-O B-S_PP_RB
of B-O B-IN
turning B-O B-S_NP_VP_VBG
on B-O B-PRT_IN
" " B-O O-PRT
IL-2 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
activated B-O B-VBN
cell B-O B-NN
" " B-O O-NP
destroys B-O B-VP_VBZ
its B-O B-NP_PRPP
own B-O B-JJ
chromatin B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
genes B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
need B-O B-S_NP_VP_VBP
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
yet B-O B-ADVP_RB
" " B-O O-ADVP
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
unquestionably B-O B-ADVP_RB
" " B-O O-ADVP
a B-O B-NP_NP_DT
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
interesting B-O B-ADJP_JJ
" " B-O O-ADJP
that B-O B-SBAR_IN
in B-O B-S_PP_IN
humans B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
rats B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
cortical B-O B-NP_NP_JJ
thymocytes B-O B-NNS
" " B-O O-NP
undergoing B-O B-VP_VBG
negative B-O B-NP_JJ
selection B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
can B-O B-VP_MD
still B-O B-VP_VP_VP_ADVP_RB
" " B-O O-ADVP
induce B-O B-VP_VB
" " B-O B-NP_O-VP
and B-O B-CC
even B-O B-VP_ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
" " B-O B-VP_O-VP
" " B-O O-VP
, B-O B-COMMA
if B-O B-SBAR_IN
exogenous B-O B-S_NP_JJ
IL-2 B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Perhaps B-O B-S_ADVP_RB
" " B-O O-ADVP
murine B-O B-NP_JJ
thymocytes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
denied B-O B-VP_VBN
this B-O B-NP_NP_NP_DT
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
rescue B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
because B-O B-SBAR_SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
shut B-O B-VP_VBD
off B-O B-PRT_RP
" " B-O O-PRT
IL-2R B-O B-NP_NN
beta B-O B-NN
chain B-O B-NN
expression B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
an B-O B-NP_DT
earlier B-O B-JJR
stage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
or B-O B-CC
because B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
uncommonly B-O B-ADJP_RB
deficient B-O B-NP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
( B-O B-PRN_LRB
cf. B-O B-S_NP_VP_VBP
Sentman B-O B-NP_NP_NNP
et B-O B-FW
al. B-O B-FW
, B-O B-COMMA
1991 B-O B-CD
" " B-O O-NP
; B-O B-COLON
Strasser B-O B-NP_NNP
et B-O B-FW
al. B-O B-FW
, B-O B-COMMA
1991 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Even B-O B-S_ADVP_RB
so B-O B-RB
" " B-O O-ADVP
, B-O B-COMMA
medullary B-O B-NP_JJ
thymocytes B-O B-NNS
" " B-O O-NP
remain B-O B-VP_VBP
at B-O B-ADJP_ADVP_ADVP_IN
least B-O B-JJS
" " B-O O-ADVP
partially B-O B-RB
" " B-O O-ADVP
susceptible B-O B-JJ
to B-O B-PP_TO
negative B-O B-NP_JJ
selection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
even B-O B-SBAR_RB
as B-O B-IN
they B-O B-S_NP_PRP
" " B-O O-NP
continue B-O B-VP_VBP
to B-O B-S_NP_VP_TO
mature B-O B-VP_VB
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Estrogen B-O B-NP_NP_NP_NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
effects B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
danazol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
their B-O B-NP_NP_PRPP
sites B-O B-NNS
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
1 B-O B-S_LST_LS
. B-O B-PERIOD
" " B-O O-LST
This B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
designed B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
investigate B-O B-VP_VB
the B-O B-NP_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
on B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
2 B-O B-S_LST_LS
. B-O B-PERIOD
" " B-O O-LST
These B-O B-NP_NP_DT
two B-O B-CD
types B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
estrogen B-O B-NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
existed B-O B-VP_VBD
in B-O B-PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
3 B-O B-S_LST_LS
. B-O B-PERIOD
" " B-O O-LST
Danazol B-O B-NP_NN
" " B-O O-NP
bound B-O B-VP_VP_VBD
to B-O B-PP_TO
these B-O B-NP_DT
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
high B-O B-NP_NP_JJ
concentration B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
, B-O B-NP_NP_UCP_NP_COMMA
serum B-O B-ADJP_NN
concentration B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
danazol B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
decreased B-O B-VP_VBD
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
4 B-O B-S_LST_LS
. B-O B-PERIOD
" " B-O O-LST
It B-O B-NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
suggested B-O B-VP_VBN
that B-O B-SBAR_IN
danazol B-O B-S_NP_NN
" " B-O O-NP
has B-O B-VP_VBZ
an B-O B-NP_NP_DT
anti-estrogenic B-O B-JJ
action B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
through B-O B-PP_IN
the B-O B-NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
as B-O B-SBAR_IN
seen B-O B-S_NP_VP_VBN
" " B-O B-NP_PP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-NP_LRB
Mechanism B-O B-NP_NN
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
steroid B-O B-NP_NN
hormones B-O B-NNS
. B-O B-PERIOD
I B-O B-LS
. B-O B-PERIOD
Estrogens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
] B-O B-RRB
" " B-O O-NP
  
The B-O B-S_S_NP_DT
steroid B-O B-NN
hormone B-O B-NN
" " B-O O-NP
are B-O B-VP_VBP
very B-O B-NP_ADJP_RB
versatile B-O B-JJ
" " B-O O-ADJP
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
although B-O B-S_SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
are B-O B-VP_VBP
related B-O B-ADJP_JJ
" " B-O O-ADJP
among B-O B-PP_IN
them B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
their B-O B-NP_PRPP
chemical B-O B-JJ
structure B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
they B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
very B-O B-NP_NP_ADJP_RB
diverse B-O B-JJ
" " B-O O-ADJP
functions B-O B-NNS
" " B-O O-NP
and B-O B-CC
including B-O B-PP_VBG
antagonic B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Their B-O B-S_NP_PRPP
action B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
completely B-O B-ADVP_RB
" " B-O O-ADVP
cleared B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
estrogens B-O B-NNS
" " B-O O-NP
participate B-O B-VP_VBP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
practically B-O B-NP_NP_QP_RB
all B-O B-PDT
" " B-O O-QP
the B-O B-DT
reproductive B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
sexual B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
events B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
female B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
although B-O B-SBAR_IN
the B-O B-S_S_NP_NP_DT
intracellular B-O B-JJ
actions B-O B-NNS
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
they B-O B-S_NP_PRP
" " B-O O-NP
take B-O B-VP_VBP
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
well B-O B-ADVP_RB
" " B-O O-ADVP
known B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_DT
proposed B-O B-JJ
models B-O B-NNS
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
adequately B-O B-ADVP_RB
" " B-O O-ADVP
satisfy B-O B-VP_VB
the B-O B-NP_DT
questions B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Currently B-O B-S_ADVP_RB
" " B-O O-ADVP
it B-O B-NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
accepted B-O B-VP_VBN
the B-O B-NP_NP_DT
existence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
cytoplasmic B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and/or B-O B-CC
nuclear B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
without B-O B-PP_IN
explaining B-O B-S_NP_VP_VBG
satisfactorily B-O B-ADVP_RB
" " B-O O-ADVP
how B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
hormones B-O B-NNS
" " B-O O-NP
come B-O B-VP_VBN
" " B-O B-PP_ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
endocrine B-O B-JJ
events B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
rapidly B-O B-ADVP_ADVP_RB
" " B-O O-ADVP
" " B-O B-PRN_O-ADVP
expressed B-O B-VP_VBN
( B-O B-NP_PRN_LRB
seconds B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
are B-O B-VP_VBP
due B-O B-PP_JJ
to B-O B-TO
a B-O B-NP_NP_DT
possible B-O B-JJ
interaction B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
cellular B-O B-NP_JJ
membrane B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
purpose B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
review B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
analyze B-O B-VP_VP_VP_VB
" " B-O B-NP_O-VP
and B-O B-CC
concilliate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-VP
the B-O B-NP_NP_DT
reported B-O B-VBN
data B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Stable B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transdominant B-O B-NP_JJ
Rev B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibits B-O B-VP_VBZ
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
Rev B-O B-NN
protein B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_PP_IN
viral B-O B-NP_NP_JJ
structural B-O B-JJ
protein B-O B-NN
expression B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Gag B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Pol B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Env B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
, B-O B-COMMA
hence B-O B-RB
, B-O B-COMMA
for B-O B-PP_IN
viral B-O B-NP_JJ
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
transient B-O B-NP_JJ
transfection B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
mutant B-O B-NP_NP_JJ
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Rev B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-SBAR_O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
identified B-O B-VP_VBN
that B-O B-NP_SBAR_WHNP_WDT
" " B-O O-WHNP
inhibit B-O B-S_NP_VP_VP_VBP
wild-type B-O B-NP_JJ
Rev B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
therefore B-O B-RB
suppress B-O B-VP_VBP
viral B-O B-NP_JJ
replication B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
such B-O B-S_NP_JJ
transdominant B-O B-JJ
Rev B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
could B-O B-VP_MD
provide B-O B-VP_VB
without B-O B-NP_NP_PP_PP_IN
" " B-O B-S_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
T B-O B-NP_NN
leukemia B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
stably B-O B-ADVP_RB
" " B-O O-ADVP
transduced B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
retroviral B-O B-JJ
vector B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
a B-O B-NP_NP_NP_DT
transdominant B-O B-JJ
mutant B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
M10 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
While B-O B-S_SBAR_IN
all B-O B-S_NP_PDT
the B-O B-DT
M10-expressing B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
remained B-O B-VP_VBD
infectable B-O B-ADJP_JJ
by B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
these B-O B-NP_DT
same B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
support B-O B-VP_VB
a B-O B-NP_DT
productive B-O B-JJ
replication B-O B-NN
cycle B-O B-NN
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
infected B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
two B-O B-NP_QP_CD
out B-O B-IN
of B-O B-IN
three B-O B-CD
" " B-O O-QP
M10-expressing B-O B-JJ
CEM B-O B-NN
clones B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADJP_RB
resistant B-O B-JJ
to B-O B-PP_TO
highly B-O B-NP_NP_ADJP_RB
productive B-O B-JJ
" " B-O O-ADJP
infection B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
a B-O B-NP_DT
heterogeneous B-O B-JJ
HIV-1 B-O B-NN
pool B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
M10 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
affect B-O B-VP_VB
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
kappa B-O B-NN
B B-O B-NN
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
or B-O B-CC
Tat B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Importantly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
constitutive B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Rev B-O B-NP_NN
M10 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
alter B-O B-VP_VB
the B-O B-NP_NP_DT
secretion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interleukin B-O B-NP_NN
2 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
mitogen B-O B-NP_NP_NN
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
EL-4 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
Jurkat B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
stably B-O B-VP_ADVP_RB
" " B-O O-ADVP
expressing B-O B-VBG
a B-O B-NP_DT
transdominant B-O B-JJ
Rev B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
the B-O B-DT
absence B-O B-NN
of B-O B-IN
any B-O B-NP_NP_DT
deleterious B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
such B-O B-S_NP_PDT
a B-O B-DT
strategy B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
provide B-O B-VP_VB
a B-O B-NP_DT
therapeutic B-O B-JJ
effect B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Glucocorticoid B-O B-NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
lupus B-O B-NP_NN
nephritis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
relationship B-O B-NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
receptor B-O B-NP_NP_NP_NN
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
effect B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
clinical B-O B-JJ
significance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
receptor B-O B-NN
determination B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
20 B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
who B-O B-SBAR_WHNP_WP
" " B-O O-WHNP
" " B-O B-S_NP_ADVP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Glucocorticoid B-O B-S_NP_NP_NN
receptor B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
MNL B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
these B-O B-NP_DT
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
comparable B-O B-ADJP_JJ
with B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_CC
other B-O B-NP_NP_JJ
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
healthy B-O B-NP_JJ
persons B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Improvement B-O B-S_NP_NP_NN
" " B-O O-NP
in B-O B-PP_PP_IN
urinary B-O B-NP_JJ
protein B-O B-NN
excretion B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
disease B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
scored B-O B-VP_VBN
according B-O B-NP_PP_VBG
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
closely B-O B-ADVP_RB
" " B-O O-ADVP
related B-O B-VP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
glucocorticoid B-O B-NN
receptor B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
MNL B-O B-NP_NP_NN
" " B-O O-NP
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_DT
corresponding B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
summary B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
glucocorticoid B-O B-NP_NP_NN
receptor B-O B-NN
determination B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
lupus B-O B-NP_NN
nephritis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
a B-O B-NP_NP_DT
predictive B-O B-JJ
clue B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
assessing B-O B-S_NP_VP_VBG
responsiveness B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Selection B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
optimal B-O B-NP_JJ
kappa B-O B-ADJP_NN
B/Rel B-O B-NN
" " B-O O-ADJP
DNA-binding B-O B-JJ
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
interaction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_NP_DT
subunits B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
transcriptional B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
p50 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
subunits B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
transcription B-O B-NN
factor B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
revealed B-O B-VP_VBN
that B-O B-SBAR_IN
both B-O B-S_NP_DT
proteins B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
interact B-O B-VP_VB
with B-O B-PP_IN
related B-O B-NP_JJ
DNA B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
formation B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
product B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
proto-oncogene B-O B-NN
c-rel B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
bind B-O B-VP_VB
to B-O B-PP_TO
similar B-O B-NP_JJ
DNA B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_PP_IN
itself B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
as B-O B-PP_IN
a B-O B-NP_NP_DT
heterodimer B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
p50 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-S_S_NP_DT
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
used B-O B-VP_VBN
a B-O B-NP_NP_DT
limited B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
known B-O B-NP_JJ
kappa B-O B-NN
B B-O B-NN
DNA B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_NP_DT
question B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
optimal B-O B-JJ
DNA B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
preferred B-O B-VP_VBN
by B-O B-NP_PP_IN
each B-O B-NP_DT
homodimer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
not B-O B-RB
been B-O B-VP_VBN
addressed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
purified B-O B-NP_VBN
recombinant B-O B-JJ
p50 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p65 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
c-Rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
optimal B-O B-NP_JJ
DNA-binding B-O B-JJ
motifs B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
selected B-O B-VP_VBN
from B-O B-NP_PP_IN
a B-O B-NP_NP_DT
pool B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
random B-O B-NP_JJ
oligonucleotides B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Alignment B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
selected B-O B-VBN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
allowed B-O B-VP_VBD
us B-O B-S_NP_PRP
" " B-O O-NP
to B-O B-VP_TO
predict B-O B-VP_VB
a B-O B-NP_NP_DT
consensus B-O B-NN
sequence B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
DNA-protein B-O B-S_NP_NP_NN
binding B-O B-NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
selected B-O B-VBN
DNA B-O B-NN
sequences B-O B-VBZ
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
sequence B-O B-NP_NP_NN
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Contrary B-O B-S_PP_JJ
to B-O B-TO
previous B-O B-NP_JJ
assumptions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
that B-O B-SBAR_IN
p65 B-O B-S_NP_NN
homodimers B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
interact B-O B-VP_VB
with B-O B-PP_IN
a B-O B-NP_NP_DT
subset B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Differential B-O B-S_NP_JJ
binding B-O B-NN
affinities B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
obtained B-O B-VP_VBN
with B-O B-NP_PP_IN
p50- B-O B-NP_ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
c-Rel-selected B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
either B-O B-NP_NP_CC
a B-O B-DT
p50- B-O B-ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
or B-O B-CC
"p65- selected" B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
kappa B-O B-NN
B B-O B-NN
motif B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
displayed B-O B-S_NP_VP_VBD
differential B-O B-NP_JJ
binding B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
respect B-O B-NN
to B-O B-TO
the B-O B-NP_DT
other B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
little B-O B-NP_QP_JJ
to B-O B-TO
no B-O B-DT
" " B-O O-QP
binding B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
heterodimeric B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similarly B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
transfection B-O B-NP_NP_NN
experiments B-O B-NNS
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
the B-O B-S_NP_DT
selective B-O B-JJ
kappa B-O B-NN
B B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_S_NP_VP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
p65- B-O B-ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
p50-selected B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
motifs B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
activated B-O B-VP_VBN
only B-O B-NP_PP_RB
in B-O B-IN
the B-O B-DT
presence B-O B-NN
of B-O B-IN
p65 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
p50/65 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
expression B-O B-NN
vectors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
neither B-O B-S_NP_DT
" " B-O O-NP
demonstrated B-O B-VP_VBD
a B-O B-NP_NP_DT
significant B-O B-JJ
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
stimuli B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
induce B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VP_VBP
that B-O B-SBAR_IN
interaction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_NP_DT
subunits B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
with B-O B-PP_IN
DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
transcriptional B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
individual B-O B-JJ
rel-related B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
will B-O B-VP_MD
differ B-O B-VP_VB
dramatically B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
depending B-O B-PP_VBG
on B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_DT
candidate B-O B-NN
oncoprotein B-O B-NN
Bcl-3 B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
antagonist B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p50/NF-kappa B-O B-NP_ADJP_NN
B-mediated B-O B-JJ
" " B-O O-ADJP
inhibition B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
candidate B-O B-NN
oncogene B-O B-NN
bcl-3 B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
discovered B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_NP_DT
translocation B-O B-NN
" " B-O O-NP
into B-O B-PP_IN
the B-O B-NP_DT
immunoglobulin B-O B-NN
alpha-locus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
some B-O B-NP_NP_DT
cases B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
B-cell B-O B-NP_NN
chronic B-O B-JJ
lymphocytic B-O B-JJ
leukaemias B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
protein B-O B-NN
Bcl-3 B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
seven B-O B-NP_CD
so-called B-O B-JJ
ankyrin B-O B-NN
repeats B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_S_NP_JJ
repeat B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
found B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
diverse B-O B-NP_JJ
regulatory B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
but B-O B-CC
the B-O B-S_NP_NP_DT
motifs B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Bcl-3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
most B-O B-ADJP_ADVP_RBS
closely B-O B-RB
" " B-O O-ADVP
related B-O B-JJ
to B-O B-PP_TO
those B-O B-NP_NP_DT
" " B-O O-NP
found B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_S_NP_DT
biological B-O B-JJ
function B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
yet B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
described B-O B-VP_VBN
for B-O B-NP_PP_IN
Bcl-3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
noted B-O B-VP_VBN
recently B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
Bcl-3 B-O B-S_NP_NN
" " B-O O-NP
interferes B-O B-VP_VBZ
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
Bcl-3 B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
aid B-O B-VP_VB
kappa B-O B-NP_ADJP_NN
B B-O B-NN
site-dependent B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
" " B-O O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
by B-O B-PP_IN
counteracting B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Bcl-3 B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
therefore B-O B-ADVP_RB
" " B-O O-ADVP
aid B-O B-VP_VB
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
select B-O B-NP_NP_JJ
NF-kappa B-O B-ADJP_NN
B-regulated B-O B-JJ
" " B-O O-ADJP
genes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_NP_DT
microtitre B-O B-NN
assay B-O B-NN
system B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
decreased B-O B-NP_NP_VBN
receptor B-O B-NN
concentration B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
myocardial B-O B-NP_JJ
infarction B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
A B-O B-S_NP_NP_DT
major B-O B-JJ
difficulty B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
determination B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_DT
very B-O B-ADJP_RB
complicated B-O B-JJ
" " B-O O-ADJP
assay B-O B-NN
procedure B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
describe B-O B-VP_VBP
a B-O B-NP_NP_DT
microtitre B-O B-NN
assay B-O B-NN
system B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
a B-O B-NP_DT
whole-cell B-O B-JJ
competitive B-O B-JJ
binding B-O B-NN
radioassay B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
using B-O B-S_NP_VP_VBG
[3H]-dexamethasone B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_IN
radioligand B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
modification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
previously B-O B-ADJP_RB
described B-O B-VBN
" " B-O O-ADJP
protocol B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
simplifies B-O B-VP_VP_VP_VP_VBZ
" " B-O B-NP_O-VP
and B-O B-CC
reduces B-O B-VP_VBZ
" " B-O B-NP_O-VP
" " B-O O-VP
laboratory B-O B-NP_NN
work B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
allows B-O B-VP_VBZ
assay B-O B-S_NP_NN
reproducibility B-O B-NN
" " B-O O-NP
to B-O B-VP_TO
be B-O B-VP_VB
controlled B-O B-VP_VBN
more B-O B-NP_ADVP_RBR
reliably B-O B-RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_S_NP_VP_ADVP_RB
" " B-O O-ADVP
enabled B-O B-VBN
to B-O B-S_NP_VP_TO
perform B-O B-VP_VB
the B-O B-NP_DT
test B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
multiple B-O B-NP_JJ
blood B-O B-NN
samples B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
parallel B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
cardiac B-O B-NP_JJ
infarction B-O B-NN
patients B-O B-NNS
" " B-O O-NP
over B-O B-PP_IN
a B-O B-NP_DT
12-day B-O B-JJ
period B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
test B-O B-VP_VB
if B-O B-SBAR_IN
glucocorticoid B-O B-S_NP_NN
receptor B-O B-NN
binding B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
altered B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_S_PP_IN
the B-O B-NP_NP_DT
first B-O B-JJ
day B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
capacity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
decreased B-O B-VP_VBN
without B-O B-NP_PP_IN
alteration B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
receptor-ligand B-O B-JJ
affinity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
on B-O B-S_PP_IN
days B-O B-NP_NNS
4 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
12 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
receptor B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
normal B-O B-ADJP_JJ
" " B-O O-ADJP
again B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
result B-O B-NN
" " B-O O-NP
fits B-O B-VP_VBZ
well B-O B-ADVP_RB
" " B-O O-ADVP
into B-O B-PP_IN
the B-O B-NP_NP_DT
general B-O B-JJ
observation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
stress-induced B-O B-NP_NP_JJ
down-regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immune B-O B-NP_JJ
responses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
monocytic B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
okadaic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
present B-O B-JJ
work B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
okadaic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
type B-O B-NP_NN
protein B-O B-NP_NN
phosphatases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
monocytic B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
okadaic B-O B-S_NP_JJ
acid B-O B-NN
treatment B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
monocytic B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
transient B-O B-NP_NP_JJ
increases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
c-jun B-O B-NP_NP_NN
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_NP_JJ
effects B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
obtained B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_DT
c-fos B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Run-on B-O B-S_NP_JJ
analysis B-O B-NN
" " B-O O-NP
demonstrated B-O B-VP_VBD
detectable B-O B-UCP_NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
U-937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
that B-O B-SBAR_IN
this B-O B-S_NP_DT
rate B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
increased B-O B-VP_VBN
approximately B-O B-NP_ADVP_RB
40-fold B-O B-RB
" " B-O O-ADVP
following B-O B-PP_VBG
okadaic B-O B-NP_JJ
acid B-O B-NN
exposure B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
c-jun B-O B-S_S_NP_NN
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
superinduced B-O B-VP_VBN
in B-O B-NP_PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
treated B-O B-VP_VBN
with B-O B-NP_PP_IN
both B-O B-NP_CC
and B-O B-NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
little B-O B-NP_NP_JJ
, B-O B-PRN_COMMA
if B-O B-SBAR_IN
any B-O B-FRAG_ADJP_DT
" " B-O O-ADJP
" " B-O O-FRAG
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-PRN
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
okadaic B-O B-NP_ADJP_JJ
acid-induced B-O B-JJ
" " B-O O-ADJP
c-jun B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
half-life B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
similar B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
45-50 B-O B-NP_QP_CD
" " B-O O-QP
min B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
in B-O B-PP_IN
both B-O B-NP_ADJP_CC
untreated B-O B-ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
okadaic B-O B-ADJP_JJ
acid-induced B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
both B-O B-NP_DT
okadaic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
and B-O B-CC
cycloheximide B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
stabilization B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
t B-O B-S_NP_NN
1/2 B-O B-CD
" " B-O O-NP
= B-O B-VP_JJ
" " B-O B-NP_O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
these B-O B-NP_DT
findings B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
okadaic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
controlled B-O B-VP_VBN
primarily B-O B-NP_ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
a B-O B-NP_DT
transcriptional B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
previous B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_DT
c-jun B-O B-NN
gene B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
autoinduced B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
studied B-O B-VP_VBD
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
promoter B-O B-NN
( B-O B-PRN_LRB
positions B-O B-NP_NNS
-132/+170 B-O B-NP_NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
-reporter B-O B-JJ
gene B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_PP_PP_IN
" " B-O B-NP_O-PP
and B-O B-CC
without B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-PP
a B-O B-NP_DT
mutated B-O B-VBN
AP-1 B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LRB
ABSTRACT B-O B-NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-S
Activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
interleukin B-O B-NP_NN
2 B-O B-CD
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
interleukin B-O B-S_NP_NP_NN
2 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
acts B-O B-VP_VBZ
on B-O B-PP_IN
human B-O B-NP_JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
enhancing B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similarly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
IL-2 B-O B-NP_NN
" " B-O O-NP
activates B-O B-VP_VBZ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
the B-O B-NP_DT
human B-O B-JJ
monocytic B-O B-JJ
cell B-O B-NN
line B-O B-NN
U B-O B-NN
937 B-O B-CD
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
resting B-O B-NP_VBG
human B-O B-JJ
T-cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
detectable B-O B-ADJP_JJ
" " B-O O-ADJP
within B-O B-PP_IN
15 B-O B-NP_CD
min B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
peaks B-O B-VP_VBZ
1 B-O B-PP_NP_CD
h B-O B-NN
" " B-O O-NP
after B-O B-IN
exposure B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Enhanced B-O B-S_NP_VBN
NF-kappa B-O B-NN
B B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
followed B-O B-VP_VBN
by B-O B-NP_PP_IN
functional B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
in B-O B-WHPP_IN
that B-O B-SBAR_SBAR_WHNP_IN
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
and B-O B-CC
that B-O B-SBAR_WHNP_IN
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-SBAR
" " B-O O-WHPP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
IL-2 B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
capable B-O B-ADJP_JJ
of B-O B-PP_IN
increasing B-O B-S_NP_VP_VBG
transcript B-O B-NP_NP_NN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
mRNA B-O B-S_NP_NP_NN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
p65 B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
remained B-O B-VP_VBD
unchanged B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Single B-O B-NP_NP_JJ
point B-O B-NN
estimation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_PP_IN
normal B-O B-NP_JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
of B-O B-PP_IN
children B-O B-NP_NP_NNS
" " B-O O-NP
under B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
A B-O B-S_NP_NP_DT
single B-O B-JJ
point B-O B-NN
assay B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
GR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
based B-O B-PP_VBN
on B-O B-PP_IN
the B-O B-NP_NP_DT
measurement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_JJ
dexamethasone B-O B-NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
developed B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
compared B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_DT
common B-O B-JJ
multi-point B-O B-JJ
Scatchard B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
assay B-O B-NN
conditions B-O B-NN
" " B-O O-NP
- B-O B-COLON
concentration B-O B-NP_NP_NP_NN
of B-O B-PP_IN
the B-O B-NP_DT
ligand B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
20 B-O B-NP_CD
nmol/l B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
incubation B-O B-NP_NN
time B-O B-NN
2 B-O B-CD
h B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
cell B-O B-NN
count B-O B-NN
2-6 B-O B-QP_CD
" " B-O O-QP
mil. B-O B-CD
cells/tube B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
assay B-O B-NN
volume B-O B-NN
0.25 B-O B-CD
ml B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
optimal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_DT
attempt B-O B-NN
" " B-O B-S_O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
undertaken B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
use B-O B-VP_VB
a B-O B-NP_DT
cell B-O B-NN
harvester B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
separation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
from B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Though B-O B-S_SBAR_IN
specifically B-O B-S_NP_NP_NP_ADJP_RB
bound B-O B-VBN
" " B-O O-ADJP
dexamethasone B-O B-NN
" " B-O O-NP
measured B-O B-VP_VBN
by B-O B-NP_PP_IN
whole-cell B-O B-NP_JJ
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
and B-O B-CC
that B-O B-NP_NP_DT
" " B-O O-NP
using B-O B-VP_VBG
cell B-O B-NP_NN
harvester B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
correlated B-O B-VP_VBD
well B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
almost B-O B-NP_NP_ADJP_PP_RB
by B-O B-IN
one B-O B-NP_CD
order B-O B-NN
" " B-O O-NP
" " B-O O-PP
lower B-O B-JJR
" " B-O O-ADJP
values B-O B-NNS
" " B-O O-NP
obtained B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
latter B-O B-JJ
method B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
render B-O B-VP_VBP
it B-O B-S_NP_PRP
" " B-O O-NP
non-applicable B-O B-ADJP_JJ
for B-O B-PP_IN
receptor B-O B-NP_NN
quantitation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
results B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
9 B-O B-NP_CD
healthy B-O B-JJ
volunteers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
average B-O B-FRAG_NP_JJ
GR B-O B-NN
concentration B-O B-NN
7131 B-O B-NP_QP_CD
+/- B-O B-CC
1256 B-O B-CD
" " B-O O-QP
sites/cell B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
correlated B-O B-VP_VBD
excellently B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
obtained B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
Scatchard B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
single B-O B-JJ
point B-O B-NN
assay B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
also B-O B-ADVP_RB
" " B-O O-ADVP
applied B-O B-VP_VBN
for B-O B-NP_PP_IN
determination B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
GH B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
average B-O B-JJ
values B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
healthy B-O B-NP_JJ
volunteers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
differ B-O B-VP_VB
significantly B-O B-ADVP_RB
" " B-O O-ADVP
from B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
found B-O B-VP_VBN
in B-O B-NP_PP_IN
these B-O B-NP_DT
children B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
though B-O B-SBAR_RB
much B-O B-S_NP_ADJP_RB
broader B-O B-JJR
" " B-O O-ADJP
range B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
in B-O B-NP_PP_IN
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_NP_DT
novel B-O B-JJ
B B-O B-ADJP_NN
cell-derived B-O B-JJ
" " B-O O-ADJP
coactivator B-O B-NN
" " B-O O-NP
potentiates B-O B-VP_VBZ
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immunoglobulin B-O B-NP_NN
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
octamer-binding B-O B-NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
novel B-O B-JJ
B B-O B-ADJP_NN
cell-restricted B-O B-JJ
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
, B-O B-COMMA
required B-O B-VP_VBN
for B-O B-NP_PP_IN
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
octamer/Oct-dependent B-O B-NP_JJ
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
an B-O B-NP_DT
immunoglobulin B-O B-NP_NP_NN
heavy B-O B-JJ
chain B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
an B-O B-NP_NP_DT
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
system B-O B-NN
" " B-O O-NP
consisting B-O B-VP_VBG
of B-O B-PP_IN
extracts B-O B-NP_NP_ADJP_NNS
" " B-O O-NP
complemented B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
factor B-O B-NN
" " B-O O-NP
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
this B-O B-NP_DT
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
was B-O B-VP_VBD
designated B-O B-VP_VBN
Oct B-O B-S_NP_NP_NP_NP_NN
coactivator B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
OCA-B B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
OCA-B B-O B-S_NP_NN
" " B-O O-NP
stimulates B-O B-VP_VP_VBZ
the B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
an B-O B-NP_DT
IgH B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
conjunction B-O B-NN
with B-O B-IN
either B-O B-NP_CC
Oct-1 B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CC
shows B-O B-VP_VBZ
no B-O B-NP_NP_DT
significant B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_NP_DT
octamer/Oct-dependent B-O B-JJ
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
histone B-O B-ADJP_NN
H2B B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
promoters B-O B-NP_ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
our B-O B-NP_PRPP
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
OCA-B B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
" " B-O B-ADJP_ADJP_NP_ADJP_O-ADJP
, B-O B-COMMA
" " B-O B-ADJP_NP_ADJP_O-ADJP
, B-O B-COMMA
and B-O B-CC
factor-specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
coactivator B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
OCA-B B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
a B-O B-NP_NP_DT
major B-O B-JJ
determinant B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
light B-O B-NN
of B-O B-IN
the B-O B-NP_NP_DT
evidence B-O B-NN
" " B-O O-NP
showing B-O B-VP_VBG
physical B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
functional B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
interactions B-O B-NNS
" " B-O O-NP
between B-O B-PP_IN
Oct B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
and B-O B-CC
OCA-B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
propose B-O B-VP_VP_VBP
a B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
OCA-B B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
discuss B-O B-VP_VBP
the B-O B-NP_NP_DT
implications B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
OCA-B B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_JJ
tissue-specific B-O B-JJ
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
tumor B-O B-NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
promoter B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
macrophage B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
T B-O B-NP_NN
cell B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
B B-O B-NP_NN
cell B-O B-NN
" " B-O O-NP
" " B-O O-NP
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
1311-base B-O B-ADJP_JJ
pair B-O B-NN
" " B-O O-ADJP
human B-O B-JJ
tumor B-O B-NN
necrosis B-O B-NN
factor B-O B-NN
( B-O B-LRB
TNF B-O B-NN
) B-O B-RRB
alpha B-O B-NN
promoter B-O B-NN
region B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
fused B-O B-VP_VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
luciferase B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
Luc B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
studied B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_DT
transient B-O B-JJ
transfection B-O B-NN
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
three B-O B-NP_NP_CD
TNF B-O B-NN
producing B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
U937 B-O B-NN
macrophage B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
MLA B-O B-NN
144 B-O B-CD
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_DT
729-6 B-O B-CD
B B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
full B-O B-JJ
length B-O B-NN
promoter B-O B-NN
construct B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
phorbol B-O B-NP_NP_NN
13-myristate B-O B-NN
acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
each B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
5'-truncations B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
several B-O B-NP_NP_JJ
peaks B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
basal B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
PMA B-O B-ADJP_NN
induced B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
suggesting B-O B-VP_VBG
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_JJ
positive B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
negative B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
PMA B-O B-NN
responsive B-O B-JJ
element B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
localized B-O B-VP_JJ
to B-O B-NP_PP_TO
a B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
-95 B-O B-NP_NP_NP_CD
" " B-O O-NP
and B-O B-CC
-36 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
bp B-O B-NN
" " B-O O-NP
" " B-O O-PP
relative B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_DT
transcription B-O B-NN
start B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Within B-O B-S_PP_IN
this B-O B-NP_DT
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
single B-O B-NP_JJ
AP-2- B-O B-ADJP_ADJP_ADJP_NN
" " B-O O-ADJP
and B-O B-CC
"AP-1- like" B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-ADJP
consensus B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
noted B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
AP-2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
sites B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
each B-O B-DT
modified B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_DT
double B-O B-JJ
point B-O B-NN
mutation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
modest B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
20-50 B-O B-NP_QP_CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
reduction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
TNF B-O B-NP_NN
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
AP-2 B-O B-NN
site B-O B-NN
mutation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
mutation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
AP-1 B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
diminished B-O B-VP_VBD
both B-O B-NP_CC
the B-O B-DT
basal B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
PMA-activated B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Also B-O B-S_ADVP_RB
" " B-O O-ADVP
co-transfections B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
wild-type B-O B-JJ
promoter B-O B-NN
construct B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
an B-O B-NP_DT
AP-1/c-jun B-O B-NN
expression B-O B-NN
vector B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
augmented B-O B-NP_JJ
basal B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
PMA-induced B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Redox B-O B-S_NP_NP_NN
status B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
influences B-O B-VP_VBZ
constitutive B-O B-NP_NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
induced B-O B-ADJP_VBN
" " B-O O-ADJP
" " B-O O-ADJP
NF-kappa B-O B-NN
B B-O B-NN
translocation B-O B-NN
" " B-O O-NP
and B-O B-CC
HIV B-O B-NP_NN
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-UCP_NP_NN
" " B-O O-NP
and B-O B-CC
monocytic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-UCP
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
tested B-O B-VP_VBN
the B-O B-NP_DT
hypothesis B-O B-NN
that B-O B-SBAR_IN
cellular B-O B-S_NP_NP_JJ
activation B-O B-NN
events B-O B-NNS
" " B-O O-NP
occurring B-O B-VP_VP_VBG
and B-O B-PP_CC
mediated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-NP
are B-O B-VP_VBP
dependent B-O B-ADJP_JJ
upon B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
used B-O B-VP_VBD
phenolic B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
lipid-soluble B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
chain-breaking B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
antioxidants B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
butylated B-O B-NP_NP_NP_VBN
hydroxyanisole B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
BHA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
nordihydroquairetic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
alpha-tocopherol B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
vitamin B-O B-NP_NN
E B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PRN
" " B-O O-NP
to B-O B-S_NP_VP_TO
show B-O B-VP_VB
that B-O B-SBAR_IN
peroxyl B-O B-S_NP_NP_JJ
radical B-O B-JJ
scavenging B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
blocks B-O B-VP_VBZ
the B-O B-NP_DT
functions B-O B-NNS
" " B-O O-NP
depending B-O B-PP_VBG
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
BHA B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
suppress B-O B-VP_VB
, B-O B-NP_NP_ADJP_CONJP_ADJP_COMMA
, B-O B-CONJP_ADJP_COMMA
" " B-O O-ADJP
HIV-enhancer B-O B-JJ
activity B-O B-NN
" " B-O O-NP
concomitant B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
true B-O B-ADJP_JJ
" " B-O O-ADJP
for B-O B-PP_IN
KBF B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
p50 B-O B-NP_NN
homodimer B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Secretion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
TNF B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
product B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
another B-O B-NP_DT
NF-kappa B-O B-ADJP_NN
B-dependent B-O B-JJ
" " B-O O-ADJP
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
abolished B-O B-VP_VBN
by B-O B-NP_PP_IN
BHA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
PMA-stimulated B-O B-NP_JJ
U937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
anti-oxidative B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
BHA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
content B-O B-NP_NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
TNF B-O B-S_NP_NP_NN
stimulation B-O B-NN
" " B-O O-NP
itself B-O B-NP_PRP
" " B-O O-NP
" " B-O O-NP
barely B-O B-ADVP_RB
" " B-O O-ADVP
modified B-O B-VP_VBD
the B-O B-NP_DT
cellular B-O B-JJ
thiol B-O B-NN
level B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Oxidative B-O B-S_NP_NP_JJ
stress B-O B-NN
" " B-O O-NP
obtained B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
H2O2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_NP_DT
culture B-O B-NN
medium B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
could B-O B-VP_MD
not B-O B-RB
by B-O B-PP_IN
itself B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
induce B-O B-VP_VB
NF-kappa B-O B-NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
observations B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
TNF B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
lead B-O B-VP_VB
to B-O B-PP_TO
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
through B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Rather B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
TNF B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
exert B-O B-VP_VB
their B-O B-NP_PRPP
effect B-O B-NN
" " B-O O-NP
only B-O B-SBAR_RB
if B-O B-IN
cells B-O B-S_NP_NNS
" " B-O O-NP
are B-O B-VP_VBP
in B-O B-PP_IN
an B-O B-NP_DT
appropriate B-O B-JJ
redox B-O B-NN
status B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
because B-O B-SBAR_IN
prevents B-O B-S_NP_NP_PP_PP_VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
appears B-O B-VP_VBZ
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
basal B-O B-JJ
redox B-O B-NN
equilibrium B-O B-NN
" " B-O O-NP
tending B-O B-VP_VBG
toward B-O B-PP_IN
oxidation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
prerequisite B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
regulating B-O B-NP_NP_NP_PP_VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
c-jun B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
jun B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
young B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
elderly B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
adults B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
c-jun B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
jun B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
proto-oncogenes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
in B-O B-NP_PP_IN
phytohemagglutinin B-O B-NP_NP_ADJP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
activated B-O B-VBN
" " B-O O-ADJP
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
PBL B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
young B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
aged B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
humans B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Specific B-O B-S_NP_NP_JJ
mRNAs B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
c-fos B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VP_VBD
detectable B-O B-ADJP_JJ
" " B-O O-ADJP
within B-O B-PP_IN
30 B-O B-NP_NP_CD
min B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
cell B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
reached B-O B-VP_VBD
maximal B-O B-NP_JJ
levels B-O B-NNS
" " B-O O-NP
within B-O B-PP_IN
2 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_NP_CC
c-fos B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
jun B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
mRNAs B-O B-NNS
" " B-O O-NP
decreased B-O B-VP_VBD
to B-O B-PP_TO
pre-activation B-O B-NP_NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
6 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
while B-O B-SBAR_IN
c-jun B-O B-S_NP_NN
mRNA B-O B-NN
" " B-O O-NP
remained B-O B-VP_VBD
elevated B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
PHA-activated B-O B-NP_JJ
PBL B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
no B-O B-NP_DT
age-related B-O B-JJ
differences B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
c-fos B-O B-NP_NP_NP_NN
" " B-O O-NP
or B-O B-CC
jun B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
c-jun B-O B-NP_NN
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
decreased B-O B-VP_VBD
significantly B-O B-ADVP_ADVP_RB
" " B-O O-ADVP
( B-O B-PRN_LRB
1.73 B-O B-FRAG_NP_NP_NP_QP_CD
+/- B-O B-CC
0.08 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
vs. B-O B-CC
1.16 B-O B-NP_QP_CD
+/- B-O B-CC
0.09 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
" " B-O O-NP
arbitrary B-O B-NP_JJ
units B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-FRAG
, B-O B-COMMA
P B-O B-S_NP_NN
" " B-O O-NP
< B-O B-VP_VBG
0.01 B-O B-NP_CD
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
young B-O B-FRAG_ADJP_ADJP_JJ
" " B-O O-ADJP
vs. B-O B-CC
old B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADVP
in B-O B-PP_IN
PBL B-O B-NP_NN
" " B-O O-NP
from B-O B-PP_IN
elderly B-O B-NP_JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
activated B-O B-VP_VBN
with B-O B-NP_PP_IN
PHA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
previous B-O B-S_NP_JJ
work B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
T B-O B-S_NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_O-NP
may B-O B-VP_MD
display B-O B-VP_VB
" " B-O B-NP_SBAR_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
c-jun B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
jun B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
studied B-O B-VP_VBN
in B-O B-NP_PP_IN
anti-CD2-activated B-O B-NP_JJ
purified B-O B-VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_DT
age-related B-O B-JJ
differences B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
two B-O B-CD
proto-oncogenes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
anti-CD2 B-O B-NP_NN
activated B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
decreased B-O B-VBN
IL-2 B-O B-NN
production B-O B-NN
" " B-O O-NP
and B-O B-CC
proliferative B-O B-NP_JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-NP
displayed B-O B-VP_VBN
by B-O B-NP_PP_IN
PHA-activated B-O B-NP_NP_JJ
PBL B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
related B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Characterization B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
novel B-O B-JJ
T B-O B-NN
lymphocyte B-O B-NN
protein B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
a B-O B-NP_NP_DT
site B-O B-NN
" " B-O O-NP
related B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
identified B-O B-VP_VBN
a B-O B-NP_NP_DT
T B-O B-NN
lymphocyte B-O B-NN
protein B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_O-VP
and B-O B-CC
exerts B-O B-VP_VBZ
an B-O B-NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
palindromic B-O B-JJ
site B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
site B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
this B-O B-NP_DT
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
related B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
palindromic B-O B-JJ
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
members B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
hormone B-O B-NP_NN
receptor B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
characterize B-O B-VP_VBP
the B-O B-NP_NP_DT
T B-O B-NN
cell B-O B-NN
protein B-O B-NN
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
this B-O B-NP_DT
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
100 B-O B-ADJP_CD
kD B-O B-NN
" " B-O O-ADJP
protein B-O B-NN
" " B-O O-NP
which B-O B-SBAR_SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
most B-O B-ADJP_RBS
abundant B-O B-JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
as B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
protein B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
distinct B-O B-ADJP_JJ
from B-O B-PP_IN
other B-O B-NP_NP_JJ
members B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
steroid/thyroid B-O B-NP_JJ
" " B-O O-NP
hormone B-O B-NN
receptor B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
including B-O B-PP_VBG
the B-O B-NP_NP_DT
COUP B-O B-NN
protein B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Membrane B-O B-NP_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
a B-O B-NP_NP_DT
novel B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
mineralocorticoid B-O B-NP_NN
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Rapid B-O B-S_NP_NP_JJ
nongenomic B-O B-JJ
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
intracellular B-O B-NP_NP_JJ
electrolytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
cell B-O B-NP_NN
volume B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Na(+)-H+ B-O B-NP_JJ
antiport B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
found B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
HML B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Binding B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
125I-labeled B-O B-NP_JJ
aldosterone B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
plasma B-O B-NP_NP_NN
membranes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HML B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
shares B-O B-VP_VBZ
important B-O B-NP_JJ
features B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
these B-O B-NP_DT
functional B-O B-JJ
data B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
includes B-O B-VP_VBZ
a B-O B-NP_NP_NP_NP_DT
very B-O B-ADJP_RB
low B-O B-JJ
" " B-O O-ADJP
apparent B-O B-JJ
dissociation B-O B-NP_NP_NN
constant B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Kd B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
0.1 B-O B-NP_CD
nM B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
for B-O B-PP_IN
both B-O B-NP_CC
aldosterone B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
Na(+)-H(+)-antiport B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
high B-O B-JJ
turnover B-O B-NN
rate B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_NP_DT
almost B-O B-ADJP_RB
exclusive B-O B-JJ
" " B-O O-ADJP
binding B-O B-NN
selectivity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Dexamethasone B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
RU B-O B-NP_NN
26988 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
corticosterone B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
ouabain B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
amiloride B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
18-hydroxyprogesterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
inactive B-O B-ADJP_JJ
" " B-O O-ADJP
as B-O B-PP_IN
ligands B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deoxycorticosterone B-O B-S_NP_NN
acetate B-O B-NN
" " B-O O-NP
had B-O B-VP_VBD
an B-O B-NP_DT
intermediate B-O B-JJ
activity B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
an B-O B-NP_NP_DT
apparent B-O B-JJ
Kd B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
100 B-O B-NP_CD
nM B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
the B-O B-NP_NP_DT
first B-O B-JJ
" " B-O O-NP
to B-O B-SBAR_WHNP_S_NP_VP_TO
demonstrate B-O B-VP_VB
being B-O B-S_NP_NP_PP_VP_VBG
" " B-O B-ADJP_O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Natural B-O B-NP_NP_NP_JJ
variants B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NN
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
analysis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
promoters B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
duplicated B-O B-NP_JJ
DNA B-O B-NN
regulatory B-O B-JJ
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Sequence B-O B-S_NP_NP_NN
variation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
long B-O B-NP_NP_JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
LTR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
analyzed B-O B-VP_VBN
in B-O B-NP_PP_IN
viral B-O B-NP_NP_JJ
isolates B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
17 B-O B-NP_CD
infected B-O B-JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_CD
classes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
LTR B-O B-NP_NN
size B-O B-NN
variants B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_CD
HIV-1 B-O B-NN
variant B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
containing B-O B-S_NP_VP_VBG
an B-O B-NP_NP_DT
additional B-O B-JJ
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
Sp1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Another B-O B-S_NP_DT
LTR B-O B-NN
size B-O B-NN
variation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
four B-O B-NP_CD
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
just B-O B-ADJP_RB
upstream B-O B-JJ
of B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
variation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
the B-O B-NP_NP_DT
result B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
duplication B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
short B-O B-JJ
DNA B-O B-NN
sequence B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CTG-motif B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cell B-O B-S_NP_NN
culture B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
natural B-O B-JJ
variant B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
four B-O B-NP_CD
Sp1 B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
a B-O B-NP_NP_DT
slightly B-O B-ADJP_RB
higher B-O B-JJR
" " B-O O-ADJP
promoter B-O B-NP_NP_NN
activity B-O B-NN
" " B-O O-NP
and B-O B-CC
viral B-O B-NP_JJ
replication B-O B-NN
rate B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
than B-O B-PP_IN
the B-O B-NP_NP_DT
isogenic B-O B-JJ
control B-O B-NN
LTR B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_NP_DT
positive B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
duplicated B-O B-JJ
CTG-motif B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
detected B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_SBAR_IN
order B-O B-NN
to B-O B-TO
measure B-O B-S_NP_VP_VB
small B-O B-NP_NP_JJ
differences B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
virus B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
more B-O B-ADVP_RBR
accurately B-O B-RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
equal B-O B-NP_NP_JJ
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
size B-O B-NN
variant B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
wild-type B-O B-JJ
plasmid B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
cotransfected B-O B-VP_VBN
into B-O B-NP_PP_IN
T-cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
virus B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
four B-O B-NP_CD
Sp1 B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
outgrow B-O B-VP_VB
the B-O B-NP_DT
three B-O B-CD
Sp1 B-O B-NN
virus B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
35 B-O B-NP_NP_CD
days B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
culture B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
CTG-monomer B-O B-S_NP_NN
virus B-O B-NN
" " B-O O-NP
outcompeted B-O B-VP_VBD
the B-O B-NP_DT
CTG-dimer B-O B-NN
virus B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
42 B-O B-NP_CD
days B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Based B-O B-S_PP_VBN
on B-O B-PP_IN
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
estimate B-O B-VP_VBP
a B-O B-NP_NP_DT
5-10 B-O B-ADJP_QP_CD
" " B-O O-QP
% B-O B-NN
" " B-O O-ADJP
difference B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
virus B-O B-NP_NP_NN
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
LTR B-O B-NN
variants B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
wild-type B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
SCL B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
related B-O B-NP_JJ
hemopoietic B-O B-JJ
helix-loop-helix B-O B-JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
helix-loop-helix B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
HLH B-O B-ADJP_JJ
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
proteins B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
a B-O B-NP_NP_DT
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
include B-O B-S_NP_VP_VBP
" " B-O B-NP_NP_ADJP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Five B-O B-S_NP_NP_NP_CD
members B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
MYC B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
SCL B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
TAL-2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
LYL-1 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
E2A B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
are B-O B-VP_VBP
implicated B-O B-VP_VBN
in B-O B-NP_PP_IN
oncogenic B-O B-NP_NP_JJ
events B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
lymphoid B-O B-JJ
tumors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
because B-O B-PP_IN
of B-O B-IN
their B-O B-NP_NP_PRPP
consistent B-O B-JJ
involvement B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
chromosomal B-O B-NP_JJ
translocations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
activated B-O B-S_NP_VP_VBN
in B-O B-NP_PP_IN
T B-O B-NP_NN
cell B-O B-NN
leukemias B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
SCL B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
LYL-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
low B-O B-ADJP_ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
undetectable B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
in B-O B-PP_IN
normal B-O B-NP_JJ
T B-O B-NN
cell B-O B-NN
populations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
SCL B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
erythroid B-O B-NP_NP_UCP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
megakaryocyte B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
mast B-O B-NP_NN
cell B-O B-NN
" " B-O O-NP
" " B-O O-UCP
populations B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
the B-O B-NP_NP_DT
same B-O B-JJ
cell B-O B-NN
lineages B-O B-NNS
" " B-O O-NP
as B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
both B-O B-NP_CC
SCL B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
GATA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
undergo B-O B-VP_VP_VP_VBP
coordinate B-O B-NP_JJ
modulation B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
chemically B-O B-NP_NP_ADJP_RB
induced B-O B-VBN
" " B-O O-ADJP
erythroid B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mouse B-O B-NP_NN
erythroleukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
are B-O B-VP_VBP
down-modulated B-O B-VP_VBN
during B-O B-NP_PP_IN
myeloid B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
K562 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
thus B-O B-S_ADVP_RB
" " B-O O-ADVP
implying B-O B-NP_VP_VBG
a B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
SCL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
erythroid B-O B-NP_JJ
differentiation B-O B-NN
events B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
contrast B-O B-NN
to B-O B-TO
GATA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
SCL B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
developing B-O B-VBG
brain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Studies B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
SCL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggest B-O B-VP_VBP
it B-O B-SBAR_COMP_S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADJP_RB
important B-O B-JJ
" " B-O O-ADJP
in B-O B-PP_IN
and B-O B-NP_NP_UCP_NP_CC
events B-O B-ADJP_NNS
" " B-O O-NP
in B-O B-PP_IN
erythroid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
hypersensitive B-O B-JJ
site B-O B-NN
HS2 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
erythroid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
In B-O B-S_PP_IN
the B-O B-NP_DT
human B-O B-JJ
genome B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
erythroid-specific B-O B-JJ
hypersensitive B-O B-JJ
site B-O B-NN
HS2 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
regulates B-O B-VP_VBZ
the B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
downstream B-O B-JJ
beta-like B-O B-JJ
globin B-O B-NN
genes B-O B-NNS
" " B-O O-NP
10-50 B-O B-ADVP_NP_QP_CD
" " B-O O-QP
kilobases B-O B-NNS
" " B-O O-NP
away B-O B-RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HS2 B-O B-NP_NN
enhancer B-O B-NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
known B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
employs B-O B-VP_VBZ
RNA B-O B-NP_NN
protection B-O B-NN
assays B-O B-NNS
" " B-O O-NP
to B-O B-S_NP_VP_TO
analyze B-O B-VP_VB
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
status B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HS2 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
transfected B-O B-NP_VBN
recombinant B-O B-JJ
plasmids B-O B-NP_NP_PRN_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
erythroid B-O B-NP_NP_JJ
K562 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
the B-O B-S_NP_DT
HS2 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
active B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
HS2 B-O B-NN
sequence B-O B-NN
" " B-O O-NP
directs B-O B-VP_VBZ
the B-O B-NP_NP_DT
synthesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
long B-O B-NP_NP_JJ
enhancer B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
and B-O B-VP_VP_CC
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
nonerythroid B-O B-NP_NP_JJ
HL-60 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
the B-O B-S_NP_DT
HS2 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
inactive B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
long B-O B-NP_JJ
enhancer B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
detectable B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Splitting B-O B-S_S_NP_VP_VBG
the B-O B-NP_DT
HS2 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
two B-O B-NP_CD
tandem B-O B-JJ
Ap1 B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
abolishes B-O B-VP_VP_VBZ
the B-O B-NP_NP_DT
synthesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
long B-O B-NP_JJ
enhancer B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
results B-O B-VP_VBZ
in B-O B-PP_IN
loss B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
enhancer B-O B-NP_NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
transcriptional B-O B-NP_NP_JJ
silencing B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cis-linked B-O B-JJ
CAT B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
directing B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
synthesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
RNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
through B-O B-PP_IN
the B-O B-NP_NP_DT
intervening B-O B-VBG
DNA B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
a B-O B-NP_DT
tracking B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
HS2 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
( B-O B-VP_VP_LST_LRB
i B-O B-LS
) B-O B-RRB
" " B-O O-LST
open B-O B-VB
up B-O B-PRT_RP
" " B-O O-PRT
the B-O B-NP_NP_DT
chromatin B-O B-NN
structure B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
gene B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
( B-O B-VP_LST_LRB
ii B-O B-LS
) B-O B-RRB
" " B-O O-LST
deliver B-O B-VB
enhancer B-O B-NP_NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
promoter B-O B-NN
sequence B-O B-NN
" " B-O O-NP
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
they B-O B-S_NP_PRP
" " B-O O-NP
may B-O B-VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Phorbol B-O B-S_NP_NN
ester B-O B-NN
" " B-O O-NP
reduces B-O B-VP_VP_VP_VBZ
constitutive B-O B-NP_JJ
nuclear B-O B-JJ
NF B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
inhibits B-O B-VP_VBZ
HIV-1 B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
in B-O B-PP_IN
mature B-O B-NP_JJ
human B-O B-JJ
monocytic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF B-O B-S_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
a B-O B-NP_NP_DT
potent B-O B-JJ
mediator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
play B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
little B-O B-NP_NP_JJ
information B-O B-NN
" " B-O O-NP
available B-O B-ADJP_JJ
" " B-O O-ADJP
on B-O B-PP_IN
the B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
cytokines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
normal B-O B-NP_JJ
human B-O B-JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
used B-O B-VP_VBN
a B-O B-NP_NP_DT
32P-labeled B-O B-JJ
oligonucleotide B-O B-NN
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
long B-O B-NP_NP_NP_NP_PRN_JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_DT
probe B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_DT
gel B-O B-NN
retardation B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
to B-O B-S_NP_VP_TO
study B-O B-VP_VB
this B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
this B-O B-NP_DT
assay B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
detected B-O B-VP_VBN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
extracts B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
nuclei B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
normal B-O B-NP_JJ
human B-O B-JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
normal B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
12-0-tetradecanoyl B-O B-NP_NP_JJ
phorbol-13-acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TPA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
4-24 B-O B-NP_QP_CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
caused B-O B-VP_VBD
the B-O B-NP_NP_DT
complete B-O B-JJ
disappearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
similar B-O B-JJ
result B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
obtained B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
mature B-O B-JJ
monocytic B-O B-JJ
leukemia B-O B-NN
cell B-O B-NN
line B-O B-NN
THP-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
constitutive B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
SP1 B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
unaffected B-O B-VP_JJ
by B-O B-NP_PP_IN
addition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
TPA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
disappearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
concentration B-O B-ADJP_NP_NN
" " B-O O-NP
dependent B-O B-JJ
" " B-O O-ADJP
between B-O B-PP_IN
10 B-O B-NP_NP_QP_CD
and B-O B-CC
50 B-O B-CD
" " B-O O-QP
ng/ml B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
phorbol B-O B-NP_NN
ester B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
THP-1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
TPA B-O B-NP_NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBD
a B-O B-NP_NP_DT
new B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
faster-migrating B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
NF B-O B-NN
kappa B-O B-NN
B B-O B-NN
species B-O B-NNS
" " B-O O-NP
not B-O B-VP_RB
induced B-O B-VBN
in B-O B-NP_PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Protein B-O B-S_NP_NP_NN
kinase B-O B-NN
C B-O B-NN
inhibitor B-O B-NN
staurosporine B-O B-NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
cyclic B-O B-NP_ADJP_JJ
nucleotide-dependent B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
kinase B-O B-NN
inhibitor B-O B-NN
HA-1004 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
dramatically B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBD
constitutive B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
NF B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
TPA B-O B-NP_NP_NN
addition B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
infected B-O B-VP_VBN
with B-O B-NP_PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibited B-O B-VP_VBD
HIV-1 B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
reverse B-O B-NP_JJ
transcriptase B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
in B-O B-PP_IN
a B-O B-NP_DT
concentration-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
are B-O B-VP_VP_VBP
in B-O B-PP_IN
striking B-O B-NP_NP_JJ
contrast B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
emphasize B-O B-VP_VBP
the B-O B-NP_NP_DT
importance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
studying B-O B-S_NP_VP_VBG
cytokine B-O B-NP_NP_NN
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Targeted B-O B-NP_NP_VBN
degradation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Fos B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
v-Fos B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
a B-O B-NP_NP_DT
phosphorylation-dependent B-O B-JJ
signal B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
c-Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
proto-oncogene B-O B-NN
products B-O B-NNS
c-Fos B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
heterodimerize B-O B-VP_VBP
through B-O B-PP_IN
their B-O B-NP_PRPP
leucine B-O B-NN
zippers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
form B-O B-VP_VB
the B-O B-NP_DT
AP-1 B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
heterodimer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
signal-dependent B-O B-NP_JJ
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
dephosphorylation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
events B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
stability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
also B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
intracellular B-O B-NP_JJ
signal B-O B-NN
transduction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
transient B-O B-NP_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
and B-O B-CC
in B-O B-NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
degradation B-O B-NN
" " B-O O-NP
" " B-O O-NP
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
stability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
decreased B-O B-VP_VBN
when B-O B-NP_SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
protein B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
dimerized B-O B-VP_JJ
with B-O B-NP_PP_IN
phosphorylated B-O B-NP_VBN
c-Jun B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
c-Jun B-O B-S_NP_NP_NN
protein B-O B-NN
" " B-O O-NP
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
phorbol B-O B-NP_ADJP_NN
ester-induced B-O B-JJ
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
did B-O B-VP_VP_VBD
not B-O B-RB
target B-O B-VP_VB
c-Fos B-O B-NP_NN
" " B-O O-NP
for B-O B-PP_IN
degradation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
suggests B-O B-S_NP_VP_VBZ
that B-O B-SBAR_IN
c-Fos B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
transiently B-O B-ADVP_RB
" " B-O O-ADVP
stabilized B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
v-Fos B-O B-S_NP_NP_NN
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
retroviral B-O B-JJ
counterpart B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
susceptible B-O B-ADJP_JJ
to B-O B-PP_TO
degradation B-O B-NP_NP_NN
" " B-O O-NP
targeted B-O B-VP_VBN
by B-O B-NP_PP_IN
c-Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Mutations B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
Pit-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
children B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
combined B-O B-NP_JJ
pituitary B-O B-JJ
hormone B-O B-NN
deficiency B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Pit-1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
pituitary-specific B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VP_VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_O-PP
" " B-O O-VP
and B-O B-CC
transactivates B-O B-VP_VBZ
" " B-O B-NP_O-VP
" " B-O O-VP
promoters B-O B-NP_NP_NNS
of B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
prolactin B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
three B-O B-NP_NP_CD
unrelated B-O B-JJ
Japanese B-O B-JJ
children B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
combined B-O B-NP_JJ
pituitary B-O B-JJ
hormone B-O B-NN
deficiency B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
identified B-O B-VP_VBD
three B-O B-NP_NP_NP_NP_CD
point B-O B-NN
mutations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
Pit-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
Pro24Leu B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Arg143Gln B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Arg271Trp B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
located B-O B-ADJP_JJ
on B-O B-PP_IN
the B-O B-NP_NP_DT
major B-O B-JJ
transactivation B-O B-NN
region B-O B-NN
" " B-O O-NP
, B-O B-COMMA
POU-specific B-O B-NP_NP_JJ
domain B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
POU-homeodomain B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interferon-gamma-treated B-O B-NP_JJ
U937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
chemiluminescence B-O B-NP_NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-SBAR_WHNP_S_NP_VP_TO
detect B-O B-VP_VB
red B-O B-NP_NP_NP_JJ
cell B-O B-NN
" " B-O O-NP
, B-O B-COMMA
platelet B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
granulocyte B-O B-NP_NN
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
potential B-O B-NP_JJ
clinical B-O B-JJ
significance B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
chemiluminescent B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
CL B-O B-ADJP_JJ
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interferon-gamma-treated B-O B-NP_NP_NP_JJ
U937 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IFN-U937 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
sensitized B-O B-NP_VBN
target B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
detect B-O B-VP_VB
red B-O B-NP_NP_JJ
cell B-O B-NN
" " B-O O-NP
, B-O B-COMMA
platelet B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
granulocyte B-O B-NP_NN
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
clone B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-SBAR_O-NP
was B-O B-VP_VBD
selected B-O B-VP_VBN
which B-O B-NP_SBAR_SBAR_WHNP_WDT
" " B-O O-WHNP
expressed B-O B-S_NP_VP_VBD
Fc B-O B-NP_NP_NN
receptor B-O B-NN
I B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
, B-O B-COMMA
after B-O B-S_PP_IN
incubation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
for B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
was B-O B-NP_VP_VBD
capable B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-S_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
CL B-O B-NN
responses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
IFN-U937 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
peripheral B-O B-NP_JJ
blood B-O B-NN
human B-O B-JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
sensitized B-O B-NP_VBN
red B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
platelets B-O B-NP_NNS
" " B-O O-NP
or B-O B-CC
granulocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
then B-O B-ADVP_RB
" " B-O O-ADVP
compared B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Assays B-O B-S_NP_NP_NNS
" " B-O O-NP
using B-O B-VP_VBG
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
or B-O B-CC
IFN-U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
of B-O B-PP_IN
comparable B-O B-NP_NP_JJ
sensitivity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
detection B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
antibodies B-O B-NP_NP_NNS
" " B-O O-NP
against B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IFN-U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reduced B-O B-VP_VP_VBD
interassay B-O B-NP_JJ
variation B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
simplified B-O B-VP_VBD
assay B-O B-NP_NN
performance B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
potential B-O B-JJ
clinical B-O B-JJ
usefulness B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
CL B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
suggested B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O B-S_O-NP
of B-O B-PP_IN
both B-O B-NP_CC
monocytes B-O B-NP_NNS
" " B-O O-NP
and B-O B-CC
IFN-U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
respond B-O B-VP_VB
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
monocytes B-O B-NP_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
IFN-U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
both B-O B-NP_DT
" " B-O O-NP
" " B-O O-NP
responded B-O B-VP_VBD
to B-O B-PP_TO
red B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
sensitized B-O B-VP_VBN
with B-O B-NP_PP_IN
antibodies B-O B-NP_NP_NNS
" " B-O O-NP
against B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
IFN-U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
responded B-O B-VP_VBD
only B-O B-ADVP_RB
weakly B-O B-RB
" " B-O O-ADVP
to B-O B-PP_TO
red B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
sensitized B-O B-VP_VBN
with B-O B-NP_PP_PP_IN
either B-O B-CC
anti-D B-O B-NP_NP_JJ
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
or B-O B-CC
with B-O B-PP_IN
antisera B-O B-NP_NP_NNS
" " B-O O-NP
containing B-O B-VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Photoaffinity B-O B-NP_NP_NN
labeling B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
plasma B-O B-NP_NP_NN
membrane B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
human B-O B-NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Non-genomic B-O B-S_NP_NP_JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_DT
sodium-proton-antiport B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
shown B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
could B-O B-S_NP_VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
paper B-O B-NN
" " B-O O-NP
" " B-O O-PP
plasma B-O B-NP_NP_NN
membranes B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
human B-O B-NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
covalently B-O B-ADVP_RB
" " B-O O-ADVP
photolabeled B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_DT
[125I]-aldosterone B-O B-NN
derivative B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Sodium B-O B-S_NP_ADJP_NN
dodecyl B-O B-NN
sulfate-polyacrylamide B-O B-JJ
" " B-O O-ADJP
gel B-O B-NN
electrophoresis B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
significant B-O B-NP_NP_JJ
aldosterone B-O B-NN
binding B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
a B-O B-NP_NP_DT
molecular B-O B-JJ
weight B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
approximately B-O B-NP_QP_RB
50000 B-O B-CD
" " B-O O-QP
Dalton B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
absent B-O B-ADJP_JJ
" " B-O O-ADJP
with B-O B-PP_IN
, B-O B-NP_NP_NP_NP_NP_COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
cortisol B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
binding B-O B-VBG
media B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
sulfhydryl B-O B-NN
agent B-O B-NN
dithiothreitol B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
affect B-O B-VP_VB
results B-O B-NP_NP_NNS
" " B-O O-NP
suggesting B-O B-VP_VBG
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
disulfide B-O B-NP_NN
bridges B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
steroid B-O B-NN
binding B-O B-NN
domain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
the B-O B-NP_NP_DT
first B-O B-JJ
" " B-O O-NP
to B-O B-SBAR_WHNP_S_NP_VP_TO
define B-O B-VP_VB
the B-O B-NP_NP_DT
molecular B-O B-JJ
weight B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Alpha-lipoic B-O B-S_NP_JJ
acid B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
potent B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Acquired B-O B-S_NP_NP_VBN
immunodeficiency B-O B-NN
syndrome B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
AIDS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
results B-O B-VP_VBZ
from B-O B-PP_IN
infection B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
long B-O B-NP_NP_JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
LTR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
proviral B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contains B-O B-VP_VBZ
binding B-O B-NP_NP_VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
this B-O B-S_NP_DT
transcriptional B-O B-JJ
activator B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
regulate B-O B-VP_VB
HIV B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Recent B-O B-S_NP_JJ
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
an B-O B-NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
reactive B-O B-NP_NP_JJ
oxygen B-O B-NN
species B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
ROS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
signal B-O B-NP_NP_NN
transduction B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
leading B-O B-VP_VBG
to B-O B-PP_TO
NF-kappa B-O B-NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
based B-O B-VP_VBN
on B-O B-NP_PP_IN
reports B-O B-NP_NNS
that B-O B-SBAR_IN
should B-O B-S_S_NP_NP_SBAR_VP_MD
" " B-O B-VP_O-S
, B-O B-COMMA
and B-O B-CC
thus B-O B-RB
antioxidants B-O B-S_NP_NNS
" " B-O O-NP
can B-O B-VP_MD
" " B-O B-VP_O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Incubation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Jurkat B-O B-NP_NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
1 B-O B-NP_QP_CD
x B-O B-CC
10(6) B-O B-CD
" " B-O O-QP
cells/ml B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_DT
natural B-O B-JJ
thiol B-O B-NN
antioxidant B-O B-ADJP_ADJP_NN
" " B-O O-ADJP
, B-O B-COMMA
alpha-lipoic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
prior B-O B-PP_JJ
to B-O B-TO
the B-O B-NP_NP_DT
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
inhibit B-O B-VP_VB
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
or B-O B-NP_PP_PP_CC
" " B-O B-PP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
inhibitory B-O B-JJ
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
alpha-lipoic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
very B-O B-ADJP_RB
potent B-O B-JJ
" " B-O O-ADJP
as B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
20 B-O B-S_NP_CD
mM B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
required B-O B-VP_VBN
for B-O B-NP_PP_IN
N-acetylcysteine B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
alpha-lipoic B-O B-S_NP_JJ
acid B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
effective B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
AIDS B-O B-NP_NN
therapeutics B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
lymphokine B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
role B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cis-acting B-O B-NP_NP_JJ
DNA B-O B-NN
elements B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
respond B-O B-S_NP_VP_VBP
to B-O B-PP_TO
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
initiated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
recognition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
antigen B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
antigen B-O B-NP_NN
presenting B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-SBAR_WHNP_S_NP_VP_TO
exert B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_NP_CD
types B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
helper B-O B-NP_NP_NP_NN
T B-O B-NN
cell B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Th B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
clones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
Th1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Th2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
are B-O B-VP_VBP
defined B-O B-VP_VBN
on B-O B-NP_PP_IN
the B-O B-DT
basis B-O B-NN
of B-O B-IN
different B-O B-NP_NP_JJ
patterns B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
secretion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
They B-O B-S_NP_PRP
" " B-O O-NP
determine B-O B-VP_VBP
the B-O B-NP_NP_DT
outcome B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
antigenic B-O B-JJ
response B-O B-NN
" " B-O O-NP
toward B-O B-PP_IN
humoral B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
cell-mediated B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
immunity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
lymphokine B-O B-S_NP_NN
genes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
coordinately B-O B-ADVP_RB
" " B-O O-ADVP
regulated B-O B-VP_VBN
upon B-O B-NP_PP_IN
antigen B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
they B-O B-NP_PRP
" " B-O O-NP
are B-O B-VP_VBP
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
common B-O B-ADJP_JJ
to B-O B-PP_TO
all B-O B-NP_DT
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
those B-O B-NP_NP_DT
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
For B-O B-S_PP_IN
most B-O B-NP_JJS
lymphokine B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
phorbol B-O B-NP_NP_NP_NN
esters B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
phorbol B-O B-NP_NP_NN
12-myristate B-O B-NN
13 B-O B-CD
acetate B-O B-NN
" " B-O O-NP
, B-O B-COMMA
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
calcium B-O B-NP_NP_NN
ionophores B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
A23187 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
their B-O B-NP_PRPP
maximal B-O B-JJ
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Yet B-O B-S_RB
phorbol B-O B-NP_NP_NP_NN
ester B-O B-NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
or B-O B-CC
calcium B-O B-NP_NP_NN
ionophore B-O B-NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-NP
produce B-O B-VP_VBP
several B-O B-NP_JJ
lymphokines B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
granulocyte-macrophage B-O B-JJ
colony B-O B-NN
stimulating B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GM-CSF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
completely B-O B-ADJP_RB
dependent B-O B-JJ
on B-O B-PP_IN
the B-O B-NP_DT
two B-O B-CD
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBN
a B-O B-NP_NP_DT
cis-acting B-O B-JJ
region B-O B-NN
" " B-O O-NP
spanning B-O B-VP_VBG
the B-O B-NP_NP_NP_DT
GM-CSF B-O B-NN
promoter B-O B-NN
region B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
positions B-O B-NP_NNS
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
confers B-O B-S_NP_VP_VBZ
" " B-O B-NP_PP_PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_NP_JJ
analysis B-O B-NN
" " B-O O-NP
identified B-O B-VP_VBD
three B-O B-NP_NP_CD
elements B-O B-NNS
" " B-O O-NP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
efficient B-O B-NP_JJ
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
referred B-O B-VP_VBN
to B-O B-PP_TO
" " B-O B-NP_O-PP
as B-O B-PP_IN
GM2 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
GC-box B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
conserved B-O B-NP_NP_VBN
lymphokine B-O B-NN
element B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CLE0 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
GM2 B-O B-S_NP_NN
" " B-O O-NP
defines B-O B-VP_VBZ
a B-O B-NP_NP_DT
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
protein B-O B-NP_NP_NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
whose B-O B-SBAR_WHNP_WPP
binding B-O B-NN
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
inducible B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
NF-GM2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
similar B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
NF-kB B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
GC-box B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
constitutively B-O B-NP_ADJP_RB
bound B-O B-VBN
" " B-O O-ADJP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CLEO B-O B-S_NP_NN
" " B-O O-NP
defines B-O B-VP_VBZ
a B-O B-NP_NP_DT
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
protein B-O B-NP_NP_NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
whose B-O B-SBAR_WHNP_WPP
optimum B-O B-NN
binding B-O B-NN
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
stimulated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Viral B-O B-S_NP_NP_JJ
trans-activators B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
Tax B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
human B-O B-NP_NP_JJ
T B-O B-NN
cell B-O B-NN
leukemia B-O B-NN
virus-1 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
HTLV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
E2 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
bovine B-O B-NP_NP_JJ
papilloma B-O B-NN
virus B-O B-NN
" " B-O O-NP
, B-O B-COMMA
BPV B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
other B-O B-NP_NP_JJ
agents B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
activate B-O B-S_NP_VP_VBP
lymphokine B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
bypassing B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
trans-activation B-O B-NN
domain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Tax B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
interchangeable B-O B-ADJP_JJ
" " B-O O-ADJP
although B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
no B-O B-NP_NP_DT
obvious B-O B-JJ
sequence B-O B-NN
homology B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
them B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
viral B-O B-JJ
trans-activators B-O B-NNS
" " B-O O-NP
appear B-O B-VP_VBP
to B-O B-S_NP_VP_TO
target B-O B-VP_VP_VB
specific B-O B-NP_NP_JJ
DNA B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
to B-O B-PP_TO
cis-acting B-O B-NP_JJ
DNA B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
promote B-O B-VP_VB
lymphokine B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
without B-O B-PP_IN
TCR-mediated B-O B-NP_JJ
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
I B-O B-S_NP_NN
kappa B-O B-NN
B/MAD-3 B-O B-NN
" " B-O O-NP
masks B-O B-VP_VP_VBZ
the B-O B-NP_NP_DT
nuclear B-O B-JJ
localization B-O B-NN
signal B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
p65 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
requires B-O B-VP_VBZ
the B-O B-S_NP_DT
transactivation B-O B-NN
domain B-O B-NN
" " B-O O-NP
to B-O B-VP_TO
inhibit B-O B-VP_VB
NF-kappa B-O B-NP_NN
B B-O B-NN
p65 B-O B-NN
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
active B-O B-JJ
nuclear B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
transcription B-O B-NN
factor B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
composed B-O B-VP_VBN
of B-O B-NP_PP_IN
two B-O B-NP_NP_NP_CD
DNA B-O B-NN
binding B-O B-NN
subunits B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
p65 B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
p50 B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
both B-O B-SBAR_WHNP_NP_DT
" " B-O O-NP
of B-O B-WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
" " B-O O-WHNP
share B-O B-S_NP_VP_VBP
extensive B-O B-NP_JJ
N-terminal B-O B-JJ
sequence B-O B-NN
homology B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
NF-kappa B-O B-NN
B B-O B-NN
p65 B-O B-NN
subunit B-O B-NN
" " B-O O-NP
provides B-O B-VP_VP_VBZ
the B-O B-NP_DT
transactivation B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
complex B-O B-JJ
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
serves B-O B-VP_VBZ
as B-O B-PP_IN
an B-O B-NP_NP_DT
intracellular B-O B-JJ
receptor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
a B-O B-NP_NP_DT
cytoplasmic B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
termed B-O B-VP_VBN
" " B-O B-S_NP_NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
p50 B-O B-NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
fails B-O B-VP_VP_VBZ
to B-O B-S_NP_VP_TO
stimulate B-O B-VP_VB
kappa B-O B-NP_ADJP_NN
B-directed B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
based B-O B-VP_PP_VBN
on B-O B-PP_IN
prior B-O B-NP_JJ
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
is B-O B-VP_VBZ
not B-O B-RB
directly B-O B-ADVP_RB
" " B-O O-ADVP
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
investigate B-O B-VP_VB
the B-O B-NP_NP_DT
molecular B-O B-JJ
basis B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
critical B-O B-JJ
regulatory B-O B-JJ
interaction B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
a B-O B-NP_NP_NP_DT
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
p65 B-O B-NN
mutants B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
identified B-O B-VP_VBN
that B-O B-NP_SBAR_WHNP_WDT
" " B-O O-WHNP
functionally B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
segregated B-O B-VP_VBD
DNA B-O B-NP_NP_NP_NN
binding B-O B-NN
" " B-O O-NP
, B-O B-COMMA
inhibition B-O B-NP_ADJP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
nuclear B-O B-NP_ADJP_JJ
exclusion B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Results B-O B-S_S_NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
in B-O B-NP_NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
expression B-O B-NN
studies B-O B-NNS
" " B-O O-NP
performed B-O B-VP_VBN
with B-O B-NP_PP_IN
these B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
p65 B-O B-NN
mutants B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
the B-O B-NP_DT
following B-O B-NN
" " B-O O-NP
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
1 B-O B-S_S_LST_LS
) B-O B-RRB
" " B-O O-LST
I B-O B-NP_NN
kappa B-O B-NN
B/MAD-3 B-O B-NN
" " B-O O-NP
completely B-O B-ADVP_RB
" " B-O O-ADVP
inhibits B-O B-VP_VBZ
NF-kappa B-O B-NP_NP_ADJP_NN
B B-O B-NN
p65-dependent B-O B-JJ
" " B-O O-ADJP
transcriptional B-O B-JJ
activation B-O B-NN
" " B-O O-NP
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
the B-O B-NP_NP_DT
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
kappa B-O B-NN
B B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
2 B-O B-S_LST_LS
) B-O B-RRB
" " B-O O-LST
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B/MAD-3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
NF-kappa B-O B-NP_NN
B B-O B-NN
p65 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
sufficient B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
retarget B-O B-VP_VB
NF-kappa B-O B-NP_NN
B B-O B-NN
p65 B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
to B-O B-NP_PP_TO
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
3 B-O B-S_LST_LS
) B-O B-RRB
" " B-O O-LST
selective B-O B-NP_NP_JJ
deletion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
functional B-O B-JJ
nuclear B-O B-JJ
localization B-O B-NN
signal B-O B-NN
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
disrupts B-O B-VP_VBZ
its B-O B-NP_PRPP
ability B-O B-NN
to B-O B-S_NP_VP_TO
engage B-O B-VP_VB
I B-O B-NP_NN
kappa B-O B-NN
B/MAD-3 B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
4 B-O B-S_LST_LS
) B-O B-RRB
" " B-O O-LST
the B-O B-NP_NP_DT
unique B-O B-JJ
C-terminus B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
p65 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
attenuates B-O B-VP_VP_VBZ
its B-O B-NP_PRPP
own B-O B-JJ
nuclear B-O B-JJ
localization B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
contains B-O B-VP_VBZ
sequences B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Together B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
nuclear B-O B-NP_NP_JJ
localization B-O B-NN
signal B-O B-NN
" " B-O O-NP
and B-O B-CC
transactivation B-O B-NP_NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
p65 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
constitute B-O B-VP_VBP
a B-O B-NP_NP_DT
bipartite B-O B-JJ
system B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-ADVP_VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Unexpectedly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
our B-O B-NP_PRPP
in B-O B-ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
studies B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
I B-O B-S_NP_NN
kappa B-O B-NN
B/MAD-3 B-O B-NN
" " B-O O-NP
binds B-O B-VP_VBZ
directly B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
NF-kappa B-O B-NP_NN
B B-O B-NN
p50 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
interaction B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
functional B-O B-ADJP_JJ
" " B-O O-ADJP
as B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
retargeting B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
p50 B-O B-NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
no B-O B-NP_NP_DT
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
observed B-O B-VP_VBN
, B-O B-NP_COMMA
presumably B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
reflecting B-O B-VP_VBG
the B-O B-NP_NP_DT
unique B-O B-JJ
C-terminal B-O B-JJ
domain B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Surrogate B-O B-NP_NP_NP_NN
thyroglobulin B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
and B-O B-CC
T B-O B-NP_NN
cell B-O B-NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
Hashimoto B-O B-NP_NP_NN
's B-O B-POS
" " B-O O-NP
thyroiditis B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Immunoglobulin B-O B-S_NP_NP_NN
molecules B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
surface B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
B B-O B-NN
lymphocyte B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
the B-O B-NP_NP_DT
endogenous B-O B-JJ
"""" B-O B-LQT
receptors B-O B-NNS
"""" B-O B-RQT
" " B-O O-NP
to B-O B-SBAR_WHPP_TO
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
specific B-O B-S_NP_JJ
antigens B-O B-NNS
" " B-O O-NP
bind B-O B-VP_VBP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Studies B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
mice B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
, B-O B-COMMA
conjugated B-O B-VP_VBN
with B-O B-NP_PP_IN
palmitate B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
inserted B-O B-VP_VBN
into B-O B-NP_PP_IN
" " B-O B-NP_S_NP_VP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
whether B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
palmitate B-O B-JJ
conjugate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
human B-O B-JJ
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
" " B-O O-PP
specific B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-ADJP
" " B-O O-NP
could B-O B-VP_MD
function B-O B-VP_VB
as B-O B-PP_IN
a B-O B-NP_DT
surrogate B-O B-JJ
TG B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
flow B-O B-NP_NN
cytometry B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
detected B-O B-VP_VBD
surrogate B-O B-NP_JJ
TG B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
on B-O B-PP_PP_PP_IN
non-T B-O B-NP_JJ
" " B-O B-NP_O-NP
" " B-O O-PP
( B-O B-LRB
but B-O B-CC
not B-O B-PP_RB
on B-O B-IN
T B-O B-NP_NN
" " B-O B-NP_O-NP
" " B-O O-PP
) B-O B-RRB
" " B-O O-PP
cells B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
11 B-O B-NP_NP_NP_QP_CD
of B-O B-IN
11 B-O B-CD
" " B-O O-QP
individuals B-O B-NNS
" " B-O O-NP
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
( B-O B-PRN_LRB
5 B-O B-NP_NP_CD
Hashimoto B-O B-NN
patients B-O B-NNS
" " B-O O-NP
and B-O B-CC
6 B-O B-NP_CD
control B-O B-NN
donors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
endogenous B-O B-NP_JJ
TG B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
could B-O B-VP_MD
only B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
detected B-O B-VP_VBN
on B-O B-NP_PP_IN
non-T B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_PP_IN
Hashimoto B-O B-NP_QP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
from B-O B-PP_IN
control B-O B-NP_QP_NN
donors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_PP_IN
of B-O B-IN
the B-O B-NP_NP_DT
efficient B-O B-JJ
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TG B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
surrogate B-O B-NP_JJ
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
non-T B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
assessed B-O B-VP_VBD
the B-O B-NP_NP_NP_DT
ability B-O B-NN
" " B-O B-S_O-NP
of B-O B-PP_IN
such B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-S_NP_VP_TO
present B-O B-VP_VB
TG B-O B-NP_NN
" " B-O O-NP
to B-O B-PP_TO
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Proliferation B-O B-S_NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
TG B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
only B-O B-NP_QP_RB
1 B-O B-CD
of B-O B-IN
5 B-O B-CD
" " B-O O-QP
Hashimoto B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
low B-O B-JJ
frequency B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
response B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-ADJP_RB
different B-O B-JJ
from B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
previously B-O B-VP_ADVP_RB
" " B-O O-ADVP
detected B-O B-VBN
using B-O B-NP_S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
successful B-O B-JJ
generation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
surrogate B-O B-NP_JJ
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
non-T B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
more B-O B-NP_NP_ADJP_RBR
efficient B-O B-JJ
" " B-O O-ADJP
TG B-O B-NN
presentation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
significance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
not B-O B-RB
the B-O B-NP_DT
antigen-presenting B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
likely B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
In B-O B-NP_NP_NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
footprint B-O B-NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HLA-DRA B-O B-NN
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
cell-specific B-O B-NP_NP_NP_JJ
interaction B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_DT
octamer B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
up-regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
X B-O B-NP_NN
box B-O B-NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
interferon B-O B-NP_NN
gamma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
major B-O B-JJ
histocompatibility B-O B-NN
complex B-O B-NN
class B-O B-NN
II B-O B-CD
gene B-O B-NN
promoter B-O B-NN
DRA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
previously B-O B-ADVP_RB
" " B-O O-ADVP
identified B-O B-VP_VBN
at B-O B-NP_NP_QP_IN
least B-O B-JJS
five B-O B-CD
" " B-O O-QP
cis-acting B-O B-JJ
regions B-O B-NNS
" " B-O O-NP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
maximal B-O B-NP_JJ
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
DRA B-O B-NN
promoter B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
protein-DNA B-O B-NP_NP_JJ
interactions B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
intact B-O B-JJ
cell B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
may B-O B-S_NP_VP_MD
mediate B-O B-VP_VB
transcriptional B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
in B-O B-NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
genomic B-O B-JJ
footprinting B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
we B-O B-NP_PRP
" " B-O O-NP
identified B-O B-VP_VBD
interactions B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
B-cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_NP_DT
octamer B-O B-NN
site B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
Y B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
X1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
X2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
boxes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Class B-O B-S_NP_NN
II B-O B-CD
antigen B-O B-NN
expressing B-O B-VBG
T-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
maintained B-O B-VP_VBD
contacts B-O B-NP_NP_NNS
" " B-O O-NP
identical B-O B-ADJP_JJ
to B-O B-PP_TO
B-cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
, B-O B-COMMA
while B-O B-SBAR_IN
class B-O B-S_NP_ADJP_NN
II-negative B-O B-JJ
" " B-O O-ADJP
T-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
exhibited B-O B-VP_VBD
no B-O B-NP_DT
interactions B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
lymphoid B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
octamer B-O B-NN
site B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
occupied B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
required B-O B-VP_VBN
for B-O B-NP_PP_IN
maximal B-O B-NP_JJ
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
is B-O B-VP_VBZ
most B-O B-PP_ADVP_RBS
likely B-O B-RB
" " B-O O-ADVP
due B-O B-JJ
to B-O B-TO
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
lymphoid-specific B-O B-JJ
OTF-2 B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
class B-O B-ADJP_NN
II-positive B-O B-JJ
" " B-O O-ADJP
nonlymphoid B-O B-JJ
glioblastoma B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
exhibit B-O B-VP_VP_VB
interactions B-O B-NP_NNS
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_DT
octamer B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
despite B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
ubiquitous B-O B-JJ
OTF-1 B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
an B-O B-VP_NP_DT
open B-O B-JJ
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
DRA B-O B-NN
promoter B-O B-NN
" " B-O O-NP
discriminates B-O B-VP_VBZ
against B-O B-PP_IN
OTF-1 B-O B-NP_NP_NN
activation B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
glioblastoma B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interferon B-O B-S_NP_NN
gamma B-O B-NN
" " B-O O-NP
induces B-O B-VP_VP_VBZ
class B-O B-NP_NN
II B-O B-CD
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
glioblastoma B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
, B-O B-COMMA
in B-O B-VP_PP_IN
parallel B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
up-regulates B-O B-VBZ
X1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
X2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
box B-O B-NN
protein-DNA B-O B-JJ
interactions B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
while B-O B-SBAR_IN
all B-O B-S_NP_DT
other B-O B-JJ
interactions B-O B-NNS
" " B-O O-NP
remain B-O B-VP_VBP
unchanged B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
interferon B-O B-S_NP_NN
gamma B-O B-NN
" " B-O O-NP
functions B-O B-VP_VBZ
on B-O B-PP_IN
a B-O B-NP_DT
poised B-O B-VBN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
altering B-O B-S_NP_VP_VBG
to B-O B-NP_NP_PP_PP_TO
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
provide B-O B-VP_VBP
direct B-O B-NP_JJ
in B-O B-ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
evidence B-O B-NN
to B-O B-S_NP_VP_TO
strongly B-O B-ADVP_RB
" " B-O O-ADVP
suggest B-O B-VP_VB
that B-O B-SBAR_IN
is B-O B-S_NP_NP_PP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Simple B-O B-NP_NP_NP_NP_JJ
derivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TFIID-dependent B-O B-NP_JJ
RNA B-O B-NN
polymerase B-O B-NN
II B-O B-CD
transcription B-O B-NN
systems B-O B-NNS
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
Schizosaccharomyces B-O B-NP_NP_FW
pombe B-O B-FW
" " B-O O-NP
and B-O B-CC
other B-O B-NP_JJ
organisms B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
factors B-O B-NP_NP_NNS
" " B-O O-NP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
transcriptional B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
Resolution B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
whole B-O B-NP_JJ
cell B-O B-NN
extract B-O B-NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
two B-O B-NP_CD
chromatographic B-O B-JJ
steps B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
yields B-O B-VP_VBZ
a B-O B-NP_NP_DT
single B-O B-JJ
protein B-O B-NN
fraction B-O B-NN
" " B-O O-NP
requiring B-O B-VP_VBG
only B-O B-NP_NP_RB
the B-O B-DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TFIID B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
initiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
RNA B-O B-NP_NN
polymerase B-O B-NN
II B-O B-CD
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
approach B-O B-NN
" " B-O O-NP
allows B-O B-VP_VBZ
the B-O B-NP_NP_DT
convenient B-O B-JJ
generation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
RNA B-O B-NP_NN
polymerase B-O B-NN
II B-O B-CD
transcription B-O B-NN
systems B-O B-NNS
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
Saccharomyces B-O B-NP_NP_FW
cerevisiae B-O B-FW
" " B-O O-NP
, B-O B-COMMA
human B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Schizosaccharomyces B-O B-NP_FW
pombe B-O B-FW
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TFIIDs B-O B-S_NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
all B-O B-NP_DT
three B-O B-CD
organisms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
interchangeable B-O B-ADJP_JJ
among B-O B-PP_IN
all B-O B-NP_DT
three B-O B-CD
systems B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
S. B-O B-NP_NP_FW
cerevisiae B-O B-FW
" " B-O O-NP
and B-O B-CC
Sch. B-O B-NP_FW
pombe B-O B-FW
" " B-O O-NP
" " B-O O-NP
systems B-O B-NNS
" " B-O O-NP
support B-O B-VP_VBP
effects B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
acidic B-O B-NP_JJ
activator B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
provided B-O B-PP_VBN
a B-O B-SBAR_WHNP_S_NP_NP_DT
further B-O B-JJ
protein B-O B-NN
fraction B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
S. B-O B-NP_FW
cerevisiae B-O B-FW
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
supplied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
further B-O B-JJ
fraction B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
distinct B-O B-ADJP_JJ
from B-O B-PP_IN
the B-O B-NP_NP_DT
mediator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcriptional B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
described B-O B-VP_VBN
previously B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
represents B-O B-VP_VBZ
a B-O B-NP_DT
second B-O B-JJ
component B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
addition B-O B-NN
to B-O B-TO
general B-O B-NP_NP_JJ
initiation B-O B-NN
factors B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
may B-O B-S_NP_VP_MD
facilitate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
NF-kappa B-O B-S_NP_NP_ADJP_NN
B-dependent B-O B-JJ
" " B-O O-ADJP
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
p50 B-O B-NN
subunit B-O B-NN
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
underlies B-O B-VP_VBZ
self-perpetuation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
molecular B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
underlying B-O B-VP_VBG
the B-O B-NP_NP_DT
sustained B-O B-JJ
nuclear B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
U937 B-O B-NP_NP_NN
monocytic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
chronically B-O B-VP_ADVP_RB
" " B-O O-ADVP
infected B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
regulating B-O B-VP_VBG
the B-O B-NP_NP_DT
synthesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
p105 B-O B-NN
precursor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
p50 B-O B-NN
subunit B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
enhanced B-O B-VP_VBN
in B-O B-NP_PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletions B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
this B-O B-S_NP_DT
upregulation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
motif B-O B-NP_NP_NP_CONJP_NP_NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
by B-O B-PP_IN
bona B-O B-NP_ADJP_FW
fide B-O B-FW
" " B-O O-ADJP
p50/p65 B-O B-NN
heterodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cytosolic B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NN
B B-O B-NN
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
increased B-O B-VP_VBN
in B-O B-NP_PP_IN
HIV-infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NN
to B-O B-TO
the B-O B-NP_NP_DT
transient B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
phorbol B-O B-NP_NN
ester B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
permanent B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
translocation B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
HIV B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
PKC B-O B-NP_NN
isoenzymes B-O B-NNS
alpha B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
beta B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
as B-O B-SBAR_IN
shown B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
observations B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
during B-O B-S_PP_IN
chronic B-O B-NP_NP_JJ
HIV B-O B-NN
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
continuous B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
( B-O B-PRN_LRB
p50/p65 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
translocation B-O B-NN
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
p105 B-O B-NP_NP_NN
promoter B-O B-NN
upregulation B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-ADJP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
HIV-mediated B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
a B-O B-NP_NP_DT
self-perpetuating B-O B-JJ
loop B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
TAR-independent B-O B-NP_NP_NP_JJ
transactivation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
Tat B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_DT
CNS B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
a B-O B-NP_NP_DT
novel B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
gene B-O B-NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
Tat B-O B-NN
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
productive B-O B-NP_JJ
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
potential B-O B-JJ
target B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
antiviral B-O B-NP_JJ
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tat B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
potent B-O B-JJ
activator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
serves B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
greatly B-O B-ADVP_RB
" " B-O O-ADVP
increase B-O B-VP_VB
the B-O B-NP_NP_DT
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
directed B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
seems B-O B-S_NP_VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
due B-O B-PP_JJ
to B-O B-TO
increased B-O B-NP_NP_VBN
transcriptional B-O B-JJ
initiation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
increased B-O B-NP_VBN
transcriptional B-O B-JJ
elongation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
a B-O B-NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
processes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Much B-O B-S_NP_JJ
attention B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
focused B-O B-VP_VBN
on B-O B-NP_PP_IN
the B-O B-NP_NP_DT
interaction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Tat B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_DT
specific B-O B-JJ
RNA B-O B-NN
target B-O B-NN
" " B-O O-NP
termed B-O B-VP_VBN
" " B-O B-S_SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
interaction B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
believed B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
an B-O B-NP_NP_DT
important B-O B-JJ
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
in B-O B-S_PP_IN
certain B-O B-NP_JJ
CNS-derived B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
Tat B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
capable B-O B-ADJP_JJ
of B-O B-PP_IN
activating B-O B-S_NP_VP_VBG
" " B-O B-NP_PP_O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
Tat-responsive B-O B-JJ
element B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
found B-O B-VP_VBN
upstream B-O B-S_NP_ADVP_RB
within B-O B-PP_IN
the B-O B-NP_NP_DT
viral B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_PP_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletion B-O B-S_NP_NP_NN
mapping B-O B-NN
" " B-O O-NP
and B-O B-CC
hybrid B-O B-NP_NN
promoter B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
newly B-O B-ADJP_RB
identified B-O B-VBN
" " B-O O-ADJP
Tat-responsive B-O B-JJ
element B-O B-NN
" " B-O O-NP
corresponds B-O B-VP_VBZ
to B-O B-PP_TO
a B-O B-NP_NP_DT
sequence B-O B-NN
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_DT
viral B-O B-JJ
" " B-O B-NP_O-PP
previously B-O B-VP_ADVP_RB
" " B-O O-ADVP
identified B-O B-VBN
as B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNA B-O B-S_NP_NN
band-shift B-O B-JJ
analysis B-O B-NN
" " B-O O-NP
reveals B-O B-VP_VBZ
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
glial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
differs B-O B-S_NP_VP_VBZ
from B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
present B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
observe B-O B-VP_VBP
that B-O B-SBAR_IN
TAR-deleted B-O B-S_NP_NP_JJ
mutants B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrate B-O B-VP_VBP
normal B-O B-NP_NP_JJ
late B-O B-JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
glial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-SBAR_IN
evidenced B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LRB
ABSTRACT B-O B-NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-S
Bcl-2 B-O B-NP_NP_NP_NN
" " B-O O-NP
: B-O B-COLON
a B-O B-NP_NP_DT
repressor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphocyte B-O B-NP_NN
death B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
genes B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
mechanisms B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
control B-O B-S_NP_VP_VBP
programmed B-O B-NP_VBN
cell B-O B-NN
death B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
are B-O B-VP_VBP
currently B-O B-ADVP_RB
" " B-O O-ADVP
the B-O B-NP_NP_DT
subject B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
intense B-O B-NP_JJ
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
bcl-2 B-O B-NN
gene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
repressor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphocyte B-O B-NP_NN
death B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
perhaps B-O B-ADVP_RB
" " B-O O-ADVP
the B-O B-NP_NP_DT
best B-O B-JJS
understood B-O B-VBN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
programmed B-O B-ADJP_NP_VBN
cell B-O B-NN
death B-O B-NN
" " B-O O-NP
associated B-O B-JJ
" " B-O O-ADJP
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
Stanley B-O B-NP_NNP
Korsmeyer B-O B-NNP
" " B-O O-NP
provides B-O B-VP_VBZ
a B-O B-NP_NP_DT
brief B-O B-JJ
overview B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
bcl-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
concentrating B-O B-S_NP_VP_VBG
on B-O B-PP_IN
its B-O B-NP_NP_PRPP
roles B-O B-NNS
" " B-O O-NP
in B-O B-PP_PP_IN
development B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
oncogenesis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Mitogen B-O B-S_NP_NP_NN
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T-cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increases B-O B-VP_VBZ
c-Fos B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
protein B-O B-NN
levels B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
AP-1 B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
analysed B-O B-VP_VBN
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mitogenic B-O B-NP_JJ
lectins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_PP_IN
c-Fos B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
protein B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
on B-O B-PP_IN
binding B-O B-NP_NP_NP_NP_PRN_NN
" " B-O O-NP
and B-O B-CC
enhancer B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
T-cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_NP_CC
c-Fos B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
c-Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
protein B-O B-NN
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
increased B-O B-VP_VBN
after B-O B-NP_PP_IN
Con B-O B-NP_NP_NP_NN
A B-O B-NN
" " B-O O-NP
and B-O B-CC
PHA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
T-cell B-O B-S_NP_NN
stimulation B-O B-NN
" " B-O O-NP
increases B-O B-VP_VP_VBZ
both B-O B-NP_CC
intracellular B-O B-JJ
Ca2+ B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
cAMP B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
activates B-O B-VP_VBZ
protein B-O B-NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PKC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-NP_NP_DT
possible B-O B-JJ
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
intracellular B-O B-JJ
messengers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
c-Fos B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PMA B-O B-S_S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
directly B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
activates B-O B-VP_VBZ
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
mimicked B-O B-VP_VBD
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
lectins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
c-Fos B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
elevation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_CC
intracellular B-O B-JJ
Ca2+ B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
cAMP B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
little B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
no B-O B-ADJP_DT
" " B-O O-ADJP
" " B-O O-ADJP
effect B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mitogen-induced B-O B-JJ
increase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Fos B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
immunoreactivity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VP_VBN
by B-O B-NP_PP_IN
H-7 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
kinase B-O B-NN
inhibitor B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
less B-O B-VP_ADVP_RBR
efficiently B-O B-RB
" " B-O O-ADVP
by B-O B-PP_IN
H-8 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
structurally B-O B-ADJP_RB
related B-O B-JJ
" " B-O O-ADJP
kinase B-O B-NN
inhibitor B-O B-NN
" " B-O O-NP
less B-O B-ADJP_ADJP_RBR
active B-O B-JJ
on B-O B-PP_IN
" " B-O B-NP_O-ADJP
, B-O B-COMMA
but B-O B-CC
more B-O B-ADJP_RBR
active B-O B-JJ
on B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Con B-O B-S_NP_NN
A B-O B-NN
stimulation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
increase B-O B-VP_VB
both B-O B-NP_NP_CC
and B-O B-NP_NP_PP_PP_CC
AP-1 B-O B-NP_NN
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PMA B-O B-S_S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
increase B-O B-VP_VB
the B-O B-NP_DT
AP-1 B-O B-NN
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
elevation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Ca2+ B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
cAMP B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
only B-O B-NP_ADJP_RB
minor B-O B-JJ
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
mitogenic B-O B-NP_JJ
lectins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
sufficient B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
act B-O B-VP_VBP
via B-O B-PP_IN
mechanisms B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Pax-5 B-O B-S_NP_NN
" " B-O O-NP
encodes B-O B-VP_VP_VBZ
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
BSAP B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
B B-O B-NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
developing B-O B-VBG
CNS B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
adult B-O B-NP_JJ
testis B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
BSAP B-O B-S_NP_NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
identified B-O B-VP_VBN
previously B-O B-NP_ADVP_RB
" " B-O O-ADVP
as B-O B-PP_IN
a B-O B-NP_NP_DT
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Biochemical B-O B-S_NP_NP_JJ
purification B-O B-NN
" " B-O O-NP
and B-O B-CC
cDNA B-O B-NP_NN
cloning B-O B-NN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
now B-O B-ADVP_RB
" " B-O O-ADVP
revealed B-O B-VP_VBN
that B-O B-SBAR_IN
BSAP B-O B-S_NP_NN
" " B-O O-NP
belongs B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
BSAP B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
encoded B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
Pax-5 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
has B-O B-VP_VBZ
been B-O B-VP_VBN
highly B-O B-ADVP_RB
" " B-O O-ADVP
conserved B-O B-VP_VBN
between B-O B-NP_PP_IN
human B-O B-NP_NP_JJ
" " B-O O-NP
and B-O B-CC
mouse B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_DT
intact B-O B-JJ
paired B-O B-JJ
domain B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
both B-O B-ADJP_ADJP_CC
necessary B-O B-ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
sufficient B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Binding B-O B-S_NP_NP_VBG
studies B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
several B-O B-NP_JJ
BSAP B-O B-NN
recognition B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
sequence B-O B-NN
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
BSAP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
differs B-O B-VP_VBZ
from B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
paired B-O B-ADJP_JJ
domain B-O B-NN
protein B-O B-NN
Pax-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
During B-O B-S_PP_IN
embryogenesis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
BSAP B-O B-NN
gene B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
transiently B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
mesencephalon B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
spinal B-O B-NP_JJ
cord B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_DT
spatial B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
temporal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
expression B-O B-NN
pattern B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
distinct B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Later B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
BSAP B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
shifts B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
fetal B-O B-JJ
liver B-O B-NN
" " B-O O-NP
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
it B-O B-S_NP_PRP
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
BSAP B-O B-S_NP_NN
expression B-O B-NN
" " B-O O-NP
persists B-O B-VP_VP_VBZ
in B-O B-PP_IN
B B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
testis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
adult B-O B-JJ
mouse B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
evidence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicates B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_DT
transcription B-O B-NN
factor B-O B-NN
BSAP B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
not B-O B-VP_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
play B-O B-VP_VB
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
B-cell B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
in B-O B-VP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Okadaic B-O B-S_NP_JJ
acid B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
potent B-O B-JJ
inducer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
tumor B-O B-NP_NN
necrosis B-O B-NN
factor-alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
an B-O B-NP_NP_DT
optimal B-O B-JJ
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
okadaic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
phosphatases B-O B-NP_NNS
" " B-O B-NP_O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
the B-O B-NP_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
marked B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
no B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
octamer B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
Oct-1 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
both B-O B-S_NP_CC
AP-1 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
reported B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-ADJP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
we B-O B-NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
okadaic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
TNF-alpha B-O B-NP_NN
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
okadaic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_DT
striking B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
TNF-alpha B-O B-NP_NN
mRNA B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
1 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
stimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
large B-O B-S_NP_NP_JJ
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
TNF-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
released B-O B-VP_VBN
into B-O B-NP_PP_IN
the B-O B-NP_DT
culture B-O B-NN
media B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
okadaic B-O B-S_NP_JJ
acid B-O B-NN
" " B-O O-NP
provides B-O B-VP_VBZ
a B-O B-NP_NP_DT
potent B-O B-JJ
inductive B-O B-JJ
signal B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
AP-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
it B-O B-NP_PRP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
induce B-O B-VP_VB
either B-O B-NP_CC
B B-O B-NP_NN
cell B-O B-NN
proliferation B-O B-NN
" " B-O O-NP
or B-O B-CC
immunoglobulin B-O B-NP_NN
secretion B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_NP_NP_DT
novel B-O B-JJ
Ets-related B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
Elf-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
2 B-O B-CD
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
HIV-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
structurally B-O B-NP_NP_ADJP_RB
related B-O B-JJ
" " B-O O-ADJP
retroviruses B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_NP_O-NP
both B-O B-VP_DT
cause B-O B-VP_VBP
AIDS B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
humans B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
both B-O B-S_NP_DT
viruses B-O B-NNS
" " B-O O-NP
establish B-O B-VP_VBP
latency B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
quiescent B-O B-NP_JJ
human-peripheral-blood B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-NP_NP_DT
asymptomatic B-O B-JJ
phase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-2 B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
more B-O B-ADJP_ADJP_JJR
prolonged B-O B-JJ
" " B-O O-ADJP
than B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
latent B-O B-JJ
phases B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_NP_CC
HIV-1 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
HIV-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
disrupted B-O B-VP_VP_VBN
, B-O B-NP_PP_COMMA
" " B-O B-NP_NP_SBAR_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
case B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
sufficient B-O B-ADJP_JJ
for B-O B-PP_IN
inducible B-O B-NP_JJ
transcriptional B-O B-JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
factors B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
addition B-O B-NN
to B-O B-TO
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
HIV-2 B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
infected B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
novel B-O B-JJ
Ets-related B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
Elf-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
binds B-O B-VP_VBZ
specifically B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
two B-O B-NP_NP_CD
purine-rich B-O B-JJ
motifs B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
HIV-2 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutagenesis B-O B-S_NP_NN
experiments B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
these B-O B-S_NP_DT
Elf-1 B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
following B-O B-NP_PP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
Elf-1 B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
only B-O B-JJ
factor B-O B-NN
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
activated B-O B-NP_NP_VBN
T-cell B-O B-NN
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
" " B-O B-PP_PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
Elf-1 B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
novel B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
appears B-O B-S_NP_VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
may B-O B-VP_VP_MD
explain B-O B-VP_VB
differences B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
clinical B-O B-JJ
spectra B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
may B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
have B-O B-VP_VB
implications B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
design B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Human B-O B-S_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
Nef B-O B-NN
protein B-O B-NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
induction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
can B-O B-VP_MD
establish B-O B-VP_VB
a B-O B-NP_NP_DT
persistent B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
latent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
infection B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
CD4+ B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
W.C.Greene B-O B-NP_NP_NP_NNP
" " B-O O-NP
, B-O B-COMMA
N.Engl.J. B-O B-NP_NNP
Med.324 B-O B-NNP
: B-O B-COLON
308-317 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
1991 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
S.M.Schnittman B-O B-NP_NP_NP_NNP
" " B-O O-NP
, B-O B-COMMA
M.C.Psallidopoulos B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
H.C. B-O B-NP_NNP
Lane B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
L.Thompson B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
M.Baseler B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
F.Massari B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
C.H.Fox B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
N.P.Salzman B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
A.S.Fauci B-O B-NP_NNP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
Science B-O B-NP_NNP
245 B-O B-CD
: B-O B-COLON
305-308 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
1989 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Production B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
latently B-O B-NP_ADJP_RB
infected B-O B-JJ
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VBZ
host B-O B-NP_NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
T-cell B-O B-NP_NN
mitogens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
T.Folks B-O B-NP_NP_NP_NP_NNP
" " B-O O-NP
, B-O B-COMMA
D.M.Powell B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
M.M.Lightfoote B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
S.Benn B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
M.A. B-O B-NP_NNP
Martin B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
A.S.Fauci B-O B-NP_NNP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
Science B-O B-NP_NNP
231 B-O B-CD
: B-O B-COLON
600-602 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
1986 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
D.Zagury B-O B-NP_NP_NP_NNP
" " B-O O-NP
, B-O B-COMMA
J. B-O B-NP_NNP
Bernard B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
R.Leonard B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
R.Cheynier B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
M.Feldman B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
P.S.Sarin B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
R.C. B-O B-NP_NNP
Gallo B-O B-NNP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
Science B-O B-NP_NNP
231 B-O B-CD
: B-O B-COLON
850-853 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
1986 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
activation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
host B-O B-NN
transcription B-O B-NN
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
[ B-O B-PRN_LRB
G.Nabel B-O B-NP_NP_NP_NNP
" " B-O O-NP
and B-O B-CC
D.Baltimore B-O B-NP_NNP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
Nature B-O B-NP_NNP
( B-O B-LRB
London B-O B-NNP
) B-O B-RRB
326 B-O B-CD
: B-O B-COLON
711-717 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
1987 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
HIV-1-encoded B-O B-JJ
Nef B-O B-NN
protein B-O B-NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
"T- cell" B-O B-NP_NN
mitogens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
Nef B-O B-NP_NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
affect B-O B-VP_VB
the B-O B-NP_NP_DT
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
implicated B-O B-VP_VBN
in B-O B-NP_PP_IN
HIV-1 B-O B-NP_NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
including B-O B-PP_VBG
SP-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
USF B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
URS B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Additionally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
Nef B-O B-S_S_NP_NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_ADJP_ADJP_NP_ADJP_O-ADJP
and B-O B-CC
interleukin B-O B-ADJP_NN
2-directed B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
HIV-1 B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
depends B-O B-VP_VBZ
on B-O B-PP_IN
an B-O B-NP_DT
intact B-O B-JJ
NF-kappa B-O B-NN
B-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
defective B-O B-S_NP_NP_JJ
recruitment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
underlie B-O B-VP_VB
Nef B-O B-NP_NP_NP_NN
's B-O B-POS
" " B-O O-NP
negative B-O B-JJ
transcriptional B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
promoters B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_NP_JJ
evidence B-O B-NN
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
Nef B-O B-S_NP_NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
NF-kappa B-O B-NP_NN
B B-O B-NN
induction B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
interfering B-O B-S_NP_VP_VBG
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_NP_NP_DT
novel B-O B-JJ
mitogen-inducible B-O B-JJ
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
related B-O B-ADJP_JJ
to B-O B-PP_TO
p50/p105-NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
participates B-O B-VP_VBZ
in B-O B-PP_IN
transactivation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
a B-O B-NP_DT
kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
Rel-related B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
mitogen-inducible B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
kappa B-O B-ADJP_NN
B-binding B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
protein B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
cloned B-O B-VP_VBN
as B-O B-NP_PP_IN
an B-O B-NP_NP_DT
immediate-early B-O B-JJ
activation B-O B-NN
gene B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
cDNA B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
an B-O B-NP_NP_DT
open B-O B-JJ
reading B-O B-NN
frame B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
900 B-O B-NP_CD
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
encoding B-O B-S_NP_VP_VBG
a B-O B-NP_DT
97-kDa B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
protein B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
most B-O B-ADJP_RBS
similar B-O B-JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
105-kDa B-O B-JJ
precursor B-O B-NN
polypeptide B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p50-NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Like B-O B-S_PP_IN
the B-O B-NP_DT
105-kDa B-O B-JJ
precursor B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
contains B-O B-VP_VBZ
an B-O B-NP_NP_NP_DT
amino-terminal B-O B-JJ
Rel-related B-O B-JJ
domain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
about B-O B-NP_QP_IN
300 B-O B-CD
" " B-O O-QP
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
carboxy-terminal B-O B-JJ
domain B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
six B-O B-NP_CD
full B-O B-NP_NP_JJ
cell B-O B-NN
cycle B-O B-NN
" " B-O O-NP
or B-O B-CC
ankyrin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
repeats B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_NP_ADJP_FW
vitro-translated B-O B-JJ
" " B-O O-ADJP
proteins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
truncated B-O B-VP_VP_VBN
downstream B-O B-NP_ADVP_RB
of B-O B-PP_IN
the B-O B-NP_DT
Rel B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
and B-O B-CC
excluding B-O B-VP_VBG
the B-O B-NP_DT
repeats B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
bind B-O B-VP_VBP
kappa B-O B-NP_NN
B B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
refer B-O B-VP_VBP
to B-O B-PP_PP_TO
the B-O B-NP_NP_DT
kappa B-O B-ADJP_NN
B-binding B-O B-JJ
" " B-O O-ADJP
" " B-O O-NP
, B-O B-COMMA
truncated B-O B-NP_NP_VBN
protein B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
p50B B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
analogy B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
to B-O B-PP_TO
the B-O B-NP_NP_DT
full-length B-O B-JJ
protein B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
p97 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
p50B B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
form B-O B-VP_VB
heteromeric B-O B-NP_JJ
kappa B-O B-ADJP_NN
B-binding B-O B-JJ
" " B-O O-ADJP
complexes B-O B-NNS
" " B-O O-NP
with B-O B-PP_PP_IN
RelB B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
with B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transient-transfection B-O B-S_NP_NP_NN
experiments B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
embryonal B-O B-NP_JJ
carcinoma B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrate B-O B-VP_VBP
a B-O B-NP_NP_DT
functional B-O B-JJ
cooperation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
p50B B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
RelB B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
transactivation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
reporter B-O B-NN
plasmid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
a B-O B-NP_DT
kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
imply B-O B-VP_VBP
the B-O B-NP_NP_DT
existence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
complex B-O B-JJ
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_ADJP_NN
B-like B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcriptional B-O B-NP_NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
T-cell B-O B-NP_NN
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
the B-O B-NP_NP_DT
alpha B-O B-NN
TCR B-O B-NN
gene B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_DT
molecular B-O B-JJ
model B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
lymphocyte B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
complex B-O B-JJ
process B-O B-NN
" " B-O O-NP
involving B-O B-VP_VBG
interactions B-O B-NP_NP_NNS
" " B-O O-NP
between B-O B-PP_IN
multiple B-O B-NP_JJ
positive B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
negative B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
transcriptional B-O B-JJ
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
article B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
transcriptional B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
archetypal B-O B-JJ
T-cell-specific B-O B-JJ
gene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
alpha B-O B-NP_NN
TCR B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
discussed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Major B-O B-S_NP_NP_JJ
recent B-O B-JJ
developments B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
the B-O B-NP_NP_DT
identification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
novel B-O B-NP_NP_JJ
families B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
described B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
An B-O B-S_NP_NP_DT
11-base-pair B-O B-JJ
DNA B-O B-NN
sequence B-O B-NN
motif B-O B-NN
" " B-O O-NP
apparently B-O B-ADJP_RB
unique B-O B-JJ
to B-O B-PP_TO
the B-O B-NP_DT
human B-O B-JJ
interleukin B-O B-NN
4 B-O B-CD
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
confers B-O B-VP_VBZ
responsiveness B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
T-cell B-O B-NP_NN
activation B-O B-NN
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
a B-O B-NP_NP_DT
DNA B-O B-NN
segment B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
confers B-O B-S_NP_VP_VBZ
responsiveness B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
on B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
human B-O B-JJ
IL-4 B-O B-NN
gene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
of B-O B-PP_IN
10 B-O B-NP_CD
kilobases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
composed B-O B-VP_VBN
of B-O B-NP_PP_IN
four B-O B-NP_NP_CD
exons B-O B-NNS
" " B-O O-NP
and B-O B-CC
three B-O B-NP_CD
introns B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_S_NP_NP_DT
cis-acting B-O B-JJ
element B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-NP_NN
sequence B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
resides B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_DT
5' B-O B-ADJP_NP_JJ
" " B-O O-NP
upstream B-O B-JJ
" " B-O O-ADJP
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
no B-O B-S_NP_NP_DT
additional B-O B-JJ
DNA B-O B-NN
segments B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
enhancer B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
human B-O B-JJ
IL-4 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
For B-O B-S_PP_IN
further B-O B-NP_JJ
mapping B-O B-NN
purposes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_DT
fusion B-O B-NN
promoter B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
constructed B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
granulocyte/macrophage B-O B-ADJP_JJ
colony-stimulating B-O B-JJ
" " B-O O-ADJP
factor B-O B-NN
basic B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
60 B-O B-NP_NP_NP_CD
base B-O B-NN
pairs B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
upstream B-O B-NP_ADJP_JJ
" " B-O B-PP_O-NP
and B-O B-CC
various B-O B-NP_NP_JJ
lengths B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
P B-O B-NN
sequence B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
located B-O B-ADJP_JJ
between B-O B-PP_IN
positions B-O B-NP_NNS
-79 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
-69 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
relative B-O B-PP_JJ
to B-O B-TO
the B-O B-NP_NP_DT
transcription B-O B-NN
start B-O B-NN
site B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
IL-4 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
this B-O B-S_NP_DT
location B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
confirmed B-O B-VP_VBN
by B-O B-NP_PP_IN
base-substitution B-O B-NP_NN
mutations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
plasmids B-O B-NNS
" " B-O O-NP
carrying B-O B-VP_VBG
multiple B-O B-NP_NP_JJ
copies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
P B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
showed B-O B-VP_VBD
higher B-O B-NP_NP_JJR
responsiveness B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
binding B-O B-VBG
protein B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
recognize B-O B-S_NP_VP_VBP
the B-O B-NP_NP_DT
P B-O B-NN
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-4 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
by B-O B-NP_PP_IN
DNA-mobility-shift B-O B-NP_JJ
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF(P) B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
a B-O B-NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
specifically B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
recognizes B-O B-VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
P B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
abolished B-O B-VP_VBN
when B-O B-NP_SBAR_WHADVP_WRB
" " B-O O-WHADVP
oligonucleotides B-O B-S_NP_NP_NNS
" " B-O O-NP
carrying B-O B-VP_VBG
base B-O B-NP_NN
substitutions B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_DT
NF(P) B-O B-NN
interaction B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-ADJP_O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
binding B-O B-NP_NP_NN
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
paralleled B-O B-VP_VBD
" " B-O B-NP_NP_PP_ADVP_O-VP
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
P B-O B-NN
sequence B-O B-NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
share B-O B-VP_VB
homology B-O B-NP_NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
5' B-O B-ADJP_NP_JJ
" " B-O O-NP
upstream B-O B-JJ
" " B-O O-ADJP
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
even B-O B-SBAR_RB
though B-O B-IN
surrounding B-O B-S_NP_NP_VBG
sequences B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-4 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
share B-O B-VP_NN
high B-O B-NP_JJ
homology B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
different B-O B-JJ
set B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
proteins B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
recognize B-O B-VP_VBP
IL-2 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
genes B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Studies B-O B-NP_NP_NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
biological B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
triiodothyronine B-O B-NP_NN
sulfate B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Hepatic B-O B-S_NP_NP_NP_JJ
microsomes B-O B-NNS
" " B-O O-NP
and B-O B-CC
isolated B-O B-NP_VBN
hepatocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
short B-O B-NP_JJ
term B-O B-NN
culture B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
desulfate B-O B-VP_VBP
T3 B-O B-NP_NP_NN
sulfate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
T3SO4 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
, B-O B-COMMA
therefore B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
wished B-O B-VP_VBD
to B-O B-S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
T3SO4 B-O B-S_NP_NN
" " B-O O-NP
could B-O B-VP_MD
mimic B-O B-VP_VB
" " B-O B-NP_ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
T3SO4 B-O B-S_NP_NN
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
thyromimetic B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Ca(2+)-ATPase B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
erythrocyte B-O B-NN
membranes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
doses B-O B-NP_NP_NNS
" " B-O O-NP
up B-O B-NP_NP_NP_QP_RB
to B-O B-TO
10,000 B-O B-CD
times B-O B-NNS
" " B-O O-QP
the B-O B-DT
maximally B-O B-ADJP_RB
effective B-O B-JJ
" " B-O O-ADJP
dose B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
10(-10) B-O B-NP_CD
mol/L B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
GH4C1 B-O B-NP_NN
pituitary B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
T3SO4 B-O B-NP_NN
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
displace B-O B-VP_VB
[125I]T3 B-O B-NP_NN
" " B-O O-NP
from B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
T3SO4 B-O B-NP_NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
directly B-O B-ADVP_RB
" " B-O O-ADVP
thyromimetic B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
either B-O B-NP_NP_CC
an B-O B-NP_DT
isolated B-O B-VBN
human B-O B-JJ
membrane B-O B-NN
system B-O B-NN
" " B-O O-NP
or B-O B-CC
a B-O B-NP_DT
pituitary B-O B-JJ
cell B-O B-NN
system B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
nuclear B-O B-S_NP_JJ
receptor B-O B-NN
occupancy B-O B-NN
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
GH B-O B-NP_NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thyroid B-O B-S_S_NP_NN
hormones B-O B-NNS
" " B-O O-NP
inhibit B-O B-VP_VBP
[3H]glycosaminoglycan B-O B-NP_NN
synthesis B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
cultured B-O B-NP_VBN
human B-O B-JJ
dermal B-O B-JJ
fibroblasts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
T3SO4 B-O B-S_NP_NN
" " B-O O-NP
displayed B-O B-VP_VBN
about B-O B-NP_NP_NP_QP_IN
0.5 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
the B-O B-NP_DT
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
T3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
at B-O B-PP_IN
72 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_NP_JJ
fibroblasts B-O B-NNS
" " B-O O-NP
contained B-O B-VP_VBD
roughly B-O B-NP_NP_NP_ADVP_RB
" " B-O O-ADVP
the B-O B-DT
same B-O B-JJ
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
microsomal B-O B-NP_JJ
p-nitrophenyl B-O B-NN
sulfatase B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
previously B-O B-VP_ADVP_RB
" " B-O O-ADVP
observed B-O B-VBN
in B-O B-NP_PP_IN
hepatic B-O B-NP_JJ
microsomes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Propylthiouracil B-O B-S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
50 B-O B-FRAG_NP_CD
mumol/L B-O B-NN
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
affect B-O B-VP_VB
the B-O B-NP_NP_DT
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T3SO4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
deiodination B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
important B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
appears B-O B-VP_VBZ
T3SO4 B-O B-SBAR_WHNP_S_NP_NN
" " B-O O-NP
has B-O B-VP_VP_VBZ
no B-O B-NP_DT
intrinsic B-O B-JJ
biological B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
, B-O B-COMMA
under B-O B-VP_PP_IN
certain B-O B-NP_JJ
circumstances B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
may B-O B-VP_MD
be B-O B-VP_VB
reactivated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Nuclear B-O B-S_NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contains B-O B-VP_VBZ
Fos B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
nuclear B-O B-JJ
factor B-O B-NN
NF-AT B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ref. B-O B-NP_NN
1 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VP_VBZ
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
through B-O B-NP_PP_IN
the B-O B-NP_DT
complex B-O B-ADJP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
interleukin-2 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
gene B-O B-NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
NF-AT B-O B-S_NP_NN
" " B-O O-NP
has B-O B-VP_VBZ
not B-O B-RB
been B-O B-VP_VBN
cloned B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
or B-O B-CC
purified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
evidence B-O B-NP_NN
that B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
major B-O B-JJ
target B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-AT B-O B-S_NP_NN
induction B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
require B-O B-VP_VB
two B-O B-NP_NP_CD
activation-dependent B-O B-JJ
events B-O B-NNS
" " B-O O-NP
: B-O B-COLON
the B-O B-NP_NP_NP_DT
CsA-sensitive B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
pre-existing B-O B-JJ
component B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
CsA-resistant B-O B-JJ
synthesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
nuclear B-O B-JJ
component B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
newly B-O B-ADJP_RB
synthesized B-O B-VBN
" " B-O O-ADJP
nuclear B-O B-JJ
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
AP-1 B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
inducible B-O B-JJ
nuclear B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contains B-O B-VP_VBZ
Fos B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
identify B-O B-VP_VBP
a B-O B-NP_NP_DT
pre-existing B-O B-JJ
NF-AT-binding B-O B-JJ
factor B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
present B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-DT
basis B-O B-NN
of B-O B-IN
binding B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
reconstitution B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
cotransfection B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
that B-O B-SBAR_IN
activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurs B-O B-VP_VBZ
in B-O B-PP_IN
at B-O B-NP_NP_QP_IN
least B-O B-JJS
two B-O B-CD
" " B-O O-QP
stages B-O B-NNS
" " B-O O-NP
: B-O B-COLON
, B-O B-NP_NP_NP_VP_COMMA
and B-O B-CC
" " B-O B-NP_NP_VP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
NFAT-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
putative B-O B-JJ
NFAT-1 B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
analyzed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
the B-O B-NP_DT
T-cell B-O B-NN
antigen B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
minimal B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
kappa B-O B-NN
B B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
putative B-O B-JJ
NFAT-1 B-O B-NN
region B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
required B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
to B-O B-PP_PP_TO
anti-CD3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
to B-O B-PP_TO
mitogens B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
in B-O B-PP_IN
, B-O B-NP_NP_NP_COMMA
, B-O B-NP_COMMA
or B-O B-CC
lines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
nor B-O B-CC
is B-O B-SINV_VP_VBZ
" " B-O O-VP
it B-O B-NP_PRP
" " B-O O-NP
a B-O B-NP_DT
cis-acting B-O B-JJ
negative B-O B-JJ
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-SINV
. B-O B-PERIOD
" " B-O O-S
Cytoplasmic B-O B-NP_NP_NP_JJ
domain B-O B-NN
heterogeneity B-O B-NN
" " B-O O-NP
and B-O B-CC
functions B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
IgG B-O B-NP_NN
Fc B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
B B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
B B-O B-S_NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
express B-O B-VP_VBP
closely B-O B-NP_NP_ADJP_RB
related B-O B-JJ
" " B-O O-ADJP
immunoglobulin B-O B-NP_NP_NN
G B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IgG B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
Fc B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
Fc B-O B-PRN_NN
gamma B-O B-NN
RII B-O B-NN
" " B-O O-PRN
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
differ B-O B-S_NP_VP_VBP
only B-O B-ADVP_RB
in B-O B-IN
the B-O B-NP_NP_DT
structures B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_PP_IN
of B-O B-IN
cell B-O B-NP_ADJP_NN
type-specific B-O B-JJ
" " B-O O-ADJP
alternative B-O B-JJ
messenger B-O B-NN
RNA B-O B-NN
splicing B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
B-cell B-O B-NP_NN
Fc B-O B-NN
gamma B-O B-NN
RII B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
an B-O B-NP_NP_DT
insertion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
47 B-O B-NP_CD
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
participates B-O B-S_NP_VP_VBZ
in B-O B-PP_IN
determining B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transfection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
Fc B-O B-ADJP_NN
gamma B-O B-NN
RII-negative B-O B-JJ
" " B-O O-ADJP
B-cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
complementary B-O B-S_NP_JJ
DNA B-O B-NN
's B-O B-POS
" " B-O O-NP
encoding B-O B-VP_VBG
the B-O B-NP_NP_DT
two B-O B-CD
splice B-O B-NN
products B-O B-NNS
" " B-O O-NP
and B-O B-CC
various B-O B-NP_JJ
receptor B-O B-NN
mutants B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
insertion B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
preventing B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
insertion B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
required B-O B-VP_VBN
for B-O B-NP_PP_IN
Fc B-O B-S_NP_NN
gamma B-O B-NN
RII B-O B-NN
" " B-O O-NP
to B-O B-VP_TO
modulate B-O B-VP_VB
surface B-O B-NP_NN
immunoglobulin-triggered B-O B-JJ
B-cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Instead B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involved B-O B-VP_VBD
a B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cytoplasmic B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
common B-O B-ADJP_JJ
to B-O B-PP_TO
both B-O B-NP_CC
the B-O B-DT
lymphocyte B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
macrophage B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
receptor B-O B-NN
isoforms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
insertion B-O B-NN
" " B-O O-NP
did B-O B-VP_VBD
contribute B-O B-VP_VB
to B-O B-PP_TO
the B-O B-NP_NP_DT
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
caps B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
receptor B-O B-NP_NN
cross-linking B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
consistent B-O B-S_NP_ADJP_JJ
with B-O B-PP_IN
suggestions B-O B-NP_NNS
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Interleukin B-O B-S_NP_NP_ADJP_NN
6-induced B-O B-JJ
" " B-O O-ADJP
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
human B-O B-JJ
B B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
IgM-secreting B-O B-NP_JJ
plasma B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
protooncogene B-O B-NN
c-fos B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
interleukin B-O B-NP_ADJP_NN
( B-O B-LRB
IL B-O B-NN
) B-O B-RRB
6-induced B-O B-JJ
" " B-O O-ADJP
B B-O B-NN
cell B-O B-NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
assessed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
SKW B-O B-NP_NN
6.4 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
IL B-O B-NP_NN
6 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induced B-O B-VP_VBD
a B-O B-NP_NP_DT
transient B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
early B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
sense B-O B-NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
appeared B-O B-VP_VP_VBD
within B-O B-PP_IN
30 B-O B-NP_CD
min B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
returned B-O B-VP_VBD
to B-O B-PP_TO
basal B-O B-NP_JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
2 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
antisense B-O B-NP_JJ
oligonucleotides B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
significantly B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
IL B-O B-NP_ADJP_NN
6-induced B-O B-JJ
" " B-O O-ADJP
IgM B-O B-NN
production B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
SKW B-O B-NP_NN
6.4 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
p B-O B-S_NP_NN
" " B-O O-NP
less B-O B-NP_QP_JJR
than B-O B-IN
0.001 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
control B-O B-S_NP_NN
oligonucleotides B-O B-NNS
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
differentiation B-O B-NP_NP_ADJP_NN
" " B-O O-NP
of B-O B-PP_IN
into B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
erythroid B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
non-erythroid B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
nuclear B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_NP_DT
silencer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
epsilon-globin-encoding B-O B-JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
To B-O B-S_S_NP_VP_TO
clarify B-O B-VP_VB
the B-O B-NP_NP_DT
molecular B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
developmental B-O B-JJ
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
studying B-O B-VP_VBG
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
continuous B-O B-NP_JJ
culture B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
reported B-O B-VP_VBN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
transcriptional B-O B-JJ
control B-O B-NN
element B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
properties B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
[ B-O B-PRN_LRB
Cao B-O B-FRAG_NP_NP_NNP
" " B-O O-NP
et B-O B-FW
al. B-O B-NP_FW
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
Proc.Natl.Acad.Sci.USA B-O B-NP_NNP
86 B-O B-CD
( B-O B-LRB
1989 B-O B-CD
) B-O B-RRB
5306-5309 B-O B-CD
" " B-O O-NP
" " B-O O-FRAG
] B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
this B-O B-S_NP_DT
silencer B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
stronger B-O B-NP_JJR
inhibitory B-O B-JJ
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-SBAR_IN
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
deletion B-O B-NP_NP_NN
mutants B-O B-NNS
" " B-O O-NP
and B-O B-CC
cis-cloned B-O B-NP_JJ
synthetic B-O B-JJ
oligodeoxyribonucleotides B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
transient B-O B-NP_JJ
expression B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
nucleotide B-O B-NP_NP_NN
sequences B-O B-NNS
" " B-O O-NP
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
this B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
have B-O B-VP_VBP
now B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
further B-O B-ADVP_RBR
" " B-O O-ADVP
delimited B-O B-VP_VBN
to B-O B-NP_PP_TO
44 B-O B-NP_NP_CD
bp B-O B-NN
" " B-O O-NP
located B-O B-ADJP_JJ
bp B-O B-PP_PP_PP_PP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Gel B-O B-S_NP_NP_NN
electrophoresis B-O B-NN
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
and B-O B-CC
DNaseI B-O B-NP_NN
footprinting B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
these B-O B-S_NP_DT
negative B-O B-JJ
regulatory B-O B-JJ
sequences B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
recognized B-O B-VP_VBN
differently B-O B-NP_ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
proteins B-O B-NP_NP_NNS
" " B-O O-NP
present B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_CD
binding B-O B-VBG
proteins B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
K562 B-O B-NP_NN
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
while B-O B-SBAR_IN
only B-O B-S_NP_QP_RB
one B-O B-CD
" " B-O O-QP
" " B-O O-NP
is B-O B-VP_VBZ
found B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Possible B-O B-S_NP_NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
these B-O B-S_NP_DT
proteins B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
regulate B-O B-VP_VB
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
epsilon-globin-encoding B-O B-JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
cells B-O B-NP_ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
are B-O B-VP_VBP
discussed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
T B-O B-NP_NP_ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
negative B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
cytokine B-O B-NN
IL-4 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
IL-4 B-O B-S_NP_NP_NN
" " B-O O-NP
secreted B-O B-VP_VBN
by B-O B-NP_PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
pleiotropic B-O B-JJ
cytokine B-O B-NN
" " B-O O-NP
affecting B-O B-VP_VBG
growth B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
diverse B-O B-NP_NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
upstream B-O B-JJ
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
IL-4 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_NP_NP_DT
novel B-O B-JJ
T B-O B-ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
negative B-O B-JJ
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NRE B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O B-NP_O-NP
composed B-O B-VP_VBN
of B-O B-NP_PP_IN
two B-O B-NP_CD
protein-binding B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
mapped B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
5' B-O B-JJ
flanking B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-4 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
-311CTCCCTTCT-303 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
NRE-I B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
-288CTTTTTGCTT-TGC-300 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
NRE-II B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_NP_DT
T B-O B-ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
Neg-1 B-O B-NN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_DT
ubiquitous B-O B-JJ
protein B-O B-NN
Neg-2 B-O B-NN
" " B-O O-NP
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
NRE-I B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NRE-II B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
a B-O B-NP_DT
positive B-O B-JJ
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
45 B-O B-NP_ADVP_NP_CD
bp B-O B-NN
" " B-O O-NP
downstream B-O B-RB
of B-O B-PP_IN
the B-O B-NP_DT
NRE B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
PRE B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
completely B-O B-ADVP_RB
" " B-O O-ADVP
suppressed B-O B-VP_VBN
when B-O B-NP_SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
NRE B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
present B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
IL-4 B-O B-S_NP_NN
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
normally B-O B-ADVP_RB
" " B-O O-ADVP
down-regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_DT
NRE B-O B-NN
" " B-O O-NP
" " B-O O-PP
via B-O B-PP_IN
repression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
have B-O B-VP_VB
implications B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
stringent B-O B-JJ
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-4 B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Human B-O B-S_NP_NP_JJ
T B-O B-NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
through B-O B-PP_IN
the B-O B-NP_DT
activation-inducer B-O B-JJ
molecule/CD69 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
enhances B-O B-VP_VBZ
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factor B-O B-NN
AP-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
AP-1 B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
ascribed B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
early B-O B-JJ
events B-O B-NNS
" " B-O O-NP
leading B-O B-VP_VBG
to B-O B-PP_TO
T B-O B-NP_NN
cell B-O B-NN
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
studied B-O B-VP_VBN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
through B-O B-NP_PP_IN
the B-O B-NP_DT
activation B-O B-NN
inducer B-O B-NN
molecule B-O B-NN
( B-O B-LRB
AIM B-O B-NN
) B-O B-RRB
/CD69 B-O B-NN
activation B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Phorbol B-O B-S_NP_NN
esters B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
to B-O B-UCP_S_NP_VP_TO
induce B-O B-VP_VB
AIM/CD69 B-O B-NP_NN
cell-surface B-O B-JJ
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
for B-O B-PP_IN
triggering B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
proliferation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
in B-O B-PP_IN
conjunction B-O B-NN
with B-O B-IN
anti-AIM B-O B-NP_JJ
mAb B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mobility B-O B-S_NP_NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
addition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
anti-AIM B-O B-NP_JJ
mAb B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
PMA-treated B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VBD
the B-O B-NP_NP_DT
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
its B-O B-NP_NP_PRPP
cognate B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
phorbol B-O B-NN
ester B-O B-NN
response B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
anti-AIM B-O B-NP_NN
mAb B-O B-NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
induce B-O B-VP_VB
any B-O B-NP_NP_DT
change B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-NP_NP_SBAR_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
AP-1-binding B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
marked B-O B-JJ
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
that B-O B-NP_DT
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Blockade B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
DNA-binding B-O B-JJ
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
an B-O B-NP_DT
anti-Fos B-O B-JJ
mAb B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
a B-O B-NP_NP_DT
direct B-O B-JJ
participation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
AP-1 B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
anti-AIM B-O B-NP_NN
mAb B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Most B-O B-S_NP_NP_JJS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
AP-1 B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
eliminated B-O B-VP_VBN
when B-O B-NP_SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
anti-AIM B-O B-NN
mAb B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
added B-O B-VP_VBN
to B-O B-NP_PP_TO
in B-O B-NP_PP_IN
the B-O B-DT
presence B-O B-NN
of B-O B-IN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
protein B-O B-S_NP_ADJP_NN
synthesis B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
provide B-O B-VP_VBP
the B-O B-NP_DT
evidence B-O B-NN
that B-O B-SBAR_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
the B-O B-NP_DT
AIM B-O B-NN
activation B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
regulate B-O B-VP_VBP
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
this B-O B-NP_DT
pathway B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
as B-O B-PP_IN
a B-O B-NP_NP_DT
crucial B-O B-JJ
step B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
initiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
early B-O B-NP_JJ
T B-O B-NN
cell B-O B-NN
activation B-O B-NN
events B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
cis-acting B-O B-S_NP_NP_JJ
sequences B-O B-NNS
" " B-O O-NP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
inducible B-O B-NP_JJ
interleukin-2 B-O B-NN
enhancer B-O B-NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
bind B-O B-VP_VBP
a B-O B-NP_NP_DT
novel B-O B-JJ
Ets-related B-O B-JJ
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
Elf-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
recent B-O B-JJ
definition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
consensus B-O B-NN
DNA B-O B-NN
binding B-O B-NN
sequence B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
Ets B-O B-NN
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
allowed B-O B-VP_VBN
the B-O B-NP_NP_DT
identification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
potential B-O B-NP_NP_JJ
Ets B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
studies B-O B-NNS
" " B-O O-NP
described B-O B-VP_VBN
in B-O B-NP_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
two B-O B-NP_NP_NP_CD
potential B-O B-JJ
Ets B-O B-NNS
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
EBS1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
EBS2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
conserved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Within B-O B-S_PP_IN
the B-O B-NP_DT
human B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
these B-O B-NP_DT
two B-O B-CD
sites B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
located B-O B-ADJP_JJ
within B-O B-PP_IN
the B-O B-NP_NP_DT
previously B-O B-ADJP_RB
defined B-O B-VBN
" " B-O O-ADJP
DNase B-O B-NN
I B-O B-CD
footprints B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
NFAT-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NFIL-2B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Electrophoretic B-O B-S_NP_NP_NP_JJ
mobility B-O B-NN
shift B-O B-NN
" " B-O O-NP
and B-O B-CC
methylation B-O B-NP_NN
interference B-O B-NN
" " B-O O-NP
" " B-O O-NP
analyses B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
EBS1 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
EBS2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
essential B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_NP_DT
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
mutagenesis B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
inducible B-O B-S_NP_JJ
interleukin-2 B-O B-NN
enhancer B-O B-NN
function B-O B-NN
" " B-O O-NP
requires B-O B-VP_VBZ
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_CC
EBS1 B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
EBS2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_CD
well-characterized B-O B-JJ
Ets B-O B-NN
family B-O B-NN
members B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
Ets-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Ets-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
reciprocally B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
during B-O B-NP_PP_IN
T-cell B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Surprisingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
neither B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
bound B-O B-VP_VBD
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
to B-O B-PP_TO
EBS1 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
EBS2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
screened B-O B-VP_VP_VBD
a B-O B-NP_DT
T-cell B-O B-NN
cDNA B-O B-NN
library B-O B-NN
" " B-O O-NP
under B-O B-PP_IN
low-stringency B-O B-NP_NN
conditions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_DT
probe B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
domain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Ets-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
isolated B-O B-VP_VBD
a B-O B-NP_NP_DT
novel B-O B-JJ
Ets B-O B-NN
family B-O B-NN
member B-O B-NN
" " B-O O-NP
, B-O B-COMMA
Elf-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Elf-1 B-O B-S_NP_NN
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
domain B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
nearly B-O B-ADJP_RB
identical B-O B-JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
( B-O B-PRN_LRB
hence B-O B-FRAG_ADVP_RB
" " B-O O-ADVP
the B-O B-NP_DT
name B-O B-NN
Elf-1 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
for B-O B-PP_IN
E74-like B-O B-NP_JJ
factor B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Elf-1 B-O B-S_NP_NN
" " B-O O-NP
bound B-O B-VP_VBD
specifically B-O B-PP_RB
to B-O B-TO
both B-O B-NP_CC
EBS1 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
EBS2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
bound B-O B-VP_VBD
to B-O B-PP_TO
the B-O B-NP_NP_DT
purine-rich B-O B-JJ
CD3R B-O B-NN
element B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_NP_DT
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
2 B-O B-CD
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
multiple B-O B-S_NP_NP_JJ
Ets B-O B-NN
family B-O B-NN
members B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
apparently B-O B-NP_ADJP_RB
distinct B-O B-JJ
" " B-O O-ADJP
DNA B-O B-NN
binding B-O B-NN
specificities B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
regulate B-O B-VP_VBP
differential B-O B-NP_NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
and B-O B-NP_ADJP_ADJP_CC
T B-O B-ADJP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Glucocorticoid B-O B-NP_NP_NP_NN
receptor B-O B-NN
binding B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
three B-O B-NP_NP_CD
different B-O B-JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
major B-O B-NP_JJ
depressive B-O B-JJ
disorder B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
lack B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
evidence B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
receptor B-O B-NP_NN
binding B-O B-NN
defect B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
1 B-O B-S_S_LST_LS
. B-O B-PERIOD
" " B-O O-LST
In B-O B-SBAR_IN
order B-O B-NN
to B-O B-TO
further B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
understand B-O B-VP_VB
the B-O B-NP_NP_DT
apparent B-O B-JJ
glucocorticoid B-O B-NN
resistance B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
major B-O B-NP_JJ
depressive B-O B-JJ
disorder B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
circadian B-O B-NP_NP_NP_JJ
variation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cortisol B-O B-NP_NN
concentration B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
dexamethasone B-O B-NP_NN
suppression B-O B-NN
" " B-O O-NP
and B-O B-CC
glucocorticoid B-O B-NP_NP_NN
receptor B-O B-NN
binding B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
polymorphonuclear B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
cultured B-O B-NP_VBN
skin B-O B-NN
fibroblasts B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
measured B-O B-VP_VBN
in B-O B-NP_PP_IN
rigidly B-O B-NP_NP_ADJP_RB
defined B-O B-VBN
" " B-O O-ADJP
major B-O B-JJ
depressive B-O B-JJ
disorder B-O B-NN
patients B-O B-NNS
" " B-O O-NP
and B-O B-CC
non-depressed B-O B-NP_JJ
psychiatric B-O B-JJ
controls B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
2 B-O B-S_LST_LS
. B-O B-PERIOD
" " B-O O-LST
Mononuclear B-O B-S_S_NP_NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
glucocorticoid B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
correlated B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
polymorphonuclear B-O B-NP_NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
glucocorticoid B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
both B-O B-S_NP_DT
determinations B-O B-NNS
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
differentiate B-O B-VP_VB
major B-O B-NP_NP_JJ
depressive B-O B-JJ
disorder B-O B-NN
" " B-O O-NP
and B-O B-CC
control B-O B-NP_NN
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
3 B-O B-S_LST_LS
. B-O B-PERIOD
" " B-O O-LST
Initial B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
post-dexamethasone B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
fibroblast B-O B-NN
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
glucocorticoid B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
different B-O B-ADJP_JJ
" " B-O O-ADJP
between B-O B-PP_IN
major B-O B-NP_NP_JJ
depressive B-O B-JJ
disorder B-O B-NN
" " B-O O-NP
and B-O B-CC
non-depressed B-O B-NP_JJ
control B-O B-NN
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
4 B-O B-S_LST_LS
. B-O B-PERIOD
" " B-O O-LST
The B-O B-NP_NP_DT
phenomenon B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
resistance B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
major B-O B-NP_JJ
depressive B-O B-JJ
disorder B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
remains B-O B-VP_VBZ
unexplained B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_DT
B B-O B-ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
nuclear B-O B-JJ
factor B-O B-NN
OTF-2 B-O B-NN
" " B-O O-NP
positively B-O B-ADVP_RB
" " B-O O-ADVP
regulates B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
human B-O B-JJ
class B-O B-NN
II B-O B-CD
transplantation B-O B-NN
gene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
DRA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
promoter B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
major B-O B-JJ
histocompatibility B-O B-NN
class B-O B-NN
II B-O B-CD
gene B-O B-NN
DRA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contains B-O B-VP_VBZ
an B-O B-NP_NP_NP_DT
octamer B-O B-NN
element B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ATTTGCAT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Several B-O B-S_NP_JJ
DNA-binding B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
this B-O B-NP_DT
sequence B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-SINV_ADJP_DT
best B-O B-RBS
characterized B-O B-VBN
" " B-O O-ADJP
are B-O B-VP_VBP
" " B-O B-ADJP_O-VP
the B-O B-NP_NP_DT
B B-O B-ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
OTF-2 B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
ubiquitous B-O B-JJ
OTF-1 B-O B-NN
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-SINV
  
This B-O B-S_NP_DT
report B-O B-NN
" " B-O O-NP
directly B-O B-ADVP_RB
" " B-O O-ADVP
demonstrates B-O B-VP_VBZ
that B-O B-SBAR_IN
OTF-2 B-O B-S_NP_NP_NN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
OTF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
regulates B-O B-VP_VBZ
the B-O B-NP_DT
DRA B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
transcription B-O B-NN
analysis B-O B-NN
" " B-O O-NP
using B-O B-VP_VBG
protein B-O B-NP_NP_NN
fractions B-O B-NNS
" " B-O O-NP
enriched B-O B-ADJP_VBN
for B-O B-PP_IN
the B-O B-NP_DT
octamer-binding B-O B-JJ
protein B-O B-NN
OTF-2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
demonstrate B-O B-VP_VBP
a B-O B-NP_NP_DT
positive B-O B-JJ
functional B-O B-JJ
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
OTF-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
DRA B-O B-NP_NN
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
OTF-1-enriched B-O B-NP_JJ
protein B-O B-NN
fractions B-O B-NNS
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
affect B-O B-VP_VB
DRA B-O B-NP_NN
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
although B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
functionally B-O B-ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VBD
the B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
another B-O B-NP_DT
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recombinant B-O B-S_NP_NP_JJ
OTF-2 B-O B-NN
protein B-O B-NN
" " B-O O-NP
produced B-O B-VP_VBN
by B-O B-NP_PP_IN
in B-O B-NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
transcription/translation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
could B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
enhance B-O B-VP_VB
DRA B-O B-NP_NN
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
transient B-O B-JJ
transfection B-O B-NN
studies B-O B-NNS
" " B-O O-NP
utilizing B-O B-VP_VBG
an B-O B-NP_DT
OTF-2 B-O B-NN
expression B-O B-NN
vector B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
similar B-O B-NP_JJ
findings B-O B-NNS
: B-O B-COLON
that B-O B-SBAR_SBAR_IN
OTF-2 B-O B-S_NP_NN
protein B-O B-NN
" " B-O O-NP
enhanced B-O B-VP_VBD
DRA B-O B-NP_NN
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
this B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
requires B-O B-VP_VBZ
an B-O B-NP_DT
intact B-O B-JJ
octamer B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Together B-O B-S_ADVP_RB
" " B-O O-ADVP
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
constitute B-O B-VP_VBP
the B-O B-NP_NP_DT
first B-O B-JJ
direct B-O B-JJ
evidence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
positive B-O B-JJ
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
lymphoid-specific B-O B-JJ
octamer-binding B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
DRA B-O B-NP_NN
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Corticosteroid B-O B-NP_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
and B-O B-CC
lymphocyte B-O B-NP_NN
subsets B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
aging B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Plasma B-O B-S_NP_NP_NP_NN
cortisol B-O B-NN
" " B-O O-NP
and B-O B-CC
aldosterone B-O B-NP_NP_NN
levels B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
number B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
related B-O B-NP_JJ
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
measured B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
49 B-O B-NP_NP_CD
healthy B-O B-JJ
aged B-O B-JJ
subjects B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
yr B-O B-FRAG_NP_QP_NN
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
21 B-O B-NP_NP_CD
adult B-O B-JJ
controls B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
yr B-O B-FRAG_NP_QP_NN
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
all B-O B-NP_DT
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
lymphocyte B-O B-NP_NN
subsets B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
determined B-O B-VP_VBN
as B-O B-NP_PP_IN
an B-O B-NP_NP_DT
index B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
corticosteroid B-O B-NP_NN
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mean B-O B-NN
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
type B-O B-NP_NP_NP_NN
I B-O B-CD
" " B-O O-NP
and B-O B-CC
type B-O B-NP_NN
II B-O B-CD
" " B-O O-NP
" " B-O O-NP
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VP_VBD
significantly B-O B-ADJP_ADJP_RB
lower B-O B-JJR
" " B-O O-ADJP
" " B-O B-PP_O-ADJP
in B-O B-PP_IN
aged B-O B-NP_JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
than B-O B-PP_IN
in B-O B-FRAG_PP_IN
controls B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
" " B-O O-VP
( B-O B-PRN_LRB
respectively B-O B-FRAG_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
198 B-O B-NP_NP_NP_NP_QP_CD
+/- B-O B-CC
96 B-O B-CD
and B-O B-CC
272 B-O B-CD
+/- B-O B-CC
97 B-O B-CD
" " B-O O-QP
receptors/cell B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
type B-O B-NP_NN
I B-O B-CD
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
1,794 B-O B-NP_NP_QP_CD
+/- B-O B-CC
803 B-O B-CD
and B-O B-CC
3,339 B-O B-CD
+/- B-O B-CC
918 B-O B-CD
" " B-O O-QP
" " B-O O-NP
for B-O B-PP_IN
type B-O B-NP_NN
II B-O B-CD
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
receptors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Plasma B-O B-S_NP_NP_NN
aldosterone B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
cortisol B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
lymphocyte B-O B-NP_NN
subsets B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
different B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
the B-O B-NP_DT
two B-O B-CD
groups B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
parameters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
tested B-O B-VP_VBN
for B-O B-NP_PP_IN
correlation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
a B-O B-S_NP_DT
significant B-O B-JJ
inverse B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
between B-O B-NP_PP_IN
age B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
type B-O B-NP_NP_NP_NN
I B-O B-CD
" " B-O O-NP
and B-O B-CC
type B-O B-NP_NN
II B-O B-CD
" " B-O O-NP
" " B-O O-NP
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
all B-O B-S_NP_DT
subjects B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
plotted B-O B-VP_VBN
and B-O B-NP_CC
between B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
aged B-O B-S_NP_JJ
subjects B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
reductions B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
corticosteroid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
this B-O B-S_NP_DT
situation B-O B-NN
" " B-O O-NP
probably B-O B-ADVP_RB
" " B-O O-ADVP
represents B-O B-VP_VBZ
a B-O B-NP_NP_DT
concomitant B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
normal B-O B-JJ
aging B-O B-NN
process B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Specific B-O B-S_NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
subunits B-O B-NNS
" " B-O O-NP
act B-O B-VP_VBP
in B-O B-PP_IN
concert B-O B-NN
with B-O B-IN
Tat B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
stimulate B-O B-VP_VB
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
protein B-O B-NN
complex B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
functions B-O B-S_NP_VP_VBZ
in B-O B-PP_IN
concert B-O B-NN
with B-O B-IN
the B-O B-NP_DT
tat-I B-O B-NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
stimulate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
specific B-O B-S_NP_NP_JJ
members B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contribute B-O B-VP_VBP
to B-O B-PP_TO
this B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
abilities B-O B-NNS
" " B-O B-S_O-NP
of B-O B-PP_IN
different B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
subunits B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
act B-O B-VP_VB
with B-O B-PP_IN
Tat-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
found B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_DT
p49 B-O B-NN
( B-O B-LRB
100 B-O B-CD
) B-O B-RRB
DNA B-O B-NN
binding B-O B-NN
subunit B-O B-NN
" " B-O O-NP
, B-O B-COMMA
together B-O B-PP_RB
with B-O B-IN
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
can B-O B-VP_MD
act B-O B-VP_VB
in B-O B-PP_IN
concert B-O B-NN
with B-O B-IN
Tat-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Little B-O B-S_NP_JJ
effect B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
with B-O B-NP_PP_IN
50-kDa B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
p105 B-O B-NP_NP_NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
or B-O B-CC
rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
combination B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_NP_NP_SBAR_O-NP
or B-O B-CC
" " B-O B-NP_NP_SBAR_O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p49 B-O B-NP_NP_NN
( B-O B-LRB
100 B-O B-CD
) B-O B-RRB
" " B-O O-NP
and B-O B-CC
p65 B-O B-NP_NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
act B-O B-VP_VB
in B-O B-PP_IN
concert B-O B-NN
with B-O B-IN
the B-O B-NP_DT
tat-I B-O B-NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
stimulate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Eicosanoids B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
breast B-O B-NP_NN
cancer B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
before B-O B-PP_PP_PP_IN
" " B-O B-NP_O-PP
and B-O B-CC
after B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-PP
mastectomy B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
In B-O B-S_PP_IN
19 B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_DT
malignant B-O B-JJ
breast B-O B-NN
tumor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
tumor B-O B-NP_NP_NN
tissue B-O B-NN
" " B-O O-NP
and B-O B-CC
blood B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
taken B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
determine B-O B-VP_VB
the B-O B-NP_DT
eicosanoid B-O B-NP_NP_NN
profile B-O B-NN
" " B-O O-NP
and B-O B-CC
platelet B-O B-NP_NN
aggregation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Values B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
compared B-O B-VP_VBN
with B-O B-NP_PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-UCP_PP_IN
, B-O B-NP_COMMA
or B-O B-CC
undergoing B-O B-VP_VBG
" " B-O B-NP_O-UCP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Postoperatively B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
blood B-O B-NP_NN
" " B-O O-NP
was B-O B-VP_VBD
taken B-O B-VP_VBN
as B-O B-NP_PP_RB
well B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-PP
in B-O B-SBAR_IN
order B-O B-NN
to B-O B-TO
compare B-O B-S_NP_VP_VB
pre- B-O B-NP_ADJP_ADJP_JJ
" " B-O B-ADJP_O-ADJP
and B-O B-CC
postoperative B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
values B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Eicosanoids B-O B-S_S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
measured B-O B-VP_VBN
in B-O B-NP_PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
mammary B-O B-NP_JJ
tissue B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
means B-O B-NNS
of B-O B-IN
HPLC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
furthermore B-O B-S_ADVP_RBR
" " B-O O-ADVP
, B-O B-COMMA
TXA2 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
6-keto-PGF1 B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
PGE2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
determined B-O B-VP_VBN
by B-O B-NP_PP_IN
RIA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Differences B-O B-S_S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
pre- B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O B-ADJP_O-ADJP
and B-O B-CC
postoperative B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
values B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
cancer B-O B-NP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
plasma B-O B-NP_NN
RIA B-O B-NN
values B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
PGE2 B-O B-S_S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
6-k-PGF1 B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
significantly B-O B-ADJP_RB
higher B-O B-JJR
" " B-O O-ADJP
preoperatively B-O B-ADVP_RB
" " B-O O-ADVP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
compared B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
" " B-O B-FRAG_ADVP_O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
however B-O B-RB
, B-O B-COMMA
such B-O B-S_NP_JJ
differences B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
control B-O B-NN
groups B-O B-NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_RB
well B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Compared B-O B-S_PP_VBN
to B-O B-PP_TO
benign B-O B-NP_NP_NP_JJ
tumor B-O B-NN
" " B-O O-NP
or B-O B-CC
mammary B-O B-NP_JJ
reduction B-O B-NN
" " B-O O-NP
" " B-O O-NP
test B-O B-NN
material B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
the B-O B-NP_NP_DT
eicosanoid B-O B-NN
profile B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tissue B-O B-NP_NP_NN
" " B-O O-NP
obtained B-O B-VP_VBN
from B-O B-NP_PP_IN
malignant B-O B-NP_JJ
mammary B-O B-JJ
tumors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
important B-O B-NP_JJ
differences B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Except B-O B-S_S_PP_IN
for B-O B-IN
PGF2 B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
, B-O B-COMMA
HHT B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
15-HETE B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
no B-O B-NP_NP_DT
detectable B-O B-JJ
quantities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
eicosanoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
non-tumor B-O B-JJ
material B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
in B-O B-S_PP_IN
the B-O B-NP_DT
malignant B-O B-JJ
tumor B-O B-NN
material B-O B-NN
" " B-O O-NP
" " B-O O-PP
substantial B-O B-NP_NP_JJ
quantities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
eicosanoid B-O B-NP_NN
metabolites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
present B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Statistically B-O B-S_NP_ADJP_RB
significant B-O B-JJ
" " B-O O-ADJP
correlations B-O B-NNS
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
established B-O B-VP_VBN
between B-O B-NP_PP_PP_IN
patient/histopathology B-O B-NP_NP_NN
data B-O B-NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
results B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
e.g. B-O B-FW
between B-O B-PP_IN
menopausal B-O B-NP_NP_NP_JJ
status B-O B-NN
" " B-O O-NP
and B-O B-CC
ADP B-O B-NP_NN
aggregation B-O B-NN
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
oestrogen B-O B-NP_NP_NN
receptor B-O B-NN
and B-O B-PRN_CC
collagen B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
arachidonic B-O B-NP_JJ
acid B-O B-NN
aggregation B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
inflammatory B-O B-NP_NP_JJ
cell B-O B-NN
infiltration B-O B-NN
score B-O B-NN
" " B-O O-NP
and B-O B-CC
arachidonic B-O B-NP_JJ
acid B-O B-NN
aggregation B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
fibrosis B-O B-NP_NP_NN
score B-O B-NN
" " B-O O-NP
and B-O B-CC
ADP B-O B-NP_NN
aggregation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
eicosanoid B-O B-S_NP_NP_NN
synthesis B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
material B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
mammary B-O B-NP_JJ
cancer B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
different B-O B-ADJP_JJ
from B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
implications B-O B-NNS
" " B-O O-NP
, B-O B-PP_COMMA
in B-O B-PP_IN
particular B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-IN
relation B-O B-NN
to B-O B-TO
future B-O B-NP_NP_JJ
prognosis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
patient B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-PP
" " B-O O-NP
remain B-O B-VP_VBP
obscure B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
c-myc B-O B-NP_NP_NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
minor B-O B-NP_NP_JJ
salivary B-O B-JJ
glands B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
Sjogren B-O B-NP_NP_NN
's B-O B-POS
" " B-O O-NP
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
c-myc B-O B-S_S_S_NP_NN
protooncogene B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
implicated B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
pathogenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B B-O B-NP_NN
cell B-O B-NN
lymphoid B-O B-JJ
malignancies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
high B-O B-S_NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
c-myc B-O B-NP_NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
activated B-O B-NP_VBN
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Sjogren B-O B-S_NP_NP_NP_NN
's B-O B-POS
" " B-O O-NP
syndrome B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
SS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
lymphocytic B-O B-NP_NP_NP_JJ
infiltrates B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
exocrine B-O B-NP_JJ
glands B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
remarkable B-O B-NP_JJ
B B-O B-NN
cell B-O B-NN
hyperreactivity B-O B-NN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
strong B-O B-JJ
predisposition B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
B B-O B-NP_NN
cell B-O B-NN
neoplasia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
c-myc B-O B-NP_NP_NN
protooncogene B-O B-NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
29 B-O B-NP_NP_CD
labial B-O B-JJ
minor B-O B-JJ
salivary B-O B-JJ
gland B-O B-NN
biopsies B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
patients B-O B-NP_NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
primary B-O B-NP_JJ
SS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
15 B-O B-NP_CD
controls B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
examined B-O B-VP_VBN
using B-O B-NP_S_NP_VP_VBG
in B-O B-NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
histochemistry B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_CD
40mer B-O B-JJ
oligonucleotides B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_NP_NP_NP_DT
1st B-O B-JJ
" " B-O B-NP_O-NP
and B-O B-CC
the B-O B-NP_DT
2nd B-O B-JJ
" " B-O B-NP_O-NP
" " B-O O-NP
exon B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
c-myc B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
labeled B-O B-VP_VBN
with B-O B-NP_PP_IN
35S B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
as B-O B-NP_PP_IN
probes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
detect B-O B-VP_VB
the B-O B-NP_NP_DT
origin B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
cell B-O B-NN
" " B-O O-NP
hybridized B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
a B-O B-NP_DT
combined B-O B-JJ
immunochemistry B-O B-NN
in B-O B-ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
histochemistry B-O B-NN
technique B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
High B-O B-S_NP_JJ
c-myc B-O B-NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
on B-O B-NP_PP_IN
acinar B-O B-NP_JJ
epithelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
c-myc B-O B-S_NP_NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
correlate B-O B-VP_VB
with B-O B-PP_IN
c-fos B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
protein B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Stronger B-O B-S_NP_JJR
c-myc B-O B-NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
labial B-O B-NP_NP_JJ
salivary B-O B-JJ
glands B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
although B-O B-SBAR_IN
these B-O B-S_NP_DT
patients B-O B-NNS
" " B-O O-NP
revealed B-O B-VP_VBD
no B-O B-NP_DT
hypergammaglobulinemia B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_DT
correlation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
between B-O B-NP_PP_IN
c-myc B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
and B-O B-CC
B B-O B-NP_NN
lymphocyte B-O B-NN
monoclonicity B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
lymphoma B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
conclusion B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
strong B-O B-NP_JJ
c-myc B-O B-NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
on B-O B-NP_PP_IN
epithelial B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
labial B-O B-NP_NP_JJ
salivary B-O B-JJ
glands B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
findings B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
indicate B-O B-VP_VB
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
reactivated B-O B-VBN
virus B-O B-NN
" " B-O O-NP
hosted B-O B-VP_VBN
in B-O B-NP_PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Heterodimerization B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
transcriptional B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
by B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
NF-kappa B-O B-NN
B B-O B-NN
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
represents B-O B-VP_VBZ
multiple B-O B-NP_NP_JJ
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
, B-O B-COMMA
rel B-O B-NP_NP_ADJP_NP_NN
" " B-O O-NP
related B-O B-JJ
" " B-O O-ADJP
polypeptides B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contribute B-O B-S_NP_VP_VBP
to B-O B-PP_TO
, B-O B-NP_NP_COMMA
" " B-O B-CONJP_NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
multiple B-O B-NP_NP_JJ
NF-kappa B-O B-ADJP_NP_NN
B B-O B-NN
" " B-O O-NP
related B-O B-JJ
" " B-O O-ADJP
polypeptides B-O B-NNS
" " B-O O-NP
ranging B-O B-VP_VBG
from B-O B-PP_QP_IN
85 B-O B-CD
to B-O B-TO
45 B-O B-CD
" " B-O O-QP
kDa B-O B-NN
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VP_VBD
examined B-O B-VP_VBN
for B-O B-NP_PP_IN
their B-O B-NP_PRPP
capacity B-O B-NN
to B-O B-S_NP_VP_TO
interact B-O B-VP_VB
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
were B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
possess B-O B-VP_VP_VB
" " B-O B-NP_NP_PP_O-VP
and B-O B-CC
form B-O B-VP_VB
multiple B-O B-NP_JJ
DNA B-O B-NN
binding B-O B-NN
homo- B-O B-JJ
and B-O B-CC
heterodimer B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
using B-O B-S_NP_VP_VBG
DNA B-O B-NP_NP_NN
templates B-O B-NNS
" " B-O O-NP
containing B-O B-VP_VBG
two B-O B-NP_NP_CD
copies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
PRDII B-O B-NN
domain B-O B-NN
" " B-O O-NP
linked B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
the B-O B-NP_DT
purified B-O B-VBN
polypeptides B-O B-NNS
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
stimulated B-O B-VP_VBD
NF-kappa B-O B-NP_NP_ADJP_NP_NN
B B-O B-NN
" " B-O O-NP
dependent B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
an B-O B-NP_DT
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
reconstitution B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-PP_PP_IN
heterodimers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
as B-O B-IN
p50 B-O B-NP_NN
homodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
experiments B-O B-NNS
" " B-O O-NP
emphasize B-O B-VP_VBP
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
dimerization B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_NP_DT
distinct B-O B-JJ
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
control B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Oct2 B-O B-S_NP_NP_NN
transactivation B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
a B-O B-NP_DT
remote B-O B-JJ
enhancer B-O B-NN
position B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VBZ
a B-O B-NP_DT
B-cell-restricted B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Previous B-O B-S_NP_JJ
cotransfection B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
had B-O B-VP_VBD
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
ectopic B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
lymphocyte-specific B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
Oct2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
efficiently B-O B-ADVP_RB
" " B-O O-ADVP
activate B-O B-VP_VB
a B-O B-NP_NP_DT
promoter B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Oct2 B-O B-S_NP_NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
unable B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
stimulate B-O B-VP_VB
a B-O B-NP_NP_DT
multimerized B-O B-JJ
octamer B-O B-NN
enhancer B-O B-NN
element B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
tested B-O B-VP_VBN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Oct2 B-O B-NP_NP_NN
isoforms B-O B-VBZ
" " B-O O-NP
generated B-O B-VP_VBN
by B-O B-NP_PP_IN
alternative B-O B-NP_JJ
splicing B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
capability B-O B-NN
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
an B-O B-NP_DT
octamer B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
analyses B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
several B-O B-S_NP_JJ
Oct2 B-O B-NN
isoforms B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
stimulate B-O B-VP_VB
from B-O B-PP_IN
a B-O B-NP_DT
remote B-O B-JJ
position B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
but B-O B-CC
that B-O B-SBAR_IN
this B-O B-S_NP_DT
stimulation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
restricted B-O B-VP_JJ
to B-O B-NP_PP_TO
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
result B-O B-NN
" " B-O O-NP
indicates B-O B-VP_VBZ
the B-O B-NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_CC
a B-O B-NP_DT
B-cell-specific B-O B-JJ
cofactor B-O B-NN
" " B-O O-NP
or B-O B-CC
a B-O B-NP_NP_DT
specific B-O B-JJ
modification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
cofactor B-O B-NN
" " B-O O-NP
or B-O B-CC
the B-O B-NP_DT
Oct2 B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Oct2-mediated B-O B-NP_JJ
enhancer B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutational B-O B-S_NP_JJ
analyses B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
carboxy-terminal B-O B-JJ
domain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Oct2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
critical B-O B-ADJP_JJ
for B-O B-PP_IN
enhancer B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
this B-O B-NP_DT
domain B-O B-NN
" " B-O O-NP
conferred B-O B-VP_VBD
enhancing B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
when B-O B-SBAR_ADVP_WRB
" " B-O O-ADVP
fused B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
Oct1 B-O B-NN
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_PP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
glutamine-rich B-O B-JJ
activation B-O B-NN
domain B-O B-NN
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_NP_DT
amino-terminal B-O B-JJ
portion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Oct2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
POU B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
contribute B-O B-VP_VBP
only B-O B-ADVP_RB
marginally B-O B-RB
" " B-O O-ADVP
to B-O B-PP_TO
the B-O B-NP_DT
transactivation B-O B-NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
a B-O B-NP_DT
distal B-O B-JJ
position B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
POU B-O B-NN
domain B-O B-NN
transcription B-O B-NN
factor B-O B-NN
Oct-2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
T-cell B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
cognate B-O B-NP_JJ
antigen B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Oct-2 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
specifically B-O B-PP_RB
to B-O B-TO
octamer B-O B-NP_NP_NN
DNA B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_NP_NP_DT
tumor B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
B-cell B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
few B-O B-JJ
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
T-cell B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
express B-O B-VP_VBP
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
address B-O B-VP_VB
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
T-cell B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Oct-2 B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
and B-O B-CC
protein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
nontransformed B-O B-NP_JJ
human B-O B-UCP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
mouse B-O B-NP_NN
" " B-O O-NP
" " B-O O-UCP
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Oct-2 B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
CD4+ B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
CD8+ B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
prepared B-O B-VP_VBN
from B-O B-NP_PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
mouse B-O B-NP_NN
lymph B-O B-NN
node B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
a B-O B-NP_NP_DT
T-cell B-O B-NN
clone B-O B-NN
" " B-O O-NP
specific B-O B-ADJP_JJ
for B-O B-PP_IN
pigeon B-O B-NP_NN
cytochrome B-O B-NN
c B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-DT
context B-O B-NN
of B-O B-IN
I-Ek B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
Oct-2 B-O B-NP_NN
" " B-O O-NP
was B-O B-VP_VBD
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
antigen B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
with B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Oct-2 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
seen B-O B-VP_VP_VBN
first B-O B-NP_ADVP_RB
" " B-O O-ADVP
at B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
and B-O B-CC
continuing B-O B-VP_VBG
for B-O B-PP_IN
h B-O B-NP_QP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Oct-2 B-O B-S_NP_NP_NN
mRNA B-O B-NN
induction B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
antigen-driven B-O B-NP_JJ
T-cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
blocked B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
cyclosporin B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
by B-O B-PP_IN
protein B-O B-NP_NN
synthesis B-O B-NN
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
Oct-2 B-O B-S_NP_NN
" " B-O O-NP
participates B-O B-VP_VBZ
in B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
T-cell B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
relatively B-O B-ADJP_RB
delayed B-O B-VBN
" " B-O O-ADJP
kinetics B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Oct-2 B-O B-NP_NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
Oct-2 B-O B-S_NP_NN
" " B-O O-NP
mediates B-O B-VP_VBZ
the B-O B-NP_NP_DT
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
occur B-O B-S_NP_VP_VBP
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-NP_LRB
Changes B-O B-NP_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
plasma B-O B-NP_NN
interleukin-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
their B-O B-NP_NP_PRPP
possible B-O B-JJ
relationship B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
aged B-O B-NP_JJ
long-distance B-O B-JJ
runner B-O B-NN
" " B-O O-NP
" " B-O O-PP
] B-O B-RRB
" " B-O O-NP
  
For B-O B-S_PP_IN
the B-O B-NP_NP_DT
study B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
plasma B-O B-NP_NN
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
their B-O B-NP_NP_PRPP
possible B-O B-JJ
relationship B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
plasma B-O B-NP_NP_NP_NN
IL-1 B-O B-NN
" " B-O O-NP
and B-O B-CC
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
leukocytes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
aged B-O B-NP_JJ
long-distance B-O B-JJ
runner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
measured B-O B-VP_VBN
simultaneously B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
expressed B-O B-VP_VBN
as B-O B-NP_PP_IN
its B-O B-NP_PRPP
ability B-O B-NN
to B-O B-S_NP_VP_TO
stimulate B-O B-VP_VB
3H-TdR B-O B-NP_NN
incorporation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
GR B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
determined B-O B-VP_VBN
by B-O B-NP_PP_IN
whole B-O B-NP_NP_JJ
cell B-O B-NN
assay B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
3H-Dex B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
plasma B-O B-NP_NP_NN
IL-1 B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
aged B-O B-NP_JJ
long-distance B-O B-JJ
runner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
209 B-O B-NP_NP_NP_CD
% B-O B-NN
" " B-O O-NP
, B-O B-COMMA
223 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
and B-O B-CC
145 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
control B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
at B-O B-PP_IN
, B-O B-NP_ADJP_QP_QP_COMMA
and B-O B-QP_CC
KD B-O B-QP_NN
" " B-O O-ADJP
fractions B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
GR B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
leukocytes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
aged B-O B-NP_JJ
runner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
65 B-O B-NP_NP_CD
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
control B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Possible B-O B-S_NP_NP_NP_JJ
relationship B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
IL-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
aged B-O B-NP_JJ
long-distance B-O B-JJ
runner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
its B-O B-NP_PRPP
physiological B-O B-JJ
significance B-O B-NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
discussed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcription B-O B-S_NP_NN
factor B-O B-NN
AP-2 B-O B-NN
" " B-O O-NP
activates B-O B-VP_VBZ
gene B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HTLV-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
HTLV-I B-O B-NN
LTR B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
three B-O B-NP_NP_CD
conserved B-O B-VBN
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
known B-O B-VP_VBN
as B-O B-NP_PP_IN
21 B-O B-NP_NP_ADJP_CD
base B-O B-NN
pair B-O B-NN
" " B-O O-ADJP
repeats B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutagenesis B-O B-S_NP_NN
" " B-O O-NP
indicates B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_DT
21 B-O B-ADJP_CD
bp B-O B-NN
" " B-O O-ADJP
repeats B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
subdivided B-O B-VP_VBN
into B-O B-NP_PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-SBAR_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
A B-O B-NN
site B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
21 B-O B-ADJP_CD
bp B-O B-NN
" " B-O O-ADJP
repeat B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
strong B-O B-NP_NP_JJ
homology B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
previously B-O B-NP_NP_ADJP_RB
described B-O B-VBN
" " B-O O-ADJP
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
AP-2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_SBAR_IN
AP-2 B-O B-S_NP_NN
mRNA B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
present B-O B-ADJP_JJ
in B-O B-PP_IN
T-lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
cellular B-O B-S_NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
both B-O B-NP_ADJP_CC
and B-O B-ADJP_CC
T-lymphocytes B-O B-ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
bound B-O B-VP_VBD
to B-O B-PP_TO
the B-O B-NP_NP_DT
consensus B-O B-NN
motif B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
determine B-O B-VP_VB
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HTLV-I B-O B-NN
LTR B-O B-NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
used B-O B-VP_VBD
an B-O B-NP_DT
AP-2 B-O B-NN
cDNA B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
DNA B-O B-NP_NP_NP_NN
binding B-O B-NN
" " B-O O-NP
and B-O B-CC
transient B-O B-NP_JJ
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Gel B-O B-S_NP_NP_NP_NN
retardation B-O B-NN
" " B-O O-NP
and B-O B-CC
methylation B-O B-NP_NN
interference B-O B-NN
" " B-O O-NP
" " B-O O-NP
studies B-O B-NNS
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_SBAR_IN
bacterially B-O B-S_NP_ADJP_RB
produced B-O B-VBN
" " B-O O-ADJP
AP-2 B-O B-NN
" " B-O O-NP
bound B-O B-VP_VBD
specifically B-O B-UCP_ADVP_RB
" " B-O O-ADVP
and B-O B-CC
with B-O B-PP_IN
high B-O B-NP_JJ
affinity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-UCP
to B-O B-PP_TO
all B-O B-NP_QP_DT
three B-O B-CD
" " B-O O-QP
21 B-O B-ADJP_CD
bp B-O B-NN
" " B-O O-ADJP
repeats B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
required B-O B-VP_VBD
the B-O B-NP_DT
core B-O B-NN
sequence B-O B-NN
AGGC B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
specific B-O B-NP_JJ
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Binding B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
AP-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
prevented B-O B-VP_VBD
the B-O B-NP_NP_DT
subsequent B-O B-JJ
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
members B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CREB/ATF B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
an B-O B-NP_NP_DT
adjacent B-O B-JJ
regulatory B-O B-JJ
motif B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
21 B-O B-ADJP_CD
bp B-O B-NN
" " B-O O-ADJP
repeat B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transfection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
AP-2 B-O B-NN
expression B-O B-NN
construct B-O B-NN
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
T-lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
activated B-O B-VP_VBD
gene B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
HTLV-I B-O B-NN
LTR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
At B-O B-S_S_NP_QP_IN
least B-O B-JJS
two B-O B-CD
" " B-O O-QP
21 B-O B-ADJP_CD
bp B-O B-NN
" " B-O O-ADJP
repeats B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
required B-O B-VP_VBN
for B-O B-NP_PP_IN
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
AP-2 B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
mutagenesis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
AP-2 B-O B-NN
consensus B-O B-NN
binding B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
21 B-O B-ADJP_CD
bp B-O B-NN
" " B-O O-ADJP
repeats B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
eliminate B-O B-VP_VBP
this B-O B-NP_DT
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LRB
ABSTRACT B-O B-NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-S
Cell B-O B-NP_NP_NP_ADJP_NN
cycle-dependent B-O B-JJ
" " B-O O-ADJP
initiation B-O B-NN
" " B-O O-NP
and B-O B-CC
lineage-dependent B-O B-NP_JJ
abrogation B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
pure B-O B-NP_JJ
differentiating B-O B-VBG
hematopoietic B-O B-JJ
progenitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
programmed B-O B-VBN
activation/repression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
early B-O B-NP_JJ
hematopoietic B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
not B-O B-RB
yet B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
explored B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
DNA-binding B-O B-JJ
protein B-O B-NN
GATA-1 B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
normal B-O B-NP_JJ
erythroid B-O B-JJ
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
regulates B-O B-VP_VBZ
erythroid-expressed B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
maturing B-O B-NP_VBG
erythroblasts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
analyzed B-O B-VP_VBD
GATA-1 B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
early B-O B-NP_JJ
human B-O B-JJ
adult B-O B-JJ
hematopoiesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
using B-O B-S_NP_VP_VBG
an B-O B-NP_NP_DT
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
system B-O B-NN
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
"""" B-O B-S_NP_LQT
pure B-O B-JJ
"""" B-O B-RQT
early B-O B-JJ
hematopoietic B-O B-JJ
progenitors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
GATA-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
though B-O B-SBAR_IN
virtually B-O B-FRAG_ADJP_RB
silent B-O B-JJ
in B-O B-PP_IN
quiescent B-O B-NP_JJ
progenitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-FRAG
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
activated B-O B-VP_VBN
after B-O B-NP_PP_IN
entrance B-O B-NP_NP_NN
" " B-O O-NP
into B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
hematopoietic B-O B-NP_JJ
growth B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Subsequently B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
increasing B-O B-NP_NP_VBG
expression B-O B-NN
" " B-O O-NP
along B-O B-PP_IN
the B-O B-NP_DT
erythroid B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contrasts B-O B-VP_VBZ
with B-O B-PP_IN
an B-O B-NP_NP_DT
abrupt B-O B-JJ
downregulation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
granulocyte-macrophage B-O B-JJ
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
a B-O B-NP_NP_DT
microenvironment-directed B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
two-step B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
model B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
GATA-1 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
differentiating B-O B-NP_VBG
hematopoietic B-O B-JJ
progenitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
involves B-O B-S_NP_VP_VBZ
( B-O B-NP_NP_LST_LRB
i B-O B-LS
) B-O B-RRB
" " B-O O-LST
cycle-dependent B-O B-JJ
initiation B-O B-NN
" " B-O O-NP
and B-O B-CC
( B-O B-NP_LST_LRB
ii B-O B-LS
) B-O B-RRB
" " B-O O-LST
lineage-dependent B-O B-JJ
or B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Hypothetically B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
on/off B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
switches B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
lineage-restricted B-O B-NP_JJ
transactivators B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
underlie B-O B-VP_VB
the B-O B-NP_NP_DT
binary B-O B-JJ
fate B-O B-NN
decisions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
hematopoietic B-O B-NP_JJ
progenitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_NP_DT
human B-O B-JJ
myelomonocytic B-O B-JJ
cell B-O B-NN
line B-O B-NN
U-937 B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
model B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
studying B-O B-S_NP_VP_VBG
alterations B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
marked B-O B-NP_NP_JJ
enhancement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lipopolysaccharide-stimulated B-O B-NP_JJ
interleukin-1 B-O B-NN
beta B-O B-NN
messenger B-O B-NN
RNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
1,25-dihydroxyvitamin B-O B-NP_NN
D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
active B-O B-JJ
metabolite B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
vitamin B-O B-NP_NP_NN
D B-O B-NN
" " B-O O-NP
, B-O B-COMMA
1,25-dihydroxyvitamin B-O B-NP_NP_NN
D3 B-O B-NN
" " B-O O-NP
[ B-O B-PRN_LRB
1,25-(OH)2D3 B-O B-NP_NN
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
potent B-O B-JJ
regulator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
monocyte/macrophage B-O B-JJ
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
establish B-O B-VP_VB
a B-O B-NP_NP_DT
model B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
1,25-(OH)2D3 B-O B-NP_NP_NN
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
monocyte B-O B-NN
monokine B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
three B-O B-NP_NP_CD
human B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
U-937 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
THP-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
HL-60 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
for B-O B-NP_PP_IN
: B-O B-COLON
1 B-O B-NP_NP_LST_LS
) B-O B-RRB
" " B-O O-LST
the B-O B-NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
functional B-O B-NP_JJ
1,25-(OH)2D3 B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
; B-O B-COLON
2 B-O B-NP_LST_LS
) B-O B-RRB
" " B-O O-LST
the B-O B-NP_DT
accumulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mRNA B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-1 B-O B-NP_NN
beta B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
lipopolysaccharide B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
; B-O B-COLON
and B-O B-CC
3 B-O B-NP_LST_LS
) B-O B-RRB
" " B-O O-LST
the B-O B-NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
1,25-(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_DT
three B-O B-CD
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VP_VBD
vitamin B-O B-NP_NN
D B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
had B-O B-VP_VBD
increased B-O B-VP_VBN
levels B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
IL-1 B-O B-NP_NN
beta B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Preincubation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
1,25-(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
augmented B-O B-VP_VBD
IL-1 B-O B-NP_NN
beta B-O B-NN
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
only B-O B-PP_RB
in B-O B-IN
U-937 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
HL-60 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
From B-O B-S_UCP_PP_IN
these B-O B-NP_DT
data B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
taking B-O B-S_NP_VP_VBG
into B-O B-PP_IN
consideration B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
their B-O B-NP_PRPP
state B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
relative B-O B-NP_NP_JJ
ease B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
culture B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-UCP
, B-O B-COMMA
U-937 B-O B-NP_NN
" " B-O O-NP
was B-O B-VP_VBD
chosen B-O B-VP_VBN
over B-O B-NP_PP_IN
HL-60 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
THP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
the B-O B-NP_NP_DT
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
we B-O B-SBAR_WHNP_S_NP_PRP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
characterized B-O B-VP_VBD
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
U-937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
optimum B-O B-NP_NP_JJ
time B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
dose B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
pretreatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
1,25-(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
determined B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
12-24 B-O B-NP_QP_CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
( B-O B-NP_NP_NP_PP_PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Preincubation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
1,25-(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
time B-O B-NN
course B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-1 B-O B-NP_NP_NN
beta B-O B-NN
mRNA B-O B-NN
appearance B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
exposure B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
U-937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
1,25-(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VP_VBD
by B-O B-PP_IN
200 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-1 B-O B-NP_NP_NN
beta B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
detected B-O B-VP_VBD
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
decreased B-O B-VP_VBD
by B-O B-PP_IN
three B-O B-NP_NP_CD
orders B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
magnitude B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
required B-O B-VP_VBN
to B-O B-S_NP_VP_TO
achieve B-O B-VP_VB
" " B-O B-NP_NP_ADJP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
Expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
alveolar B-O B-NP_NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
pulmonary B-O B-NP_JJ
granulomatous B-O B-JJ
diseases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
1,25(OH)2D3 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
produced B-O B-VP_VBN
at B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_SBAR_IN
order B-O B-NN
to B-O B-TO
characterize B-O B-S_NP_VP_VB
the B-O B-NP_NP_DT
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
evaluated B-O B-VP_VBN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
T-lymphocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
those B-O B-NP_NP_DT
" " B-O O-NP
recovered B-O B-VP_VBN
from B-O B-NP_PP_IN
by B-O B-NP_PP_IN
" " B-O B-NP_S_NP_VP_O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Lavage B-O B-S_NP_NP_NP_NN
T-lymphocytes B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_PP_IN
tuberculosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
with B-O B-PP_IN
sarcoidosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
those B-O B-NP_NP_DT
" " B-O O-NP
from B-O B-PP_IN
normal B-O B-NP_JJ
control B-O B-NN
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
expressed B-O B-VP_VBD
1,25(OH)2D3 B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
as B-O B-SBAR_IN
demonstrated B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
binding B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
receptor-positive B-O B-NP_NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
: B-O B-COLON
, B-O B-NP_NP_NP_COMMA
; B-O B-FRAG_COLON
, B-O B-NP_NP_COMMA
" " B-O B-FRAG_O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
blood B-O B-NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
granulomatous B-O B-NP_JJ
diseases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
express B-O B-VP_VB
detectable B-O B-NP_JJ
1,25(OH)2D3 B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
percentage B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lavage B-O B-NP_NP_NN
T-lymphocytes B-O B-NNS
" " B-O O-NP
expressing B-O B-VP_VBG
1,25(OH)2D3 B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADJP_ADJP_RB
greater B-O B-JJR
" " B-O O-ADJP
" " B-O B-PP_O-ADJP
for B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
tuberculosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
presenting B-O B-VP_VBG
with B-O B-PP_IN
isolated B-O B-NP_VBN
hilar B-O B-JJ
adenopathy B-O B-JJ
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
than B-O B-PP_IN
for B-O B-FRAG_PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
pulmonary B-O B-NP_JJ
and/or B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
1,25(OH)2D3 B-O B-S_S_NP_NN
receptors B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
expressed B-O B-VP_VBN
to B-O B-NP_PP_TO
a B-O B-NP_NP_DT
greater B-O B-JJR
extent B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-NP
" " B-O O-PP
on B-O B-PP_IN
CD8+ B-O B-NP_JJ
T-lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
than B-O B-PP_IN
on B-O B-FRAG_PP_IN
CD4+ B-O B-NP_JJ
T-lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
in B-O B-PP_IN
sarcoidosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
a B-O B-S_NP_NP_NP_NP_DT
greater B-O B-JJR
proportion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD4+ B-O B-NP_JJ
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
than B-O B-PP_IN
of B-O B-FRAG_PP_IN
CD8+ B-O B-NP_JJ
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
T-lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
tuberculosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
receptor-positive B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_S_NP_DT
findings B-O B-NNS
" " B-O O-NP
support B-O B-VP_VBP
the B-O B-NP_DT
conclusion B-O B-NN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
interaction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
may B-O B-VP_MD
play B-O B-VP_VB
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
because B-O B-S_SBAR_IN
these B-O B-S_NP_DT
receptors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
expressed B-O B-VP_VBN
on B-O B-NP_PP_IN
different B-O B-NP_JJ
lymphocyte B-O B-NN
populations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-NP_NP_DT
net B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
potent B-O B-JJ
immunoregulatory B-O B-JJ
molecule B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
likely B-O B-ADJP_RB
different B-O B-JJ
" " B-O O-ADJP
in B-O B-PP_IN
sarcoidosis B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
tuberculosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Severe B-O B-NP_NP_JJ
5-fluorouracil B-O B-NN
toxicity B-O B-NN
" " B-O O-NP
secondary B-O B-ADJP_JJ
to B-O B-PP_TO
dihydropyrimidine B-O B-NP_NN
dehydrogenase B-O B-NN
deficiency B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
. B-O B-PERIOD
" " B-O O-NP
  
A B-O B-NP_NP_DT
potentially B-O B-ADJP_RB
more B-O B-RBR
common B-O B-JJ
" " B-O O-ADJP
pharmacogenetic B-O B-JJ
syndrome B-O B-NN
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
This B-O B-S_NP_DT
study B-O B-NN
" " B-O O-NP
describes B-O B-VP_VBZ
the B-O B-NP_NP_NP_NP_DT
inheritance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
defect B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
pyrimidine B-O B-NP_NN
catabolism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
its B-O B-NP_NP_PRPP
association B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
drug-induced B-O B-NP_JJ
toxicity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
patient B-O B-NN
" " B-O O-NP
receiving B-O B-VP_VBG
5-fluorouracil B-O B-NP_NN
( B-O B-PRN_LRB
FUra B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
as B-O B-PP_IN
adjuvant B-O B-NP_NP_JJ
chemotherapy B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
study B-O B-NN
population B-O B-NN
" " B-O O-NP
included B-O B-VP_VBD
the B-O B-NP_NP_NP_NP_DT
affected B-O B-VBN
patient B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
proband B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
nine B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
her B-O B-NP_PRPP
blood B-O B-NN
relatives B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
and B-O B-CC
seven B-O B-NP_CD
healthy B-O B-JJ
volunteers B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
dihydropyrimidine B-O B-NP_NP_NP_NP_NN
dehydrogenase B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
DPD B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
initial B-O B-JJ
enzyme B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
( B-O B-NP_NP_NP_LRB
and B-O B-CC
) B-O B-NP_RRB
" " B-O O-NP
catabolism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
measured B-O B-VP_VBN
in B-O B-NP_PP_IN
each B-O B-NP_DT
subject B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
a B-O B-NP_NP_DT
specific B-O B-JJ
radiometric B-O B-JJ
assay B-O B-NN
" " B-O O-NP
using B-O B-VP_VBG
FUra B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_IN
the B-O B-NP_DT
substrate B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
proband B-O B-NN
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
detectable B-O B-JJ
DPD B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
enzyme B-O B-S_NP_NP_NN
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
proband B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
relatives B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
compared B-O B-VP_VBN
with B-O B-NP_PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
in B-O B-PP_IN
controls B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
an B-O B-NP_NP_DT
autosomal B-O B-JJ
recessive B-O B-JJ
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
inheritance B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
demonstrated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_NP_DT
third B-O B-JJ
patient B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
severe B-O B-NP_NP_JJ
FUra B-O B-NN
toxicity B-O B-NN
" " B-O O-NP
secondary B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
second B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
our B-O B-NP_PRPP
clinic B-O B-NN
population B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
frequency B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
genetic B-O B-JJ
defect B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
" " B-O B-ADJP_ADJP_SBAR_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Monitoring B-O B-S_S_NP_VP_VBG
DPD B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
may B-O B-VP_MD
be B-O B-VP_VB
important B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
the B-O B-NP_NP_DT
management B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
experiencing B-O B-VP_VBG
" " B-O B-NP_NP_ADJP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-PRN_PRN_LRB
Differential B-O B-NP_NP_ADJP_JJ
diagnostic B-O B-JJ
" " B-O O-ADJP
value B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
receptors B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
determination B-O B-NP_NP_NP_NP_PRN_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-PRN
  
The B-O B-S_S_NP_DT
authors B-O B-NNS
" " B-O O-NP
provide B-O B-VP_VBP
the B-O B-NP_NP_DT
results B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
studying B-O B-S_NP_VP_VBG
in B-O B-NP_NP_NP_PRN_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
proposed B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
character B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
their B-O B-NP_NP_PRPP
expression B-O B-NN
" " B-O O-NP
under B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
used B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Enhancement B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
1 B-O B-CD
replication B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
1,25-dihydroxycholecalciferol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Human B-O B-S_NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
expression B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
replication B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
under B-O B-PP_IN
tight B-O B-NP_JJ
regulatory B-O B-JJ
control B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
1,25-dihydroxycholecalciferol B-O B-S_NP_NP_NN
" " B-O O-NP
[ B-O B-PRN_LRB
1,25-(OH)2D3 B-O B-NP_NN
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
enhances B-O B-VP_VBZ
the B-O B-NP_NP_DT
replication B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
strains B-O B-NP_NP_ADJP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
up B-O B-PP_IN
to B-O B-TO
10,000-fold B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-PP
in B-O B-PP_IN
monocyte B-O B-NP_NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
peripheral B-O B-NP_JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
unfractionated B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
1,25(OH)2D3 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
therefore B-O B-ADVP_RB
" " B-O O-ADVP
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
most B-O B-ADJP_RBS
potent B-O B-JJ
" " B-O O-ADJP
regulators B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
described B-O B-VP_VBN
to B-O B-NP_PP_TO
date B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Precursors B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
enhance B-O B-VP_VBP
HIV-1 B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
proportion B-O B-NN
to B-O B-TO
their B-O B-NP_NP_PRPP
affinity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
1,25(OH)2D3 B-O B-NN
intracellular B-O B-JJ
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
1,25(OH)2D3 B-O B-S_NP_NN
" " B-O O-NP
influences B-O B-VP_VBZ
HIV-1 B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
have B-O B-VP_VB
important B-O B-NP_NP_JJ
implications B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
design B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
effective B-O B-NP_NP_JJ
therapy B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Lymphocyte B-O B-NP_NP_NN
glucocorticoid B-O B-NN
receptor B-O B-NN
binding B-O B-NN
" " B-O O-NP
during B-O B-PP_PP_IN
depression B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
after B-O B-PP_IN
clinical B-O B-NP_JJ
recovery B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Lymphocyte B-O B-S_NP_NN
glucocorticoid B-O B-NN
receptor B-O B-NN
binding B-O B-NN
parameters B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
studied B-O B-VP_VP_VBN
in B-O B-NP_PP_IN
15 B-O B-NP_CD
severely B-O B-ADJP_RB
depressed B-O B-JJ
" " B-O O-ADJP
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_PP_IN
depression B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
after B-O B-PP_IN
clinical B-O B-NP_JJ
recovery B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
in B-O B-VP_PP_IN
15 B-O B-NP_CD
healthy B-O B-JJ
controls B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_NP_DT
difference B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
number B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
affinity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
between B-O B-PP_IN
depressed B-O B-NP_NP_JJ
patients B-O B-NNS
" " B-O O-NP
and B-O B-CC
recovered B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
control B-O B-ADJP_NN
" " B-O O-ADJP
" " B-O O-ADJP
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Afternoon B-O B-S_NP_NN
ACTH B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
cortisol B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
concentrations B-O B-NNS
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
differ B-O B-VP_VB
significantly B-O B-ADVP_RB
" " B-O O-ADVP
between B-O B-PP_IN
the B-O B-NP_DT
three B-O B-CD
groups B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_DT
relationship B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
established B-O B-VP_VBN
between B-O B-NP_PP_IN
glucocorticoid B-O B-NP_NP_NN
receptor B-O B-NN
binding B-O B-NN
" " B-O O-NP
and B-O B-CC
antidepressant B-O B-NP_JJ
medication B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
support B-O B-VP_VBP
the B-O B-NP_NP_NP_DT
view B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
impaired B-O B-ADJP_JJ
ligand-induced B-O B-JJ
" " B-O O-ADJP
plasticity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
rather B-O B-CONJP_RB
than B-O B-IN
" " B-O O-CONJP
the B-O B-NP_NP_DT
hypothesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
decreased B-O B-NP_NP_VBN
glucocorticoid B-O B-NN
receptor B-O B-NN
numbers B-O B-NNS
" " B-O O-NP
during B-O B-PP_IN
depression B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
NF-kappa B-O B-S_NP_NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
tumor B-O B-NP_NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
Jurkat B-O B-NN
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
independent B-O B-ADJP_JJ
of B-O B-PP_IN
protein B-O B-NP_NP_NN
kinase B-O B-NN
A B-O B-NN
" " B-O O-NP
, B-O B-COMMA
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Ca(2+)-regulated B-O B-NP_JJ
kinases B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
DNA-binding B-O B-ADJP_JJ
" " B-O O-ADJP
regulatory B-O B-JJ
factor B-O B-NN
" " B-O O-NP
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
control B-O B-VP_VB
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
activated B-O B-VP_VBN
upon B-O B-NP_PP_IN
cellular B-O B-NP_NP_JJ
treatment B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
phorbol B-O B-NP_NP_NN
esters B-O B-NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
cytokine B-O B-NN
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
work B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
molecular B-O B-JJ
events B-O B-NNS
" " B-O O-NP
leading B-O B-VP_VBG
to B-O B-PP_TO
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
and B-O B-NP_NP_NP_PRN_CC
, B-O B-NP_NP_COMMA
" " B-O B-SBAR_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
in B-O B-S_PP_IN
both B-O B-NP_DT
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
both B-O B-NP_CC
phorbol B-O B-NP_NN
ester B-O B-NN
" " B-O O-NP
and B-O B-CC
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Phorbol B-O B-S_NP_NN
activation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
positively B-O B-ADVP_RB
" " B-O O-ADVP
modulated B-O B-VP_VBN
by B-O B-NP_PP_IN
Ca2+ B-O B-NP_NN
influx B-O B-NN
" " B-O O-NP
" " B-O O-PP
while B-O B-SBAR_IN
TNF B-O B-S_NP_NN
alpha B-O B-NN
activation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
while B-O B-SBAR_IN
PMA B-O B-S_NP_NN
activation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
PKC B-O B-NN
inhibitor B-O B-NN
staurosporin B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-NP_DT
TNF B-O B-NN
alpha B-O B-NN
effect B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
unchanged B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TNF B-O B-S_S_NP_NN
alpha B-O B-NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
activate B-O B-VP_VB
cAMP B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
its B-O B-S_NP_PRPP
signal B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
modulated B-O B-VP_VBN
by B-O B-NP_PP_IN
cAMP B-O B-NP_NN
activators B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
cAMP B-O B-NP_NN
activators B-O B-NNS
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
activate B-O B-VP_VB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
TNF B-O B-NP_ADJP_NN
alpha-induced B-O B-JJ
" " B-O O-ADJP
NF-kappa B-O B-NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
cytoplasmic B-O B-S_NP_JJ
acidification B-O B-NN
" " B-O O-NP
facilitated B-O B-VP_VBD
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
both B-O B-NP_CC
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
and B-O B-CC
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
by B-O B-PP_IN
a B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
USF-related B-O B-S_NP_NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
HIV-TF1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
stimulates B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
transcription B-O B-NN
factor B-O B-NN
HIV-TF1 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
a B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
bp B-O B-ADJP_NP_QP_NN
" " B-O O-NP
upstream B-O B-JJ
from B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
purified B-O B-VP_VBN
from B-O B-NP_PP_IN
human B-O B-NP_JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HIV-TF1 B-O B-S_NP_NN
" " B-O O-NP
had B-O B-VP_VBD
a B-O B-NP_NP_DT
molecular B-O B-JJ
weight B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
39,000 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Binding B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HIV-TF1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
HIV B-O B-NN
long B-O B-NP_NP_JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
LTR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
activated B-O B-VP_VBD
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
HIV-TF1-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HIV B-O B-NP_NN
LTR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
similar B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
site B-O B-NN
" " B-O O-NP
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
in B-O B-NP_NP_NP_PRN_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNA-binding B-O B-S_NP_NP_JJ
properties B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HIV-TF1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
HIV-TF1 B-O B-S_NP_NN
" " B-O O-NP
might B-O B-VP_MD
be B-O B-VP_VB
identical B-O B-ADJP_ADJP_ADJP_JJ
" " B-O B-PP_O-ADJP
or B-O B-CC
related B-O B-ADJP_JJ
" " B-O B-PP_O-ADJP
" " B-O O-ADJP
to B-O B-PP_TO
USF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
treatment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
purified B-O B-NP_VBN
HIV-TF1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
phosphatase B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
greatly B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBD
its B-O B-NP_PRPP
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
phosphorylation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HIV-TF1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
essential B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
disruption B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-TF1-binding B-O B-NP_JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induced B-O B-VP_VBD
a B-O B-NP_NP_DT
60 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
decrease B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
HIV-TF1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
transcriptional B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Nuclear B-O B-NP_NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bind B-O B-S_NP_VP_VBP
to B-O B-PP_TO
elements B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-NP
  
Induction B-O B-NP_NP_NN
requirements B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
primary B-O B-NP_JJ
human B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Prior B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
several B-O B-NP_NP_JJ
elements B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contribute B-O B-S_NP_VP_VBP
to B-O B-PP_TO
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
sites B-O B-NNS
" " B-O O-NP
and B-O B-CC
their B-O B-NP_PRPP
corresponding B-O B-JJ
nuclear B-O B-JJ
binding B-O B-VBG
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
include B-O B-VP_VBP
: B-O B-COLON
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
AP-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
AP-3 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
OCT-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
latter B-O B-JJ
"""" B-O B-LQT
nuclear B-O B-NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
"""" B-O B-RQT
" " B-O O-NP
likely B-O B-ADVP_RB
" " B-O O-ADVP
contributes B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
tissue B-O B-NN
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
studied B-O B-VP_VBN
these B-O B-NP_DT
transcription B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
primary B-O B-NP_NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
human B-O B-NP_JJ
blood B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
to B-O B-S_NP_VP_VP_TO
verify B-O B-VP_VB
their B-O B-NP_NP_PRPP
presence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
to B-O B-VP_TO
identify B-O B-VP_VB
the B-O B-NP_NP_DT
signals B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_DT
factors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
nuclei B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_PP_IN
mitogens B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
with B-O B-IN
exogenous B-O B-NP_JJ
IL-2 B-O B-NN
growth B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
signaling B-O B-NN
requirements B-O B-NNS
" " B-O O-NP
and B-O B-CC
sensitivity B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
protein B-O B-NP_NN
synthesis B-O B-NN
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
differ B-O B-VP_VBP
considerably B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Only B-O B-S_NP_RB
the B-O B-DT
activities B-O B-NNS
for B-O B-PP_IN
NF-AT B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
require B-O B-VP_VBP
two B-O B-NP_NP_NP_CD
signals B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
optimal B-O B-NP_JJ
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-NP_COMMA
i.e. B-O B-PP_FW
" " B-O O-PP
, B-O B-COMMA
PMA B-O B-NP_NP_NN
" " B-O O-NP
plus B-O B-CC
either B-O B-NP_CC
lectin B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
antibody B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
surface B-O B-NP_NN
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Other B-O B-S_NP_JJ
factors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
lectin B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
antibody B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and/or B-O B-CC
PMA B-O B-NP_NP_NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_PP_IN
appropriate B-O B-NP_JJ
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
both B-O B-NP_CC
NF-AT B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
peculiarly B-O B-ADJP_RB
sensitive B-O B-JJ
to B-O B-PP_TO
the B-O B-NP_DT
protein B-O B-NN
synthesis B-O B-NN
inhibitor B-O B-NN
anisomycin B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
data B-O B-NNS
" " B-O O-NP
correlate B-O B-VP_VBP
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
gel B-O B-NP_NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
two B-O B-CD
signals B-O B-NNS
requirements B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
IL-2 B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
An B-O B-NP_NP_NP_DT
erythroid B-O B-ADJP_JJ
specific B-O B-JJ
" " B-O O-ADJP
enhancer B-O B-NN
" " B-O O-NP
upstream B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
gene B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
the B-O B-NP_DT
cell-type B-O B-ADJP_JJ
specific B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
factor B-O B-NN
GATA-1 B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
transcription B-O B-NN
factor B-O B-NN
GATA-1 B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_NP_DT
subset B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hemopoietic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
it B-O B-S_NP_PRP
" " B-O O-NP
mediates B-O B-VP_VBZ
" " B-O B-NP_NP_PP_ADVP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
cloned B-O B-VP_VBN
the B-O B-NP_DT
mouse B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
human B-O B-NP_JJ
" " B-O O-NP
" " B-O O-NP
GATA-1 B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
region B-O B-NN
" " B-O O-NP
upstream B-O B-RRC_ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_DT
first B-O B-JJ
exon B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
and B-O B-CC
highly B-O B-VP_ADVP_RB
" " B-O O-ADVP
conserved B-O B-VBN
between B-O B-NP_PP_IN
mouse B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
man B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-RRC
" " B-O O-NP
acts B-O B-VP_VBZ
as B-O B-PP_IN
an B-O B-NP_DT
erythroid B-O B-ADJP_JJ
specific B-O B-JJ
" " B-O O-ADJP
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
transient B-O B-NP_JJ
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
if B-O B-SBAR_IN
linked B-O B-S_NP_VP_VBN
to B-O B-NP_PP_PP_PP_TO
the B-O B-NP_DT
GATA-1 B-O B-NN
" " B-O B-NP_O-NP
" " B-O O-PP
or B-O B-CC
to B-O B-PP_TO
the B-O B-NP_DT
SV40 B-O B-NN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-PP
promoter B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
almost B-O B-ADJP_ADVP_RB
completely B-O B-RB
" " B-O O-ADVP
dependent B-O B-JJ
on B-O B-PP_IN
the B-O B-NP_NP_DT
integrity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
dimeric B-O B-JJ
GATA-1 B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Demonstration B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
1,25-dihydroxyvitamin B-O B-ADJP_NN
D3-responsive B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
immunologic B-O B-NP_NP_NP_JJ
crossreactivity B-O B-NN
" " B-O O-NP
and B-O B-CC
inverse B-O B-NP_JJ
regulation B-O B-NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
vitamin B-O B-NN
D B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
Using B-O B-S_S_NP_VP_VBG
Western B-O B-NP_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
recognizing B-O B-VP_VBG
a B-O B-NP_NP_DT
17-amino B-O B-NN
acid B-O B-NN
epitope B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
detected B-O B-VP_VBN
two B-O B-NP_CD
crossreacting B-O B-VBG
proteins B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
activated B-O B-NP_VBN
normal B-O B-JJ
human B-O B-JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
smaller B-O B-JJR
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
two B-O B-CD
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
50 B-O B-NP_CD
kDa B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VP_VBD
indistinguishable B-O B-ADJP_JJ
from B-O B-PP_IN
the B-O B-NP_DT
classical B-O B-JJ
1,25(OH)2D3 B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
, B-O B-COMMA
similar B-O B-VP_S_NP_ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_DT
classical B-O B-JJ
1,25(OH)2D3 B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-ADJP
" " B-O O-S
was B-O B-VBD
upregulated B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_DT
dose-dependent B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
larger B-O B-JJR
crossreacting B-O B-VBG
protein B-O B-NN
" " B-O O-NP
exhibited B-O B-VP_VP_VBD
an B-O B-NP_NP_DT
electrophoretic B-O B-JJ
mobility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
80 B-O B-NP_CD
kDa B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
was B-O B-VP_VBD
localized B-O B-VP_JJ
in B-O B-NP_PP_IN
the B-O B-NP_DT
cell B-O B-NN
cytosol B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
specific B-O B-ADJP_JJ
for B-O B-PP_IN
activated B-O B-NP_VBN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
since B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
More B-O B-S_S_ADVP_RBR
strikingly B-O B-RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
80-kDa B-O B-JJ
protein B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
downregulated B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_DT
dose-dependent B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
this B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
independent B-O B-ADJP_ADJP_JJ
of B-O B-PP_IN
the B-O B-NP_NP_DT
mode B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphocyte B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
and B-O B-CC
specific B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_NP_DT
1,25(OH)2D3 B-O B-NN
metabolite B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
vitamin B-O B-NP_NN
D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
two B-O B-NP_NP_CD
potent B-O B-JJ
immunosuppressive B-O B-JJ
agents B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
glucocorticoids B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
cyclosporin B-O B-NP_NN
A B-O B-DT
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
the B-O B-NP_DT
80-kDa B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Clone B-O B-S_NP_NN
pAT B-O B-NN
133 B-O B-CD
" " B-O O-NP
identifies B-O B-VP_VBZ
a B-O B-NP_NP_DT
gene B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
encodes B-O B-S_NP_VP_VBZ
another B-O B-NP_NP_DT
human B-O B-JJ
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O O-NP
report B-O B-VP_VBP
the B-O B-NP_NP_DT
structure B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
regulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
gene B-O B-NN
" " B-O O-NP
represented B-O B-VP_VBN
by B-O B-NP_PP_IN
clone B-O B-NP_NP_NN
pAT B-O B-NN
133 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
pAT B-O B-NN
133 B-O B-CD
gene B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
immediately B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBN
, B-O B-NP_COMMA
with B-O B-PP_IN
FOS-like B-O B-NP_JJ
kinetics B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
fibroblasts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Primary B-O B-S_NP_JJ
structure B-O B-NN
analysis B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
encoded B-O B-VBN
protein B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
three B-O B-NP_NP_CD
tandem B-O B-JJ
zinc-finger B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
type B-O B-NN
Cys2-Xaa12-His2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
zinc-finger B-O B-NN
region B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
thought B-O B-VP_VBN
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
similar B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
greater B-O B-FRAG_NP_QP_JJR
than B-O B-IN
80 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
amino B-O B-NN
acid B-O B-NN
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
to B-O B-PP_TO
two B-O B-NP_CD
previously B-O B-ADJP_RB
described B-O B-VBN
" " B-O O-ADJP
transcription B-O B-NN
factors B-O B-NNS
pAT B-O B-NP_NP_NN
225/EGR1 B-O B-NN
" " B-O O-NP
and B-O B-CC
pAT B-O B-NP_NN
591/EGR2 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Except B-O B-S_PP_IN
for B-O B-IN
the B-O B-NP_DT
conserved B-O B-VBN
zinc-finger B-O B-NN
domains B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
amino B-O B-NN
acid B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
three B-O B-CD
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
distinct B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
structural B-O B-JJ
similarity B-O B-NN
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_DT
pAT B-O B-NN
133 B-O B-CD
gene B-O B-NN
" " B-O O-NP
encodes B-O B-VP_VBZ
a B-O B-NP_NP_DT
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_DT
specific B-O B-JJ
biological B-O B-JJ
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Comparing B-O B-S_S_NP_VP_VBG
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
related B-O B-JJ
zinc-finger-encoding B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
showed B-O B-VP_VBD
coordinate B-O B-NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
upon B-O B-PP_IN
mitogenic B-O B-NP_NP_JJ
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_PP_IN
resting B-O B-NP_VBG
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
of B-O B-PP_IN
resting B-O B-NP_VBG
fibroblasts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
upon B-O B-PP_IN
transition B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
a B-O B-NP_NP_NP_DT
proliferating B-O B-JJ
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
G1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O B-PP_O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_NP_DT
resting B-O B-JJ
" " B-O B-NP_O-NP
" " B-O B-PP_O-NP
" " B-O O-PP
state B-O B-NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
three B-O B-CD
genes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
differently B-O B-ADVP_RB
" " B-O O-ADVP
regulated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
human B-O B-NP_JJ
histiocytic B-O B-JJ
U937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
mRNA B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
clone B-O B-NP_NN
pAT B-O B-NN
133 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
mRNA B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
pAT B-O B-NP_NN
225/EGR1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
induced B-O B-VP_VBN
upon B-O B-NP_PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
terminal B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
mRNA B-O B-NP_NP_NN
" " B-O O-NP
representing B-O B-VP_VBG
pAT B-O B-NP_NN
591/EGR2 B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
difference B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
gene B-O B-NP_NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggests B-O B-VP_VBZ
distinct B-O B-NP_NP_JJ
biological B-O B-JJ
roles B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
the B-O B-NP_DT
respective B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Elevated B-O B-NP_NP_NP_JJ
glucocorticoid B-O B-NN
receptor B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
before B-O B-PP_PP_IN
" " B-O B-NP_O-PP
and B-O B-CC
after B-O B-PP_IN
" " B-O B-NP_O-PP
glucocorticoid B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
atopic B-O B-NP_JJ
dermatitis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
number B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
affinity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
determined B-O B-VP_VBN
under B-O B-NP_PP_PP_IN
baseline B-O B-NP_NN
conditions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
after B-O B-PP_IN
a B-O B-NP_DT
defined B-O B-VBN
oral B-O B-JJ
glucocorticoid B-O B-NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Patients B-O B-S_NP_NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
AD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
n B-O B-NP_NP_NN
" " B-O O-NP
= B-O B-ADJP_JJ
15 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
exhibited B-O B-VP_VBD
significantly B-O B-NP_ADJP_RB
more B-O B-JJR
" " B-O O-ADJP
glucocorticoid B-O B-NP_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
GR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
per B-O B-PP_IN
cell B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
than B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
control B-O B-NN
group B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
n B-O B-NP_NP_NN
" " B-O O-NP
= B-O B-ADJP_JJ
" " B-O B-NP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
while B-O B-SBAR_IN
the B-O B-S_NP_DT
GR B-O B-NN
affinity B-O B-NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
differ B-O B-VP_VB
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Methylprednisolone B-O B-S_NP_NN
treatment B-O B-NN
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_DT
significant B-O B-JJ
reduction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
GR B-O B-NN
sites B-O B-NNS
" " B-O O-NP
per B-O B-PP_IN
cell B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
steroid-treated B-O B-JJ
control B-O B-NN
group B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
n B-O B-NP_NP_NN
" " B-O B-ADJP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
contrast B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
dissociation B-O B-NN
constant B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
affected B-O B-VP_VBN
by B-O B-NP_PP_IN
methylprednisolone B-O B-NP_JJ
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
either B-O B-NP_DT
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
view B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
therapeutic B-O B-JJ
efficiency B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
AD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
findings B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
abnormal B-O B-NP_NP_JJ
cAMP B-O B-NN
" " B-O O-NP
and B-O B-CC
cAMP-phosphodiesterase B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
elevated B-O B-JJ
GR B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
AD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
lend B-O B-VP_VBP
support B-O B-NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
hypothesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
compensatory B-O B-JJ
GR B-O B-NN
upregulation B-O B-NN
" " B-O O-NP
due B-O B-ADJP_JJ
to B-O B-PP_PP_TO
or B-O B-NP_CC
to B-O B-PP_TO
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
High B-O B-S_NP_NP_JJ
affinity B-O B-NN
aldosterone B-O B-NN
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
plasma B-O B-NP_NP_NN
membrane B-O B-NN
rich B-O B-JJ
fractions B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
mononuclear B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
: B-O B-COLON
is B-O B-SQ_VBZ
there B-O B-NP_EX
" " B-O O-NP
a B-O B-NP_NP_DT
membrane B-O B-NN
receptor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
mineralocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
? B-O B-PERIOD
" " B-O O-SQ
" " B-O O-S
  
In B-O B-S_NP_NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
intracellular B-O B-JJ
concentrations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
sodium B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
potassium B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
calcium B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
cell B-O B-NP_NN
volume B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
sodium-proton-antiport B-O B-NN
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
described B-O B-VP_VBN
in B-O B-NP_PP_IN
intact B-O B-NP_JJ
human B-O B-NP_NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
HML B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
paper B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
[125I]-labeled B-O B-JJ
aldosterone B-O B-NN
derivative B-O B-JJ
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
plasma B-O B-NP_NP_ADJP_NP_NN
membrane B-O B-NN
" " B-O O-NP
rich B-O B-JJ
" " B-O O-ADJP
fractions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HML B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
High B-O B-S_NP_NP_JJ
affinity B-O B-NN
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
radioligand B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
an B-O B-NP_NP_DT
apparent B-O B-JJ
Kd B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
approximately B-O B-NP_QP_RB
0.1 B-O B-CD
" " B-O O-QP
nM B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Aldosterone B-O B-S_NP_NN
" " B-O O-NP
displaced B-O B-VP_VBD
the B-O B-NP_DT
tracer B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
a B-O B-NP_DT
similar B-O B-JJ
Kd B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
canrenone B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
cortisol B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
inactive B-O B-ADJP_JJ
" " B-O O-ADJP
as B-O B-PP_IN
ligands B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
up B-O B-PP_RB
to B-O B-TO
concentrations B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
0.1 B-O B-NP_CD
microM B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
the B-O B-NP_NP_DT
first B-O B-JJ
" " B-O O-NP
to B-O B-SBAR_WHNP_S_NP_VP_TO
demonstrate B-O B-VP_VB
membrane B-O B-NP_NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
, B-O B-NP_PP_PP_COMMA
but B-O B-CC
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
are B-O B-VP_VP_VBP
perfectly B-O B-ADJP_RB
compatible B-O B-JJ
with B-O B-PP_IN
major B-O B-NP_NP_JJ
properties B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
steroidal B-O B-NP_NP_JJ
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
thus B-O B-RB
very B-O B-VP_ADVP_RB
likely B-O B-RB
" " B-O O-ADVP
represent B-O B-VBP
membrane B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Every B-O B-S_S_NP_DT
enhancer B-O B-NN
" " B-O O-NP
works B-O B-VP_VBZ
with B-O B-PP_IN
every B-O B-NP_DT
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
all B-O B-NP_NP_PDT
the B-O B-DT
combinations B-O B-NNS
" " B-O O-NP
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
could B-O B-SQ_MD
new B-O B-NP_JJ
regulatory B-O B-JJ
pathways B-O B-NNS
" " B-O O-NP
evolve B-O B-VP_VBP
by B-O B-PP_IN
enhancer B-O B-NP_NN
shuffling B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
? B-O B-PERIOD
" " B-O O-SQ
" " B-O O-S
  
The B-O B-S_S_S_NP_NP_DT
promoters B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
enhancers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_ADJP_NN
type-specific B-O B-JJ
" " B-O O-ADJP
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
often B-O B-ADVP_RB
" " B-O O-ADVP
conserved B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
in B-O B-PP_IN
evolution B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
hence B-O B-RB
one B-O B-S_NP_NN
" " B-O O-NP
might B-O B-VP_MD
expect B-O B-VP_VB
that B-O B-SBAR_IN
a B-O B-S_NP_DT
given B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
evolved B-O B-VP_VBN
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
While B-O B-S_SBAR_IN
this B-O B-S_NP_DT
expectation B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
realized B-O B-VP_VBN
in B-O B-NP_PP_IN
some B-O B-NP_DT
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
not B-O B-RB
found B-O B-VP_VBN
evidence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
it B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
total B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
27 B-O B-NP_NP_CD
combinations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
different B-O B-NP_JJ
promoters B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
enhancers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
tested B-O B-VP_VBN
by B-O B-NP_PP_IN
transfection B-O B-NP_NP_NN
" " B-O O-NP
into B-O B-PP_IN
cultured B-O B-NP_VBN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_S_NP_NP_DT
relative B-O B-JJ
efficiency B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
enhancers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
approximately B-O B-NP_ADVP_RB
" " B-O O-ADVP
the B-O B-DT
same B-O B-JJ
" " B-O O-NP
, B-O B-COMMA
irrespective B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
, B-O B-COMMA
" " B-O O-VP
" " B-O O-S
i.e. B-O B-FW
, B-O B-COMMA
there B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_NP_DT
strong B-O B-JJ
preference B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
any B-O B-NP_DT
given B-O B-JJ
combination B-O B-ADJP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Notably B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
see B-O B-VP_VB
particularly B-O B-NP_ADJP_RB
strong B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_NP_DT
immunoglobulin B-O B-NN
kappa B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
( B-O B-LRB
or B-O B-CC
the B-O B-NP_DT
immunoglobulin B-O B-NN
heavy B-O B-JJ
chain B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-NP
is B-O B-VP_VBZ
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_S_NP_DT
generally B-O B-ADJP_RB
permissive B-O B-JJ
" " B-O O-ADJP
enhancer/promoter B-O B-ADJP_JJ
" " B-O O-ADJP
interaction B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
by B-O B-S_PP_IN
enhancer B-O B-NP_NN
shuffling B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
genes B-O B-NP_NNS
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
easily B-O B-ADVP_RB
" " B-O O-ADVP
brought B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
Activation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
CD4 B-O B-NN
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Interaction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
fibronectin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
VLA-5 B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
CD4 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
the B-O B-NP_DT
AP-1 B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Fibronectin B-O B-S_S_NP_NN
" " B-O O-NP
synergized B-O B-VP_VBD
with B-O B-PP_IN
anti-CD3 B-O B-NP_JJ
antibody B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
promote B-O B-VP_VB
CD4 B-O B-NP_NN
cell B-O B-NN
proliferation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
serum-free B-O B-JJ
culture B-O B-NN
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
whereas B-O B-SBAR_IN
no B-O B-S_NP_DT
proliferation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
CD4 B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
anti-CD29 B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
integrin B-O B-NP_NN
beta B-O B-NN
1 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
" " B-O B-NP_O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
anti-VLA-5 B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
human B-O B-NP_JJ
fibronectin B-O B-NN
receptor B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
" " B-O B-NP_O-NP
antibodies B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
blocked B-O B-VP_VBD
this B-O B-NP_DT
CD4 B-O B-NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
anti-CD3 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
or B-O B-CC
fibronectin B-O B-NP_NP_NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
not B-O B-RB
induce B-O B-VP_VB
IL-2 B-O B-NP_NN
message B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
CD4 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
anti-CD3 B-O B-NP_NP_NN
" " B-O O-NP
plus B-O B-CC
fibronectin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induced B-O B-VP_VBD
IL-2 B-O B-NP_NN
message B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
CD4 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
an B-O B-NP_NP_DT
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
molecular B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
IL-2 B-O B-S_NP_NN
message B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
generated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
a B-O B-S_NP_DT
fibronectin-VLA-5 B-O B-NN
fibronectin B-O B-NN
receptor B-O B-NN
interaction B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
contribute B-O B-VP_VB
an B-O B-NP_NP_DT
independent B-O B-JJ
signal B-O B-NN
" " B-O O-NP
distinct B-O B-ADJP_JJ
from B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
the B-O B-NP_NP_DT
VLA-5 B-O B-NN
fibronectin B-O B-NN
receptor B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
CD4 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
play B-O B-VP_VB
a B-O B-NP_DT
complementary B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
CD3-TCR-mediated B-O B-NP_NP_JJ
signal B-O B-NN
transduction B-O B-NN
" " B-O O-NP
through B-O B-PP_IN
its B-O B-NP_NP_PRPP
interaction B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
fibronectin B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_DT
functional B-O B-JJ
domains B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
murine B-O B-JJ
Thy-1 B-O B-NN
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
Thy-1 B-O B-NN
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
resembles B-O B-VP_VBZ
a B-O B-NP_DT
"""" B-O B-LQT
housekeeping B-O B-JJ
"""" B-O B-RQT
promoter B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
that B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VP_VBZ
located B-O B-ADJP_JJ
within B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
, B-O B-COMMA
lacks B-O B-VP_VBZ
a B-O B-NP_DT
canonical B-O B-JJ
TATA B-O B-NN
box B-O B-NN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
displays B-O B-VP_VBZ
heterogeneity B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
transgenic B-O B-NP_JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
this B-O B-S_NP_DT
promoter B-O B-NN
" " B-O O-NP
does B-O B-VP_VP_VBZ
not B-O B-RB
confer B-O B-VP_VB
any B-O B-NP_DT
tissue B-O B-NN
specificity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
active B-O B-ADJP_JJ
" " B-O O-ADJP
only B-O B-PP_RB
in B-O B-IN
a B-O B-NP_DT
position-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
can B-O B-VP_MD
only B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
activated B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_DT
tissue-specific B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
elements B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
lie B-O B-S_NP_VP_VBP
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VP_VBP
analyzed B-O B-VP_VBN
the B-O B-NP_NP_DT
functional B-O B-JJ
domains B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
minimal B-O B-JJ
Thy-1 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
show B-O B-VP_VB
that B-O B-SBAR_IN
the B-O B-S_NP_DT
dominant B-O B-JJ
promoter B-O B-NN
elements B-O B-NNS
" " B-O O-NP
consist B-O B-VP_VBP
of B-O B-PP_IN
multiple B-O B-NP_NP_JJ
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNase B-O B-S_NP_NN
I B-O B-CD
and B-O B-CC
gel B-O B-NN
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
these B-O B-NP_NP_DT
elements B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
Sp1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
CP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
structure B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
only B-O B-ADVP_RB
" " B-O O-ADVP
permits B-O B-VP_VBZ
productive B-O B-NP_NP_JJ
interactions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
two B-O B-CD
transcription B-O B-NN
factors B-O B-NNS
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
basal B-O B-JJ
transcription B-O B-NN
machinery B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-DT
presence B-O B-NN
of B-O B-IN
enhancer B-O B-NP_NN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
belonging B-O B-VP_VBG
to B-O B-PP_TO
the B-O B-NP_DT
rel/NF-kappa B-O B-NN
B B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
a B-O B-NP_DT
transdominant B-O B-JJ
negative B-O B-JJ
mutant B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
KBF1 B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
enhancer B-O B-NN
A B-O B-NN
" " B-O O-NP
located B-O B-VP_JJ
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
indistinguishable B-O B-ADJP_JJ
from B-O B-PP_IN
the B-O B-NP_NP_DT
p50 B-O B-NN
DNA B-O B-NN
binding B-O B-NN
subunit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
regulates B-O B-S_NP_VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
KBF1/p50 B-O B-NN
factor B-O B-NN
" " B-O O-NP
binds B-O B-VP_VP_VBZ
as B-O B-PP_IN
a B-O B-NP_DT
homodimer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CC
can B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
form B-O B-VP_VB
heterodimers B-O B-NP_NNS
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
products B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_NP_JJ
members B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
like B-O B-PP_IN
the B-O B-NP_DT
and B-O B-NP_NP_CC
( B-O B-NP_LRB
proto B-O B-NN
) B-O B-RRB
oncogenes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
dimerization B-O B-NN
domain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
KBF1/p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
contained B-O B-VP_VBN
between B-O B-NP_PP_IN
amino B-O B-NP_NN
acids B-O B-NNS
201 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
367 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_NP_DT
mutant B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
KBF1/p50 B-O B-NP_NN
( B-O B-LRB
delta B-O B-NN
SP B-O B-NN
) B-O B-RRB
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
unable B-O B-ADJP_ADJP_JJ
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
to B-O B-PP_TO
DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
but B-O B-CC
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
form B-O B-VP_VB
homo- B-O B-NP_NP_JJ
" " B-O B-NP_O-NP
or B-O B-CC
heterodimers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-ADJP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
constructed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
protein B-O B-NN
" " B-O O-NP
reduces B-O B-VP_VP_VP_VBZ
" " B-O B-NP_O-VP
or B-O B-CC
abolishes B-O B-VP_VBZ
" " B-O B-NP_O-VP
" " B-O O-VP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
the B-O B-NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
wild-type B-O B-NP_NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
same B-O B-JJ
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
KBF1/p50 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
c- B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
v-rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_DT
mutant B-O B-JJ
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
functions B-O B-VP_NNS
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
as B-O B-PP_IN
a B-O B-NP_DT
trans-acting B-O B-JJ
dominant B-O B-JJ
negative B-O B-JJ
regulator B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
the B-O B-S_NP_NP_DT
transcriptional B-O B-JJ
inducibility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
HIV B-O B-NN
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
( B-O B-LRB
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contains B-O B-S_NP_VP_VBZ
two B-O B-NP_CD
potential B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
) B-O B-RRB
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
phorbol B-O B-NP_NP_NN
ester B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
inhibited B-O B-VP_VBN
when B-O B-NP_SBAR_WHADVP_WRB
" " B-O O-WHADVP
it B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
co-transfected B-O B-VP_VBN
into B-O B-NP_PP_IN
with B-O B-NP_PP_IN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Similarly B-O B-S_ADVP_RB
" " B-O O-ADVP
the B-O B-NP_NP_DT
basal B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
TNF B-O B-ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
or B-O B-CC
IL1-induced B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
MHC B-O B-NN
class B-O B-NN
I B-O B-CD
H-2Kb B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
this B-O B-NP_DT
mutant B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
two B-O B-NP_CD
different B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
constitute B-O B-VP_VBP
the B-O B-NP_DT
first B-O B-JJ
formal B-O B-JJ
demonstration B-O B-NN
that B-O B-SBAR_IN
these B-O B-S_NP_DT
genes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Towards B-O B-S_FRAG_PP_IN
a B-O B-NP_NP_DT
molecular B-O B-JJ
understanding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T-cell B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-FRAG
" " B-O O-S
  
Lymphoid B-O B-S_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
best B-O B-ADJP_RBS
studied B-O B-VBN
" " B-O O-ADJP
examples B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
mammalian B-O B-NP_JJ
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
Hans B-O B-NP_NP_NNP
Clevers B-O B-NNP
" " B-O O-NP
and B-O B-CC
Michael B-O B-NP_NNP
Owen B-O B-NNP
" " B-O O-NP
" " B-O O-NP
describe B-O B-VP_VBP
how B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_NP_DT
cloning B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
genes B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
allows B-O B-VP_VBZ
the B-O B-NP_NP_DT
identification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Such B-O B-S_NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
play B-O B-VP_VBP
a B-O B-NP_DT
key B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
development B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
mature B-O B-JJ
T-cell B-O B-NN
phenotype B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
functioning B-O B-S_NP_VP_VBG
as B-O B-PP_IN
' B-O B-LQT
master B-O B-NP_NP_JJ
regulators B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
T-cell B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
' B-O B-RQT
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cloning B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
human B-O B-JJ
homeobox B-O B-NN
gene B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
resembles B-O B-S_NP_VP_VP_VBZ
a B-O B-NP_DT
diverged B-O B-JJ
Drosophila B-O B-NN
homeobox B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
A B-O B-S_NP_NP_DT
new B-O B-JJ
homeobox B-O B-NN
gene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
HB24 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
a B-O B-NP_DT
human B-O B-JJ
B-lymphocyte B-O B-NN
cDNA B-O B-NN
library B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_NP_NP_JJ
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
polyadenylated B-O B-NP_NP_JJ
RNA B-O B-NN
" " B-O O-NP
purified B-O B-VP_VBN
from B-O B-NP_PP_IN
activated B-O B-NP_VBN
human B-O B-JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
a B-O B-NP_NP_DT
single B-O B-JJ
mRNA B-O B-NN
transcript B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
approximately B-O B-NP_QP_RB
2.3 B-O B-CD
" " B-O O-QP
kb B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_CD
cDNA B-O B-NN
clones B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
sequenced B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
provided B-O B-VP_VBN
2,250 B-O B-NP_NP_NP_CD
nucleotides B-O B-NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
nt B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
sequence B-O B-NN
information B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_S_NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
single B-O B-JJ
methionine B-O B-ADJP_NN
codon-initiated B-O B-JJ
" " B-O O-ADJP
open B-O B-JJ
reading B-O B-NN
frame B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1,458 B-O B-NP_CD
nt B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
frame B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
homeobox B-O B-NN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_DT
CAX B-O B-NN
repeat B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_DT
open B-O B-JJ
reading B-O B-NN
frame B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
predicted B-O B-VP_VBN
to B-O B-S_NP_VP_TO
encode B-O B-VP_VB
a B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_NP_DT
homeodomain B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
HB24 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
compared B-O B-VP_VBN
to B-O B-NP_PP_TO
known B-O B-NP_JJ
and B-O B-UCP_ADJP_CC
homeodomains B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
it B-O B-NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
only B-O B-ADJP_ADVP_RB
moderately B-O B-RB
" " B-O O-ADVP
conserved B-O B-VBN
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
when B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
it B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
compared B-O B-VP_VBN
to B-O B-NP_PP_TO
a B-O B-NP_NP_DT
Drosophila B-O B-ADJP_FW
homeodomain B-O B-NN
" " B-O O-NP
, B-O B-COMMA
H2.0 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
it B-O B-NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
80 B-O B-ADJP_NP_CD
% B-O B-NN
" " B-O O-NP
identical B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
HB24 B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
absent B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
present B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
at B-O B-PP_IN
low B-O B-NP_JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
normal B-O B-NP_JJ
B B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
T B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
however B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
with B-O B-PP_IN
the B-O B-NP_DT
appropriate B-O B-JJ
activation B-O B-NN
signal B-O B-NN
" " B-O O-NP
" " B-O O-PP
HB24 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
induced B-O B-VP_VBN
within B-O B-NP_PP_IN
several B-O B-NP_JJ
hours B-O B-NNS
" " B-O O-NP
" " B-O O-PP
even B-O B-PP_RB
in B-O B-IN
the B-O B-DT
presence B-O B-NN
of B-O B-IN
cycloheximide B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Characterization B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HB24 B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lymphoid B-O B-NP_NP_JJ
" " B-O O-NP
and B-O B-CC
select B-O B-NP_JJ
developing B-O B-VBG
tissues B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
performed B-O B-VP_VBN
by B-O B-NP_PP_IN
in B-O B-NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Positive B-O B-S_NP_JJ
hybridization B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
thymus B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
tonsil B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
bone B-O B-NP_NN
marrow B-O B-NN
" " B-O O-NP
, B-O B-COMMA
developing B-O B-NP_VBG
vessels B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
in B-O B-PP_IN
fetal B-O B-NP_JJ
brain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HB24 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
likely B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
certain B-O B-NP_JJ
developing B-O B-VBG
tissues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
stably B-O B-VP_ADVP_RB
" " B-O O-ADVP
expressing B-O B-VBG
the B-O B-NP_NP_DT
Tax B-O B-NN
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cell B-O B-NN
lymphotropic B-O B-JJ
virus B-O B-NN
type B-O B-NN
I B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
constitutive B-O B-NP_JJ
Tax B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_PP_IN
the B-O B-NP_NP_DT
interaction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
its B-O B-NP_PRPP
recognition B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
on B-O B-PP_IN
NF-kappa B-O B-NP_ADJP_NN
B-dependent B-O B-JJ
" " B-O O-ADJP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
examined B-O B-VP_VBN
in B-O B-NP_PP_IN
T B-O B-NP_NP_NP_NN
lymphoid B-O B-JJ
Jurkat B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
19D B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
9J B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
stably B-O B-VP_ADVP_RB
" " B-O O-ADVP
transformed B-O B-VBN
with B-O B-NP_PP_IN
a B-O B-NP_DT
Tax B-O B-NN
expression B-O B-NN
vector B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tax B-O B-S_NP_NN
expressing B-O B-NN
T B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
contained B-O B-VP_VBD
a B-O B-NP_NP_DT
constitutive B-O B-JJ
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
, B-O B-COMMA
detectable B-O B-ADJP_JJ
by B-O B-PP_IN
and B-O B-NP_NP_NP_CC
using B-O B-NP_VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
Jurkat B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NC2.10 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
induction B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
phorbol B-O B-NP_NN
esters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
the B-O B-NP_NP_DT
appearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
new B-O B-NP_NP_JJ
DNA B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
kDa B-O B-NP_QP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
in B-O B-S_PP_IN
Tax B-O B-NP_NN
expressing B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
85-kDa B-O B-JJ
protein B-O B-NN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_DT
92-kDa B-O B-JJ
DNA B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Tax B-O B-NP_NP_NN
protein B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
19D B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
9J B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
transcription B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
endogenous B-O B-JJ
NF-kappa B-O B-ADJP_NN
B-dependent B-O B-JJ
" " B-O O-ADJP
granulocyte-macrophage B-O B-JJ
colony B-O B-NN
stimulating B-O B-NN
factor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
increased B-O B-NP_NP_VBD
basal B-O B-JJ
level B-O B-NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transfected B-O B-NP_VBN
NF-kappa B-O B-ADJP_NN
B-regulated B-O B-JJ
" " B-O O-ADJP
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nonetheless B-O B-S_ADVP_RB
" " B-O O-ADVP
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_NP_CC
the B-O B-NP_DT
endogenous B-O B-JJ
" " B-O B-NP_O-NP
and B-O B-CC
the B-O B-NP_DT
transfected B-O B-VBN
" " B-O B-NP_O-NP
" " B-O O-NP
gene B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
inducible B-O B-ADJP_JJ
by B-O B-PP_IN
PMA B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tax B-O B-S_NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
alter B-O B-VP_VP_VB
the B-O B-NP_NP_DT
stoichiometry B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
DNA B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
thus B-O B-RB
change B-O B-VP_VB
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_ADJP_NN
B-regulated B-O B-JJ
" " B-O O-ADJP
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Anti-CD2 B-O B-S_NP_JJ
receptor B-O B-NN
antibodies B-O B-NNS
" " B-O O-NP
activate B-O B-VP_VBP
the B-O B-NP_NP_DT
HIV B-O B-NN
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
CD2 B-O B-NN
T B-O B-NN
lymphocyte B-O B-NN
glycoprotein B-O B-NN
surface B-O B-NN
molecule B-O B-NN
" " B-O O-NP
mediates B-O B-VP_VBZ
both B-O B-NP_NP_CC
cell B-O B-NP_NN
to B-O B-TO
cell B-O B-NN
adhesion B-O B-NN
" " B-O O-NP
and B-O B-CC
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
two B-O B-NP_NP_CD
processes B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
chronically B-O B-NP_ADJP_RB
HIV-infected B-O B-JJ
" " B-O O-ADJP
PBMC B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
anti-CD2 B-O B-NP_JJ
mAb B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
whereby B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
anti-CD2 B-O B-S_NP_JJ
antibodies B-O B-NNS
" " B-O O-NP
stimulate B-O B-VP_VBP
viral B-O B-NP_JJ
production B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transiently B-O B-NP_ADJP_RB
transfected B-O B-VBN
" " B-O O-ADJP
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
anti-CD2 B-O B-NP_JJ
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NN
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
CAT B-O B-NP_NP_NP_NN
assays B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
mutated B-O B-NP_VBN
HIV B-O B-NN
long B-O B-ADJP_JJ
terminal B-O B-JJ
repeat-CAT B-O B-NN
" " B-O O-ADJP
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
and B-O B-CC
gel B-O B-NP_NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
this B-O B-S_NP_DT
activation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
interaction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
its B-O B-NP_NP_PRPP
natural B-O B-JJ
ligand B-O B-NN
" " B-O O-NP
, B-O B-COMMA
LFA-3 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
play B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
v-erbA B-O B-S_NP_NN
overexpression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
to B-O B-S_NP_VP_TO
extinguish B-O B-VP_VB
c-erbA B-O B-NP_NP_NP_NN
function B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
v-erbA B-O B-NN
oncoprotein B-O B-NN
" " B-O O-NP
represents B-O B-VP_VBZ
a B-O B-NP_NP_DT
retrovirus-transduced B-O B-JJ
oncogenic B-O B-JJ
version B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
thyroid B-O B-NN
hormone B-O B-NN
( B-O B-LRB
T3/T4 B-O B-NN
) B-O B-RRB
receptor B-O B-NN
c-erbA B-O B-NN
( B-O B-LRB
type B-O B-NN
alpha B-O B-NN
) B-O B-RRB
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
contributes B-O B-VP_VBZ
to B-O B-PP_TO
virus-induced B-O B-NP_JJ
erythroleukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_PP_IN
efficiently B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
arresting B-O B-VP_VBG
differentiation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
red B-O B-NP_JJ
cell B-O B-NN
progenitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
and B-O B-CC
by B-O B-PP_IN
suppressing B-O B-S_NP_VP_VBG
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
erythrocyte-specific B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
v-erbA B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-erbA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
bind B-O B-VP_VBP
directly B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
sequences B-O B-NP_NP_NNS
" " B-O O-NP
within B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
erbA-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
confers B-O B-VP_VP_VBZ
thyroid B-O B-NP_NP_NN
hormone B-O B-NN
responsiveness B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_DT
heterologous B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
transient B-O B-NP_JJ
expression B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
target B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
efficient B-O B-NP_NP_JJ
down-regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CAII B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
v-erbA B-O B-NN
oncoprotein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
stably B-O B-NP_NP_ADJP_RB
transformed B-O B-VBN
" " B-O O-ADJP
erythroblasts B-O B-NNS
" " B-O O-NP
coexpressing B-O B-VP_VBG
the B-O B-NP_NP_DT
v-erbA B-O B-NN
oncoprotein B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
c-erbA/T3 B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
at B-O B-PP_IN
an B-O B-NP_DT
approximately B-O B-ADJP_RB
equimolar B-O B-JJ
" " B-O O-ADJP
ratio B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
c-erbA B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
dominant B-O B-ADJP_JJ
over B-O B-PP_IN
v-erbA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
T3 B-O B-S_NP_NN
" " B-O O-NP
efficiently B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBD
erythroid B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
thus B-O B-RB
overcoming B-O B-S_NP_VP_VBG
the B-O B-NP_DT
v-erbA-mediated B-O B-JJ
differentiation B-O B-NN
arrest B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Likewise B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
T3 B-O B-NP_NN
" " B-O O-NP
activated B-O B-VP_VBD
CAII B-O B-NP_NP_NN
transcription B-O B-NN
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
transient B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
T3-responsive B-O B-JJ
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_DT
CAII-specific B-O B-JJ
erbA-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
c-erbA-dependent B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
CAII B-O B-NN
reporter B-O B-NN
construct B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
only B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
suppressed B-O B-VP_VBN
by B-O B-NP_PP_IN
very B-O B-NP_NP_ADJP_RB
high B-O B-JJ
" " B-O O-ADJP
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
v-erbA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
overexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
v-erbA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
its B-O B-NP_NP_PRPP
function B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Mapping B-O B-NP_NP_NN
of B-O B-PP_IN
B-cell B-O B-NP_NP_NN
epitopes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
hepatitis B-O B-NN
B B-O B-NN
virus B-O B-NN
X B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
immune B-O B-JJ
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
X B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
hepatitis B-O B-NN
B B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HBV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
by B-O B-NP_PP_IN
epitope B-O B-NP_NN
mapping B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
using B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
set B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Antibodies B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
sera B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_ADJP_NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
HBV B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
a B-O B-NP_DT
multispecific B-O B-JJ
immune B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Each B-O B-S_NP_DT
serum B-O B-NN
" " B-O O-NP
contained B-O B-VP_VBD
antibodies B-O B-NP_NP_NNS
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_NP_DT
different B-O B-JJ
set B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
epitopes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
taken B-O B-S_NP_S_NP_VP_VBN
" " B-O B-ADVP_NP_O-VP
" " B-O O-S
cover B-O B-VP_VBP
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Some B-O B-S_S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
epitopes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
detectable B-O B-ADJP_JJ
only B-O B-PP_ADVP_RB
" " B-O O-ADVP
by B-O B-IN
immunoblotting B-O B-S_NP_VP_VBG
with B-O B-PP_IN
fusion B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
others B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
detectable B-O B-ADJP_JJ
only B-O B-PP_ADVP_RB
" " B-O O-ADVP
by B-O B-IN
an B-O B-NP_NP_DT
enzyme-linked B-O B-NP_NP_JJ
immunosorbent B-O B-JJ
assay B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
synthetic B-O B-NP_JJ
peptides B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
carboxy-terminal B-O B-NP_JJ
half B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HBx B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VP_VBD
preferentially B-O B-ADVP_RB
" " B-O O-ADVP
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
antibodies B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
contained B-O B-VP_VBD
a B-O B-NP_NP_DT
short B-O B-JJ
immunodominant B-O B-NP_JJ
antigenic B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
at B-O B-NP_QP_IN
least B-O B-JJS
two B-O B-CD
" " B-O O-QP
major B-O B-JJ
nonoverlapping B-O B-NP_JJ
epitopes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Anti-HBx B-O B-S_NP_NP_JJ
antibody B-O B-NN
titers B-O B-NNS
" " B-O O-NP
as B-O B-SBAR_IN
revealed B-O B-S_NP_NP_VBN
by B-O B-NP_PP_IN
peptide B-O B-NP_NN
ELISAs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
were B-O B-VP_VBD
highest B-O B-ADJP_ADJP_ADJP_JJS
" " B-O O-ADJP
and B-O B-CC
most B-O B-ADJP_RBS
frequent B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
chronic B-O B-NP_JJ
hepatitis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
usually B-O B-ADJP_RB
low B-O B-JJ
in B-O B-PP_IN
acutely B-O B-NP_NP_ADJP_RB
infected B-O B-JJ
" " B-O O-ADJP
patients B-O B-NNS
" " B-O O-NP
and B-O B-CC
asymptomatic B-O B-NP_JJ
carriers B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
a B-O B-NP_NP_DT
remarkable B-O B-JJ
qualitative B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
quantitative B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
heterogeneity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
humoral B-O B-JJ
HBx B-O B-NP_NN
" " B-O O-NP
immune B-O B-JJ
response B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
can B-O B-S_NP_VP_MD
be B-O B-VP_VB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Such B-O B-S_NP_JJ
tests B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
become B-O B-VP_VB
useful B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
diagnostic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
tools B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Complementary B-O B-NP_NP_NP_JJ
DNA B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
the B-O B-NP_NP_DT
human B-O B-NP_JJ
T-cell B-O B-NN
FK506-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
peptidylprolyl B-O B-NP_JJ
cis-trans B-O B-JJ
isomerase B-O B-NN
" " B-O O-NP
" " B-O O-NP
distinct B-O B-ADJP_JJ
from B-O B-PP_IN
cyclophilin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
recently B-O B-ADJP_RB
discovered B-O B-VBN
" " B-O O-ADJP
macrolide B-O B-NN
" " B-O O-NP
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
demonstrated B-O B-VP_VBN
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
activity B-O B-NP_ADJP_NN
" " B-O O-NP
at B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
After B-O B-S_PP_IN
the B-O B-NP_DT
recent B-O B-JJ
discovery B-O B-NN
that B-O B-SBAR_IN
the B-O B-S_NP_DT
cyclosporin B-O B-NP_NP_NN
A-binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
cyclophilin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
identical B-O B-ADJP_JJ
to B-O B-PP_TO
peptidylprolyl B-O B-NP_JJ
cis-trans B-O B-JJ
isomerase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_NP_DT
cellular B-O B-NP_JJ
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_VP_TO
be B-O B-VP_VB
distinct B-O B-ADJP_JJ
from B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-VP
but B-O B-CC
to B-O B-VP_TO
have B-O B-VP_VB
the B-O B-NP_DT
same B-O B-JJ
enzymatic B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
isolated B-O B-VP_VBD
a B-O B-NP_NP_DT
cDNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
coding B-O B-VP_VBG
for B-O B-PP_IN
FK506-binding B-O B-NP_NP_JJ
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
FKBP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
from B-O B-PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
using B-O B-S_NP_VP_VBG
mixed B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
20-mer B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
oligonucleotide B-O B-NN
probes B-O B-NNS
" " B-O O-NP
synthesized B-O B-VP_VBN
on B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
DNA B-O B-NN
" " B-O O-NP
isolated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
contained B-O B-VP_VBD
an B-O B-NP_NP_DT
open B-O B-JJ
reading B-O B-NN
frame B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
108 B-O B-NP_CD
amino B-O B-NN
acid B-O B-NN
residues B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
first B-O B-JJ
40 B-O B-CD
residues B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
deduced B-O B-VBN
amino B-O B-NN
acid B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
identical B-O B-ADJP_JJ
to B-O B-PP_TO
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
reported B-O B-VBN
amino-terminal B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
bovine B-O B-NP_JJ
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
DNA B-O B-NN
sequence B-O B-NN
" " B-O O-NP
isolated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
represents B-O B-VP_VBZ
the B-O B-NP_NP_DT
gene B-O B-NN
" " B-O O-NP
coding B-O B-VP_VBG
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Computer-assisted B-O B-S_NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
deduced B-O B-VBN
amino B-O B-NN
acid B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicates B-O B-VP_VBZ
that B-O B-SBAR_IN
FKBP B-O B-S_NP_NN
" " B-O O-NP
exhibits B-O B-VP_VP_VBZ
no B-O B-NP_DT
internal B-O B-JJ
homology B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
does B-O B-VP_VBZ
not B-O B-RB
have B-O B-VP_VB
significant B-O B-NP_NP_JJ
sequence B-O B-NN
similarity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
result B-O B-NN
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
two B-O B-S_NP_NP_CD
catalytically B-O B-ADJP_RB
similar B-O B-JJ
" " B-O O-ADJP
proteins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
cyclophilin B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
FKBP B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
evolved B-O B-VP_VBD
independently B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
Northern B-O B-NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
mRNA B-O B-NP_NP_NN
species B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
approximately B-O B-NP_QP_RB
1.8 B-O B-CD
" " B-O O-QP
kilobases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
hybridized B-O B-S_NP_VP_VBD
with B-O B-PP_IN
human B-O B-NP_JJ
FKBP B-O B-NN
cDNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
poly(A)+ B-O B-NP_NP_JJ
RNAs B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
brain B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
lung B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
liver B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
placental B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
leukocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Jurkat B-O B-NP_NN
leukemic B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
phorbol B-O B-NP_NP_NN
12-myristate B-O B-NN
13-acetate B-O B-NN
" " B-O O-NP
and B-O B-CC
ionomycin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
affect B-O B-VP_VB
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
FKBP B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Southern B-O B-S_NP_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
genomic B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
digested B-O B-VP_VBN
with B-O B-NP_PP_IN
different B-O B-NP_JJ
restriction B-O B-NP_NN
enzymes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggests B-O B-VP_VBZ
the B-O B-NP_NP_DT
existence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
only B-O B-NP_NP_QP_RB
a B-O B-DT
few B-O B-JJ
" " B-O O-QP
copies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
DNA B-O B-NN
sequence B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
FKBP B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
is B-O B-VP_VBZ
in B-O B-PP_IN
contrast B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
result B-O B-NN
that B-O B-SBAR_IN
may B-O B-S_NP_NP_PP_VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
NF-X2 B-O B-S_S_NP_NP_NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-VP_TO
the B-O B-NP_DT
DRA B-O B-NN
X2-box B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
activator B-O B-NP_NN
protein B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Expression B-O B-NP_NP_NN
cloning B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Human B-O B-S_S_NP_JJ
class B-O B-NN
II B-O B-CD
MHC B-O B-NN
Ag B-O B-NN
" " B-O O-NP
are B-O B-VP_VBP
a B-O B-NP_NP_DT
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NN
surface B-O B-NN
glycoproteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Their B-O B-S_NP_PRPP
constitutive B-O B-JJ
expression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
limited B-O B-ADJP_JJ
to B-O B-PP_TO
B B-O B-NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
thymic B-O B-NP_JJ
epithelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
many B-O B-NP_JJ
other B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
their B-O B-NP_PRPP
expression B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
IFN-gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Conserved B-O B-S_NP_VBN
upstream B-O B-JJ
promoter B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
regulate B-O B-VP_VBP
this B-O B-NP_NP_DT
tissue-specific B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
class B-O B-NP_NN
II B-O B-CD
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
DRA B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cis-acting B-O B-JJ
regulatory B-O B-JJ
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
X2-box B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHPP_TO
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
nuclear B-O B-S_NP_NP_JJ
factor B-O B-NN
X2 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-X2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
binds B-O B-VP_VBZ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
present B-O B-VP_VBP
the B-O B-NP_NP_DT
isolation B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
characterization B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
full-length B-O B-JJ
cDNA B-O B-NN
clone B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
NF-X2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
cDNA B-O B-NN
clone B-O B-NN
" " B-O O-NP
was B-O B-VP_VP_VBD
isolated B-O B-VP_VBN
by B-O B-NP_PP_IN
expression B-O B-NP_NN
cDNA B-O B-NN
cloning B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
encodes B-O B-VP_VBZ
the B-O B-NP_NP_DT
human B-O B-JJ
c-Jun B-O B-NN
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
together B-O B-S_NP_PP_ADVP_RB
" " B-O O-ADVP
with B-O B-IN
c-Fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
forms B-O B-VP_VBZ
the B-O B-NP_DT
heterodimeric B-O B-JJ
activator B-O B-NN
protein-1 B-O B-NN
transcription B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Whereas B-O B-S_SBAR_IN
c-Fos/c-Jun B-O B-S_NP_NN
heterodimers B-O B-NNS
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
exist B-O B-VP_VB
in B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
they B-O B-S_NP_PRP
" " B-O O-NP
form B-O B-VP_VP_VBP
" " B-O B-NP_O-VP
and B-O B-CC
bind B-O B-VP_VBP
to B-O B-PP_TO
the B-O B-NP_NP_DT
X2-box B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
class B-O B-NP_NN
II B-O B-CD
nonexpressing B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
c-Fos/c-Jun B-O B-NP_NN
heterodimers B-O B-NNS
" " B-O O-NP
might B-O B-VP_MD
contribute B-O B-VP_VB
to B-O B-PP_TO
the B-O B-NP_NP_DT
repression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DRA B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_NP_DT
actions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
cyclosporin B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggest B-O B-VP_VBP
a B-O B-NP_DT
novel B-O B-JJ
step B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Cyclosporin B-O B-S_S_NP_NP_NN
A B-O B-NN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
immunosuppressive B-O B-NP_NP_JJ
compounds B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
have B-O B-S_NP_VP_VBP
similar B-O B-NP_JJ
inhibitory B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Despite B-O B-S_PP_IN
their B-O B-NP_PRPP
similar B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
drugs B-O B-NNS
" " B-O O-NP
bind B-O B-VP_VBP
to B-O B-PP_TO
two B-O B-NP_CD
different B-O B-JJ
cytosolic B-O B-NP_NP_JJ
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
cyclophilin B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
FKBP B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
respectively B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
raises B-O B-S_NP_VP_VBZ
the B-O B-NP_DT
possibility B-O B-NN
that B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
constructs B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
mRNA B-O B-S_NP_NP_NN
production B-O B-NN
" " B-O O-NP
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
readily B-O B-ADVP_RB
" " B-O O-ADVP
measured B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
we B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
both B-O B-S_NP_CC
cyclosporin B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
completely B-O B-VP_ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
transcription B-O B-NP_NP_NN
" " B-O O-NP
activated B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-VP
and B-O B-CC
partially B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
transcription B-O B-NP_NP_NN
" " B-O O-NP
activated B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Cyclosporin B-O B-S_NP_NP_NN
A B-O B-NN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inhibited B-O B-VP_VBD
only B-O B-NP_NP_RB
transcriptional B-O B-JJ
activation B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
Ca2+ B-O B-NP_NN
mobilization B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
cyclosporin B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
inhibit B-O B-VP_VB
Ca2+ B-O B-NP_NP_NN
mobilization B-O B-NN
dependent B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
only B-O B-S_NP_NP_RB
a B-O B-DT
subset B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
signalling B-O B-NP_NN
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-PP
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
is B-O B-VP_VBZ
sensitive B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
observe B-O B-VP_VB
any B-O B-NP_DT
qualitative B-O B-JJ
differences B-O B-NNS
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cyclosporin B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
six B-O B-NP_CD
different B-O B-JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
suggests B-O B-S_NP_VP_VBZ
that B-O B-SBAR_IN
these B-O B-S_NP_DT
drugs B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
interfere B-O B-VP_VB
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-VP
" " B-O O-S
1,25-Dihydroxyvitamin B-O B-NP_NP_NP_NN
D3 B-O B-NN
receptor B-O B-NN
RNA B-O B-NN
" " B-O O-NP
: B-O B-COLON
" " B-O O-NP
expression B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
hematopoietic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
1,25-Dihydroxyvitamin B-O B-S_S_NP_NP_NN
D3 B-O B-NN
" " B-O O-NP
[ B-O B-PRN_LRB
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
induces B-O B-VP_VP_VP_VBZ
differentiation B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-PP_O-NP
" " B-O O-VP
and B-O B-CC
inhibits B-O B-VP_VBZ
proliferation B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-VP
of B-O B-PP_IN
myeloid B-O B-NP_NP_JJ
leukemic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
various B-O B-NP_JJ
lines B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
these B-O B-S_NP_DT
effects B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
probably B-O B-ADVP_RB
" " B-O O-ADVP
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
the B-O B-NP_DT
1,25(OH)2D3 B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Little B-O B-S_NP_NP_JJ
" " B-O O-NP
" " B-O B-PP_O-NP
is B-O B-VP_VBZ
known B-O B-VP_VBN
of B-O B-NP_PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
receptor B-O B-NN
RNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
hematopoietic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
modulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
receptor B-O B-NN
RNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
various B-O B-NP_JJ
proliferating B-O B-ADJP_ADJP_VBG
" " B-O O-ADJP
and B-O B-CC
nonproliferating B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
hematopoietic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Constitutive B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
receptor B-O B-NN
RNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
various B-O B-NP_NP_JJ
kinds B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
hematopoietic B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
, B-O B-NP_COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
cell B-O B-NP_NN
lines B-O B-NNS
KG-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
HL-60 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
ML-3 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
U937 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
THP-1 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
K562 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
S-LB1 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Receptor B-O B-S_S_NP_NN
transcripts B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
4.6 B-O B-NP_CD
kilobases B-O B-NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
kb B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
no B-O B-S_NP_DT
variant B-O B-JJ
sizes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_NP_DT
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
examined B-O B-VP_VBN
in B-O B-NP_PP_IN
this B-O B-NP_DT
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBD
1,25(OH)2D3 B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Most B-O B-S_S_NP_JJS
B B-O B-NN
lymphocyte B-O B-NN
lines B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VBD
negligible B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
receptor B-O B-NN
RNA B-O B-NN
and B-O B-CC
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
however B-O B-RB
; B-O B-COLON
analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
lymphoid/myeloid B-O B-JJ
somatic B-O B-JJ
hybrid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
suppression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
in B-O B-PP_IN
B B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
a B-O B-NP_DT
dominant B-O B-JJ
characteristic B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
HL-60 B-O B-S_S_NP_NN
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
cultured B-O B-VP_VBN
with B-O B-NP_PP_IN
10(-7) B-O B-NP_NP_CD
mol/L B-O B-NN
" " B-O O-NP
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
24 B-O B-NP_QP_CD
to B-O B-TO
72 B-O B-CD
" " B-O O-QP
hours B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
levels B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
and B-O B-CC
its B-O B-NP_PRPP
RNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Levels B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
RNA B-O B-NP_NP_NN
" " B-O O-NP
coding B-O B-VP_NN
for B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
modulated B-O B-VP_VBN
by B-O B-NP_PP_IN
exposure B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
ligand B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Levels B-O B-S_S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
occupied B-O B-NP_VBN
1,25(OH)2D3 B-O B-NN
receptor B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBD
in B-O B-PP_IN
these B-O B-NP_DT
HL-60 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
but B-O B-CC
the B-O B-S_NP_NP_DT
total B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
decreased B-O B-VP_VP_VBD
about B-O B-NP_QP_RB
50 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
24 B-O B-NP_CD
hours B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
returned B-O B-VP_VBD
toward B-O B-PP_IN
normal B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
72 B-O B-NP_CD
hours B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Steady-state B-O B-S_NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
receptor B-O B-NN
RNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
affected B-O B-VP_VBN
by B-O B-NP_PP_IN
terminal B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HL-60 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
toward B-O B-PP_IN
either B-O B-NP_CC
granulocytes B-O B-NP_NNS
" " B-O O-NP
or B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nondividing B-O B-S_NP_NP_JJ
macrophages B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
normal B-O B-NP_JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBD
1,25(OH)2D3 B-O B-NP_NN
receptor B-O B-NN
RNA B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
nondividing B-O B-NP_NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
normal B-O B-NP_JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
express B-O B-VP_VB
1,25(OH)2D3 B-O B-NP_NN
receptor B-O B-NN
RNA B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
with B-O B-S_PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
proliferation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
accumulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
receptor B-O B-NN
RNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBD
markedly B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Half-life B-O B-S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
t1/2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NP_NN
receptor B-O B-NN
RNA B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
short B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
1 B-O B-NP_CD
hour B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
measuring B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Consistent B-O B-S_S_NP_ADJP_JJ
with B-O B-PP_IN
this B-O B-NP_DT
short B-O B-JJ
t1/2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
, B-O B-COMMA
accumulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
receptor B-O B-NN
RNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBD
in B-O B-PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-SBAR_IN
their B-O B-S_NP_PRPP
protein B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
understand B-O B-VP_VB
the B-O B-NP_NP_DT
physiologic B-O B-JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Immune B-O B-NP_NP_JJ
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
HBx-antigen B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
hepatitis B-O B-NP_NN
B B-O B-NN
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
hepatitis B-O B-NN
B B-O B-NN
virus B-O B-NN
genome B-O B-NN
" " B-O O-NP
encodes B-O B-VP_VBZ
a B-O B-NP_NP_DT
transcriptional B-O B-JJ
transactivator B-O B-NN
protein B-O B-NN
" " B-O O-NP
designated B-O B-VP_VBN
HBxAg B-O B-S_NP_NP_NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
whether B-O B-SBAR_IN
this B-O B-S_NP_DT
antigen B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
target B-O B-NN
structure B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
human B-O B-NP_JJ
T-lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
recombinant B-O B-NP_JJ
HBxAg B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
HBxAg-specific B-O B-NP_NP_JJ
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
acute B-O B-NP_NP_JJ
hepatitis B-O B-NN
B B-O B-NN
virus B-O B-NN
infection B-O B-NN
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
chronic B-O B-NP_JJ
hepatitis B-O B-NN
B B-O B-NN
virus B-O B-NN
infection B-O B-NN
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
healthy B-O B-NP_JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
With B-O B-S_PP_IN
HBxAg-specific B-O B-NP_JJ
synthetic B-O B-JJ
polypeptides B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
several B-O B-NP_JJ
T-cell B-O B-NN
epitopes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Most B-O B-S_NP_JJS
" " B-O O-NP
were B-O B-VP_VBD
located B-O B-VP_JJ
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
carboxyterminal B-O B-JJ
half B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HBxAg B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Five B-O B-S_NP_NP_CD
T-cell B-O B-NN
clones B-O B-NNS
" " B-O O-NP
specific B-O B-ADJP_JJ
for B-O B-PP_IN
a B-O B-NP_DT
T-cell B-O B-NN
epitope B-O B-NN
" " B-O O-NP
located B-O B-ADJP_JJ
at B-O B-PP_IN
the B-O B-NP_NP_DT
carboxyterminal B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HBxAg B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
were B-O B-VP_VBD
established B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
belong B-O B-VP_VB
to B-O B-PP_TO
the B-O B-NP_DT
subtype B-O B-ADJP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
establish B-O B-VP_VBP
for B-O B-PP_IN
the B-O B-NP_DT
first B-O B-JJ
time B-O B-NN
" " B-O O-NP
" " B-O O-PP
HBxAg B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_IN
an B-O B-NP_NP_DT
antigen B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
cellular B-O B-JJ
immune B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
jun B-O B-NP_NP_NN
and B-O B-CC
fos B-O B-NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
macrophage B-O B-ADJP_NN
colony-stimulating B-O B-JJ
" " B-O O-ADJP
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
macrophage B-O B-NP_ADJP_NN
colony-stimulating B-O B-JJ
" " B-O O-ADJP
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
M-CSF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_NP_DT
growth B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
mononuclear B-O B-NP_JJ
phagocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
signaling B-O B-NN
events B-O B-NNS
" " B-O O-NP
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
these B-O B-NP_DT
effects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
remain B-O B-VP_VBP
unclear B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
present B-O B-JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
M-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
potential B-O B-NP_NP_JJ
signaling B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
involving B-O B-VP_VBG
expression B-O B-NP_NN
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Low B-O B-S_NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
detectable B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
resting B-O B-NP_VBG
human B-O B-JJ
peripheral B-O B-JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
10(3) B-O B-NP_CD
units/ml B-O B-NNS
human B-O B-JJ
recombinant B-O B-JJ
M-CSF B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
rapid B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
transient B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
increases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
c-jun B-O B-NP_NN
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_NP_JJ
run-on B-O B-JJ
assays B-O B-NNS
" " B-O O-NP
and B-O B-CC
mRNA B-O B-NP_NN
stability B-O B-NN
studies B-O B-NNS
" " B-O O-NP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
M-CSF B-O B-S_NP_NN
" " B-O O-NP
regulates B-O B-VP_VBZ
c-jun B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
both B-O B-NP_CC
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
a B-O B-NP_NP_DT
prolongation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
M-CSF B-O B-S_NP_NN
treatment B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
rapid B-O B-JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
jun-B B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
although B-O B-SBAR_IN
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
prolonged B-O B-VP_JJ
compared B-O B-NP_S_NP_VP_VBN
" " B-O B-NP_PP_O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
M-CSF B-O B-S_NP_NN
" " B-O O-NP
increases B-O B-VP_VBZ
c-fos B-O B-NP_NP_NN
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
through B-O B-PP_IN
control B-O B-NP_NP_NN
" " B-O O-NP
at B-O B-PP_IN
both B-O B-NP_CC
the B-O B-DT
levels B-O B-ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Maximal B-O B-S_NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
c-fos B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
followed B-O B-VP_VBN
by B-O B-NP_PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
fos-B B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
M-CSF-induced B-O B-NP_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
fos-related B-O B-JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
fra-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
delayed B-O B-VP_VBN
compared B-O B-NP_S_NP_VP_VBN
to B-O B-NP_PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
for B-O B-PP_IN
both B-O B-NP_DT
and B-O B-NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
the B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
M-CSF B-O B-S_NP_NN
treatment B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
contribute B-O B-VP_VB
to B-O B-PP_TO
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Nuclear B-O B-NP_NP_NP_JJ
association B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
T-cell B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
FK-506 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
cyclosporin B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
[ B-O B-PRN_LRB
see B-O B-S_NP_VP_VB
comments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
] B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
  
Cyclosporin B-O B-S_NP_NP_NN
A B-O B-NN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inhibit B-O B-VP_VBP
T- B-O B-NP_NP_NP_ADJP_ADJP_NN
" " B-O B-NP_O-ADJP
and B-O B-CC
B-cell B-O B-ADJP_NN
" " B-O O-ADJP
" " B-O O-ADJP
activation B-O B-NN
" " B-O O-NP
and B-O B-CC
other B-O B-NP_JJ
processes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
essential B-O B-ADJP_JJ
to B-O B-PP_TO
an B-O B-NP_DT
effective B-O B-JJ
immune B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
these B-O B-NP_DT
drugs B-O B-NNS
" " B-O O-NP
disrupt B-O B-VP_VBP
an B-O B-NP_NP_DT
unknown B-O B-JJ
step B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
transmission B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
signals B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
the B-O B-NP_DT
T-cell B-O B-NN
antigen B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
cytokine B-O B-NP_NP_NN
genes B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
putative B-O B-JJ
intracellular B-O B-JJ
receptors B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
FK506 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
cyclosporin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
cis-trans B-O B-NP_JJ
prolyl B-O B-JJ
isomerases B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Binding B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
drug B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibits B-O B-VP_VBZ
isomerase B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
studies B-O B-S_NP_NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
other B-O B-NP_JJ
prolyl B-O B-JJ
isomerase B-O B-NN
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
analysis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cyclosporin-resistant B-O B-NP_NP_JJ
mutants B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
yeast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
drug B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
result B-O B-VP_VBP
from B-O B-PP_PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
, B-O B-COMMA
and B-O B-CC
not B-O B-PP_RB
from B-O B-IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_NP_DT
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
NF-AT B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
early B-O B-NP_JJ
T-cell B-O B-NN
gene B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
seems B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
a B-O B-NP_NP_DT
specific B-O B-JJ
target B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_NP_CC
action B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
because B-O B-SBAR_IN
transcription B-O B-S_NP_NP_NN
" " B-O O-NP
directed B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
is B-O B-VP_VBZ
blocked B-O B-VP_VBN
, B-O B-NP_PP_COMMA
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
NF-AT B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
formed B-O B-VP_VBN
when B-O B-NP_SBAR_WHADVP_WRB
" " B-O O-WHADVP
" " B-O B-S_NP_NP_PP_VP_VP_ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
FK506 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
cyclosporin B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-NP
block B-O B-VP_VBP
translocation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cytoplasmic B-O B-JJ
component B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
without B-O B-PP_IN
affecting B-O B-S_NP_VP_VBG
synthesis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
nuclear B-O B-JJ
subunit B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
To B-O B-S_S_S_S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
or B-O B-CC
not B-O B-S_NP_RB
to B-O B-VP_TO
be B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
a B-O B-NP_NP_DT
responder B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T-cell B-O B-NP_NN
responses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-S
: B-O B-COLON
ubiquitous B-O B-NP_NP_JJ
oligopeptides B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
all B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Amino B-O B-S_S_NP_NP_NN
acid B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
all B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
essays B-O B-NP_NP_NNS
" " B-O O-NP
written B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
same B-O B-JJ
language B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Accordingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
same B-O B-JJ
set B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
words B-O B-NP_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
phrases B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
oligopeptides B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appear B-O B-VP_VBP
in B-O B-PP_IN
totally B-O B-NP_ADJP_ADVP_RB
" " B-O O-ADVP
unrelated B-O B-JJ
" " B-O O-ADJP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
reason B-O B-NN
that B-O B-SBAR_IN
only B-O B-S_NP_NP_RB
certain B-O B-JJ
individuals B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
particular B-O B-NP_JJ
major B-O B-JJ
histocompatibility B-O B-NN
complex B-O B-NN
( B-O B-LRB
MHC B-O B-NN
) B-O B-RRB
haplotypes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
mount B-O B-VP_VB
T-cell B-O B-NP_NN
responses B-O B-NNS
" " B-O O-NP
against B-O B-PP_IN
a B-O B-NP_NP_DT
given B-O B-JJ
antigen B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
found B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
fact B-O B-NN
that B-O B-SBAR_IN
T-cell B-O B-S_NP_NN
receptors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
designed B-O B-VP_VBN
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
At B-O B-S_PP_IN
this B-O B-NP_NP_DT
range B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
peptide B-O B-NP_NN
lengths B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
most B-O B-NP_JJS
" " B-O O-NP
would B-O B-VP_MD
appear B-O B-VP_VB
as B-O B-PP_IN
self B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
while B-O B-SBAR_IN
nonselfness B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
remainders B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
destined B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-ADJP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
hence B-O B-ADVP_RB
" " B-O O-ADVP
creating B-O B-S_NP_VP_VBG
responders B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
nonresponders B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
T-helper-cell B-O B-S_NP_NP_JJ
determinants B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
protein B-O B-NP_NN
antigens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
preferentially B-O B-ADVP_RB
located B-O B-JJ
in B-O B-PP_IN
cysteine-rich B-O B-NP_NP_JJ
antigen B-O B-NN
segments B-O B-NNS
" " B-O O-NP
resistant B-O B-ADJP_JJ
to B-O B-PP_TO
proteolytic B-O B-NP_NP_JJ
cleavage B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
on B-O B-PP_IN
a B-O B-NP_NP_DT
computer B-O B-NN
algorithm B-O B-NN
" " B-O O-NP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
predicting B-O B-S_NP_VP_VBG
by B-O B-NP_NP_PP_PP_PP_IN
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
algorithm B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
constructed B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
aim B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
identifying B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_SBAR_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_S_NP_DT
" " B-O O-NP
are B-O B-VP_VBP
prominent B-O B-NP_NP_JJ
enzymes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
endocytic B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
through B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
soluble B-O B-S_NP_JJ
protein B-O B-NN
Ag B-O B-NN
" " B-O O-NP
enter B-O B-VP_VBP
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
resistant B-O B-S_NP_NP_JJ
segments B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
Ag B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
, B-O B-COMMA
therefore B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
be B-O B-VP_VB
expected B-O B-VP_VBN
to B-O B-S_NP_VP_TO
contain B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
From B-O B-S_PP_IN
information B-O B-NP_NP_NN
" " B-O O-NP
available B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_NP_DT
literature B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
substrate B-O B-JJ
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
it B-O B-NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
clear B-O B-ADJP_JJ
" " B-O O-ADJP
that B-O B-SBAR_IN
a B-O B-S_NP_DT
cysteine B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
accepted B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
" " B-O B-NP_NP_PP_O-PP
, B-O B-COMMA
and B-O B-CC
not B-O B-PP_RB
in B-O B-IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
noticed B-O B-VP_VBN
that B-O B-SBAR_IN
cysteine-containing B-O B-S_NP_NP_JJ
T-cell B-O B-NN
determinants B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
particularly B-O B-ADJP_RB
rich B-O B-JJ
" " B-O O-ADJP
in B-O B-PP_IN
the B-O B-NP_DT
amino B-O B-NN
acids B-O B-NNS
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
, B-O B-NP_COMMA
, B-O B-NP_COMMA
, B-O B-NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
searching B-O B-S_NP_VP_VBG
protein B-O B-NP_NN
Ag B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
clusters B-O B-NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
and B-O B-CC
two B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
other B-O B-JJ
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
were B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
predict B-O B-VP_VB
17 B-O B-NP_NP_QP_CD
out B-O B-IN
of B-O B-IN
23 B-O B-CD
" " B-O O-QP
empirically B-O B-ADJP_RB
known B-O B-VBN
" " B-O O-ADJP
T-cell B-O B-NN
determinants B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
Ag B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
number B-O B-ADJP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
present B-O B-VP_VBP
a B-O B-NP_NP_DT
new B-O B-JJ
principle B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
searching B-O B-S_NP_VP_VBG
Ag B-O B-NP_NN
" " B-O O-NP
for B-O B-PP_IN
potential B-O B-NP_JJ
amphipatic B-O B-JJ
alpha-helical B-O B-JJ
protein B-O B-NN
segments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Such B-O B-S_S_NP_JJ
segments B-O B-NNS
" " B-O O-NP
accord B-O B-VP_VBP
well B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
empirically B-O B-NP_ADJP_RB
known B-O B-JJ
" " B-O O-ADJP
T-cell B-O B-NN
determinants B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
our B-O B-S_NP_PRPP
algorithm B-O B-NN
" " B-O O-NP
produces B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
lower B-O B-JJR
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
false B-O B-NP_JJ
positive B-O B-JJ
predictions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
than B-O B-PP_IN
the B-O B-NP_NP_DT
principle B-O B-NN
" " B-O O-NP
based B-O B-PP_VBN
on B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Charybdotoxin-sensitive B-O B-S_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
Ca(2+)-dependent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
membrane B-O B-NN
potential B-O B-JJ
changes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_JJ
T B-O B-NN
or B-O B-CC
B B-O B-NN
cell B-O B-NN
activation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
proliferation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ion B-O B-NP_NN
channels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
B B-O B-NP_NN
and B-O B-CC
T B-O B-NN
lymphocyte B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
supported B-O B-VP_VBN
by B-O B-NP_PP_IN
many B-O B-NP_NP_JJ
reports B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
changes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
after B-O B-PP_IN
mitogen B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_NP_JJ
T B-O B-NN
and B-O B-CC
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
an B-O B-NP_DT
early B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
transient B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
hyperpolarization B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
ligand B-O B-NP_JJ
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Inasmuch B-O B-S_SBAR_RB
as B-O B-IN
the B-O B-S_NP_NP_DT
change B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
membrane B-O B-NP_NN
potential B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
elevation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
free B-O B-NP_JJ
cytosolic B-O B-JJ
calcium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-NP_DT
hyperpolarization B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
presumably B-O B-ADVP_RB
" " B-O O-ADVP
through B-O B-PP_IN
opening B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Ca(2+)-stimulated B-O B-NP_JJ
K+ B-O B-NN
channels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
used B-O B-VP_VBN
charybdotoxin B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
known B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Ca(2+)-dependent B-O B-NP_JJ
K+ B-O B-NN
channels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
to B-O B-S_NP_VP_TO
study B-O B-VP_VB
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
channels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
lymphocyte B-O B-NP_NN
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
charybdotoxin B-O B-S_NP_NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
the B-O B-NP_NP_DT
ligand-induced B-O B-JJ
transient B-O B-JJ
membrane B-O B-NN
hyperpolarization B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
and B-O B-NP_NP_NP_CC
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
dose-dependent B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
without B-O B-PP_IN
affecting B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
blockade B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Ca(2+)-activated B-O B-JJ
K+ B-O B-NN
channel B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
changes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
cell-cycle B-O B-NP_NP_JJ
gene B-O B-NN
activation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
IL-2 B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
, B-O B-COMMA
IL-2R B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
or B-O B-CC
and B-O B-NP_NP_NP_CC
cell B-O B-NP_NN
mitogenesis B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
imply B-O B-VP_VBP
that B-O B-SBAR_IN
membrane B-O B-S_NP_NP_NN
potential B-O B-JJ
changes B-O B-NNS
" " B-O O-NP
secondary B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
ligand-dependent B-O B-JJ
opening B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
lymphocyte B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
cAMP-dependent B-O B-NP_NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
proenkephalin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
JunD B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
JunB B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
positive B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
negative B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
JunD B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
AP-1 B-O B-NN
transcription B-O B-NN
factor B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
activates B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
proenkephalin B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
fashion B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
proenkephalin B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
JunD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
dependent B-O B-ADJP_JJ
upon B-O B-PP_IN
a B-O B-NP_DT
previously B-O B-ADJP_RB
characterized B-O B-VBN
" " B-O O-ADJP
cAMP- B-O B-ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
, B-O B-COMMA
phorbol B-O B-ADJP_NP_NN
ester- B-O B-NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
, B-O B-COMMA
and B-O B-CC
Ca(2+)-inducible B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
JunD B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
the B-O B-NP_DT
enhancer B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_DT
homodimer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Another B-O B-S_NP_NP_NP_DT
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
AP-1 B-O B-NN
transcription B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
JunB B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
inhibit B-O B-VP_VB
activation B-O B-NP_NP_NN
" " B-O O-NP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_S_PP_IN
a B-O B-NP_DT
homodimer B-O B-NN
" " B-O O-NP
" " B-O O-PP
JunB B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
unable B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
the B-O B-NP_DT
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
however B-O B-RB
in B-O B-S_PP_IN
the B-O B-DT
presence B-O B-NN
of B-O B-IN
c-Fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
high-affinity B-O B-NP_JJ
binding B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
JunD B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
protein B-O B-ADJP_NN
kinase B-O B-NN
A-dependent B-O B-JJ
" " B-O O-ADJP
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
further B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
blurring B-O B-VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
AP-1-related B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
cAMP-dependent B-O B-JJ
second-messenger B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
JunD B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
other B-O B-NP_JJ
AP-1-related B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
play B-O B-VP_VB
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_DT
novel B-O B-JJ
primer B-O B-NN
extension B-O B-NN
method B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHNP_S_NP_VP_TO
detect B-O B-VP_VB
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CAG B-O B-NP_NP_NN
repeats B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-NP
  
X-linked B-O B-S_NP_NP_NP_JJ
spinal B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
bulbar B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
muscular B-O B-JJ
atrophy B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
SBMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
adult-onset B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
motor B-O B-NP_NN
neuron B-O B-NN
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
recently B-O B-ADVP_RB
" " B-O O-ADVP
reported B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
caused B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
a B-O B-NP_NP_DT
simple B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
rapid B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
strategy B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHADVP_S_NP_VP_TO
detect B-O B-VP_VB
the B-O B-NP_NP_DT
precise B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_S_SBAR_IN
the B-O B-S_NP_NP_DT
DNA B-O B-NN
fragment B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_DT
CAG B-O B-NN
repeats B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
amplified B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
polymerase B-O B-NN
chain B-O B-NN
reaction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
a B-O B-NP_DT
primer B-O B-NN
extension B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
carried B-O B-VP_VBN
out B-O B-PRT_RP
" " B-O O-PRT
" " B-O B-NP_O-VP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
the B-O B-S_NP_NP_DT
extension B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
end-labelled B-O B-JJ
reverse B-O B-JJ
primer B-O B-NN
" " B-O O-NP
adjacent B-O B-ADJP_JJ
to B-O B-PP_TO
3' B-O B-NP_NP_JJ
end B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
stops B-O B-VP_VBZ
at B-O B-PP_IN
the B-O B-NP_NP_DT
first B-O B-JJ
T B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
CAG B-O B-NP_NN
repeats B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_NP_DT
incorporation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
dideoxy B-O B-NP_JJ
ATP B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
reaction B-O B-NN
mixture B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
resultant B-O B-JJ
primer B-O B-NN
products B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
analysed B-O B-VP_VBN
by B-O B-NP_PP_IN
denaturing B-O B-S_NP_VP_VBG
polyacrylamide B-O B-NP_NP_NN
gel B-O B-NN
electrophoresis B-O B-NN
" " B-O O-NP
and B-O B-CC
autoradiography B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
method B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
quite B-O B-ADJP_RB
useful B-O B-JJ
to B-O B-S_NP_VP_TO
detect B-O B-VP_VB
not B-O B-NP_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
but B-O B-NP_NP_PP_CONJP_CC
also B-O B-RB
" " B-O O-CONJP
other B-O B-NP_JJ
polymorphic B-O B-JJ
repeats B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Influence B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
estradiol B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
tamoxifen B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
susceptibility B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
breast B-O B-NN
cancer B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
lysis B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
lymphokine-activated B-O B-NP_JJ
killer B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
design B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
combination B-O B-NP_NP_NN
hormonal B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
immunotherapeutic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
protocols B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
breast B-O B-NP_NN
cancer B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
facilitated B-O B-VP_VBN
by B-O B-NP_PP_IN
analysis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
preclinical B-O B-NP_JJ
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
model B-O B-JJ
systems B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Estrogen B-O B-S_NP_NN
receptor B-O B-NN
positive B-O B-ADJP_ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
ER+ B-O B-FRAG_ADJP_JJ
" " B-O O-ADJP
: B-O B-COLON
MCF-7 B-O B-NP_NN
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
and B-O B-CC
negative B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
ER- B-O B-FRAG_ADJP_JJ
" " B-O O-ADJP
: B-O B-COLON
MDA-MB-231 B-O B-NP_NN
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
" " B-O O-ADJP
human B-O B-JJ
breast B-O B-NN
cancer B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
utilized B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
evaluate B-O B-VP_VB
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
on B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
E2-stimulated B-O B-S_NP_JJ
ER+ B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
more B-O B-ADJP_ADJP_RBR
susceptible B-O B-JJ
to B-O B-PP_TO
lysis B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
LAK B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
than B-O B-PP_IN
corresponding B-O B-NP_VBG
TAM-treated B-O B-UCP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
control B-O B-NP_NN
" " B-O O-NP
" " B-O O-UCP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
while B-O B-SBAR_IN
treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ER- B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
either B-O B-NP_NP_CC
E2 B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
TAM B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
alter B-O B-VP_VB
from B-O B-PP_IN
control B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
their B-O B-NP_NP_PRPP
susceptibility B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
this B-O B-NP_DT
immune-mediated B-O B-JJ
lysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_NP_DT
ER+ B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
ER- B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
remained B-O B-VP_VBD
sensitive B-O B-ADJP_JJ
" " B-O B-PP_O-ADJP
after B-O B-PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
TAM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
lysis B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
LAK B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
an B-O B-NP_NP_DT
adenocarcinoma B-O B-ADJP_NP_NN
" " B-O O-NP
reactive B-O B-JJ
" " B-O O-ADJP
human-mouse B-O B-ADJP_JJ
chimeric B-O B-JJ
" " B-O O-ADJP
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ING-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
significantly B-O B-ADVP_RB
" " B-O O-ADVP
boost B-O B-VP_VB
generated B-O B-NP_NP_ADJP_ADVP_VBN
" " B-O O-ADJP
LAK B-O B-ADJP_NN
cell-mediated B-O B-JJ
" " B-O O-ADJP
lysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_UCP_ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
results B-O B-NNS
" " B-O O-NP
provide B-O B-VP_VBP
a B-O B-NP_NP_DT
preclinical B-O B-JJ
rationale B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
in B-O B-NP_NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
testing B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TAM B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
, B-O B-NP_NP_PRN_COMMA
and B-O B-CC
breast B-O B-NP_NN
cancer B-O B-NN
reactive B-O B-JJ
antibody-dependent B-O B-JJ
cellular B-O B-JJ
cytotoxicity B-O B-NN
" " B-O O-NP
" " B-O O-NP
facilitating B-O B-VP_VBG
antibody B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Glucocorticoid B-O B-NP_NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
and B-O B-CC
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
3-O-methyl-D-glucose B-O B-NP_NN
uptake B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
leukocytes B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
normal B-O B-NP_JJ
humans B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
correlation B-O B-NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
receptor B-O B-NP_NP_NP_NN
level B-O B-NN
" " B-O O-NP
and B-O B-CC
hormone B-O B-NP_NN
effect B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
measured B-O B-VP_VBN
the B-O B-NP_NP_DT
glucocorticoid B-O B-NN
receptor B-O B-NN
concentration B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
polymorphonuclear B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
leukocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
both B-O B-SBAR_WHNP_NP_DT
" " B-O O-NP
of B-O B-WHPP_IN
" " B-O B-WHNP_O-WHNP
were B-O B-S_NP_VP_VBD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
parallel B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
3-O-methyl-D-glucose B-O B-NP_NN
uptake B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
assayed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
corresponding B-O B-JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
glucocorticoid B-O B-NN
receptor B-O B-NN
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlated B-O B-VP_VBD
with B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
in B-O B-PP_IN
polymorphonuclear B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
there B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_DT
linear B-O B-JJ
relationship B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_NP_NP_DT
cellular B-O B-JJ
glucocorticoid B-O B-NN
receptor B-O B-NN
levels B-O B-NNS
" " B-O O-NP
and B-O B-CC
glucocorticoid-mediated B-O B-NP_NP_JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
mononuclear B-O B-S_NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
incubated B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-DT
presence B-O B-NN
of B-O B-IN
8-bromo-cAMP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
cellular B-O B-S_S_NP_JJ
glucocorticoid B-O B-NN
receptor B-O B-NN
levels B-O B-NNS
" " B-O O-NP
increased B-O B-VP_VBD
" " B-O O-VP
" " B-O O-S
and B-O B-CC
a B-O B-S_NP_NP_DT
more B-O B-ADJP_RBR
pronounced B-O B-JJ
" " B-O O-ADJP
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
on B-O B-NP_PP_IN
the B-O B-NP_NP_DT
transport B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
3-O-methyl-D-glucose B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_NP_DT
cellular B-O B-JJ
glucocorticoid B-O B-NN
receptor B-O B-NN
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reflect B-O B-VP_VBP
in B-O B-NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
responsiveness B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_DT
individual B-O B-JJ
responsiveness B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
alter B-O B-VP_VB
upon B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cortisol B-O B-NP_NP_NN
resistance B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
acquired B-O B-NP_VBN
immunodeficiency B-O B-NN
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
This B-O B-S_NP_DT
study B-O B-NN
" " B-O O-NP
concerns B-O B-VP_VBZ
9 B-O B-NP_CD
iv B-O B-NN
drug B-O B-NN
abusers B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
acquired B-O B-NP_NP_VBN
immunodeficiency B-O B-NN
syndrome B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
AIDS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
who B-O B-SBAR_WHNP_WP
" " B-O O-WHNP
developed B-O B-S_NP_VP_VBD
hypercortisolism B-O B-NP_NN
" " B-O O-NP
without B-O B-PP_IN
the B-O B-NP_NP_DT
or B-O B-NP_NP_CC
" " B-O B-NP_O-NP
of B-O B-PP_IN
hypercortisolism B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_DT
patients B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_NP_DT
Addisonian B-O B-JJ
picture B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
weakness B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
weight B-O B-NP_NN
loss B-O B-NN
" " B-O O-NP
, B-O B-COMMA
hypotension B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
hyponatremia B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
intense B-O B-NP_JJ
mucocutaneous B-O B-JJ
melanosis B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_NP_DT
acquired B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
resistance B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
suspected B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
, B-O B-COMMA
therefore B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
examined B-O B-VP_VBD
glucocorticoid B-O B-NP_NP_NN
receptor B-O B-NN
characteristics B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
mononuclear B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
measuring B-O B-S_NP_VP_VBG
[3H]dexamethasone B-O B-NP_NP_NN
binding B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-SBAR_O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Glucocorticoid B-O B-S_S_NP_NN
receptor B-O B-NN
density B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
increased B-O B-VP_VBN
in B-O B-NP_PP_IN
AIDS B-O B-NP_NP_NP_NN
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
an B-O B-NP_DT
Addisonian B-O B-JJ
picture B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
; B-O B-FRAG_NP_NP_COLON
" " B-O B-NP_O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
values B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
affinity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
Kd B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
strikingly B-O B-ADVP_RB
" " B-O O-ADVP
decreased B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
( B-O B-PRN_LRB
9.36 B-O B-NP_NP_NP_QP_CD
+/- B-O B-CC
3.44 B-O B-CD
" " B-O O-QP
nM B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
group B-O B-NP_NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
; B-O B-COLON
3.2 B-O B-NP_NP_QP_CD
+/- B-O B-CC
1.5 B-O B-CD
" " B-O O-QP
nM B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
group B-O B-NP_NN
2 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
; B-O B-COLON
2.0 B-O B-NP_NP_QP_CD
+/- B-O B-CC
0.8 B-O B-CD
" " B-O O-QP
nM B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
controls B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
P B-O B-S_NP_NN
" " B-O O-NP
less B-O B-NP_QP_JJR
than B-O B-IN
0.01 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
[3H]Thymidine B-O B-S_S_NP_NN
incorporation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
decreased B-O B-VP_VBN
dose-dependently B-O B-NP_ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
controls B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
the B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
blunted B-O B-VP_VP_VBN
( B-O B-NP_PRN_LRB
P B-O B-S_NP_NN
" " B-O O-NP
less B-O B-NP_QP_JJR
than B-O B-IN
0.05 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
in B-O B-PP_IN
group B-O B-NP_NN
1 B-O B-CD
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
suggests B-O B-S_NP_VP_VBZ
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
conclusion B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
AIDS B-O B-NP_NP_NN
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
hypercortisolism B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
clinical B-O B-NP_NP_JJ
features B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
resistance B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
abnormal B-O B-NP_NP_JJ
glucocorticoid B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Resistance B-O B-S_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
implies B-O B-VP_VBZ
a B-O B-NP_NP_DT
complex B-O B-JJ
change B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
immune-endocrine B-O B-NP_NP_JJ
function B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
may B-O B-S_NP_VP_MD
be B-O B-VP_VB
" " B-O B-ADJP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
monocytic B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_ADJP_NN
B-like B-O B-JJ
" " B-O O-ADJP
activities B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
1 B-O B-CD
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
myelomonoblastic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
cellular B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
investigated B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
new B-O B-JJ
model B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
myeloid B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PLB-985 B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
represent B-O B-VP_VBP
a B-O B-NP_NP_DT
bipotential B-O B-JJ
myelomonoblastic B-O B-JJ
cell B-O B-NN
population B-O B-NN
" " B-O O-NP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
either B-O B-NP_NP_ADJP_CC
granulocytic B-O B-ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
monocytic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
differentiation B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
virtue B-O B-NN
of B-O B-IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
surface B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
PLB-985 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
chronically B-O B-ADVP_RB
" " B-O O-ADVP
infected B-O B-VP_VBN
with B-O B-NP_PP_IN
HIV-1 B-O B-NP_NN
strain B-O B-NN
IIIB B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PLB-IIIB B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
clearly B-O B-ADVP_RB
" " B-O O-ADVP
possessed B-O B-VP_VBD
a B-O B-NP_NP_DT
more B-O B-ADJP_RBR
monocytic B-O B-JJ
" " B-O O-ADJP
phenotype B-O B-NN
" " B-O O-NP
than B-O B-PP_IN
the B-O B-NP_DT
parental B-O B-JJ
myeloblasts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
differential B-O B-NP_NP_JJ
staining B-O B-NN
" " B-O O-NP
, B-O B-COMMA
increased B-O B-NP_NP_VBN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-kappa B-O B-S_NP_NN
B B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
inducible B-O B-ADJP_JJ
" " B-O O-ADJP
by B-O B-PP_IN
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
" " B-O O-NP
and B-O B-CC
phorbol B-O B-NP_NN
myristate B-O B-NN
acetate B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
PLB-985 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
PLB-IIIB B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
constitutive B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
novel B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
, B-O B-NP_COMMA
composed B-O B-S_NP_VP_VBN
of B-O B-NP_PP_IN
proteins B-O B-NP_NP_NNS
" " B-O O-NP
ranging B-O B-VP_VBG
between B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
proteins B-O B-NNS
" " B-O O-NP
interacted B-O B-VP_VBD
specifically B-O B-PP_RB
with B-O B-IN
the B-O B-NP_NP_DT
symmetric B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
interferon B-O B-NP_NP_NN
beta B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IFN-beta B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutations B-O B-S_NP_NP_NNS
" " B-O O-NP
affecting B-O B-VP_VBG
the B-O B-NP_NP_DT
5' B-O B-JJ
guanine B-O B-JJ
residues B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
unable B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
compete B-O B-VP_VB
for B-O B-PP_IN
these B-O B-NP_DT
NF-kappa B-O B-ADJP_NN
B-related B-O B-JJ
" " B-O O-ADJP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Inducibility B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
endogenous B-O B-NP_JJ
IFN-beta B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IFN-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
RNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBN
in B-O B-NP_PP_IN
PLB-IIIB B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
HIV-1 B-O B-S_NP_NP_NN
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
myelomonoblastic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
select B-O B-VP_VB
for B-O B-PP_IN
a B-O B-NP_DT
monocytic B-O B-ADJP_JJ
phenotype B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
unique B-O B-S_NP_NP_JJ
subunit B-O B-NN
associations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
DNA B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
contribute B-O B-VP_VB
to B-O B-PP_TO
differential B-O B-NP_JJ
gene B-O B-ADJP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_NP_NP_DT
AP-1 B-O B-NN
site B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
-150 B-O B-NP_CD
bp B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
likely B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
represent B-O B-VP_VB
the B-O B-NP_NP_DT
major B-O B-JJ
target B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
interleukin B-O B-NN
2 B-O B-CD
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
antigen B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_NP_JJ
kinases B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
protein B-O B-NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
may B-O B-S_NP_VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
potential B-O B-JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
gene B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
prolonged B-O B-S_NP_NP_JJ
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
untransformed B-O B-JJ
T B-O B-NN
cell B-O B-NN
clone B-O B-NN
Ar-5 B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
phorbol B-O B-NP_NN
esters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VP_VBZ
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
abrogates B-O B-VP_VBZ
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
phorbol B-O B-S_NP_NN
ester B-O B-NN
treatment B-O B-NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
abolishes B-O B-VP_VBZ
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
chloramphenicol B-O B-NP_NP_JJ
acetyltransferase B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
IL-2 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
binding B-O B-NP_NP_VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
including B-O B-PP_VBG
NFAT-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Oct B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
trimer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
sensitive B-O B-ADJP_JJ
to B-O B-PP_TO
phorbol B-O B-NP_NN
ester B-O B-NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
mutations B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
inducibility B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
mutations B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
AP-1 B-O B-NN
site B-O B-NN
" " B-O O-NP
located B-O B-ADJP_JJ
at B-O B-PP_IN
-150 B-O B-NP_CD
bp B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
almost B-O B-ADVP_RB
completely B-O B-RB
" " B-O O-ADVP
abrogate B-O B-VP_VBP
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
appearance B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
inducible B-O B-JJ
nuclear B-O B-JJ
factor B-O B-NN
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
this B-O B-NP_DT
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
sensitive B-O B-ADJP_JJ
to B-O B-PP_TO
PKC B-O B-NP_NN
depletion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
cotransfections B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
c-fos B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
expression B-O B-NN
plasmids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
enhance B-O B-VP_VBP
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
minimally B-O B-NP_ADJP_RB
stimulated B-O B-VBN
" " B-O O-ADJP
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
AP-1 B-O B-NN
site B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
-150 B-O B-NP_CD
bp B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
represents B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
major B-O B-JJ
" " B-O B-NP_O-NP
, B-O B-PRN_COMMA
if B-O B-SBAR_IN
, B-O B-FRAG_COMMA
" " B-O O-PRN
site B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
responsiveness B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
jun B-O B-NP_NN
and B-O B-CC
fos B-O B-NN
gene B-O B-NN
family B-O B-NN
members B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
12-O-tetradecanoylphorbol-13-acetate B-O B-NP_ADJP_NN
induced B-O B-VBD
" " B-O O-ADJP
hemopoietic B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Terminal B-O B-S_NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
leukemic B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
U-937 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
HL-60 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
12-O-tetradecanoylphorbol-13-acetate B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
marked B-O B-NP_NP_JJ
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
jun B-O B-NP_NN
and B-O B-CC
fos B-O B-NN
gene B-O B-NN
family B-O B-NN
members B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
induced B-O B-VP_VBN
with B-O B-NP_PP_IN
variable B-O B-NP_JJ
kinetics B-O B-NNS
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
12-O-tetradecanoylphorbol-13-acetate B-O B-NP_ADJP_NN
induced B-O B-VBD
" " B-O O-ADJP
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
with B-O B-PP_IN
c-jun B-O B-S_NP_NN
expression B-O B-NN
" " B-O O-NP
best B-O B-ADVP_RB
" " B-O O-ADVP
paralleling B-O B-VP_JJ
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
generation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-SBAR_IN
measured B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
DNA B-O B-NP_NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
closely B-O B-ADVP_RB
" " B-O O-ADVP
parallels B-O B-VP_VBZ
morphological B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O B-S_O-NP
of B-O B-PP_IN
these B-O B-NP_DT
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
regulate B-O B-VP_VB
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
is B-O B-VP_VBZ
demonstrated B-O B-VP_VBN
by B-O B-NP_PP_IN
increased B-O B-NP_NP_NP_VBN
transcription B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
an B-O B-NP_DT
AP-1 B-O B-ADJP_NN
driven B-O B-VBN
" " B-O O-ADJP
reporter B-O B-NN
construct B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
marked B-O B-NP_NP_JJ
increases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Differentiation B-O B-S_NP_NP_NN
assays B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
water B-O B-NP_ADJP_NN
soluble B-O B-JJ
" " B-O O-ADJP
phorbol B-O B-NN
esters B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
reveal B-O B-VP_VBP
that B-O B-SBAR_IN
differentiation B-O B-S_NP_NN
" " B-O O-NP
becomes B-O B-VP_VBZ
irreversible B-O B-ADJP_JJ
" " B-O O-ADJP
soon B-O B-ADVP_RB
after B-O B-SBAR_IN
AP-1 B-O B-S_NP_NN
" " B-O O-NP
appears B-O B-VP_VBZ
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
tight B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
c-jun B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
generation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggests B-O B-VP_VBZ
a B-O B-NP_NP_DT
critical B-O B-JJ
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
this B-O B-NP_DT
gene B-O B-UCP_NP_NN
" " B-O O-NP
and B-O B-CC
transcriptional B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-UCP
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
this B-O B-NP_DT
process B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-PRN_PRN_LRB
Endocrine B-O B-NP_NP_JJ
status B-O B-NN
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
children B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
bronchial B-O B-NP_JJ
asthma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-PRN
  
A B-O B-S_S_NP_DT
study B-O B-NN
" " B-O B-PP_O-NP
was B-O B-VP_VBD
made B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
of B-O B-PP_IN
adrenocortical B-O B-NP_NP_NP_JJ
function B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
measuring B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
thyroid B-O B-NP_NP_NN
function B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
measuring B-O B-S_NP_VP_VBG
and B-O B-NP_NP_CC
" " B-O B-NP_PP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
authors B-O B-NNS
" " B-O O-NP
revealed B-O B-VP_VBD
alterations B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
functional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
indicated B-O B-VBN
endocrine B-O B-JJ
glands B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
depending B-O B-PP_VBG
on B-O B-PP_IN
the B-O B-NP_NP_NP_DT
intensity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
bronchial B-O B-NP_JJ
patency B-O B-NN
disorders B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
nature B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
therapeutic B-O B-JJ
measures B-O B-NNS
" " B-O O-NP
carried B-O B-VP_VBN
" " B-O B-PRT_NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_NP_DT
29-kDa B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
phosphorylated B-O B-VP_VBN
in B-O B-NP_PP_IN
thrombin-activated B-O B-NP_JJ
human B-O B-JJ
platelets B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
forms B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
estrogen B-O B-ADJP_NN
receptor-related B-O B-JJ
" " B-O O-ADJP
27-kDa B-O B-JJ
heat B-O B-NN
shock B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thrombin B-O B-S_NP_NN
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
critical B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
platelet B-O B-NP_NP_NN
activation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
hemostasis B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
thrombosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cellular B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
thrombin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
multiple B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
most B-O B-SBAR_WHNP_NP_JJS
" " B-O O-NP
of B-O B-WHPP_IN
" " B-O B-WHNP_O-WHNP
are B-O B-S_NP_VP_VBP
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
characterized B-O B-VP_VBN
several B-O B-NP_NP_JJ
29-kDa B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
phosphorylated B-O B-VP_VBN
following B-O B-NP_PP_VBG
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
murine B-O B-JJ
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
raised B-O B-VP_VBN
to B-O B-PP_TO
an B-O B-NP_DT
unidentified B-O B-JJ
estrogen B-O B-ADJP_NN
receptor-related B-O B-JJ
" " B-O O-ADJP
29-kDa B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
selectively B-O B-ADVP_RB
" " B-O O-ADVP
recognized B-O B-VP_VBD
these B-O B-NP_NP_DT
proteins B-O B-NNS
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
a B-O B-NP_DT
more B-O B-ADJP_ADJP_RBR
basic B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
unphosphorylated B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
27-kDa B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cellular B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
thrombin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
led B-O B-VP_VBN
to B-O B-PP_TO
a B-O B-NP_NP_DT
marked B-O B-JJ
shift B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
proportion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
the B-O B-NP_DT
27-kDa B-O B-JJ
unphosphorylated B-O B-JJ
form B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
29-kDa B-O B-JJ
phosphoprotein B-O B-NN
species B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
this B-O B-NP_DT
antibody B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
isolated B-O B-VP_VP_VP_VBD
" " B-O B-NP_O-VP
and B-O B-CC
sequenced B-O B-VP_VBD
" " B-O B-NP_O-VP
" " B-O O-VP
a B-O B-NP_NP_DT
human B-O B-JJ
cDNA B-O B-NN
clone B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
a B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
identical B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
29-kDa B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
confirmed B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
phosphorylated B-O B-NP_NP_VBN
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HSP27 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
by B-O B-PP_IN
immunoprecipitation B-O B-NP_NN
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
"""" B-O B-LQT
estrogen B-O B-ADJP_NN
receptor-related B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
"""" B-O B-RQT
" " B-O O-NP
is B-O B-VP_VBZ
HSP27 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_NP_DT
three B-O B-CD
major B-O B-JJ
29-kDa B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
phosphorylated B-O B-VP_VBN
in B-O B-NP_PP_IN
thrombin-activated B-O B-NP_JJ
platelets B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
forms B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
HSP27 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
a B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
HSP27 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
signal B-O B-NN
transduction B-O B-NN
events B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
platelet B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Characterization B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
cofactor B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
regulates B-O B-S_NP_VP_VBZ
dimerization B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
mammalian B-O B-JJ
homeodomain B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Dimerization B-O B-S_NP_NP_NN
" " B-O O-NP
among B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
become B-O B-VP_VBN
a B-O B-NP_NP_DT
recurrent B-O B-JJ
theme B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
eukaryotic B-O B-NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Hepatocyte B-O B-S_NP_NP_NN
nuclear B-O B-JJ
factor-1 B-O B-NN
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HNF-1 B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
homeodomain-containing B-O B-JJ
protein B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
functions B-O B-S_NP_VP_VBZ
as B-O B-PP_IN
a B-O B-NP_DT
dimer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_NP_DT
dimerization B-O B-NN
cofactor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HNF-1 B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
DCoH B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O B-SBAR_O-NP
was B-O B-VP_VBD
identified B-O B-VP_VBN
that B-O B-NP_SBAR_WHNP_WDT
" " B-O O-WHNP
displayed B-O B-S_NP_VP_VP_VBD
a B-O B-NP_DT
restricted B-O B-JJ
tissue B-O B-NN
distribution B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
did B-O B-VP_VBD
not B-O B-RB
bind B-O B-VP_VB
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CONJP_CC
, B-O B-COMMA
rather B-O B-RB
" " B-O O-CONJP
, B-O B-COMMA
selectively B-O B-VP_ADVP_RB
" " B-O O-ADVP
stabilized B-O B-VBD
HNF-1 B-O B-NP_NN
alpha B-O B-NN
dimers B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
stable B-O B-JJ
tetrameric B-O B-JJ
DCoH-HNF-1 B-O B-NN
alpha B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
required B-O B-S_NP_VP_VBD
the B-O B-NP_NP_DT
dimerization B-O B-NN
domain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HNF-1 B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
did B-O B-VP_VP_VBD
not B-O B-RB
change B-O B-VP_VB
the B-O B-NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
characteristics B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HNF-1 B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
enhanced B-O B-VP_VBD
its B-O B-NP_PRPP
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
DCoH B-O B-NP_NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
confer B-O B-VP_VB
transcriptional B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
GAL4 B-O B-NN
DNA B-O B-NN
binding B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
DCoH B-O B-S_NP_NN
" " B-O O-NP
regulates B-O B-VP_VP_VBZ
formation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
tetrameric B-O B-NP_ADJP_JJ
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
may B-O B-VP_MD
contribute B-O B-VP_VB
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcription B-O B-NP_NP_NN
factor B-O B-NN
requirements B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
U2 B-O B-NP_ADJP_NN
snRNA-encoding B-O B-JJ
" " B-O O-ADJP
gene B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
B B-O B-NP_NN
lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Transcription B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
human B-O B-JJ
U2 B-O B-ADJP_NN
small B-O B-JJ
nuclear B-O B-JJ
RNA B-O B-NN
( B-O B-LRB
snRNA B-O B-NN
) B-O B-RRB
-encoding B-O B-JJ
" " B-O O-ADJP
gene B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VBZ
a B-O B-NP_NP_DT
distal B-O B-JJ
enhancer B-O B-NN
element B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
composed B-O B-VP_VBN
of B-O B-NP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
study B-O B-VP_VB
the B-O B-NP_NP_DT
transcription B-O B-NN
factor B-O B-NN
requirement B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
B-cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
different B-O B-NP_JJ
U2 B-O B-NN
enhancer B-O B-NN
constructions B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
transfected B-O B-VP_VBN
into B-O B-NP_PP_IN
the B-O B-NP_NP_DT
lymphoid B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
BJA-B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
U2 B-O B-NP_NN
snRNA B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
B-cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
requires B-O B-VP_VBZ
an B-O B-NP_NP_DT
enhancer B-O B-NN
" " B-O O-NP
comprising B-O B-VP_VBG
both B-O B-NP_CC
the B-O B-NP_DT
Oct B-O B-NN
" " B-O O-NP
and B-O B-CC
site B-O B-NP_QP_ADJP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletion B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
all B-O B-NP_PDT
the B-O B-DT
Sp B-O B-ADJP_NN
1-binding B-O B-JJ
" " B-O O-ADJP
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
the B-O B-NP_DT
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reduces B-O B-VP_VBZ
transcription B-O B-NP_NN
" " B-O O-NP
by B-O B-PP_IN
80-90 B-O B-NP_QP_CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_PP_IN
HeLa B-O B-NP_NN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
BJA-B B-O B-NP_NN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-PP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
the B-O B-S_NP_NP_DT
removal B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
octamer-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reduces B-O B-VP_VBZ
transcription B-O B-NP_NN
" " B-O O-NP
to B-O B-PP_TO
levels B-O B-NP_NP_NNS
" " B-O O-NP
below B-O B-PP_IN
detection B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
both B-O B-NP_DT
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Enhancers B-O B-S_NP_NP_NNS
" " B-O O-NP
containing B-O B-VP_VBG
a B-O B-NP_DT
single B-O B-JJ
Oct B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
have B-O B-VP_VBP
, B-O B-COMMA
nevertheless B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
capacity B-O B-NN
to B-O B-S_NP_VP_TO
partially B-O B-ADVP_RB
" " B-O O-ADVP
activate B-O B-VP_VB
U2 B-O B-NP_NN
snRNA B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
in B-O B-PP_PP_IN
both B-O B-NP_NP_DT
HeLa B-O B-NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
only B-O B-S_NP_RB
OTF-1 B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
in B-O B-PP_IN
BJA-B B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
OTF-2 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_DT
octamer-binding B-O B-ADJP_JJ
factor B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
most B-O B-ADJP_RBS
likely B-O B-JJ
" " B-O O-ADJP
interpretation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
our B-O B-NP_PRPP
results B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
that B-O B-SBAR_IN
both B-O B-S_NP_CC
the B-O B-NP_NP_DT
ubiquitous B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
OTF-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
B-cell-specific B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
OTF-2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
activate B-O B-VP_VB
U2 B-O B-NP_NN
snRNA B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
revealed B-O B-VP_VBD
a B-O B-NP_NP_DT
similar B-O B-JJ
functional B-O B-JJ
cooperation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bind B-O B-S_NP_VP_VBP
to B-O B-PP_TO
in B-O B-NP_PP_IN
, B-O B-NP_COMMA
as B-O B-SBAR_IN
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
since B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
template B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contains B-O B-S_NP_VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
expresses B-O B-VP_VBZ
wild-type B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
U2 B-O B-NP_NN
snRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_DT
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
weak B-O B-JJ
octamer-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
combined B-O B-VP_VBN
" " B-O B-NP_PP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Kappa B-O B-S_NP_ADJP_NN
B-specific B-O B-JJ
" " B-O O-ADJP
DNA B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
differentially B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
enhancer B-O B-NP_NP_NN
mutations B-O B-NNS
" " B-O O-NP
and B-O B-CC
biological B-O B-NP_JJ
oxidation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Kappa B-O B-S_NP_NP_NP_NP_NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
enhancer B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_NP_DT
nuclei B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
human B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
produce B-O B-VP_VBP
two B-O B-NP_CD
distinct B-O B-JJ
nucleoprotein B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
incubated B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
kappa B-O B-NN
B B-O B-NN
element B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
gene B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
two B-O B-CD
DNA-protein B-O B-JJ
complexes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
composed B-O B-VP_VBN
of B-O B-NP_PP_IN
at B-O B-NP_NP_NP_QP_IN
least B-O B-JJS
four B-O B-CD
" " B-O O-QP
host B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
p50 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p55 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
p75 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
p85 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
each B-O B-SBAR_WHNP_NP_DT
" " B-O O-NP
of B-O B-WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
" " B-O O-WHNP
shares B-O B-S_NP_VP_VBZ
structural B-O B-NP_JJ
similarity B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
induced B-O B-VP_VBN
with B-O B-NP_PP_IN
distinctly B-O B-NP_ADJP_RB
biphasic B-O B-JJ
" " B-O O-ADJP
kinetics B-O B-NNS
" " B-O O-NP
" " B-O O-PP
following B-O B-PP_VBG
phorbol B-O B-NP_NN
ester B-O B-NN
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
p55/p75 B-O B-NP_NP_NN
early B-O B-JJ
" " B-O B-NP_O-NP
and B-O B-CC
p50/p85 B-O B-NP_NN
late B-O B-JJ
" " B-O B-NP_O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNA-protein B-O B-S_NP_JJ
crosslinking B-O B-NN
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
revealed B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_DT
more B-O B-ADJP_ADVP_RBR
rapidly B-O B-RB
" " B-O O-ADVP
migrating B-O B-VBG
" " B-O O-ADJP
B2 B-O B-NN
complex B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
both B-O B-NP_CC
p50 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
p55 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
while B-O B-SBAR_IN
the B-O B-S_NP_DT
B1 B-O B-ADJP_NN
complex B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Site-directed B-O B-S_NP_NP_JJ
mutagenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
wild-type B-O B-JJ
IL-2R B-O B-NN
alpha B-O B-NN
kappa B-O B-NN
B B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GGGGAATCTCCC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
revealed B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_NP_CC
( B-O B-NP_PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
particularly B-O B-ADJP_RB
sensitive B-O B-JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
formation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
B1 B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
reflecting B-O B-VP_VBG
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p75 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
p85 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
critically B-O B-ADVP_RB
" " B-O O-ADVP
depends B-O B-VP_VBZ
upon B-O B-PP_IN
the B-O B-NP_NP_DT
more B-O B-RBR
3' B-O B-JJ
sequences B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
enhancer B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNA B-O B-S_NP_NP_NN
binding B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
all B-O B-NP_NP_DT
four B-O B-CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
Rel-related B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
selective B-O B-NP_NP_JJ
chemical B-O B-JJ
modification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lysine B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
arginine B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
residues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
both B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similarly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
covalent B-O B-NP_NP_JJ
modification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
free B-O B-NP_JJ
sulfhydryl B-O B-NN
groups B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
diamide B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
reversible B-O B-FRAG_ADJP_JJ
" " B-O O-ADJP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
or B-O B-CC
N-ethylmaleimide B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
irreversible B-O B-FRAG_ADJP_JJ
" " B-O O-ADJP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
a B-O B-NP_NP_DT
complete B-O B-JJ
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
mild B-O B-NP_NP_JJ
oxidation B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
glucose B-O B-NP_NN
oxidase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
selectively B-O B-ADVP_RB
" " B-O O-ADVP
inhibits B-O B-VP_VBZ
p75 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
p85 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
while B-O B-SBAR_IN
not B-O B-S_NP_VP_RB
blocking B-O B-VBG
p50 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
p55 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
interactions B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
reduced B-O B-S_NP_VBN
cysteine B-O B-NN
thiols B-O B-NNS
" " B-O O-NP
play B-O B-VP_VBP
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-NP_LRB
Changes B-O B-NP_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
leucocytic B-O B-NP_NP_JJ
estrogen B-O B-NN
receptor B-O B-NN
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
climacteric B-O B-NP_JJ
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
therapeutic B-O B-NP_NP_JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
liuwei B-O B-NP_FW
dihuang B-O B-FW
pills B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
] B-O B-RRB
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
numbers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
estrogen B-O B-NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ER B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
peripheral B-O B-JJ
leucocytes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
22 B-O B-NP_NP_CD
women B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
measured B-O B-VP_VBN
by B-O B-NP_PP_IN
radioligand B-O B-NP_NN
method B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
compared B-O B-VP_VBN
with B-O B-NP_PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
12 B-O B-NP_CD
normal B-O B-JJ
child-bearing-age B-O B-JJ
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
wat B-O B-VP_VBD
found B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
contents B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
leucocytic B-O B-NP_NP_JJ
ER B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
significantly B-O B-ADJP_ADJP_RB
lower B-O B-JJR
" " B-O O-ADJP
than B-O B-PP_IN
normal B-O B-NP_JJ
child-bearing-age B-O B-JJ
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
authors B-O B-NNS
" " B-O O-NP
used B-O B-VP_VBD
a B-O B-NP_NP_DT
Chinese B-O B-JJ
prescription B-O B-NN
" " B-O O-NP
-- B-O B-COLON
Liuwei B-O B-NP_NP_FW
Dihuang B-O B-FW
Pills B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
LDP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
to B-O B-S_NP_VP_TO
treat B-O B-VP_VB
the B-O B-NP_DT
patients B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
2 B-O B-NP_CD
months B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
numbers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
leucocytic B-O B-NP_JJ
ER B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBN
after B-O B-NP_PP_IN
treatment B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
decrease B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ER B-O B-NP_NP_NN
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
cell B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
involve B-O B-VP_VB
in B-O B-PP_IN
the B-O B-NP_NP_DT
pathogenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LDP B-O B-S_NP_NN
" " B-O O-NP
not B-O B-VP_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
increases B-O B-VP_VBZ
plasma B-O B-NP_NN
estradiol B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
increases B-O B-VP_VBZ
the B-O B-NP_DT
leucocytic B-O B-JJ
ER B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
the B-O B-NP_NP_DT
basis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
therapeutic B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activity B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
kappa B-O B-NN
B B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
interleukin-2 B-O B-NN
receptor B-O B-NN
alpha B-O B-NN
chain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
somatic B-O B-NP_JJ
cell B-O B-NN
hybrids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
nuclear B-O B-JJ
localization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
two B-O B-CD
nuclear B-O B-JJ
proteins B-O B-NNS
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-LRB
consisting B-O B-VP_VBG
of B-O B-PP_IN
subunits B-O B-NP_NNS
p50 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_NP_DT
DNA-binding B-O B-JJ
subunit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
p50 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
itself B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
called B-O B-VBN
KBF1 B-O B-S_NP_NP_NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
localized B-O B-VP_JJ
" " B-O B-NP_O-VP
" " B-O O-VP
in B-O B-PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
T-cell B-O B-NN
line B-O B-NN
IARC B-O B-NN
301.5 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_SBAR_IN
order B-O B-NN
to B-O B-TO
define B-O B-S_NP_VP_VB
the B-O B-NP_NP_DT
roles B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_NP_DT
two B-O B-CD
factors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
in B-O B-PP_IN
transcription B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
prepared B-O B-VP_VBN
somatic B-O B-NP_NP_JJ
cell B-O B-NN
hybrids B-O B-NNS
" " B-O O-NP
between B-O B-PP_IN
IARC B-O B-NP_NP_NN
301.5 B-O B-CD
" " B-O O-NP
and B-O B-CC
a B-O B-NP_DT
murine B-O B-JJ
myeloma B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Most B-O B-S_S_NP_JJS
hybrids B-O B-NNS
" " B-O O-NP
express B-O B-VP_VBP
both B-O B-NP_CC
KBF1 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
their B-O B-NP_PRPP
nuclei B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
one B-O B-S_NP_CD
hybrid B-O B-NN
" " B-O O-NP
expresses B-O B-VP_VBZ
only B-O B-NP_RB
KBF1 B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
kappa B-O B-NN
B B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
gene B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
the B-O B-NP_NP_DT
interleukin-2 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
receptor B-O B-NN
alpha B-O B-NN
chain B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-2R B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
functional B-O B-ADJP_JJ
" " B-O O-ADJP
only B-O B-PP_RB
in B-O B-IN
the B-O B-NP_NP_DT
hybrids B-O B-NNS
" " B-O O-NP
expressing B-O B-VP_VBG
nuclear B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
nuclear B-O B-S_NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
necessary B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-ADJP
, B-O B-COMMA
while B-O B-SBAR_IN
KBF1 B-O B-S_NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_O-NP
is B-O B-VP_VBZ
not B-O B-RB
sufficient B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VP_VBP
that B-O B-SBAR_IN
KBF1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
competitive B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
discuss B-O B-VP_VB
how B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
these B-O B-S_NP_DT
factors B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
interferon B-O B-NP_NP_NN
beta B-O B-NN
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
purified B-O B-NP_NP_VBN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_DT
novel B-O B-JJ
TH B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
human B-O B-JJ
interferon B-O B-NP_NP_NN
beta B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IFN-beta B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
consists B-O B-VP_VBZ
of B-O B-PP_IN
multiple B-O B-NP_NP_JJ
enhanson B-O B-NN
domains B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
targets B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
further B-O B-ADVP_RB
" " B-O O-ADVP
characterize B-O B-VP_VB
the B-O B-NP_NP_DT
protein-DNA B-O B-JJ
interactions B-O B-NNS
" " B-O O-NP
mediating B-O B-VP_VBG
IFN-beta B-O B-NP_NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
positive B-O B-NP_NP_NP_JJ
regulatory B-O B-JJ
domain B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PRD B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
II B-O B-CD
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
purified B-O B-VP_VBN
from B-O B-NP_PP_PP_IN
phorbol B-O B-NP_ADJP_NP_NN
ester B-O B-NN
" " B-O O-NP
induced B-O B-JJ
" " B-O O-ADJP
Jurkat B-O B-NN
T-cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
from B-O B-PP_IN
IFN B-O B-ADJP_ADJP_NP_NN
" " B-O O-NP
primed B-O B-VBN
" " B-O O-ADJP
, B-O B-COMMA
cycloheximide/polyinosinic-polycytidylic B-O B-ADJP_NP_JJ
acid B-O B-NN
" " B-O O-NP
treated B-O B-VBN
" " B-O O-ADJP
" " B-O O-ADJP
HeLa B-O B-NN
S3 B-O B-NN
cells B-O B-NNS
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
From B-O B-S_S_PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
two B-O B-NP_NP_CD
major B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
52 B-O B-NP_QP_NP_CD
" " B-O O-NP
and B-O B-CC
45 B-O B-NP_CD
" " B-O O-NP
" " B-O O-QP
kilodaltons B-O B-NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
kD B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
copurified B-O B-VP_VBD
with B-O B-PP_IN
DNA B-O B-NP_NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
from B-O B-S_PP_IN
T-cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
four B-O B-NP_NP_CD
proteins B-O B-NNS
" " B-O O-NP
-- B-O B-COLON
a B-O B-NP_NP_NP_DT
major B-O B-JJ
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
52 B-O B-NP_CD
kD B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
three B-O B-NP_NP_CD
minor B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
82 B-O B-NP_QP_CD
, B-O B-COMMA
67 B-O B-CD
, B-O B-COMMA
and B-O B-CC
43-47 B-O B-CD
" " B-O O-QP
kD B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
-- B-O B-COLON
" " B-O O-NP
were B-O B-VP_VBD
purified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Also B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
an B-O B-NP_DT
induction B-O B-ADJP_NP_NN
" " B-O O-NP
specific B-O B-JJ
" " B-O O-ADJP
DNA B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
purified B-O B-VP_VBN
from B-O B-NP_PP_IN
HeLa B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
interacted B-O B-S_NP_VP_VBD
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
protein B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
immunologically B-O B-ADJP_RB
distinct B-O B-JJ
from B-O B-PP_IN
IRF-1/ISGF2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Uninduced B-O B-S_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
Sendai B-O B-ADJP_NP_NN
virus B-O B-NN
" " B-O O-NP
induced B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
HeLa B-O B-NN
extracts B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
examine B-O B-VP_VB
transcription B-O B-NP_NN
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
using B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletions B-O B-S_NP_NP_NNS
" " B-O O-NP
upstream B-O B-ADJP_JJ
of B-O B-PP_IN
the B-O B-NP_DT
PRDII B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
increased B-O B-VP_VBD
transcription B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
uninduced B-O B-JJ
extract B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
predominantly B-O B-NP_NP_ADJP_RB
negative B-O B-JJ
" " B-O O-ADJP
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_S_NP_NP_DT
2-4-fold B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
IFN-beta B-O B-NP_NN
promoter B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
Sendai B-O B-NP_ADJP_NP_NN
virus B-O B-NN
" " B-O O-NP
induced B-O B-JJ
" " B-O O-ADJP
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
deletion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
PRDI B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
PRDII B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
decreased B-O B-VP_VBD
this B-O B-NP_NP_DT
induced B-O B-VBN
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
purified B-O B-S_NP_NP_VBN
PRDII B-O B-NN
" " B-O O-NP
and B-O B-CC
tetrahexamer B-O B-NP_NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
added B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
induced B-O B-VBN
extract B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
a B-O B-NP_NP_DT
4-fold B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
experiments B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VP_VBP
that B-O B-SBAR_IN
it B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-S_O-NP
is B-O B-VP_VBZ
possible B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
modulate B-O B-VP_VB
" " B-O B-NP_ADVP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
but B-O B-CC
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
additional B-O B-S_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
required B-O B-VP_VBN
" " B-O B-S_NP_VP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-NP_LRB
Regulatory B-O B-NP_JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
insulin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
] B-O B-RRB
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
regulatory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
insulin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
specific B-O B-JJ
binding B-O B-VBG
power B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
assessed B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
unoccupied B-O B-JJ
receptor B-O B-NN
sites B-O B-NNS
" " B-O O-NP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
combining B-O B-S_NP_VP_VBG
" " B-O B-PP_O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_PP_IN
3 B-O B-NP_ADJP_CD
h B-O B-NN
" " B-O O-ADJP
incubation B-O B-NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
specific B-O B-JJ
binding B-O B-VBG
power B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
[3H] B-O B-NP_NN
Dex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
decreased B-O B-VP_VBN
by B-O B-NP_PP_IN
23.3 B-O B-NP_NP_NP_NP_QP_CD
+/- B-O B-CC
10.0 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
, B-O B-COMMA
32.2 B-O B-NP_QP_CD
+/- B-O B-CC
13.2 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
and B-O B-CC
54.3 B-O B-NP_QP_CD
+/- B-O B-CC
9.2 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
" " B-O O-NP
% B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
, B-O B-NP_NP_NP_NP_ADJP_COMMA
and B-O B-NP_NP_ADJP_CC
" " B-O B-NP_NP_ADJP_O-NP
as B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
respectively B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
the B-O B-DT
presence B-O B-NN
of B-O B-IN
20 B-O B-NP_NP_NP_NP_NP_CD
mU/L B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
200 B-O B-NP_NP_CD
mU/L B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
2,000 B-O B-NP_NP_CD
mU/L B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
insulin B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
incubation B-O B-NN
medium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_PP_IN
24 B-O B-NP_ADJP_CD
h B-O B-NN
" " B-O O-ADJP
incubation B-O B-NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
decrease B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
values B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBD
respectively B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
43.5 B-O B-NP_NP_NP_QP_CD
+/- B-O B-CC
19.0 B-O B-CD
" " B-O O-QP
" " B-O O-NP
, B-O B-COMMA
56.1 B-O B-NP_QP_CD
+/- B-O B-CC
20.7 B-O B-CD
" " B-O O-QP
" " B-O O-NP
and B-O B-CC
80.2 B-O B-NP_QP_CD
+/- B-O B-CC
15.5 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_ADJP_PP_O-NP
, B-O B-COMMA
P B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_ADJP_PP_O-NP
and B-O B-CC
P B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_ADJP_PP_O-NP
" " B-O O-NP
compared B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
the B-O B-NP_NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
insulin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_DT
GR B-O B-NN
binding B-O B-NN
power B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
both B-O B-ADJP_CC
dose- B-O B-ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
time-dependent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
strongly B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
GR B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
tonically B-O B-ADVP_RB
" " B-O O-ADVP
controlled B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-PRN_PRN_LRB
Hormonal B-O B-NP_NP_NP_JJ
interactions B-O B-NNS
" " B-O O-NP
and B-O B-CC
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
nephrotic B-O B-JJ
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-PRN
  
As B-O B-S_S_NP_NP_NP_QP_RB
many B-O B-JJ
as B-O B-IN
27 B-O B-CD
" " B-O O-QP
children B-O B-NNS
" " B-O O-NP
aged B-O B-ADJP_JJ
6 B-O B-NP_QP_CD
to B-O B-TO
15 B-O B-CD
" " B-O O-QP
years B-O B-NNS
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
with B-O B-PP_IN
morphologically B-O B-NP_ADJP_RB
verified B-O B-VBN
" " B-O O-ADJP
nephropathies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Four B-O B-S_S_NP_NP_CD
variants B-O B-NNS
" " B-O B-NP_O-NP
of B-O B-PP_IN
changes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
thyroid B-O B-NN
status B-O B-NN
" " B-O O-NP
, B-O B-COMMA
characteristic B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
distinguished B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
1 B-O B-NP_NP_LST_LS
) B-O B-RRB
" " B-O O-LST
biochemical B-O B-NP_JJ
signs B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
primary B-O B-NP_JJ
hypothyroidism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
2 B-O B-NP_LST_LS
) B-O B-RRB
" " B-O O-LST
biochemical B-O B-NP_JJ
signs B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
secondary B-O B-NP_JJ
hypothyroidism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
3 B-O B-NP_LST_LS
) B-O B-RRB
" " B-O O-LST
low B-O B-NP_JJ
content B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
4 B-O B-NP_LST_LS
) B-O B-RRB
" " B-O O-LST
dysfunction B-O B-NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
hypophyseal B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
thyroid B-O B-NP_NN
" " B-O B-NP_O-NP
system B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
shown B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
low B-O B-JJ
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
steroid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-NP_NP_PRN_PRN_CC
cortisol B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
typical B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
assumed B-O B-VP_VBN
that B-O B-SBAR_IN
superaddition B-O B-S_NP_NP_NN
" " B-O O-NP
under B-O B-PP_IN
such B-O B-NP_NP_JJ
conditions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
gives B-O B-VP_VBZ
rise B-O B-NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
resistance B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-NP_LRB
Regulation B-O B-NP_NN
" " B-O O-NP
of B-O B-PP_IN
intracellular B-O B-NP_NP_JJ
cholesterol B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
hypercholesterolemia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
] B-O B-RRB
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
endogenous B-O B-NP_NP_JJ
cholesterol B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
blood B-O B-NP_NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
skin B-O B-NP_NN
fibroblasts B-O B-NNS
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
increased B-O B-VP_VBN
in B-O B-NP_PP_IN
comparison B-O B-NN
with B-O B-IN
healthy B-O B-NP_JJ
donors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
cells B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
hyperlipidemic B-O B-NP_JJ
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
lowered B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
concomitantly B-O B-PP_RB
with B-O B-IN
a B-O B-NP_NP_DT
partial B-O B-JJ
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
their B-O B-NP_NP_PRPP
sensitivity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
fibroblasts B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
hereditary B-O B-NP_NP_JJ
hypercholesteremia B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
homozygous B-O B-NP_JJ
type B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
exceed B-O B-VP_VB
10 B-O B-NP_NP_CD
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
their B-O B-NP_NP_PRPP
content B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
normal B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
decrease B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
seems B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
a B-O B-NP_NP_DT
compensatory B-O B-JJ
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
culminating B-O B-VP_VBG
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-NP_LRB
Plasma B-O B-NP_NP_NN
cortisol B-O B-NN
concentration B-O B-NN
" " B-O O-NP
and B-O B-CC
blood B-O B-NP_NP_NN
leukocyte B-O B-NN
content B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
deficiency-cold B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
vs B-O B-CC
deficiency-heat B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
syndromes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
] B-O B-RRB
" " B-O O-NP
  
Plasma B-O B-S_NP_NP_NN
cortisol B-O B-NN
concentration B-O B-NN
" " B-O O-NP
and B-O B-CC
blood B-O B-NP_NP_NN
leukocyte B-O B-NN
content B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
GCR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
assayed B-O B-VP_VP_VP_VBN
in B-O B-NP_PP_IN
20 B-O B-NP_NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
, B-O B-NP_NP_NP_ADJP_COMMA
" " B-O B-NP_NP_ADJP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
also B-O B-RB
in B-O B-VP_PP_IN
10 B-O B-NP_CD
healthy B-O B-JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
normal B-O B-NP_JJ
control B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
for B-O B-PP_IN
the B-O B-NP_NP_DT
purpose B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
investigating B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_S_PP_IN
a B-O B-NP_DT
result B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
cases B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
deficiency-cold B-O B-NP_NP_JJ
syndrome B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
DCS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
a B-O B-NP_NP_NP_DT
normal B-O B-JJ
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
plasma B-O B-NP_NN
cortisol B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
but B-O B-CC
a B-O B-NP_NP_DT
lowered B-O B-JJ
content B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GCR B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
leukocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
compared B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
normal B-O B-JJ
control B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-S_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
the B-O B-S_NP_NP_DT
cases B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
deficiency-heat B-O B-NP_NP_JJ
syndrome B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
DHS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
a B-O B-NP_NP_NP_NP_DT
higher B-O B-JJR
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
plasma B-O B-NP_NN
cortisol B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O B-NP_O-NP
than B-O B-PP_IN
the B-O B-NP_NP_DT
normal B-O B-JJ
control B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-S_NP_NN
" " B-O O-NP
" " B-O B-NP_QP_O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
a B-O B-NP_NP_DT
slightly B-O B-ADJP_RB
higher B-O B-JJR
" " B-O O-ADJP
content B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GCR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
leukocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
concluded B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_S_NP_DT
DCS B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
while B-O B-IN
the B-O B-S_NP_DT
DHS B-O B-NN
" " B-O O-NP
, B-O B-COMMA
by B-O B-PP_IN
augmented B-O B-NP_NP_JJ
biological B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Protein B-O B-NP_NP_NP_NN
kinase B-O B-NN
C B-O B-NN
activation B-O B-NN
" " B-O O-NP
and B-O B-CC
protooncogene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
differentiation/retrodifferentiation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
U-937 B-O B-NN
leukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Human B-O B-S_NP_JJ
U-937 B-O B-NN
leukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
differentiate B-O B-VP_VBP
along B-O B-PP_IN
the B-O B-NP_DT
monocytic B-O B-JJ
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
following B-O B-PP_VBG
3-day B-O B-NP_NP_JJ
exposures B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
12-O-tetradecanoylphorbol-13-acetate B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
TPA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
adherence B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
loss B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
proliferation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
expression/repression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
differentiation-associated B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Long B-O B-S_NP_NP_ADJP_JJ
term B-O B-NN
" " B-O O-ADJP
culture B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TPA-differentiated B-O B-NP_JJ
U-937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-DT
absence B-O B-NN
of B-O B-IN
phorbol B-O B-NP_NN
ester B-O B-NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
32-36 B-O B-NP_QP_CD
" " B-O O-QP
days B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_DT
process B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
retrodifferentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
retrodifferentiated B-O B-VBN
cells B-O B-NNS
" " B-O O-NP
detached B-O B-VP_VP_VBD
from B-O B-PP_IN
the B-O B-NP_DT
substrate B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
reinitiated B-O B-VP_VBD
proliferation B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Other B-O B-S_NP_NP_JJ
cellular B-O B-JJ
parameters B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
such B-O B-PP_JJ
as B-O B-IN
glycosidase B-O B-NP_NP_NN
activities B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
cytokine B-O B-NP_NN
release B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
filament B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
returned B-O B-VP_VBD
to B-O B-PP_TO
levels B-O B-NP_NP_NNS
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
U-937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
TPA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_DT
rapid B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PKC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
the B-O B-NP_DT
cytosol B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
cell B-O B-NP_NN
membrane B-O B-NN
fractions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
2-8 B-O B-NP_QP_CD
" " B-O O-QP
min B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Increased B-O B-S_NP_NP_VBN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
membrane-associated B-O B-NP_JJ
PKC B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
persisted B-O B-VP_VBD
until B-O B-PP_IN
17-29 B-O B-NP_QP_CD
" " B-O O-QP
days B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
longer B-O B-NP_NP_JJR
periods B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
incubation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
return B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
distribution B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
control B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
implicated B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
certain B-O B-NP_JJ
immediate B-O B-JJ
early B-O B-JJ
response B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
in B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
TPA B-O B-NP_NN
" " B-O O-NP
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBD
c-fos B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Levels B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
remained B-O B-VP_VP_VP_VBD
elevated B-O B-ADJP_JJ
" " B-O O-ADJP
during B-O B-PP_IN
periods B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
also B-O B-RB
returned B-O B-VP_VBD
to B-O B-PP_TO
levels B-O B-NP_NP_NNS
" " B-O O-NP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
control B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
days B-O B-NP_QP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
cells B-O B-NNS
" " B-O O-NP
entered B-O B-VP_VBD
retrodifferentiation B-O B-NP_NN
" " B-O O-NP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Staurosporine B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
nonspecific B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
partially B-O B-VP_VP_ADVP_RB
" " B-O O-ADVP
blocked B-O B-VBD
TPA-induced B-O B-NP_NP_JJ
adherence B-O B-NN
" " B-O O-NP
and B-O B-CC
growth B-O B-NP_NN
inhibition B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
concomitantly B-O B-VP_ADVP_RB
" " B-O O-ADVP
prevented B-O B-VBD
TPA-induced B-O B-NP_JJ
c-fos B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LRB
ABSTRACT B-O B-NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-S
Cloning B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
murine B-O B-NP_NP_JJ
TCF-1 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
T B-O B-ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
interacting B-O B-VP_VBG
with B-O B-PP_IN
functional B-O B-NP_NP_JJ
motifs B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
CD3-epsilon B-O B-NN
and B-O B-CC
T B-O B-NN
cell B-O B-NN
receptor B-O B-NN
alpha B-O B-NN
enhancers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
CD3-epsilon B-O B-S_NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
confined B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
T B-O B-NN
cell B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
recently B-O B-VP_ADVP_RB
" " B-O O-ADVP
identified B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
cloned B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
a B-O B-NP_NP_NP_DT
human B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
TCF-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
a B-O B-NP_NP_DT
panel B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
TCF-1 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
restricted B-O B-ADJP_JJ
to B-O B-PP_TO
T B-O B-NP_NN
lineage B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TCF-1 B-O B-S_NP_NN
" " B-O O-NP
belonged B-O B-VP_VBD
to B-O B-PP_TO
a B-O B-NP_NP_DT
novel B-O B-JJ
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contain B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
the B-O B-NP_NP_DT
cloning B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
murine B-O B-NP_JJ
TCF-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_CD
splice B-O B-NN
alternatives B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
that B-O B-NP_SBAR_WHNP_WDT
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
not B-O B-RB
previously B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_JJ
TCF-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Murine B-O B-S_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
human B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
TCF-1 B-O B-NN
" " B-O O-NP
displayed B-O B-VP_VBD
a B-O B-NP_DT
95.5 B-O B-QP_CD
% B-O B-NN
" " B-O O-QP
overall B-O B-JJ
amino B-O B-NN
acid B-O B-NN
homology B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recombinant B-O B-S_NP_JJ
murine B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
human B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
TCF-1 B-O B-NN
" " B-O O-NP
recognized B-O B-VP_VBD
the B-O B-NP_DT
same B-O B-JJ
sequence B-O B-NN
motif B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
CD3-epsilon B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-SBAR_IN
judged B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
gel B-O B-NP_NP_NP_NN
retardation B-O B-NN
" " B-O O-NP
and B-O B-CC
methylation B-O B-NP_NN
interference B-O B-NN
" " B-O O-NP
" " B-O O-NP
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
With B-O B-S_PP_IN
the B-O B-NP_DT
murine B-O B-JJ
cDNA B-O B-NN
clones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
several B-O B-NP_NP_JJ
aspects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
TCF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
analyzed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
First B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
deletion B-O B-NP_NN
analysis B-O B-NN
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TCF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
containing B-O B-VP_VBG
the B-O B-NP_DT
HMG B-O B-NN
box B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
sufficient B-O B-ADJP_JJ
for B-O B-PP_IN
sequence-specific B-O B-NP_JJ
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Second B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
by B-O B-PP_IN
high B-O B-NP_NP_JJ
stringency B-O B-NN
Northern B-O B-NN
blotting B-O B-NN
" " B-O O-NP
and B-O B-CC
in B-O B-NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
TCF-1 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
confined B-O B-VP_VBN
to B-O B-NP_PP_PP_TO
and B-O B-NP_CC
to B-O B-PP_TO
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Third B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
TCF-1 B-O B-NP_NN
" " B-O O-NP
bound B-O B-VP_VBD
specifically B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
a B-O B-NP_NP_DT
functional B-O B-JJ
T B-O B-ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
element B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
T B-O B-NP_NP_NN
cell B-O B-NN
receptor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TCR-alpha B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
T B-O B-ADJP_NN
lineage-specific B-O B-JJ
" " B-O O-ADJP
expression B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
affinity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
functional B-O B-NP_NP_JJ
motifs B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
TCR-alpha B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
CD3-epsilon B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
enhancers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
imply B-O B-VP_VBP
an B-O B-NP_NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
TCF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
establishment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
mature B-O B-JJ
T B-O B-NN
cell B-O B-NN
phenotype B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Characterization B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
immediate-early B-O B-JJ
gene B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
adherent B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
encodes B-O B-S_NP_VP_VBZ
I B-O B-NP_ADJP_NN
kappa B-O B-NN
B-like B-O B-JJ
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
cloned B-O B-VP_VBN
a B-O B-NP_NP_DT
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cDNAs B-O B-NP_NP_NNS
" " B-O O-NP
representing B-O B-VP_VBG
mRNAs B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
induced B-O B-VBN
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
MAD-3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
encodes B-O B-VP_VBZ
a B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
317 B-O B-NP_CD
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
one B-O B-NP_NP_CD
domain B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
five B-O B-NP_NP_CD
tandem B-O B-JJ
repeats B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cdc10/ankyrin B-O B-JJ
motif B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
60 B-O B-ADJP_ADJP_NP_CD
% B-O B-NN
" " B-O O-NP
similar B-O B-JJ
" " B-O B-PP_O-ADJP
( B-O B-PRN_LRB
identical B-O B-ADJP_NP_JJ
" " B-O B-PP_O-ADJP
) B-O B-RRB
" " B-O O-PRN
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
C-terminus B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
a B-O B-NP_DT
putative B-O B-JJ
protein B-O B-NN
kinase B-O B-NN
C B-O B-NN
phosphorylation B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_ADJP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
translated B-O B-VBN
" " B-O O-ADJP
MAD-3 B-O B-NN
protein B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
specifically B-O B-ADVP_RB
" " B-O O-ADVP
inhibit B-O B-VP_VB
the B-O B-NP_NP_NP_DT
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
that B-O B-NP_NP_DT
" " B-O O-NP
or B-O B-PP_PP_CC
" " B-O B-PP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
MAD-3 B-O B-NN
cDNA B-O B-NN
" " B-O O-NP
encodes B-O B-VP_VBZ
an B-O B-NP_NP_DT
I B-O B-ADJP_NN
kappa B-O B-NN
B-like B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
likely B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
toremifene B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
serum B-O B-NP_NP_NN
immunoglobulin B-O B-NN
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
breast B-O B-NP_NN
cancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Estrogens B-O B-S_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
anti-estrogens B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
enhance B-O B-VP_VBP
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immunoglobulin B-O B-NP_ADJP_NN
( B-O B-LRB
Ig B-O B-NN
) B-O B-RRB
-secreting B-O B-NN
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
pokeweed B-O B-NP_ADJP_NN
mitogen B-O B-NN
( B-O B-LRB
PWM B-O B-NN
) B-O B-RRB
-stimulated B-O B-JJ
" " B-O O-ADJP
lymphocyte B-O B-NN
cultures B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Lymphocytes B-O B-S_NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
who B-O B-SBAR_WHNP_WP
" " B-O O-WHNP
have B-O B-S_NP_VP_VBP
received B-O B-VP_VBN
anti-estrogen B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
show B-O B-VP_VBP
similar B-O B-NP_NP_NP_JJ
enhancement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Ig-secreting B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
after B-O B-PP_IN
PWM B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
anti-estrogen B-O B-NP_NN
( B-O B-LRB
toremifene B-O B-NN
) B-O B-RRB
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
serum B-O B-NP_NP_NP_NP_NN
immunoglobulin B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IgA B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
IgM B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
IgG B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
breast B-O B-NP_NN
cancer B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
investigated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Serum B-O B-S_NP_NN
Ig B-O B-NN
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
followed B-O B-VP_VBN
up B-O B-NP_NP_QP_RB
to B-O B-TO
two B-O B-CD
" " B-O O-QP
years B-O B-NNS
" " B-O O-NP
after B-O B-PP_PP_PP_IN
" " B-O B-NP_O-PP
or B-O B-CC
during B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-PP
the B-O B-NP_DT
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_DT
unexpected B-O B-JJ
finding B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
Ig B-O B-NN
levels B-O B-NNS
" " B-O O-NP
decreased B-O B-VP_VBD
during B-O B-PP_IN
the B-O B-NP_DT
follow-up B-O B-JJ
period B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
decrease B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
seen B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
who B-O B-SBAR_WHNP_WP
" " B-O O-WHNP
responded B-O B-S_NP_VP_VBD
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
who B-O B-SBAR_WHNP_WP
" " B-O O-WHNP
did B-O B-S_NP_VP_VBD
not B-O B-RB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
TCF-1 B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
T B-O B-ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HMG B-O B-NN
box B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
interacts B-O B-VP_VBZ
with B-O B-PP_IN
sequence B-O B-NP_NP_NN
motifs B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
TCR B-O B-NP_NP_NN
beta B-O B-NN
" " B-O O-NP
and B-O B-CC
TCR B-O B-NP_NN
delta B-O B-NN
" " B-O O-NP
" " B-O O-NP
enhancers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
recently B-O B-ADVP_RB
" " B-O O-ADVP
identified B-O B-VP_VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
cloned B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
TCF-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
T B-O B-ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
specificity B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_PP_IN
and B-O B-NP_CC
for B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TCF-1 B-O B-S_NP_NN
" " B-O O-NP
belongs B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription-regulating B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
share B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
by B-O B-PP_IN
gel B-O B-NP_NN
retardation B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
TCF-1 B-O B-NP_NN
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
recognizes B-O B-VP_VBZ
the B-O B-NP_NP_NP_DT
T B-O B-NN
beta B-O B-NN
5 B-O B-CD
element B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TCR B-O B-NN
beta B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
T B-O B-NN
delta B-O B-NN
7 B-O B-CD
element B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TCR B-O B-NN
delta B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Comparison B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
sequences B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
all B-O B-NP_NP_DT
elements B-O B-NNS
" " B-O O-NP
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
TCF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
defines B-O B-VP_VBZ
a B-O B-NP_DT
consensus B-O B-NN
motif B-O B-NN
A/T B-O B-NN
A/T B-O B-NN
C B-O B-NN
A B-O B-NN
A/G B-O B-NN
A B-O B-NN
G B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
observations B-O B-NNS
" " B-O O-NP
imply B-O B-VP_VBP
that B-O B-SBAR_IN
TCF-1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
might B-O B-VP_MD
thus B-O B-ADVP_RB
" " B-O O-ADVP
play B-O B-VP_VB
an B-O B-NP_NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Platelet-activating B-O B-S_NP_JJ
factor B-O B-NN
" " B-O O-NP
induces B-O B-VP_VBZ
phospholipid B-O B-NP_NP_NP_JJ
turnover B-O B-NN
" " B-O O-NP
, B-O B-COMMA
calcium B-O B-NP_NN
flux B-O B-NN
" " B-O O-NP
, B-O B-COMMA
arachidonic B-O B-NP_JJ
acid B-O B-NN
liberation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
eicosanoid B-O B-NP_NN
generation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
oncogene B-O B-NP_JJ
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
human B-O B-JJ
B B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Platelet-activating B-O B-S_NP_JJ
factor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
potent B-O B-JJ
mediator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
inflammatory B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Studies B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
actions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
platelet-activating B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
centered B-O B-VP_VBN
mainly B-O B-PP_RB
around B-O B-IN
neutrophils B-O B-NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
monocytes B-O B-NP_NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
platelets B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
begin B-O B-VP_VBP
to B-O B-S_NP_VP_TO
uncover B-O B-VP_VB
the B-O B-NP_NP_DT
influence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
platelet-activating B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
B B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Employing B-O B-S_S_NP_VP_VBG
the B-O B-NP_DT
EBV-transformed B-O B-JJ
human B-O B-JJ
B B-O B-NN
cell B-O B-NN
line B-O B-NN
SKW6.4 B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
platelet-activating B-O B-S_NP_JJ
factor B-O B-NN
" " B-O O-NP
significantly B-O B-ADVP_RB
" " B-O O-ADVP
alters B-O B-VP_VBZ
membrane B-O B-NP_NP_NN
phospholipid B-O B-JJ
metabolism B-O B-NN
" " B-O O-NP
indicated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_PP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
inactive B-O B-JJ
precursor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
lyso-platelet-activating B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
at B-O B-PP_IN
a B-O B-NP_NP_DT
concentration B-O B-NN
" " B-O O-NP
as B-O B-ADJP_ADJP_RB
high B-O B-JJ
" " B-O O-ADJP
as B-O B-PP_IN
10(-7) B-O B-NP_CD
M B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
any B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
membrane B-O B-NN
phospholipids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
show B-O B-VP_VBP
that B-O B-SBAR_IN
platelet-activating B-O B-S_S_NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
10(-12) B-O B-NP_QP_CD
to B-O B-TO
10(-6) B-O B-CD
" " B-O O-QP
M B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induced B-O B-VP_VBD
and B-O B-NP_NP_ADJP_ADJP_CC
elevation B-O B-ADJP_NN
" " B-O O-NP
in B-O B-PP_IN
intracellular B-O B-NP_JJ
calcium B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
lyso-platelet-activating B-O B-S_NP_JJ
factor B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
again B-O B-ADVP_RB
" " B-O O-ADVP
ineffective B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
the B-O B-NP_NP_DT
impact B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
platelet-activating B-O B-NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
measuring B-O B-S_NP_VP_VBG
platelet-activating B-O B-NP_NP_ADJP_NP_JJ
factor B-O B-NN
" " B-O O-NP
induced B-O B-JJ
" " B-O O-ADJP
arachidonic B-O B-JJ
acid B-O B-NN
release B-O B-NN
" " B-O O-NP
and B-O B-CC
5-hydroxyeicosatetraenoic B-O B-NP_JJ
acid B-O B-NN
production B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
platelet-activating B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
capable B-O B-ADJP_JJ
of B-O B-PP_IN
inducing B-O B-S_NP_VP_VBG
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
nuclear B-O B-JJ
proto-oncogenes B-O B-NNS
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
explored B-O B-VP_VBD
the B-O B-NP_NP_DT
possible B-O B-JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
5-hydroxyeicosatetraenoic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_NP_DT
regulator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
arachidonic B-O B-NP_JJ
acid B-O B-NN
liberation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
endogenous B-O B-S_NP_JJ
5-lipoxygenase B-O B-NN
activity B-O B-NN
" " B-O O-NP
modulates B-O B-VP_VBZ
induced B-O B-NP_ADJP_NP_JJ
" " B-O O-ADJP
arachidonic B-O B-JJ
acid B-O B-NN
release B-O B-NN
" " B-O O-NP
perhaps B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
acting B-O B-VP_VBG
" " B-O B-PP_O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
summary B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
platelet-activating B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
shown B-O B-VP_VBN
here B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
a B-O B-NP_DT
direct B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
profound B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
a B-O B-NP_DT
pure B-O B-JJ
B B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Vitamin B-O B-NP_NP_NN
D B-O B-NN
receptor B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Signal B-O B-NP_NP_NP_NN
requirements B-O B-NNS
" " B-O O-NP
and B-O B-CC
characterization B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
by B-O B-PP_IN
western B-O B-NP_NP_NN
blots B-O B-NNS
" " B-O O-NP
and B-O B-CC
DNA B-O B-NP_NN
sequencing B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_NP_DT
signals B-O B-NNS
" " B-O O-NP
controlling B-O B-VP_VBG
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
receptor B-O B-NN
protein B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
1 B-O B-NP_CD
alpha,25-dihydroxyvitamin B-O B-NN
D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
normal B-O B-NP_JJ
human B-O B-JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
relationship B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
classical B-O B-JJ
vitamin B-O B-NN
D B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Lymphocytes B-O B-S_NP_NP_NNS
" " B-O O-NP
activated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
OKT3 B-O B-NN
antibody B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
T-cell B-O B-NN
antigen B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
expressed B-O B-VP_VBD
fewer B-O B-NP_JJR
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
as B-O B-SBAR_IN
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
combination B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
OKT3 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
phorbol B-O B-NP_NN
myristate B-O B-NN
acetate B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
produced B-O B-VP_VBD
a B-O B-NP_NP_DT
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
binding B-O B-NP_VBG
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_DT
PHA-activated B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
receptor B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
OKT3 B-O B-NP_ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
OKT3 B-O B-ADJP_NN
+ B-O B-CC
phorbol B-O B-NN
myristate B-O B-NN
acetate-activated B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
exhibited B-O B-VP_VBD
decreased B-O B-NP_NP_VBN
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
DNA-cellulose B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
PHA-activated B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_PP_IN
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
activated B-O B-VP_VBN
either B-O B-NP_PP_CC
by B-O B-IN
PHA B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
OKT3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
( B-O B-LRB
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
resting B-O B-NP_VBG
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
) B-O B-RRB
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_NP_DT
50-kDa B-O B-JJ
species B-O B-NNS
" " B-O O-NP
cross-reacting B-O B-VP_VBG
with B-O B-PP_IN
a B-O B-NP_NP_DT
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
against B-O B-PP_IN
the B-O B-NP_DT
intestinal B-O B-JJ
vitamin B-O B-NN
D B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
RNA B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
activated B-O B-NP_VBN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
amplified B-O B-VP_VBN
by B-O B-NP_PP_IN
polymerase B-O B-NP_NN
chain B-O B-NN
reaction B-O B-NN
" " B-O O-NP
" " B-O O-PP
using B-O B-S_NP_VP_VBG
oligonucleotide B-O B-NP_NP_NN
primers B-O B-NNS
" " B-O O-NP
flanking B-O B-VP_VBG
the B-O B-NP_NP_DT
196 B-O B-CD
base B-O B-NN
pair B-O B-NN
long B-O B-JJ
region B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
amplified B-O B-VBN
product B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
an B-O B-NP_NP_DT
identical B-O B-JJ
nucleotide B-O B-NN
sequence B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
DNA-binding B-O B-JJ
domain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
intestinal B-O B-JJ
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
1,25-(OH)2D3 B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
triggered B-O B-VP_VBN
by B-O B-NP_PP_IN
signals B-O B-NP_ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
protein B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
encoding B-O B-VP_VBG
it B-O B-NP_PRP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
identical B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_DT
classical B-O B-JJ
vitamin B-O B-NN
D B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-PRN_PRN_LRB
Estrogen B-O B-NP_NP_NN
receptor B-O B-NN
content B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
systemic B-O B-NP_JJ
lupus B-O B-NN
erythematosus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-PRN
  
ER B-O B-S_S_NP_NP_NN
content B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
determined B-O B-VP_VBN
by B-O B-NP_PP_IN
dextran-coated B-O B-NP_JJ
charcoal B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
ER B-O B-S_NP_NP_NN
content B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
each B-O B-NP_DT
sample B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
expressed B-O B-VP_VBN
by B-O B-NP_PP_IN
both B-O B-NP_CC
fmol/mg B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
lymphocyte B-O B-NP_NN
cytosolic B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
fmol/micrograms B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
lymphocyte B-O B-NP_NN
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
there B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_DT
significant B-O B-JJ
difference B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_NP_DT
ER B-O B-NN
content B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
that B-O B-NP_NP_DT
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
But B-O B-S_CC
the B-O B-NP_NP_NP_DT
logarithmic B-O B-JJ
mean B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ER B-O B-NP_NP_NN
content B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
expressed B-O B-VP_VBN
by B-O B-NP_PP_IN
fmol/mg B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cytosolic B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
in B-O B-PP_IN
14 B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
active B-O B-NP_NP_JJ
SLE B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
0.9356 B-O B-NP_CD
+/- B-O B-CC
0.31 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADJP_ADJP_RB
higher B-O B-JJR
" " B-O O-ADJP
than B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
in B-O B-PP_PP_IN
13 B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
the B-O B-NP_NP_DT
controls B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
normal B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
upper B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
limit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ER B-O B-NP_NP_NN
content B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
expressed B-O B-VP_VBN
by B-O B-NP_PP_IN
fmol/micrograms B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
0.136 B-O B-NP_CD
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
elevated B-O B-JJ
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ER B-O B-NP_NP_NN
content B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
14 B-O B-NP_NP_CD
active B-O B-JJ
SLE B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
higher B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
in B-O B-PP_PP_IN
patients B-O B-NP_NP_ADJP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
the B-O B-NP_NP_DT
controls B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
elevated B-O B-JJ
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ER B-O B-NP_NN
content B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
related B-O B-ADJP_JJ
to B-O B-PP_TO
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Role B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
Epstein-Barr B-O B-JJ
virus B-O B-NN
nuclear B-O B-JJ
antigen B-O B-NN
2 B-O B-CD
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
viral B-O B-NP_NP_JJ
promoter B-O B-NN
switching B-O B-VBG
" " B-O O-NP
during B-O B-PP_IN
initial B-O B-NP_NP_JJ
stages B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
infection B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
During B-O B-S_PP_IN
latent B-O B-NP_NP_JJ
Epstein-Barr B-O B-NP_NP_JJ
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EBV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
six B-O B-NP_NP_CD
viral B-O B-JJ
nuclear B-O B-JJ
antigen B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EBNAs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
are B-O B-VP_VBP
expressed B-O B-VP_VBN
from B-O B-NP_PP_IN
long B-O B-NP_JJ
primary B-O B-JJ
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
means B-O B-NNS
of B-O B-IN
alternative B-O B-NP_NP_JJ
splicing B-O B-NN
" " B-O O-NP
and B-O B-CC
alternative B-O B-NP_JJ
polyadenylylation B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
transcripts B-O B-NNS
" " B-O O-NP
initiate B-O B-VP_VBP
from B-O B-PP_IN
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_NP_NP_CD
promoters B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
Cp B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
Wp B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
function B-O B-S_NP_VP_VBP
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Wp B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
exclusively B-O B-ADVP_RB
" " B-O O-ADVP
utilized B-O B-VP_VBN
during B-O B-NP_PP_IN
the B-O B-NP_NP_DT
initial B-O B-JJ
stages B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
infection B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
primary B-O B-NP_JJ
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
followed B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
switch B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
Cp B-O B-NP_NN
usage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
extended B-O B-VP_VBN
to B-O B-S_NP_VP_TO
show B-O B-VP_VB
that B-O B-SBAR_IN
; B-O B-S_S_COLON
; B-O B-S_COLON
; B-O B-S_COLON
and B-O B-CC
" " B-O B-S_O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
support B-O B-VP_VBP
a B-O B-NP_NP_DT
model B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
viral B-O B-NP_NP_JJ
promoter B-O B-NN
switching B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
the B-O B-NP_NP_DT
initial B-O B-JJ
stages B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
infection B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
Wp B-O B-S_NP_NN
activity B-O B-NN
" " B-O O-NP
leads B-O B-VP_VBZ
, B-O B-PP_PP_COMMA
" " B-O B-S_O-S
" " B-O O-SBAR
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
phosphatases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
okadaic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
AP1 B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
examine B-O B-VP_VB
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
phosphatases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
Jurkat B-O B-S_S_NP_NN
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
treated B-O B-VP_VBN
with B-O B-NP_PP_IN
okadaic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
nuclear B-O B-S_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_NP_DT
measure B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
early B-O B-NP_JJ
T B-O B-NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Okadaic B-O B-S_NP_JJ
acid B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
a B-O B-NP_NP_DT
potent B-O B-JJ
inducer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NN
to B-O B-TO
phorbol B-O B-NP_NP_NN
esters B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
phorbol B-O B-NP_NP_NN
myristate B-O B-NN
acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
okadaic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurs B-O B-VP_VBZ
predominantly B-O B-PP_RB
by B-O B-IN
transcriptional B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
jun B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
proto-oncogenes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Surprisingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
while B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
phytohemagglutinin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VBD
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibited B-O B-VP_VBD
it B-O B-NP_PRP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Okadaic B-O B-S_NP_JJ
acid B-O B-NN
treatment B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
dramatically B-O B-ADVP_RB
" " B-O O-ADVP
increase B-O B-VP_VP_VB
mRNA B-O B-NP_NP_NN
transcripts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
and B-O B-CC
to B-O B-VP_PP_TO
a B-O B-NP_DT
lesser B-O B-JJR
extent B-O B-NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
fos B-O B-NN
family B-O B-NN
" " B-O O-NP
including B-O B-PP_VBG
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
comparison B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
PMA B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
very B-O B-ADJP_RB
inefficient B-O B-JJ
" " B-O O-ADJP
inducer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
jun B-O B-NN
gene B-O B-NN
family B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_S_NP_ADJP_JJ
to B-O B-PP_TO
its B-O B-NP_NP_PRPP
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
okadaic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
, B-O B-COMMA
PMA B-O B-NP_NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
okadaic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transfection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
promoter B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
confirmed B-O B-VP_VBD
the B-O B-NP_NP_DT
marked B-O B-JJ
difference B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
PMA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
okadaic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
inducing B-O B-S_NP_VP_VBG
c-jun B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
okadaic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
protein B-O B-S_NP_NP_NN
phosphatases B-O B-NNS
1 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
2A B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
PP1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
PP2A B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Differentiation-associated B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Epstein-Barr B-O B-JJ
virus B-O B-NN
BZLF1 B-O B-NN
transactivator B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
oral B-O B-NP_JJ
hairy B-O B-JJ
leukoplakia B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
BZLF1 B-O B-NN
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Epstein-Barr B-O B-NP_NP_JJ
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EBV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
key B-O B-JJ
immediate-early B-O B-JJ
protein B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
has B-O B-S_NP_VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
" " B-O B-S_NP_VP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
generated B-O B-VP_VBN
a B-O B-NP_NP_NP_DT
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
, B-O B-COMMA
BZ1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
to B-O B-PP_TO
BZLF1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_SBAR_WHNP_WDT
" " B-O O-WHNP
reacts B-O B-S_NP_VP_VBZ
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
recognizes B-O B-S_NP_VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Biopsies B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
oral B-O B-NP_NP_JJ
hairy B-O B-JJ
leukoplakia B-O B-NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
AIDS-associated B-O B-JJ
lesion B-O B-NN
" " B-O O-NP
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
high-level B-O B-NP_JJ
EBV B-O B-NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
by B-O B-NP_PP_IN
immunohistochemistry B-O B-NP_NP_NN
" " B-O O-NP
using B-O B-VP_VBG
the B-O B-NP_DT
BZ1 B-O B-NN
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
differentiation-associated B-O B-JJ
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
BZLF1 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
, B-O B-NP_COMMA
BZ1 B-O B-S_NP_NN
" " B-O O-NP
reacting B-O B-VP_VBG
with B-O B-PP_IN
nuclei B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
finding B-O B-NN
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_DT
BZLF1 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
comparison B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_NP_NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
EBV B-O B-NP_NN
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
viral B-O B-NP_JJ
capsid B-O B-NN
antigen B-O B-NN
staining B-O B-VBG
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
BZ1 B-O B-NP_NN
reactivity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
BZLF1 B-O B-S_NP_NN
expression B-O B-NN
" " B-O O-NP
precedes B-O B-VP_VBZ
rampant B-O B-NP_JJ
virus B-O B-NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
inability B-O B-NN
to B-O B-S_NP_VP_TO
detect B-O B-VP_VB
EBV B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
lower B-O B-RBR
epithelial B-O B-JJ
layers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
raises B-O B-VP_VBZ
questions B-O B-NP_NP_NNS
" " B-O O-NP
concerning B-O B-PP_VBG
the B-O B-NP_NP_DT
nature B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
EBV B-O B-NP_NP_NN
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
in B-O B-PP_IN
stratified B-O B-NP_JJ
squamous B-O B-JJ
epithelium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transactivation B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
human B-O B-NP_NP_NP_NP_JJ
herpesvirus B-O B-NN
6 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HHV-6 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
strains B-O B-VBZ
" " B-O O-NP
GS B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Z-29 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
primary B-O B-NP_JJ
human B-O B-JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
identification B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transactivating B-O B-NP_VBG
HHV-6 B-O B-NN
( B-O B-LRB
GS B-O B-NN
) B-O B-RRB
gene B-O B-NN
fragments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
Human B-O B-S_NP_NP_JJ
herpesvirus B-O B-NN
6 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HHV-6 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
can B-O B-VP_MD
activate B-O B-VP_VP_VP_VB
the B-O B-NP_DT
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
promoter B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
accelerate B-O B-VP_VB
cytopathic B-O B-NP_JJ
effects B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
in B-O B-PP_IN
HIV-infected B-O B-NP_JJ
human B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
study B-O B-NN
" " B-O O-NP
examines B-O B-VP_VBZ
the B-O B-NP_NP_DT
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
HHV-6 B-O B-NP_NP_NN
transactivation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
heterogeneous B-O B-JJ
population B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
with B-O B-PP_PP_PP_IN
" " B-O B-NP_O-PP
or B-O B-CC
without B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-PP
antigenic B-O B-NP_JJ
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_NP_CD
different B-O B-JJ
strains B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HHV-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
GS B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Z29 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
transactivated B-O B-VP_VBD
the B-O B-NP_DT
HIV B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
GS B-O B-NN
strain B-O B-NN
" " B-O O-NP
transactivated B-O B-VP_VBD
the B-O B-NP_DT
promoter B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_ADJP_CC
stimulated B-O B-ADJP_VBN
" " B-O O-ADJP
and B-O B-CC
resting B-O B-ADJP_VBG
" " B-O O-ADJP
" " B-O O-ADJP
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
while B-O B-SBAR_IN
the B-O B-S_NP_DT
Z29 B-O B-NN
strain B-O B-NN
" " B-O O-NP
increased B-O B-VP_VBD
HIV B-O B-NP_NN
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
only B-O B-PP_RB
in B-O B-IN
stimulated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Three B-O B-S_NP_NP_CD
DNA B-O B-NN
clones B-O B-NNS
" " B-O O-NP
containing B-O B-VP_VBG
HHV-6 B-O B-NP_NN
( B-O B-LRB
GS B-O B-NN
) B-O B-RRB
genomic B-O B-JJ
fragments B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
transactivated B-O B-VP_VBD
the B-O B-NP_NP_DT
HIV B-O B-NN
promoter B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cotransfected B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
21.4-kb B-O B-JJ
DNA B-O B-NN
clone B-O B-NN
" " B-O O-NP
, B-O B-COMMA
pZVB70 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
showed B-O B-VP_VBD
the B-O B-NP_DT
highest B-O B-JJS
transactivating B-O B-NN
ability B-O B-NN
" " B-O O-NP
, B-O B-COMMA
while B-O B-SBAR_IN
two B-O B-S_NP_NP_CD
other B-O B-JJ
DNA B-O B-NN
fragments B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
pZVB10 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
6.2 B-O B-NP_CD
kb B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
pZVH14 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
8.7 B-O B-NP_CD
kb B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
showed B-O B-VP_VBD
lower B-O B-NP_JJR
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
clones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
pZVH14 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
activated B-O B-VP_VBD
the B-O B-NP_NP_DT
HIV B-O B-NN
promoter B-O B-NN
construct B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
a B-O B-NP_DT
mutation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
NF B-O B-NN
kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
this B-O B-NP_DT
mutated B-O B-VBN
NF B-O B-NN
kappa B-O B-NN
B B-O B-NN
promoter B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
transactivated B-O B-VP_VBN
during B-O B-NP_PP_PP_IN
HHV-6 B-O B-NP_NN
( B-O B-LRB
GS B-O B-NN
) B-O B-RRB
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
after B-O B-PP_IN
cotransfection B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
pZVB70 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
pZVB10 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
NF B-O B-NN
kappa B-O B-NN
B B-O B-NN
sites B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
essential B-O B-ADJP_JJ
for B-O B-PP_IN
its B-O B-NP_NP_PRPP
transactivation B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
increasing B-O B-S_NP_VP_VBG
HIV B-O B-NP_NP_NN
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
primary B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
HHV-6 B-O B-NP_NN
" " B-O O-NP
may B-O B-VP_MD
consequently B-O B-ADVP_RB
" " B-O O-ADVP
increase B-O B-VP_VB
HIV B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
, B-O B-COMMA
leading B-O B-S_NP_VP_VBG
to B-O B-PP_TO
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Glucocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
systemic B-O B-NP_JJ
lupus B-O B-NN
erythematosus B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Glucocorticosteroids B-O B-S_S_S_NP_NNS
" " B-O O-NP
remain B-O B-VP_VBP
the B-O B-NP_NP_DT
major B-O B-JJ
treatment B-O B-NN
modality B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
systemic B-O B-NP_NP_JJ
lupus B-O B-NN
erythematosus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
SLE B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
their B-O B-S_NP_NP_PRPP
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
unclear B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Over B-O B-S_PP_IN
the B-O B-NP_DT
past B-O B-JJ
decade B-O B-NN
" " B-O O-NP
" " B-O O-PP
it B-O B-NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
has B-O B-VP_VBZ
become B-O B-VP_VBN
clear B-O B-ADJP_JJ
" " B-O O-ADJP
that B-O B-SBAR_IN
glucocorticosteroid B-O B-S_NP_NN
receptors B-O B-NNS
" " B-O O-NP
play B-O B-VP_VBP
a B-O B-NP_DT
significant B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
glucocorticosteroid B-O B-NP_NP_NN
receptor B-O B-NN
density B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
affinity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
the B-O B-NP_DT
glucocorticosteroid B-O B-NN
binding B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
33 B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
SLE B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
who B-O B-SBAR_WHNP_WP
" " B-O O-WHNP
had B-O B-S_NP_VP_VBD
taken B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
32 B-O B-NP_CD
healthy B-O B-JJ
controls B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Patients B-O B-S_NP_NP_NNS
' B-O B-POS
" " B-O O-NP
disease B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
measured B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
SLE B-O B-NN
Disease B-O B-NN
Activity B-O B-NN
Index B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
SLEDAI B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Glucocorticosteroid B-O B-S_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
leukocytes B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
SLE B-O B-NN
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
significantly B-O B-ADJP_ADJP_ADJP_RB
higher B-O B-JJR
" " B-O O-ADJP
than B-O B-PP_IN
in B-O B-FRAG_PP_IN
healthy B-O B-NP_JJ
controls B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
" " B-O O-ADJP
( B-O B-PRN_LRB
4419 B-O B-FRAG_NP_NP_QP_CD
+/- B-O B-CC
306 B-O B-CD
" " B-O O-QP
" " B-O O-NP
vs B-O B-CC
3369 B-O B-NP_QP_CD
+/- B-O B-CC
196 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-NP
" " B-O O-FRAG
, B-O B-COMMA
p B-O B-S_NP_NN
" " B-O O-NP
less B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
0.005 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
binding B-O B-NN
affinity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
different B-O B-ADJP_JJ
" " B-O O-ADJP
between B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
controls B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_DT
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
glucocorticosteroid B-O B-NP_NP_NN
receptor B-O B-NN
number B-O B-NN
" " B-O O-NP
and B-O B-CC
SLE B-O B-NP_NN
disease B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-NP_LRB
Changes B-O B-NP_NNS
" " B-O O-NP
in B-O B-PP_IN
leucocytic B-O B-NP_NP_JJ
estrogen B-O B-NN
receptor B-O B-NN
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
gynecomastia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
] B-O B-RRB
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
estrogen B-O B-NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ER B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
peripheral B-O B-JJ
leucocytes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
13 B-O B-NP_NP_CD
men B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
measured B-O B-VP_VBN
by B-O B-NP_PP_IN
radioligand B-O B-NP_NN
binding B-O B-NN
method B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
compared B-O B-VP_VBN
with B-O B-NP_PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
13 B-O B-NP_CD
sex- B-O B-ADJP_NN
and B-O B-CC
age-matched B-O B-JJ
" " B-O O-ADJP
healthy B-O B-JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ER B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBN
in B-O B-NP_PP_IN
gynecomastia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
) B-O B-S_NP_VP_RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
increase B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ER B-O B-NP_NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
play B-O B-VP_VBP
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
pathogenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gynecomastia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-NP_LRB
Changes B-O B-NP_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
levels B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
leucocytic B-O B-NP_NP_JJ
estrogen B-O B-NN
receptor B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
its B-O B-NP_PRPP
significance B-O B-NN
" " B-O O-NP
" " B-O O-NP
] B-O B-RRB
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
estrogen B-O B-NP_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
ER B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
peripheral B-O B-JJ
leucocytes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
12 B-O B-NP_NP_CD
women B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
measured B-O B-VP_VBN
with B-O B-NP_PP_IN
radio-ligand B-O B-NP_JJ
binding B-O B-NN
method B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
compared B-O B-VP_VBN
with B-O B-NP_PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
12 B-O B-NP_NP_NP_CD
menopausal B-O B-JJ
women B-O B-NNS
" " B-O O-NP
without B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
12 B-O B-NP_NP_CD
normal B-O B-JJ
women B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ER B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
decreased B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
data B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
decrease B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ER B-O B-NP_NP_NN
level B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
leukocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
related B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
M-CSF B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
M-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
role B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
and B-O B-CC
transcription B-O B-NP_NN
factor B-O B-NN
NF B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Macrophage-colony-stimulating B-O B-S_NP_NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
M-CSF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
referred B-O B-VBN
to B-O B-PP_TO
" " B-O B-NP_O-PP
as B-O B-PP_IN
CSF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
regulates B-O B-VP_VBZ
the B-O B-NP_NP_DT
survival B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
growth B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
differentiation B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
functional B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
binding B-O B-S_NP_VP_VBG
to B-O B-PP_TO
a B-O B-NP_NP_NP_DT
single B-O B-JJ
class B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
known B-O B-VP_VBN
" " B-O B-S_NP_VP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
detection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_NP_NP_CC
M-CSF B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
c-fms B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
monocyte B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
suggested B-O B-VP_VBN
that B-O B-SBAR_IN
M-CSF B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
act B-O B-VP_VB
by B-O B-PP_IN
an B-O B-NP_DT
autocrine B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
that B-O B-SBAR_IN
M-CSF B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
induce B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
sensitivity B-O B-S_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
M-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
modulated B-O B-VP_VBN
by B-O B-NP_PP_IN
regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
M-CSF B-O B-NP_NN
responsiveness B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
largely B-O B-ADVP_RB
" " B-O O-ADVP
determined B-O B-VP_VBN
at B-O B-NP_PP_IN
a B-O B-NP_DT
postreceptor B-O B-NN
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_PP_TO
date B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
little B-O B-NP_JJ
" " B-O O-NP
is B-O B-VP_VBZ
known B-O B-VP_VBN
about B-O B-NP_PP_IN
the B-O B-NP_NP_DT
intracellular B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
M-CSF B-O B-NP_NN
signal B-O B-NN
transduction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
investigated B-O B-VP_VBN
the B-O B-NP_NP_DT
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
protein B-O B-NP_NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PKC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_IN
exposure B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
M-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
M-CSF B-O B-S_NP_NN
" " B-O O-NP
activates B-O B-VP_VP_VP_VBZ
" " B-O B-NP_O-VP
and B-O B-CC
translocates B-O B-VP_VBZ
" " B-O B-NP_O-VP
" " B-O O-VP
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
isoquinoline B-O B-NN
derivative B-O B-JJ
H7 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
abolishes B-O B-VP_VBZ
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
M-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
M-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VP_VBD
pertussis-toxin-sensitive B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
was B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
detection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
NF B-O B-NN
kappa B-O B-NN
B B-O B-NN
protein B-O B-NN
" " B-O O-NP
but B-O B-PP_PP_CC
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
M-CSF B-O B-S_NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
M-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involves B-O B-VP_VBZ
G B-O B-NP_NP_NN
proteins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
PKC B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
effects B-O B-NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
Cushing B-O B-NP_NP_NP_NN
's B-O B-POS
" " B-O O-NP
disease B-O B-NN
" " B-O O-NP
and B-O B-CC
ketoconazole B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Glucocorticoid B-O B-S_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
GcR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
were B-O B-VP_VBD
determined B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
whole B-O B-JJ
cell B-O B-NN
assay B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_NP_NP_JJ
mononulear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
from B-O B-PP_IN
, B-O B-NP_NP_COMMA
and B-O B-NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Prolonged B-O B-S_NP_JJ
corticosteroid B-O B-NN
treatment B-O B-NN
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
down-regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
GcR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
while B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
mean B-O B-NN
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GcR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Cushing B-O B-NP_NP_NN
's B-O B-POS
" " B-O O-NP
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
normal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
receptor B-O B-NP_NP_NN
levels B-O B-NNS
" " B-O O-NP
and B-O B-CC
morning B-O B-NP_NN
plasma B-O B-NN
cortisol B-O B-NN
values B-O B-NNS
" " B-O O-NP
" " B-O O-NP
showed B-O B-VP_VBD
a B-O B-NP_DT
negative B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
a B-O B-NP_DT
subtle B-O B-JJ
down-regulatory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
GcR B-O B-NP_NN
" " B-O O-NP
were B-O B-VP_VBD
unaltered B-O B-ADJP_JJ
" " B-O O-ADJP
after B-O B-SBAR_IN
these B-O B-S_NP_DT
patients B-O B-NNS
" " B-O O-NP
received B-O B-VP_VBD
ketoconazole B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
in B-O B-PP_IN
spite B-O B-NN
of B-O B-IN
a B-O B-NP_NP_DT
marked B-O B-JJ
reduction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
morning B-O B-NP_NP_NN
plasma B-O B-NN
cortisol B-O B-NN
" " B-O O-NP
and B-O B-CC
urinary B-O B-NP_ADJP_JJ
free B-O B-JJ
" " B-O O-ADJP
cortisol B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBD
that B-O B-SBAR_IN
ketoconazole B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_NP_DT
weak B-O B-JJ
competitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GcR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
intact B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
although B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
significantly B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
[3H] B-O B-NP_NN
dexamethasone B-O B-NN
binding B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
GcR B-O B-S_S_NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
hMNL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
down-regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
they B-O B-S_NP_PRP
" " B-O O-NP
showed B-O B-VP_VBD
very B-O B-NP_ADJP_RB
mild B-O B-JJ
" " B-O O-ADJP
down-regulation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
hypercortisolemic B-O B-NP_NP_JJ
patients B-O B-NNS
" " B-O O-NP
suffering B-O B-VP_VBG
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
observed B-O B-VP_VBN
either B-O B-NP_NP_CC
up-regulation B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
antagonism B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
GcR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
ketoconazole B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
at B-O B-PP_IN
the B-O B-NP_NP_DT
time B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHADVP_IN
" " B-O O-WHADVP
cortisol B-O B-S_NP_NP_NN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
were B-O B-VP_VBD
reduced B-O B-VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
indicates B-O B-VP_VBZ
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_NP_DT
beneficial B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
ketoconazole B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Cushing B-O B-NP_NP_NN
's B-O B-POS
" " B-O O-NP
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
due B-O B-PP_JJ
to B-O B-PP_PP_TO
and B-O B-NP_CC
not B-O B-PP_RB
to B-O B-TO
" " B-O B-NP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
process B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GcR B-O B-NP_NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
hMNL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
complex B-O B-JJ
phenomenon B-O B-NN
" " B-O O-NP
awaiting B-O B-VP_VBG
further B-O B-NP_RBR
elucidation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Glucocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
anorexia B-O B-NP_NN
nervosa B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
OBJECTIVE B-O B-NP_NP_NP_NN
: B-O B-COLON
" " B-O O-NP
The B-O B-S_NP_DT
aim B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
to B-O B-S_NP_VP_TO
explore B-O B-VP_VB
the B-O B-NP_NP_DT
down-regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
during B-O B-NP_PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
" " B-O O-NP
  
DESIGN B-O B-NP_NP_NN
: B-O B-COLON
" " B-O O-NP
Urine B-O B-S_S_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
plasma B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
samples B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
obtained B-O B-VP_VBN
for B-O B-NP_PP_IN
cortisol B-O B-NP_NN
determination B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
blood B-O B-S_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
isolated B-O B-VP_VBN
for B-O B-NP_PP_IN
receptor B-O B-NP_NN
binding B-O B-NN
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
PATIENTS B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
Sixteen B-O B-S_NP_NP_NP_CD
anorexic B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
aged B-O B-ADJP_JJ
16-27 B-O B-NP_QP_CD
" " B-O O-QP
years B-O B-NNS
" " B-O O-NP
" " B-O O-ADJP
, B-O B-COMMA
with B-O B-PP_IN
a B-O B-NP_NP_DT
mean B-O B-NN
+/- B-O B-CC
SEM B-O B-NN
body B-O B-NN
mass B-O B-NN
index B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
14.2 B-O B-NP_CD
+/- B-O B-CC
2.0 B-O B-CD
" " B-O O-NP
" " B-O O-PP
( B-O B-LRB
ranging B-O B-VP_VBG
from B-O B-PP_PP_IN
to B-O B-NP_PP_TO
" " B-O B-NP_O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
and B-O B-CC
15 B-O B-NP_CD
normal B-O B-JJ
women B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
Six B-O B-S_NP_CD
patients B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
reinvestigated B-O B-VP_VBN
after B-O B-NP_PP_IN
a B-O B-NP_DT
significant B-O B-JJ
weight B-O B-NN
gain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
MEASUREMENTS B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
The B-O B-S_NP_NP_DT
binding B-O B-NP_NN
capacity B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
affinity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
measured B-O B-VP_VBN
with B-O B-NP_PP_IN
dexamethasone B-O B-NP_NP_NN
" " B-O O-NP
as B-O B-PP_IN
ligand B-O B-NP_NP_NN
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
RESULTS B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
In B-O B-S_PP_IN
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
both B-O B-NP_ADJP_DT
total B-O B-ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
free B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
plasma B-O B-NN
cortisol B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
higher B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
in B-O B-FRAG_PP_IN
the B-O B-NP_DT
normal B-O B-JJ
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
as B-O B-SBAR_IN
was B-O B-SINV_VBD
their B-O B-NP_PRPP
urinary B-O B-JJ
free B-O B-JJ
cortisol B-O B-NN
" " B-O O-NP
" " B-O B-ADJP_O-SINV
" " B-O O-SBAR
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
the B-O B-S_NP_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
per B-O B-PP_IN
cell B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
Ro B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_NP_DT
binding B-O B-NN
affinity B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Kd B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
for B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
not B-O B-ADJP_ADVP_RB
significantly B-O B-RB
" " B-O O-ADVP
different B-O B-JJ
( B-O B-PRN_LRB
Ro B-O B-NP_NP_NP_NN
" " B-O O-NP
: B-O B-COLON
7687 B-O B-NP_QP_CD
+/- B-O B-CC
1750 B-O B-CD
vs B-O B-CC
7347 B-O B-CD
+/- B-O B-CC
1285 B-O B-CD
" " B-O O-QP
sites/cell B-O B-NN
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
Kd B-O B-NP_NP_NN
" " B-O O-NP
: B-O B-COLON
nM B-O B-NP_NP_QP_NN
" " B-O O-NP
at B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
After B-O B-S_S_PP_IN
weight B-O B-NP_NP_NN
gain B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
14 B-O B-NP_QP_CD
+/- B-O B-CC
2 B-O B-CD
to B-O B-TO
16 B-O B-CD
+/- B-O B-CC
2 B-O B-CD
" " B-O O-QP
kg/m2 B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
receptor B-O B-NP_NN
numbers B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
8421 B-O B-NP_NP_NP_NP_QP_CD
+/- B-O B-CC
2126 B-O B-CD
" " B-O O-QP
( B-O B-NP_PRN_LRB
pre B-O B-FRAG_JJ
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
9011 B-O B-NP_QP_CD
+/- B-O B-CC
500 B-O B-CD
" " B-O O-QP
( B-O B-NP_PRN_LRB
post B-O B-FRAG_JJ
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
sites/cell B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
not B-O B-RB
significantly B-O B-ADJP_RB
different B-O B-JJ
( B-O B-PRN_LRB
) B-O B-S_RRB
" " B-O O-PRN
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
the B-O B-S_NP_DT
Kd B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
unchanged B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
9.3 B-O B-NP_QP_CD
+/- B-O B-CC
2.6 B-O B-CD
vs B-O B-CC
9.2 B-O B-CD
+/- B-O B-CC
2.4 B-O B-CD
" " B-O O-QP
nM B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
CONCLUSIONS B-O B-NP_NP_NNS
" " B-O O-NP
Hypercortisolaemia B-O B-S_S_NP_NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
down-regulate B-O B-VP_VB
the B-O B-NP_NP_DT
lymphocyte B-O B-NN
glucocorticoid B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
anorexia B-O B-NP_NN
nervosa B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
a B-O B-S_NP_DT
post-receptor B-O B-JJ
defect B-O B-NN
" " B-O O-NP
might B-O B-VP_MD
be B-O B-VP_VB
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
peripheral B-O B-NP_NP_JJ
tissue B-O B-NN
resistance B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
HIV1 B-O B-S_NP_NP_NN
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
promotes B-O B-VP_VBZ
induction B-O B-NP_NP_NP_NN
" " B-O O-NP
or B-O B-CC
translocation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
NF-KB-related B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
1991 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrated B-O B-VP_VBD
, B-O B-COMMA
using B-O B-S_NP_VP_VBG
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
that B-O B-SBAR_IN
3 B-O B-S_NP_NP_CD
different B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
( B-O B-LRB
termed B-O B-VP_VBN
B1 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
B2 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
B3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
) B-O B-RRB
with B-O B-PP_IN
affinity B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
KB-enhancer B-O B-JJ
target B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
specifically B-O B-ADVP_RB
" " B-O O-ADVP
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
B2 B-O B-NN
factor B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
nuclei B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
only B-O B-PP_RB
upon B-O B-IN
HIV1 B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
B3 B-O B-NN
factor B-O B-NN
" " B-O O-NP
was B-O B-VP_VP_VBD
only B-O B-ADJP_ADVP_RB
slightly B-O B-RB
" " B-O O-ADVP
evident B-O B-JJ
" " B-O O-ADJP
in B-O B-PP_IN
nuclei B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
uninfected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CC
was B-O B-VP_VBD
readily B-O B-ADJP_RB
detectable B-O B-JJ
" " B-O O-ADJP
in B-O B-PP_IN
nuclei B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
infected B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Its B-O B-S_NP_PRPP
expression B-O B-NN
" " B-O O-NP
remained B-O B-VP_VBD
very B-O B-ADJP_RB
low B-O B-JJ
in B-O B-PP_IN
nuclei B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
HIV1-infected B-O B-NP_JJ
macrophages B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
paper B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
B2 B-O B-NN
factor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
cytosol B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_DT
DNA-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
factor B-O B-NN
" " B-O O-NP
remained B-O B-VP_VP_VBD
clustered B-O B-ADJP_VBN
in B-O B-PP_IN
the B-O B-NP_DT
cytosol B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
was B-O B-VP_VBD
translocated B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
nuclei B-O B-NNS
" " B-O O-NP
" " B-O O-PP
only B-O B-PP_RB
after B-O B-IN
HIV1 B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
B3 B-O B-NN
factor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
cytosol B-O B-NN
" " B-O O-NP
" " B-O O-PP
only B-O B-SBAR_RB
when B-O B-WHADVP_WRB
" " B-O O-WHADVP
cells B-O B-S_NP_NNS
" " B-O O-NP
are B-O B-VP_VBP
HIV1-infected B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV1 B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
translocation B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
discussed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
monocyte B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HIV-gene B-O B-NP_JJ
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cells B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
monocyte-macrophage B-O B-JJ
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
important B-O B-NP_NP_JJ
targets B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
phenotypic B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
monocyte B-O B-NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
phorbol B-O B-NP_NP_NN
esters B-O B-NNS
" " B-O O-NP
or B-O B-CC
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
parallel B-O B-NN
with B-O B-IN
such B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
HIV B-O B-NP_NP_NN
transcription B-O B-NN
" " B-O O-NP
, B-O B-COMMA
monitored B-O B-VP_VBN
using B-O B-NP_S_NP_VP_VBG
an B-O B-NP_DT
HIV B-O B-NN
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
reporter B-O B-NN
gene B-O B-NN
construct B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
activated B-O B-VP_VBN
in B-O B-NP_PP_IN
such B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
under B-O B-PP_IN
the B-O B-NP_NP_DT
influence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
enhanced B-O B-NP_VBN
NF-kappa B-O B-NN
B B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Also B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
a B-O B-NP_NP_DT
promonocyte B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
chronically B-O B-ADJP_RB
infected B-O B-VBN
with B-O B-PP_IN
HIV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
expression B-O B-NN
" " B-O O-NP
and B-O B-CC
HIV B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
enhanced B-O B-VP_VBN
on B-O B-NP_PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
phorbol B-O B-NP_NP_NN
ester B-O B-NN
" " B-O O-NP
or B-O B-CC
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
monocyte B-O B-NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
phorbol B-O B-NP_NP_NN
esters B-O B-NNS
" " B-O O-NP
or B-O B-CC
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VP_VBZ
cell B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
activates B-O B-VP_VBZ
HIV B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Such B-O B-S_NP_PDT
a B-O B-DT
process B-O B-NN
" " B-O O-NP
may B-O B-VP_VP_MD
have B-O B-VP_VB
fundamental B-O B-NP_JJ
implications B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
AIDS B-O B-NP_NN
pathogenesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
may B-O B-VP_MD
be B-O B-VP_VB
important B-O B-ADJP_JJ
in B-O B-PP_IN
disease B-O B-NP_NP_NN
progression B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
jun B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
jun B-O B-NP_NN
D B-O B-NN
" " B-O O-NP
" " B-O O-NP
proto-oncogenes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
peripheral-blood B-O B-JJ
granulocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
found B-O B-VP_VBN
that B-O B-SBAR_IN
purified B-O B-S_NP_VBN
human B-O B-JJ
peripheral-blood B-O B-JJ
granulocytes B-O B-NNS
" " B-O O-NP
express B-O B-VP_VBP
constitutively B-O B-NP_NP_ADJP_RB
significant B-O B-JJ
" " B-O O-ADJP
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
mRNA B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Upon B-O B-S_PP_IN
functional B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
granulocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
4 B-O B-NP_NP_CD
beta-phorbol B-O B-NN
12-myristate B-O B-NN
13-acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
jun B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
jun B-O B-NP_NN
D B-O B-NN
" " B-O O-NP
" " B-O O-NP
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
increased B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
three B-O B-CD
jun B-O B-NN
genes B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
a B-O B-NP_DT
similar B-O B-JJ
time B-O B-NN
course B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
their B-O B-NP_NP_PRPP
induction B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
maximal B-O B-S_NP_JJ
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
being B-O B-VP_VBG
reached B-O B-VP_VBN
after B-O B-NP_PP_IN
60 B-O B-NP_NP_CD
min B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
induction B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
jun B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
jun B-O B-NP_NN
D B-O B-NN
" " B-O O-NP
" " B-O O-NP
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
might B-O B-VP_MD
be B-O B-VP_VB
involved B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
or B-O B-NP_CC
in B-O B-PP_IN
" " B-O B-S_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_DT
study B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
circadian B-O B-JJ
rhythm B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Circadian B-O B-S_NP_NP_JJ
rhythm B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
rat B-O B-UCP_NP_NN
liver B-O B-NN
" " B-O O-NP
and B-O B-CC
human B-O B-ADJP_JJ
peripheral B-O B-JJ
" " B-O O-ADJP
" " B-O O-UCP
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
For B-O B-S_PP_IN
rats B-O B-NP_NP_NNS
" " B-O O-NP
exposed B-O B-VP_VBN
to B-O B-NP_PP_TO
a B-O B-NP_NP_DT
natural B-O B-ADJP_JJ
environmental B-O B-JJ
" " B-O O-ADJP
photic B-O B-JJ
cycle B-O B-NN
" " B-O O-NP
or B-O B-CC
a B-O B-NP_DT
12L B-O B-NN
: B-O B-COLON
12D B-O B-NN
artificial B-O B-JJ
light B-O B-NN
regime B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
peak B-O B-NP_NP_JJ
values B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
hepatic B-O B-NP_JJ
GR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
between B-O B-NP_PP_IN
23:00 B-O B-NP_QP_CD
and B-O B-CC
02:00 B-O B-CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Except B-O B-S_PP_IN
for B-O B-IN
a B-O B-NP_NP_DT
4-hour B-O B-JJ
advancement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
peak B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_NP_DT
similar B-O B-JJ
circadian B-O B-JJ
rhythm B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hepatic B-O B-NP_JJ
GR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
rats B-O B-NP_NP_NNS
" " B-O O-NP
reared B-O B-VP_VBN
under B-O B-NP_PP_IN
a B-O B-NP_NP_DT
reversed B-O B-VBN
lighting B-O B-NN
regimen B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
; B-O B-NP_COLON
) B-O B-S_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
human B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
peak B-O B-JJ
value B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
parallel B-O B-VP_VB
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
suffering B-O B-VP_VBG
from B-O B-PP_IN
Cushing B-O B-NP_NP_NN
's B-O B-POS
" " B-O O-NP
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
circadian B-O B-JJ
rhythm B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
plasma B-O B-NP_NN
cortisol B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
either B-O B-VP_VP_CC
disappeared B-O B-VP_VBD
" " B-O O-VP
or B-O B-CC
was B-O B-VP_VBD
inverted B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
while B-O B-SBAR_IN
that B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
significantly B-O B-ADVP_RB
" " B-O O-ADVP
deviate B-O B-VP_VB
from B-O B-PP_IN
the B-O B-NP_DT
normal B-O B-JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
For B-O B-S_PP_IN
apoplexic B-O B-NP_NP_JJ
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
lesions B-O B-NP_NP_NNS
" " B-O O-NP
localized B-O B-VP_JJ
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
base B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
as B-O B-SBAR_IN
indicated B-O B-S_NP_VP_VBN
" " B-O B-NP_PP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
diurnal B-O B-JJ
variation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
abolished B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Conversely B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
diurnal B-O B-NP_JJ
rhythmicity B-O B-NN
" " B-O O-NP
persisted B-O B-VP_VBD
in B-O B-PP_IN
apoplexy B-O B-NP_NP_NN
patients B-O B-NNS
" " B-O O-NP
whose B-O B-SBAR_WHNP_WPP
lesions B-O B-NNS
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
in B-O B-PP_IN
the B-O B-NP_DT
cerebral B-O B-JJ
cortex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
postulated B-O B-VP_VBD
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_NP_DT
circadian B-O B-JJ
modification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
independent B-O B-ADJP_JJ
of B-O B-PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_DT
rhythmicity B-O B-NN
" " B-O O-NP
might B-O B-VP_MD
be B-O B-VP_VB
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_NP_DT
diurnal B-O B-JJ
variations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
might B-O B-VP_MD
serve B-O B-VP_VB
to B-O B-S_NP_VP_TO
coordinate B-O B-VP_VB
the B-O B-NP_NP_DT
reactivity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
target B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
cortisol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
because B-O B-SBAR_IN
, B-O B-S_NP_NP_COMMA
, B-O B-NP_COMMA
" " B-O O-NP
were B-O B-VP_VBD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transforming B-O B-S_NP_VBG
growth B-O B-NN
factor-beta B-O B-NN
" " B-O O-NP
suppresses B-O B-VP_VBZ
human B-O B-NP_JJ
B B-O B-NN
lymphocyte B-O B-NN
Ig B-O B-NN
production B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
inhibiting B-O B-S_NP_VP_VBG
synthesis B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
switch B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
of B-O B-PP_IN
Ig B-O B-NN
mRNA B-O B-NN
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transforming B-O B-S_NP_NP_VBG
growth B-O B-NN
factor-beta B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TGF-beta B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
inhibits B-O B-VP_VP_VBZ
B B-O B-NP_NN
cell B-O B-NN
Ig B-O B-NN
secretion B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
reduces B-O B-VP_VBZ
B B-O B-NP_NN
cell B-O B-NN
membrane B-O B-NN
Ig B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TGF-beta B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
human B-O B-NP_NP_JJ
B B-O B-NN
lymphocyte B-O B-NN
cultures B-O B-NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
Staphylococcus B-O B-NP_NP_FW
aureus B-O B-FW
Cowan B-O B-NN
strain B-O B-NN
I B-O B-NN
" " B-O O-NP
and B-O B-CC
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
completely B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VP_VP_VBD
B B-O B-NP_NN
cell B-O B-NN
Ig B-O B-NN
secretion B-O B-NN
" " B-O O-NP
" " B-O O-VP
( B-O B-PRN_LRB
greater B-O B-FRAG_ADVP_ADVP_JJR
" " B-O O-ADVP
than B-O B-PP_IN
90 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
and B-O B-CC
decreased B-O B-VP_VBD
B B-O B-NP_NN
cell B-O B-NN
surface B-O B-NN
IgM B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
IgD B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
kappa B-O B-NP_NN
L B-O B-NN
chain B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
lambda B-O B-NP_NN
L B-O B-NN
chain B-O B-NN
" " B-O O-NP
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
TGF-beta B-O B-NP_NN
" " B-O O-NP
had B-O B-VP_VBD
only B-O B-NP_ADJP_RB
minimal B-O B-JJ
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
two B-O B-NP_NP_CD
other B-O B-JJ
B B-O B-NN
cell B-O B-NN
membrane B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
HLA-DR B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
CD20 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Internal B-O B-S_NP_NP_NP_JJ
labeling B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
[35S]methionine B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
immunoprecipitation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
anti-IgM B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
anti-kappa B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
and B-O B-CC
anti-lambda B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
revealed B-O B-VP_VBD
a B-O B-NP_NP_NP_DT
striking B-O B-JJ
reduction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
kappa B-O B-NP_NN
L B-O B-NN
chain B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-DT
presence B-O B-NN
of B-O B-IN
TGF-beta B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
less B-O B-ADJP_RBR
pronounced B-O B-JJ
" " B-O O-ADJP
reduction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lambda B-O B-NP_NP_NN
L B-O B-NN
chain B-O B-NN
" " B-O O-NP
and B-O B-CC
microH B-O B-NP_NN
chain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
noted B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_NP_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
RNA B-O B-NP_NP_NN
" " B-O O-NP
purified B-O B-VP_VBN
from B-O B-NP_PP_IN
B B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
treated B-O B-VP_VBN
with B-O B-NP_PP_IN
for B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
a B-O B-NP_NP_DT
significant B-O B-JJ
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
steady B-O B-NP_JJ
state B-O B-NN
kappa B-O B-NN
and B-O B-CC
lambda B-O B-NN
L B-O B-NN
chain B-O B-NN
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
a B-O B-NP_NP_DT
significant B-O B-JJ
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
switch B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_NP_DT
membrane B-O B-NN
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
mu B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
their B-O B-NP_PRPP
respective B-O B-JJ
secreted B-O B-JJ
forms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
noted B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-DT
presence B-O B-NN
of B-O B-IN
TGF-beta B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_JJ
run-on B-O B-JJ
experiments B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
decreased B-O B-NP_NP_VBN
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
kappa B-O B-NP_NN
L B-O B-NN
chain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
TGF-beta B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
two B-O B-NP_NP_NP_CD
transcriptional B-O B-JJ
regulatory B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
Oct-2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
nuclear B-O B-NP_NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
important B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Oct-2 B-O B-S_NP_NP_NP_NN
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
and B-O B-CC
both B-O B-NP_NP_DT
Oct-2 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
altered B-O B-VP_VBN
by B-O B-NP_PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
TGF-beta B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
levels B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
factor B-O B-NN
AP-1 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
not B-O B-RB
known B-O B-VP_VBN
" " B-O B-S_NP_VP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
reduced B-O B-VP_VBN
by B-O B-NP_PP_IN
TGF-beta B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
TGF-beta B-O B-S_NP_NN
" " B-O O-NP
decreases B-O B-VP_VBZ
B B-O B-NP_NN
lymphocyte B-O B-NN
Ig B-O B-NN
secretion B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
inhibiting B-O B-S_NP_VP_VP_VBG
and B-O B-NP_CC
inhibiting B-O B-VP_VBG
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
TGF-beta B-O B-S_NP_NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
Ig B-O B-NP_NN
chain B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
unclear B-O B-ADJP_JJ
" " B-O O-ADJP
although B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
involve B-O B-VP_VB
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
HTLV-1 B-O B-S_NP_NN
Tax B-O B-NN
" " B-O O-NP
induces B-O B-VP_VBZ
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
various B-O B-NP_JJ
immediate B-O B-JJ
early B-O B-JJ
serum B-O B-NN
responsive B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_NP_NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
etiological B-O B-JJ
agent B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
adult B-O B-NP_NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ATL B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
showed B-O B-VP_VBD
here B-O B-ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
mobility-shift B-O B-NP_NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
T-cell B-O B-S_NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
transformed B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
contained B-O B-VP_VBD
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
activities B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Consistent B-O B-S_S_NP_ADJP_JJ
with B-O B-PP_IN
this B-O B-NP_DT
result B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
, B-O B-COMMA
these B-O B-NP_DT
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VBD
increased B-O B-NP_NP_VBN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
mRNAs B-O B-NP_NP_NNS
" " B-O O-NP
encoding B-O B-VP_VBG
the B-O B-NP_NP_DT
AP-1 B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
c-Fos B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Fra-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
c-Jun B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
JunB B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
JunD B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Previously B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
c-fos B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
reported B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
transactivated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
using B-O B-S_NP_VP_VBG
the B-O B-NP_NP_NP_DT
human B-O B-JJ
T-cell B-O B-NN
line B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
JPX-9 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
is B-O B-VP_VBZ
inducible B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
mRNAs B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
transactivated B-O B-VP_VBN
by B-O B-NP_PP_IN
Tax1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
Tax1 B-O B-NP_NN
" " B-O O-NP
activated B-O B-VP_VBD
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_NP_NP_NP_CD
other B-O B-JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
having B-O B-VP_VBG
zinc B-O B-NP_NN
finger B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
Egr-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Egr-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
same B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
Tax1-inducible B-O B-JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
identified B-O B-VP_VBN
here B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
encoded B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
members B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
immediate B-O B-NP_JJ
early B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
under B-O B-PP_IN
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
growth B-O B-NP_NN
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_RB
, B-O B-COMMA
Tax1 B-O B-NP_NN
" " B-O O-NP
was B-O B-VP_VBD
suggested B-O B-VP_VBN
to B-O B-S_NP_VP_TO
replace B-O B-VP_VB
growth B-O B-NP_NN
signals B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
at B-O B-PP_ADVP_IN
least B-O B-JJS
" " B-O O-ADVP
in B-O B-IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
by B-O B-PP_IN
this B-O B-NP_DT
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NP_NN
replication B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
cysteine B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
cysteine B-O B-NP_NN
derivatives B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
HIV-1 B-O B-S_NP_NN
proviral B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
two B-O B-NP_NP_CD
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HIV-1-infected B-O B-S_NP_JJ
individuals B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
, B-O B-COMMA
on B-O B-PP_IN
average B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
abnormally B-O B-NP_NP_NP_ADJP_RB
high B-O B-JJ
" " B-O O-ADJP
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
tumour B-O B-NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
abnormally B-O B-NP_ADJP_RB
low B-O B-JJ
" " B-O O-ADJP
plasma B-O B-NN
cysteine B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
cysteine B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
related B-O B-NP_JJ
thiols B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
HIV-1 B-O B-NP_NP_NN
replication B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
experiments B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
cysteine B-O B-S_NP_NP_NN
" " B-O O-NP
or B-O B-CC
N-acetylcysteine B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
NAC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
raise B-O B-VP_VP_VP_VBP
the B-O B-NP_NP_DT
intracellular B-O B-JJ
glutathione B-O B-NN
( B-O B-LRB
GSH B-O B-NN
) B-O B-RRB
level B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-NP
" " B-O O-VP
and B-O B-CC
inhibit B-O B-VP_VBP
HIV-1 B-O B-NP_NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-VP
in B-O B-PP_IN
persistently B-O B-NP_ADJP_RB
infected B-O B-JJ
" " B-O O-ADJP
Molt-4 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
U937 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appears B-O B-VP_VBZ
not B-O B-VP_RB
to B-O B-TO
be B-O B-VP_VB
directly B-O B-ADVP_RB
" " B-O O-ADVP
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
GSH B-O B-NP_NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cysteine B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
NAC B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
inhibit B-O B-VP_VBP
NF-kappa B-O B-NP_NP_NP_NN
B B-O B-NN
activity B-O B-NN
" " B-O O-NP
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
and B-O B-CC
chloramphenicol B-O B-NP_NP_NP_NP_NN
acetyl-transferase B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CAT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
under B-O B-PP_IN
control B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
cysteine B-O B-NN
deficiency B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HIV-1-infected B-O B-NP_JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
cause B-O B-VP_VP_VB
an B-O B-NP_NP_DT
over-expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
and B-O B-CC
enhance B-O B-VP_VB
HIV-1 B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NAC B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
considered B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_NP_DT
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1-infected B-O B-NP_JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor-alpha B-O B-NN
mRNA B-O B-NN
accumulation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
myelomonocytic B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Role B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
DNA B-O B-NP_NN
sequence B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
mRNA B-O B-NP_NN
stabilization B-O B-NN
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
cytokine B-O B-NN
TNF B-O B-NN
" " B-O O-NP
mediates B-O B-VP_VBZ
many B-O B-NP_NP_JJ
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
pathologic B-O B-JJ
signs B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
cachexia B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
inflammation B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
sepsis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
current B-O B-JJ
work B-O B-NN
" " B-O O-NP
describes B-O B-VP_VBZ
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TNF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
myelomonocytic B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
PMA B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
exhibit B-O B-VP_VBP
a B-O B-NP_NP_DT
low B-O B-JJ
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
constitutive B-O B-NP_JJ
TNF B-O B-NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Within B-O B-S_PP_IN
2 B-O B-NP_NP_QP_CD
to B-O B-TO
4 B-O B-CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PMA B-O B-NP_NN
exposure B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
steady B-O B-NP_NP_JJ
state B-O B-NN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
TNF B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
elevated B-O B-VP_JJ
in B-O B-NP_PP_IN
all B-O B-NP_NP_DT
myelomonocytic B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
rise B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
due B-O B-PP_JJ
to B-O B-PP_PP_TO
increased B-O B-NP_NP_VBN
mRNA B-O B-NN
stability B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
increased B-O B-S_NP_VP_VBD
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
to B-O B-PP_TO
an B-O B-NP_NP_DT
overall B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
rises B-O B-S_NP_VP_VBZ
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
At B-O B-S_PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
genomic B-O B-JJ
TNF B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_DT
DNase B-O B-NN
I B-O B-CD
hypersensitive B-O B-JJ
site B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
detected B-O B-VP_VBN
within B-O B-NP_PP_IN
the B-O B-NP_NP_DT
TNF B-O B-NN
promoter B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
-200 B-O B-NP_QP_CD
to B-O B-TO
-100 B-O B-CD
" " B-O O-QP
bp B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
relative B-O B-PP_JJ
to B-O B-TO
the B-O B-NP_DT
transcription B-O B-NN
initiation B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
absent B-O B-S_NP_ADJP_JJ
in B-O B-PP_IN
nonexpressing B-O B-NP_VBG
erythroleukemia B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-NP_DT
DNase B-O B-NN
I B-O B-CD
site B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
present B-O B-ADJP_JJ
in B-O B-PP_IN
uninduced B-O B-NP_JJ
myelomonocytic B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
not B-O B-RB
changed B-O B-VP_VBN
after B-O B-NP_PP_IN
PMA B-O B-NP_NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
PMA B-O B-NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlated B-O B-VP_VBD
well B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
TNF B-O B-NP_NN
gene B-O B-NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
encoding B-O B-VP_VBG
other B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
resting B-O B-NP_ADJP_ADJP_VBG
" " B-O O-ADJP
and B-O B-CC
induced B-O B-ADJP_VBN
" " B-O O-ADJP
" " B-O O-ADJP
ML-1 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contain B-O B-VP_VBP
proteins B-O B-NP_NP_NNS
" " B-O O-NP
binding B-O B-VP_VBG
specifically B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
the B-O B-NP_NP_DT
AP-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
AP-2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
located B-O B-ADJP_JJ
within B-O B-PP_IN
the B-O B-NP_DT
TNF B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PMA B-O B-S_NP_NN
induction B-O B-NN
" " B-O O-NP
increases B-O B-VP_VBZ
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_JJ
binding B-O B-VBG
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
relative B-O B-PP_JJ
to B-O B-TO
the B-O B-NP_DT
resting B-O B-VBG
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
regulatory B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
murine B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
TNF B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
discussed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_NP_DT
nuclear B-O B-JJ
factor B-O B-NN
NF-GM2 B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
interacts B-O B-S_NP_VP_VBZ
with B-O B-PP_IN
a B-O B-NP_NP_DT
regulatory B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_ADJP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
: B-O B-COLON
" " B-O O-NP
purification B-O B-NP_NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
human B-O B-NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
line B-O B-NN
Jurkat B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
similarity B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
antigen B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
lectin B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
a B-O B-NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
phorbol-12-myristate B-O B-NP_NP_NP_NN
acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
calcium B-O B-NP_NP_NN
ionophore B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
a B-O B-NP_NP_DT
set B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrated B-O B-VP_VBD
in B-O B-PP_IN
earlier B-O B-NP_JJR
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
upstream B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
mouse B-O B-NN
GM-CSF B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
positions B-O B-NP_NP_NNS
" " B-O O-NP
between B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
region B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
two B-O B-NP_NP_CD
DNA-binding B-O B-JJ
motifs B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
GM2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
GC-box B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
GM2 B-O B-NN
sequence B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GGTAGTTCCC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_DT
inducible B-O B-JJ
factor B-O B-NN
NF-GM2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
the B-O B-S_NP_NP_DT
other B-O B-JJ
" " B-O O-NP
( B-O B-PRN_LRB
CCGCCC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
by B-O B-VP_PP_IN
constitutive B-O B-NP_JJ
factors B-O B-NNS
A1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
A2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
elucidate B-O B-VP_VB
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GM-CSF B-O B-NP_NN
gene B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
purified B-O B-VP_VBN
the B-O B-NP_DT
inducible B-O B-JJ
factor B-O B-NN
NF-GM2 B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_NP_DT
nuclear B-O B-JJ
extract B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
stimulated B-O B-NP_VBN
Jurkat B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-DT
basis B-O B-NN
of B-O B-IN
specific B-O B-NP_JJ
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
purified B-O B-VBN
NF-GM2 B-O B-NN
" " B-O O-NP
consists B-O B-VP_VP_VBZ
of B-O B-PP_IN
50 B-O B-NP_NP_NP_NP_NP_CD
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
65 B-O B-NP_NP_CD
" " B-O O-NP
" " B-O B-PRN_O-NP
" " B-O O-NP
kDa B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
p65 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
polypeptides B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
has B-O B-VP_VBZ
a B-O B-NP_NP_DT
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
specific B-O B-ADJP_JJ
for B-O B-PP_IN
both B-O B-NP_CC
the B-O B-DT
GM-CSF B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
" " B-O B-NP_NP_PRN_O-NP
enhancers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Electrophoretically B-O B-S_S_NP_NP_ADJP_RB
purified B-O B-VBN
" " B-O O-ADJP
p50 B-O B-NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
can B-O B-VP_MD
form B-O B-VP_VB
a B-O B-NP_DT
protein-DNA B-O B-JJ
complex B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
in B-O B-S_PP_IN
the B-O B-NP_DT
mixture B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
p50 B-O B-NP_NN
" " B-O O-NP
associates B-O B-VP_VBZ
preferentially B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
form B-O B-VP_VB
the B-O B-NP_DT
NF-GM2 B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
p65 B-O B-NP_NN
" " B-O O-NP
gave B-O B-VP_VBD
per B-O B-ADVP_FW
se B-O B-FW
" " B-O O-ADVP
, B-O B-COMMA
with B-O B-PP_IN
low B-O B-NP_JJ
affinity B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_NP_DT
protein-DNA B-O B-JJ
complex B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
migrated B-O B-S_NP_VP_VBD
more B-O B-ADVP_ADVP_RBR
slowly B-O B-RB
" " B-O O-ADVP
than B-O B-PP_IN
native B-O B-NP_JJ
NF-GM2 B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
an B-O B-NP_NP_DT
antiserum B-O B-NN
" " B-O O-NP
against B-O B-PP_IN
KBF1 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
identical B-O B-ADJP_JJ
to B-O B-PP_TO
50 B-O B-NP_CD
kDa B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reacted B-O B-VP_VBD
with B-O B-PP_IN
the B-O B-NP_NP_DT
p50 B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-GM2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_DT
NF-GM2 B-O B-NN
polypeptide B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
not B-O B-RB
be B-O B-VP_VB
immunologically B-O B-ADVP_RB
" " B-O O-ADVP
differentiated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
purified B-O B-VBN
NF-GM2 B-O B-NN
" " B-O O-NP
activated B-O B-VP_VBD
in B-O B-NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
transcription B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
kappa B-O B-NN
B B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
while B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
stimulate B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
activation B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GM-CSF B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
the B-O B-NP_DT
GM2/GC-box B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
different B-O B-ADJP_JJ
from B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Glucocorticoid B-O B-NP_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
normal B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
effects B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
age B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
gender B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
season B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
plasma B-O B-NP_NN
cortisol B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
measured B-O B-VP_VBD
glucocorticoid B-O B-NP_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
GR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_NP_NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
MNL B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_S_NP_NP_DT
age-related B-O B-JJ
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
suggested B-O B-VP_VBN
between B-O B-NP_PP_IN
subjects B-O B-NP_NP_NP_NNS
" " B-O O-NP
younger B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
and B-O B-CC
elderly B-O B-NP_JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
there B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_NP_DT
apparent B-O B-JJ
seasonal B-O B-JJ
variation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Gender B-O B-S_NP_NP_NN
difference B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
significant B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
although B-O B-SBAR_IN
women B-O B-S_NP_NNS
" " B-O O-NP
showed B-O B-VP_VBD
slightly B-O B-NP_ADJP_RB
fewer B-O B-JJR
" " B-O O-ADJP
GR B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Eight B-O B-S_NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
dermatomyositis/polymyositis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
could B-O B-S_NP_NP_PP_VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
MNL B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
these B-O B-NP_DT
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
decreased B-O B-VP_VBN
one B-O B-NP_PP_NP_CD
month B-O B-NN
" " B-O O-NP
after B-O B-IN
the B-O B-NP_NP_DT
initiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
prednisolone B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
normal B-O B-NP_JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
GR B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
MNL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
demonstrate B-O B-VP_VB
circadian B-O B-NP_JJ
variation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
in B-O B-PP_IN
contrast B-O B-NN
to B-O B-TO
concentrations B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
plasma B-O B-NP_NN
cortisol B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_NP_NP_DT
human B-O B-JJ
putative B-O B-JJ
lymphocyte B-O B-NN
G0/G1 B-O B-NN
switch B-O B-NN
gene B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
a B-O B-NP_DT
CpG-rich B-O B-JJ
island B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
encodes B-O B-VP_VBZ
a B-O B-NP_NP_DT
small B-O B-JJ
basic B-O B-JJ
protein B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
potential B-O B-NN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
phosphorylated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Genes B-O B-S_NP_NP_NP_NNS
" " B-O O-NP
actively B-O B-VP_ADVP_RB
" " B-O O-ADVP
involved B-O B-VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
G0/G1 B-O B-NN
switch B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
( B-O B-PRN_LRB
G0S B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
differentially B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
during B-O B-NP_PP_IN
the B-O B-NP_NP_DT
lectin-induced B-O B-JJ
switch B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
the B-O B-NP_DT
G0 B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_NP_DT
G1 B-O B-NN
phases B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
paper B-O B-NN
" " B-O O-NP
presents B-O B-VP_VBZ
studies B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
G0S2 B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
for B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
cDNAs B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
" " B-O B-VP_VP_PP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
G0S2 B-O B-S_NP_NN
mRNA B-O B-NN
" " B-O O-NP
increases B-O B-VP_VBZ
transiently B-O B-ADVP_RB
" " B-O O-ADVP
within B-O B-PP_IN
1-2 B-O B-NP_NP_QP_CD
" " B-O O-QP
hr B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lectin B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
cycloheximide B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
cultured B-O B-NP_VBN
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Comparison B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
nearly B-O B-ADJP_RB
full-length B-O B-JJ
" " B-O O-ADJP
cDNA B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
corresponding B-O B-JJ
genomic B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reveals B-O B-VP_VBZ
one B-O B-NP_NP_NP_CD
small B-O B-JJ
intron B-O B-NN
" " B-O O-NP
and B-O B-CC
an B-O B-NP_DT
open B-O B-JJ
reading B-O B-NN
frame B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
second B-O B-JJ
exon B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
derived B-O B-VBN
103-amino-acid B-O B-JJ
basic B-O B-JJ
protein B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
two B-O B-NP_NP_CD
potential B-O B-JJ
alpha-helical B-O B-JJ
domains B-O B-NNS
" " B-O O-NP
separated B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
hydrophobic B-O B-JJ
region B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
potential B-O B-NN
" " B-O B-S_NP_VP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Consistent B-O B-S_S_NP_ADJP_JJ
with B-O B-PP_IN
involvement B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
G0/G1 B-O B-NN
switch B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
, B-O B-COMMA
the B-O B-NP_DT
protein B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
potential B-O B-NP_NP_JJ
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
protein B-O B-NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
and B-O B-CC
casein B-O B-NP_NN
kinase B-O B-NN
II B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
gene B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_DT
CpG-rich B-O B-JJ
island B-O B-NN
" " B-O O-NP
suggesting B-O B-S_NP_VP_VBG
expression B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
germ B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_DT
upstream B-O B-JJ
segment B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
tandem B-O B-NP_JJ
dinucleotide B-O B-NN
repeats B-O B-NNS
(CT)19/(CA)16 B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_S_NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
suitably B-O B-ADJP_RB
located B-O B-JJ
" " B-O O-ADJP
TATA B-O B-NN
box B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
potential B-O B-S_NP_NP_JJ
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
CCAAT-box B-O B-NP_NN
binding B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
far B-O B-ADJP_RB
upstream B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
embedded B-O B-S_NP_ADJP_JJ
in B-O B-PP_IN
a B-O B-NP_DT
42-nucleotide B-O B-JJ
repeat B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Potential B-O B-S_NP_NP_JJ
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
AP1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
AP2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
AP3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
rapid B-O B-NP_NP_JJ
transcriptional B-O B-JJ
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
inducing B-O B-NP_VBG
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Synergism B-O B-NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
two B-O B-NP_NP_CD
distinct B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HTLV-I B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
the B-O B-NP_NP_DT
trans-activator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HTLV-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
conducted B-O B-VP_VBN
functional B-O B-NP_NP_JJ
studies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
enhancer B-O B-NN
elements B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
I B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
using B-O B-S_NP_VP_VBG
the B-O B-NP_DT
human B-O B-JJ
T-cell B-O B-NN
lines B-O B-NNS
and B-O B-NP_NP_NP_NP_CC
, B-O B-NP_COMMA
, B-O B-SBAR_WHNP_S_COMMA
" " B-O O-NP
and B-O B-CC
and B-O B-NP_NP_NP_CC
, B-O B-NP_COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_CD
distinct B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
implicated B-O B-VP_VBN
in B-O B-NP_PP_IN
function B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HTLV-I B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_CD
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
21-base-pair B-O B-ADJP_JJ
( B-O B-PRN_LRB
bp B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
core B-O B-NN
element B-O B-NN
" " B-O O-NP
that B-O B-SBAR_SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
has B-O B-S_NP_VP_VBZ
the B-O B-NP_DT
ability B-O B-NN
" " B-O B-S_NP_VP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
other B-O B-JJ
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
interposed B-O B-ADJP_VBN
between B-O B-PP_IN
the B-O B-NP_DT
21-bp B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_NP_DT
subfragment B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
C26 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_DT
21-bp B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
trans-activation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
possibly B-O B-PP_RB
through B-O B-IN
binding B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Formation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
protein-DNA B-O B-JJ
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
C26 B-O B-NN
subfragment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
positively B-O B-ADVP_RB
" " B-O O-ADVP
affected B-O B-VP_VBN
by B-O B-NP_PP_IN
p40tax B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
C26 B-O B-NN
element B-O B-NN
" " B-O O-NP
conferred B-O B-VP_VBD
partial B-O B-NP_NP_JJ
responsiveness B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
p40tax B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
linked B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
one B-O B-NP_NP_CD
copy B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
21-bp B-O B-JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
, B-O B-COMMA
, B-O B-S_NP_PP_COMMA
" " B-O B-VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
C26 B-O B-NN
element B-O B-NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
, B-O B-COMMA
even B-O B-SBAR_WHADVP_RB
when B-O B-WRB
" " B-O O-WHADVP
repeated B-O B-S_NP_VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
could B-O B-VP_MD
not B-O B-RB
be B-O B-VP_VB
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
p40tax B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
unlike B-O B-PP_IN
other B-O B-NP_JJ
NF-kappa B-O B-ADJP_NN
B-binding B-O B-JJ
" " B-O O-ADJP
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
C26 B-O B-NN
element B-O B-NN
" " B-O O-NP
itself B-O B-NP_PRP
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
profoundly B-O B-ADVP_RB
" " B-O O-ADVP
activated B-O B-VP_VBN
upon B-O B-NP_PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
12-O-tetradecanoylphorbol-13-acetate B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
HTLV-I B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
multiple B-O B-NP_NP_ADJP_JJ
functional B-O B-JJ
" " B-O O-ADJP
elements B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
binding B-O B-NP_NP_VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
synergistically B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
cooperate B-O B-VP_VBP
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
TPA-dependent B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HTLV-I B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
the B-O B-NP_DT
C26 B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
phorbol B-O B-NP_ADJP_NN
ester-induced B-O B-JJ
" " B-O O-ADJP
monocytic B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
down-regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
AP-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Previous B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
myeloid B-O B-JJ
leukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
12-O-tetradecanoylphorbol-13-acetate B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
present B-O B-JJ
work B-O B-NN
" " B-O O-NP
demonstrates B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_DT
glucocorticoid B-O B-NN
dexamethasone B-O B-NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
TPA-induced B-O B-NP_NP_JJ
increases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
mRNA B-O B-NP_NP_NP_NN
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
block B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
appearance B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
monocytic B-O B-JJ
phenotype B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
including B-O B-PP_VBG
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Other B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
TPA-induced B-O B-S_NP_NP_JJ
monocytic B-O B-JJ
differentiation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
genes B-O B-NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
finding B-O B-NN
that B-O B-SBAR_IN
dexamethasone B-O B-S_NP_NN
" " B-O O-NP
has B-O B-VP_VBZ
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
TPA-induced B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
this B-O B-S_NP_DT
glucocorticoid B-O B-NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
signals B-O B-NP_NP_NNS
" " B-O O-NP
downstream B-O B-ADJP_ADJP_ADJP_JJ
" " B-O B-PP_O-ADJP
or B-O B-CC
parallel B-O B-ADJP_JJ
" " B-O B-PP_O-ADJP
" " B-O O-ADJP
to B-O B-PP_TO
this B-O B-NP_DT
enzyme B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_JJ
run-on B-O B-JJ
assays B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
: B-O B-COLON
( B-O B-S_S_LST_LRB
1 B-O B-LS
) B-O B-RRB
" " B-O O-LST
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_NP_CC
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
TPA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
transcriptional B-O B-NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
( B-O B-S_LST_LRB
2 B-O B-LS
) B-O B-RRB
" " B-O O-LST
TPA-induced B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
require B-O B-VP_VB
protein B-O B-NP_NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
( B-O B-S_LST_LRB
3 B-O B-LS
) B-O B-RRB
" " B-O O-LST
TPA-induced B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
inhibited B-O B-VP_VBN
at B-O B-NP_PP_IN
the B-O B-NP_DT
transcriptional B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
further B-O B-ADVP_RB
" " B-O O-ADVP
define B-O B-VP_VB
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
the B-O B-NP_DT
molecular B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
prepared B-O B-VP_VBD
a B-O B-NP_NP_DT
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
deleted B-O B-NP_NP_VBN
c-jun B-O B-NN
promoter B-O B-NN
fragments B-O B-NNS
" " B-O O-NP
linked B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
gene B-O B-NP_NP_PRN_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Increases B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
CAT B-O B-NP_NP_NN
activity B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
transient B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_NP_DT
constructs B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
assigned B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_NP_DT
region B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
to B-O B-NP_NP_TO
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contains B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CAT B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
sensitive B-O B-ADJP_JJ
to B-O B-PP_TO
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
dexamethasone B-O B-S_NP_NN
" " B-O O-NP
down-regulates B-O B-VP_VBZ
TPA-induced B-O B-NP_NP_JJ
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
c-jun B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
during B-O B-PP_IN
monocytic B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
inhibiting B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Evaluation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ligand B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
thermal B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_NP_JJ
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
human B-O B-NP_ADJP_JJ
glucocorticoid B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
used B-O B-VP_VBN
a B-O B-NP_DT
DNA-binding/immunoprecipitation B-O B-JJ
assay B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
analyze B-O B-VP_VB
the B-O B-NP_NP_DT
capacity B-O B-NN
" " B-O B-S_O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-VP_O-PP
, B-O B-COMMA
" " B-O O-NP
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_ADJP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
translated B-O B-VBN
" " B-O O-ADJP
hGR B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
indistinguishable B-O B-ADJP_JJ
from B-O B-PP_IN
native B-O B-NP_JJ
hGR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
migration B-O B-NP_NP_NP_NN
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
sedimentation B-O B-NP_NP_NN
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
reactivity B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
cell-free B-O B-NP_JJ
synthesized B-O B-VBN
hGR B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
capable B-O B-ADJP_JJ
of B-O B-PP_IN
specific B-O B-NP_NP_JJ
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
glucocorticoid B-O B-NP_ADJP_NN
response B-O B-NN
element B-O B-NN
( B-O B-LRB
GRE B-O B-NN
) B-O B-RRB
-containing B-O B-JJ
" " B-O O-ADJP
DNA B-O B-NN
fragments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
this B-O B-NP_DT
assay B-O B-NN
system B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
evaluated B-O B-VP_VBN
the B-O B-NP_NP_DT
contributions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
ligand B-O B-NP_NP_NN
binding B-O B-NN
" " B-O O-NP
and B-O B-CC
heat B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
DNA B-O B-NP_NP_NN
binding B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
these B-O B-NP_DT
glucocorticoid B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_ADJP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
translated B-O B-VBN
" " B-O O-ADJP
hGR B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
capable B-O B-ADJP_JJ
of B-O B-PP_IN
selective B-O B-NP_JJ
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
even B-O B-PP_RB
in B-O B-IN
the B-O B-DT
absence B-O B-NN
of B-O B-IN
glucocorticoid B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
dexamethasone B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
the B-O B-NP_DT
antiglucocorticoid B-O B-JJ
RU486 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
additional B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
DNA-binding B-O B-JJ
capacity B-O B-NN
" " B-O O-NP
" " B-O O-PP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
receptor B-O B-S_NP_NN
preparations B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
maintained B-O B-VP_VBN
at B-O B-NP_ADVP_PP_IN
0 B-O B-NP_NP_CD
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
addition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_CC
ligand B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
antagonist B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
combination B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_DT
heat B-O B-NN
activation B-O B-NN
step B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
promoted B-O B-VP_VBD
DNA B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
approximately B-O B-NP_NP_RB
3-fold B-O B-RB
" " B-O O-NP
over B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
heat-activated B-O B-NP_JJ
unliganded B-O B-JJ
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Agonist B-O B-S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
dexamethasone B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
slightly B-O B-ADJP_ADJP_ADVP_RB
more B-O B-JJR
" " B-O O-ADVP
effective B-O B-JJ
" " B-O O-ADJP
" " B-O B-PP_O-ADJP
in B-O B-PP_IN
supporting B-O B-S_NP_VP_VBG
specific B-O B-NP_JJ
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
than B-O B-PP_IN
antagonist B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
RU486 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNA B-O B-S_NP_NP_NN
binding B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
in B-O B-NP_ADJP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
synthesized B-O B-VBN
" " B-O O-ADJP
GR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
sodium B-O B-NP_NN
molybdate B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
receptor B-O B-NN
preparations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
before B-O B-PP_IN
steroid B-O B-NP_NP_NN
addition B-O B-NN
" " B-O O-NP
and B-O B-CC
thermal B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Addition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
KCl B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
less B-O B-NP_RBR
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
either B-O B-PP_CC
due B-O B-JJ
to B-O B-TO
blockage B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
DNA-receptor B-O B-NP_JJ
complex B-O B-NN
formation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
or B-O B-CC
disruption B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NP_NN
binding B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
cell-free B-O B-NP_JJ
synthesized B-O B-VBN
hGR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
analyzed B-O B-VP_VBN
further B-O B-NP_ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
examining B-O B-S_NP_VP_VBG
the B-O B-NP_NP_NP_DT
abilities B-O B-NNS
" " B-O B-S_O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Oligonucleotides B-O B-S_S_S_NP_NP_NNS
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_DT
consensus B-O B-NN
GRE B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
the B-O B-NP_DT
most B-O B-ADJP_RBS
efficient B-O B-JJ
" " B-O O-ADJP
competitors B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
fragments B-O B-S_NP_NP_NNS
" " B-O O-NP
containing B-O B-VP_VBG
regulatory B-O B-NP_NP_JJ
sequences B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
glucocorticoid-repressible B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
somewhat B-O B-ADJP_RB
competitive B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
single B-O B-S_NP_ADJP_JJ
stranded B-O B-JJ
" " B-O O-ADJP
oligonucleotides B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
unable B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
compete B-O B-VP_VB
for B-O B-PP_IN
DNA B-O B-NP_ADJP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
, B-O B-COMMA
except B-O B-PP_IN
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
competitor B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
present B-O B-ADJP_JJ
" " B-O O-ADJP
at B-O B-PP_IN
concentrations B-O B-NP_ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Together B-O B-S_ADVP_RB
" " B-O O-ADVP
these B-O B-NP_DT
studies B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
hGR B-O B-S_NP_NP_NN
" " B-O O-NP
synthesized B-O B-VP_VBN
in B-O B-NP_PP_IN
rabbit B-O B-NP_NN
reticulocyte B-O B-NN
lysates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
displays B-O B-VP_VBZ
many B-O B-NP_NP_JJ
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
same B-O B-JJ
properties B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
, B-O B-NP_COMMA
observed B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similarities B-O B-S_NP_NP_NNS
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
dexamethasone B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
RU486 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
antiglucocorticoid B-O B-JJ
properties B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
RU486 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
occur B-O B-VP_VB
at B-O B-PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
One B-O B-S_NP_CD
base B-O B-NN
pair B-O B-NN
change B-O B-NN
" " B-O O-NP
abolishes B-O B-VP_VBZ
the B-O B-NP_NP_DT
T B-O B-ADJP_NN
cell-restricted B-O B-JJ
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
kB-like B-O B-JJ
proto-enhancer B-O B-NN
element B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
interleukin B-O B-NN
2 B-O B-CD
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
inducible B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
T B-O B-ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
enhancers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
murine B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
human B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
Interleukin B-O B-NP_NP_NN
2 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
Il-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contain B-O B-VP_VBP
the B-O B-NP_DT
kB-like B-O B-JJ
sequence B-O B-NN
GGGATTTCACC B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
an B-O B-NP_DT
essential B-O B-JJ
cis-acting B-O B-JJ
enhancer B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
cloned B-O B-S_NP_VP_VBN
in B-O B-NP_PP_IN
multiple B-O B-NP_JJ
copies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
this B-O B-NP_DT
so-called B-O B-JJ
TCEd B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
distal B-O B-NP_JJ
T B-O B-NN
cell B-O B-NN
element B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
acts B-O B-VP_VBZ
as B-O B-PP_IN
an B-O B-NP_DT
inducible B-O B-JJ
proto-enhancer B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
E14 B-O B-NP_NN
T B-O B-NN
lymphoma B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
extracts B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
induced B-O B-NP_ADJP_ADJP_VBN
" " B-O O-ADJP
, B-O B-COMMA
Il-2 B-O B-ADJP_NN
secreting B-O B-NN
" " B-O O-ADJP
" " B-O O-ADJP
El4 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
three B-O B-NP_CD
individual B-O B-JJ
protein B-O B-NN
factors B-O B-NNS
" " B-O O-NP
bind B-O B-VP_VBP
to B-O B-PP_TO
TCEd B-O B-NP_NN
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
most B-O B-ADJP_RBS
prominent B-O B-JJ
" " B-O O-ADJP
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
named B-O B-VP_VBN
TCF-1 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
T B-O B-NP_NN
cell B-O B-NN
factor B-O B-NN
1 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
proto-enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TCEd B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TCF-1 B-O B-S_S_NP_NN
" " B-O O-NP
consists B-O B-VP_VBZ
of B-O B-PP_IN
two B-O B-NP_NP_CD
polypeptides B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
about B-O B-NP_ADVP_RB
" " B-O O-ADVP
kD B-O B-NP_NP_QP_NN
" " B-O O-NP
and B-O B-CC
kD B-O B-NP_QP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
the B-O B-S_NP_DT
former B-O B-JJ
" " B-O O-NP
seems B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
related B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Purified B-O B-S_S_NP_VBN
NF-kB B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADJP_RB
able B-O B-JJ
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
to B-O B-PP_TO
the B-O B-NP_DT
TCEd B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-S
but B-O B-CC
TCF-1 B-O B-S_NP_NN
" " B-O O-NP
binds B-O B-VP_VBZ
stronger B-O B-ADVP_ADVP_JJR
" " B-O O-ADVP
than B-O B-PP_IN
NF-kB B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
to B-O B-PP_TO
TCEd B-O B-NP_NN
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
conversion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TCEd B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_DT
' B-O B-LQT
perfect B-O B-JJ
' B-O B-RQT
NF-kB B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VP_VBZ
to B-O B-PP_TO
a B-O B-NP_NP_DT
tighter B-O B-JJR
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kB B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
TCEd B-O B-NP_NN
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
, B-O B-COMMA
as B-O B-VP_PP_IN
a B-O B-NP_DT
functional B-O B-JJ
consequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
to B-O B-PP_TO
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
' B-O B-LQT
converted B-O B-VBN
' B-O B-RQT
TCEd B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
substitution B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
underlined B-O B-VBN
A B-O B-NN
residue B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_DT
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
the B-O B-NP_DT
GGGATTTCACC B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
abolishes B-O B-VP_VP_VBZ
its B-O B-NP_PRPP
T B-O B-ADJP_NN
cell-restricted B-O B-JJ
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
leads B-O B-VP_VBZ
to B-O B-PP_TO
its B-O B-S_NP_PRPP
" " B-O O-NP
functioning B-O B-VP_VBG
in B-O B-PP_IN
both B-O B-NP_CC
El4 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
lymphocyte-specific B-O B-S_NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
the B-O B-NP_DT
TCEd B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Negative B-O B-NP_NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
role B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
65-kDa B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
plus B-O B-CC
50-kDa B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
NF-kappa B-O B-NN
B B-O B-NN
dimer B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Although B-O B-S_SBAR_IN
monocytic B-O B-S_NP_JJ
cells B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
provide B-O B-VP_VB
a B-O B-NP_NP_DT
reservoir B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
viral B-O B-NP_JJ
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
their B-O B-NP_NP_PRPP
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
either B-O B-ADJP_CC
latent B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
restricted B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
or B-O B-CC
productive B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_NP_DT
differences B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
not B-O B-RB
been B-O B-VP_VBN
molecularly B-O B-ADJP_RB
defined B-O B-VBN
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
THP-1 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
restricted B-O B-NP_JJ
HIV B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA-protein B-O B-NP_NP_JJ
binding B-O B-NN
complex B-O B-NN
formation B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
HIV-1 B-O B-NN
promoter-enhancer B-O B-NN
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
binding B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
localized B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
NF-kappa B-O B-NN
B B-O B-NN
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
the B-O B-S_NP_DT
65-kDa B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
plus B-O B-CC
50-kDa B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
NF-kappa B-O B-NN
B B-O B-NN
heterodimer B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
preferentially B-O B-ADJP_RB
lost B-O B-VBN
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Adding B-O B-S_S_NP_VP_VBG
purified B-O B-NP_VBN
NF-kappa B-O B-NN
B B-O B-NN
protein B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
restricted B-O B-NP_JJ
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
overcomes B-O B-VP_VBZ
this B-O B-NP_NP_DT
lack B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
binding B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
treatment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
sodium B-O B-NP_NN
deoxycholate B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
restored B-O B-VP_VBD
their B-O B-NP_PRPP
ability B-O B-NN
to B-O B-S_NP_VP_TO
form B-O B-VP_VB
the B-O B-NP_DT
heterodimer B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
treatment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
had B-O B-S_NP_VP_VBD
restricted B-O B-NP_JJ
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
lipopolysaccharide B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBD
viral B-O B-NP_NP_JJ
production B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Antiserum B-O B-S_NP_NP_NP_NN
" " B-O O-NP
specific B-O B-ADJP_JJ
for B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
c-rel-specific B-O B-NP_JJ
antiserum B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
disrupted B-O B-VP_VBD
heterodimer B-O B-NP_NN
complex B-O B-NN
formation B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
both B-O B-NP_DT
NF-kappa B-O B-ADJP_NN
B-binding B-O B-JJ
" " B-O O-ADJP
complexes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
needed B-O B-VP_VBN
for B-O B-NP_PP_IN
optimal B-O B-NP_JJ
viral B-O B-JJ
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Binding B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
65-kDa B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
plus B-O B-CC
50-kDa B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
heterodimer B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
HIV-1 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
negatively B-O B-ADVP_RB
" " B-O O-ADVP
regulated B-O B-VP_VBN
in B-O B-NP_PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
providing B-O B-S_NP_VP_VBG
one B-O B-NP_NP_CD
mechanism B-O B-NN
" " B-O O-NP
restricting B-O B-VP_VBG
HIV-1 B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Isolation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_NP_DT
candidate B-O B-NN
repressor/activator B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
NF-E1 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
YY-1 B-O B-NP_NN
, B-O B-COMMA
delta B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
immunoglobulin B-O B-NN
kappa B-O B-NN
3' B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
immunoglobulin B-O B-NN
heavy-chain B-O B-NN
mu B-O B-NN
E1 B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
determined B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
developmental B-O B-JJ
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immunoglobulin B-O B-NP_NN
kappa B-O B-NN
3' B-O B-JJ
enhancer B-O B-NN
( B-O B-LRB
kappa B-O B-NN
E3' B-O B-NN
) B-O B-RRB
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
result B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
central B-O B-JJ
core B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
kappa B-O B-NN
E3' B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
active B-O B-ADJP_JJ
" " B-O O-ADJP
at B-O B-PP_IN
the B-O B-NP_DT
pre-B-cell B-O B-JJ
stage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CC
is B-O B-VP_VBZ
repressed B-O B-VP_VBN
by B-O B-NP_PP_IN
flanking B-O B-NP_VBG
negative-acting B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
negative-acting B-O B-JJ
sequences B-O B-NNS
" " B-O O-NP
repress B-O B-VP_VBP
enhancer B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
position- B-O B-ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
orientation-independent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
the B-O B-NP_DT
pre-B-cell B-O B-JJ
stage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
isolated B-O B-VP_VBN
a B-O B-NP_NP_DT
human B-O B-JJ
cDNA B-O B-NN
clone B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
a B-O B-NP_NP_NP_DT
zinc B-O B-NN
finger B-O B-NN
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-E1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
protein B-O B-NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
binds B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_DT
immunoglobulin B-O B-NN
heavy-chain B-O B-NN
enhancer B-O B-NN
mu B-O B-NN
E1 B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-E1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
encoded B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_NP_DT
same B-O B-JJ
gene B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
the B-O B-NP_DT
YY-1 B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-E1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
the B-O B-NP_NP_DT
human B-O B-JJ
homologue B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
mouse B-O B-NN
delta B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
ribosomal B-O B-NP_JJ
protein B-O B-NN
gene B-O B-NN
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
predicted B-O B-VBN
amino B-O B-NN
acid B-O B-NN
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contains B-O B-VP_VBZ
features B-O B-NP_NP_NNS
" " B-O O-NP
characteristic B-O B-ADJP_JJ
of B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
activators B-O B-NNS
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
transcriptional B-O B-NP_JJ
repressors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cotransfection B-O B-S_NP_NP_NN
studies B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
this B-O B-NP_DT
cDNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
can B-O B-VP_MD
repress B-O B-VP_VB
basal B-O B-NP_JJ
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
apparent B-O B-JJ
dual B-O B-JJ
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
discussed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Glucocorticoid B-O B-NP_NP_NN
resistance B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
chronic B-O B-NP_JJ
asthma B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Glucocorticoid B-O B-NP_NP_NN
pharmacokinetics B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
characteristics B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
T B-O B-NN
cell B-O B-NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
A B-O B-S_NP_NP_DT
total B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
37 B-O B-NP_NP_CD
chronic B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
severe B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
nonsmoking B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
asthmatic B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
documented B-O B-NP_JJ
reversible B-O B-JJ
airways B-O B-NNS
obstruction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
classified B-O B-VP_VBN
as B-O B-NP_PP_IN
glucocorticoid-sensitive B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
-resistant B-O B-ADJP_NP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-DT
basis B-O B-NN
of B-O B-IN
changes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
FEV1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
FVC B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
peak B-O B-NP_NP_JJ
expiratory B-O B-NN
flow B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
oral B-O B-NP_JJ
prednisolone B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
resistant B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
no B-O B-NP_NP_DT
significant B-O B-JJ
improvements B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
airflow B-O B-NP_NN
limitation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Phytohemagglutinin B-O B-S_NP_NP_ADJP_NN
( B-O B-LRB
PHA B-O B-NN
) B-O B-RRB
-induced B-O B-JJ
" " B-O O-ADJP
proliferation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_NP_NP_DT
sensitive B-O B-JJ
" " B-O B-NP_O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
resistant B-O B-JJ
" " B-O B-NP_O-NP
" " B-O O-NP
asthmatic B-O B-NP_JJ
patients B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
( B-O B-PRN_LRB
p B-O B-S_NP_NN
" " B-O O-NP
less B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
0.01 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADVP
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
dexamethasone B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
10(-7) B-O B-NP_CD
mol/L B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
reflecting B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
shift B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
dose-response B-O B-JJ
curve B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
all B-O B-S_NP_PDT
the B-O B-DT
asthmatic B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
analyzed B-O B-VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_NP_DT
significant B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_NP_DT
degree B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
sensitivity B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
to B-O B-NP_PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
clinical B-O B-JJ
responsiveness B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
prednisolone B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
p B-O B-S_NP_NN
" " B-O O-NP
less B-O B-ADJP_ADJP_RBR
" " B-O O-ADJP
than B-O B-PP_IN
0.01 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_DT
differences B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
observed B-O B-VP_VBN
between B-O B-NP_PP_IN
six B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
sensitive B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
resistant B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
clearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
plasma B-O B-NP_NP_NN
prednisolone B-O B-JJ
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Peripheral B-O B-S_NP_JJ
blood B-O B-NN
mononuclear B-O B-JJ
cell B-O B-NN
glucocorticoid B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
characterized B-O B-VP_VBN
in B-O B-NP_PP_IN
five B-O B-NP_NP_NP_CD
sensitive B-O B-JJ
" " B-O B-NP_O-NP
and B-O B-CC
seven B-O B-NP_CD
resistant B-O B-JJ
" " B-O B-NP_O-NP
" " B-O O-NP
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
numbers B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
binding B-O B-NP_NN
affinities B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
not B-O B-RB
account B-O B-VP_VB
for B-O B-PP_IN
the B-O B-NP_NP_DT
observed B-O B-VBN
difference B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
susceptibility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
" " B-O B-NP_NP_PP_ADJP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
clinical B-O B-S_NP_NP_JJ
glucocorticoid B-O B-NN
resistance B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
chronic B-O B-NP_JJ
asthma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
does B-O B-VP_VP_VBZ
not B-O B-RB
reflect B-O B-VP_VB
abnormal B-O B-NP_JJ
glucocorticoid B-O B-NN
clearance B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
but B-O B-CC
may B-O B-VP_MD
be B-O B-VP_VB
due B-O B-PP_JJ
partly B-O B-ADVP_ADVP_RB
" " B-O O-ADVP
to B-O B-TO
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
lack B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
sensitivity B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
unexplained B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
but B-O B-CC
is B-O B-VP_VBZ
not B-O B-RB
attributable B-O B-ADJP_JJ
to B-O B-PP_TO
abnormalities B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
cellular B-O B-NP_JJ
glucocorticoid B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
interleukin-1 B-O B-NP_NN
beta B-O B-NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
the B-O B-S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
depends B-O B-VP_VBZ
on B-O B-PP_IN
the B-O B-NP_DT
activation B-O B-NN
signal B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
Glucocorticoids B-O B-S_NP_NNS
" " B-O O-NP
are B-O B-VP_VBP
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
downregulate B-O B-VP_VB
interleukin-1 B-O B-NP_NP_NN
beta B-O B-NN
production B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
two B-O B-NP_NP_CD
different B-O B-JJ
mechanims B-O B-NNS
" " B-O O-NP
: B-O B-COLON
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Now B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
nature B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
monocyte B-O B-NN
activating B-O B-NN
signal B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
these B-O B-NP_DT
two B-O B-CD
inhibitory B-O B-JJ
mechanims B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
human B-O B-S_NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
preincubated B-O B-VP_VP_VBN
with B-O B-NP_PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
1 B-O B-NP_CD
hour B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
and B-O B-CC
then B-O B-RB
stimulated B-O B-VP_VBN
either B-O B-NP_PP_CC
with B-O B-IN
bacterial B-O B-NP_NP_JJ
lipopolysaccharide B-O B-NN
" " B-O O-NP
or B-O B-CC
phorbol B-O B-NP_NN
myristate B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
that B-O B-SBAR_IN
dexamethasone B-O B-S_S_NP_NN
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_DT
lipopolysaccharide-induced B-O B-JJ
interleukin-1 B-O B-NN
beta B-O B-NN
protein B-O B-NN
production B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
the B-O B-S_NP_DT
phorbol B-O B-ADJP_NN
myristate-induced B-O B-JJ
" " B-O O-ADJP
production B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
increased B-O B-VP_VBN
fold B-O B-NP_NP_QP_RB
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
difference B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
seen B-O B-VP_VBN
at B-O B-NP_PP_IN
the B-O B-NP_DT
mRNA B-O B-NN
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
dexamethasone B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
added B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
cultures B-O B-NNS
" " B-O O-NP
" " B-O O-PP
3 B-O B-PP_NP_CD
hours B-O B-NNS
" " B-O O-NP
after B-O B-IN
the B-O B-NP_DT
stimulators B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
clearly B-O B-ADVP_RB
" " B-O O-ADVP
decreased B-O B-VP_VBD
the B-O B-NP_DT
interleukin-1 B-O B-NN
beta B-O B-NN
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
regardless B-O B-ADVP_RB
of B-O B-PP_IN
the B-O B-NP_NP_DT
stimulator B-O B-NN
" " B-O O-NP
used B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
( B-O B-LRB
although B-O B-SBAR_IN
the B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
clearly B-O B-ADJP_RB
weaker B-O B-JJR
" " B-O O-ADJP
on B-O B-PP_IN
the B-O B-NP_DT
PMA-induced B-O B-JJ
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
) B-O B-RRB
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
these B-O B-NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_S_NP_NP_DT
phorbol B-O B-ADJP_NN
myristate-induced B-O B-JJ
" " B-O O-ADJP
signal B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
prolonged B-O B-FRAG_NP_JJ
protein B-O B-NN
kinase B-O B-NN
C B-O B-NN
activation B-O B-NN
" " B-O O-NP
? B-O B-PERIOD
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
can B-O B-VP_MD
not B-O B-RB
be B-O B-VP_VB
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
protects B-O B-VP_VBZ
the B-O B-NP_DT
induced B-O B-VBN
mRNA B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
degradative B-O B-JJ
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Identification B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
suppressor B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bind B-O B-S_NP_VP_VBP
to B-O B-PP_TO
the B-O B-NP_NP_DT
negative B-O B-JJ
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Two B-O B-S_NP_NP_CD
different B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
independently B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
bound B-O B-VP_VBD
to B-O B-PP_TO
neighboring B-O B-NP_NP_VBG
sequences B-O B-NNS
" " B-O O-NP
within B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
nuclear B-O B-JJ
extract B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
virus-infected B-O B-JJ
human B-O B-JJ
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
bound B-O B-VP_VBD
to B-O B-PP_TO
a B-O B-NP_DT
novel B-O B-JJ
dyad B-O B-NN
symmetrical B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_DT
sequence B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
well B-O B-ADVP_RB
" " B-O O-ADVP
conserved B-O B-VP_VBN
in B-O B-NP_PP_IN
various B-O B-NP_JJ
HIV-1 B-O B-NN
isolates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
partial B-O B-S_NP_JJ
homology B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
promoter B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
retinoblastoma B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_NP_JJ
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
virus-uninfected B-O B-NP_JJ
human B-O B-JJ
T B-O B-NP_NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
and B-O B-CC
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
means B-O B-NNS
of B-O B-IN
a B-O B-NP_DT
gel B-O B-NN
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
other B-O B-JJ
factor B-O B-NN
" " B-O O-NP
bound B-O B-VP_VBN
to B-O B-PP_TO
a B-O B-NP_NP_DT
putative B-O B-JJ
AP-1 B-O B-NN
recognition B-O B-NN
sequence B-O B-NN
" " B-O O-NP
predicted B-O B-VP_VBD
for B-O B-NP_PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NN
NRE B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
this B-O B-NP_DT
factor B-O B-NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
bind B-O B-VP_VB
to B-O B-PP_TO
a B-O B-NP_DT
typical B-O B-JJ
AP-1 B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
insertion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
multiple B-O B-NP_NP_JJ
copies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
or B-O B-ADJP_ADJP_CC
factor B-O B-ADJP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
a B-O B-NP_DT
heterologous B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reduced B-O B-VP_VBD
the B-O B-NP_DT
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
one-tenth B-O B-NP_NP_CD
" " B-O O-NP
or B-O B-CC
one-third B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
each B-O B-NP_DT
factor B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
function B-O B-VP_VB
as B-O B-PP_IN
a B-O B-NP_NP_DT
novel B-O B-JJ
negative B-O B-JJ
regulator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Constitutive B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kB B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
thymocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
NF-kB B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
eukaryotic B-O B-JJ
transcription B-O B-NN
regulatory B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
T B-O B-NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
NF-kB B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
bound B-O B-VP_VBN
to B-O B-NP_PP_TO
a B-O B-NP_NP_DT
cytoplasmic B-O B-JJ
proteic B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
IkB B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
mitogens B-O B-NP_NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
phorbol B-O B-NP_NN
esters B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
or B-O B-CC
cytokines B-O B-NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
NF-kB B-O B-NP_NP_NN
nuclear B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
subsequent B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kB B-O B-NP_ADJP_NN
dependent B-O B-JJ
" " B-O O-ADJP
T B-O B-NN
cell B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kB B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cell B-O B-NN
thymic B-O B-JJ
progenitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
differences B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
(Ca2+)i B-O B-NP_NP_NN
requirement B-O B-NN
" " B-O O-NP
for B-O B-IN
NF-kB B-O B-NP_NP_NN
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
thymocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
as B-O B-SBAR_IN
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
mature B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
our B-O B-NP_PRPP
results B-O B-NNS
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
thymocytes B-O B-S_NP_NNS
" " B-O O-NP
have B-O B-VP_VBP
a B-O B-NP_NP_DT
constitutively B-O B-ADJP_RB
active B-O B-JJ
" " B-O O-ADJP
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kB B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
are B-O B-VP_VBP
activated B-O B-VP_VBN
in B-O B-NP_ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Glucocorticoid B-O B-NP_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
mononuclear B-O B-NP_NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
Alzheimer B-O B-NP_NN
's B-O B-POS
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Several B-O B-S_S_NP_NP_JJ
lines B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
evidence B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggest B-O B-VP_VBP
disturbances B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
hypothalamic-pituitary-adrenal B-O B-NP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
system B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Alzheimer B-O B-NP_NP_NN
's B-O B-POS
disease B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
an B-O B-NP_NP_DT
exploration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
potential B-O B-JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
AD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
GR B-O B-NP_NN
density B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
affinity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
assessed B-O B-VP_VBN
on B-O B-NP_PP_IN
mononuclear B-O B-NP_NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
12 B-O B-NP_NP_CD
AD B-O B-NN
patients B-O B-NNS
" " B-O O-NP
and B-O B-CC
12 B-O B-NP_CD
healthy B-O B-JJ
controls B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
GR B-O B-S_NP_NN
binding B-O B-NN
characteristics B-O B-NNS
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
differ B-O B-VP_VB
between B-O B-PP_PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
controls B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
between B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
subdivided B-O B-VP_VBN
according B-O B-NP_PP_VBG
to B-O B-PP_TO
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
abnormalities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
HPA B-O B-NN
system B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
AD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
related B-O B-ADJP_JJ
to B-O B-PP_TO
a B-O B-NP_DT
GR B-O B-NN
deficiency B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Sex B-O B-NP_NP_NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
age B-O B-NP_NN
" " B-O B-NP_O-NP
distribution B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
normal B-O B-NP_JJ
human B-O B-JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Specific B-O B-S_S_NP_NP_JJ
receptors B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
1,25 B-O B-NP_CD
Dihydroxyvitamin B-O B-NN
D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
described B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_JJ
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
tried B-O B-VP_VBN
to B-O B-S_NP_VP_TO
find B-O B-VP_VB
out B-O B-PRT_RP
" " B-O O-PRT
whether B-O B-SBAR_IN
these B-O B-S_NP_DT
receptors B-O B-NNS
" " B-O O-NP
could B-O B-VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Twenty B-O B-S_NP_NP_NP_NP_QP_CD
two B-O B-CD
" " B-O O-QP
healthy B-O B-JJ
men B-O B-NNS
" " B-O O-NP
aged B-O B-ADJP_JJ
21-66 B-O B-NP_QP_CD
" " B-O O-QP
yr B-O B-NN
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
( B-O B-PRN_LRB
mean B-O B-NP_NP_NN
+/- B-O B-CC
SD B-O B-NN
" " B-O O-NP
41.0 B-O B-NP_CD
+/- B-O B-CC
13.6 B-O B-CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
nineteen B-O B-NP_NP_NP_CD
healthy B-O B-JJ
women B-O B-NNS
" " B-O O-NP
aged B-O B-ADJP_JJ
22-60 B-O B-NP_QP_CD
" " B-O O-QP
yr B-O B-NN
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
( B-O B-PRN_LRB
38.9 B-O B-NP_NP_NP_CD
+/- B-O B-CC
13.9 B-O B-CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_S_NP_NP_DT
mean B-O B-NN
dissociation B-O B-NN
constant B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Kd B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
similar B-O B-ADJP_JJ
in B-O B-PP_IN
both B-O B-NP_DT
sexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
1.35 B-O B-NP_NP_NP_QP_CD
+/- B-O B-CC
0.70 B-O B-CD
x B-O B-CC
10(-10) B-O B-CD
" " B-O O-QP
M B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
males B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
1.13 B-O B-NP_NP_QP_CD
+/- B-O B-CC
0.66 B-O B-CD
x B-O B-CC
10(-10) B-O B-CD
" " B-O O-QP
M B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
females B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
the B-O B-S_S_NP_NP_NP_DT
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
binding B-O B-NP_VBG
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
Nmax B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADJP_RB
lower B-O B-JJR
in B-O B-PP_IN
females B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
2.32 B-O B-NP_NP_NP_ADJP_QP_CD
+/- B-O B-CC
0.92 B-O B-CD
" " B-O O-QP
fmol/10(7) B-O B-CD
" " B-O O-ADJP
PBMC B-O B-NNS
" " B-O O-NP
vs B-O B-CC
4.43 B-O B-NP_NP_ADJP_QP_CD
+/- B-O B-CC
1.38 B-O B-CD
" " B-O O-QP
fmol/10(7) B-O B-NN
" " B-O O-ADJP
PBMC B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
males B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
p B-O B-NP_NP_NN
" " B-O O-NP
= B-O B-ADJP_JJ
0.0001 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Neither B-O B-S_NP_CC
Kd B-O B-NP_NN
" " B-O O-NP
nor B-O B-CC
Nmax B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
age B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_DT
difference B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
between B-O B-NP_PP_IN
pre B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
postmenopausal B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
women B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
needed B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
elucidate B-O B-VP_VB
if B-O B-SBAR_IN
this B-O B-S_NP_NP_DT
sex B-O B-NN
difference B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
is B-O B-VP_VBZ
of B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Suppression B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
signals B-O B-NP_NP_NNS
" " B-O O-NP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Transient B-O B-S_S_NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
short-term B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
Tax B-O B-NN
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type-I B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-I B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
pleiotropic B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Consistent B-O B-S_ADVP_JJ
with B-O B-PP_IN
findings B-O B-NP_NP_NNS
" " B-O O-NP
obtained B-O B-VP_VBN
with B-O B-NP_PP_IN
transient B-O B-NP_JJ
expression B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
marked B-O B-NP_NP_JJ
accumulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
nucleus B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Namalwa B-O B-NP_NP_NN
B B-O B-NN
lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_ADVP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
NF-kappa B-O B-NP_NN
B B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
following B-O B-PP_VBG
long-term B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Tax B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
mitogens B-O B-NP_NNS
" " B-O O-NP
and B-O B-CC
cytokines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
blocked B-O B-VP_VBN
in B-O B-NP_PP_IN
Jurkat B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
constitutively B-O B-VP_ADVP_RB
" " B-O O-ADVP
expressing B-O B-VBG
Tax B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_NP_JJ
mitogen-inducible B-O B-JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
such B-O B-PP_JJ
as B-O B-IN
Fos B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
unaffected B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
depending B-O B-PP_VBG
on B-O B-PP_IN
the B-O B-NP_DT
cellular B-O B-JJ
environment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
short- B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_NP_O-NP
and B-O B-CC
long-term B-O B-NP_JJ
" " B-O B-NP_O-NP
effects B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
Tax B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
quite B-O B-ADJP_RB
different B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Consequently B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
one B-O B-NP_NP_CD
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Tax B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
infected B-O B-VP_VBN
with B-O B-NP_PP_IN
HTLV-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
might B-O B-VP_MD
involve B-O B-VP_VB
cell-type-specific B-O B-NP_JJ
suppression B-O B-NN
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
as B-O B-SBAR_IN
opposed B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
of B-O B-PP_IN
distinct B-O B-NP_JJ
signal B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
cells B-O B-NNS
lines B-O B-NNS
" " B-O O-NP
described B-O B-VP_VBN
" " B-O B-NP_O-VP
here B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
should B-O B-VP_MD
be B-O B-VP_VB
useful B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_NP_DT
delineation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
signaling B-O B-NP_NP_NN
pathways B-O B-NNS
" " B-O O-NP
utilized B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
In B-O B-NP_NP_NP_NP_NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
in B-O B-NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
" " B-O B-NP_O-NP
effects B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
lymphocyte B-O B-NP_NP_NN
proliferation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
man B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
relationship B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Interrelations B-O B-S_S_NP_NP_NNS
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
hypothalamic-pituitary-adrenal B-O B-NP_NP_JJ
system B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HPA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
immune B-O B-JJ
system B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
represent B-O B-VP_VBP
a B-O B-NP_DT
well-documented B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
biological B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
phenomenon B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
While B-O B-S_SBAR_IN
in B-O B-S_NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
administration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
inhibit B-O B-VP_VB
concanavalin B-O B-NP_NP_NN
A B-O B-NN
( B-O B-LRB
Con B-O B-NN
A B-O B-NN
) B-O B-RRB
- B-O B-COLON
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
phytohemagglutinin B-O B-NP_ADJP_NN
( B-O B-LRB
PHA B-O B-NN
) B-O B-RRB
-induced B-O B-JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
T-cell B-O B-NP_NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
pokeweed B-O B-S_NP_NN
mitogen B-O B-NN
( B-O B-LRB
PWM B-O B-NN
) B-O B-RRB
-driven B-O B-JJ
B-cell B-O B-NN
mitogenesis B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
relatively B-O B-ADJP_RB
resistant B-O B-JJ
to B-O B-PP_TO
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
further B-O B-ADVP_RB
" " B-O O-ADVP
explore B-O B-VP_VB
the B-O B-NP_DT
link B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
HPA B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
immune B-O B-JJ
system B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
relation B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
dose-response B-O B-S_NP_JJ
curves B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
obtained B-O B-VP_VBN
for B-O B-NP_PP_IN
Con B-O B-NP_NP_NP_NP_NN
A- B-O B-NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
T-cell B-O B-NP_NN
mitogenesis B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
PWM-generated B-O B-NP_JJ
B-cell B-O B-NN
mitogenesis B-O B-NN
" " B-O O-NP
and B-O B-CC
spontaneous B-O B-NP_JJ
lymphocyte B-O B-NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
13 B-O B-NP_CD
healthy B-O B-JJ
controls B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Glucocorticoid B-O B-S_NP_NN
effects B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
assessed B-O B-VP_VBN
in B-O B-NP_ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
by B-O B-PP_PP_IN
depletion B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
endogenous B-O B-NP_JJ
glucocorticoids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
and B-O B-CC
subsequent B-O B-NP_JJ
glucocorticoid B-O B-NN
replacement B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
by B-O B-PP_IN
incubation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
different B-O B-NP_NP_JJ
doses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_NP_NP_NP_DT
significant B-O B-JJ
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
PWM-induced B-O B-NP_JJ
B-cell B-O B-NN
mitogenesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
more B-O B-ADJP_RBR
pronounced B-O B-JJ
" " B-O O-ADJP
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DEX B-O B-NP_NP_NN
" " B-O O-NP
administered B-O B-VP_VBN
in B-O B-NP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
on B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
after B-O B-PP_IN
MET B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
compared B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
DEX B-O B-NP_NP_NN
" " B-O O-NP
plus B-O B-CC
MET B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
pretreated B-O B-JJ
condition B-O B-NN
in B-O B-ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
spontaneous B-O B-NP_JJ
lymphocyte B-O B-NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
related B-O B-ADJP_JJ
to B-O B-PP_TO
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
PWM-generated B-O B-NP_NP_JJ
B-cell B-O B-NN
proliferation B-O B-NN
" " B-O O-NP
following B-O B-PP_VBG
cortisol B-O B-NP_NP_NN
depletion B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
MET B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
connection B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
induction B-O B-NP_NP_ADJP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Anti-Ro(SSA) B-O B-S_S_NP_JJ
autoantibodies B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
T B-O B-NP_NP_NN
cell B-O B-NN
receptor B-O B-NN
beta B-O B-NN
genes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
systemic B-O B-NP_JJ
lupus B-O B-NN
erythematosus B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Several B-O B-S_S_NP_NP_JJ
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
heterogeneous B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
clinical B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
manifestations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
systemic B-O B-NP_JJ
lupus B-O B-NN
erythematosus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
specific B-O B-NP_JJ
autoantibodies B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Associations B-O B-S_NP_NP_NNS
" " B-O O-NP
between B-O B-PP_IN
HLA B-O B-NP_NP_NN
class B-O B-NN
II B-O B-CD
antigens B-O B-NNS
" " B-O O-NP
and B-O B-CC
autoantibodies B-O B-NP_NP_NNS
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
ribonucleoproteins B-O B-NP_NNS
" " B-O O-NP
Ro(SSA) B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
La(SSB) B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
reported B-O B-VP_VBN
in B-O B-NP_PP_IN
these B-O B-NP_DT
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
HLA B-O B-S_NP_NN
class B-O B-NN
II B-O B-CD
molecules B-O B-NNS
" " B-O O-NP
present B-O B-VP_VBP
antigen B-O B-NP_NN
" " B-O O-NP
to B-O B-PP_TO
T B-O B-NP_NP_NN
cell B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
TCRs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
searched B-O B-VP_VBN
for B-O B-PP_IN
a B-O B-NP_NP_DT
TCR B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_S_NP_NP_DT
pair B-O B-NN
of B-O B-PP_IN
restriction B-O B-NP_NP_NN
fragment B-O B-NN
length B-O B-NN
polymorphisms B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
RFLPs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
one B-O B-SBAR_SBAR_WHNP_NP_CD
" " B-O O-NP
of B-O B-WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
" " B-O O-WHNP
hybridizes B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
the B-O B-SBAR_S_NP_NP_DT
other B-O B-JJ
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
these B-O B-COMP_S_NP_DT
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
RFLP B-O B-NP_NN
pair B-O B-NN
" " B-O O-NP
" " B-O O-NP
occurs B-O B-VP_VBZ
in B-O B-PP_IN
76 B-O B-NP_NP_NP_CD
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
precipitins B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
84 B-O B-NP_NP_CD
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
anti-Ro(SSA)-positive B-O B-NP_NP_JJ
patients B-O B-NNS
" " B-O O-NP
lacking B-O B-VP_VBG
" " B-O B-NP_NP_NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CC
only B-O B-NP_NP_QP_RB
41 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
patients B-O B-NNS
" " B-O O-NP
lacking B-O B-VP_VBG
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
) B-O B-NP_NP_ADJP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
disproportionate B-O B-JJ
occurrence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
subset B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lupus B-O B-NP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicates B-O B-VP_VBZ
that B-O B-SBAR_IN
these B-O B-S_NP_DT
RFLPs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VP_VBP
not B-O B-RB
disease B-O B-NP_NN
susceptibility B-O B-NN
markers B-O B-NNS
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
rather B-O B-ADVP_RB
" " B-O O-ADVP
are B-O B-VP_VBP
important B-O B-NP_NP_JJ
markers B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
majority B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
who B-O B-SBAR_WHNP_WP
" " B-O O-WHNP
have B-O B-S_NP_VP_VBP
these B-O B-NP_NP_NP_DT
RFLPs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
HLA B-O B-NP_NN
class B-O B-NN
II B-O B-CD
antigens B-O B-NNS
" " B-O O-NP
" " B-O O-NP
previously B-O B-VP_ADVP_RB
" " B-O O-ADVP
associated B-O B-VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
anti-Ro(SSA) B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
make B-O B-VP_VBP
this B-O B-NP_DT
antibody B-O B-NN
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
interactions B-O B-S_NP_NP_NNS
" " B-O O-NP
between B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
occur B-O B-VP_VBP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Steroid B-O B-S_S_NP_NP_NN
mediated B-O B-JJ
lysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphoblasts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VBZ
the B-O B-NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
steroid B-O B-NN
hormone B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Glucocorticoids B-O B-S_S_S_NP_NNS
" " B-O O-NP
kill B-O B-VP_VBP
certain B-O B-NP_NP_JJ
types B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
lymphoblasts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
the B-O B-S_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
unknown B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
clear B-O B-ADJP_JJ
" " B-O O-ADJP
that B-O B-SBAR_IN
sufficient B-O B-S_NP_NP_JJ
numbers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
functional B-O B-NP_JJ
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
mediate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
whether B-O B-S_SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
do B-O B-VP_VBP
so B-O B-ADVP_RB
" " B-O O-ADVP
through B-O B-PP_IN
the B-O B-NP_NP_NP_DT
classical B-O B-JJ
model B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
modulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
has B-O B-VP_VBZ
not B-O B-RB
been B-O B-VP_VBN
established B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
asked B-O B-VP_VBN
which B-O B-SBAR_S_NP_WHNP_WDT
region B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-WHNP
of B-O B-PP_IN
the B-O B-NP_DT
steroid B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
important B-O B-ADJP_JJ
for B-O B-NP_PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CEM-ICR B-O B-S_NP_NP_NN
27 B-O B-CD
leukemic B-O B-JJ
lymphoblasts B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
clone B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CEM B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
lack B-O B-S_NP_VP_VP_VBP
functional B-O B-NP_JJ
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
therefore B-O B-ADVP_RB
" " B-O O-ADVP
are B-O B-VP_VBP
neither B-O B-CC
lysed B-O B-UCP_VP_VBN
nor B-O B-NP_PP_CC
capable B-O B-ADJP_JJ
" " B-O B-PP_O-UCP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
provided B-O B-VP_VBN
with B-O B-NP_PP_IN
steroid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
DNA B-O B-NP_NP_NN
transfections B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
various B-O B-NP_JJ
receptor B-O B-NN
gene B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
measured B-O B-VP_VBD
steroid B-O B-NP_NP_NP_NN
mediated B-O B-JJ
lysis B-O B-NN
" " B-O O-NP
, B-O B-COMMA
receptor B-O B-NP_NN
number B-O B-NN
" " B-O O-NP
and B-O B-CC
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
glutamine B-O B-NP_NN
synthetase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
transfected B-O B-NP_VBN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
provide B-O B-VP_VBP
evidence B-O B-NP_NN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
lysis B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
ICR27 B-O B-NP_NN
lymphoblasts B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
restored B-O B-VP_VBN
" " B-O B-NP_O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
functional B-O B-S_NP_JJ
receptor B-O B-NN
number B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
DNA B-O B-NP_NN
binding B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
specifying B-O B-VP_VBG
high B-O B-NP_NP_JJ
affinity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
GRE B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Lysis B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
any B-O B-NP_NP_DT
steroid B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
allows B-O B-S_NP_VP_VBZ
for B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
data B-O B-NNS
" " B-O O-NP
support B-O B-VP_VBP
the B-O B-NP_DT
view B-O B-NN
that B-O B-SBAR_IN
steroid-mediated B-O B-S_NP_JJ
cell B-O B-NN
death B-O B-NN
" " B-O O-NP
occurs B-O B-VP_VBZ
by B-O B-PP_IN
a B-O B-NP_NP_DT
process B-O B-NN
" " B-O O-NP
requiring B-O B-VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Increased B-O B-NP_NP_NP_VBN
glucocorticoid B-O B-NN
responsiveness B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD4+ B-O B-NP_NP_JJ
T-cell B-O B-NN
clonal B-O B-JJ
lines B-O B-NNS
" " B-O O-NP
grown B-O B-VP_VBN
in B-O B-NP_PP_IN
serum-free B-O B-NP_JJ
media B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
CEM-C7 B-O B-S_S_NP_NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
human B-O B-NP_JJ
leukemic B-O B-JJ
CD4+ B-O B-JJ
T-lymphocyte B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
three B-O B-NP_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_PRPP
subclones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
CEM-4R4 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
CEM-3R43 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
ICR-27 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
previously B-O B-VP_ADVP_RB
" " B-O O-ADVP
cultured B-O B-VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
medium B-O B-NN
" " B-O O-NP
supplemented B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
adapted B-O B-VP_VBN
to B-O B-NP_PP_TO
serum-free B-O B-NP_JJ
media B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
best B-O B-JJS
medium B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
RPMI B-O B-NP_NP_NN
1640 B-O B-CD
" " B-O O-NP
supplemented B-O B-VP_VBN
with B-O B-NP_PP_IN
5 B-O B-NP_NP_NP_ADJP_CD
micrograms/ml B-O B-NNS
" " B-O O-ADJP
each B-O B-DT
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
+ B-O B-CC
5 B-O B-NP_ADJP_CD
ng/ml B-O B-NN
" " B-O O-ADJP
sodium B-O B-NN
selenite B-O B-NN
" " B-O O-NP
" " B-O O-NP
+/- B-O B-CC
0.1 B-O B-NP_ADJP_CD
% B-O B-NN
" " B-O O-ADJP
bovine B-O B-NP_JJ
serum B-O B-NN
albumin B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
While B-O B-S_SBAR_IN
growing B-O B-S_NP_VP_VBG
either B-O B-PP_CC
with B-O B-PP_IN
" " B-O B-NP_O-PP
or B-O B-CC
without B-O B-PP_IN
" " B-O B-NP_O-PP
albumin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
several B-O B-JJ
clonal B-O B-NP_JJ
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
CEM B-O B-NP_NP_NN
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
displayed B-O B-VP_VBD
growth B-O B-NP_NP_NN
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
serum-supplemented B-O B-NP_JJ
cultures B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Cell B-O B-S_NP_NP_NN
proliferation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CEM-C7 B-O B-NP_NP_NP_NN
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
cultured B-O B-VP_VBN
in B-O B-NP_PP_IN
both B-O B-NP_DT
serum-free B-O B-JJ
media B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
sustained B-O B-VP_JJ
for B-O B-NP_PP_IN
3 B-O B-NP_CD
mo. B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
culture B-O B-NP_NP_NN
doubling B-O B-VBG
times B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
about B-O B-NP_QP_RB
25 B-O B-CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
both B-O B-NP_CC
" " B-O B-NP_ADJP_NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
cultures B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
viability B-O B-NP_NP_NN
" " B-O O-NP
greater B-O B-ADJP_ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-ADJP
or B-O B-CC
equal B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-PP
" " B-O O-ADJP
90 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cell B-O B-S_NP_NN
morphology B-O B-NN
" " B-O O-NP
remained B-O B-VP_VBD
essentially B-O B-NP_ADVP_RB
" " B-O O-ADVP
the B-O B-DT
same B-O B-JJ
" " B-O O-NP
in B-O B-PP_IN
serum-free B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
or B-O B-CC
serum B-O B-NP_ADJP_NN
containing B-O B-NN
" " B-O O-ADJP
" " B-O B-NP_O-NP
media B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD4 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
marker B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
T-derived B-O B-NP_JJ
lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
significantly B-O B-ADJP_RB
different B-O B-JJ
in B-O B-PP_IN
serum-free B-O B-NP_JJ
medium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
grown B-O B-S_NP_VP_VBN
in B-O B-NP_PP_IN
serum-free B-O B-NP_JJ
medium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
CEM-C7 B-O B-S_NP_NP_NN
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
exhibited B-O B-VP_VBD
increased B-O B-NP_VBN
steroid B-O B-NN
responsiveness B-O B-NN
" " B-O O-NP
as B-O B-SBAR_IN
evidenced B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
increased B-O B-NP_NP_VBN
binding B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
, B-O B-NP_NP_PP_COMMA
and B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Receptor B-O B-S_NP_NP_NN
mutant B-O B-NN
subclones B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
CEM-C7 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
proven B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-ADJP_O-VP
" " B-O O-S
" " B-O O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
grown B-O B-S_NP_VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
become B-O B-VP_VBP
partially B-O B-ADJP_RB
sensitive B-O B-JJ
to B-O B-PP_TO
the B-O B-NP_DT
hormone B-O B-NN
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
growth B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
defined B-O B-NP_VBN
medium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
increased B-O B-VBN
sensitivity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CEM-C7 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
its B-O B-NP_PRPP
subclones B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
serum-free B-O B-NP_JJ
medium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
returned B-O B-VP_VBD
to B-O B-PP_TO
previous B-O B-NP_JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
these B-O B-S_NP_DT
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
recultured B-O B-VP_VBN
in B-O B-NP_PP_IN
serum-containing B-O B-NP_JJ
medium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
substances B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
serum B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
influence B-O B-VP_VBP
steroid B-O B-NP_NN
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
molecular B-O B-JJ
details B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
hormone B-O B-NN
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
pursued B-O B-VP_VBN
more B-O B-NP_ADVP_RBR
precisely B-O B-RB
" " B-O O-ADVP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Stimulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
2 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
cytomegalovirus B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
HIV-2 B-O B-NP_NN
transactivator B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
Human B-O B-S_S_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
often B-O B-ADVP_RB
" " B-O O-ADVP
causes B-O B-VP_VBZ
latent B-O B-NP_JJ
infection B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Transactivation B-O B-S_NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
some B-O B-NP_DT
DNA B-O B-NN
viruses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
implicated B-O B-VP_VBN
in B-O B-NP_PP_IN
inducing B-O B-S_NP_VP_VBG
HIV-1 B-O B-NP_NN
replication B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
pathogenesis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
transactivator B-O B-NP_NN
( B-O B-LRB
IE-2 B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
cytomegalovirus B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
CMV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
enhance B-O B-VP_VB
HIV-2 B-O B-NP_NP_NN
" " B-O B-NP_O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
HIV-1 B-O B-NP_NN
" " B-O B-NP_O-NP
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
inducer B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
act B-O B-VP_VB
in B-O B-PP_IN
concert B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
HIV-2 B-O B-NP_NN
tat B-O B-NN
gene B-O B-NN
" " B-O O-NP
and B-O B-CC
T-cell B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
enhancing B-O B-S_NP_VP_VBG
gene B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
CD4+ B-O B-JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
While B-O B-S_SBAR_IN
the B-O B-S_NP_NP_DT
HIV-2 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
HIV-1 B-O B-NP_NN
tat B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
T-cell B-O B-NP_NN
activators B-O B-NNS
" " B-O O-NP
" " B-O O-NP
apparently B-O B-ADVP_RB
" " B-O O-ADVP
employ B-O B-VP_VBP
independent B-O B-NP_NP_JJ
modes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
CMV B-O B-NP_NN
transactivator B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
combination B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
HIV-2 B-O B-NP_NN
tat B-O B-NN
" " B-O O-NP
or B-O B-CC
T-cell B-O B-NP_NN
activators B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
employ B-O B-VP_VB
a B-O B-NP_NP_DT
gene B-O B-NN
activation B-O B-NN
pathway B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
some B-O B-NP_NP_ADJP_DT
common B-O B-JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
some B-O B-NP_ADJP_DT
distinct B-O B-JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
components B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
HIV-2 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
CMV B-O B-NP_NN
transactivators B-O B-NNS
" " B-O O-NP
" " B-O O-NP
enhance B-O B-VP_VBP
HIV-2 B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
involving B-O B-VP_VBG
transcript B-O B-NP_NN
initiation B-O B-NP_NN
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
elongation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
with B-O B-PP_IN
CMV B-O B-S_NP_NN
transactivator B-O B-NN
" " B-O O-NP
affecting B-O B-VP_VBG
elongation B-O B-NP_NN
" " B-O O-NP
more B-O B-ADVP_ADVP_JJR
" " B-O O-ADVP
than B-O B-PP_IN
the B-O B-NP_DT
initiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
significant B-O B-JJ
proportion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcripts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appear B-O B-VP_VBP
to B-O B-S_NP_VP_TO
terminate B-O B-VP_VB
prematurely B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transactivators B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletion B-O B-S_NP_NP_NN
mutation B-O B-NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
HIV-2 B-O B-NP_NN
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
LTR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
element B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
responds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
either B-O B-UCP_CC
a B-O B-NP_DT
diffuse B-O B-JJ
one B-O B-CD
" " B-O O-NP
or B-O B-CC
located B-O B-ADJP_JJ
downstream B-O B-ADVP_RB
of B-O B-PP_IN
" " B-O B-NP_O-ADVP
" " B-O O-ADJP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Oncogene B-O B-S_S_NP_NN
amplification B-O B-NN
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
dense B-O B-NP_NP_JJ
lymphocyte B-O B-NN
infiltration B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
breast B-O B-NN
cancers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
a B-O B-FRAG_NP_NP_DT
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
hematopoietic B-O B-NP_NP_JJ
growth B-O B-NN
factor B-O B-NN
release B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
tumor B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
? B-O B-PERIOD
" " B-O O-FRAG
" " B-O O-S
  
One B-O B-S_S_NP_QP_CD
hundred B-O B-CD
six B-O B-CD
" " B-O O-QP
primary B-O B-JJ
breast B-O B-NN
cancer B-O B-NN
samples B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
analysed B-O B-VP_VBN
for B-O B-NP_PP_IN
c-erbB2 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-NP_COMMA
int-2 B-O B-NP_NN
" " B-O O-NP
, B-O B-NP_COMMA
and B-O B-CC
c-myc B-O B-NP_NN
" " B-O B-NP_O-NP
gene B-O B-NP_NN
amplification B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Surgically B-O B-S_NP_ADJP_ADJP_RB
confirmed B-O B-VBN
" " B-O O-ADJP
nodal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
involvement B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
42 B-O B-NP_ADJP_CD
% B-O B-NN
" " B-O O-ADJP
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Level B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NN
amplification B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
by B-O B-NP_PP_IN
Southern B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and/or B-O B-CC
slot B-O B-NP_NN
" " B-O B-NP_O-NP
blot B-O B-NP_NN
techniques B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Amplified B-O B-S_NP_VBN
c-erbB2 B-O B-NN
gene B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
present B-O B-ADJP_JJ
in B-O B-PP_IN
21.5 B-O B-NP_NP_CD
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
all B-O B-NP_DT
samples B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Int-2 B-O B-S_S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
amplified B-O B-VP_VBN
in B-O B-NP_PP_IN
13.1 B-O B-NP_ADJP_CD
% B-O B-NN
" " B-O O-ADJP
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
c-myc B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
amplified B-O B-VP_VBN
in B-O B-NP_PP_IN
10.3 B-O B-NP_ADJP_CD
% B-O B-NN
" " B-O O-ADJP
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
a B-O B-NP_NP_DT
non-parametric B-O B-JJ
test B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Kruskal-Wallis B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
a B-O B-NP_DT
strong B-O B-ADJP_JJ
negative B-O B-JJ
" " B-O O-ADJP
association B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
between B-O B-NP_PP_IN
high B-O B-NP_NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
c-erbB2 B-O B-NP_NN
amplification B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
absence B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_NP_PRN_NP_O-NP
or B-O B-CC
" " B-O B-NP_NP_PRN_NP_O-NP
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_DT
correlations B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
between B-O B-NP_PP_IN
all B-O B-NP_NP_NP_DT
" " B-O B-NP_O-NP
or B-O B-CC
high B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
amplification B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
each B-O B-NP_DT
oncogene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
separately B-O B-UCP_ADVP_RB
" " B-O O-ADVP
or B-O B-CC
combined B-O B-VP_VBN
with B-O B-NP_PP_IN
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
or B-O B-CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-UCP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_NP_DT
trend B-O B-NN
" " B-O O-NP
approaching B-O B-VP_VBG
statistical B-O B-NP_JJ
significance B-O B-NN
" " B-O O-NP
" " B-O O-VP
for B-O B-SBAR_WHNP_IN
patients B-O B-S_NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
c-erbB2 B-O B-NP_NN
amplifications B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-VP_TO
have B-O B-VP_VB
( B-O B-NP_NP_NP_PP_PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
somewhat B-O B-ADJP_RB
surprising B-O B-JJ
" " B-O O-ADJP
finding B-O B-NN
" " B-O O-NP
however B-O B-ADVP_RB
" " B-O O-ADVP
was B-O B-VP_VBD
a B-O B-NP_NP_DT
very B-O B-ADJP_RB
strong B-O B-JJ
" " B-O O-ADJP
association B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
oncogene B-O B-NP_NP_NN
amplification B-O B-NN
" " B-O O-NP
and B-O B-CC
dense B-O B-NP_NP_NP_JJ
lymphocyte B-O B-NN
infiltration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
tumor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-NP_NP_NN
" " B-O O-NP
= B-O B-ADJP_JJ
" " B-O B-NP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
correlation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
even B-O B-ADJP_RB
stronger B-O B-JJR
" " B-O O-ADJP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
only B-O B-S_NP_NP_RB
high B-O B-JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
amplification B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
considered B-O B-VP_VBN
, B-O B-NP_COMMA
either B-O B-CC
for B-O B-PP_IN
each B-O B-NP_DT
oncogene B-O B-NN
" " B-O O-NP
" " B-O O-PP
separately B-O B-UCP_ADVP_ADVP_RB
" " B-O O-ADVP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-ADVP
or B-O B-CC
in B-O B-PP_PP_IN
( B-O B-NP_PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-PP
" " B-O O-UCP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
that B-O B-SBAR_IN
malignant B-O B-S_NP_JJ
cell B-O B-NN
cytokine B-O B-NN
production B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
help B-O B-VP_VB
explain B-O B-S_NP_VP_VB
this B-O B-NP_DT
observation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Human B-O B-NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type-2 B-O B-JJ
gene B-O B-NN
expression B-O B-NN
: B-O B-COLON
" " B-O O-NP
two B-O B-NP_NP_CD
enhancers B-O B-NNS
" " B-O O-NP
and B-O B-CC
their B-O B-NP_NP_PRPP
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
T-cell B-O B-NP_NN
activators B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
viruses B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
HIVs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
include B-O B-VP_VB
a B-O B-NP_NP_DT
spectrum B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
retroviruses B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
varying B-O B-NP_VBG
potential B-O B-NN
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Since B-O B-S_SBAR_IN
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
viruses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
in B-O B-PP_IN
large B-O B-NP_JJ
part B-O B-NN
" " B-O O-NP
" " B-O O-PP
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
sequence B-O B-NN
elements B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
their B-O B-NP_PRPP
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
this B-O B-S_NP_DT
study B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
directed B-O B-VP_VBN
to B-O B-NP_PP_TO
an B-O B-NP_NP_DT
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
HIV-2 B-O B-NN
LTR B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
contain B-O B-VP_VB
two B-O B-NP_CD
enhancers B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
enhancers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
, B-O B-COMMA
in B-O B-PP_IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
identical B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_DT
HIV-1 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_NP_DT
enhancer B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_DT
T-cell B-O B-NN
activation B-O B-NN
response B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
in B-O B-S_PP_IN
HIV-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
second B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
mainly B-O B-ADJP_RB
responsible B-O B-JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
second B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
interacts B-O B-VP_VBZ
with B-O B-PP_IN
two B-O B-NP_NP_NP_CD
nuclear B-O B-JJ
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
85 B-O B-NP_NP_CD
kD B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
27 B-O B-NP_CD
kD B-O B-NN
" " B-O B-NP_O-NP
mobility B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
appear B-O B-S_NP_VP_VBP
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Observations B-O B-S_NP_NP_NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
these B-O B-NP_DT
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
encourage B-O B-VP_VBP
the B-O B-NP_DT
speculation B-O B-NN
that B-O B-SBAR_IN
there B-O B-S_NP_EX
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
subtle B-O B-NP_JJ
differences B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-KB B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
monocyte B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
HIV B-O B-NP_NN
type B-O B-NN
1 B-O B-CD
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
progeny B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
followed B-O B-VP_VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
U937 B-O B-NN
promonocytic B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
either B-O B-PP_CC
with B-O B-IN
retinoic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
or B-O B-CC
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
in B-O B-VP_PP_IN
purified B-O B-NP_VBN
human B-O B-JJ
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Electrophoretic B-O B-S_NP_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
and B-O B-CC
Southwestern B-O B-NP_NN
blotting B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
detect B-O B-VP_VB
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cellular B-O B-NP_JJ
transactivation B-O B-NN
factor B-O B-NN
NF-KB B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
" " B-O B-NP_NP_ADJP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PMA B-O B-S_NP_NP_NP_NN
treatment B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
retinoic B-O B-NP_JJ
acid B-O B-NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
U937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
acts B-O B-VP_VBZ
in B-O B-PP_IN
inducing B-O B-S_NP_VP_VBG
NF-KB B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
nuclei B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
or B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-KB B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurred B-O B-VP_VBD
only B-O B-SBAR_RB
if B-O B-IN
the B-O B-S_NP_DT
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
previously B-O B-ADVP_RB
" " B-O O-ADVP
infected B-O B-VP_VBN
with B-O B-NP_PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
U937 B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
infected B-O B-VP_VBN
with B-O B-NP_PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
no B-O B-S_S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-KB B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
high B-O B-S_NP_NP_JJ
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
progeny B-O B-NP_NN
virions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
produced B-O B-VP_VBN
, B-O B-NP_COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
in B-O B-S_PP_IN
monocytic B-O B-NP_JJ
cell B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
HIV-1 B-O B-NP_NN
" " B-O O-NP
could B-O B-VP_MD
mimic B-O B-VP_VB
some B-O B-NP_NP_DT
differentiation/activation B-O B-NP_JJ
" " B-O O-NP
stimuli B-O B-NNS
" " B-O O-NP
allowing B-O B-VP_VBG
nuclear B-O B-NP_JJ
NF-KB B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Positive B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
negative B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immunoglobulin B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
a B-O B-NP_DT
novel B-O B-JJ
B-cell-specific B-O B-JJ
enhancer B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
A B-O B-S_NP_DT
new B-O B-JJ
B-cell-specific B-O B-JJ
enhancer B-O B-NN
element B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
identified B-O B-VP_VBN
3' B-O B-NP_PP_NP_JJ
" " B-O O-NP
of B-O B-IN
E4 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
octamerlike B-O B-JJ
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
immunoglobulin B-O B-NN
heavy-chain B-O B-NN
gene B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tandem B-O B-S_NP_NP_JJ
copies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
67-bp B-O B-JJ
MnlI-AluI B-O B-NN
fragment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
fused B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
chloramphenicol B-O B-JJ
acetyltransferase B-O B-NN
gene B-O B-NN
" " B-O O-NP
driven B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
conalbumin B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
stimulated B-O B-VP_VBD
transcription B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
Jurkat B-O B-NP_NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
or B-O B-CC
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Footprinting B-O B-S_NP_NN
analysis B-O B-NN
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
identical B-O B-JJ
sequence B-O B-NN
CCGAAACTGAAAAGG B-O B-NN
" " B-O O-NP
, B-O B-COMMA
designated B-O B-VP_VBN
E6 B-O B-S_NP_NP_NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
protected B-O B-VP_VBN
by B-O B-NP_PP_IN
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Gel B-O B-S_NP_NP_NN
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
a B-O B-NP_DT
synthetic B-O B-JJ
E6 B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
detected B-O B-VP_VBD
a B-O B-NP_DT
B-cell-specific B-O B-JJ
complex B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
addition B-O B-NN
to B-O B-TO
a B-O B-NP_NP_DT
ubiquitous B-O B-JJ
band B-O B-NN
" " B-O O-NP
found B-O B-VP_VBN
also B-O B-NP_PP_RB
in B-O B-IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
agreement B-O B-NN
with B-O B-IN
the B-O B-NP_NP_DT
results B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
gel B-O B-NP_NN
retardation B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
tandem B-O B-NP_NP_JJ
copies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
E6 B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
stimulated B-O B-VP_VBD
transcription B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_PP_IN
ARH77 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
Raji B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
Jurkat B-O B-NP_NP_NP_NN
" " B-O O-NP
or B-O B-CC
HeLa B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
a B-O B-NP_DT
mutant B-O B-JJ
E6 B-O B-NN
motif B-O B-NN
" " B-O O-NP
lost B-O B-VP_VBD
both B-O B-PP_CC
in B-O B-NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
and B-O B-CC
in B-O B-NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
striking B-O B-NP_NP_JJ
contrast B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
mouse B-O B-NN
Ig B-O B-NN
heavy-chain B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
, B-O B-COMMA
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
the B-O B-S_NP_DT
octamer B-O B-NN
motif B-O B-NN
" " B-O O-NP
acts B-O B-VP_VBZ
as B-O B-PP_IN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
human B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
an B-O B-NP_NP_DT
octamerlike B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
one B-O B-NP_CD
base B-O B-NN
substitution B-O B-NN
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bound B-O B-S_NP_VP_VP_VBD
octamer-binding B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
and B-O B-CC
showed B-O B-VP_VBD
no B-O B-NP_NP_DT
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
MnlI-AluI B-O B-NN
fragment B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
suppress B-O B-VP_VB
the B-O B-NP_NP_DT
basal-level B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
conalbumin B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
both B-O B-NP_NP_CC
Jurkat B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
HeLa B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
simian B-O B-NP_JJ
virus B-O B-NN
40 B-O B-CD
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
MnlI-AluI B-O B-NN
fragment B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
novel B-O B-JJ
enhancer B-O B-NN
element B-O B-NN
" " B-O O-NP
identified B-O B-VP_VBN
in B-O B-NP_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
probably B-O B-ADVP_RB
" " B-O O-ADVP
a B-O B-NP_NP_DT
target B-O B-NN
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
both B-O B-NP_ADJP_CC
positive B-O B-ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
negative B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_DT
NF B-O B-NN
kappa B-O B-NN
B B-O B-NN
independent B-O B-JJ
cis-acting B-O B-JJ
sequences B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
HIV-1 B-O B-NP_NP_NN
LTR B-O B-NN
" " B-O O-NP
responsive B-O B-ADJP_NN
to B-O B-PP_TO
T-cell B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
initiation B-O B-NN
" " B-O O-NP
directed B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_NP_DT
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increases B-O B-VP_VBZ
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
mitogenic B-O B-NP_NP_JJ
stimuli B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NN
LTR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
governed B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_ADJP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LTR-directed B-O B-NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VP_VBD
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
either B-O B-NP_CC
a B-O B-NP_DT
phorbol B-O B-NN
ester B-O B-NN
" " B-O O-NP
or B-O B-CC
tumor B-O B-NP_NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
if B-O B-SBAR_IN
either B-O B-S_NP_CC
the B-O B-DT
NFAT-1 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
deleted B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
respond B-O B-VP_VB
to B-O B-PP_TO
these B-O B-NP_DT
mitogenic B-O B-JJ
stimuli B-O B-NNS
" " B-O O-NP
" " B-O O-PP
if B-O B-SBAR_IN
both B-O B-S_NP_DT
sequences B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
HIV-1 B-O B-NN
mutant B-O B-JJ
virus B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
both B-O B-NP_NP_CC
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
NFAT-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
deletion B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
replicate B-O B-VP_VB
although B-O B-SBAR_IN
at B-O B-FRAG_PP_IN
" " B-O B-NP_O-FRAG
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
, B-O B-COMMA
while B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
deletion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFAT-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
increased B-O B-VP_VBD
the B-O B-NP_NP_DT
viral B-O B-JJ
growth B-O B-NN
rate B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Neither B-O B-S_NP_CC
deletion B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
nor B-O B-CC
deletion B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NFAT-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
decreased B-O B-VP_VBD
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
viral B-O B-NP_JJ
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
phorbol B-O B-NP_NN
ester B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Specific B-O B-NP_NP_JJ
depletion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
B-cell B-O B-NN
population B-O B-NN
" " B-O O-NP
" " B-O O-PP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
aberrant B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
interferon B-O B-NN
regulatory B-O B-JJ
factor B-O B-NN
1 B-O B-CD
gene B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
transgenic B-O B-NP_JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-NP
  
Interferons B-O B-S_NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
IFNs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
are B-O B-VP_VBP
well B-O B-ADVP_RB
" " B-O O-ADVP
known B-O B-VP_VBN
both B-O B-NP_PP_CC
as B-O B-PP_IN
antiviral B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
as B-O B-PP_IN
potent B-O B-NP_NP_JJ
regulators B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NN
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
fact B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
IFNs B-O B-NP_NNS
" " B-O O-NP
inhibit B-O B-VP_VBP
growth B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
various B-O B-NP_JJ
normal B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
transformed B-O B-ADJP_VBN
" " B-O O-ADJP
" " B-O O-ADJP
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Previously B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
a B-O B-NP_NP_NP_DT
nuclear B-O B-JJ
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
IRF-1 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
interferon B-O B-NP_NN
regulatory B-O B-JJ
factor B-O B-NN
1 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
type B-O B-NP_NP_NN
I B-O B-CD
IFN B-O B-NN
" " B-O O-NP
and B-O B-CC
some B-O B-NP_DT
IFN-inducible B-O B-JJ
gene B-O B-NN
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
was B-O B-VP_VBD
identified B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
cloned B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
the B-O B-S_NP_DT
IRF-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
both B-O B-ADJP_NP_CC
virus B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
IFN B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inducible B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
an B-O B-NP_DT
intriguing B-O B-JJ
issue B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
raised B-O B-VP_VBN
as B-O B-NP_PP_IN
to B-O B-TO
whether B-O B-SBAR_IN
the B-O B-S_NP_DT
IRF-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
functioning B-O B-VP_VBG
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
generated B-O B-VP_VBD
transgenic B-O B-NP_NP_JJ
mice B-O B-NNS
" " B-O O-NP
carrying B-O B-VP_VBG
the B-O B-NP_NP_DT
human B-O B-JJ
IRF-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
linked B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
human B-O B-JJ
immunoglobulin B-O B-NN
heavy-chain B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
transgenic B-O B-JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
all B-O B-NP_NP_PDT
the B-O B-DT
lymphoid B-O B-JJ
tissues B-O B-NNS
" " B-O O-NP
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
showed B-O B-VP_VBD
a B-O B-NP_NP_DT
dramatic B-O B-JJ
reduction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B B-O B-NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Preparation B-O B-S_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
analysis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
bone B-O B-NP_NP_NN
marrow B-O B-NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
chimeric B-O B-JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
bone B-O B-NN
marrow B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
effective B-O B-JJ
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
specific B-O B-NP_NP_JJ
depletion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
fact B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
transgenic B-O B-NP_NP_JJ
bone B-O B-NN
marrow B-O B-NN
cells B-O B-NNS
" " B-O O-NP
cocultured B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_DT
bone B-O B-ADJP_NN
marrow-derived B-O B-JJ
" " B-O O-ADJP
stromal B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
revealed B-O B-VP_VBD
an B-O B-NP_DT
altered B-O B-JJ
B-cell B-O B-NN
maturation B-O B-NN
pattern B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Identification B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
cloning B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
TCF-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
T B-O B-ADJP_NN
lymphocyte-specific B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
a B-O B-NP_DT
sequence-specific B-O B-JJ
HMG B-O B-NN
box B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
CD3-epsilon B-O B-S_NP_NN
expression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_DT
downstream B-O B-JJ
T B-O B-ADJP_NN
lymphocyte-specific B-O B-JJ
" " B-O O-ADJP
enhancer B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
the B-O B-NP_NP_DT
identification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_NP_DT
T B-O B-ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
TCF-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
this B-O B-NP_DT
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
multimerized B-O B-JJ
recognition B-O B-NN
motif B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TCF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
constituted B-O B-VP_VBD
a B-O B-NP_DT
T B-O B-ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Subsequent B-O B-S_NP_NP_JJ
cloning B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TCF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
identified B-O B-VP_VBD
three B-O B-NP_CD
splice B-O B-NN
alternatives B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TCF-1 B-O B-S_NP_NN
" " B-O O-NP
contained B-O B-VP_VBD
a B-O B-NP_NP_DT
single B-O B-JJ
DNA-binding B-O B-JJ
HMG B-O B-NN
box B-O B-NN
" " B-O O-NP
most B-O B-ADJP_ADVP_RBS
closely B-O B-RB
" " B-O O-ADVP
related B-O B-JJ
to B-O B-PP_TO
similar B-O B-NP_NP_JJ
boxes B-O B-NNS
" " B-O O-NP
in B-O B-PP_PP_IN
the B-O B-NP_DT
putative B-O B-JJ
mammalian B-O B-JJ
sex-determining B-O B-JJ
gene B-O B-NN
SRY B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
the B-O B-NP_DT
Schizosaccharomyces B-O B-FW
pombe B-O B-FW
Mc B-O B-NN
mating B-O B-NN
type B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TCF-1 B-O B-S_ADVP_NN
mRNA B-O B-NN
" " B-O O-ADVP
was B-O B-VP_VBD
expressed B-O B-VP_VBN
uniquely B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Upon B-O B-S_PP_IN
cotransfection B-O B-NP_NP_NN
" " B-O O-NP
into B-O B-PP_IN
non-T B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
TCF-1 B-O B-NP_NN
" " B-O O-NP
could B-O B-VP_MD
transactivate B-O B-VP_VB
through B-O B-PP_IN
its B-O B-NP_PRPP
cognate B-O B-JJ
motif B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
identify B-O B-VP_VBP
TCF-1 B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
T B-O B-ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
might B-O B-S_NP_VP_MD
play B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Nuclear B-O B-S_NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
activates B-O B-VP_VBZ
proenkephalin B-O B-NP_NP_NN
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Upon B-O B-S_PP_IN
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
accumulate B-O B-VP_VBP
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
neuropeptide B-O B-NN
enkephalin B-O B-NN
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
correlate B-O B-S_NP_VP_VBP
with B-O B-PP_IN
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
basis B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
these B-O B-NP_DT
changes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
proenkephalin B-O B-NN
promoter B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_NP_DT
sequence B-O B-NN
GGGGACGTCCCC B-O B-NN
" " B-O O-NP
, B-O B-COMMA
named B-O B-VP_VBN
B2 B-O B-S_NP_NP_NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
similar B-O B-ADJP_JJ
to B-O B-PP_TO
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
an B-O B-NP_DT
NF-kappa B-O B-ADJP_NN
B-like B-O B-JJ
" " B-O O-ADJP
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
B2 B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
concomitant B-O B-S_NP_ADJP_JJ
with B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
proenkephalin B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutations B-O B-S_NP_NP_NNS
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_DT
B2 B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
abolish B-O B-VP_VBP
this B-O B-NP_DT
transcriptional B-O B-JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
purified B-O B-VBN
homodimer B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
two B-O B-NP_CD
p50s B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
DNA-binding B-O B-JJ
subunit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
binds B-O B-VP_VBZ
the B-O B-NP_NP_DT
B2 B-O B-NN
site B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
proenkephalin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
relatively B-O B-ADVP_ADVP_RB
better B-O B-JJR
" " B-O O-ADVP
than B-O B-SBAR_IN
does B-O B-SINV_VBZ
the B-O B-NP_NP_DT
heterotetramer B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O B-VP_O-SINV
" " B-O O-SBAR
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
appears B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
T-cell-specific B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
proenkephalin B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
as B-O B-SBAR_IN
NF-kappa B-O B-S_S_NP_NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
ubiquitous B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_NP_DT
transcriptional B-O B-JJ
activation B-O B-NN
" " B-O O-NP
through B-O B-PP_IN
the B-O B-NP_DT
B2 B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
T B-O B-ADJP_NP_NN
cell B-O B-NN
" " B-O O-NP
specific B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
yet B-O B-NP_NP_RB
another B-O B-DT
T-cell-specific B-O B-JJ
factor B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
synergizes B-O B-S_NP_VP_VBZ
with B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
should B-O B-VP_MD
be B-O B-VP_VB
considered B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_DT
novel B-O B-JJ
HIV-1 B-O B-NN
isolate B-O B-JJ
" " B-O O-NP
containing B-O B-VP_VBG
alterations B-O B-NP_NP_NNS
" " B-O O-NP
affecting B-O B-VP_VBG
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-NP
  
Three B-O B-S_NP_NP_NP_CD
molecular B-O B-JJ
clones B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
a B-O B-NP_NP_DT
single B-O B-JJ
isolate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
AL1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
exhibited B-O B-VP_VBD
distinct B-O B-NP_JJ
replicative B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
cytopathic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
properties B-O B-NNS
" " B-O O-NP
during B-O B-PP_IN
propagation B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
human B-O B-JJ
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
phenotypic B-O B-JJ
differences B-O B-NNS
" " B-O O-NP
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
were B-O B-VP_VBD
attributable B-O B-ADJP_JJ
" " B-O B-PP_O-ADJP
, B-O B-COMMA
in B-O B-PP_IN
large B-O B-NP_JJ
part B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
to B-O B-PP_TO
changes B-O B-NP_NP_NNS
" " B-O O-NP
affecting B-O B-VP_VBG
the B-O B-NP_DT
viral B-O B-JJ
LTR B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nucleotide B-O B-S_NP_NP_NN
sequence B-O B-NN
" " B-O O-NP
and B-O B-CC
PCR B-O B-NP_NN
analyses B-O B-NNS
" " B-O O-NP
" " B-O O-NP
demonstrated B-O B-VP_VBD
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
novel B-O B-NP_JJ
duplications B-O B-NP_NP_NP_NNS
" " B-O O-NP
or B-O B-CC
deletions B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
involving B-O B-VP_VBG
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_NP_DT
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
enhancer B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
original B-O B-JJ
AL1 B-O B-NN
virus B-O B-NN
stock B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Subcloning B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
variant B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
segments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
LTR-driven B-O B-NP_JJ
CAT B-O B-NN
expression B-O B-NN
vectors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
confirmed B-O B-VP_VBD
a B-O B-NP_NP_DT
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
promoter B-O B-NP_NP_JJ
activity B-O B-NN
" " B-O O-NP
and B-O B-CC
replicative/cytopathic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
capacity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Kappa B-O B-S_NP_NN
B B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
an B-O B-NP_DT
IL-2 B-O B-NN
autocrine B-O B-NN
human B-O B-JJ
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
IL-2 B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
IL-2-R B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
genes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
both B-O B-VP_DT
expressed B-O B-VP_VBN
transiently B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
normal B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
Ag B-O B-NP_NP_NP_NN
" " B-O O-NP
or B-O B-CC
mitogen B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
human B-O B-JJ
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
IARC B-O B-NP_NN
301 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
expresses B-O B-VP_VBZ
these B-O B-NP_DT
two B-O B-CD
genes B-O B-NNS
" " B-O O-NP
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
its B-O B-S_NP_PRPP
growth B-O B-NN
" " B-O O-NP
depends B-O B-VP_VBZ
on B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
dissect B-O B-VP_VB
the B-O B-NP_NP_DT
molecular B-O B-JJ
basis B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
unusual B-O B-JJ
persistent B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
analyzed B-O B-VP_VBN
the B-O B-NP_NP_DT
interactions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
constitutively B-O B-NP_ADJP_RB
expressed B-O B-VBN
" " B-O O-ADJP
nuclear B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_NP_DT
5' B-O B-JJ
flanking B-O B-JJ
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
and B-O B-NP_NP_CC
genes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
using B-O B-S_NP_VP_VBG
both B-O B-NP_NP_DT
DNase B-O B-NP_NN
I B-O B-CD
footprinting B-O B-NN
" " B-O O-NP
and B-O B-CC
gel B-O B-NP_NN
retardation B-O B-NN
" " B-O O-NP
" " B-O O-NP
techniques B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
found B-O B-VP_VBN
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
region B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_DT
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
and B-O B-NP_NP_NP_PP_CC
" " B-O B-NP_NP_PP_O-NP
) B-O B-RRB
" " B-O O-PRN
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
corresponds B-O B-S_NP_VP_VBZ
" " B-O B-PP_O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
specifically B-O B-ADVP_RB
" " B-O O-ADVP
protected B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
agreement B-O B-NN
with B-O B-IN
this B-O B-NP_DT
finding B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
both B-O B-NP_CC
the B-O B-DT
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-2-R B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
promoters B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
active B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
transient B-O B-NP_NP_JJ
transfection B-O B-NN
assays B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
IARC B-O B-NP_NN
301 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
mutation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
kappa B-O B-NN
B B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
markedly B-O B-NP_NP_ADJP_RB
attenuated B-O B-VBN
" " B-O O-ADJP
activities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_NP_CD
proteins B-O B-NNS
" " B-O O-NP
binding B-O B-VP_VBG
the B-O B-NP_DT
kappa B-O B-NN
B B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
KBF1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VP_VBN
in B-O B-NP_PP_IN
IARC B-O B-NP_NN
301 B-O B-CD
nuclei B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
PMA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
PHA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
They B-O B-S_NP_PRP
" " B-O O-NP
bind B-O B-VP_VBP
to B-O B-PP_TO
the B-O B-NP_NP_DT
kappa B-O B-NN
B B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
different B-O B-NP_JJ
relative B-O B-JJ
affinities B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
may B-O B-S_NP_VP_MD
reflect B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Comparison B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
constitutive B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
inducible B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
transcriptional B-O B-JJ
enhancement B-O B-NN
" " B-O O-NP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
kappa B-O B-NP_ADJP_NN
B-related B-O B-JJ
" " B-O O-ADJP
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
modulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
activity B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
human B-O B-NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
I B-O B-CD
tax B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
kappa B-O B-NN
B B-O B-NN
sequence B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GGGACTTTCC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
binds B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBN
in B-O B-NP_PP_IN
its B-O B-NP_PRPP
form B-O B-ADJP_NN
" " B-O O-NP
" " B-O O-PP
only B-O B-PP_RB
in B-O B-IN
B B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
factor B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
apparently B-O B-NP_ADJP_RB
indistinguishable B-O B-JJ
" " B-O O-ADJP
sequence B-O B-NN
specificity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
many B-O B-NP_NP_JJ
other B-O B-JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
it B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
For B-O B-S_PP_IN
example B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
kappa B-O B-NP_ADJP_NN
B-related B-O B-JJ
" " B-O O-ADJP
sequences B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
important B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
genes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
constitutively B-O B-ADJP_RB
active B-O B-JJ
in B-O B-PP_IN
B B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
other B-O B-S_NP_JJ
regulatory B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
must B-O B-VP_MD
play B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-S_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
the B-O B-NP_NP_DT
constitutive B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
inducible B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
mediated B-O B-VP_VBN
by B-O B-PP_IN
five B-O B-NP_NP_CD
kappa B-O B-ADJP_NN
B-related B-O B-JJ
" " B-O O-ADJP
sequence B-O B-NN
elements B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
two B-O B-NP_CD
different B-O B-JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
in B-O B-S_PP_IN
S194 B-O B-NP_NN
plasma B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
each B-O B-NP_DT
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlates B-O B-VP_VBZ
well B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
the B-O B-NP_NP_DT
relative B-O B-JJ
affinity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B-cell-derived B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
that B-O B-NP_DT
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
significantly B-O B-NP_NP_ADJP_RB
lower B-O B-RBR
" " B-O O-ADJP
transcription B-O B-NN
enhancement B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
sites B-O B-NP_NP_NNS
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
either B-O B-NP_CC
EL-4 B-O B-NP_NN
( B-O B-LRB
T B-O B-NN
) B-O B-RRB
cells B-O B-NNS
" " B-O O-NP
or B-O B-CC
S194 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
both B-O B-NP_DT
lower-affinity B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
significantly B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
tax B-O B-NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
I B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
showing B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NN
B B-O B-NN
activity B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Isolation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
rel-related B-O B-JJ
human B-O B-JJ
cDNA B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
potentially B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
encodes B-O B-VP_VBZ
the B-O B-NP_NP_DT
65-kD B-O B-JJ
subunit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
[ B-O B-S_LRB
published B-O B-NP_VBN
erratum B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
in B-O B-PP_IN
Science B-O B-NP_NNP
1991 B-O B-CD
Oct B-O B-NNP
4 B-O B-CD
; B-O B-COLON
254 B-O B-CD
( B-O B-LRB
5028 B-O B-CD
) B-O B-RRB
: B-O B-COLON
11 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-NP
  
A B-O B-S_NP_NP_DT
DNA B-O B-NN
probe B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
spanned B-O B-S_NP_VP_VBD
a B-O B-NP_NP_DT
domain B-O B-NN
" " B-O O-NP
conserved B-O B-VP_VBN
among B-O B-NP_PP_IN
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
was B-O B-VP_VBD
generated B-O B-VP_VBN
from B-O B-NP_PP_IN
Jurkat B-O B-NP_NP_NN
T B-O B-NN
cell B-O B-NN
complementary B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_NP_DT
polymerase B-O B-NN
chain B-O B-NN
reaction B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
degenerate B-O B-NP_JJ
oligonucleotides B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
probe B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
identify B-O B-VP_VB
a B-O B-NP_NP_DT
rel-related B-O B-JJ
complementary B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
transcription B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
translation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
complementary B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
the B-O B-NP_NP_DT
synthesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
an B-O B-NP_NP_DT
apparent B-O B-JJ
molecular B-O B-JJ
size B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
translated B-O B-VBN
protein B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
weak B-O B-NP_NP_JJ
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
specificity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
kappa B-O B-NN
B B-O B-NN
binding B-O B-VBG
motif B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_DT
protein-DNA B-O B-JJ
complex B-O B-JJ
" " B-O O-NP
comigrated B-O B-VP_VBN
with B-O B-PP_IN
the B-O B-NP_NP_DT
complex B-O B-NN
" " B-O O-NP
obtained B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
purified B-O B-VBN
human B-O B-JJ
p65 B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
subunit B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
binding B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
I B-O B-NP_NP_NP_NN
kappa B-O B-NN
B-alpha B-O B-NN
" " B-O O-NP
and B-O B-CC
-beta B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
65-kD B-O B-JJ
protein B-O B-NN
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-PP_IN
the B-O B-NP_NP_NP_DT
p50 B-O B-NN
subunit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
kappa B-O B-NN
B B-O B-NN
probe B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
form B-O B-VP_VB
a B-O B-NP_NP_DT
complex B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
same B-O B-JJ
electrophoretic B-O B-JJ
mobility B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
the B-O B-NP_DT
rel-related B-O B-JJ
65-kD B-O B-JJ
protein B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
represent B-O B-VP_VB
the B-O B-NP_NP_DT
p65 B-O B-NN
subunit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
active B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
transcription B-O B-NN
factor B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Lymphocyte B-O B-NP_NP_NN
glucocorticoid B-O B-NN
receptor B-O B-NN
number B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
posttraumatic B-O B-NP_JJ
stress B-O B-NN
disorder B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
OBJECTIVE B-O B-NP_NP_NN
" " B-O O-NP
: B-O B-COLON
The B-O B-S_NP_NP_DT
authors B-O B-NNS
' B-O B-POS
" " B-O O-NP
objective B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
to B-O B-S_NP_VP_TO
investigate B-O B-VP_VB
the B-O B-NP_DT
possibility B-O B-NN
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
METHOD B-O B-NP_NP_NN
" " B-O O-NP
: B-O B-COLON
They B-O B-S_NP_PRP
" " B-O O-NP
measured B-O B-VP_VBD
the B-O B-NP_NP_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphocyte B-O B-NP_NN
cytosolic B-O B-JJ
glucocorticoid B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
plasma B-O B-NP_NN
cortisol B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
15 B-O B-NP_NP_CD
consecutively B-O B-ADJP_RB
admitted B-O B-VBN
" " B-O O-ADJP
male B-O B-JJ
combat B-O B-NN
Vietnam B-O B-NN
veterans B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
PTSD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
in B-O B-PP_IN
a B-O B-NP_NP_DT
normal B-O B-JJ
comparison B-O B-NN
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
11 B-O B-NP_CD
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
RESULTS B-O B-NP_NP_NNS
" " B-O O-NP
: B-O B-COLON
Both B-O B-S_NP_CC
the B-O B-NP_DT
patients B-O B-NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
normal B-O B-JJ
comparison B-O B-NN
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-NP
showed B-O B-VP_VBD
a B-O B-NP_NP_DT
morning-to-afternoon B-O B-JJ
decline B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
paralleling B-O B-VP_VBG
the B-O B-NP_NP_DT
normal B-O B-JJ
diurnal B-O B-JJ
decline B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cortisol B-O B-NP_NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
63 B-O B-ADJP_ADJP_ADJP_ADJP_NP_CD
% B-O B-NN
" " B-O O-NP
greater B-O B-JJR
" " B-O O-ADJP
in B-O B-PP_PP_PP_IN
the B-O B-NP_DT
morning B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
and B-O B-CC
26 B-O B-ADJP_ADJP_NP_CD
% B-O B-NN
" " B-O O-NP
greater B-O B-JJR
" " B-O O-ADJP
in B-O B-PP_PP_PP_IN
the B-O B-NP_DT
afternoon B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-ADJP
in B-O B-PP_IN
the B-O B-NP_NP_DT
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
PTSD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
than B-O B-PP_IN
in B-O B-FRAG_PP_IN
the B-O B-NP_DT
normal B-O B-JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_S_NP_NP_DT
group B-O B-NN
differences B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
cortisol B-O B-NP_NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
nor B-O B-CC
were B-O B-SINV_VBD
glucocorticoid B-O B-NP_NP_NN
receptor B-O B-NN
number B-O B-NN
" " B-O O-NP
and B-O B-CC
cortisol B-O B-NP_NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-NP
correlated B-O B-ADJP_VBD
" " B-O O-ADJP
" " B-O O-SINV
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
morning B-O B-NP_NN
glucocorticoid B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
positively B-O B-ADJP_RB
correlated B-O B-VBN
with B-O B-PP_IN
symptoms B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
PTSD B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
anxiety B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CONCLUSIONS B-O B-NP_NP_NNS
" " B-O O-NP
: B-O B-COLON
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
provide B-O B-VP_VBP
further B-O B-NP_NP_JJ
evidence B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
a B-O B-NP_NP_DT
dysregulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HPA B-O B-JJ
axis B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
PTSD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
The B-O B-S_NP_DT
finding B-O B-NN
that B-O B-SBAR_IN
patients B-O B-S_NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
PTSD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
a B-O B-NP_NP_NP_DT
substantially B-O B-ADJP_RB
greater B-O B-JJR
" " B-O O-ADJP
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphocyte B-O B-NP_NN
glucocorticoid B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
than B-O B-PP_IN
normal B-O B-NP_JJ
comparison B-O B-NN
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_NP_NP_DT
authors B-O B-NNS
' B-O B-POS
" " B-O O-NP
previous B-O B-JJ
observations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
low B-O B-NP_NP_JJ
24-hour B-O B-JJ
urinary B-O B-JJ
cortisol B-O B-NN
excretion B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
receptor B-O B-NN
changes B-O B-NNS
" " B-O O-NP
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
are B-O B-VP_VBP
opposite B-O B-ADJP_JJ
of B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
reported B-O B-VP_VBN
in B-O B-NP_PP_IN
major B-O B-NP_JJ
depressive B-O B-JJ
disorder B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
present B-O B-JJ
data B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
along B-O B-PP_IN
with B-O B-IN
other B-O B-NP_NP_JJ
findings B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HPA B-O B-NP_NP_JJ
abnormalities B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
PTSD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
support B-O B-VP_VBP
the B-O B-NP_NP_DT
possibility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
greater B-O B-JJR
negative B-O B-JJ
feedback B-O B-NN
sensitivity B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
one B-O B-NP_NP_QP_CD
or B-O B-CC
more B-O B-JJR
" " B-O O-QP
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HPA B-O B-JJ
axis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_NP_NP_DT
thymus-specific B-O B-JJ
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HMG B-O B-NN
protein B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
regulates B-O B-VP_VBZ
the B-O B-NP_DT
human B-O B-JJ
T B-O B-NN
cell B-O B-NN
receptor B-O B-NN
C B-O B-NN
alpha B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
human B-O B-ADJP_JJ
T B-O B-NN
cell-specific B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
TCF-1 B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
plays B-O B-VP_VP_VBZ
a B-O B-NP_DT
key B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
tissue-specific B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
T B-O B-NN
cell B-O B-NN
receptor B-O B-NN
( B-O B-LRB
TCR B-O B-NN
) B-O B-RRB
C B-O B-NN
alpha B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
binds B-O B-VP_VBZ
to B-O B-PP_TO
pyrimidine-rich B-O B-NP_NP_NP_JJ
elements B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
5'-PyCTTTG-3' B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
a B-O B-NP_DT
variety B-O B-NN
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
amino B-O B-NP_NP_NN
acid B-O B-NN
sequence B-O B-NN
information B-O B-NN
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_DT
DNA B-O B-NN
affinity-purified B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
now B-O B-ADVP_RB
" " B-O O-ADVP
isolated B-O B-VP_VBN
cDNA B-O B-NP_NP_NN
clones B-O B-NNS
" " B-O O-NP
encoding B-O B-VP_VBG
TCF-1 B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
TCF-1 B-O B-NN
alpha B-O B-NN
cDNA B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_NP_DT
single B-O B-JJ
68-amino-acid B-O B-JJ
domain B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
homologous B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_VP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
full-length B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
mutant B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
cDNA B-O B-NN
clones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
bacteria B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reveal B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
single B-O B-JJ
HMG B-O B-NN
motif B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
predicted B-O B-VP_VBN
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
sufficient B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
direct B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_NP_NN
blot B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
further B-O B-ADVP_RBR
" " B-O O-ADVP
that B-O B-SBAR_IN
TCF-1 B-O B-S_NP_NN
alpha B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
highly B-O B-UCP_ADJP_RB
tissue B-O B-NN
specific B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
found B-O B-VP_VBN
primarily B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
immature B-O B-JJ
CEM B-O B-NN
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
expresses B-O B-VP_VBZ
relatively B-O B-NP_NP_RB
low B-O B-JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
TCF-1 B-O B-NP_NN
alpha B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
increased B-O B-VP_VBN
upon B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
cloned B-O B-VBN
TCF-1 B-O B-NN
alpha B-O B-NN
protein B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
potent B-O B-JJ
transcriptional B-O B-JJ
activator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
human B-O B-JJ
TCR B-O B-NN
alpha B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
nonlymphoid B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
the B-O B-S_NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
endogenous B-O B-JJ
protein B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
strongly B-O B-ADJP_RB
dependent B-O B-JJ
on B-O B-PP_IN
an B-O B-NP_NP_DT
additional B-O B-JJ
T B-O B-ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
interacts B-O B-S_NP_VP_VBZ
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
TCF-1 B-O B-S_NP_NN
alpha B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
currently B-O B-ADJP_RB
unique B-O B-JJ
" " B-O O-ADJP
among B-O B-PP_IN
the B-O B-NP_NP_DT
newly B-O B-ADJP_RB
emerging B-O B-VBG
" " B-O O-ADJP
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA-binding B-O B-NP_NP_JJ
regulatory B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
share B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Multiple B-O B-S_NP_JJ
Oct2 B-O B-NN
isoforms B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
generated B-O B-VP_VBN
by B-O B-NP_PP_IN
alternative B-O B-NP_JJ
splicing B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
interaction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Oct2 B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
cognate B-O B-JJ
octamer B-O B-NN
motif B-O B-NN
ATGCAAAT B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
critical B-O B-JJ
determinant B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
lymphoid-specific B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immunoglobulin B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Ectopic B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cloned B-O B-NP_VBN
Oct2 B-O B-NN
cDNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
sufficient B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
describe B-O B-VP_VBP
the B-O B-NP_NP_DT
isolation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
characterization B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
multiple B-O B-NP_NP_JJ
cDNAs B-O B-NNS
" " B-O O-NP
encoding B-O B-VP_VBG
mouse B-O B-NP_NP_NN
Oct2 B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
we B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
isoforms B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
generated B-O B-VP_VBN
from B-O B-NP_PP_IN
a B-O B-NP_DT
single B-O B-JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
an B-O B-NP_DT
alternative B-O B-JJ
splicing B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_PDT
the B-O B-DT
isoforms B-O B-NNS
" " B-O O-NP
retain B-O B-VP_VP_VBP
the B-O B-NP_DT
previously B-O B-ADJP_RB
characterized B-O B-VBN
" " B-O O-ADJP
POU-domain B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
are B-O B-VP_VBP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
to B-O B-PP_TO
the B-O B-NP_DT
octamer B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Different B-O B-S_S_NP_NP_JJ
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
various B-O B-JJ
isoforms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
present B-O B-ADJP_JJ
within B-O B-PP_IN
the B-O B-NP_DT
same B-O B-JJ
B-cell B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
regardless B-O B-ADVP_RB
of B-O B-PP_IN
the B-O B-NP_NP_DT
developmental B-O B-JJ
stage B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B-cell B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
at B-O B-S_NP_NP_ADVP_IN
least B-O B-JJS
" " B-O O-ADVP
some B-O B-DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
isoforms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
conserved B-O B-VP_VBN
between B-O B-NP_PP_IN
mouse B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
humans B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
cotransfection B-O B-NP_NN
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
all B-O B-S_NP_PDT
the B-O B-DT
isoforms B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
" " B-O B-NP_S_O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
one B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
isoforms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
encodes B-O B-VP_VBZ
the B-O B-NP_NP_DT
previously B-O B-ADJP_RB
described B-O B-VBN
" " B-O O-ADJP
lymphoid-specific B-O B-JJ
Oct2B B-O B-NN
protein B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
has B-O B-S_NP_VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Murine B-O B-S_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
human B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
T-lymphocyte B-O B-NN
GATA-3 B-O B-NN
factors B-O B-NNS
" " B-O O-NP
mediate B-O B-VP_VBP
transcription B-O B-NP_NN
" " B-O O-NP
through B-O B-PP_IN
a B-O B-NP_NP_DT
cis-regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
T-cell B-O B-NN
receptor B-O B-NN
delta B-O B-NN
gene B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_S_NP_NP_DT
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcriptional B-O B-NP_JJ
activators B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
recently B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
identified B-O B-VP_VBN
in B-O B-NP_PP_IN
chickens B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
these B-O B-S_NP_DT
transcriptional B-O B-JJ
activators B-O B-NNS
" " B-O O-NP
recognize B-O B-VP_VBP
a B-O B-NP_NP_DT
common B-O B-JJ
consensus B-O B-NN
motif B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
WGATAR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
through B-O B-PP_IN
a B-O B-NP_DT
conserved B-O B-VBN
C4 B-O B-NN
zinc B-O B-NN
finger B-O B-NN
DNA-binding B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
One B-O B-S_NP_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
members B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
multigene B-O B-JJ
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
cGATA-3 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
most B-O B-ADVP_RBS
abundantly B-O B-RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
T-lymphocyte B-O B-NN
cell B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
murine B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
GATA-3 B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
shows B-O B-VP_VBZ
a B-O B-NP_NP_NP_NP_DT
striking B-O B-JJ
degree B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
amino B-O B-NP_NN
acid B-O B-NN
sequence B-O B-NN
identity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
similar B-O B-NP_NP_JJ
patterns B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
tissue B-O B-NP_NP_NN
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
three B-O B-CD
organisms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
murine B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
human B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
factors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VP_VBP
abundantly B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_DT
variety B-O B-NN
of B-O B-PP_IN
and B-O B-NP_ADJP_ADJP_CC
T-cell B-O B-ADJP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
can B-O B-VP_MD
activate B-O B-VP_VB
transcription B-O B-NP_NN
" " B-O O-NP
through B-O B-PP_IN
a B-O B-NP_NP_DT
tissue-specific B-O B-JJ
GATA-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
identified B-O B-VP_VBN
within B-O B-NP_PP_IN
the B-O B-NP_DT
human B-O B-JJ
T-cell B-O B-NN
receptor B-O B-NN
delta B-O B-NN
gene B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
infer B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
murine B-O B-ADJP_NP_JJ
" " B-O O-NP
and B-O B-CC
human B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
GATA-3 B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
play B-O B-VP_VBP
a B-O B-NP_DT
central B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
highly B-O B-ADJP_RB
conserved B-O B-VBN
" " B-O O-ADJP
" " B-O O-ADJP
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
vertebrate B-O B-NP_NN
T-cell-specific B-O B-JJ
transcriptional B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Processing B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
precursor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NN
protease B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
acute B-O B-NP_JJ
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Transcription B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type-1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
genome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
regulated B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-IN
cellular B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
stimulated B-O B-VP_VBN
by B-O B-NP_PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
latently B-O B-NP_ADJP_RB
infected B-O B-JJ
" " B-O O-ADJP
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
T-cell B-O B-S_NP_NN
activation B-O B-NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
factor B-O B-NN
" " B-O O-NP
consists B-O B-VP_VBZ
of B-O B-PP_IN
two B-O B-NP_NP_CD
DNA-binding B-O B-JJ
subunits B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
relative B-O B-NP_JJ
molecular B-O B-JJ
mass B-O B-NN
50,000 B-O B-NP_NP_CD
" " B-O O-NP
( B-O B-PRN_LRB
50K B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
two B-O B-NP_CD
65K B-O B-CD
subunits B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VP_VBZ
located B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_NP_DT
nucleus B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
mature B-O B-NP_JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
is B-O B-VP_VBZ
present B-O B-ADJP_JJ
in B-O B-PP_IN
other B-O B-NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
an B-O B-NP_DT
inactive B-O B-JJ
cytoplasmic B-O B-JJ
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
External B-O B-S_NP_NP_JJ
stimuli B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
those B-O B-NP_NP_DT
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
activate B-O B-S_NP_VP_VBP
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
result B-O B-VP_VBP
in B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
active B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
cloning B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
complementary B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
50K B-O B-CD
subunit B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
helped B-O B-VP_VBD
to B-O B-S_NP_VP_TO
identify B-O B-VP_VB
an B-O B-NP_NP_DT
exclusively B-O B-ADJP_RB
cytoplasmic B-O B-JJ
" " B-O O-ADJP
105K B-O B-CD
precursor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
p105 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
( B-O B-PRN_LRB
V.B. B-O B-NP_NP_NNP
" " B-O O-NP
, B-O B-COMMA
P.K. B-O B-NP_NNP
" " B-O O-NP
and B-O B-CC
A.I. B-O B-NP_NNP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
manuscript B-O B-FRAG_NP_NP_NN
" " B-O O-NP
submitted B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
active B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
might B-O B-VP_MD
therefore B-O B-ADVP_RB
" " B-O O-ADVP
also B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
extent B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
processing B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
HIV-1 B-O B-S_NP_NN
" " B-O O-NP
requires B-O B-VP_VBZ
active B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
efficient B-O B-NP_JJ
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
tested B-O B-VP_VBD
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
processing B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
105K B-O B-CD
precursor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
HIV-1 B-O B-NN
protease B-O B-NN
" " B-O O-NP
can B-O B-VP_VP_MD
process B-O B-VP_VB
p105 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
increases B-O B-VP_VBZ
levels B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
active B-O B-NP_JJ
nuclear B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
HIV B-O B-NP_NP_NP_NN
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
perpetuated B-O B-VP_VBN
by B-O B-NP_PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
induction B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
infection B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
[ B-O B-S_LRB
see B-O B-NP_VP_VB
comments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-NP
  
Permissiveness B-O B-S_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
replication B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
differs B-O B-VP_VBZ
in B-O B-PP_IN
T B-O B-NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
HIV B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
poorly B-O B-ADVP_RB
" " B-O O-ADVP
detected B-O B-VP_VBN
in B-O B-NP_ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cloned B-O B-S_NP_ADJP_ADJP_VBN
" " B-O O-ADJP
, B-O B-COMMA
normal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
very B-O B-NP_NP_NP_ADJP_RB
little B-O B-JJ
" " B-O O-ADJP
, B-O B-PRN_COMMA
if B-O B-SBAR_IN
any B-O B-FRAG_DT
" " B-O O-FRAG
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-PRN
basal B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
low B-O B-NP_NP_JJ
nuclear B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
potent B-O B-JJ
transcriptional B-O B-JJ
activator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
fixed B-O B-NP_JJ
tissue B-O B-NN
macrophages B-O B-NNS
" " B-O O-NP
express B-O B-VP_VBP
detectable B-O B-NP_JJ
HIV B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
permanent B-O B-NP_JJ
virus B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
explanation B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
perpetuation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
virus B-O B-NP_NP_NN
infection B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
sustained B-O B-NP_JJ
nuclear B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
U937 B-O B-NN
monocytic B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
fully B-O B-ADJP_RB
permissive B-O B-JJ
to B-O B-PP_TO
HIV B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
express B-O B-VP_VB
only B-O B-NP_NP_ADJP_RB
low B-O B-JJ
" " B-O O-ADJP
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
chronic B-O B-S_NP_JJ
HIV B-O B-VBP
infection B-O B-NN
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
both B-O B-NP_CC
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
permanently B-O B-NP_ADJP_RB
increased B-O B-VBN
" " B-O O-ADJP
HIV B-O B-NN
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
phenomenon B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
independent B-O B-ADJP_JJ
of B-O B-PP_IN
tumour B-O B-NP_NN
necrosis B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
HIV B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
is B-O B-VP_VBZ
thus B-O B-RB
likely B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
explain B-O B-VP_VB
at B-O B-PP_ADVP_IN
least B-O B-JJS
" " B-O O-ADVP
in B-O B-IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
perpetuation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Glucocorticoid B-O B-NP_NP_NN
receptor B-O B-NN
characteristics B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
corticosteroid-resistant B-O B-NP_JJ
bronchial B-O B-JJ
asthma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
corticosteroid B-O B-NP_NN
resistance B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
bronchial B-O B-NP_JJ
asthma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
studied B-O B-VP_VBN
by B-O B-NP_PP_IN
determining B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
rank B-O B-NN
order B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
for B-O B-NP_PP_IN
in B-O B-NP_PP_IN
" " B-O B-S_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
binding B-O B-NP_NP_VBG
studies B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
( B-O B-NP_LRB
3H B-O B-NN
) B-O B-RRB
dexamethasone B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
performed B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
determine B-O B-VP_VB
and B-O B-NP_NP_NP_CC
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
corticosteroid B-O B-NP_NP_NN
" " B-O O-NP
producing B-O B-VP_VBG
50 B-O B-NP_NP_CD
% B-O B-NN
inhibition B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IC50 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
600 B-O B-NP_NP_NP_CD
nM B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-NP
, B-O B-COMMA
70 B-O B-NP_NP_CD
nM B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
0.5 B-O B-NP_NP_CD
nM B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
" " B-O O-NP
for B-O B-PP_IN
hydrocortisone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
methylprednisolone B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
dexamethasone B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
CS B-O B-NP_JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
only B-O B-NP_NP_ADJP_RB
weak B-O B-JJ
" " B-O O-ADJP
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
generation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
enhancing B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
corticosteroids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
CR B-O B-ADJP_JJ
asthmatic B-O B-JJ
" " B-O O-ADJP
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
dexamethasone B-O B-NN
Kd B-O B-NN
" " B-O O-NP
was B-O B-VP_VP_VP_VBD
2.45 B-O B-NP_NP_QP_CD
+/- B-O B-CC
0.58 B-O B-CD
" " B-O O-QP
nM B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
mean B-O B-NP_NP_NN
" " B-O O-NP
+/- B-O B-CC
SEM B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
n B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
6 B-O B-NP_CD
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
CS B-O B-NP_JJ
" " B-O O-NP
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
1.6 B-O B-VP_NP_NP_QP_CD
+/- B-O B-CC
0.35 B-O B-CD
" " B-O O-QP
nM B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
mean B-O B-NP_NP_NN
" " B-O O-NP
+/- B-O B-CC
SEM B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
n B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
6 B-O B-NP_CD
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
CR B-O B-NP_JJ
" " B-O O-NP
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
( B-O B-PRN_LRB
p B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
0.14 B-O B-NP_CD
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
Ro B-O B-NN
" " B-O O-NP
in B-O B-VP_VP_VP_PP_IN
the B-O B-NP_DT
CS B-O B-JJ
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
was B-O B-VBD
3,605 B-O B-NP_QP_CD
+/- B-O B-CC
984 B-O B-CD
" " B-O O-QP
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
per B-O B-PP_IN
nucleus B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
mean B-O B-NP_NP_NN
" " B-O O-NP
+/- B-O B-CC
SEM B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
n B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
6 B-O B-NP_CD
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
and B-O B-CC
4,757 B-O B-VP_NP_QP_CD
+/- B-O B-CC
692 B-O B-CD
" " B-O O-QP
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
per B-O B-PP_IN
nucleus B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
mean B-O B-NP_NP_NN
" " B-O O-NP
+/- B-O B-CC
SEM B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
n B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
6 B-O B-NP_CD
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
in B-O B-PP_IN
the B-O B-NP_DT
CR B-O B-JJ
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
( B-O B-PRN_LRB
p B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
0.23 B-O B-NP_CD
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
corticosteroid B-O B-S_NP_NP_NN
resistance B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
bronchial B-O B-NP_JJ
asthma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
not B-O B-RB
be B-O B-VP_VB
explained B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Tissue-specific B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
platelet B-O B-NN
GPIIb B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
One B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
major B-O B-JJ
objectives B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
study B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
thrombogenesis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
determine B-O B-VP_VB
the B-O B-NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
a B-O B-S_NP_DT
hematopoietic B-O B-JJ
progenitor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recent B-O B-S_NP_NP_NP_JJ
development B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
primary B-O B-NP_NP_JJ
cultures B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
megakaryocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
molecular B-O B-JJ
cloning B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
specific B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
offer B-O B-VP_VBP
the B-O B-NP_NP_DT
possibility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
getting B-O B-S_NP_VP_VBG
some B-O B-NP_NP_DT
insights B-O B-NNS
" " B-O O-NP
into B-O B-PP_IN
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_S_NP_NP_CD
gene B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interest B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_DT
glycoprotein B-O B-NP_NP_NN
IIb B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GPIIb B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
gene B-O B-NN
" " B-O O-NP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
GPIIb B-O B-S_S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
alpha B-O B-NN
subunit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
platelet B-O B-NN
cytoadhesin B-O B-NN
GPIIb-IIIa B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
produced B-O B-VP_VBN
in B-O B-NP_PP_IN
megakaryocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
an B-O B-NP_NP_DT
early B-O B-JJ
stage B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
the B-O B-S_NP_NP_NP_DT
other B-O B-JJ
subunit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
GPIIIa B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
other B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
For B-O B-S_PP_IN
these B-O B-NP_DT
reasons B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
5'-flanking B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GPIIb B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
identify B-O B-VP_VB
the B-O B-NP_NP_DT
regions B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
fragment B-O B-NN
" " B-O O-NP
extending B-O B-VP_VBG
from B-O B-PP_PP_IN
-643 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
+33 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
capable B-O B-ADJP_JJ
of B-O B-PP_IN
controlling B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
tissue-specific B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CAT B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
transfection B-O B-NP_NN
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Within B-O B-S_PP_IN
this B-O B-NP_DT
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
several B-O B-NP_NP_JJ
sequences B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
implicated B-O B-VP_VBN
in B-O B-NP_PP_IN
as B-O B-NP_SBAR_IN
" " B-O B-S_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_S_NP_NP_CD
region B-O B-NN
" " B-O O-NP
, B-O B-COMMA
centered B-O B-ADJP_VBN
at B-O B-PP_IN
-54 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
similar B-O B-ADJP_JJ
to B-O B-PP_TO
a B-O B-NP_DT
nuclear B-O B-ADJP_JJ
factor B-O B-NN
E1-binding B-O B-JJ
" " B-O O-ADJP
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
a B-O B-S_NP_NP_DT
region B-O B-NN
" " B-O O-NP
located B-O B-ADJP_JJ
at B-O B-PP_IN
position B-O B-NP_NN
-233 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_DT
CCAAT B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_CD
domains B-O B-NNS
" " B-O O-NP
centered B-O B-ADJP_VBN
at B-O B-PP_IN
positions B-O B-NP_NNS
-345 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
-540 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
" " B-O O-ADJP
" " B-O O-NP
bind B-O B-VP_VBP
proteins B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
present B-O B-ADJP_JJ
in B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-ADJP
as B-O B-PP_RB
well B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
two B-O B-NP_NP_CD
other B-O B-JJ
domains B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
located B-O B-ADJP_JJ
at B-O B-PP_IN
positions B-O B-NP_NNS
-460 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
-510 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
" " B-O O-NP
interact B-O B-VP_VBP
with B-O B-PP_IN
proteins B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
only B-O B-ADJP_RB
present B-O B-JJ
" " B-O O-ADJP
in B-O B-PP_IN
megakaryocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
deletion B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
these B-O B-NP_DT
two B-O B-CD
domains B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
a B-O B-NP_NP_DT
significant B-O B-JJ
decrease B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
very B-O B-ADJP_RB
likely B-O B-JJ
" " B-O O-ADJP
that B-O B-SBAR_IN
these B-O B-S_NP_DT
domains B-O B-NNS
" " B-O O-NP
bind B-O B-VP_VBP
megakaryocyte-specific B-O B-NP_NP_JJ
nuclear B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
acting B-O B-VP_VBG
as B-O B-PP_IN
positive B-O B-NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Demonstration B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
estrogen B-O B-NP_NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
progesterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
receptors B-O B-NNS
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
Ki-67 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
p-145 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
antigens B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
single B-O B-NP_NP_JJ
tumor B-O B-NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
blood B-O B-NP_UCP_NP_NN
" " B-O O-NP
and B-O B-CC
pleural B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-UCP
effusions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
using B-O B-VP_VBG
a B-O B-NP_DT
slide B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
describe B-O B-VP_VBP
a B-O B-NP_NP_DT
slide B-O B-NN
assay B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
allows B-O B-S_NP_VP_VBZ
the B-O B-NP_NP_DT
demonstration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_ADJP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
With B-O B-S_PP_IN
the B-O B-NP_DT
antibodies B-O B-NNS
Ki-67 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
anti-p-145 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
an B-O B-NP_NP_DT
increased B-O B-VBN
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
nucleolar B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
staining B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
highly B-O B-NP_ADJP_RB
malignant B-O B-JJ
" " B-O O-ADJP
lymphomas B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_DT
almost B-O B-ADJP_RB
identical B-O B-JJ
" " B-O O-ADJP
reaction B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
obtained B-O B-VP_VBN
when B-O B-NP_SBAR_WHADVP_WRB
" " B-O O-WHADVP
tumor B-O B-S_NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
malignant B-O B-NP_JJ
effusions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
tested B-O B-VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cells B-O B-S_NP_NP_NNS
" " B-O O-NP
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_NP_DT
blood B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
yielded B-O B-VP_VBD
a B-O B-NP_NP_DT
weak B-O B-JJ
staining B-O B-NN
" " B-O O-NP
comparable B-O B-ADJP_JJ
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
normal B-O B-NP_NP_JJ
mesothelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
detection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
estrogen B-O B-NP_NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
progesterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
ER B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
PR B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
localized B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
achieved B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
same B-O B-JJ
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
reaction B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
enhanced B-O B-VP_VBN
by B-O B-NP_PP_IN
incubation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
tumor B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
30 B-O B-NP_CD
min B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
37 B-O B-NP_CD
degrees B-O B-NNS
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
prior B-O B-PP_RB
to B-O B-TO
fixation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Pleural B-O B-S_NP_NP_JJ
effusions B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
20 B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
breast B-O B-NP_NN
cancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
ER B-O B-S_S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
positive B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
13 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
PR B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
positive B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
12 B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
20 B-O B-CD
samples B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
5 B-O B-NP_CD
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
there B-O B-NP_EX
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_NP_DT
divergent B-O B-JJ
reaction B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
ER B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
PR B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
antibody B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
hormone B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
primary B-O B-JJ
tumor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
known B-O B-VP_VBN
in B-O B-NP_PP_IN
15 B-O B-NP_NP_NP_CD
( B-O B-PRN_LRB
ER B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
and B-O B-CC
14 B-O B-NP_CD
( B-O B-PRN_LRB
PR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
" " B-O O-NP
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
each B-O B-NP_DT
cohort B-O B-NN
" " B-O O-NP
" " B-O O-PP
there B-O B-NP_EX
" " B-O O-NP
was B-O B-VP_VBD
only B-O B-NP_NP_QP_RB
one B-O B-CD
" " B-O O-QP
case B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_NP_DT
negative B-O B-JJ
reaction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
primary B-O B-JJ
tumor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
positive B-O B-JJ
reaction B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
isolated B-O B-VBN
tumor B-O B-NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_NP_DT
demonstration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hormone B-O B-NP_NP_NN
receptor B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
possible B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
there B-O B-S_NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
correlation B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_NP_DT
rhombotin B-O B-NN
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cysteine-rich B-O B-NP_JJ
LIM-domain B-O B-JJ
oncogenes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
distinct B-O B-S_NP_JJ
members B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
T-cell B-O B-NP_NP_NN
translocations B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
human B-O B-NP_JJ
chromosomes B-O B-NNS
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
A B-O B-S_NP_NP_DT
chromosomal B-O B-NN
translocation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
T-cell B-O B-NN
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
involving B-O B-VP_VBG
the B-O B-NP_NP_DT
short B-O B-JJ
arm B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
chromosome B-O B-NN
11 B-O B-CD
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
band B-O B-NP_NN
11p15 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
disrupts B-O B-VP_VBZ
the B-O B-NP_DT
rhombotin B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
gene B-O B-NN
" " B-O O-NP
encodes B-O B-VP_VBZ
a B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
duplicated B-O B-NP_NP_JJ
cysteine-rich B-O B-JJ
regions B-O B-NNS
" " B-O O-NP
called B-O B-VP_VBN
LIM B-O B-S_NP_NP_NN
domains B-O B-NNS
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
show B-O B-S_NP_VP_VBP
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_CD
homologues B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
rhombotin B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
now B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
isolated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
designated B-O B-VP_VBN
Rhom-2 B-O B-S_NP_NP_NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
located B-O B-ADJP_JJ
on B-O B-PP_IN
human B-O B-NP_NP_JJ
chromosome B-O B-NN
11 B-O B-CD
" " B-O O-NP
at B-O B-PP_IN
band B-O B-NP_NN
11p13 B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
occur B-O B-S_NP_NP_PP_VP_VBP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
all B-O B-S_NP_NP_DT
translocation B-O B-NN
breakpoints B-O B-NNS
" " B-O O-NP
at B-O B-PP_IN
11p13 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
upstream B-O B-ADJP_JJ
of B-O B-PP_IN
the B-O B-NP_DT
Rhom-2 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Human B-O B-S_NP_UCP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
mouse B-O B-NP_NN
" " B-O O-NP
" " B-O O-UCP
Rhom-2 B-O B-NN
" " B-O O-NP
are B-O B-VP_VP_VBP
highly B-O B-ADVP_RB
" " B-O O-ADVP
conserved B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
and B-O B-CC
, B-O B-COMMA
like B-O B-VP_PP_IN
rhombotin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
encode B-O B-VP_VBP
two B-O B-NP_CD
tandem B-O B-JJ
cysteine-rich B-O B-JJ
LIM B-O B-NN
domains B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Rhom-2 B-O B-S_S_NP_NN
mRNA B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
early B-O B-NP_NP_JJ
mouse B-O B-NN
development B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
central B-O B-NP_NP_JJ
nervous B-O B-JJ
system B-O B-NN
" " B-O O-NP
, B-O B-COMMA
lung B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
kidney B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
liver B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
spleen B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
but B-O B-CC
only B-O B-S_NP_ADJP_RB
very B-O B-RB
low B-O B-JJ
" " B-O O-ADJP
levels B-O B-NNS
" " B-O O-NP
occur B-O B-VP_VBP
in B-O B-PP_IN
thymus B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
other B-O B-JJ
gene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
designated B-O B-VP_VBN
Rhom-3 B-O B-S_NP_NP_NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VP_VBZ
not B-O B-RB
on B-O B-PP_IN
chromosome B-O B-NP_NN
11 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
retains B-O B-VP_VBZ
homology B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
LIM B-O B-NN
domain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
rhombotin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
the B-O B-S_NP_DT
Rhom-2 B-O B-NN
gene B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
such B-O B-NP_NP_JJ
a B-O B-DT
common B-O B-JJ
site B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
chromosomal B-O B-NP_JJ
damage B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T-cell B-O B-NP_NN
tumors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-NP_NP_DT
consistency B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
translocations B-O B-NP_NP_NNS
" " B-O O-NP
near B-O B-PP_IN
the B-O B-NP_DT
rhombotin B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
further B-O B-ADVP_RB
" " B-O O-ADVP
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
second B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
adjacent B-O B-ADJP_JJ
to B-O B-PP_TO
rhombotin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-UCP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
at B-O B-PP_IN
the B-O B-NP_NP_DT
same B-O B-JJ
position B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
in B-O B-FRAG_PP_IN
the B-O B-NP_DT
previous B-O B-JJ
example B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
chromosome B-O B-NP_NN
bands B-O B-NNS
11p15 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
rhombotin B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
11p13 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
Rhom-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
consistent B-O B-NP_NP_JJ
sites B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
chromosome B-O B-NP_NN
translocation B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T-cell B-O B-NP_NN
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
with B-O B-SBAR_IN
the B-O B-S_NP_DT
11p15 B-O B-NN
target B-O B-NN
" " B-O O-NP
more B-O B-VP_ADVP_RBR
rarely B-O B-RB
" " B-O O-ADVP
involved B-O B-VBN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
define B-O B-VP_VBP
the B-O B-NP_DT
rhombotin B-O B-NN
gene B-O B-NN
family B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
class B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T-cell B-O B-NP_NN
oncogenes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
duplicated B-O B-NP_JJ
cysteine-rich B-O B-JJ
LIM B-O B-NN
domains B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cortivazol B-O B-NP_NP_NN
mediated B-O B-VBD
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
receptor B-O B-NN
messenger B-O B-NN
ribonucleic B-O B-JJ
acid B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
wild-type B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
dexamethasone-resistant B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
human B-O B-JJ
leukemic B-O B-NN
( B-O B-LRB
CEM B-O B-NN
) B-O B-RRB
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Cortivazol B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
phenylpyrazolo B-O B-JJ
glucocorticoid B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
high B-O B-NP_NP_JJ
potency B-O B-NN
" " B-O O-NP
and B-O B-CC
unusual B-O B-NP_JJ
structure B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
both B-O B-NP_NP_ADJP_CC
wild-type B-O B-ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
highly B-O B-ADJP_RB
dexamethasone B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
dex B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
-resistant B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
clones B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
leukemic B-O B-JJ
cell B-O B-NN
line B-O B-NN
CEM B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
exposure B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
cortivazol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
cell B-O B-NP_NN
death B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
recently B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
in B-O B-S_PP_PP_IN
wild-type B-O B-NP_JJ
CEM B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
a B-O B-NP_DT
clone B-O B-ADJP_NN
ICR-27 B-O B-NN
TK-3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
dex B-O B-NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
GR B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
test B-O B-VP_VB
the B-O B-NP_DT
hypothesis B-O B-NN
that B-O B-SBAR_IN
cortivazol B-O B-S_NP_NN
" " B-O O-NP
acts B-O B-VP_VBZ
in B-O B-PP_IN
by B-O B-NP_PP_IN
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
wild-type B-O B-S_S_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
dex-resistant B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
clones B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
treated B-O B-VP_VBN
with B-O B-NP_PP_IN
various B-O B-NP_NP_JJ
concentrations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
cortivazol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Cortivazol B-O B-S_NP_NN
" " B-O O-NP
significantly B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBD
GR B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
the B-O B-NP_DT
normal B-O B-JJ
CEM-C7 B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
two B-O B-NP_NP_CD
classes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
dex-resistant B-O B-NP_JJ
clones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
although B-O B-SBAR_IN
the B-O B-S_NP_DT
dex-resistant B-O B-JJ
clones B-O B-NNS
" " B-O O-NP
needed B-O B-VP_VBD
at B-O B-NP_NP_ADJP_QP_IN
least B-O B-JJS
10 B-O B-CD
times B-O B-NNS
" " B-O O-QP
more B-O B-JJR
" " B-O O-ADJP
cortivazol B-O B-NN
" " B-O O-NP
than B-O B-PP_IN
the B-O B-NP_DT
normal B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
for B-O B-PP_IN
significant B-O B-NP_JJ
GR B-O B-NN
mRNA B-O B-NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Increased B-O B-S_NP_NP_VBN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
noticed B-O B-VP_VBN
as B-O B-NP_ADVP_ADVP_RB
early B-O B-RB
" " B-O O-ADVP
as B-O B-PP_IN
3 B-O B-PP_NP_CD
h B-O B-NN
" " B-O O-NP
after B-O B-IN
treatment B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
general B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
induction B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
lysis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
normal B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
dex-resistant B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Positive B-O B-S_NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
might B-O B-VP_VP_MD
be B-O B-VP_VB
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
earliest B-O B-JJS
crucial B-O B-JJ
steps B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
or B-O B-CC
might B-O B-VP_MD
serve B-O B-VP_VB
as B-O B-PP_IN
a B-O B-NP_NP_DT
marker B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
process B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
lysis B-O B-NN
pathway B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
dex-resistant B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
defective B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
that B-O B-SBAR_IN
dex-resistant B-O B-S_NP_JJ
clones B-O B-NNS
" " B-O O-NP
needed B-O B-VP_VBD
significantly B-O B-NP_NP_ADJP_RB
more B-O B-JJR
" " B-O O-ADJP
cortivazol B-O B-NN
" " B-O O-NP
than B-O B-PP_IN
the B-O B-NP_DT
normal B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
for B-O B-PP_IN
lysis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Human B-O B-NP_NP_NP_JJ
erythroid B-O B-JJ
5-aminolevulinate B-O B-NN
synthase B-O B-NN
" " B-O O-NP
: B-O B-COLON
" " B-O O-NP
promoter B-O B-NP_NP_NP_NN
analysis B-O B-NN
" " B-O O-NP
and B-O B-CC
identification B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
iron-responsive B-O B-JJ
element B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
5-Aminolevulinate B-O B-S_NP_NP_NN
synthase B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ALAS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
catalyzes B-O B-VP_VBZ
the B-O B-NP_NP_DT
first B-O B-JJ
step B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
heme B-O B-NN
biosynthetic B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
cDNA B-O B-S_NP_NP_NN
clones B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
erythroid B-O B-JJ
ALAS B-O B-NN
isozyme B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
a B-O B-NP_DT
fetal B-O B-JJ
liver B-O B-NN
library B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
deduced B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_DT
erythroid B-O B-JJ
ALAS B-O B-NN
precursor B-O B-NN
protein B-O B-NN
" " B-O O-NP
has B-O B-VP_VP_VBZ
" " B-O B-NP_NP_PP_O-VP
, B-O B-COMMA
and B-O B-CC
is B-O B-VP_VBZ
similar B-O B-ADJP_JJ
" " B-O B-PP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mature B-O B-JJ
mitochondrial B-O B-JJ
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
erythroid B-O B-UCP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
housekeeping B-O B-NP_JJ
" " B-O O-NP
" " B-O O-UCP
ALAS B-O B-NN
isozymes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
predicted B-O B-VP_VBN
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
molecular B-O B-NP_NP_JJ
weights B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
two B-O B-CD
isozymes B-O B-NNS
" " B-O O-NP
show B-O B-VP_VP_VBP
little B-O B-NP_JJ
amino B-O B-NN
acid B-O B-NN
identity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
their B-O B-NP_PRPP
N-terminal B-O B-JJ
signal B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CC
have B-O B-VP_VBP
considerable B-O B-NP_JJ
sequence B-O B-NN
identity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
C-terminal B-O B-JJ
two-thirds B-O B-CD
" " B-O O-NP
of B-O B-PP_IN
their B-O B-NP_PRPP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_NP_DT
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
immediate B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
erythroid B-O B-JJ
ALAS B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
several B-O B-NP_NP_JJ
putative B-O B-JJ
erythroid-specific B-O B-JJ
cis-acting B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
including B-O B-PP_VBG
both B-O B-NP_NP_PDT
a B-O B-NP_DT
GATA-1 B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
an B-O B-NP_DT
NF-E2 B-O B-NN
" " B-O B-NP_O-NP
" " B-O O-NP
binding B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_DT
iron-responsive B-O B-NP_NP_JJ
element B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IRE B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
motif B-O B-NN
" " B-O O-NP
has B-O B-VP_VP_VBZ
been B-O B-VP_VBN
identified B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
5'-untranslated B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
erythroid B-O B-JJ
ALAS B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
is B-O B-VP_VBZ
not B-O B-RB
present B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_DT
housekeeping B-O B-JJ
ALAS B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Gel B-O B-S_NP_NN
retardation B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
established B-O B-VP_VBD
that B-O B-SBAR_IN
this B-O B-S_S_NP_DT
IRE B-O B-NN
motif B-O B-NN
" " B-O O-NP
formed B-O B-VP_VBD
a B-O B-NP_DT
"protein - RNA" B-O B-NP_JJ
" " B-O O-NP
complex B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
cytosolic B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
this B-O B-S_NP_DT
binding B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
strongly B-O B-ADVP_RB
" " B-O O-ADVP
competed B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
transcript B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
ALAS B-O B-NN
IRE B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
mutated B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
conserved B-O B-VBN
loop B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IRE B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
readily B-O B-ADVP_RB
" " B-O O-ADVP
form B-O B-VP_VB
this B-O B-NP_DT
"protein - RNA" B-O B-NP_JJ
" " B-O O-NP
complex B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
IRE B-O B-NN
motif B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
ALAS B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
functional B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
imply B-O B-VP_VBP
that B-O B-SBAR_IN
translation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
cellular B-O B-NP_JJ
iron B-O B-NN
availability B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
erythropoiesis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Human B-O B-NP_NP_JJ
tumor B-O B-NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
gene B-O B-NN
regulation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
phorbol B-O B-NP_ADJP_NN
ester B-O B-NN
stimulated B-O B-VBD
" " B-O O-ADJP
T B-O B-NN
and B-O B-CC
B B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
minimal B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
human B-O B-JJ
tumor B-O B-NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
( B-O B-LRB
TNF-alpha B-O B-NN
) B-O B-RRB
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
necessary B-O B-ADJP_JJ
for B-O B-PP_IN
its B-O B-NP_NP_PRPP
transcriptional B-O B-JJ
induction B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
and B-O B-CC
B B-O B-NN
lymphocyte B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
localized B-O B-VP_JJ
between B-O B-NP_PP_IN
-52 B-O B-NP_NP_NP_CD
" " B-O O-NP
and B-O B-CC
+89 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
nucleotides B-O B-NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
nt B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
relative B-O B-ADVP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
gene B-O B-NN
's B-O B-POS
" " B-O O-NP
transcriptional B-O B-JJ
start B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Comparison B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
those B-O B-NP_NP_DT
" " B-O O-NP
required B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
mediate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reveal B-O B-VP_VB
significant B-O B-NP_JJ
differences B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
thus B-O B-RB
, B-O B-COMMA
the B-O B-S_NP_NP_DT
sequence B-O B-NN
requirements B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
PMA B-O B-NP_NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
distinct B-O B-ADJP_JJ
from B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
mediate B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
three B-O B-S_NP_NP_NP_CD
sites B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
TNF-alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
kappa B-O B-NP_NP_NN
1 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
kappa B-O B-NP_NN
2 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
kappa B-O B-NP_NN
3 B-O B-CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
bind B-O B-VP_VBP
the B-O B-NP_NP_DT
transcription B-O B-NN
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lymphoid B-O B-NP_JJ
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
TNF-alpha B-O B-NP_NP_NN
mRNA B-O B-NN
induction B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
correlate B-O B-VP_VB
with B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
binding B-O B-NN
activities B-O B-NNS
" " B-O O-NP
displayed B-O B-VP_VBN
by B-O B-NP_PP_IN
different B-O B-NP_JJ
T B-O B-NN
and B-O B-CC
B B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
kappa B-O B-NP_NP_NN
1 B-O B-CD
" " B-O O-NP
- B-O B-COLON
kappa B-O B-NP_NN
3 B-O B-CD
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
each B-O B-DT
be B-O B-VP_VB
deleted B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_DT
TNF-alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
little B-O B-NP_NP_JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
inducibility B-O B-NP_NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
TNF-alpha B-O B-NP_NP_NN
mRNA B-O B-NN
induction B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
like B-O B-PP_IN
its B-O B-NP_NP_PRPP
induction B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
virus B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
is B-O B-VP_VP_VBZ
not B-O B-RB
primarily B-O B-ADVP_RB
" " B-O O-ADVP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CONJP_CC
rather B-O B-RB
" " B-O O-CONJP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
other B-O B-NP_JJ
sequences B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
protein B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Surprisingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
multimers B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
kappa B-O B-NP_NP_NN
1 B-O B-CD
" " B-O O-NP
- B-O B-COLON
kappa B-O B-NP_NN
3 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
confer B-O B-VP_VB
PMA B-O B-NP_NN
inducibility B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
a B-O B-NP_NP_DT
heterologous B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_NP_DT
" " B-O B-NP_NP_O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
a B-O B-NP_DT
" " B-O B-NP_NP_O-NP
" " B-O O-NP
cell B-O B-NP_NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_WRB
" " B-O O-ADVP
they B-O B-NP_PRP
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
functional B-O B-ADJP_JJ
" " B-O O-ADJP
on B-O B-PP_IN
a B-O B-NP_DT
truncated B-O B-VBN
TNF-alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
promoter B-O B-S_NP_NP_NN
context B-O B-NN
" " B-O O-NP
and B-O B-CC
cell B-O B-NP_NN
type B-O B-NN
specificity B-O B-NN
" " B-O O-NP
" " B-O O-NP
influence B-O B-VP_VBP
the B-O B-NP_NP_DT
PMA B-O B-NN
inducible B-O B-JJ
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Reactive B-O B-NP_NP_JJ
oxygen B-O B-NN
intermediates B-O B-NNS
" " B-O O-NP
as B-O B-PP_IN
apparently B-O B-ADJP_RB
widely B-O B-RB
used B-O B-VBN
" " B-O O-ADJP
messengers B-O B-NNS
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
and B-O B-CC
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Hydrogen B-O B-S_NP_NP_NP_NN
peroxide B-O B-NN
" " B-O O-NP
and B-O B-CC
oxygen B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
radicals B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
agents B-O B-NP_NP_NNS
" " B-O O-NP
commonly B-O B-VP_ADVP_RB
" " B-O O-ADVP
produced B-O B-VP_VBN
during B-O B-NP_PP_IN
inflammatory B-O B-NP_JJ
processes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
micromolar B-O B-S_NP_NP_JJ
concentrations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
H2O2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
induce B-O B-VP_VB
the B-O B-NP_NP_DT
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_DT
human B-O B-JJ
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
NF-kappa B-O B-NN
B B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
and B-O B-ADVP_ADVP_CC
activated B-O B-ADVP_VP_VBN
by B-O B-NP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
N-acetyl-L-cysteine B-O B-S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
NAC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
well B-O B-ADJP_RB
characterized B-O B-VBN
" " B-O O-ADJP
antioxidant B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
counteracts B-O B-S_NP_VP_VBZ
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
in B-O B-PP_IN
living B-O B-NP_VBG
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
prevented B-O B-VP_VBD
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
H2O2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NAC B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
other B-O B-NP_JJ
thiol B-O B-JJ
compounds B-O B-NNS
" " B-O O-NP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
blocked B-O B-VP_VBD
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
cycloheximide B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
double-stranded B-O B-NP_ADJP_JJ
" " B-O O-ADJP
RNA B-O B-NN
" " B-O O-NP
, B-O B-COMMA
calcium B-O B-NP_NN
ionophore B-O B-NN
" " B-O O-NP
, B-O B-COMMA
TNF-alpha B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
active B-O B-NP_JJ
phorbol B-O B-NN
ester B-O B-NN
" " B-O O-NP
, B-O B-COMMA
interleukin-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
lipopolysaccharide B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
lectin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
diverse B-O B-S_NP_NP_JJ
agents B-O B-NNS
" " B-O O-NP
thought B-O B-VP_VBN
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
might B-O B-VP_MD
all B-O B-ADVP_RB
" " B-O O-ADVP
act B-O B-VP_VB
through B-O B-PP_IN
a B-O B-NP_NP_DT
common B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
involving B-O B-VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
ROI B-O B-S_NP_NN
" " B-O O-NP
appear B-O B-VP_VBP
to B-O B-S_NP_VP_TO
serve B-O B-VP_VB
as B-O B-PP_IN
messengers B-O B-NP_NP_NNS
" " B-O O-NP
mediating B-O B-VP_VBG
or B-O B-ADVP_ADVP_CC
" " B-O B-ADVP_NP_NP_PP_PP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Contribution B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
Sp1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
binding B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_NP_DT
replicative B-O B-JJ
capacity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
distinct B-O B-S_NP_NP_JJ
patterns B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
viral B-O B-NP_JJ
growth B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
determined B-O B-VP_VBN
by B-O B-NP_PP_IN
T-cell B-O B-NP_NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
Starting B-O B-S_S_NP_VP_VBG
with B-O B-PP_IN
a B-O B-NP_NP_DT
replication-incompetent B-O B-JJ
molecular B-O B-JJ
clone B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
lacking B-O B-VP_VBG
all B-O B-NP_NP_PDT
the B-O B-DT
and B-O B-NP_NP_CC
binding B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
proviruses B-O B-NP_NP_NNS
" " B-O O-NP
containing B-O B-VP_VBG
reconstructed B-O B-NP_NP_VBN
LTRs B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
individual B-O B-NP_NP_NP_JJ
" " B-O B-NP_O-NP
or B-O B-CC
combinations B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-NP
NF-kappa B-O B-NP_NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
Sp1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
generated B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
evaluated B-O B-VP_VBN
for B-O B-NP_PP_IN
their B-O B-NP_PRPP
capacity B-O B-NN
to B-O B-S_NP_VP_TO
produce B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Virus B-O B-S_NP_NP_NN
stocks B-O B-NNS
" " B-O O-NP
obtained B-O B-VP_VBN
from B-O B-NP_PP_IN
these B-O B-NP_DT
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
exhibited B-O B-VP_VBD
a B-O B-NP_NP_DT
continuum B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
replicative B-O B-NP_JJ
capacities B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
different B-O B-NP_JJ
human B-O B-JJ
T-cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
depending B-O B-PP_VBG
on B-O B-PP_IN
which B-O B-SBAR_WHNP_WDT
element B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
present B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
For B-O B-S_PP_IN
example B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
experiments B-O B-NP_NP_NNS
" " B-O O-NP
involving B-O B-VP_VBG
proviral B-O B-NP_NP_JJ
clones B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
LTRs B-O B-NP_NP_NNS
" " B-O O-NP
containing B-O B-VP_VBG
( B-O B-NP_NP_LRB
and B-O B-CC
) B-O B-NP_RRB
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_NP_DT
hierarchy B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cellular B-O B-NP_NP_JJ
permissivity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
virus B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
peripheral B-O B-S_NP_JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
= B-O B-VP_JJ
MT4 B-O B-NP_NP_NN
" " B-O O-NP
greater B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
" " B-O B-NP_NP_ADJP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Of B-O B-SINV_PP_IN
note B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
was B-O B-VP_VBD
" " B-O B-PP_O-VP
the B-O B-NP_NP_DT
associated B-O B-VBN
emergence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
second-site B-O B-NP_JJ
LTR B-O B-NN
revertants B-O B-NNS
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
involved B-O B-S_NP_VP_VBD
an B-O B-NP_NP_DT
alteration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TATA B-O B-NN
box B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-SINV
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
LTR B-O B-NN
" " B-O O-NP
possesses B-O B-VP_VP_VBZ
functional B-O B-NP_NP_JJ
redundancy B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
capable B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
depending B-O B-PP_VBG
on B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Estrogen B-O B-NP_NP_NP_NP_NN
receptor B-O B-NN
concentration B-O B-NN
" " B-O O-NP
and B-O B-CC
social B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
as B-O B-PP_IN
predictors B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
natural B-O B-NP_NP_JJ
killer B-O B-NN
cell B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
early-stage B-O B-NP_JJ
breast B-O B-NN
cancer B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Confirmation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
model B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Previous B-O B-S_S_NP_NP_JJ
work B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ours B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
significant B-O B-JJ
amount B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
accounted B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
As B-O B-S_SBAR_IN
considerable B-O B-NP_JJ
evidence B-O B-NN
" " B-O B-SBAR_O-NP
has B-O B-VP_VBZ
accumulated B-O B-VP_VBN
" " B-O O-VP
" " B-O O-VP
that B-O B-SBAR_IN
social B-O B-S_NP_NP_JJ
support B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_CC
animal B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
human B-O B-NP_JJ
" " B-O B-NP_O-NP
populations B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
have B-O B-VP_VB
survival B-O B-NP_NN
value B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
sought B-O B-VP_VBD
to B-O B-S_NP_VP_TO
test B-O B-VP_VB
the B-O B-NP_NP_DT
reliability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
regression B-O B-NN
model B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
using B-O B-S_NP_VP_VBG
and B-O B-NP_NP_NP_CC
obtained B-O B-NP_VP_VBN
" " B-O B-NP_PP_O-NP
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
most B-O B-ADJP_RBS
significant B-O B-JJ
" " B-O O-ADJP
variable B-O B-NN
" " B-O O-NP
predicting B-O B-VP_VBG
NK B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
follow-up B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
tumor B-O B-NP_NN
ER B-O B-NN
concentration B-O B-NN
" " B-O O-NP
, B-O B-COMMA
with B-O B-PP_IN
higher B-O B-S_NP_JJR
NK B-O B-NN
activity B-O B-NN
" " B-O O-NP
associated B-O B-VP_VBN
" " B-O B-PP_O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
seeking B-O B-UCP_S_NP_VP_VBG
social B-O B-NP_JJ
support B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_DT
coping B-O B-NN
strategy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
the B-O B-NP_NP_DT
perceived B-O B-VBN
quality B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
support B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-UCP
also B-O B-ADVP_RB
" " B-O O-ADVP
entered B-O B-VP_VBD
the B-O B-NP_NP_DT
model B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHADVP_S_NP_VP_TO
account B-O B-VP_VB
for B-O B-PP_IN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
multivariate B-O B-NP_NP_NP_JJ
F B-O B-NN
" " B-O O-NP
= B-O B-ADJP_JJ
5.25 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
, B-O B-COMMA
p B-O B-NP_NP_NN
" " B-O O-NP
less B-O B-ADJP_JJR
than B-O B-PP_IN
0.001 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
  
If B-O B-S_SBAR_SBAR_IN
" " B-O B-S_O-SBAR
, B-O B-COMMA
as B-O B-SBAR_IN
the B-O B-S_NP_DT
literature B-O B-NN
" " B-O O-NP
suggests B-O B-VP_VBZ
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
NK B-O B-S_NP_NN
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
relevant B-O B-ADJP_JJ
to B-O B-PP_TO
breast B-O B-NP_NN
cancer B-O B-NN
control B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
since B-O B-SBAR_IN
ER- B-O B-S_NP_JJ
tumors B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
a B-O B-NP_DT
worse B-O B-JJR
prognosis B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
suggest B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
perhaps B-O B-S_ADVP_RB
" " B-O O-ADVP
such B-O B-NP_JJ
tumors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
resistant B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
because B-O B-SBAR_SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
, B-O B-COMMA
or B-O B-CC
because B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
finding B-O B-NN
" " B-O O-NP
related B-O B-ADJP_JJ
to B-O B-PP_TO
social B-O B-NP_JJ
support B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
replicates B-O B-VP_VBZ
results B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
an B-O B-NP_NP_DT
independent B-O B-JJ
sample B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
breast B-O B-NP_NN
cancer B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
finding B-O B-NN
, B-O B-COMMA
" " B-O O-NP
taken B-O B-S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
other B-O B-NP_JJ
evidence B-O B-NN
that B-O B-SBAR_IN
this B-O B-S_NP_DT
social B-O B-JJ
variable B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
underscores B-O B-VP_VBZ
the B-O B-NP_NP_DT
potential B-O B-JJ
importance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
social B-O B-JJ
support B-O B-NN
variable B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
findings B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
suggest B-O B-VP_VBP
one B-O B-NP_CD
possible B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
immunological B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
variable B-O B-NN
" " B-O O-NP
involved B-O B-VP_JJ
" " B-O B-NP_O-VP
, B-O B-COMMA
with B-O B-PP_IN
potential B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
clinical B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
significance B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
for B-O B-PP_IN
this B-O B-NP_DT
patient B-O B-NN
population B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Purification B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
TCF-1 B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
T-cell-specific B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
activates B-O B-S_NP_VP_VBZ
the B-O B-NP_DT
T-cell B-O B-NN
receptor B-O B-NN
C B-O B-NN
alpha B-O B-NN
gene B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_S_NP_NP_DT
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
functionally B-O B-NP_ADJP_RB
diverse B-O B-JJ
" " B-O O-ADJP
subpopulations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
controlled B-O B-VP_VBN
in B-O B-NP_PP_IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
by B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
and B-O B-CC
silencing B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
however B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
little B-O B-NP_JJ
" " B-O B-PP_O-NP
is B-O B-VP_VBZ
known B-O B-VP_VBN
in B-O B-NP_PP_IN
detail B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
about B-O B-PP_IN
the B-O B-NP_NP_DT
proteins B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
influence B-O B-S_NP_VP_VBP
this B-O B-NP_DT
developmental B-O B-JJ
process B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
purified B-O B-VP_VBN
a B-O B-NP_NP_DT
new B-O B-JJ
T-cell-specific B-O B-JJ
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
TCF-1 B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
, B-O B-COMMA
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
implicated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TCF-1 B-O B-S_NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
, B-O B-COMMA
originally B-O B-VP_ADVP_RB
" " B-O O-ADVP
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
purified B-O B-VP_VBN
through B-O B-NP_PP_IN
its B-O B-NP_NP_PRPP
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
to B-O B-PP_PP_TO
the B-O B-NP_DT
TCR B-O B-NN
alpha B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Sequences B-O B-S_NP_NP_NNS
" " B-O O-NP
related B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_DT
TCF-1 B-O B-NP_NP_NN
alpha B-O B-NN
binding B-O B-NN
motif B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
5'-GGCACCCTTTGA-3' B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
are B-O B-VP_VBP
also B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
human B-O B-NP_JJ
TCR B-O B-NN
delta B-O B-NN
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
and B-O B-CC
possibly B-O B-ADVP_RB
" " B-O O-ADVP
TCR B-O B-NP_NN
beta B-O B-NN
" " B-O B-NP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
enhancers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Southwestern B-O B-S_NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
gel B-O B-NP_NN
renaturation B-O B-NN
" " B-O B-NP_O-NP
experiments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
purified B-O B-NP_VBN
protein B-O B-NN
fractions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
TCF-1 B-O B-S_NP_NN
alpha B-O B-NN
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
a B-O B-NP_NP_DT
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
small B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
95-bp B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
fragment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TCR B-O B-NN
alpha B-O B-NN
control B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contains B-O B-S_NP_VP_VBZ
the B-O B-NP_NP_DT
TCF-1 B-O B-NN
alpha B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
juxtaposed B-O B-VP_VBD
between B-O B-NP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
behaved B-O B-VP_VBD
as B-O B-PP_IN
a B-O B-NP_DT
potent B-O B-JJ
T-cell-specific B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tandem B-O B-S_NP_NP_JJ
copies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
functioned B-O B-VP_VBD
synergistically B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
mature B-O B-NP_NP_JJ
( B-O B-LRB
Jurkat B-O B-NN
) B-O B-RRB
T-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
resting B-O B-NP_NP_VBG
" " B-O B-NP_O-NP
and B-O B-CC
activated B-O B-NP_VBN
" " B-O B-NP_O-NP
immature B-O B-NP_JJ
( B-O B-LRB
CCRF-CEM B-O B-NN
) B-O B-RRB
T-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TCF-1 B-O B-NN
alpha B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
diminished B-O B-VP_VP_VBD
enhancer B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
disrupted B-O B-VP_VBD
the B-O B-NP_NP_DT
synergism B-O B-NN
" " B-O O-NP
observed B-O B-VP_VBN
in B-O B-NP_ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
between B-O B-PP_IN
tandem B-O B-NP_JJ
enhancer B-O B-NN
repeats B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
TCF-1 B-O B-NN
alpha B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
TCR B-O B-NP_NP_NN
alpha B-O B-NN
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
transcriptionally B-O B-NP_NP_ADJP_RB
active B-O B-JJ
" " B-O O-ADJP
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_NP_CONJP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
confirming B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
TCF-1 B-O B-S_NP_NN
alpha B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
T-cell-specific B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Curiously B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
TCF-1 B-O B-NN
alpha B-O B-NN
binding B-O B-NN
element B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
inactive B-O B-ADJP_JJ
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-ADJP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
removed B-O B-S_NP_UCP_VP_VBN
from B-O B-NP_PP_IN
its B-O B-NP_NP_PRPP
neighboring B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
positioned B-O B-ADJP_JJ
in B-O B-PP_IN
or B-O B-NP_NP_NP_CC
upstream B-O B-NP_NP_ADVP_RB
" " B-O O-ADVP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O B-ADVP_O-UCP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TCF-1 B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
depend B-O B-VP_VB
on B-O B-PP_IN
the B-O B-NP_NP_DT
TCF-2 B-O B-NP_NN
alpha B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
" " B-O B-NP_NP_PRN_NP_O-NP
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
context B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_NP_DT
novel B-O B-JJ
T-cell B-O B-NN
trans-activator B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
recognizes B-O B-S_NP_VP_VBZ
a B-O B-NP_NP_DT
phorbol B-O B-NN
ester-inducible B-O B-JJ
element B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
interleukin-2 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
interleukin B-O B-NN
2 B-O B-CD
( B-O B-LRB
IL-2 B-O B-NN
) B-O B-RRB
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
several B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
cell-type-specific B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
ubiquitous B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
transcriptional B-O B-NP_JJ
regulators B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
integrate B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
a B-O B-NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transfection B-O B-NP_NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
protein-DNA B-O B-NP_JJ
binding B-O B-NN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
in B-O B-NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
transcription B-O B-NN
" " B-O B-NP_O-NP
methods B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
discovered B-O B-VP_VBN
the B-O B-NP_NP_DT
novel B-O B-NP_NP_NP_JJ
T-cell-specific B-O B-JJ
transcriptional B-O B-JJ
activator B-O B-NN
" " B-O O-NP
TCF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
for B-O B-PP_IN
T-Cell B-O B-NP_NN
Factor-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
recognizes B-O B-S_NP_VP_VBZ
a B-O B-NP_NP_DT
located B-O B-NP_ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
the B-O B-S_NP_DT
TCE B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
similar B-O B-ADJP_JJ
in B-O B-PP_IN
sequence B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_DT
consensus B-O B-NN
NF B-O B-NN
kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
several B-O B-S_NP_JJ
criteria B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
TCF-1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
distinct B-O B-ADJP_JJ
from B-O B-PP_IN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
like B-O B-PP_IN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
TCF-1 B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
phorbol B-O B-NP_NP_NN
esters B-O B-NNS
" " B-O O-NP
and B-O B-CC
other B-O B-NP_JJ
T-cell B-O B-NN
activators B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Reactivity B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_DT
progesterone B-O B-NP_NN
receptor-specific B-O B-JJ
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
In B-O B-S_S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
present B-O B-VP_VBP
evidence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
reactivity B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
pregnancy B-O B-NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
nonpregnancy B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
with B-O B-PP_IN
the B-O B-NP_DT
progesterone B-O B-NP_NP_NN
receptor-specific B-O B-JJ
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
mPRI B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
an B-O B-NP_DT
avidin-biotin B-O B-NP_JJ
peroxidase B-O B-NN
" " B-O O-NP
detection B-O B-NN
system B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
a B-O B-NP_NP_DT
nuclear B-O B-JJ
staining B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
14.6 B-O B-NP_NP_NP_QP_CD
+/- B-O B-CC
3.7 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
, B-O B-NP_NP_COMMA
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
pregnancy B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
while B-O B-SBAR_IN
only B-O B-S_NP_NP_NP_QP_RB
0.47 B-O B-CD
+/- B-O B-CC
0.33 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
, B-O B-NP_NP_COMMA
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
nonpregnancy B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reacted B-O B-VP_VBD
with B-O B-PP_IN
the B-O B-NP_DT
antibody B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
characterize B-O B-VP_VB
the B-O B-NP_DT
receptor-bearing B-O B-JJ
subset B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
CD8+ B-O B-S_NP_NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
CD4+ B-O B-NP_JJ
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
depleted B-O B-VP_VBN
by B-O B-NP_PP_IN
complement-dependent B-O B-NP_JJ
lysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Depletion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD8+ B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
62 B-O B-NP_NP_ADJP_QP_CD
+/- B-O B-CC
18 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-ADJP
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
progesterone B-O B-NP_NN
receptor-bearing B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
while B-O B-SBAR_IN
depletion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD4+ B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_DT
twofold B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
nonpregnancy B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
a B-O B-NP_DT
3-day B-O B-JJ
PHA B-O B-NP_NP_NN
" " B-O O-NP
treatment B-O B-NN
" " B-O O-NP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
allogeneic B-O B-NP_JJ
stimulation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_DT
significant B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
receptor-containing B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
pregnancy B-O B-S_NP_NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
nonpregnancy B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
contain B-O B-VP_VBP
progesterone B-O B-NP_NN
binding B-O B-NN
structures B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
these B-O B-S_NP_DT
" " B-O O-NP
are B-O B-VP_VBP
inducible B-O B-ADJP_JJ
by B-O B-PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Two B-O B-NP_NP_NP_CD
distinct B-O B-JJ
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bind B-O B-S_NP_VP_VBP
the B-O B-NP_DT
immunoglobulin B-O B-NP_NP_NN
enhancer B-O B-NN
" " B-O O-NP
microE5/kappa B-O B-NP_NN
2 B-O B-CD
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Activity B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
immunoglobulin B-O B-NP_NP_NN
heavy B-O B-JJ
" " B-O B-NP_O-NP
and B-O B-CC
kappa B-O B-NP_NN
light B-O B-JJ
" " B-O B-NP_O-NP
" " B-O O-NP
chain B-O B-NP_NN
gene B-O B-NN
enhancers B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
depends B-O B-VP_VBZ
on B-O B-PP_IN
a B-O B-NP_NP_DT
complex B-O B-JJ
interplay B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ubiquitous B-O B-NP_JJ
and B-O B-CC
developmentally B-O B-RB
regulated B-O B-VBN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Two B-O B-S_NP_CD
complementary B-O B-NP_JJ
DNAs B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_O-NP
were B-O B-VP_VBD
isolated B-O B-VP_VBN
" " B-O O-VP
" " B-O O-VP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
encode B-O B-S_NP_VP_VBP
proteins B-O B-NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
denoted B-O B-VP_VBN
ITF-1 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
ITF-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VP_VBP
and B-O B-VP_CC
bind B-O B-VP_VBP
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
complementary B-O B-NP_JJ
DNAs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
the B-O B-NP_NP_DT
products B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
distinct B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
yet B-O B-CC
both B-O B-S_NP_CC
ITF-1 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
ITF-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
structurally B-O B-ADJP_ADJP_ADVP_RB
" " B-O O-ADVP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
functionally B-O B-ADJP_ADVP_RB
" " B-O O-ADVP
" " B-O B-ADJP_O-ADJP
similar B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
two B-O B-CD
proteins B-O B-NNS
" " B-O O-NP
interact B-O B-VP_VBP
with B-O B-PP_IN
one B-O B-NP_CD
another B-O B-DT
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
their B-O B-NP_PRPP
putative B-O B-JJ
helix-loop-helix B-O B-NP_JJ
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
each B-O B-S_NP_DT
" " B-O O-NP
possesses B-O B-VP_VBZ
a B-O B-NP_DT
distinct B-O B-JJ
domain B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
dictates B-O B-S_NP_VP_VBZ
transcription B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_S_NP_NP_NP_DT
factor B-O B-NN
" " B-O O-NP
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
to B-O B-PP_TO
in B-O B-NP_PP_ADVP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
is B-O B-VP_VBZ
a B-O B-NP_DT
ubiquitously B-O B-NP_RB
active B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
transcriptional B-O B-NP_JJ
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
located B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_NP_DT
first B-O B-JJ
intron B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
major B-O B-JJ
determinant B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B-cell-specific B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immunoglobulin B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Like B-O B-S_PP_IN
other B-O B-NP_JJ
enhancers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
Ig B-O B-NP_NN
heavy B-O B-JJ
chain B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
contains B-O B-VP_VBZ
several B-O B-NP_NP_JJ
short B-O B-JJ
sequence B-O B-NP_NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bind B-O B-S_NP_VP_VBP
specific B-O B-NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Each B-O B-S_S_NP_DT
binding B-O B-NP_VBG
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
contributes B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
overall B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
enhancer B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
no B-O B-S_NP_DT
single B-O B-JJ
element B-O B-NN
" " B-O O-NP
seems B-O B-VP_VBZ
absolutely B-O B-ADVP_RB
" " B-O O-ADVP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
For B-O B-S_PP_IN
a B-O B-NP_NP_DT
better B-O B-JJR
understanding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Ig B-O B-NP_NN
heavy B-O B-JJ
chain B-O B-NN
enhancer B-O B-NN
components B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
have B-O B-VP_VBP
cloned B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
analyzed B-O B-VP_VBN
individual B-O B-NP_NP_JJ
sequence B-O B-NP_NN
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
find B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
factor B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
ubiquitous B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
present B-O B-ADJP_JJ
in B-O B-PP_IN
an B-O B-NP_NP_DT
active B-O B-JJ
form B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_NP_CC
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
non-B B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
despite B-O B-PP_IN
its B-O B-NP_PRPP
ability B-O B-NN
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
factor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
apparently B-O B-ADJP_RB
unable B-O B-JJ
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
In B-O B-S_PP_IN
previous B-O B-NP_NP_JJ
experiments B-O B-NNS
" " B-O O-NP
by B-O B-PP_IN
others B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
characteristic B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
in B-O B-ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
" " B-O O-ADJP
footprint B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_NP_DT
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
designated B-O B-VP_VBN
NF-muE3 B-O B-S_NP_NP_NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
non-B B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
From B-O B-S_S_PP_IN
this B-O B-NP_NP_DT
" " B-O B-NP_O-NP
and B-O B-CC
other B-O B-NP_JJ
" " B-O B-NP_O-NP
findings B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
picture B-O B-NN
" " B-O B-SBAR_O-NP
emerges B-O B-VP_VBZ
" " B-O O-VP
that B-O B-SBAR_IN
there B-O B-S_NP_EX
" " B-O O-NP
are B-O B-VP_VBP
at B-O B-NP_NP_NP_QP_IN
least B-O B-JJS
three B-O B-CD
" " B-O O-QP
categories B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
factors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-S
: B-O B-COLON
( B-O B-NP_NP_LST_LRB
a B-O B-LS
) B-O B-RRB
" " B-O O-LST
cell-specific B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
Oct-2A B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Oct-2B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
not B-O B-RB
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
: B-O B-COLON
" " B-O O-NP
( B-O B-NP_LST_LRB
b B-O B-LS
) B-O B-RRB
" " B-O O-LST
ubiquitous B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VP_VBP
constitutively B-O B-ADJP_RB
active B-O B-JJ
" " B-O B-PP_O-VP
but B-O B-CC
are B-O B-VP_VBP
sequestered B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
; B-O B-COLON
" " B-O O-NP
( B-O B-NP_LST_LRB
c B-O B-LS
) B-O B-RRB
" " B-O O-LST
ubiquitously B-O B-NP_NP_RB
active B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
exemplified B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
one B-O B-NN
binding B-O B-VBG
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
factor B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
present B-O B-ADJP_JJ
in B-O B-PP_IN
an B-O B-NP_NP_DT
active B-O B-JJ
form B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
but B-O B-CC
is B-O B-VP_VBZ
apparently B-O B-ADJP_RB
unable B-O B-JJ
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
to B-O B-PP_TO
the B-O B-NP_DT
" " B-O B-NP_O-PP
in B-O B-PP_IN
non-B B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
perhaps B-O B-PP_ADVP_RB
" " B-O O-ADVP
due B-O B-JJ
to B-O B-TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcriptional B-O B-NP_NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
post-transcriptional B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
regulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
monocytic B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
myeloid B-O B-JJ
leukemic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
AP-1 B-O B-S_S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
polypeptide B-O B-NN
product B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
recognizes B-O B-VP_VP_VP_VBZ
" " B-O B-NP_O-VP
and B-O B-CC
binds B-O B-VP_VBZ
to B-O B-NP_PP_TO
specific B-O B-NP_JJ
DNA B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
stimulates B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
responsive B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
TPA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NP_NN
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HL-60 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
monocytic B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Low B-O B-S_NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VP_VBD
detectable B-O B-ADJP_JJ
in B-O B-PP_IN
untreated B-O B-NP_JJ
HL-60 B-O B-NN
leukemic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
increased B-O B-VP_VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
6 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
reached B-O B-VP_VBD
near B-O B-PP_IN
maximal B-O B-NP_JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
24 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
exposure B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_NP_NP_JJ
kinetics B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NP_NN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
TPA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_NP_NP_JJ
U-937 B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
THP-1 B-O B-NP_NN
monocytic B-O B-JJ
leukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_NP_JJ
findings B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
obtained B-O B-VP_VBN
with B-O B-NP_PP_IN
bryostatin B-O B-NP_NP_NP_NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
10 B-O B-NP_CD
nM B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
another B-O B-NP_DT
activator B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
inducer B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
1,25-dihydroxyvitamin B-O B-NP_NP_NP_NN
D3 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
0.5 B-O B-NP_CD
microM B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
structurally B-O B-ADJP_RB
distinct B-O B-JJ
" " B-O O-ADJP
agent B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
also B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
induces B-O B-VP_VBZ
HL-60 B-O B-NP_NN
monocytic B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
increased B-O B-VP_VBD
c-jun B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TPA B-O B-S_NP_NP_NN
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HL-60 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cycloheximide B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
superinduction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NN
" " B-O O-NP
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Run-on B-O B-S_S_NP_JJ
analysis B-O B-NN
" " B-O O-NP
demonstrated B-O B-VP_VBD
detectable B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NN
" " B-O O-NP
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
untreated B-O B-NP_JJ
HL-60 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
that B-O B-S_NP_NP_IN
exposure B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
TPA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increases B-O B-VP_VBZ
this B-O B-NP_DT
rate B-O B-NN
" " B-O O-NP
3.3-fold B-O B-NP_RB
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HL-60 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
both B-O B-NP_CC
TPA B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
cycloheximide B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
rates B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
half-life B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
RNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
treating B-O B-S_NP_VP_VBG
HL-60 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
was B-O B-VP_VBD
30 B-O B-NP_CD
min B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
half-life B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NN
RNA B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
TPA-treated B-O B-NP_NP_JJ
HL-60 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
exposed B-O B-VP_VBN
to B-O B-NP_PP_TO
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
greater B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
2 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
c-jun B-O B-NP_NN
RNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
observed B-O B-VP_VBN
during B-O B-NP_PP_IN
TPA-induced B-O B-NP_JJ
monocytic B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
both B-O B-NP_CC
" " B-O B-NP_ADJP_NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
mechanisms B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Identification B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
novel B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
interacts B-O B-S_NP_VP_VP_VBZ
with B-O B-PP_IN
" " B-O B-NP_O-VP
and B-O B-CC
stimulates B-O B-VP_VBZ
transcription B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
tissue-specific B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
MOPC B-O B-NP_NN
141 B-O B-CD
immunoglobulin B-O B-NN
heavy-chain B-O B-JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
by B-O B-NP_PP_IN
using B-O B-S_NP_NP_VBG
in B-O B-NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
B-cell-specific B-O B-S_NP_NP_JJ
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
the B-O B-NP_NP_DT
octamer B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
5'-ATGCAAAG-3' B-O B-NN
" " B-O O-NP
, B-O B-COMMA
located B-O B-ADJP_JJ
in B-O B-PP_PP_IN
" " B-O B-NP_NP_PP_O-PP
and B-O B-CC
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
interaction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
purified B-O B-NP_NP_VBN
octamer B-O B-NP_NN
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
1 B-O B-NP_CD
" " B-O O-NP
and B-O B-CC
2 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
OTF1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
OTF2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
MOPC B-O B-NP_NN
141 B-O B-CD
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
by B-O B-NP_PP_IN
using B-O B-S_NP_VP_VBG
electrophoretic B-O B-NP_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
and B-O B-CC
DNase B-O B-NP_NP_NN
I B-O B-CD
" " B-O O-NP
footprinting B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Purified B-O B-S_NP_VBN
OTF1 B-O B-NP_NP_NP_NN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
OTF1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
OTF2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
bound B-O B-VP_VBD
to B-O B-PP_TO
identical B-O B-NP_NP_JJ
sequences B-O B-NNS
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_DT
heavy-chain B-O B-NP_JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
OTF B-O B-NN
interactions B-O B-NNS
" " B-O O-NP
we B-O B-SBAR_WHNP_S_NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
extended B-O B-VP_VBD
over B-O B-PP_IN
the B-O B-NP_DT
heptamer B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
5'-CTCAGGA-3' B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
seems B-O B-VP_VBZ
likely B-O B-ADJP_RB
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
involves B-O B-VP_VBZ
cooperation B-O B-NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
these B-O B-NP_DT
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
identified B-O B-VP_VBD
a B-O B-NP_NP_DT
second B-O B-JJ
regulatory B-O B-NP_JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
N B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
sequence B-O B-NN
5'-GGAACCTCCCCC-3' B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
N B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
could B-O B-VP_MD
independently B-O B-ADVP_RB
" " B-O O-ADVP
mediate B-O B-VP_VB
low B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_CC
and B-O B-NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
, B-O B-COMMA
in B-O B-S_PP_IN
conjunction B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
octamer B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
can B-O B-VP_MD
promote B-O B-VP_VB
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
B-cell B-O B-NP_NN
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
N B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
bound B-O B-VP_VBD
a B-O B-NP_NP_DT
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
NTF B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
ubiquitous B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
NTF B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
distinct B-O B-ADJP_JJ
from B-O B-PP_IN
any B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
" " B-O B-NP_SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Based B-O B-S_PP_VBN
on B-O B-PP_IN
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
NTF B-O B-S_NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
OTF2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
interactions B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
both B-O B-PP_CC
with B-O B-PP_IN
and B-O B-NP_CC
possibly B-O B-ADVP_RB
" " B-O O-ADVP
at B-O B-PP_IN
" " B-O B-NP_O-PP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
critical B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
these B-O B-S_NP_DT
interactions B-O B-NNS
" " B-O O-NP
provide B-O B-VP_VBP
additional B-O B-NP_NP_JJ
pathways B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Effects B-O B-NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
mitogenic B-O B-NP_JJ
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
action B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
tonsillar B-O B-NN
T-lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
tonsillar B-O B-NN
T-lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
4-phorbol B-O B-NP_NP_NN
12-myristate B-O B-NN
13-acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
about B-O B-NP_NP_ADJP_QP_RB
two B-O B-CD
" " B-O O-QP
fold B-O B-JJ
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
number B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
without B-O B-PP_IN
any B-O B-NP_NP_DT
significant B-O B-JJ
change B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NN
affinity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_NP_DT
increase B-O B-NN
" " B-O O-NP
disappeared B-O B-VP_VBD
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cycloheximide B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Alone B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
PMA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
calcium B-O B-NP_NN
ionophore B-O B-NN
A23187 B-O B-NN
" " B-O O-NP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
affect B-O B-VP_VP_VB
" " B-O B-NP_O-VP
, B-O B-COMMA
but B-O B-CC
together B-O B-ADVP_RB
" " B-O O-ADVP
stimulated B-O B-VP_VBD
" " B-O B-NP_O-VP
, B-O B-COMMA
like B-O B-PP_IN
phytohaemagglutinin B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
PHA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
leucine B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
, B-O B-COMMA
in B-O B-PP_IN
particular B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
thymidine B-O B-NP_NN
" " B-O B-NP_O-NP
incorporation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PMA B-O B-S_NP_NN
" " B-O O-NP
enhanced B-O B-VP_VBD
slightly B-O B-ADVP_RB
" " B-O O-ADVP
the B-O B-NP_NP_DT
stimulatory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PHA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Alone B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
agents B-O B-NNS
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
alter B-O B-VP_VB
the B-O B-NP_NP_DT
suppressive B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
however B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
PMA-A23187 B-O B-NP_NP_NP_JJ
" " B-O O-NP
and B-O B-CC
PMA-PHA B-O B-NP_JJ
" " B-O O-NP
" " B-O O-NP
combinations B-O B-NNS
" " B-O O-NP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
antagonize B-O B-VP_VB
the B-O B-NP_NP_DT
suppression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Involvement B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
second B-O B-JJ
lymphoid-specific B-O B-NP_JJ
enhancer B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immunoglobulin B-O B-NP_NP_NN
heavy-chain B-O B-NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
To B-O B-S_S_S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
enhancer B-O B-S_NP_NP_NN
elements B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
are B-O B-VP_VBP
important B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mutating B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
NF-microB-binding B-O B-NP_JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
critical B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
IgH B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
because B-O B-SBAR_IN
mutation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
microB B-O B-NN
DNA B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
decreased B-O B-VP_VBD
transcriptional B-O B-NP_NP_JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IgH B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
" " B-O B-NP_NP_PP_O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
nonlymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
comparable B-O B-ADJP_ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-PP
" " B-O O-ADJP
or B-O B-CC
even B-O B-ADJP_ADJP_RB
stronger B-O B-JJR
" " B-O O-ADJP
than B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-ADJP
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
mutation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
OCTA B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
combined B-O B-NP_NP_JJ
mutation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
microB B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
OCTA B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
further B-O B-ADVP_RBR
" " B-O O-ADVP
reduced B-O B-VP_VBD
enhancer B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
alteration B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_NP_CC
the B-O B-DT
microB B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
or B-O B-CC
E3 B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
70-base-pair B-O B-NP_JJ
fragment B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
" " B-O B-NP_SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
abolished B-O B-VP_VBD
enhancer B-O B-NP_NP_NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
completely B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nevertheless B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
a B-O B-NP_NP_NP_DT
multimer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
microB B-O B-NP_NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
showed B-O B-VP_VBD
no B-O B-NP_DT
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNase B-O B-S_NP_NN
footprinting B-O B-NN
analysis B-O B-NN
" " B-O O-NP
corroborated B-O B-VP_VBD
the B-O B-NP_NP_DT
functional B-O B-JJ
data B-O B-NNS
" " B-O O-NP
showing B-O B-VP_VBG
that B-O B-SBAR_IN
a B-O B-S_NP_DT
lymphoid-specific B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_DT
microB B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
element B-O B-ADJP_ADJP_ADJP_NN
" " B-O O-NP
important B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
but B-O B-CC
that B-O B-SBAR_IN
interaction B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
another B-O B-NP_DT
enhancer B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
its B-O B-NP_PRPP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
, B-O B-COMMA
c-jun B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
c-myc B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
heat B-O B-NP_NP_NN
shock B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
heat B-O B-NP_NN
shock B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
nuclear B-O B-NP_JJ
protooncogenes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
c-fos B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
c-jun B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
c-myc B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_JJ
lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Heat B-O B-S_NP_NN
shock B-O B-NN
" " B-O O-NP
caused B-O B-VP_VBD
an B-O B-NP_NP_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
c-fos B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O B-NP_O-NP
mRNA B-O B-NP_NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
c-myc B-O B-NP_NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_PP_IN
pre-B B-O B-NP_NP_NP_JJ
" " B-O O-NP
( B-O B-PRN_LRB
Hyon B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
and B-O B-CC
T B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
DND-41 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
freshly B-O B-NP_ADJP_RB
isolated B-O B-VBN
" " B-O O-ADJP
normal B-O B-JJ
human B-O B-JJ
thymocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_NP_DT
protooncogenes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
Hyon B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
most B-O B-ADVP_RBS
" " B-O O-ADVP
pronounced B-O B-VP_JJ
at B-O B-NP_PP_IN
42 B-O B-NP_QP_CD
and B-O B-CC
43 B-O B-CD
" " B-O O-QP
degrees B-O B-NNS
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
kinetic B-O B-S_NP_JJ
analysis B-O B-NN
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
changes B-O B-NNS
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
detected B-O B-VP_VBN
within B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Altered B-O B-S_NP_NP_JJ
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
c-myc B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
the B-O B-NP_NP_DT
primary B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
heat B-O B-NP_NN
shock B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Secondarily B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
heat B-O B-NP_NP_NN
shock B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Hyon B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
stabilized B-O B-VP_VBD
the B-O B-NP_DT
c-myc B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
level B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
increasing B-O B-S_NP_VP_VBG
its B-O B-NP_PRPP
half-life B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
24 B-O B-NP_QP_CD
to B-O B-TO
45 B-O B-CD
" " B-O O-QP
min B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
overall B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
heat B-O B-NP_NN
shock B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
c-myc B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
was B-O B-VP_VBD
a B-O B-NP_NP_DT
marked B-O B-JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_PRPP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
protooncogenes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
heat B-O B-NP_NP_NN
shock B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
indicating B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_NP_DT
novel B-O B-JJ
B-cell B-O B-NP_NN
lineage-specific B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
present B-O B-ADJP_JJ
at B-O B-PP_IN
early B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
late B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
stages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
A B-O B-S_S_NP_NP_DT
novel B-O B-JJ
B-cell-specific B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
BSAP B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
identified B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_NP_DT
mammalian B-O B-NP_JJ
homolog B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
TSAP B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
As B-O B-S_S_SBAR_IN
shown B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
mobility-shift B-O B-NP_NP_JJ
" " B-O B-NP_O-NP
, B-O B-COMMA
methylation B-O B-NP_NN
interference B-O B-NN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
mutational B-O B-NP_JJ
" " B-O B-NP_O-NP
analyses B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_DT
mammalian B-O B-NP_NP_JJ
protein B-O B-NN
" " B-O O-NP
BSAP B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
recognizes B-O B-VP_VBZ
all B-O B-NP_DT
four B-O B-CD
sea B-O B-NP_NN
urchin B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
manner B-O B-NN
" " B-O O-NP
indistinguishable B-O B-ADJP_JJ
from B-O B-PP_IN
TSAP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
; B-O B-COLON
however B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
two B-O B-CD
proteins B-O B-NNS
" " B-O O-NP
differ B-O B-VP_VBP
in B-O B-PP_IN
molecular B-O B-NP_JJ
weight B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
BSAP B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
exclusively B-O B-ADJP_RB
restricted B-O B-JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
B-cell B-O B-NN
lineage B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphoid B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Its B-O B-S_NP_PRPP
expression B-O B-NN
" " B-O O-NP
appears B-O B-VP_VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
activated B-O B-VP_VBN
during B-O B-NP_PP_IN
pro-B-cell B-O B-NP_JJ
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
is B-O B-VP_VP_VBZ
abundant B-O B-ADJP_JJ
at B-O B-PP_IN
the B-O B-NP_DT
pre-B- B-O B-NP_JJ
" " B-O B-NP_NP_O-NP
and B-O B-CC
mature B-O B-NP_JJ
B-cell B-O B-NN
" " B-O B-NP_O-NP
stages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
is B-O B-VP_VBZ
absent B-O B-ADJP_JJ
in B-O B-PP_IN
terminally B-O B-NP_RB
differentiated B-O B-VBN
plasma B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
BSAP B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
clearly B-O B-ADVP_RB
" " B-O O-ADVP
a B-O B-NP_DT
B-cell-specific B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
as B-O B-PP_IN
a B-O B-NP_NP_NP_DT
wild-type B-O B-NP_JJ
" " B-O O-NP
" " B-O B-NP_O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
a B-O B-NP_DT
mutant B-O B-NP_JJ
TSAP-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
sea B-O B-NN
urchin B-O B-NN
functions B-O B-NNS
" " B-O O-NP
only B-O B-PP_ADVP_RB
" " B-O O-ADVP
in B-O B-IN
transfected B-O B-NP_VBN
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
an B-O B-NP_DT
upstream B-O B-NP_JJ
promoter B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Competition B-O B-S_NP_NN
experiments B-O B-NNS
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
reveal B-O B-VP_VB
any B-O B-NP_NP_DT
high-affinity B-O B-NP_JJ
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
BSAP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
known B-O B-NP_NP_JJ
regulatory B-O B-NP_JJ
regions B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
immunoglobulin B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
" " B-O B-NP_NP_NP_O-NP
genes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
BSAP B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
regulator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Tandem B-O B-S_S_NP_NP_JJ
AP-1-binding B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
beta-globin B-O B-NN
dominant B-O B-JJ
control B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
function B-O B-VP_VBP
as B-O B-PP_IN
an B-O B-NP_NP_DT
inducible B-O B-NP_JJ
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
erythroid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_S_NP_DT
powerful B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
mapped B-O B-VP_VBN
to B-O B-NP_PP_TO
an B-O B-NP_NP_DT
18-bp B-O B-NP_JJ
DNA B-O B-NN
segment B-O B-NN
" " B-O O-NP
" " B-O O-NP
located B-O B-ADJP_JJ
to B-O B-PP_NP_TO
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_NP_DT
enhancer B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
inducible B-O B-ADJP_JJ
in B-O B-PP_IN
K562 B-O B-NP_NN
human B-O B-JJ
erythroleukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
increasing B-O B-S_NP_VP_VBG
linked B-O B-NP_VBN
gamma-globin B-O B-NP_NN
promoter/luciferase B-O B-NN
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
170-fold B-O B-NP_RB
" " B-O O-NP
" " B-O O-PP
over B-O B-PP_IN
an B-O B-NP_DT
enhancerless B-O B-NP_JJ
construct B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
enhancer B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
consists B-O B-VP_VBZ
of B-O B-PP_IN
tandem B-O B-NP_NP_JJ
AP-1-binding B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
phased B-O B-ADJP_JJ
10 B-O B-ADVP_NP_CD
bp B-O B-NN
" " B-O O-NP
apart B-O B-RB
" " B-O O-ADVP
" " B-O O-ADJP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
both B-O B-DT
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNA-protein B-O B-S_NP_NP_NN
binding B-O B-NN
assays B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
induced B-O B-NP_VBN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrate B-O B-VP_VBP
a B-O B-NP_DT
high B-O B-NP_JJ
molecular B-O B-JJ
weight B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
enhancer B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
requires B-O B-VP_VP_VBZ
both B-O B-NP_DT
AP-1 B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
correlates B-O B-VP_VBZ
with B-O B-PP_IN
maximal B-O B-NP_JJ
enhancer B-O B-NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
enhancer B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
have B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
globin B-O B-NP_NP_NP_NN
gene B-O B-NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Enhancer B-O B-S_NP_NN
activity B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
to B-O B-NP_PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Nuclear B-O B-NP_NP_NP_NP_JJ
3,5,3'-triiodothyronine B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
T3R B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
circulating B-O B-NP_VBG
human B-O B-JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
hyper- B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
hypothyroidism B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
nonthyroidal B-O B-NP_JJ
diseases B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
clinical B-O B-JJ
implications B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
T3R B-O B-NN
alterations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
circulating B-O B-NP_VBG
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
hyperthyroidism B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
hypothyroidism B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
nonthyroidal B-O B-NP_JJ
diseases B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
investigated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Nuclear B-O B-S_NP_NP_JJ
T3R B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
determined B-O B-VP_VBN
by B-O B-NP_PP_IN
radio-ligand B-O B-NP_JJ
binding B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
in B-O B-S_PP_IN
hyper- B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_NP_O-NP
and B-O B-CC
hypothyroid B-O B-NP_JJ
" " B-O B-NP_O-NP
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_NP_DT
nuclear B-O B-JJ
affinity B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Ka B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
for B-O B-PP_IN
T3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
similar B-O B-ADJP_JJ
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
hyperthyroidism B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
nuclear B-O B-NP_JJ
T3 B-O B-NN
maximal B-O B-NP_NP_JJ
binding B-O B-NN
capacity B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MBC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
unaltered B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
whereas B-O B-SBAR_IN
in B-O B-S_PP_IN
hypothyroidism B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
MBC B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
diabetes B-O B-NP_NP_NN
mellitus B-O B-NN
" " B-O O-NP
, B-O B-COMMA
chronic B-O B-NP_JJ
renal B-O B-JJ
failure B-O B-NN
" " B-O O-NP
and B-O B-CC
hepatic B-O B-NP_JJ
cirrhosis B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
nuclear B-O B-JJ
T3R B-O B-NN
MBC B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
about B-O B-NP_NP_QP_RB
1.5-1.6 B-O B-CD
times B-O B-NNS
" " B-O O-QP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
normal B-O B-JJ
controls B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
concluded B-O B-VP_VBN
that B-O B-SBAR_SBAR_IN
there B-O B-S_NP_EX
" " B-O O-NP
existed B-O B-VP_VBD
hormonal B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
up-regulation B-O B-COMP_S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Adherence-dependent B-O B-S_S_NP_NP_JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocyte B-O B-NN
PDGF(B) B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
increases B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
c-fos B-O B-NP_NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
c-jun B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
EGR2 B-O B-NP_NN
" " B-O B-NP_O-NP
mRNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Adherence B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_DT
important B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
initial B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
step B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
transition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
circulating B-O B-VBG
monocyte B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_DT
tissue B-O B-NN
macrophage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_NP_DT
differentiation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_DT
augmented B-O B-JJ
capacity B-O B-NN
to B-O B-S_NP_VP_TO
generate B-O B-VP_VB
growth B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
hypothesized B-O B-VP_VBD
that B-O B-SBAR_IN
adherence B-O B-S_NP_NN
itself B-O B-PRP
" " B-O O-NP
might B-O B-VP_MD
be B-O B-VP_VB
an B-O B-NP_NP_DT
important B-O B-JJ
trigger B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_PP_IN
in B-O B-NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
adherence B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
had B-O B-VP_VBD
a B-O B-NP_NP_DT
biphasic B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
PDGF(B) B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
with B-O B-PP_IN
peaks B-O B-NP_NP_NNS
" " B-O O-NP
at B-O B-PP_IN
6 B-O B-NP_CD
h B-O B-NN
and B-O B-CC
13 B-O B-CD
d B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
TGF-beta B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
6-h B-O B-ADJP_JJ
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
PDGF(B) B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VP_VBD
adherence B-O B-NP_NN
dependent B-O B-JJ
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
in B-O B-PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
was B-O B-VP_VBD
abrogated B-O B-VP_VBN
" " B-O B-NP_O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
cytoskeletal B-O B-JJ
integrity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
compromised B-O B-VP_VBN
by B-O B-NP_PP_IN
cytochalasin B-O B-NP_NN
D B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
6-h B-O B-ADJP_JJ
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
PDGF(B) B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
unaltered B-O B-ADJP_JJ
by B-O B-PP_IN
adherence B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
monocyte B-O B-NN
stimulus B-O B-NN
lipopolysaccharide B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Adherence B-O B-S_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
either B-O B-NP_CC
fibronectin B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
collagen-coated B-O B-NP_JJ
plastic B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
little B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
consistent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
PDGF(B) B-O B-NP_NN
mRNA B-O B-NN
accumulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
increased B-O B-VBN
PDGF(B) B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
adherent B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
increases B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
mRNAs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
of B-O B-PP_IN
the B-O B-NP_NP_DT
early B-O B-JJ
growth B-O B-NN
response B-O B-NN
genes B-O B-NNS
" " B-O O-NP
, B-O B-NP_NP_NP_PRN_COMMA
c-jun B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
c-jun B-O B-NP_NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
EGR2 B-O B-NP_NN
" " B-O B-NP_O-NP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
c-fos B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
mRNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
abrogated B-O B-VP_VBN
by B-O B-NP_PP_IN
cytochalasin B-O B-NP_NN
D B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
observations B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
adherence B-O B-S_NP_NN
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
increases B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
increases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
c-jun B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
EGR2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
PDGF(B) B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
depend B-O B-VP_VB
on B-O B-PP_IN
cytoskeletal B-O B-NP_JJ
rearrangement B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Modulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
events B-O B-NNS
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
the B-O B-NP_NP_DT
time B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
adherence B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
offers B-O B-VP_VBZ
a B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
differential B-O B-S_NP_NP_JJ
priming B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
accomplished B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Interferon-gamma B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
sexual B-O B-JJ
dimorphism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
autoimmunity B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
sexual B-O B-JJ
difference B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
incidence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
autoimmune B-O B-NP_JJ
diseases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
remained B-O B-VP_VBN
an B-O B-NP_DT
enigma B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
many B-O B-NP_JJ
years B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
examination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
autoimmunity B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
transgenic B-O B-NP_JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
evidence B-O B-NP_NN
" " B-O B-VP_O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
obtained B-O B-VP_VBN
further B-O B-NP_ADVP_JJ
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
implicating B-O B-VP_VBG
the B-O B-NP_DT
lymphokine B-O B-NP_NP_NN
" " B-O O-NP
interferon-gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
etiology B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
autoimmunity B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Sex B-O B-S_NP_NP_NN
steroid B-O B-NN
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_NP_DT
molecule B-O B-NN
" " B-O O-NP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
other B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
may B-O B-VP_MD
help B-O B-VP_VB
explain B-O B-S_NP_VP_VB
the B-O B-NP_NP_DT
gender-specific B-O B-JJ
differences B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
immune B-O B-JJ
system B-O B-NN
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Single B-O B-S_S_NP_NP_JJ
cell B-O B-NN
assay B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reveals B-O B-VP_VBZ
a B-O B-NP_DT
threshold B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
signals B-O B-NP_NP_NNS
" " B-O O-NP
emanating B-O B-VP_VBG
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Stimulation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
their B-O B-NP_PRPP
antigen B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
appearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
, B-O B-NP_NP_COMMA
" " B-O B-SBAR_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
investigate B-O B-VP_VB
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
single B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
individual B-O B-NP_JJ
viable B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
applied B-O B-VP_VBN
an B-O B-NP_NP_DT
assay B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
uses B-O B-S_NP_VP_VBZ
the B-O B-NP_DT
fluorescence-activated B-O B-JJ
cell B-O B-NN
sorter B-O B-NN
" " B-O O-NP
" " B-O B-S_NP_VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
analyzed B-O B-VP_VBN
the B-O B-NP_NP_DT
distribution B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NN
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
among B-O B-PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
undergoing B-O B-VP_VBG
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
using B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
construct B-O B-NN
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
" " B-O B-WHNP_S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Unexpectedly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cloned B-O B-NP_VBN
stably B-O B-RB
transfected B-O B-VBN
Jurkat B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
a B-O B-NP_NP_DT
bimodal B-O B-JJ
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
beta-gal B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
some B-O B-S_S_NP_DT
cells B-O B-NNS
" " B-O O-NP
express B-O B-VP_VBP
no B-O B-NP_DT
beta-gal B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-S
and B-O B-CC
others B-O B-S_NP_NNS
" " B-O O-NP
express B-O B-VP_VBP
high B-O B-NP_JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
expression B-O B-NN
pattern B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
not B-O B-RB
be B-O B-VP_VB
accounted B-O B-VP_VBN
for B-O B-NP_PP_IN
by B-O B-PP_IN
cell-cycle B-O B-NP_NP_JJ
position B-O B-NN
" " B-O O-NP
or B-O B-CC
heritable B-O B-NP_JJ
variation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_NP_NP_JJ
results B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
beta-gal B-O B-S_NP_NN
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
NF-AT-binding B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
must B-O B-VP_MD
exceed B-O B-VP_VB
a B-O B-NP_DT
critical B-O B-JJ
threshold B-O B-NN
" " B-O O-NP
" " B-O O-VP
before B-O B-SBAR_IN
transcription B-O B-S_NP_NN
" " B-O O-NP
initiates B-O B-VP_VBZ
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
threshold B-O B-NN
" " B-O O-NP
likely B-O B-ADVP_RB
" " B-O O-ADVP
reflects B-O B-VP_VBZ
the B-O B-NP_NP_DT
NF-AT B-O B-NN
concentration-dependent B-O B-JJ
assembly B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
complexes B-O B-NNS
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_DT
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_NP_NP_JJ
constructs B-O B-NNS
" " B-O O-NP
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
or B-O B-CC
the B-O B-NP_DT
entire B-O B-JJ
interleukin-2 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
show B-O B-VP_VBP
bimodal B-O B-NP_JJ
expression B-O B-NN
patterns B-O B-NNS
" " B-O O-NP
during B-O B-PP_IN
induction B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
thresholds B-O B-S_NP_NP_NNS
" " B-O O-NP
set B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Two B-O B-S_S_NP_NP_CD
distinct B-O B-JJ
signal B-O B-NN
transmission B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
complexes B-O B-NP_NP_NNS
" " B-O O-NP
formed B-O B-VP_VBN
between B-O B-NP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Proliferation B-O B-S_S_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
immunologic B-O B-NP_JJ
function B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
initiated B-O B-VP_VBN
by B-O B-NP_PP_IN
signals B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
antigen B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-NP_DT
other B-O B-JJ
hand B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
interleukin B-O B-NP_NN
2 B-O B-CD
( B-O B-LRB
IL-2 B-O B-NN
) B-O B-RRB
-induced B-O B-JJ
signals B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
blocked B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
rapamycin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
by B-O B-IN
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Remarkably B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
two B-O B-CD
drugs B-O B-NNS
" " B-O O-NP
inhibit B-O B-VP_VBP
each B-O B-NP_DT
other B-O B-JJ
's B-O B-POS
actions B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
raising B-O B-S_NP_VP_VBG
the B-O B-NP_DT
possibility B-O B-NN
that B-O B-SBAR_IN
both B-O B-S_NP_DT
" " B-O O-NP
act B-O B-VP_VBP
by B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
find B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
dissociation B-O B-NN
constant B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
rapamycin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
" " B-O B-NP_NP_NP_O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
Kd B-O B-NP_NP_NN
" " B-O O-NP
= B-O B-ADJP_JJ
0.2 B-O B-NP_CD
nM B-O B-NN
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
close B-O B-ADJP_JJ
to B-O B-PP_PP_TO
" " B-O B-NP_NP_PRN_O-PP
and B-O B-CC
to B-O B-PP_TO
their B-O B-NP_PRPP
concentrations B-O B-ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
an B-O B-NP_NP_DT
excess B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
rapamycin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
needed B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
revert B-O B-VP_VB
FK506-mediated B-O B-NP_JJ
inhibition B-O B-NN
of B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
production B-O B-NN
" " B-O O-NP
, B-O B-COMMA
apoptosis B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similarly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
an B-O B-NP_NP_DT
excess B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
needed B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
revert B-O B-VP_VB
rapamycin-mediated B-O B-NP_NP_JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2-induced B-O B-NP_JJ
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
drug B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
antagonism B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
explained B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
the B-O B-NP_NP_DT
relative B-O B-JJ
affinity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
drugs B-O B-NNS
" " B-O B-PP_O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
by B-O B-PP_IN
the B-O B-NP_NP_DT
abundance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-PP
, B-O B-COMMA
the B-O B-NP_DT
" " B-O B-NP_NP_NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
FKBP B-O B-S_S_NP_NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
catalyze B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
rapamycin B-O B-S_NP_NN
, B-O B-COMMA
" " B-O O-NP
like B-O B-PP_IN
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
is B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
potent B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
) B-O B-NP_NP_ADJP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Neither B-O B-S_NP_CC
FKBP B-O B-NP_NN
binding B-O B-NN
" " B-O B-ADVP_O-NP
nor B-O B-CC
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
rotamase B-O B-NP_NP_NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
FKBP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
is B-O B-VP_VBZ
sufficient B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
explain B-O B-VP_VB
the B-O B-NP_NP_DT
biologic B-O B-JJ
actions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
drugs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Rather B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
immunophilin B-O B-S_NP_NP_NN
" " B-O O-NP
bound B-O B-VP_VBN
to B-O B-NP_PP_TO
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
interferes B-O B-VP_VBZ
with B-O B-PP_IN
antigen B-O B-NP_NN
receptor-induced B-O B-JJ
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
while B-O B-SBAR_IN
rapamycin B-O B-S_NP_NP_NN
" " B-O O-NP
bound B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
interferes B-O B-VP_VBZ
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
TAR B-O B-NP_NP_NP_NN
independent B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
phorbol B-O B-NP_NN
ester B-O B-NN
stimulated B-O B-JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Multiple B-O B-S_S_NP_NP_JJ
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV B-O B-NP_NN
LTR B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Previous B-O B-S_NP_NP_JJ
transfection B-O B-NN
studies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NP_NN
LTR B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
linked B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
chloramphenicol B-O B-NN
acetyltransferase B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
multiple B-O B-S_NP_NP_JJ
regulatory B-O B-JJ
regions B-O B-NNS
" " B-O O-NP
including B-O B-PP_VBG
the B-O B-NP_NP_DT
enhancer B-O B-NN
" " B-O O-NP
, B-O B-COMMA
SP1 B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
TATA B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
TAR B-O B-NP_NN
regions B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
important B-O B-ADJP_JJ
for B-O B-PP_IN
HIV B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
characterize B-O B-VP_VB
these B-O B-NP_DT
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
further B-O B-ADVP_RBR
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
mutations B-O B-S_S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
regions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
inserted B-O B-VP_VBN
into B-O B-NP_PP_IN
both B-O B-NP_CC
the B-O B-DT
5' B-O B-NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
3' B-O B-NP_JJ
" " B-O B-NP_O-NP
HIV B-O B-NP_NN
LTRs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
infectious B-O B-S_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
proviral B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
constructs B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
assembled B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
constructs B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
transfected B-O B-VP_VBN
into B-O B-NP_PP_IN
either B-O B-NP_CC
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
or B-O B-CC
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
both B-O B-NP_CC
the B-O B-DT
presence B-O B-NP_NN
" " B-O B-PP_O-NP
and B-O B-CC
absence B-O B-NP_NN
" " B-O B-PP_O-NP
" " B-O O-NP
of B-O B-PP_IN
phorbol B-O B-NP_NP_NN
esters B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
have B-O B-S_NP_VP_VBP
" " B-O B-ADVP_VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Viral B-O B-S_NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
assayed B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p24 B-O B-NP_NP_NN
gag B-O B-NN
protein B-O B-NN
" " B-O O-NP
released B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Results B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
all B-O B-NP_DT
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
mutations B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
SP1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
TATA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
TAR B-O B-NN
loop B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
stem B-O B-NP_NN
secondary B-O B-JJ
structure B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
marked B-O B-NP_NP_JJ
decreases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
while B-O B-SBAR_IN
resulted B-O B-S_S_NP_NP_PP_VP_VBD
" " B-O B-PP_O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
viruses B-O B-NP_NP_NNS
" " B-O O-NP
containing B-O B-VP_VBG
mutations B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
either B-O B-NP_CC
the B-O B-DT
TAR B-O B-NN
loop B-O B-NP_NN
sequences B-O B-NNS
" " B-O O-NP
or B-O B-CC
stem B-O B-NP_NN
secondary B-O B-JJ
structure B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
very B-O B-ADJP_RB
defective B-O B-JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
gave B-O B-VP_VBD
nearly B-O B-NP_NP_ADJP_RB
wild-type B-O B-JJ
" " B-O O-ADJP
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
phorbol B-O B-NP_NN
ester-treated B-O B-JJ
Jurkat B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
phorbol B-O B-NP_NN
ester-treated B-O B-JJ
HeLa B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
High B-O B-S_NP_NP_JJ
level B-O B-NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
TAR B-O B-NN
mutant B-O B-JJ
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
phorbol B-O B-NP_NN
ester-treated B-O B-JJ
Jurkat B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
eliminated B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
second B-O B-NP_NP_JJ
site B-O B-NN
mutations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
enhancer B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
by B-O B-PP_IN
disruption B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
tat B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
Transcriptional B-O B-NP_NP_NP_JJ
down-regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-myc B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
protein B-O B-NP_NP_NN
synthesis-dependent B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
-independent B-O B-NP_ADJP_NP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
pathways B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
human B-O B-JJ
T B-O B-NN
lymphoblastic B-O B-JJ
tumor B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
in B-O B-S_PP_IN
the B-O B-NP_DT
human B-O B-JJ
T B-O B-NN
lymphoblastic B-O B-JJ
tumor B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
Molt4 B-O B-NP_NP_NN
c-myc B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
and B-O B-CC
protein B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
down-regulated B-O B-VP_VBN
after B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_NP_NP_DT
block B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
RNA B-O B-NP_NN
elongation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
largely B-O B-ADJP_RB
responsible B-O B-JJ
for B-O B-PP_IN
decreased B-O B-NP_VBN
c-myc B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
negative B-O B-S_NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
dimethyl B-O B-NP_JJ
sulfoxide B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
takes B-O B-VP_VBZ
place B-O B-NP_NN
" " B-O O-NP
even B-O B-SBAR_WHADVP_RB
when B-O B-WRB
" " B-O O-WHADVP
protein B-O B-S_NP_NN
synthesis B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_DT
phorbol B-O B-NN
myristate B-O B-NN
acetate B-O B-NN
effect B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
blocked B-O B-VP_VBN
to B-O B-NP_PP_TO
some B-O B-NP_DT
extent B-O B-NN
" " B-O O-NP
" " B-O O-PP
only B-O B-PP_ADVP_RB
" " B-O O-ADVP
by B-O B-IN
cycloheximide B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
calcium B-O B-NN
ionophore-induced B-O B-JJ
c-myc B-O B-NN
suppression B-O B-NN
, B-O B-COMMA
" " B-O O-NP
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
strictly B-O B-ADVP_RB
" " B-O O-ADVP
requires B-O B-VP_VBZ
de B-O B-NP_ADJP_FW
novo B-O B-FW
" " B-O O-ADJP
protein B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
two B-O B-NP_CD
different B-O B-JJ
negative B-O B-JJ
regulatory B-O B-JJ
pathways B-O B-NNS
" " B-O B-NP_O-NP
are B-O B-VP_VBP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
c-myc B-O B-NP_NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
one B-O B-NP_NP_NP_CD
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
independent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
and B-O B-CC
one B-O B-NP_NP_CD
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
depends B-O B-S_NP_VP_VBZ
on B-O B-PP_IN
de B-O B-NP_ADJP_FW
novo B-O B-FW
" " B-O O-ADJP
protein B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
latter B-O B-JJ
one B-O B-CD
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_DT
calcium-dependent B-O B-ADJP_ADVP_JJ
induced B-O B-VBN
" " B-O O-ADJP
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_NP_DT
case B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hypersensitivity B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
thyroid B-O B-NP_NP_NN
hormones B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
and B-O B-NP_NP_ADVP_VP_NP_CC
increased B-O B-NP_VBN
nuclear B-O B-JJ
triiodothyronine B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
A B-O B-S_S_NP_DT
52-year-old B-O B-JJ
male B-O B-NN
" " B-O O-NP
presented B-O B-VP_VBD
himself B-O B-NP_PRP
" " B-O O-NP
with B-O B-PP_IN
tachycardia B-O B-NP_NP_NN
crises B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
appeared B-O B-S_NP_VP_VBD
first B-O B-ADVP_RB
" " B-O O-ADVP
during B-O B-PP_IN
" " B-O B-NP_O-VP
, B-O B-COMMA
increased B-O B-VP_VBD
in B-O B-PP_IN
without B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Cardiac B-O B-S_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
adrenergic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
diseases B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
excluded B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
thyroid B-O B-NN
function B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
normal B-O B-ADJP_JJ
regarding B-O B-PP_VBG
T4 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
free B-O B-NP_ADJP_JJ
" " B-O O-ADJP
T4 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
T3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
TBG B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
radioiodine B-O B-NP_NN
uptake B-O B-NN
" " B-O O-NP
, B-O B-COMMA
TSH B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-NP_CC
T3 B-O B-NP_NN
" " B-O B-NP_O-NP
suppressibility B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
however B-O B-S_ADVP_RB
" " B-O O-ADVP
the B-O B-NP_NP_DT
TSH B-O B-NN
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
TRH B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
decreased B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
lymphocyte B-O B-NN
nuclear B-O B-JJ
T3 B-O B-NN
receptor B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
with B-O B-NP_PP_IN
an B-O B-NP_NP_DT
affinity B-O B-NN
" " B-O O-NP
close B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
a B-O B-S_S_NP_DT
binding B-O B-NN
capacity B-O B-NN
" " B-O O-NP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBD
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
9.9 B-O B-NP_NP_NP_CD
" " B-O B-NP_O-NP
vs B-O B-CC
3.7 B-O B-NP_QP_CD
+/- B-O B-CC
0.4 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
fmol B-O B-NP_NN
T3 B-O B-NN
/ B-O B-COLON
100 B-O B-CD
micrograms B-O B-NNS
DNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Pindolol B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
inefficient B-O B-ADJP_JJ
on B-O B-PP_IN
the B-O B-NP_NP_DT
dysrhythmia B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
disappeared B-O B-S_NP_VP_VP_VBD
and B-O B-PP_CC
relapsed B-O B-VP_VBD
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Under B-O B-S_PP_IN
carbimazole B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-S_S_S_NP_DT
plasma B-O B-NN
T4 B-O B-NN
" " B-O O-NP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
decreased B-O B-VP_VBD
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
27.7 B-O B-NP_QP_CD
+/- B-O B-CC
3.6 B-O B-CD
" " B-O O-QP
nmol/l B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-S
but B-O B-CC
the B-O B-S_NP_DT
patient B-O B-NN
" " B-O O-NP
remained B-O B-VP_VBD
euthyroid B-O B-ADJP_NN
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
clinical B-O B-JJ
course B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
laboratory B-O B-NN
data B-O B-NNS
" " B-O O-NP
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
tachycardia B-O B-NN
crises B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
the B-O B-NP_NP_DT
consequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
hypersensitivity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
to B-O B-NP_PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Pseudohypoaldosteronism B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
eight B-O B-NP_CD
families B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
different B-O B-S_NP_NP_JJ
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
inheritance B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
evidence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
various B-O B-NP_JJ
genetic B-O B-JJ
defects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Pseudohypoaldosteronism B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
rare B-O B-JJ
hereditary B-O B-JJ
disorder B-O B-NN
" " B-O O-NP
presenting B-O B-VP_VBG
in B-O B-PP_IN
early B-O B-NP_JJ
infancy B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
renal B-O B-NP_NP_JJ
salt B-O B-NN
loss B-O B-NN
" " B-O O-NP
leading B-O B-VP_VBG
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
despite B-O B-PP_IN
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
plasma B-O B-NP_NN
aldosterone B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_DT
patients B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
insensitive B-O B-ADJP_JJ
to B-O B-PP_TO
mineralocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
however B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
sodium B-O B-NP_NN
supplementation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
correct B-O B-VP_VB
electrolyte B-O B-NP_NN
abnormalities B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Absent B-O B-S_NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
or B-O B-CC
greatly B-O B-NP_ADJP_RB
diminished B-O B-VBN
" " B-O O-ADJP
type B-O B-NN
I B-O B-NP_CD
aldosterone B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_JJ
mononuclear B-O B-JJ
leucocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VP_VBP
been B-O B-VP_VBN
recently B-O B-ADVP_RB
" " B-O O-ADVP
demonstrated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
explain B-O B-VP_VB
the B-O B-NP_NP_DT
lack B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
mineralocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
studied B-O B-VP_VBN
the B-O B-NP_NP_DT
mode B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
inheritance B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
eight B-O B-NP_CD
families B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_DT
total B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nine B-O B-NP_CD
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
evidence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
an B-O B-NP_NP_DT
autosomal B-O B-JJ
recessive B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
inheritance B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
four B-O B-NP_CD
families B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
while B-O B-SBAR_IN
the B-O B-S_NP_DT
other B-O B-JJ
four B-O B-CD
families B-O B-NNS
" " B-O O-NP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
three B-O B-NP_CD
families B-O B-NNS
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
autosomal B-O B-JJ
recessive B-O B-JJ
form B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
normal B-O B-NP_NP_NP_JJ
receptor B-O B-NN
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
hormone B-O B-NP_NN
data B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_DT
parents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
while B-O B-SBAR_IN
in B-O B-S_PP_IN
one B-O B-NP_CD
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
receptor B-O B-S_S_NP_NP_NN
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_DT
parents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
greatly B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
hormone B-O B-S_NP_NN
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
normal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
four B-O B-CD
families B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
an B-O B-NP_NP_DT
autosomal B-O B-JJ
dominant B-O B-JJ
mode B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transmission B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
there B-O B-NP_RB
" " B-O O-NP
was B-O B-VP_VBD
always B-O B-ADVP_RB
" " B-O O-ADVP
one B-O B-NP_NP_CD
parent B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
reduced B-O B-NP_NP_NP_VBN
receptor B-O B-NN
binding B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_JJ
mononuclear B-O B-JJ
leucocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
elevated B-O B-NP_JJ
serum B-O B-NN
hormone B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
parents B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
entirely B-O B-ADJP_RB
asymptomatic B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
an B-O B-NP_DT
extended B-O B-VBN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
were B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
study B-O B-VP_VB
an B-O B-NP_NP_NP_DT
aunt B-O B-NN
" " B-O O-NP
and B-O B-CC
her B-O B-NP_PRPP
newborn B-O B-JJ
daughter B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
who B-O B-SBAR_WHNP_WP
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
, B-O B-COMMA
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
appears B-O B-VP_VBZ
that B-O B-SBAR_IN
this B-O B-S_NP_NP_DT
dual B-O B-JJ
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
genetic B-O B-NP_JJ
transmission B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
indicate B-O B-VP_VB
differing B-O B-NP_NP_VBG
genetic B-O B-JJ
defects B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Human B-O B-S_S_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
vpr B-O B-NN
product B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
virion-associated B-O B-NP_JJ
regulatory B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
vpr B-O B-NP_NN
product B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
acts B-O B-VP_VBZ
in B-O B-PP_IN
trans B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
accelerate B-O B-VP_VB
virus B-O B-NP_NP_NN
replication B-O B-NN
" " B-O O-NP
and B-O B-CC
cytopathic B-O B-NP_JJ
effect B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
it B-O B-NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
shown B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_DT
HIV-1 B-O B-NN
viral B-O B-JJ
particle B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
multiple B-O B-NP_NP_JJ
copies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
vpr B-O B-NP_NN
product B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
first B-O B-JJ
regulatory B-O B-JJ
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-SBAR_WHNP_S_NP_VP_TO
be B-O B-VP_VB
found B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
observation B-O B-NN
" " B-O O-NP
raises B-O B-VP_VBZ
the B-O B-NP_DT
possibility B-O B-NN
that B-O B-SBAR_IN
vpr B-O B-S_NP_NN
" " B-O O-NP
acts B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
facilitate B-O B-VP_VB
before B-O B-NP_SBAR_IN
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Two B-O B-NP_NP_NP_CD
distinct B-O B-JJ
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
active B-O B-NP_NP_JJ
transcription B-O B-NN
factor B-O B-NN
CREB B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
cAMP B-O B-NP_NN
response B-O B-NN
element B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Mammalian B-O B-S_S_NP_JJ
cells B-O B-NNS
" " B-O O-NP
express B-O B-VP_VBP
two B-O B-NP_NP_CD
distinct B-O B-JJ
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NP_NN
factor B-O B-NN
CREB B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
cAMP B-O B-NP_NN
response B-O B-NN
element B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
" " B-O B-ADVP_NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
two B-O B-CD
proteins B-O B-NNS
" " B-O O-NP
differ B-O B-VP_VBP
by B-O B-PP_IN
a B-O B-NP_NP_DT
14-amino B-O B-NP_NN
acid B-O B-NN
serine-rich B-O B-JJ
insertion B-O B-NN
" " B-O O-NP
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
both B-O B-S_NP_DT
CREB B-O B-NP_NN
isoforms B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
many B-O B-NP_NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
and B-O B-CC
mammalian B-O B-NP_ADJP_JJ
species B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_DT
" " B-O O-NP
encode B-O B-VP_VBP
proteins B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bind B-O B-S_NP_VP_VBP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
a B-O B-NP_NP_DT
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_SBAR_IN
expected B-O B-S_NP_VP_VBN
for B-O B-NP_PP_IN
proteins B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
class B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_DT
CREB B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
bind B-O B-VP_VBP
DNA B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_IN
dimers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_DT
proteins B-O B-NNS
" " B-O O-NP
impart B-O B-VP_VBP
cAMP-regulated B-O B-NP_JJ
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_DT
heterologous B-O B-NP_JJ
DNA-binding B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
showing B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
cAMP B-O B-S_NP_NN
" " B-O O-NP
directly B-O B-ADVP_RB
" " B-O O-ADVP
modulates B-O B-VP_VBZ
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
stimulatory B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
multiple B-O B-NP_NP_JJ
CREB B-O B-NP_NN
isoforms B-O B-NNS
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
identical B-O B-NP_NP_ADJP_JJ
DNA-binding B-O B-JJ
" " B-O O-ADJP
specificities B-O B-NP_NNS
" " B-O O-NP
but B-O B-CC
differences B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
presumed B-O B-JJ
regulatory B-O B-NP_JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
raises B-O B-VP_VBZ
the B-O B-NP_DT
possibility B-O B-NN
that B-O B-SBAR_IN
CREB B-O B-S_NP_NN
proteins B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
able B-O B-ADJP_JJ
" " B-O B-S_NP_VP_O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Induction B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
immediate B-O B-NP_JJ
early B-O B-JJ
response B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
macrophage B-O B-NP_NN
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
normal B-O B-NP_JJ
human B-O B-JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
A B-O B-S_S_S_NP_NP_DT
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
coordinately B-O B-NP_NP_RB
induced B-O B-VBN
protooncogenes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
cytoskeletal B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
extracellular B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
matrix B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
termed B-O B-VP_VBN
immediate B-O B-S_NP_NP_JJ
early B-O B-JJ
response B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
their B-O B-S_NP_PRPP
induction B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
growth B-O B-NP_NN
factor-stimulated B-O B-JJ
cell B-O B-NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
genes B-O B-NNS
" " B-O B-SBAR_O-NP
" " B-O O-PP
by B-O B-PP_IN
macrophage-CSF B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
M-CSF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
do B-O B-S_NP_VP_VP_VBP
not B-O B-RB
proliferate B-O B-VP_VB
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
but B-O B-CC
require B-O B-VP_VBP
the B-O B-NP_NP_DT
factor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
optimal B-O B-NP_JJ
cell B-O B-NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-S
  
Normal B-O B-S_NP_JJ
human B-O B-JJ
monocytes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
isolated B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
, B-O B-COMMA
carefully B-O B-VP_ADVP_RB
" " B-O O-ADVP
washed B-O B-VBN
" " B-O B-NP_O-VP
, B-O B-COMMA
and B-O B-CC
incubated B-O B-VP_VBN
for B-O B-NP_PP_IN
36 B-O B-NP_QP_CD
to B-O B-TO
48 B-O B-CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
fetal B-O B-NP_JJ
bovine B-O B-NN
serum-containing B-O B-JJ
medium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
At B-O B-S_PP_IN
the B-O B-NP_NP_DT
end B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
incubation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
the B-O B-S_S_NP_DT
resting B-O B-VBG
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
M-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
RNA B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
isolated B-O B-VP_VBN
for B-O B-NP_PP_IN
analysis B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
Northern B-O B-NP_JJ
blotting B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
RNA B-O B-S_NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
control B-O B-NP_JJ
resting B-O B-VBG
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contained B-O B-VP_VBD
low B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
to B-O B-PP_TO
undetectable B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
fibronectin B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
actin B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Within B-O B-S_PP_IN
15 B-O B-NP_NP_QP_CD
to B-O B-TO
30 B-O B-CD
" " B-O O-QP
min B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
addition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
M-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_NP_DT
dramatic B-O B-JJ
coordinate B-O B-JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
c-jun B-O B-NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VP_VBD
very B-O B-ADJP_RB
transient B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
was B-O B-VP_VBD
not B-O B-RB
detectable B-O B-ADJP_JJ
by B-O B-PP_IN
60 B-O B-NP_NP_CD
min B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
M-CSF B-O B-NP_NN
addition B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-S_S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
actin B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
fibronectin B-O B-NP_NN
receptor B-O B-NN
" " B-O B-NP_O-NP
mRNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
more B-O B-ADVP_RBR
" " B-O O-ADVP
sustained B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
remained B-O B-VP_VBD
elevated B-O B-ADJP_JJ
at B-O B-PP_IN
24 B-O B-NP_NP_QP_CD
to B-O B-TO
48 B-O B-CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
M-CSF B-O B-NP_NN
addition B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBD
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
myelomonocytic B-O B-JJ
specific B-O B-JJ
tyrosine B-O B-NN
kinase B-O B-NN
hck B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
simultaneously B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
the B-O B-NP_DT
other B-O B-JJ
immediate B-O B-JJ
early B-O B-JJ
response B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
protein B-O B-NN
synthesis B-O B-NN
inhibitor B-O B-NN
cycloheximide B-O B-NN
" " B-O O-NP
did B-O B-VP_VP_VBD
not B-O B-RB
block B-O B-VP_VB
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
any B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
in B-O B-PP_IN
fact B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
super-induced B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
hck B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-NP_NP_JJ
run B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
c-jun B-O B-NN
" " B-O O-NP
, B-O B-COMMA
hck B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
actin B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
normal B-O B-NP_JJ
human B-O B-JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
M-CSF B-O B-NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
immediate B-O B-NP_JJ
early B-O B-JJ
response B-O B-NN
genes B-O B-NNS
" " B-O O-NP
without B-O B-PP_IN
inducing B-O B-S_NP_VP_VBG
cell B-O B-NP_NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
genes B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
then B-O B-ADVP_RB
" " B-O O-ADVP
play B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
altering B-O B-S_NP_NP_VBG
the B-O B-NP_NP_DT
physiologic B-O B-JJ
status B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Retroviral B-O B-NP_NP_NP_NP_NP_ADJP_JJ
mediated B-O B-VBN
" " B-O O-ADJP
transfer B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
exogenous B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
primary B-O B-NP_JJ
lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
assaying B-O B-S_NP_VP_VBG
for B-O B-PP_IN
a B-O B-NP_NP_DT
viral B-O B-JJ
transactivator B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_ADJP_NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
In B-O B-S_S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
describe B-O B-VP_VBP
the B-O B-NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
recombinant B-O B-NP_JJ
retroviruses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-S_NP_VP_TO
characterize B-O B-VP_VB
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
exogenous B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cultured B-O B-NP_NP_NP_ADJP_VBN
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
primary B-O B-NP_JJ
lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
recombinant B-O B-JJ
retrovirus B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
result B-O B-VP_VB
in B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
similar B-O B-JJ
infection B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
recombinant B-O B-JJ
retrovirus B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_NP_DT
beta-galactosidase B-O B-NN
gene B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
an B-O B-NP_DT
adenovirus B-O B-NN
E2 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
beta-galactosidase B-O B-NP_NP_NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
limited B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_ADJP_NP_O-NP
and B-O B-CC
primary B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
the B-O B-S_NP_DT
adenovirus B-O B-NN
E2 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
has B-O B-VP_VP_VBZ
been B-O B-VP_VBN
well B-O B-ADVP_RB
" " B-O O-ADVP
characterized B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
specific B-O B-NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
discussed B-O B-VP_VBN
in B-O B-NP_PP_IN
reference B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-VP_TO
both B-O B-NP_CC
and B-O B-NP_NP_PP_CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Stimulation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
human B-O B-JJ
T-cell B-O B-NN
clone B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
anti-CD3 B-O B-NP_NP_JJ
" " B-O O-NP
or B-O B-CC
tumor B-O B-NP_NN
necrosis B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
translocation B-O B-NN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
1 B-O B-CD
enhancer-dependent B-O B-JJ
transcription B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transiently B-O B-NP_ADJP_RB
transfected B-O B-VBN
" " B-O O-ADJP
expression B-O B-NN
vectors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
under B-O B-PP_IN
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NP_NP_NN
enhancer-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
analyzed B-O B-VP_VBN
in B-O B-NP_PP_IN
two B-O B-NP_NP_CD
human B-O B-JJ
T-cell B-O B-NN
clones B-O B-NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
through B-O B-NP_PP_PP_IN
or B-O B-NP_CC
by B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
a B-O B-NP_NP_DT
dissociation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
translocation B-O B-NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
transactivation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_CC
the B-O B-NP_DT
HIV B-O B-NN
LTR B-O B-NN
" " B-O O-NP
or B-O B-CC
the B-O B-NP_DT
HIV B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interleukin B-O B-S_NP_NN
2 B-O B-CD
" " B-O O-NP
induced B-O B-VP_VBD
proliferation B-O B-NP_NP_NN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
translocation B-O B-NN
" " B-O O-NP
or B-O B-CC
LTR B-O B-NP_NN
transactivation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Phorbol B-O B-S_NP_NP_NN
ester B-O B-NN
" " B-O O-NP
or B-O B-CC
specific B-O B-NP_JJ
antigen B-O B-NN
recognition B-O B-NN
" " B-O O-NP
" " B-O O-NP
induced B-O B-VP_VBD
HIV B-O B-NP_NN
LTR B-O B-NN
transactivation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
whereas B-O B-SBAR_IN
stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
" " B-O O-NP
or B-O B-CC
antibody B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
two B-O B-CD
latter B-O B-JJ
signals B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
nevertheless B-O B-ADVP_RB
" " B-O O-ADVP
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
NF-kappa B-O B-NP_NN
B B-O B-NN
translocation B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
pattern B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
using B-O B-S_NP_VP_VBG
phorbol B-O B-NP_NN
ester B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
finding B-O B-NN
that B-O B-SBAR_IN
induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
" " B-O O-NP
or B-O B-CC
antibody B-O B-NP_NN
to B-O B-TO
CD3 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
sufficient B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
HIV B-O B-NP_NN
enhancer-dependent B-O B-JJ
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-VP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
contrasts B-O B-VP_VP_VBZ
with B-O B-PP_IN
results B-O B-NP_NP_NNS
" " B-O O-NP
obtained B-O B-VP_VBN
in B-O B-NP_PP_IN
most B-O B-NP_JJS
lymphoblastoid B-O B-JJ
T-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
indicates B-O B-VP_VBZ
that B-O B-SBAR_IN
normal B-O B-S_NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
differ B-O B-VP_VBP
from B-O B-PP_IN
tumoral B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
terms B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
our B-O B-NP_PRPP
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
events B-O B-S_NP_NP_NNS
" " B-O O-NP
linked B-O B-VP_VBN
to B-O B-NP_PP_TO
T-cell B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
in B-O B-PP_IN
addition B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
induce B-O B-VP_VBP
functional B-O B-NP_NP_JJ
interactions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Extrarenal B-O B-NP_NP_NP_NP_JJ
receptor-effector-mechanisms B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
the B-O B-NP_NP_NP_DT
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
effects B-O B-NP_NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
cellular B-O B-JJ
electrolyte B-O B-NN
transport B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
their B-O B-NP_NP_PRPP
implications B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
disorders B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
water B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
electrolyte B-O B-NP_NN
" " B-O B-NP_O-NP
balances B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
High B-O B-S_S_NP_JJ
affinity B-O B-NN
aldosterone B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
not B-O B-CONJP_RB
only B-O B-RB
" " B-O O-CONJP
been B-O B-VP_VBN
described B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
the B-O B-NP_NP_DT
classic B-O B-JJ
target B-O B-NN
tissues B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
in B-O B-PP_IN
non-classic B-O B-NP_NP_JJ
target B-O B-NN
tissues B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
An B-O B-S_NP_NP_DT
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
intracellular B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
sodium B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
potassium B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
calcium B-O B-NP_NN
" " B-O B-NP_O-NP
concentrations B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
cell B-O B-NP_NN
volume B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
shown B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
intracellular B-O B-ADJP_JJ
" " B-O O-ADJP
Na+ B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
K+ B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
Ca2+ B-O B-NP_NN
" " B-O B-NP_O-NP
concentrations B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
cell B-O B-NN
volume B-O B-NN
" " B-O O-NP
" " B-O O-NP
decreased B-O B-VP_VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
remained B-O B-VP_VBD
constant B-O B-ADJP_JJ
" " B-O O-ADJP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
aldosterone B-O B-S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
1.4 B-O B-NP_CD
nmol/l B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
added B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
incubation B-O B-NN
medium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
aldosterone B-O B-NN
antagonist B-O B-NN
canrenone B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
140 B-O B-NP_CD
nmol/l B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
sodium/proton B-O B-JJ
exchanger B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
membrane B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
identified B-O B-VP_VBN
as B-O B-NP_PP_IN
the B-O B-NP_NP_DT
primary B-O B-JJ
target B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
aldosterone B-O B-NN
action B-O B-NN
" " B-O O-NP
, B-O B-COMMA
mediated B-O B-VP_ADVP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
clinical B-O B-JJ
significance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
model B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
underlined B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_NP_DT
demonstration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_ADJP_NP_O-NP
or B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O B-PP_O-NP
and B-O B-CC
the B-O B-NP_NP_DT
lack B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
electrolyte B-O B-NP_NP_NN
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Additionally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
an B-O B-NP_DT
abnormal B-O B-JJ
effector B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
demonstrated B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
essential B-O B-NP_JJ
hypertensives B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
the B-O B-NP_NP_DT
first B-O B-JJ
" " B-O O-NP
to B-O B-SBAR_WHNP_S_NP_VP_TO
demonstrate B-O B-VP_VB
the B-O B-NP_NP_DT
significance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Lymphoid B-O B-S_S_NP_NP_JJ
specific B-O B-JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
adenovirus B-O B-NN
early B-O B-JJ
region B-O B-NN
3 B-O B-CD
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
binding B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_S_NP_NP_DT
primary B-O B-JJ
site B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
infection B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
human B-O B-NP_JJ
adenoviruses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
analysis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
viral B-O B-JJ
control B-O B-NN
elements B-O B-NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
cellular B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
regulate B-O B-S_NP_VP_VBP
adenoviral B-O B-NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
not B-O B-RB
been B-O B-VP_VBN
reported B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
adenovirus B-O B-NN
early B-O B-JJ
region B-O B-NN
3 B-O B-CD
( B-O B-LRB
ES B-O B-NN
) B-O B-RRB
gene B-O B-NN
products B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
maintenance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
viral B-O B-NP_JJ
persistence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
complexing B-O B-S_NP_VP_VP_VBG
with B-O B-PP_IN
the B-O B-NP_DT
class B-O B-NN
I B-O B-CD
MHC B-O B-NN
antigens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
thus B-O B-ADVP_RB
" " B-O O-ADVP
preventing B-O B-VP_VBG
their B-O B-NP_PRPP
cell B-O B-NN
surface B-O B-NN
expression B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
different B-O B-S_NP_JJ
cellular B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
as B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
both B-O B-S_NP_CC
DNA B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
and B-O B-CC
transfection B-O B-NP_NN
analysis B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
E3 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_DT
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
performed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
detected B-O B-VP_VBD
two B-O B-NP_NP_CD
novel B-O B-JJ
domains B-O B-NNS
" " B-O O-NP
referred B-O B-VP_VBN
to B-O B-PP_TO
" " B-O B-NP_O-PP
as B-O B-PP_RB
L1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
L2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Each B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
domains B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
possessed B-O B-VP_VBD
strong B-O B-NP_NP_JJ
homology B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
motifs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
previously B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
the B-O B-NP_DT
cellular B-O B-JJ
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transfections B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
E3 B-O B-NP_NP_NN
constructs B-O B-NNS
" " B-O O-NP
linked B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
chloramphenicol B-O B-NN
acetyltransferase B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
mutagenesis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
distal B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
motif B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
L2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VP_VBD
minimal B-O B-NP_JJ
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
promoter B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
resulted B-O B-VP_VBD
in B-O B-PP_IN
dramatic B-O B-NP_NP_JJ
decreases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
mutagenesis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
proximal B-O B-NP_NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
motif B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
L1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VP_VBD
minimal B-O B-NP_JJ
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
gene B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_CC
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CC
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_DT
small B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
but B-O B-CC
reproducible B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
, B-O B-COMMA
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
gene B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
coupled B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
L2 B-O B-NN
mutation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Reversing B-O B-S_UCP_S_NP_VP_VBG
the B-O B-NP_DT
position B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
subsequent B-O B-NP_NP_JJ
mutagenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
L1 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
L2 B-O B-NP_NN
" " B-O B-NP_O-NP
domains B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-UCP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
primary B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
rather B-O B-CONJP_RB
than B-O B-IN
" " B-O O-CONJP
their B-O B-NP_NP_PRPP
position B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
E3 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
critical B-O B-ADJP_JJ
for B-O B-PP_IN
regulating B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
Constitutive B-O B-NP_NP_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
tat B-O B-NN
protein B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
Jurkat B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
using B-O B-S_NP_VP_VBG
a B-O B-NP_DT
BK B-O B-NN
virus B-O B-NN
vector B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
production B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
characterization B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
Jurkat B-O B-NP_NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
constitutively B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
express B-O B-VP_VBP
functional B-O B-NP_JJ
human B-O B-NP_JJ
immune B-O B-JJ
deficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
( B-O B-LRB
HIV-1 B-O B-NN
) B-O B-RRB
tat B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-PP
, B-O B-COMMA
using B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
BK B-O B-NN
virus B-O B-NN
plasmid B-O B-NN
expression B-O B-NN
vector B-O B-NN
" " B-O O-NP
and B-O B-CC
HIV-1 B-O B-NP_NN
tat B-O B-NN
cDNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
described B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
An B-O B-S_NP_NP_DT
increased B-O B-VBN
growth B-O B-NN
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
Jurkat-tat B-O B-NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
as B-O B-SBAR_IN
compared B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
control B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Risk B-O B-NP_NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
breast B-O B-NP_NP_NN
recurrence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
premenopausal B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
postmenopausal B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
ductal B-O B-NP_NP_JJ
cancers B-O B-NNS
" " B-O O-NP
treated B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Risk B-O B-S_S_NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
local B-O B-NP_JJ
failure B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
evaluated B-O B-VP_VBN
for B-O B-NP_PP_IN
496 B-O B-NP_NP_CD
clinical B-O B-JJ
Stage B-O B-NN
I-II B-O B-CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
infiltrating B-O B-NP_JJ
ductal B-O B-JJ
carcinomas B-O B-NNS
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
median B-O B-NP_NP_NN
follow-up B-O B-NN
" " B-O O-NP
, B-O B-COMMA
71 B-O B-NP_CD
months B-O B-NNS
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
treated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Monofactorial B-O B-S_S_NP_JJ
analysis B-O B-NN
" " B-O O-NP
identified B-O B-VP_VBD
the B-O B-NP_NP_DT
following B-O B-JJ
factors B-O B-NNS
" " B-O B-NP_O-NP
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
moderate/marked B-O B-NP_NP_NP_JJ
mononuclear B-O B-JJ
cell B-O B-NN
reaction B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MCR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
high B-O B-NP_NP_JJ
histologic B-O B-JJ
grade B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
G B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
extensive B-O B-NP_NP_JJ
intraductal B-O B-JJ
component B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EIC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
tumor B-O B-NP_NN
necrosis B-O B-NN
" " B-O O-NP
, B-O B-COMMA
macroscopic B-O B-NP_JJ
multiplicity B-O B-NN
" " B-O O-NP
, B-O B-COMMA
estrogen B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
negativity B-O B-NN
" " B-O O-NP
, B-O B-COMMA
anatomic B-O B-NP_JJ
tumor B-O B-NN
size B-O B-NN
" " B-O O-NP
, B-O B-COMMA
age B-O B-NP_NP_NN
" " B-O O-NP
younger B-O B-ADJP_JJR
than B-O B-PP_IN
40 B-O B-NP_CD
years B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
vascular B-O B-NP_JJ
invasion B-O B-NN
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
Only B-O B-S_NP_RB
MCR B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
G B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
EIC B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
proved B-O B-VP_VBD
significant B-O B-ADJP_JJ
in B-O B-PP_IN
Cox B-O B-NP_NN
multivariate B-O B-JJ
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
risk B-O B-NN
factors B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
highly B-O B-ADJP_ADVP_RB
" " B-O O-ADVP
age B-O B-NN
dependent B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
with B-O B-PP_IN
EIC B-O B-S_S_NP_NN
" " B-O O-NP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
more B-O B-ADJP_RBR
prevalent B-O B-JJ
in B-O B-PP_IN
women B-O B-NP_NP_NNS
" " B-O O-NP
younger B-O B-ADJP_JJR
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
, B-O B-COMMA
MCR B-O B-S_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
G B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
women B-O B-NP_NP_NNS
" " B-O O-NP
younger B-O B-ADJP_JJR
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-S
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Separate B-O B-S_S_NP_NP_JJ
Cox B-O B-NN
analysis B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
premenopausal B-O B-NP_JJ
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
MCR/EIC B-O B-S_NP_NN
" " B-O O-NP
determined B-O B-VP_VBD
risk B-O B-NP_NN
" " B-O O-NP
independent B-O B-ADVP_JJ
of B-O B-PP_IN
resection B-O B-NP_NN
margins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
tumors B-O B-S_S_NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
MCR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
a B-O B-NP_DT
28 B-O B-ADJP_CD
% B-O B-NN
" " B-O O-ADJP
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
with B-O B-S_NP_NP_PP_IN
EIC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
a B-O B-NP_DT
22 B-O B-ADJP_CD
% B-O B-NN
" " B-O O-ADJP
probability B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
recurring B-O B-S_NP_VP_VBG
locally B-O B-ADJP_RB
" " B-O O-ADJP
by B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Premenopausal B-O B-S_NP_NP_JJ
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
neither B-O B-NP_DT
risk B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
a B-O B-NP_NP_DT
very B-O B-ADJP_RB
low B-O B-JJ
" " B-O O-ADJP
failure B-O B-NN
rate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
2.6 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
5 B-O B-NP_CD
years B-O B-NNS
" " B-O O-NP
" " B-O O-PP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
regardless B-O B-ADVP_RB
of B-O B-PP_IN
age B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
For B-O B-S_PP_IN
postmenopausal B-O B-NP_JJ
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
risk B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
breast B-O B-NP_NN
recurrence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
determined B-O B-VP_VBN
both B-O B-NP_CC
by B-O B-PP_IN
adequacy B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
resection B-O B-NP_NP_NN
margins B-O B-NP_NNS
" " B-O O-NP
and B-O B-CC
grade B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
with B-O B-PP_IN
a B-O B-NP_NP_DT
high B-O B-JJ
local B-O B-JJ
failure B-O B-NN
rate B-O B-NN
" " B-O B-PRN_O-NP
for B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
having B-O B-VP_VBG
G3 B-O B-NP_NP_NN
tumors B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
( B-O B-PRN_LRB
31 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
5 B-O B-NP_CD
years B-O B-NNS
" " B-O O-NP
" " B-O O-PP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
authors B-O B-NNS
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
microscopic B-O B-JJ
examination B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
only B-O B-JJ
useful B-O B-JJ
tool B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
assessing B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
High-risk B-O B-S_NP_JJ
patients B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
recognized B-O B-VP_VBN
morphologically B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
age B-O B-NN
dependence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
morphologic B-O B-NP_JJ
risk B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
explain B-O B-VP_VB
the B-O B-NP_NP_DT
high B-O B-JJ
local B-O B-JJ
failure B-O B-NN
rate B-O B-NN
" " B-O O-NP
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_ADJP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Effects B-O B-NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
intralymphocytic B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
sodium B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
potassium B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
essential B-O B-NP_JJ
hypertension B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
In B-O B-S_S_NP_NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
mineralocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
human B-O B-NP_NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
its B-O B-NP_NP_PRPP
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
intracellular B-O B-ADJP_JJ
" " B-O O-ADJP
sodium B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
potassium B-O B-NP_NN
" " B-O B-NP_O-NP
concentrations B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
HML B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
already B-O B-ADJP_RB
" " B-O O-ADJP
been B-O B-VP_VBN
described B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
paper B-O B-NN
" " B-O O-NP
" " B-O O-PP
this B-O B-NP_DT
easily B-O B-ADJP_RB
accessible B-O B-JJ
" " B-O O-ADJP
human B-O B-JJ
cell B-O B-NN
model B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
investigated B-O B-VP_VBN
in B-O B-NP_PP_IN
13 B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
essential B-O B-NP_JJ
hypertension B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
only B-O B-NP_QP_RB
four B-O B-CD
" " B-O O-QP
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
sodium B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_RP
HML B-O B-NP_NP_NNS
" " B-O O-NP
without B-O B-PP_IN
incubation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
elevated B-O B-VP_JJ
compared B-O B-NP_PP_VBN
with B-O B-PP_IN
the B-O B-NP_NP_DT
range B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
normal B-O B-NP_JJ
persons B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
decrease B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
intracellular B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
sodium B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
potassium B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurred B-O B-VP_VBD
during B-O B-PP_IN
incubation B-O B-NP_NP_NP_NN
" " B-O O-NP
without B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-NP_NP_NN
" " B-O O-NP
less B-O B-ADJP_JJR
than B-O B-PP_IN
0.02 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1.4 B-O B-NP_ADJP_CD
nM B-O B-NN
" " B-O O-ADJP
aldosterone B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
prevent B-O B-VP_VB
this B-O B-NP_NP_DT
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
electrolytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
as B-O B-SBAR_IN
observed B-O B-S_NP_VP_VBN
in B-O B-NP_PP_IN
normal B-O B-NP_JJ
persons B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Plasma B-O B-S_NP_NP_NP_NN
renin B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
and B-O B-CC
aldosterone B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VP_VBD
not B-O B-RB
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
electrolyte B-O B-NN
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
were B-O B-VP_VBD
within B-O B-PP_IN
the B-O B-NP_DT
normal B-O B-JJ
limits B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mineralocorticoid B-O B-NP_NN
receptors/cell B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
within B-O B-UCP_PP_IN
" " B-O B-NP_O-PP
or B-O B-CC
close B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-PP
" " B-O O-ADJP
the B-O B-NP_DT
normal B-O B-JJ
range B-O B-NN
" " B-O O-NP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
n B-O B-NP_NP_NN
" " B-O O-NP
= B-O B-ADJP_JJ
9 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
independence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
intracellular B-O B-NP_JJ
electrolytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
despite B-O B-PP_IN
a B-O B-NP_NP_DT
normal B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mineralocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
reflect B-O B-VP_VB
an B-O B-NP_NP_DT
impairment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
mineralocorticoid B-O B-NN
effector B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
HML B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
essential B-O B-NP_JJ
hypertension B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
1,25(OH)2D2 B-O B-NP_NP_NP_NN
production B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
T B-O B-NP_NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
alveolar B-O B-NP_JJ
macrophages B-O B-NNS
" " B-O O-NP
" " B-O O-NP
recovered B-O B-VP_VBN
by B-O B-NP_PP_IN
lavage B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
To B-O B-S_S_S_S_NP_VP_TO
compare B-O B-VP_VB
extra-renal B-O B-NP_NP_JJ
1,25(OH)2D3 B-O B-NN
production B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
to B-O B-S_NP_VP_TO
identify B-O B-VP_VB
the B-O B-NP_NP_DT
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
responsible B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
evaluated B-O B-VP_VBN
the B-O B-NP_NP_DT
conversion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
25(OH)D3 B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
uncultured B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
recovered B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
1,25(OH)2D3 B-O B-S_S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
produced B-O B-VP_VBN
both B-O B-NP_CC
by B-O B-PP_IN
lavage B-O B-NP_NP_NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
blood B-O B-NP_NP_NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
controls B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
significantly B-O B-S_NP_NP_ADJP_RB
greater B-O B-JJR
" " B-O O-ADJP
amounts B-O B-NNS
" " B-O O-NP
" " B-O B-PP_O-NP
were B-O B-VP_VBD
produced B-O B-VP_VBN
by B-O B-NP_PP_IN
lavage B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
tuberculosis B-O B-NP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
than B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
sarcoidosis B-O B-NP_NP_NN
patients B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-NP_NP_NN
" " B-O O-NP
less B-O B-ADJP_JJR
" " B-O B-PP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
1,25(OH)2D3 B-O B-S_NP_NP_NN
production B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
lavage B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
tuberculosis B-O B-NP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlated B-O B-VP_VBD
with B-O B-PP_IN
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD8+ B-O B-NP_NP_NP_JJ
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
present B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
other B-O B-NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
T B-O B-S_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
an B-O B-NP_NP_DT
important B-O B-JJ
source B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
since B-O B-SBAR_IN
purified B-O B-S_S_NP_NP_VBN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
all B-O B-NP_NP_DT
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
produced B-O B-VP_VBD
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
1,25(OH)2D3 B-O B-S_NP_NP_NN
production B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlated B-O B-VP_VBD
closely B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
produced B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
1,25(OH)2D3 B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
improve B-O B-VP_VB
the B-O B-NP_NP_DT
capacity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
kill B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
support B-O B-VP_VBP
the B-O B-NP_DT
conclusion B-O B-NN
that B-O B-SBAR_IN
macrophage-lymphocyte B-O B-S_NP_NP_JJ
interactions B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
mediated B-O B-VP_VBN
in B-O B-NP_PP_ADVP_IN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
, B-O B-COMMA
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Effects B-O B-NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
1 B-O B-NP_CD
alpha B-O B-NN
, B-O B-COMMA
25-dihydroxyvitamin B-O B-NN
D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_NP_JJ
chronic B-O B-JJ
myelogenous B-O B-JJ
leukemia B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
RWLeu-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
1 B-O B-NP_NP_CD
alpha B-O B-NN
, B-O B-COMMA
25-dihydroxyvitamin B-O B-NN
D3 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
VD3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
proliferation B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
differentiation B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
macromolecular B-O B-NP_JJ
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
new B-O B-JJ
, B-O B-NP_NP_NP_COMMA
RWLeu-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
investigated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Binding B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
[3H]VD3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
saturable B-O B-ADJP_JJ
, B-O B-COMMA
with B-O B-PP_IN
approximately B-O B-NP_QP_RB
2000-3000 B-O B-CD
" " B-O O-QP
sites/cell B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
half-maximal B-O B-S_NP_JJ
binding B-O B-NN
" " B-O O-NP
occurring B-O B-VP_VBG
at B-O B-PP_IN
0.21-0.33 B-O B-NP_QP_CD
" " B-O O-QP
nM B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
RWLeu-4 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
VD3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induced B-O B-VP_VBD
24R-hydroxylase B-O B-NP_NP_NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
marker B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
vitamin B-O B-NP_NN
D3 B-O B-NN
responsiveness B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
many B-O B-NP_JJ
tissues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Exposure B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
RWLeu-4 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
VD3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
proliferation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
DNA B-O B-NP_NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
50 B-O B-ADJP_CD
% B-O B-NN
" " B-O O-ADJP
effective B-O B-JJ
dose B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
3.5-10 B-O B-NP_QP_CD
" " B-O O-QP
nM B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
72 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
in B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
protein B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
RNA B-O B-NP_NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
VD3 B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Exposure B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
RWLeu-4 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
5 B-O B-NP_ADJP_CD
nM B-O B-NN
" " B-O O-ADJP
VD3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
72 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
caused B-O B-VP_VBD
50 B-O B-S_NP_NP_CD
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-VP_TO
differentiate B-O B-VP_VB
into B-O B-PP_IN
macrophage/monocyte B-O B-NP_JJ
type B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
as B-O B-SBAR_IN
judged B-O B-S_NP_NP_VBN
by B-O B-NP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Progressive B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NP_NN
surface B-O B-NN
maturation-specific B-O B-JJ
antigens B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
monocyte/macrophage B-O B-NP_JJ
lineage B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
RWLeu-4 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
VD3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
24 B-O B-NP_QP_CD
to B-O B-TO
72 B-O B-CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
doses B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
inhibited B-O B-S_NP_VP_VBD
cellular B-O B-NP_JJ
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
c-myc B-O B-S_NP_NP_NN
RNA B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
RWLeu-4 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
increased B-O B-VP_VP_VBD
after B-O B-PP_IN
0.5 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
VD3 B-O B-NP_ADJP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
then B-O B-ADVP_RB
" " B-O O-ADVP
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
decreased B-O B-VP_VBD
to B-O B-PP_TO
barely B-O B-NP_ADJP_RB
detectable B-O B-JJ
" " B-O O-ADJP
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
4 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
treatment B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
tyrosine B-O B-NN
kinase B-O B-NN
activity B-O B-NN
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
p210bcr-abl B-O B-NP_NN
oncogene B-O B-NN
product B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
decreased B-O B-VP_VBN
approximately B-O B-NP_NP_QP_RB
50 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
VD3 B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_PP_IN
of B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
functional B-O B-JJ
receptor-effector B-O B-JJ
system B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
VD3 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
provide B-O B-VP_VBP
a B-O B-NP_NP_DT
unique B-O B-JJ
model B-O B-NN
system B-O B-NN
" " B-O O-NP
with B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
to B-O B-S_NP_VP_TO
probe B-O B-VP_VB
the B-O B-NP_NP_DT
specific B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
on B-O B-NP_PP_IN
" " B-O B-NP_O-NP
in B-O B-PP_IN
chronic B-O B-NP_JJ
myelogenous B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_DT
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
( B-O B-LRB
EBV B-O B-NN
) B-O B-RRB
ORI1yt B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VP_VBZ
not B-O B-RB
B-cell B-O B-ADJP_NN
specific B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
does B-O B-VP_VBZ
not B-O B-RB
respond B-O B-VP_VB
synergistically B-O B-ADJP_RB
" " B-O O-ADJP
to B-O B-PP_TO
the B-O B-NP_DT
EBV B-O B-NN
transcription B-O B-NN
factors B-O B-NNS
R B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
Z B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_S_NP_DT
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
DR B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
located B-O B-ADJP_JJ
upstream B-O B-ADVP_RB
of B-O B-PP_IN
the B-O B-NP_DT
PstI B-O B-NP_NN
repeats B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
in B-O B-S_PP_IN
addition B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
TATA B-O B-NP_NN
box B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
contains B-O B-VP_VBZ
an B-O B-NP_NP_NP_DT
upstream B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
positions B-O B-NP_NP_NNS
" " B-O O-NP
-69 B-O B-QP_CD
to B-O B-TO
-220 B-O B-CD
" " B-O O-QP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
responsive B-O B-ADJP_JJ
to B-O B-PP_TO
and B-O B-NP_NP_NP_PRN_CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Domain B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
described B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_NP_DT
B-cell-specific B-O B-NP_JJ
EB1-responsive B-O B-JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
, B-O B-NP_NP_NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
, B-O B-NP_COMMA
J.Virol.63 B-O B-NP_NNP
" " B-O O-NP
: B-O B-COLON
3040-3050 B-O B-NP_CD
" " B-O O-NP
, B-O B-COMMA
1989 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
activated B-O B-VP_VBN
synergistically B-O B-NP_ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
and B-O B-NP_NP_NP_CC
, B-O B-NP_COMMA
" " B-O B-NP_NP_VP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
domain B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
an B-O B-NP_NP_DT
R-responsive B-O B-NP_JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
therefore B-O B-ADVP_RB
" " B-O O-ADVP
not B-O B-RB
an B-O B-NP_DT
EB1-responsive B-O B-NP_JJ
B-cell-specific B-O B-JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_NP_DT
EB1-binding B-O B-NP_JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
ZRE-B B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
located B-O B-ADJP_JJ
within B-O B-PP_IN
the B-O B-NP_DT
R-responsive B-O B-NP_JJ
enhancer B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
ZRE-B B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
deleted B-O B-VP_VBN
without B-O B-NP_PP_IN
affecting B-O B-S_NP_VP_VBG
the B-O B-NP_DT
R-dependent B-O B-JJ
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
no B-O B-NP_NP_DT
cooperation B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
synergy B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
between B-O B-PP_IN
R B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
EB1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
activating B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
B B-O B-NP_NN
domain B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
plus B-O B-NP_NP_CC
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
positioned B-O B-ADJP_JJ
as B-O B-PP_IN
an B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
ZRE-B B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
therefore B-O B-ADVP_RB
" " B-O O-ADVP
not B-O B-RB
part B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
"R- inducible" B-O B-NP_JJ
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
tested B-O B-VP_VBN
several B-O B-NP_NP_JJ
subregions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
DR B-O B-NP_NP_NN
enhancer B-O B-NN
" " B-O O-NP
B B-O B-NP_NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
either B-O B-UCP_CC
alone B-O B-ADVP_RB
" " B-O O-ADVP
or B-O B-CC
in B-O B-PP_IN
combination B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-UCP
, B-O B-COMMA
for B-O B-PP_IN
their B-O B-NP_PRPP
capacity B-O B-NN
to B-O B-S_NP_VP_TO
transmit B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
R-responsive B-O B-NP_JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
composed B-O B-VP_VBN
of B-O B-NP_PP_IN
four B-O B-NP_NP_CD
" " B-O B-NP_SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_NP_DT
protoenhancers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
are B-O B-VP_VBP
weakly B-O B-ADJP_ADJP_JJ
" " B-O B-ADJP_PP_O-ADJP
or B-O B-CC
not B-O B-ADJP_RB
responsive B-O B-JJ
" " B-O B-PP_O-ADJP
to B-O B-PP_TO
R B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
protoenhancers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contains B-O B-VP_VBZ
the B-O B-NP_NP_DT
overlapping B-O B-NP_VBG
palindromes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
5'-TTGTCCcgtGGACAAaTGTCC-3' B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
one B-O B-NP_NP_NP_CD
palindrome B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
either B-O B-UCP_CC
alone B-O B-ADVP_RB
" " B-O O-ADVP
or B-O B-CC
duplicated B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-UCP
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
the B-O B-NP_DT
overlapping B-O B-NP_VBG
palindromes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
respond B-O B-VP_VB
to B-O B-PP_TO
R B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Type B-O B-NP_NP_NP_NP_NN
II B-O B-CD
estrogen B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
variations B-O B-NP_NP_NNS
" " B-O O-NP
during B-O B-PP_IN
the B-O B-NP_DT
menstrual B-O B-JJ
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
reported B-O B-VP_VBN
that B-O B-SBAR_IN
human B-O B-S_NP_NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
PBMC B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
contain B-O B-VP_VBP
type B-O B-NP_NP_NN
( B-O B-NP_PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
fluctuations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
type B-O B-NP_NN
II B-O B-CD
EBS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
the B-O B-NP_DT
menstrual B-O B-JJ
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
analyzed B-O B-VP_VBN
in B-O B-NP_PP_IN
6 B-O B-NP_CD
normally B-O B-ADJP_RB
menstruating B-O B-VBG
" " B-O O-ADJP
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Approximately B-O B-S_NP_NP_ADJP_QP_RB
3 B-O B-CD
times B-O B-NNS
" " B-O O-QP
higher B-O B-JJR
" " B-O O-ADJP
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
type B-O B-NP_NN
II B-O B-CD
EBS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
periovulatory B-O B-JJ
period B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
respect B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
both B-O B-NP_CC
follicular B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
luteal B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
phases B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
postmenopausal B-O B-NP_JJ
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
mean B-O B-NN
type B-O B-NP_NN
II B-O B-CD
EBS B-O B-NNS
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
similar B-O B-ADJP_JJ
to B-O B-PP_TO
those B-O B-NP_NP_DT
" " B-O O-NP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
follicular B-O B-JJ
phase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
3 B-O B-NP_CD
postmenopausal B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
a B-O B-NP_DT
short B-O B-JJ
course B-O B-NN
of B-O B-PP_IN
estrogen B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
tamoxifen B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_DT
marked B-O B-JJ
increase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
type B-O B-NP_NP_NN
II B-O B-CD
EBS B-O B-NNS
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tamoxifen B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
compete B-O B-VP_VB
with B-O B-PP_IN
17 B-O B-NP_NP_CD
beta-estradiol B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
although B-O B-SBAR_IN
to B-O B-FRAG_PP_TO
a B-O B-NP_NP_DT
lesser B-O B-JJR
extent B-O B-NN
" " B-O O-NP
than B-O B-PP_IN
diethylstilbestrol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Lymphocyte B-O B-S_S_NP_NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
vitamin B-O B-NP_NN
D-dependent B-O B-JJ
rickets B-O B-NN
type B-O B-NN
II B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
show B-O B-VP_VBP
functional B-O B-NP_JJ
defects B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
1 B-O B-NP_CD
alpha,25-dihydroxyvitamin B-O B-NN
D3 B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Lymphocyte B-O B-S_S_NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
established B-O B-VP_VBN
from B-O B-NP_PP_IN
five B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
vitamin B-O B-NP_NP_NN
D-dependent B-O B-JJ
rickets B-O B-NN
, B-O B-COMMA
type B-O B-NN
II B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
These B-O B-S_NP_DT
lines B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
established B-O B-VP_VBN
by B-O B-NP_PP_IN
infection B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
human B-O B-NP_NP_JJ
T-lymphotrophic B-O B-JJ
virus B-O B-NN
type B-O B-NN
I B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-I B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Binding B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
[3H]1 B-O B-NP_NP_NP_NN
alpha,25-dihydroxyvitamin B-O B-NN
D3 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
its B-O B-NP_NP_PRPP
receptor B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
compared B-O B-VP_VBN
to B-O B-NP_PP_TO
binding B-O B-NP_NN
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
using B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
T-lymphocyte B-O B-NP_NP_NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
S-LB1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
a B-O B-NP_DT
normal B-O B-JJ
individual B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
1,25(OH)2D3 B-O B-NN
receptor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
S-LB1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
comparable B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_DT
well-characterized B-O B-JJ
chick B-O B-NP_NN
intestinal B-O B-JJ
1,25(OH)2D3 B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
terms B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_NP_PRPP
ligand B-O B-NN
binding B-O B-NN
affinity B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
capacity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
its B-O B-NP_NP_PRPP
mobility B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
and B-O B-NP_NP_NP_PP_CC
DNA-cellulose B-O B-NP_NP_PP_NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Three B-O B-S_S_NP_NP_CD
cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
established B-O B-VP_VBN
from B-O B-NP_PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
VDDR-II B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
showed B-O B-VP_VBD
no B-O B-NP_NP_DT
specific B-O B-JJ
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_DT
receptor B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cultured B-O B-NP_VBN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
stimulate B-O B-VP_VB
production B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
24,25-dihydroxy-vitamin B-O B-NP_NP_NN
D3 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
a B-O B-NP_DT
fourth B-O B-JJ
cell B-O B-NP_NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
A1-VDR B-O B-S_S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
receptor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
had B-O B-VP_VBD
a B-O B-NP_DT
low B-O B-JJ
binding B-O B-NN
capacity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
25(OH)D3-24-hydroxylase B-O B-S_NP_NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
detectable B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
24,25-(OH)2D3 B-O B-NP_NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
fifth B-O B-JJ
cell B-O B-NP_NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
designated B-O B-VP_VBN
Ro-VDR B-O B-S_NP_NP_NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
although B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
sensitivity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
hormone B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
lower B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
capacity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
low B-O B-ADJP_JJ
in B-O B-PP_IN
Ro-VDR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
all B-O B-NP_NP_DT
cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
1,25(OH)2D3 B-O B-S_NP_NP_NN
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_DT
receptor B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
detectable B-O B-ADJP_JJ
" " B-O B-ADVP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
receptor B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
had B-O B-VP_VBD
the B-O B-NP_NP_DT
typical B-O B-JJ
sedimentation B-O B-NN
coefficient B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
3.7 B-O B-NP_CD
S B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
sucrose B-O B-NP_NN
density B-O B-NN
gradient B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Binding B-O B-S_NP_NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
elution B-O B-NP_NN
" " B-O B-NP_O-NP
properties B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
to B-O B-PP_TO
DNA-cellulose B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
differed B-O B-VP_VBD
from B-O B-PP_IN
normal B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
" " B-O O-PP
in B-O B-PP_IN
both B-O B-NP_NP_CC
Ro-VDR B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
A1-VDR B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
elution B-O B-S_NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
DNA-cellulose B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurred B-O B-VP_VBD
at B-O B-PP_IN
a B-O B-NP_DT
lower B-O B-JJR
salt B-O B-NN
concentration B-O B-NN
" " B-O O-NP
" " B-O O-PP
than B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
While B-O B-S_SBAR_IN
Ro-VDR B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
typical B-O B-NP_NP_JJ
nuclear B-O B-JJ
localization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
unoccupied B-O B-NP_JJ
1,25(OH)2D3 B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
neither B-O B-S_NP_NP_CC
the B-O B-NP_DT
unoccupied B-O B-JJ
" " B-O B-NP_O-NP
nor B-O B-CC
the B-O B-NP_DT
occupied B-O B-JJ
" " B-O B-NP_O-NP
receptor B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
A1-VDR B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
completely B-O B-ADJP_RB
localized B-O B-JJ
in B-O B-PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
a B-O B-NP_NP_DT
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
functional B-O B-NP_JJ
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
modulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlated B-O B-VP_VBD
with B-O B-PP_IN
the B-O B-NP_NP_DT
1,25(OH)2D3 B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
status B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Use B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
will B-O B-VP_VP_MD
facilitate B-O B-VP_VB
further B-O B-NP_NP_JJ
study B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
molecular B-O B-JJ
defect B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
will B-O B-VP_MD
allow B-O B-VP_VB
a B-O B-NP_NP_DT
correlation B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
impairment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cellular B-O B-NP_JJ
functions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Heterogeneity B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
antigen B-O B-NP_NP_NN
molecules B-O B-NNS
" " B-O O-NP
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
anti-tax1 B-O B-NP_NP_NP_JJ
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
Lt-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
bearing B-O B-VP_VBG
and B-O B-NP_NP_CC
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Using B-O B-S_S_S_NP_VP_VBG
a B-O B-NP_NP_NP_DT
monoclonal B-O B-NP_JJ
antibody B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
Lt-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
directed B-O B-VP_VBN
against B-O B-NP_PP_IN
human B-O B-NP_JJ
T B-O B-NN
cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
I B-O B-CD
( B-O B-LRB
HTLV-I B-O B-NN
) B-O B-RRB
trans-activator B-O B-NN
( B-O B-LRB
tax1 B-O B-NN
) B-O B-RRB
antigen B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tax1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
related B-O B-NP_JJ
antigens B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
by B-O B-PP_IN
immunofluorescence B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
immunoblot B-O B-NP_NN
" " B-O B-NP_O-NP
assays B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Lt-4 B-O B-S_NP_NN
" " B-O O-NP
reacted B-O B-VP_VBD
with B-O B-PP_PP_IN
all B-O B-NP_NP_NP_DT
HTLV-I-bearing B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
and B-O B-CC
five B-O B-NP_NP_QP_CD
out B-O B-IN
of B-O B-IN
eight B-O B-CD
" " B-O O-QP
simian B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
bearing B-O B-VP_VBG
STLV-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
with B-O B-PP_IN
an B-O B-NP_DT
HTLV-II-bearing B-O B-NP_JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Lt-4 B-O B-S_NP_NN
" " B-O O-NP
detected B-O B-VP_VBD
40 B-O B-NP_ADJP_CD
kd B-O B-NN
" " B-O O-ADJP
tax1 B-O B-NP_NN
antigen B-O B-NN
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
most B-O B-NP_JJS
HTLV-I B-O B-NP_JJ
-bearing B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
except B-O B-PP_IN
one B-O B-NP_NP_CD
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
expressed B-O B-S_NP_VP_VBD
39 B-O B-NP_CD
kd B-O B-NN
tax1 B-O B-NN
antigen B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
STLV-I-bearing B-O B-NP_JJ
T B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
tax1-related B-O B-NP_NP_JJ
antigen B-O B-NN
molecules B-O B-NNS
" " B-O O-NP
detected B-O B-VP_VBN
by B-O B-NP_PP_IN
Lt-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
heterogeneous B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
having B-O B-S_NP_VP_VBG
molecular B-O B-NP_NP_JJ
weights B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
range B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
kd B-O B-NP_QP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Sequence-specific B-O B-S_S_NP_NP_JJ
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
proto-oncoprotein B-O B-NP_NP_NN
" " B-O O-NP
ets-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
defines B-O B-VP_VBZ
a B-O B-NP_NP_DT
transcriptional B-O B-NP_JJ
activator B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_NP_DT
long B-O B-NP_JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Moloney B-O B-NN
murine B-O B-JJ
sarcoma B-O B-NN
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_DT
ets B-O B-NP_NN
proto-oncogene B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
sequence-related B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
whose B-O B-SBAR_WHNP_WPP
normal B-O B-JJ
cellular B-O B-JJ
function B-O B-NN
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
unknown B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
a B-O B-NP_NP_DT
study B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cellular B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
discovered B-O B-VP_VBN
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
ets B-O B-NP_NN
gene B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
encodes B-O B-VP_VBZ
a B-O B-NP_DT
sequence-specific B-O B-NP_JJ
DNA-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
mouse B-O B-NP_NN
ets-1 B-O B-NN
cDNA B-O B-NN
clone B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
obtained B-O B-VP_VBN
by B-O B-NP_PP_IN
screening B-O B-S_NP_VP_VBG
a B-O B-NP_DT
mouse B-O B-NN
thymus B-O B-NN
cDNA B-O B-NN
expression B-O B-NN
library B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
representing B-O B-NP_VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
cDNA B-O B-NP_NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
an B-O B-NP_NP_DT
813-bp B-O B-NP_JJ
open B-O B-JJ
reading B-O B-NN
frame B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ORF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
whose B-O B-SBAR_WHNP_WPP
predicted B-O B-VBN
amino B-O B-NN
acid B-O B-NN
sequence B-O B-NN
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
97.6 B-O B-ADJP_NP_CD
% B-O B-NN
" " B-O O-NP
identical B-O B-JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
ORF B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
bacteria B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_DT
30-kD B-O B-NP_JJ
protein B-O B-NN
product B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
DNA B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
sequence-specific B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
by B-O B-PP_IN
mobility-shift B-O B-NP_NP_JJ
assays B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
Southwestern B-O B-NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
methylation B-O B-NP_NN
interference B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
mutant B-O B-NP_JJ
LTR B-O B-NN
" " B-O O-NP
" " B-O O-NP
containing B-O B-VP_VBG
four B-O B-NP_CD
base B-O B-NN
pair B-O B-NN
substitutions B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
ets-1 B-O B-NP_NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VP_VBD
constructed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
and B-O B-CC
was B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
reduced B-O B-NP_VBN
binding B-O B-NN
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transcriptional B-O B-S_S_NP_NP_JJ
efficiency B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
MSV B-O B-NP_NN
LTR B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
containing B-O B-VP_VBG
this B-O B-NP_DT
disrupted B-O B-VBN
ets-1 B-O B-NP_NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
compared B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
15- B-O B-S_NP_NP_ADJP_CD
to B-O B-TO
20-fold B-O B-JJ
" " B-O O-ADJP
reduction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
reporter B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VP_VBP
that B-O B-SBAR_IN
ets-1 B-O B-S_NP_NN
" " B-O O-NP
functions B-O B-VP_VBZ
as B-O B-PP_IN
a B-O B-NP_NP_DT
transcriptional B-O B-JJ
activator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
speculate B-O B-VP_VBP
that B-O B-SBAR_IN
ets-related B-O B-S_NP_JJ
genes B-O B-NNS
" " B-O O-NP
constitute B-O B-VP_VBP
a B-O B-NP_NP_DT
new B-O B-JJ
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
eukaryotic B-O B-NP_JJ
DNA-binding B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_NP_DT
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
( B-O B-LRB
EBV B-O B-NN
) B-O B-RRB
BMRF1 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
early B-O B-NP_NP_JJ
antigen B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EA-D B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
EBV B-O B-NP_NN
transactivators B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
BRLF1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
BZLF1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
a B-O B-NP_DT
cell-specific B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_S_NP_NP_DT
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
early B-O B-JJ
antigen B-O B-NN
diffuse B-O B-NN
component B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
EA-D B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
Epstein-Barr B-O B-NP_JJ
virus B-O B-NP_NN
DNA B-O B-NN
" " B-O O-NP
polymerase B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
its B-O B-S_NP_PRPP
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
suppressed B-O B-VP_VBN
during B-O B-NP_PP_IN
latent B-O B-NP_JJ
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
promoter B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
BMRF1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
for B-O B-PP_IN
this B-O B-NP_DT
early B-O B-JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
studying B-O B-S_NP_VP_VBG
its B-O B-NP_NP_PRPP
responsiveness B-O B-NN
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
to B-O B-PP_TO
two B-O B-NP_NP_CD
, B-O B-NP_COMMA
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
focusing B-O B-S_NP_VP_VBG
on B-O B-PP_IN
the B-O B-NP_NP_DT
differences B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
Z B-O B-NP_NP_NP_NN
" " B-O O-NP
" " B-O B-ADVP_O-NP
or B-O B-CC
R B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-ADVP_O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
produced B-O B-VP_VBD
only B-O B-NP_RB
small B-O B-JJ
increases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
EA-D B-O B-NP_NP_NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
whereas B-O B-SBAR_IN
both B-O B-S_NP_DT
transactivators B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
together B-O B-ADVP_RB
" " B-O O-ADVP
produced B-O B-VP_VBD
a B-O B-NP_DT
large B-O B-JJ
stimulatory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
epithelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-S_S_NP_NP_DT
Z B-O B-NP_NN
transactivator B-O B-NN
" " B-O O-NP
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
produced B-O B-VP_VBD
maximal B-O B-NP_NP_JJ
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
EA-D B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
the B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
R B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
Z B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
together B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-ADJP_ADJP_DT
greater B-O B-JJR
" " B-O O-ADJP
than B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Deletional B-O B-S_NP_NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
and B-O B-CC
site-directed B-O B-NP_JJ
mutagenesis B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
EA-D B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
in B-O B-S_PP_IN
epithelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
potential B-O B-JJ
AP-1 B-O B-NP_NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
plays B-O B-VP_VBZ
an B-O B-NP_DT
essential B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Z B-O B-NP_NP_NN
" " B-O O-NP
responsiveness B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
although B-O B-SBAR_IN
sequences B-O B-S_NP_NP_NNS
" " B-O O-NP
further B-O B-ADVP_RB
upstream B-O B-JJ
" " B-O O-ADVP
" " B-O O-NP
are B-O B-VP_VBP
also B-O B-ADVP_RB
" " B-O O-ADVP
important B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
only B-O B-S_S_NP_RB
the B-O B-DT
upstream B-O B-NP_JJ
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
transactivation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
the B-O B-NP_DT
combination B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_DT
AP-1 B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
dispensable B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
EA-D B-O B-S_NP_NP_NP_NN
( B-O B-LRB
BMRF1 B-O B-NN
) B-O B-RRB
promoter B-O B-NN
" " B-O O-NP
regulation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
Z B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
R B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
cell B-O B-ADJP_NN
type B-O B-NN
specific B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
involve B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Decreased B-O B-NP_NP_NP_NP_VBN
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1,25-dihydroxyvitamin B-O B-NP_NN
D3 B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
X-linked B-O B-NP_JJ
hypophosphatemic B-O B-JJ
rickets B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
effect B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
phosphate B-O B-NP_NN
supplementation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Abnormal B-O B-S_S_NP_JJ
renal B-O B-JJ
tubular B-O B-JJ
phosphate B-O B-NN
transport B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
considered B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
the B-O B-NP_NP_DT
primary B-O B-JJ
defect B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
resistance B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
vitamin B-O B-NP_NN
D B-O B-NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
XLH B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
not B-O B-RB
be B-O B-VP_VB
explained B-O B-VP_VBN
by B-O B-NP_PP_IN
hypophosphatemia B-O B-NP_NP_NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
most B-O B-S_NP_NP_JJS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
actions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
vitamin B-O B-NP_NN
D B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
its B-O B-NP_NP_PRPP
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
VDR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
abnormalities B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
VDR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
postulated B-O B-VP_VBN
in B-O B-NP_PP_IN
XLH B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_SBAR_IN
order B-O B-NN
to B-O B-S_NP_VP_TO
investigate B-O B-VP_VB
this B-O B-NP_DT
possibility B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
measured B-O B-VP_VBD
the B-O B-NP_NP_DT
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
VDR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
PHA-activated B-O B-NP_NP_JJ
peripheral B-O B-JJ
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
10 B-O B-NP_CD
XLH B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Patients B-O B-S_NP_NP_NNS
" " B-O O-NP
without B-O B-PP_IN
phosphate B-O B-NP_NN
supplementation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
significantly B-O B-NP_NP_ADJP_RB
lower B-O B-JJR
" " B-O O-ADJP
concentration B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
21.7 B-O B-NP_NP_QP_CD
+/- B-O B-CC
5.1 B-O B-CD
" " B-O O-QP
fmol/mg B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
mean B-O B-NP_NN
+/- B-O B-CC
SEM B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
compared B-O B-PP_VBN
to B-O B-PP_TO
the B-O B-NP_NP_DT
normal B-O B-JJ
controls B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
60.7 B-O B-NP_QP_CD
+/- B-O B-CC
4.0 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-NP_DT
contrary B-O B-JJ
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_NP_DT
significant B-O B-JJ
difference B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_NP_DT
phosphate-supplemented B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
58.3 B-O B-NP_QP_CD
+/- B-O B-CC
2.7 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
controls B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_DT
significant B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
positive B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
VDR B-O B-NP_NP_NN
concentration B-O B-NN
" " B-O O-NP
and B-O B-CC
serum B-O B-NP_NP_NN
phosphate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-NP_NP_NN
" " B-O O-NP
less B-O B-ADJP_JJR
than B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
two B-O B-NP_CD
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
VDR B-O B-NP_NN
" " B-O O-NP
was B-O B-VP_VBD
increased B-O B-VP_VBN
" " B-O B-NP_O-VP
after B-O B-SBAR_IN
daily B-O B-S_NP_JJ
phosphate B-O B-NN
supplementation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
started B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
decreased B-O B-VBN
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
VDR B-O B-NP_NP_NN
" " B-O O-NP
secondary B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
causes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Characterization B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
defensin B-O B-NP_NP_NN
resistance B-O B-NN
phenotypes B-O B-NNS
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
mutations B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
defensin B-O B-NN
sensitivities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Salmonella B-O B-NP_NP_FW
typhimurium B-O B-FW
strains B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
mutations B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
phoP/phoQ B-O B-NN
two-component B-O B-JJ
virulence B-O B-NN
regulon B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
tested B-O B-VP_VBN
by B-O B-NP_PP_IN
using B-O B-S_NP_VP_VBG
purified B-O B-NP_VBN
defensins B-O B-NNS
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Strains B-O B-S_NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
mutations B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
either B-O B-NP_NP_DT
gene B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
regulatory B-O B-JJ
pair B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
increased B-O B-VP_VBN
sensitivities B-O B-NP_NP_NNS
" " B-O O-NP
to B-O B-PP_TO
defensin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
predicted B-O B-VBN
periplasmic B-O B-JJ
domain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
PhoQ B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contained B-O B-VP_VBD
a B-O B-NP_NP_DT
markedly B-O B-ADJP_RB
anionic B-O B-JJ
" " B-O O-ADJP
domain B-O B-NN
" " B-O O-NP
that B-O B-SBAR_SBAR_WHNP_WDT
" " B-O O-WHNP
could B-O B-S_NP_MD
interact B-O B-VP_VB
with B-O B-PP_IN
cationic B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
could B-O B-S_NP_MD
be B-O B-VP_VB
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
insertion B-O B-S_NP_NP_NN
mutations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
phoP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
polar B-O B-ADJP_JJ
on B-O B-PP_IN
phoQ B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
constructed B-O B-VP_VBD
strains B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
expressed B-O B-S_NP_VP_VBD
the B-O B-NP_DT
PhoQ B-O B-NN
protein B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
to B-O B-S_NP_VP_TO
test B-O B-VP_VB
whether B-O B-SBAR_IN
requires B-O B-S_NP_NP_PP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
resistance B-O B-S_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
defensin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VBZ
the B-O B-NP_NP_DT
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_NP_DT
components B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
because B-O B-SBAR_IN
strains B-O B-S_NP_NP_NNS
" " B-O O-NP
expressing B-O B-VP_VBG
" " B-O B-NP_PP_O-NP
were B-O B-VP_VBD
still B-O B-ADVP_RB
" " B-O O-ADVP
markedly B-O B-ADJP_RB
sensitive B-O B-JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
implied B-O B-VP_VBD
that B-O B-SBAR_IN
a B-O B-S_NP_DT
pag B-O B-NN
( B-O B-LRB
phoP-activated B-O B-JJ
gene B-O B-NN
) B-O B-RRB
product B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
defensin B-O B-NP_NN
resistance B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
tested B-O B-VP_VP_VBD
for B-O B-PP_IN
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
defensins B-O B-NP_NP_NNS
" " B-O O-NP
NP-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
NP-5 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
HNP-1 B-O B-NP_NNP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
pag B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
found B-O B-VP_VBD
that B-O B-SBAR_IN
these B-O B-S_NP_DT
peptides B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Defensin B-O B-S_NP_NN
resistance B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
the B-O B-NP_NP_DT
only B-O B-JJ
virulence B-O B-NN
characteristic B-O B-NN
" " B-O O-NP
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
PhoP-PhoQ B-O B-JJ
regulon B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
because B-O B-SBAR_IN
mutations B-O B-S_NP_NP_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
pagC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
ones B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
phoP B-O B-NN
locus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
resulted B-O B-S_NP_VP_VBD
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
defensin B-O B-NP_NN
resistance B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
even B-O B-SBAR_RB
though B-O B-IN
they B-O B-S_NP_PRP
" " B-O O-NP
rendered B-O B-VP_VBD
" " B-O B-S_NP_ADJP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
virulence B-O B-NN
defect B-O B-NN
" " B-O O-NP
conferred B-O B-VP_VBN
by B-O B-NP_PP_IN
mutations B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
phoP-phoQ B-O B-JJ
two-component B-O B-NN
regulatory B-O B-JJ
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VP_VBZ
not B-O B-RB
completely B-O B-ADVP_RB
" " B-O O-ADVP
explained B-O B-VP_VBN
by B-O B-NP_PP_IN
alterations B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
resistance B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
involves B-O B-VP_VBZ
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
necessary B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Immunohistochemical B-O B-NP_NP_NP_NP_JJ
study B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
steroid B-O B-NP_NN
hormones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
an B-O B-NP_NP_DT
estrogen B-O B-NN
binding B-O B-NN
assay B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
malignant B-O B-NP_JJ
soft B-O B-JJ
tissue B-O B-NN
tumors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Immunohistochemically B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
immunoreaction B-O B-NN
" " B-O O-NP
against B-O B-PP_IN
5 B-O B-NP_NP_CD
steroid B-O B-NN
hormone B-O B-NN
anti-sera B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
estradiol B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
estriol B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
cortisol B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
progesterone B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
testosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
examined B-O B-VP_VBN
in B-O B-NP_PP_IN
39 B-O B-NP_NP_NP_CD
cases B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
malignant B-O B-JJ
soft B-O B-JJ
tissue B-O B-NN
tumors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
, B-O B-NP_NP_NP_NP_COMMA
, B-O B-NP_NP_NP_COMMA
, B-O B-NP_NP_NP_COMMA
, B-O B-NP_NP_NP_COMMA
" " B-O B-NP_NP_NP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Seventeen B-O B-S_NP_CD
cases B-O B-NNS
" " B-O O-NP
revealed B-O B-VP_VBD
distinct B-O B-NP_NP_JJ
immunostaining B-O B-NN
" " B-O O-NP
against B-O B-PP_IN
at B-O B-NP_NP_QP_IN
least B-O B-JJS
1 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
of B-O B-PP_IN
the B-O B-NP_DT
5 B-O B-CD
steroid B-O B-NP_NN
hormones B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Immunostained B-O B-S_NP_VBN
tumor B-O B-NN
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
more B-O B-ADVP_RBR
frequently B-O B-RB
" " B-O O-ADVP
distributed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
area B-O B-NN
" " B-O O-NP
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
tumor B-O B-S_NP_NN
cell B-O B-NN
infiltration B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
more B-O B-ADJP_RBR
invasive B-O B-JJ
" " B-O B-ADVP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
majority B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
positive B-O B-JJ
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurred B-O B-VP_VBD
in B-O B-PP_IN
female B-O B-NP_JJ
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
existence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
estrogen B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
estrogen B-O B-NP_NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
examined B-O B-VP_VBN
histochemically B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
39 B-O B-NP_CD
cases B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
8 B-O B-NP_QP_CD
" " B-O O-QP
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
concluded B-O B-VP_VBD
that B-O B-SBAR_IN
steroid B-O B-S_NP_NN
hormones B-O B-NNS
" " B-O O-NP
might B-O B-VP_MD
be B-O B-VP_VB
closely B-O B-ADJP_RB
related B-O B-JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Steroid B-O B-NP_NP_NP_NN
dose B-O B-NN
sparing B-O B-NN
: B-O B-COLON
" " B-O O-NP
pharmacodynamic B-O B-NP_NP_JJ
responses B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
single B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
versus B-O B-CC
divided B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
doses B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
methylprednisolone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
man B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Inhibitory B-O B-S_S_NP_NP_JJ
drug B-O B-NN
interactions B-O B-NNS
" " B-O O-NP
affecting B-O B-VP_VBG
the B-O B-NP_NP_DT
metabolism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
methylprednisolone B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
MP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
may B-O B-VP_MD
produce B-O B-VP_VB
either B-O B-NP_NP_CC
steroid B-O B-NP_NN
sparing B-O B-NN
" " B-O O-NP
or B-O B-CC
adverse B-O B-NP_JJ
effects B-O B-NNS
" " B-O O-NP
" " B-O O-NP
partly B-O B-PP_ADVP_RB
" " B-O O-ADVP
by B-O B-IN
increasing B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_NP_DT
phenomenon B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
mimicked B-O B-VP_VBN
by B-O B-NP_PP_IN
administering B-O B-S_NP_VP_VBG
MP B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
divided B-O B-NP_JJ
doses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_CD
types B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
responses B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
compared B-O B-VP_VBN
after B-O B-NP_PP_IN
a B-O B-NP_NP_DT
single B-O B-JJ
MP B-O B-NN
dose B-O B-NN
( B-O B-PRN_LRB
40 B-O B-NP_QP_CD
mg B-O B-NN
" " B-O O-QP
bolus B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
divided B-O B-JJ
regimen B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
bolus B-O B-NP_NP_QP_NN
" " B-O O-NP
and B-O B-CC
" " B-O B-NP_NP_ADVP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
six B-O B-NP_CD
healthy B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
male B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
volunteers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
suppression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
basophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
measured B-O B-VP_VBN
as B-O B-NP_PP_IN
whole B-O B-NP_ADJP_JJ
" " B-O O-ADJP
blood B-O B-NP_NN
histamine B-O B-NN
" " B-O O-NP
and B-O B-CC
plasma B-O B-NP_NN
cortisol B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
assessed B-O B-VP_VBN
during B-O B-NP_PP_IN
32 B-O B-NP_CD
hours B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
37.5 B-O B-ADJP_CD
% B-O B-NN
" " B-O O-ADJP
reduction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
dose B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
produced B-O B-VP_VBD
a B-O B-NP_DT
23 B-O B-ADJP_CD
% B-O B-NN
" " B-O O-ADJP
overall B-O B-RB
decreased B-O B-VBN
blood B-O B-NN
histamine B-O B-NN
response B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
pharmacodynamic B-O B-JJ
model B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
basophil B-O B-NP_NP_NN
cell B-O B-NN
distribution B-O B-NN
" " B-O O-NP
to B-O B-PP_PP_TO
" " B-O B-NP_O-PP
and B-O B-CC
from B-O B-PP_IN
" " B-O B-NP_O-PP
an B-O B-NP_DT
extravascular B-O B-JJ
compartment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
describes B-O B-VP_VBZ
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
MP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
both B-O B-NP_DT
regimens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
slower B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
initial B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
decline B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
blood B-O B-NP_NN
histamine B-O B-NN
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
the B-O B-NP_DT
divided B-O B-JJ
regimen B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
related B-O B-ADJP_JJ
to B-O B-PP_TO
incomplete B-O B-NP_NP_JJ
suppression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
return B-O B-NP_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
50 B-O B-ADJP_CD
% B-O B-NN
" " B-O O-ADJP
inhibitory B-O B-JJ
concentrations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
MP B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
about B-O B-NP_QP_RB
5 B-O B-CD
" " B-O O-QP
ng/ml B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
similar B-O B-ADJP_JJ
for B-O B-PP_IN
both B-O B-NP_DT
regimens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
decline B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
return B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
cortisol B-O B-NP_NN
concentrations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
similar B-O B-ADJP_JJ
between B-O B-PP_IN
MP B-O B-NP_NP_NN
treatments B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
suppression B-O B-NP_NP_NN
" " B-O O-NP
continuing B-O B-VP_VBG
for B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
50 B-O B-ADJP_CD
% B-O B-NN
" " B-O O-ADJP
inhibitory B-O B-JJ
concentrations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
MP B-O B-NP_NN
values B-O B-NNS
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
adrenal B-O B-NP_JJ
suppression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
about B-O B-NP_QP_RB
1 B-O B-CD
" " B-O O-QP
ng/ml B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Pharmacodynamic B-O B-S_NP_JJ
modeling B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
useful B-O B-ADJP_JJ
in B-O B-PP_IN
quantitating B-O B-S_NP_VP_VBG
corticosteroid B-O B-NP_NN
responses B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
generally B-O B-ADVP_RB
" " B-O O-ADVP
predicted B-O B-VP_VBD
the B-O B-NP_NP_DT
"""" B-O B-LQT
dose-sparing B-O B-JJ
"""" B-O B-RQT
effects B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
achieved B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-S_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
study B-O B-NN
" " B-O O-NP
supports B-O B-VP_VBZ
previous B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
clinical B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
observations B-O B-NNS
that B-O B-SBAR_IN
patients B-O B-S_NP_NNS
" " B-O O-NP
may B-O B-VP_MD
require B-O B-VP_VB
exposure B-O B-NP_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-VP
to B-O B-S_NP_VP_TO
optimize B-O B-VP_VB
while B-O B-NP_SBAR_IN
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Involvement B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cyclic B-O B-NP_JJ
AMP-dependent B-O B-JJ
protein B-O B-NN
kinases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
signal B-O B-NN
transduction B-O B-NN
pathway B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
interleukin-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Expression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
highly B-O B-ADJP_RB
specific B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
inhibitor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
cyclic B-O B-NP_NP_JJ
AMP-dependent B-O B-JJ
protein B-O B-NN
kinases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
interleukin-1 B-O B-NP_NN
( B-O B-LRB
IL-1 B-O B-NN
) B-O B-RRB
-responsive B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
blocked B-O B-VP_VBD
IL-1-induced B-O B-NP_NP_NP_JJ
gene B-O B-NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
driven B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
affect B-O B-VP_VB
protein B-O B-NP_ADJP_NN
kinase B-O B-NN
C-mediated B-O B-JJ
" " B-O O-ADJP
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
cyclic B-O B-S_NP_JJ
AMP-dependent B-O B-JJ
protein B-O B-NN
kinases B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Lipopolysaccharide B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
potent B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
monocyte/macrophage-specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
stimulator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Lipopolysaccharide B-O B-S_S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
LPS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
potently B-O B-ADVP_RB
" " B-O O-ADVP
stimulates B-O B-VP_VBZ
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1-long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
( B-O B-LRB
HIV-1-LTR B-O B-NN
) B-O B-RRB
CAT B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
transfected B-O B-VP_VBN
into B-O B-NP_PP_IN
monocyte/macrophage-like B-O B-NP_NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
a B-O B-NP_DT
T B-O B-NP_NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Electrophoretic B-O B-S_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
LPS B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
a B-O B-NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
indistinguishable B-O B-ADJP_JJ
from B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LPS B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
dramatically B-O B-ADVP_RB
" " B-O O-ADVP
increase B-O B-VP_VB
HIV-1 B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
, B-O B-NP_NP_NP_COMMA
, B-O B-NP_COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
viral B-O B-NP_NP_JJ
production B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
this B-O B-NP_DT
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurs B-O B-VP_VBZ
only B-O B-SBAR_RB
if B-O B-IN
these B-O B-S_NP_DT
cells B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
treated B-O B-VP_VBN
with B-O B-NP_PP_IN
granulocyte/macrophage B-O B-NP_NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
before B-O B-PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
an B-O B-NP_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
and B-O B-NP_NP_CC
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LPS B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
HIV-1 B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
cloned B-O B-VBN
T B-O B-NP_NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
HIV-1 B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurs B-O B-VP_VP_VBZ
at B-O B-PP_IN
picogram B-O B-NP_NP_NN
per B-O B-PP_IN
milliliter B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
concentrations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
may B-O B-VP_MD
be B-O B-VP_VB
clinically B-O B-ADJP_RB
significant B-O B-JJ
in B-O B-PP_IN
understanding B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cloning B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
transcriptionally B-O B-NP_RB
active B-O B-JJ
human B-O B-JJ
TATA B-O B-NN
binding B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Transcription B-O B-S_S_NP_NP_NN
factor B-O B-NN
IID B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TFIID B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
binds B-O B-VP_VP_VBZ
to B-O B-PP_TO
the B-O B-NP_DT
TATA B-O B-NP_NN
box B-O B-NN
promoter B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
regulates B-O B-VP_VBZ
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
most B-O B-NP_NP_JJS
eukaryotic B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
transcribed B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Complementary B-O B-S_NP_NP_NP_JJ
DNA B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
cDNA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
encoding B-O B-VP_VBG
a B-O B-NP_DT
human B-O B-NP_JJ
TFIID B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
cloned B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
human B-O B-NP_JJ
TFIID B-O B-NN
polypeptide B-O B-NN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
339 B-O B-NP_NP_CD
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
molecular B-O B-JJ
size B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
37,745 B-O B-NP_CD
daltons B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
carboxyl-terminal B-O B-NP_JJ
181 B-O B-CD
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
TFIID B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
shares B-O B-VP_VBZ
80 B-O B-NP_ADJP_CD
% B-O B-NN
" " B-O O-ADJP
identity B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
TFIID B-O B-NP_NN
" " B-O O-NP
protein B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
Saccharomyces B-O B-NP_FW
cerevisiae B-O B-FW
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
amino B-O B-NP_NN
terminus B-O B-NN
" " B-O O-NP
" " B-O O-NP
contains B-O B-VP_VBZ
an B-O B-NP_NP_NP_DT
unusual B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
38 B-O B-NP_CD
consecutive B-O B-JJ
glutamine B-O B-NN
residues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
an B-O B-NP_DT
X-Thr-Pro B-O B-NP_NN
repeat B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
reticulocyte B-O B-NP_NN
lysates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
in B-O B-PP_IN
Escherichia B-O B-NP_FW
coli B-O B-FW
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
yielded B-O B-VP_VBD
a B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
competent B-O B-ADJP_JJ
for B-O B-PP_IN
both B-O B-NP_CC
and B-O B-NP_CC
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Inducible B-O B-S_S_NP_NP_JJ
nuclear B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
kappa B-O B-NP_NN
B B-O B-NN
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
of B-O B-PP_IN
the B-O B-NP_NP_DT
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
cyclosporin B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_DT
signal-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Cyclosporin B-O B-S_S_NP_NP_NN
A B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CsA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
thought B-O B-VP_VBN
to B-O B-S_NP_VP_TO
exert B-O B-VP_VB
its B-O B-NP_PRPP
immunosuppressive B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
partially B-O B-ADVP_RB
" " B-O O-ADVP
suppressed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
better B-O B-ADVP_RBR
" " B-O O-ADVP
understand B-O B-VP_VB
the B-O B-NP_NP_DT
molecular B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
underlying B-O B-VP_VBG
suppression B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
CsA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
drug B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
transcription B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_NP_CD
distinct B-O B-JJ
mitogen-inducible B-O B-NP_JJ
DNA-binding B-O B-JJ
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-NP_NP_NP_PP_CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
inhibited B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
kappa B-O B-NN
B-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
inhibited B-O B-VP_VBN
" " B-O B-NP_O-VP
only B-O B-SBAR_RB
if B-O B-IN
it B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
activated B-O B-VP_VBN
via B-O B-NP_PP_IN
the B-O B-NP_DT
mitogen B-O B-NP_NN
" " B-O O-NP
phytohemagglutinin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
whereas B-O B-SBAR_IN
phorbol B-O B-S_NP_ADJP_NN
myristate B-O B-NN
acetate-mediated B-O B-JJ
" " B-O O-ADJP
activation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
completely B-O B-ADJP_RB
insensitive B-O B-JJ
to B-O B-PP_TO
the B-O B-NP_DT
drug B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
suggests B-O B-VP_VBZ
a B-O B-NP_NP_DT
model B-O B-NN
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
functionally B-O B-S_NP_ADJP_RB
indistinguishable B-O B-JJ
" " B-O O-ADJP
kappa B-O B-NP_NN
B B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
activated B-O B-VP_VBN
via B-O B-NP_PP_IN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cell-specific B-O B-NP_NP_NP_JJ
differences B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
beta B-O B-NP_NN
interferon B-O B-NN
" " B-O B-NP_O-NP
promoters B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
tumor B-O B-NP_NN
necrosis B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Three B-O B-S_S_NP_NP_CD
aspects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tumor B-O B-NP_NN
necrosis B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
pathogenesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Tumor B-O B-S_NP_NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
( B-O B-LRB
TNF-alpha B-O B-NN
) B-O B-RRB
mRNA B-O B-NN
production B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
analyzed B-O B-VP_VBN
by B-O B-NP_PP_IN
polymerase B-O B-NP_NN
chain B-O B-NN
reaction B-O B-NN
amplification B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
monocytic B-O B-NP_JJ
U937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
a B-O B-NP_DT
chronically B-O B-NP_NP_RB
HIV B-O B-NN
infected B-O B-JJ
U937 B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
U9-IIIB B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TNF-alpha B-O B-S_NP_NN
RNA B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
undetectable B-O B-ADJP_JJ
in B-O B-PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
whereas B-O B-SBAR_IN
a B-O B-S_NP_DT
low B-O B-JJ
constitutive B-O B-JJ
level B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
U9-IIIB B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Paramyxovirus B-O B-S_NP_NN
infection B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBD
a B-O B-NP_DT
5- B-O B-NP_ADJP_CD
to B-O B-TO
10-fold B-O B-JJ
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
steady-state B-O B-JJ
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TNF-alpha B-O B-NP_NN
RNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
U9-IIIB B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
compared B-O B-PP_VBN
with B-O B-PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
HIV-infected B-O B-S_NP_JJ
monocytic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
produced B-O B-VP_VBD
higher B-O B-NP_NP_JJR
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
than B-O B-SBAR_IN
did B-O B-SINV_VBD
" " B-O B-NP_VP_PP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
TNF-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
by B-O B-NP_PP_IN
transient B-O B-NP_NP_JJ
expression B-O B-NN
assays B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
reporter B-O B-NP_NP_NN
chloramphenicol B-O B-NN
acetyltransferase B-O B-NN
plasmids B-O B-NNS
" " B-O O-NP
linked B-O B-VP_VBN
to B-O B-NP_PP_TO
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
U937 B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
Jurkat B-O B-NP_NN
T B-O B-NN
lymphoid B-O B-JJ
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
inducibility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
different B-O B-JJ
hybrid B-O B-NN
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
TNF-alpha B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
phorbol B-O B-NP_NN
ester B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
varied B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_DT
cell B-O B-NP_NN
type- B-O B-NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
promoter B-O B-NP_ADJP_NN
context-specific B-O B-JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
manner B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
the B-O B-S_NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NP_NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B-containing B-O B-JJ
plasmids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlated B-O B-VP_VBD
directly B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
the B-O B-S_NP_DT
intact B-O B-JJ
beta B-O B-NN
interferon B-O B-NN
promoter B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
only B-O B-ADVP_RB
weakly B-O B-RB
" " B-O O-ADVP
stimulated B-O B-VP_VBN
by B-O B-NP_PP_IN
phorbol B-O B-NP_NP_NN
ester B-O B-NN
" " B-O O-NP
or B-O B-CC
TNF-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
multimers B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
PRDII B-O B-NN
NF-kappa B-O B-NN
B-binding B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
inducible B-O B-ADJP_JJ
by B-O B-PP_IN
both B-O B-NP_DT
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
TNF-alpha B-O B-S_S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
increase B-O B-VP_VB
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
in B-O B-S_PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
TNF-alpha B-O B-NP_NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
induce B-O B-VP_VB
the B-O B-NP_DT
HIV B-O B-NN
LTR B-O B-NN
" " B-O O-NP
above B-O B-PP_IN
a B-O B-NP_NP_DT
constitutive B-O B-JJ
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B-independent B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
sufficient B-O B-ADJP_JJ
for B-O B-PP_IN
virus B-O B-NP_NN
multiplication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
since B-O B-SBAR_IN
TNF-alpha B-O B-S_NP_NN
treatment B-O B-NN
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
kinetics B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
TNF-alpha B-O B-NP_NN
" " B-O O-NP
dramatically B-O B-VP_ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VBD
the B-O B-NP_NP_DT
spread B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
population B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
increased B-O B-VP_VBD
viral B-O B-NP_JJ
RNA B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
in B-O B-S_PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
HIV-1 B-O B-NP_NN
multiplication B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
stimulated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Two B-O B-NP_NP_NP_CD
glucocorticoid B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
glucocorticoid B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Glucocorticoids B-O B-S_S_NP_NNS
" " B-O O-NP
are B-O B-VP_VBP
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
a B-O B-NP_DT
lytic B-O B-JJ
effect B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
leukemic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
via B-O B-VP_IN
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Cortisol B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
various B-O B-NP_JJ
synthetic B-O B-JJ
glucocorticoids B-O B-NNS
" " B-O O-NP
" " B-O O-NP
bind B-O B-VP_VBP
to B-O B-PP_TO
the B-O B-NP_DT
GR B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
one-site B-O B-NP_JJ
kinetics B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cortivazol B-O B-S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
CVZ B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
unique B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
high B-O B-JJ
potency B-O B-NN
synthetic B-O B-JJ
glucocorticoid B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
has B-O B-S_NP_VP_VP_VBZ
a B-O B-NP_NP_DT
phenylpyrazol B-O B-JJ
" " B-O O-NP
fused B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-VP
and B-O B-CC
displays B-O B-VP_VBZ
binding B-O B-NP_NP_NN
" " B-O O-NP
consistent B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
previously B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
shown B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
lower B-O B-JJR
affinity B-O B-NN
class B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
sites B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
similar B-O B-ADJP_JJ
in B-O B-PP_IN
to B-O B-NP_PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
higher B-O B-JJR
affinity B-O B-NN
sites B-O B-NNS
" " B-O O-NP
bind B-O B-VP_VBP
CVZ B-O B-NP_NN
" " B-O O-NP
with B-O B-PP_IN
20- B-O B-NP_ADJP_NP_CD
to B-O B-TO
50-fold B-O B-RB
" " B-O O-NP
greater B-O B-JJR
" " B-O O-ADJP
affinity B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
consistent B-O B-ADVP_JJ
with B-O B-PP_IN
CVZ B-O B-NP_NN
's B-O B-POS
enhanced B-O B-VBN
biological B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
mutant B-O B-NP_NP_JJ
leukemic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
resistant B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
lytic B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
CVZ B-O B-NP_NN
" " B-O O-NP
both B-O B-VP_CC
lyses B-O B-VP_VBZ
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
recognizes B-O B-VP_VBZ
a B-O B-NP_NP_DT
single B-O B-JJ
class B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
sites B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
high B-O B-JJ
affinity B-O B-NN
site B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
CEM B-O B-NP_NN
C7 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
carried B-O B-VP_VBN
out B-O B-PRT_RP
" " B-O O-PRT
experiments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
to B-O B-S_NP_VP_TO
define B-O B-VP_VB
the B-O B-NP_NP_DT
nature B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
higher B-O B-JJR
affinity B-O B-NN
CVZ B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
now B-O B-ADVP_RB
" " B-O O-ADVP
show B-O B-VP_VBP
that B-O B-SBAR_IN
: B-O B-COLON
1 B-O B-S_S_LST_LS
) B-O B-RRB
" " B-O O-LST
CVZ B-O B-NP_NN
" " B-O O-NP
has B-O B-VP_VBZ
more B-O B-NP_QP_JJR
than B-O B-IN
one B-O B-CD
" " B-O O-QP
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
, B-O B-ADJP_COMMA
B-cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
IM-9 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
2 B-O B-S_LST_LS
) B-O B-RRB
" " B-O O-LST
the B-O B-NP_DT
antiglucocorticoid B-O B-JJ
RU B-O B-NN
38486 B-O B-CD
" " B-O O-NP
is B-O B-VP_VBZ
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
3 B-O B-S_LST_LS
) B-O B-RRB
" " B-O O-LST
all B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
CVZ B-O B-NP_NN
's B-O B-POS
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
on B-O B-PP_IN
a B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
immunologically B-O B-ADJP_RB
indistinguishable B-O B-JJ
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
and B-O B-CC
4 B-O B-S_LST_LS
) B-O B-RRB
" " B-O O-LST
freshly B-O B-NP_NP_RB
isolated B-O B-VBN
clones B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
CVZ-resistant B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
lost B-O B-VP_VBN
all B-O B-NP_NP_DT
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
CVZ B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
recognizing B-O B-VP_VBG
two B-O B-NP_NP_CD
glucocorticoid B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-PRN_PRN_LRB
The B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
and B-O B-CC
HLA B-O B-NP_NN
antigens B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
pathogenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Cushing B-O B-NP_NN
's B-O B-POS
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-PRN
  
Lymphocytic B-O B-S_S_NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
evaluated B-O B-VP_VBN
in B-O B-NP_PP_IN
114 B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
suffering B-O B-VP_VBG
from B-O B-PP_IN
Icenko-Cushing B-O B-NP_NN
's B-O B-POS
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Incidence B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HLA B-O B-NP_NN
antigens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
determined B-O B-VP_VBN
in B-O B-NP_PP_IN
94 B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
them B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
significant B-O B-JJ
rise B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
A10 B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
B27 B-O B-NP_NN
antigen B-O B-NN
incidence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
compared B-O B-PP_VBN
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
in B-O B-PP_IN
normal B-O B-NP_JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
allows B-O B-VP_VBZ
these B-O B-S_NP_DT
antigens B-O B-NNS
" " B-O O-NP
to B-O B-VP_TO
be B-O B-VP_VB
considered B-O B-VP_VBN
genetic B-O B-S_NP_NP_NP_JJ
markers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
lower B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
in B-O B-PP_IN
normal B-O B-NP_JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
both B-O B-CC
in B-O B-PP_IN
the B-O B-NP_NP_NP_DT
active B-O B-JJ
stage B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
following B-O B-NP_VBG
bilateral B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
total B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
adrenalectomy B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
patients B-O B-NNS
" " B-O O-NP
carrying B-O B-VP_VBG
B27 B-O B-NP_NN
antigen B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
had B-O B-VP_VBD
lymphocytic B-O B-NP_NP_JJ
receptor B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
under B-O B-PP_IN
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
such B-O B-NP_NP_JJ
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_ADJP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Antigen B-O B-S_NP_NN
B27 B-O B-NN
" " B-O O-NP
seems B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
a B-O B-NP_NP_DT
cause B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lower B-O B-NP_NP_JJR
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Astrocytes B-O B-S_S_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
glioblastoma B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
express B-O B-VP_VBP
novel B-O B-NP_NP_JJ
octamer-DNA B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
distinct B-O B-ADJP_JJ
from B-O B-PP_IN
the B-O B-NP_DT
ubiquitous B-O B-JJ
Oct-1 B-O B-NN
and B-O B-CC
B B-O B-NN
cell B-O B-NN
type B-O B-NN
Oct-2 B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
' B-O B-LQT
octamer B-O B-NN
' B-O B-RQT
sequence B-O B-NN
" " B-O O-NP
, B-O B-COMMA
ATGCAAAT B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
its B-O B-NP_PRPP
complement B-O B-NN
ATTTGCAT B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
key B-O B-JJ
element B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
as B-O B-NP_NP_NP_PP_CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
octamer-binding B-O B-NP_NP_JJ
protein B-O B-NN
" " B-O O-NP
Oct-2A B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
variants B-O B-NP_NP_NNS
" " B-O O-NP
thereof B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
thought B-O B-VP_VBN
to B-O B-S_NP_VP_TO
contribute B-O B-VP_VB
to B-O B-PP_TO
the B-O B-NP_DT
B-cell B-O B-NN
specific B-O B-JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
while B-O B-SBAR_IN
the B-O B-S_NP_DT
ubiquitous B-O B-JJ
protein B-O B-NN
Oct-1 B-O B-NN
" " B-O O-NP
seems B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
control B-O B-VP_VB
general B-O B-NP_JJ
octamer B-O B-NN
site-dependent B-O B-JJ
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Various B-O B-S_NP_NP_JJ
other B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
for B-O B-PP_IN
example B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
interleukin-1 B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
" " B-O B-NP_O-NP
genes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
contain B-O B-VP_VP_VBP
an B-O B-NP_DT
octamer B-O B-NN
sequence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
are B-O B-VP_VBP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
the B-O B-DT
" " B-O B-NP_ADJP_NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
systems B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
prompted B-O B-VP_VBD
us B-O B-S_NP_PRP
" " B-O O-NP
to B-O B-VP_TO
analyze B-O B-VP_VB
the B-O B-NP_NP_DT
octamer-binding B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
latter B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
the B-O B-NP_DT
electrophoretic B-O B-JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
at B-O B-S_NP_QP_IN
least B-O B-JJS
six B-O B-CD
" " B-O O-QP
novel B-O B-JJ
octamer B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
cultured B-O B-NP_VBN
mouse B-O B-NN
astrocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
proteins B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
differentially B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_JJ
glioblastoma B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
neuroblastoma B-O B-NP_NN
" " B-O B-NP_O-NP
cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
nervous B-O B-JJ
system-derived B-O B-JJ
( B-O B-LRB
N-Oct B-O B-NN
) B-O B-RRB
proteins B-O B-NNS
" " B-O O-NP
bound B-O B-VP_VBD
to B-O B-PP_TO
the B-O B-NP_DT
octamer B-O B-NN
DNA B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_NP_DT
manner B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
indistinguishable B-O B-ADJP_JJ
from B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
relationship B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
N-Oct B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
Oct-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Oct-2A B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
analyzed B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
proteolytic B-O B-NP_JJ
clipping B-O B-JJ
bandshift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
by B-O B-PP_IN
their B-O B-NP_NP_PRPP
reactivity B-O B-NN
" " B-O O-NP
towards B-O B-PP_IN
antisera B-O B-NP_NP_NNS
" " B-O O-NP
raised B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-NP_NP_DT
basis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
all B-O B-NP_DT
N-Oct-factors B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
distinct B-O B-ADJP_JJ
from B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
melanoma B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contain B-O B-S_NP_VP_VBP
the B-O B-NP_DT
N-Oct-3 B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-S_S_NP_DT
transfected B-O B-VBN
lymphocyte-specific B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
neither B-O B-CC
activated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
nor B-O B-CC
was B-O B-SINV_VBD
it B-O B-NP_PRP
" " B-O O-NP
repressed B-O B-VP_VBN
upon B-O B-NP_PP_IN
contransfection B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
an B-O B-NP_DT
Oct-2A B-O B-NN
expression B-O B-NN
vector B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-SINV
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
speculate B-O B-VP_VBP
that B-O B-SBAR_IN
N-Oct-3 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
other B-O B-NP_JJ
N-Oct B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
a B-O B-NP_DT
specific B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
gene B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Circadian B-O B-NP_NP_NP_NP_JJ
rhythm B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
their B-O B-NP_NP_PRPP
reactivity B-O B-NN
" " B-O O-NP
to B-O B-VP_TO
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
1 B-O B-S_S_LST_LS
) B-O B-RRB
" " B-O O-LST
There B-O B-NP_EX
" " B-O O-NP
exists B-O B-VP_VBZ
a B-O B-NP_NP_NP_NP_DT
CR B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
PMN B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_NP_DT
peak B-O B-NN
values B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
the B-O B-NP_NP_DT
trough B-O B-NN
values B-O B-NNS
" " B-O O-NP
between B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
difference B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
them B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
significant B-O B-ADJP_JJ
statistically B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
2 B-O B-S_LST_LS
) B-O B-RRB
" " B-O O-LST
The B-O B-NP_NP_DT
FI B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
chemotactic B-O B-JJ
migration B-O B-NN
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PMN B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
cortisol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
showed B-O B-VP_VBD
diurnal B-O B-NP_NP_JJ
changes B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
synchronous B-O B-ADJP_JJ
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
indicates B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
CR B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
of B-O B-PP_IN
functional B-O B-NP_JJ
significance B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
3 B-O B-S_LST_LS
) B-O B-RRB
" " B-O O-LST
In B-O B-PP_IN
Cushing B-O B-NP_NN
's B-O B-POS
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
CR B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
normal B-O B-ADJP_JJ
in B-O B-PP_IN
spite B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
fact B-O B-NN
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
indicates B-O B-VP_VBZ
the B-O B-NP_NP_DT
independency B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
CR B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
cortisol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
4 B-O B-S_LST_LS
) B-O B-RRB
" " B-O O-LST
In B-O B-PP_IN
apoplexy B-O B-NP_NP_NN
" " B-O O-NP
caused B-O B-VP_VBN
by B-O B-NP_PP_IN
brain B-O B-NP_NN
ischemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
CR B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
abolished B-O B-VP_VP_VBN
in B-O B-NP_PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
basal B-O B-NP_JJ
lesions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CC
preserved B-O B-ADJP_JJ
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
lesions B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
located B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
main B-O B-JJ
"""" B-O B-LQT
circadian B-O B-JJ
pacemaker B-O B-NN
"""" B-O B-RQT
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
located B-O B-ADJP_JJ
in B-O B-PP_PP_IN
the B-O B-NP_DT
basal B-O B-JJ
brain B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
most B-O B-ADVP_RBS
probably B-O B-RB
" " B-O O-ADVP
in B-O B-PP_IN
the B-O B-NP_DT
suprachiasmatic B-O B-JJ
nuclei B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
as B-O B-SBAR_IN
has B-O B-S_NP_VP_VBZ
been B-O B-VP_VBN
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Progesterone B-O B-S_S_NP_NP_NN
suppression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
pregnancy B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
glucocorticoid B-O B-NP_NN
effect B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_S_NP_DT
study B-O B-NN
" " B-O O-NP
investigated B-O B-VP_VBD
whether B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
suppressive B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
progesterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
pregnancy B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
specific B-O B-NP_JJ
progesterone B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_NP_DT
competitive B-O B-JJ
progesterone B-O B-NN
antagonist B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RU486 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
specific B-O B-JJ
glucocorticoid B-O B-NN
receptor B-O B-NN
blocker B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RU43044 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
tested B-O B-VP_VBN
on B-O B-NP_PP_IN
the B-O B-NP_NP_DT
release B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
blocking B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
progesterone-treated B-O B-NP_JJ
pregnancy B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
RU B-O B-S_NP_NP_NN
486 B-O B-CD
" " B-O O-NP
tested B-O B-VP_VBN
at B-O B-NP_PP_IN
an B-O B-NP_NP_DT
equal B-O B-JJ
concentration B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
progesterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
significantly B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
blocking B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
while B-O B-SBAR_IN
RU B-O B-S_NP_NN
43044 B-O B-CD
" " B-O O-NP
was B-O B-VP_VBD
without B-O B-PP_IN
effect B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
in B-O B-S_PP_IN
pregnancy B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
lymphocyte B-O B-S_S_NP_NN
progesterone B-O B-NN
" " B-O O-NP
acts B-O B-VP_VBZ
on B-O B-PP_IN
specific B-O B-NP_JJ
progesterone B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
glucocorticoid B-O B-S_NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
involved B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cloning B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
mitogen-inducible B-O B-JJ
gene B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
a B-O B-NP_DT
kappa B-O B-NN
B B-O B-NN
DNA-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-VP
with B-O B-PP_IN
homology B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_PP_TO
the B-O B-NP_DT
rel B-O B-NN
oncogene B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
to B-O B-PP_TO
cell-cycle B-O B-NP_JJ
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
cloned B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
characterized B-O B-VP_VBN
" " B-O B-NP_O-VP
a B-O B-NP_NP_DT
mitogen-inducible B-O B-JJ
gene B-O B-NN
" " B-O O-NP
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
predicts B-O B-S_NP_VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
amino-terminal B-O B-JJ
domain B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
regions B-O B-NP_NP_NNS
" " B-O O-NP
homologous B-O B-ADJP_JJ
to B-O B-PP_PP_TO
the B-O B-NP_DT
oncogene B-O B-NN
rel B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
to B-O B-PP_TO
the B-O B-NP_NP_DT
developmentally B-O B-ADJP_RB
important B-O B-JJ
" " B-O O-ADJP
gene B-O B-NN
dorsal B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Drosophila B-O B-NP_FW
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
carboxy-terminal B-O B-JJ
domain B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
repeat B-O B-NP_NP_NN
structures B-O B-NNS
" " B-O O-NP
found B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
proteins B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
involved B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
and B-O B-NP_CC
in B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
truncated B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
product B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_NP_DT
gene B-O B-NN
" " B-O O-NP
translated B-O B-VP_VBN
in B-O B-NP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
DNA-binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
interacts B-O B-S_NP_VP_VBZ
specifically B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
the B-O B-NP_NP_DT
kappa B-O B-NN
B B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
found B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
gene B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
yet B-O B-NP_RB
another B-O B-DT
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
growing B-O B-VBG
list B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
important B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
regulatory B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
molecules B-O B-NNS
whose B-O B-SBAR_WHNP_WPP
expression B-O B-NN
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-ADVP_VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
double-stranded B-O B-NP_JJ
phosphorothioate B-O B-NN
oligonucleotides B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Alteration B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_JJ
transcriptional B-O B-JJ
regulatory B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
necessary B-O B-ADJP_JJ
for B-O B-PP_IN
determining B-O B-S_NP_VP_VBG
how B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
functions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
antagonized B-O B-VP_VBN
by B-O B-NP_PP_IN
several B-O B-NP_NP_JJ
methods B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
each B-O B-NP_NP_DT
" " B-O O-NP
with B-O B-PP_IN
specific B-O B-NP_JJ
limitations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
sequence-specific B-O B-NP_JJ
DNA-binding B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
achieved B-O B-VP_VBN
with B-O B-NP_PP_IN
double-stranded B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
ds B-O B-ADJP_JJ
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
phosphorothioate B-O B-NN
oligonucleotides B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contained B-O B-S_NP_VP_VBD
or B-O B-NP_NP_CC
" " B-O B-NP_NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
phosphorothioate B-O B-NN
oligonucleotides B-O B-NNS
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
bound B-O B-VP_VBD
either B-O B-NP_CC
octamer B-O B-NP_NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
or B-O B-CC
nuclear B-O B-NP_JJ
factor B-O B-NN
( B-O B-LRB
NF B-O B-NN
) B-O B-RRB
-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
modified B-O B-VBN
oligonucleotides B-O B-NNS
" " B-O O-NP
accumulated B-O B-VP_VBD
in B-O B-PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
more B-O B-ADVP_ADVP_RBR
effectively B-O B-RB
" " B-O O-ADVP
than B-O B-SBAR_IN
standard B-O B-S_NP_NP_JJ
ds B-O B-JJ
oligonucleotides B-O B-NNS
" " B-O O-NP
and B-O B-CC
modulated B-O B-NP_VBD
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-VP_PP_IN
a B-O B-NP_DT
specific B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Octamer-dependent B-O B-S_NP_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
reporter B-O B-NN
plasmid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
or B-O B-CC
NF-kappa B-O B-NP_NP_NN
B-dependent B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
( B-O B-LRB
HIV B-O B-NN
) B-O B-RRB
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
" " B-O B-NP_O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
appropriate B-O B-JJ
phosphorothioate B-O B-NN
oligonucleotide B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
added B-O B-VP_VBN
to B-O B-NP_PP_TO
a B-O B-NP_DT
transiently B-O B-RB
transfected B-O B-VBN
B B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Addition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
phosphorothioate B-O B-NP_NP_NN
oligonucleotides B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contained B-O B-S_NP_VP_VBD
the B-O B-NP_DT
octamer B-O B-NN
consensus B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
Jurkat B-O B-NP_NN
T B-O B-NN
leukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibited B-O B-VP_VBD
interleukin-2 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
secretion B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_NP_DT
degree B-O B-NN
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
observed B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
ds B-O B-JJ
phosphorothioate B-O B-NN
oligonucleotides B-O B-NNS
" " B-O O-NP
probably B-O B-ADVP_RB
" " B-O O-ADVP
compete B-O B-VP_VP_VBP
for B-O B-PP_IN
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
may B-O B-VP_MD
provide B-O B-VP_VB
anti-viral B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
immunosuppressive B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
or B-O B-CC
other B-O B-NP_JJ
therapeutic B-O B-JJ
" " B-O B-NP_O-NP
effects B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-PRN_PRN_LRB
The B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
24,25-dihydroxyvitamin B-O B-NP_NP_NN
D3 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
dioxyvit B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
Ca B-O B-NP_NP_NN
metabolism B-O B-NN
" " B-O O-NP
and B-O B-CC
immune B-O B-NP_JJ
status B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
chronic B-O B-NP_JJ
kidney B-O B-NN
failure B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-PRN
  
Active B-O B-S_S_NP_NP_JJ
metabolite B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
vitamin B-O B-NP_NP_NN
D3 B-O B-NN
, B-O B-COMMA
"24R,25 (OH)2D3" B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
dioxyvit B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
at B-O B-NP_PP_IN
a B-O B-NP_NP_DT
daily B-O B-JJ
dose B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
100 B-O B-NP_CD
micrograms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
children B-O B-NP_NP_NNS
" " B-O O-NP
affected B-O B-VP_VBN
" " B-O B-NP_PP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_DT
drug B-O B-NN
" " B-O O-NP
exhibited B-O B-VP_VBD
distinct B-O B-NP_JJ
normalizing B-O B-NN
effect B-O B-NN
" " B-O B-NP_O-NP
on B-O B-PP_IN
patterns B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
calcium B-O B-NP_NN
metabolism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
increase B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_PP_IN
total B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
ionized B-O B-NP_VBN
" " B-O B-NP_O-NP
Ca2+ B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
of B-O B-PP_IN
25-OHD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
decrease B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
concentration B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
parath B-O B-NP_NP_NN
hormone B-O B-NN
" " B-O O-NP
and B-O B-CC
osteocalcine B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
blood B-O B-NP_NN
serum B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
on B-O B-PP_IN
immunological B-O B-NP_JJ
parameters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
: B-O B-COLON
" " B-O O-NP
restoration B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
decreased B-O B-NP_NP_VBN
content B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T- B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
0-lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
Concentration B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
receptors B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
hormonal B-O B-NP_NP_JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
minimal B-O B-ADJP_JJ
in B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
under B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
while B-O B-SBAR_IN
their B-O B-S_NP_PRPP
expression B-O B-NN
, B-O B-COMMA
" " B-O O-NP
after B-O B-PP_IN
the B-O B-NP_DT
dioxyvit B-O B-NN
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
was B-O B-VP_VBD
detected B-O B-VP_VBN
only B-O B-NP_PP_ADVP_RB
" " B-O O-ADVP
in B-O B-IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Specific B-O B-S_NP_NP_ADJP_JJ
calcitropic B-O B-JJ
" " B-O O-ADJP
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
dioxyvit B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
simultaneous B-O B-NP_NP_JJ
correction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
vitamin B-O B-NP_NN
D B-O B-NN
deficiency B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
apparently B-O B-ADJP_RB
responsible B-O B-JJ
for B-O B-PP_IN
high B-O B-NP_NP_JJ
efficacy B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
drug B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
calcium B-O B-NP_NP_NP_NN
metabolism B-O B-NN
" " B-O O-NP
and B-O B-CC
immunity B-O B-NP_NN
impairments B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Type-II B-O B-NP_NP_NP_NP_JJ
estrogen B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
lymphoblastoid B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
growth-inhibitory B-O B-NP_NP_JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
estrogen B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
anti-estrogen B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
bioflavonoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Type-II B-O B-S_S_NP_NP_JJ
estrogen-binding B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
type-II B-O B-NP_JJ
EBS B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
demonstrated B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
human B-O B-NP_NP_JJ
lymphoblastoid B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
IM-9 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
using B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
whole-cell B-O B-JJ
assay B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
( B-O B-NP_LRB
6,7-3H B-O B-NN
) B-O B-RRB
estradiol B-O B-NN
( B-O B-LRB
3H-E2 B-O B-NN
) B-O B-RRB
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-PP_IN
tracer B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Competition B-O B-S_NP_NN
analysis B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
anti-estrogen B-O B-JJ
tamoxifen B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
flavonoids B-O B-NNS
quercetin B-O B-NN
" " B-O O-NP
and B-O B-CC
rutin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
competed B-O B-VP_VBD
for B-O B-PP_IN
(3H)-E2 B-O B-NP_NP_NN
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
type-II B-O B-NP_JJ
EBS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Growth B-O B-S_NP_NN
experiments B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
diethylstilbestrol B-O B-S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
DES B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
tamoxifen B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
TAM B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
quercetin B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
rutin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
exerted B-O B-VP_VBD
a B-O B-NP_NP_DT
reversible B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
dose-dependent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
range B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
relative B-O B-JJ
binding B-O B-NN
affinity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
quercetin B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
rutin B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
DES B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
TAM B-O B-NP_NNP
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
type-II B-O B-NP_JJ
EBS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlated B-O B-VP_VBD
well B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
their B-O B-NP_PRPP
potency B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
cell B-O B-NP_NN
growth B-O B-NN
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
hesperidin B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
flavonoid B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
does B-O B-S_NP_VP_VBZ
not B-O B-RB
bind B-O B-VP_VB
to B-O B-PP_TO
type-II B-O B-NP_JJ
EBS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
ineffective B-O B-ADJP_JJ
in B-O B-PP_IN
inhibiting B-O B-S_NP_VP_VBG
cell B-O B-NP_NN
growth B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cell-cycle B-O B-S_NP_JJ
analysis B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
growth-inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DES B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
TAM B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
quercetin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
due B-O B-ADJP_JJ
to B-O B-PP_TO
a B-O B-NP_NP_DT
blocking B-O B-NN
effect B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
high B-O B-S_NP_NP_NP_JJ
estrogen B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
anti-estrogen B-O B-NP_JJ
" " B-O B-NP_O-NP
concentrations B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
flavonoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
regulate B-O B-VP_VB
IM-9 B-O B-NP_NN
cell B-O B-NN
growth B-O B-NN
" " B-O O-NP
through B-O B-PP_IN
a B-O B-NP_NP_DT
common B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
involving B-O B-VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Disruption B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
SCL B-O B-NN
locus B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
"""" B-O B-NP_LQT
illegitimate B-O B-JJ
"""" B-O B-RQT
V-(D)-J B-O B-NN
recombinase B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
A B-O B-S_S_NP_NP_DT
fusion B-O B-NN
complementary B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
T B-O B-NN
cell B-O B-NN
line B-O B-NN
HSB-2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
elucidates B-O B-VP_VBZ
a B-O B-NP_NP_DT
provocative B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
disruption B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_NP_NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
fusion B-O B-NN
cDNA B-O B-NN
" " B-O O-NP
results B-O B-VP_VBZ
from B-O B-PP_IN
an B-O B-NP_NP_DT
interstitial B-O B-JJ
deletion B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
a B-O B-NP_NP_NP_DT
previously B-O B-ADJP_RB
unknown B-O B-JJ
" " B-O O-ADJP
locus B-O B-NN
" " B-O O-NP
, B-O B-COMMA
SIL B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_NP_DT
5' B-O B-JJ
untranslated B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
SCL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_ADVP_JJ
to B-O B-PP_TO
1 B-O B-NP_CD
; B-O B-COLON
14 B-O B-CD
translocations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
, B-O B-COMMA
this B-O B-S_NP_DT
deletion B-O B-NN
" " B-O O-NP
disrupts B-O B-VP_VBZ
the B-O B-NP_DT
SCL B-O B-NN
5' B-O B-JJ
regulatory B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
event B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
probably B-O B-ADVP_RB
" " B-O O-ADVP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
V-(D)-J B-O B-NP_NN
recombinase B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
although B-O B-SBAR_IN
neither B-O B-S_NP_DT
locus B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
immunoglobulin B-O B-NN
" " B-O O-NP
or B-O B-CC
a B-O B-NP_DT
T B-O B-NN
cell B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_CD
other B-O B-JJ
T B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
CEM B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
RPMI B-O B-NP_NN
8402 B-O B-CD
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
have B-O B-VP_VBP
essentially B-O B-NP_ADJP_RB
identical B-O B-JJ
" " B-O O-ADJP
deletions B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
growth-affecting B-O B-NP_NP_JJ
genes B-O B-NNS
" " B-O O-NP
other B-O B-CONJP_JJ
than B-O B-IN
" " B-O O-CONJP
immune B-O B-NP_JJ
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
risk B-O B-VP_VBP
rearrangements B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Differences B-O B-NP_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
enhancers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
HIV-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
T B-O B-S_S_NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
results B-O B-VP_VP_VBZ
in B-O B-PP_IN
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
thought B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-NP_NP_VP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
sequences B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
respond B-O B-S_NP_VP_VBP
to B-O B-PP_TO
these B-O B-NP_DT
signaling B-O B-NN
events B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
are B-O B-VP_VP_VBP
found B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
long B-O B-NP_NP_JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
LTR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
comprise B-O B-VP_VBP
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contains B-O B-S_NP_VP_VBZ
two B-O B-NP_NP_CD
conserved B-O B-VBN
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
corresponding B-O B-JJ
region B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
second B-O B-JJ
AIDS B-O B-NN
retrovirus B-O B-NN
" " B-O O-NP
, B-O B-COMMA
HIV-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_NP_DT
conserved B-O B-VBN
" " B-O B-NP_O-NP
and B-O B-CC
a B-O B-NP_NP_DT
divergent B-O B-JJ
" " B-O B-NP_O-NP
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
HIV-1 B-O B-NN
LTR B-O B-NN
" " B-O O-NP
responds B-O B-VP_VBZ
better B-O B-ADVP_ADVP_JJR
" " B-O O-ADVP
than B-O B-SBAR_IN
the B-O B-S_NP_DT
HIV-2 B-O B-NN
LTR B-O B-NN
" " B-O O-NP
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-ADVP
to B-O B-PP_TO
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_NP_DT
qualitative B-O B-JJ
differences B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
reproduced B-O B-VP_VBN
" " B-O B-NP_O-VP
not B-O B-SBAR_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
HIV-1 B-O B-S_NP_NP_NN
" " B-O B-NP_O-NP
or B-O B-CC
HIV-2 B-O B-NP_NN
" " B-O B-NP_O-NP
enhancers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
placed B-O B-VP_VBN
upstream B-O B-NP_ADVP_RB
of B-O B-PP_IN
" " B-O B-NP_O-ADVP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
these B-O B-S_NP_DT
enhancers B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
switched B-O B-VP_VBN
between B-O B-NP_PP_IN
their B-O B-NP_PRPP
respective B-O B-JJ
LTR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_PP_TO
both B-O B-NP_NP_CC
conserved B-O B-VBN
sites B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NN
transcriptional B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
only B-O B-PP_ADVP_RB
" " B-O O-ADVP
to B-O B-TO
the B-O B-NP_NP_DT
single B-O B-JJ
conserved B-O B-VBN
site B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
HIV-2 B-O B-NN
transcriptional B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Instead B-O B-S_ADVP_RB
of B-O B-PP_IN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-S_NP_DT
activator B-O B-NN
protein B-O B-NN
3 B-O B-CD
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
divergent B-O B-JJ
site B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HIV-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
conclusion B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
HIV-1 B-O B-S_S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
HIV-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
differentially B-O B-ADVP_RB
" " B-O O-ADVP
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
this B-O B-S_NP_DT
difference B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
account B-O B-VP_VB
for B-O B-PP_IN
the B-O B-NP_NP_DT
longer B-O B-JJR
period B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
viral B-O B-NP_JJ
latency B-O B-NN
" " B-O O-NP
" " B-O O-PP
observed B-O B-VP_VBN
with B-O B-NP_PP_IN
than B-O B-NP_PP_IN
" " B-O B-PP_NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Synthesis B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
4,19-disubstituted B-O B-NP_NP_JJ
derivatives B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
DOC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Radioreceptor B-O B-NP_NP_NN
assay B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
some B-O B-NP_NP_DT
corticosteroid B-O B-NN
derivatives B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Several B-O B-S_S_NP_NP_ADJP_JJ
new B-O B-JJ
4,19-substituted B-O B-JJ
" " B-O O-ADJP
steroids B-O B-NNS
" " B-O O-NP
and B-O B-CC
previously B-O B-NP_ADVP_RB
" " B-O O-ADVP
synthesized B-O B-VBN
corticosteroids B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
assayed B-O B-VP_VBN
for B-O B-NP_PP_IN
affinity B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
type B-O B-NP_NP_NN
1 B-O B-CD
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
11 B-O B-S_NP_NP_CD
beta,19-epoxy-4,21-dihydroxypregn-4-ene-3,20-dione B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
2 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
hydrogenated B-O B-VP_VBN
with B-O B-NP_PP_IN
Pd-C B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
to B-O B-S_NP_VP_TO
yield B-O B-VP_VB
a B-O B-NP_NP_DT
mixture B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
all B-O B-NP_DT
four B-O B-CD
dihydro B-O B-NN
derivatives B-O B-NNS
5 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
and B-O B-NP_NP_NP_PRN_CC
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
With B-O B-S_PP_IN
hot B-O B-S_NP_ADJP_JJ
acetic B-O B-JJ
+ B-O B-CC
" " B-O O-ADJP
p-toluenesulfonic B-O B-JJ
acid B-O B-NN
5 B-O B-CD
" " B-O O-NP
underwent B-O B-VP_VBD
rearrangement B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
21-acetoxy-11 B-O B-NP_NP_NN
beta,19-epoxypregn-5-ene-4,20-dione B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
8 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
Pd-C B-O B-NP_NP_NN
hydrogenation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
3,21-diacetoxy-5 B-O B-NP_NP_NN
beta,19-cyclopregna-2,9(11)-diene-4,20-dione B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
10 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
gave B-O B-VP_VBD
3,21-diacetoxy-5 B-O B-NP_NP_NP_NN
beta,19-cyclopregn-5-ene-4,20-dione B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
11 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
9,11-dihydro B-O B-NN
derivative B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
latter B-O B-JJ
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
10 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
warm B-O B-NP_JJ
HCl B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
furnished B-O B-VP_JJ
19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione B-O B-NP_NN
(13) B-O B-CD
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Pd-C B-O B-S_NP_NP_NN
hydrogenation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_PRPP
diacetate B-O B-NN
14 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
afforded B-O B-VP_VBD
the B-O B-NP_NP_NP_DT
4,5-dihydro B-O B-NN
derivative B-O B-NN
"18, 19-chloro-21-acetoxypregn-9(11)-en-20-one" B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
15 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
its B-O B-NP_PRPP
4-acetoxy B-O B-NN
derivative B-O B-NN
16 B-O B-CD
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
3,4-diacetoxy B-O B-NN
derivative B-O B-NN
17 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
tested B-O B-S_NP_VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
radioreceptor B-O B-NN
assay B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
the B-O B-S_NP_DT
synthesized B-O B-VBN
compounds B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
only B-O B-NP_NP_ADJP_RB
low B-O B-JJ
" " B-O O-ADJP
relative B-O B-NP_NP_JJ
binding B-O B-NN
affinities B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
RBA B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
to B-O B-PP_TO
type B-O B-NP_NN
1 B-O B-CD
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
the B-O B-S_NP_DT
highest B-O B-JJS
" " B-O O-NP
being B-O B-VP_VBG
0.72 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
13 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
( B-O B-PRN_LRB
aldosterone B-O B-NP_NP_NN
" " B-O O-NP
= B-O B-ADJP_JJ
100 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
For B-O B-S_S_PP_IN
comparison B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
other B-O B-NP_NP_JJ
RBA B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
" " B-O B-NP_O-VP
" " B-O O-S
: B-O B-COLON
19-noraldosterone B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
20 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
18-deoxyaldosterone B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
5.8 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
18-deoxy-19-noraldosterone B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
4.7 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
18,21-anhydroaldosterone B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
0.37 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
17-isoaldosterone B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
7.6 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
apoaldosterone B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
4.3 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-S
[ B-O B-PRN_PRN_LRB
Effect B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
regimen B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
kidney-tonifying B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
qi-invigorating B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
aging B-O B-NP_NP_NN
changes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-PRN
  
The B-O B-S_S_NP_NP_DT
plasma B-O B-NN
cortisol B-O B-NN
concentration B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
sites B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GCR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
peripheral B-O B-JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
measured B-O B-VP_VBN
in B-O B-NP_PP_IN
32 B-O B-NP_NP_CD
healthy B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
aged B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
persons B-O B-NNS
" " B-O O-NP
and B-O B-CC
13 B-O B-NP_CD
young B-O B-JJ
adults B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
animal B-O B-NP_JJ
experiment B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
GCR B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
spleen B-O B-NP_NN
lymphocytic B-O B-JJ
cell B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
measured B-O B-VP_VBN
in B-O B-NP_PP_IN
18 B-O B-NP_NP_CD
aged B-O B-JJ
rats B-O B-NNS
" " B-O O-NP
and B-O B-CC
9 B-O B-NP_CD
young B-O B-JJ
rats B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
GCR B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADJP_ADJP_RB
lower B-O B-JJR
" " B-O O-ADJP
in B-O B-PP_IN
the B-O B-NP_DT
aged B-O B-JJ
persons B-O B-NP_NNS
" " B-O O-NP
or B-O B-CC
rats B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
than B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
while B-O B-SBAR_IN
the B-O B-S_NP_DT
plasma B-O B-NN
cortisol B-O B-NN
level B-O B-NN
" " B-O O-NP
did B-O B-VP_VBD
n't B-O B-RB
change B-O B-VP_VB
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
So B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
think B-O B-VP_VBP
that B-O B-SBAR_IN
GCR B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
more B-O B-ADJP_ADJP_RBR
sensitive B-O B-JJ
" " B-O O-ADJP
than B-O B-PP_IN
the B-O B-NP_DT
plasma B-O B-NN
cortisol B-O B-NN
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
reflect B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_PP_IN
the B-O B-NP_NP_DT
treatment B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
regimen B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Kidney-tonifying B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
Qi-invigorating B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-S_S_NP_NP_DT
GCR B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
aged B-O B-JJ
persons B-O B-NP_NNS
" " B-O O-NP
and B-O B-CC
rats B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
enhanced B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
in B-O B-S_PP_IN
this B-O B-NP_DT
way B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
aged B-O B-JJ
adrenal B-O B-JJ
cortex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
improved B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
An B-O B-NP_NP_NP_DT
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
globin B-O B-NN
gene B-O B-NN
switching B-O B-NN
model B-O B-NN
" " B-O O-NP
based B-O B-VP_VBN
on B-O B-NP_PP_IN
differentiated B-O B-NP_VBN
embryonic B-O B-JJ
stem B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
used B-O B-VP_VBD
mouse B-O B-NP_NN
embryonic B-O B-JJ
stem B-O B-NN
( B-O B-LRB
ES B-O B-NN
) B-O B-RRB
cells B-O B-NNS
" " B-O O-NP
to B-O B-S_NP_VP_TO
study B-O B-VP_VB
globin B-O B-NP_NN
gene B-O B-NN
expression B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
switching B-O B-NP_NN
" " B-O O-NP
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
ES-derived B-O B-S_NP_JJ
embryoid B-O B-JJ
bodies B-O B-NNS
" " B-O O-NP
express B-O B-VP_VBP
the B-O B-NP_NP_DT
full B-O B-JJ
complement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mouse B-O B-NP_NN
embryonic B-O B-JJ
globin B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
order B-O B-ADJP_ADJP_ADJP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
on B-O B-S_PP_IN
further B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_DT
switch B-O B-NN
" " B-O O-NP
occurs B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_DT
fetal/adult B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
erythroid-specific B-O B-NP_NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
NF-E1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_VP_TO
be B-O B-NP_VP_VB
expressed B-O B-VP_VBN
coordinately B-O B-NP_ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
from B-O B-PP_IN
these B-O B-NP_DT
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
ES B-O B-NN
cell B-O B-NN
system B-O B-NN
" " B-O O-NP
provides B-O B-VP_VBZ
a B-O B-NP_NP_DT
good B-O B-JJ
model B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHADVP_S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_NP_DT
human B-O B-JJ
epsilon- B-O B-NP_NN
" " B-O B-NP_NP_O-NP
or B-O B-CC
beta-globin B-O B-NP_NN
" " B-O B-NP_O-NP
genes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
driven B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
dominant B-O B-NP_NP_JJ
control B-O B-JJ
region B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
introduced B-O B-VP_VBN
into B-O B-NP_PP_IN
this B-O B-NP_DT
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_DT
human B-O B-JJ
epsilon-globin B-O B-NN
gene B-O B-NN
, B-O B-COMMA
" " B-O O-NP
in B-O B-PP_IN
contrast B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
beta-globin B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
is B-O B-VP_VP_VBZ
not B-O B-RB
deregulated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
DCR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
strictly B-O B-NP_ADVP_RB
" " B-O O-ADVP
as B-O B-PP_IN
an B-O B-NP_DT
embryonic B-O B-JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
from B-O B-PP_IN
this B-O B-NP_DT
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
epsilon-globin B-O B-NN
gene B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
competition B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Functional B-O B-NP_NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cis-linked B-O B-NP_NP_JJ
regulatory B-O B-JJ
sequences B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
HLA B-O B-NN
DRA B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Two B-O B-S_S_NP_NP_CD
consensus B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
called B-O B-VP_VBN
X B-O B-S_NP_NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
Y B-O B-NP_NN
" " B-O B-NP_O-NP
boxes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
capable B-O B-ADJP_JJ
of B-O B-PP_IN
binding B-O B-S_NP_VP_VP_VBG
nuclear B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
regulating B-O B-VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
defined B-O B-VP_VBN
within B-O B-NP_PP_IN
the B-O B-NP_NP_DT
immediate B-O B-ADJP_JJ
upstream B-O B-JJ
" " B-O O-ADJP
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
major B-O B-NP_JJ
histocompatibility B-O B-NN
complex B-O B-NN
( B-O B-LRB
MHC B-O B-NN
) B-O B-RRB
class B-O B-NN
II B-O B-CD
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Unlike B-O B-S_PP_IN
other B-O B-NP_JJ
class B-O B-NN
II B-O B-CD
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
HLA-DR B-O B-NN
alpha B-O B-NN
( B-O B-LRB
DRA B-O B-NN
) B-O B-RRB
promoter B-O B-NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
contains B-O B-VP_VBZ
one B-O B-NP_NP_CD
element B-O B-NN
" " B-O O-NP
identical B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
"""" B-O B-LQT
octamer B-O B-NN
"""" B-O B-RQT
motif B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immunoglobulin B-O B-NP_NN
variable B-O B-JJ
region B-O B-NN
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
B B-O B-NP_NN
cell-specific B-O B-JJ
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_DT
"""" B-O B-LQT
octamer B-O B-NN
"""" B-O B-RQT
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
context B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DRA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
appears B-O B-VP_VBZ
capable B-O B-ADJP_JJ
of B-O B-PP_IN
binding B-O B-S_NP_VP_VBG
both B-O B-NP_CC
the B-O B-NP_DT
" " B-O B-ADJP_PRN_NP_O-NP
and B-O B-CC
lymphoid-specific B-O B-NP_JJ
( B-O B-LRB
OTF-2 B-O B-NN
) B-O B-RRB
"""" B-O B-LQT
octamer B-O B-NN
"""" B-O B-RQT
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
at B-O B-S_NP_QP_IN
least B-O B-JJS
one B-O B-CD
" " B-O O-QP
other B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
distinct B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
"""" B-O B-LQT
octamer B-O B-NN
"""" B-O B-RQT
complex B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_SBAR_IN
order B-O B-NN
to B-O B-S_NP_VP_TO
characterize B-O B-VP_VB
the B-O B-NP_NP_DT
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cis-acting B-O B-NP_JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
developed B-O B-VP_VBN
an B-O B-NP_NP_DT
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
system B-O B-NN
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
a B-O B-S_NP_DT
DRA B-O B-NN
promoter B-O B-NN
construct B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
transcribed B-O B-VP_VBN
" " B-O B-NP_ADVP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
5' B-O B-S_S_NP_NP_JJ
deletion B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
lacked B-O B-S_NP_VP_VP_VBD
the B-O B-NP_DT
Y B-O B-NN
box B-O B-NN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
retained B-O B-VP_VBD
the B-O B-NP_NP_DT
"""" B-O B-LQT
octamer B-O B-NN
"""" B-O B-RQT
motif B-O B-NN
" " B-O O-NP
and B-O B-CC
TATA B-O B-NP_NN
box B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
were B-O B-VP_VBD
completely B-O B-ADJP_RB
inactive B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
internal B-O B-S_NP_NP_JJ
deletion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Y B-O B-NN
box B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reduced B-O B-VP_VBD
transcription B-O B-NP_NN
" " B-O O-NP
by B-O B-PP_IN
95 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
supercoiled B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
linear B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
templates B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
differences B-O B-NP_NNS
" " B-O O-NP
in B-O B-PP_IN
transcription B-O B-NP_NP_NN
efficiencies B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
templates B-O B-NP_NP_NNS
" " B-O O-NP
lacking B-O B-VP_VP_VBG
" " B-O B-NP_O-VP
or B-O B-CC
disrupting B-O B-VP_VBG
" " B-O B-NP_O-VP
the B-O B-NP_DT
X B-O B-NN
consensus B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
reflect B-O B-S_NP_VP_VBP
in B-O B-NP_NP_PP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Demonstration B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
complete B-O B-JJ
dependence B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
Y B-O B-NN
box B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
this B-O B-NP_DT
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
, B-O B-S_COMMA
despite B-O B-PP_IN
its B-O B-NP_NP_PRPP
demonstrated B-O B-VBN
importance B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
DRA B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
DRA B-O B-NN
"""" B-O B-LQT
octamer B-O B-NN
"""" B-O B-RQT
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
utilize B-O B-VP_VB
OTF-2 B-O B-NP_NNP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
manner B-O B-NN
" " B-O O-NP
analogous B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Oestrogen B-O B-NP_NP_NP_NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ER B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
analysis B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
B-cell B-O B-NP_NN
chronic B-O B-JJ
lymphocytic B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
correlation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
biochemical B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
immunocytochemical B-O B-NP_JJ
" " B-O B-NP_O-NP
methods B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Oestrogen B-O B-S_S_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
ER B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
are B-O B-VP_VP_VBP
present B-O B-ADJP_JJ
in B-O B-PP_IN
neoplastic B-O B-NP_JJ
lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
have B-O B-VP_VBP
been B-O B-VP_VBN
considered B-O B-VP_VBN
a B-O B-NP_NP_NP_DT
physiological B-O B-JJ
marker B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Tamoxifen B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_DT
oestrogen B-O B-NN
antagonist B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
given B-O B-VP_VBN
in B-O B-NP_PP_IN
some B-O B-NP_NP_DT
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
CLL B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Hodgkin B-O B-NP_NN
's B-O B-POS
disease B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
with B-O B-PP_IN
dramatic B-O B-NP_NP_JJ
response B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
single B-O B-NP_JJ
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Until B-O B-S_PP_IN
now B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
ER B-O B-NP_NN
status B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
assessed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
using B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
steroid B-O B-NP_NP_NN
binding B-O B-NN
assay B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
SBA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
has B-O B-S_NP_VP_VBZ
many B-O B-NP_JJ
inherent B-O B-JJ
problems B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recently B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
development B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
monoclonal B-O B-NP_NP_JJ
antibodies B-O B-NNS
" " B-O O-NP
directed B-O B-VP_VBN
against B-O B-NP_PP_IN
ER B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
applied B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
study B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
breast B-O B-NP_NN
carcinomas B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
results B-O B-S_NP_NP_NNS
" " B-O O-NP
obtained B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
show B-O B-VP_VBP
good B-O B-NP_NP_JJ
correlation B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
quantitative B-O B-JJ
SBA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
49 B-O B-NP_NP_CD
cases B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
B-cell B-O B-NP_NN
chronic B-O B-NP_NP_JJ
lymphocytic B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CLL B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
using B-O B-S_NP_VP_VBG
immunostaining B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cytospin B-O B-NP_NN
preparations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
30 B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
ER B-O B-NP_NP_NN
enzyme B-O B-NN
immunoassay B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ER-EIA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
performed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cultured B-O B-S_NP_NP_VBN
MCF-7 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
derived B-O B-VP_VP_VBN
from B-O B-NP_PP_IN
a B-O B-NP_NP_DT
pleural B-O B-JJ
effusion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
breast B-O B-NN
cancer B-O B-NN
patient B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
contain B-O B-VP_VB
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_NP_DT
positive B-O B-JJ
control B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ER B-O B-NP_NP_NP_ADJP_NN
positive B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_O-NP
; B-O B-COLON
protein B-O B-NP_NP_ADJP_NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_S_NP_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CLL B-O B-NN
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
except B-O B-PP_IN
two B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
96 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
were B-O B-VP_VBD
negative B-O B-ADJP_JJ
for B-O B-PP_IN
ER B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
less B-O B-ADJP_ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
1 B-O B-NP_ADJP_CD
% B-O B-NN
" " B-O O-ADJP
staining B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
; B-O B-COLON
less B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
4 B-O B-NP_ADJP_CD
fmol/mg B-O B-NN
" " B-O O-ADJP
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
two B-O B-CD
positive B-O B-JJ
cases B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VP_VBD
granular B-O B-NP_JJ
ER B-O B-NN
staining B-O B-NN
" " B-O O-NP
over B-O B-PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
9.2 B-O B-NP_NP_ADJP_QP_CD
and B-O B-CC
12.1 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-ADJP
" " B-O O-NP
positive B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
and B-O B-CC
were B-O B-VP_VBD
positive B-O B-ADJP_JJ
by B-O B-PP_IN
EIA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
SBA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
concluded B-O B-VP_VBN
that B-O B-SBAR_IN
( B-O B-S_S_LST_LRB
i B-O B-LS
) B-O B-RRB
" " B-O O-LST
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
CLL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
rarely B-O B-ADVP_RB
" " B-O O-ADVP
express B-O B-VP_VBP
ER B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
( B-O B-S_LST_LRB
ii B-O B-LS
) B-O B-RRB
" " B-O O-LST
immunocytochemical B-O B-NP_NP_JJ
staining B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytospin B-O B-NP_NN
preparations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
valid B-O B-JJ
technique B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
of B-O B-PP_IN
interest B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
one B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
positive B-O B-JJ
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
diagnosed B-O B-VP_VBN
as B-O B-NP_PP_IN
CLL B-O B-NP_NP_NNP
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Thyroid B-O B-S_S_NP_NN
hormone B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
form B-O B-VP_VBP
distinct B-O B-NP_ADJP_JJ
" " B-O O-ADJP
nuclear B-O B-JJ
protein-dependent B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
independent B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
complexes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_DT
thyroid B-O B-NN
hormone B-O B-NN
response B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
and B-O B-CC
recombinant B-O B-NP_NP_JJ
thyroid B-O B-NN
hormone B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
( B-O B-NP_NP_NP_NP_PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
using B-O B-S_NP_VP_VBG
a B-O B-NP_DT
gel B-O B-NN
electrophoretic B-O B-JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Four B-O B-S_NP_CD
specific B-O B-JJ
protein-DNA B-O B-JJ
complexes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
after B-O B-NP_PP_IN
incubation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
from B-O B-PP_IN
T3-responsive B-O B-NP_JJ
pituitary B-O B-NN
( B-O B-LRB
GH3 B-O B-NN
) B-O B-RRB
cells B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
was B-O B-VP_VBD
compared B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
TREp B-O B-NN
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
reticulocyte B-O B-NP_NN
lysate-synthesized B-O B-JJ
TRs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TR B-O B-S_NP_NP_NP_NN
alpha B-O B-NN
1 B-O B-CD
" " B-O O-NP
and B-O B-CC
TR B-O B-NP_NN
beta B-O B-NN
2 B-O B-CD
" " B-O O-NP
" " B-O O-NP
each B-O B-DT
" " B-O O-NP
formed B-O B-VP_VBD
a B-O B-NP_NP_DT
single B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
major B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
TR B-O B-NN
: B-O B-COLON
TREp B-O B-NN
complex B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
comigrated B-O B-S_NP_VP_VBD
with B-O B-PP_IN
the B-O B-NP_NP_DT
complex B-O B-ADVP_NN
" " B-O O-NP
formed B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
while B-O B-SBAR_IN
TR B-O B-S_NP_NN
beta B-O B-NN
1 B-O B-CD
" " B-O O-NP
formed B-O B-VP_VBD
multiple B-O B-NP_JJ
complexes B-O B-NNS
" " B-O O-NP
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
coincubation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
35S-TR B-O B-NP_NP_NN
alpha B-O B-NN
1 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
GH3 B-O B-NP_NN
NE B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
unlabeled B-O B-NP_JJ
TREp B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_PP_IN
not B-O B-CONJP_RB
only B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
35S-TR B-O B-NN
: B-O B-COLON
TREp B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
in B-O B-PP_IN
two B-O B-NP_NP_CD
additional B-O B-ADJP_JJ
" " B-O O-ADJP
more B-O B-ADVP_RBR
greatly B-O B-RB
" " B-O O-ADVP
retarded B-O B-VBN
complexes B-O B-NNS
" " B-O O-NP
containing B-O B-VP_VP_VBG
35S-TR B-O B-NP_NN
alpha B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
comigrating B-O B-VP_VBG
with B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Incubation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
each B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
TRs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
NE B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
COS-7 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
do B-O B-S_NP_VP_VBP
not B-O B-RB
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
formation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
new B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
more B-O B-ADVP_RBR
" " B-O O-ADVP
greatly B-O B-RB
shifted B-O B-VBN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
similar B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
heat B-O B-ADJP_NN
labile B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
altered B-O B-S_NP_VP_VBD
mobility B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TR B-O B-NN
: B-O B-COLON
TRE B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
present B-O B-ADJP_JJ
in B-O B-PP_IN
NE B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
T3-unresponsive B-O B-NP_JJ
JEG-3 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
At B-O B-S_PP_IN
high B-O B-NP_NP_JJ
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NE B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
all B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TR B-O B-NN
" " B-O O-NP
" " B-O O-PP
bound B-O B-VP_VBN
to B-O B-NP_PP_TO
TREp B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
more B-O B-ADVP_JJR
greatly B-O B-RB
" " B-O O-ADVP
retarded B-O B-VP_VBN
than B-O B-NP_PP_IN
in B-O B-PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NE B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Truncation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
TR B-O B-NP_NN
alpha B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
amino B-O B-NP_NN
acid B-O B-NN
210 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
prevented B-O B-VP_VBD
additional B-O B-NP_JJ
complex B-O B-NN
formation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NE B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
without B-O B-PP_IN
affecting B-O B-S_NP_VP_VBG
DNA B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
carboxyl-terminus B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TRs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
[ B-O B-PRN_PRN_LRB
Glucocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
bronchial B-O B-NP_JJ
asthma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-PRN
  
Quantitation B-O B-S_S_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
GCR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
study B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
their B-O B-NP_NP_PRPP
affinity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
glucocorticosteroids B-O B-NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
made B-O B-VP_VBN
in B-O B-NP_PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NP_PRN_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
consideration B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
GCR B-O B-NP_NP_NN
treatment B-O B-NN
" " B-O O-NP
and B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
stated B-O B-VP_VBN
that B-O B-SBAR_IN
GCR B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
healthy B-O B-NP_NP_JJ
controls B-O B-NNS
" " B-O O-NP
and B-O B-CC
GCS-untreated B-O B-NP_JJ
patients B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
outnumbered B-O B-VP_VBD
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Following B-O B-S_NP_NP_VBG
discontinuation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
drugs B-O B-NNS
GCR B-O B-NN
count B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cortisol-dependent B-O B-NP_JJ
BA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
tends B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
rise B-O B-VP_VB
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Endogenous B-O B-S_NP_JJ
cortisol B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
GCR B-O B-NP_NP_NN
level B-O B-NN
" " B-O O-NP
estimated B-O B-VP_VBN
by B-O B-NP_PP_IN
3H-triamcinolone B-O B-NP_NN
acetonide B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Characterization B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
enhancer-binding B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
T-cell B-O B-NN
line B-O B-NN
" " B-O O-NP
Jurkat B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
under B-O B-PP_IN
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cellular B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Among B-O B-SINV_PP_IN
the B-O B-NP_NP_DT
protein-binding B-O B-JJ
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NP_NN
LTR B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
is B-O B-VP_VBZ
the B-O B-PP_NP_DT
transcription-enhancer B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-SINV
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
at B-O B-S_NP_NP_NP_QP_IN
least B-O B-JJS
one B-O B-CD
" " B-O O-QP
inducible B-O B-ADJP_NP_JJ
" " B-O O-NP
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
C1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
one B-O B-NP_CD
constitutive B-O B-NP_JJ
, B-O B-COMMA
C2 B-O B-NN
, B-O B-COMMA
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
bind B-O B-VP_VB
to B-O B-PP_TO
the B-O B-NP_NP_DT
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
two B-O B-CD
proteins B-O B-NNS
" " B-O O-NP
differ B-O B-VP_VBP
in B-O B-PP_IN
their B-O B-NP_PRPP
surface B-O B-NN
charge B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
since B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
are B-O B-VP_VBP
separable B-O B-ADJP_JJ
by B-O B-PP_IN
anion-exchange B-O B-NP_JJ
chromatography B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Bivalent B-O B-S_NP_NP_JJ
cations B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
Mg2+ B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Zn2+ B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
differentially B-O B-ADVP_RB
" " B-O O-ADVP
affect B-O B-VP_VBP
their B-O B-NP_NP_PRPP
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
oligonucleotides B-O B-NP_NP_NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contain B-O B-S_NP_VP_VBP
the B-O B-NP_DT
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
C1 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
C2 B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
bind B-O B-VP_VBP
to B-O B-PP_TO
a B-O B-NP_NP_DT
similar B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
found B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
interleukin-2-receptor B-O B-NP_NN
alpha-subunit B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
inducible B-O B-NP_JJ
C1 B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
partially B-O B-ADVP_RB
" " B-O O-ADVP
purified B-O B-VP_VP_VBN
by B-O B-NP_PP_IN
three B-O B-NP_CD
chromatographic B-O B-JJ
steps B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
u.v. B-O B-NP_NN
cross-linking B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_DT
47 B-O B-NP_CD
kDa B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_DT
ubiquitous B-O B-NP_JJ
octamer-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
is B-O B-VP_VBZ
sufficient B-O B-ADJP_JJ
for B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
immunoglobulin B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
All B-O B-S_S_NP_DT
immunoglobulin B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
contain B-O B-VP_VBP
a B-O B-NP_NP_NP_DT
conserved B-O B-VBN
octanucleotide B-O B-NP_NN
promoter B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
ATGCAAAT B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
has B-O B-S_NP_VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
" " B-O B-S_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Proteins B-O B-S_S_NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bind B-O B-S_NP_VP_VBP
this B-O B-NP_DT
octamer B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
purified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
cDNAs B-O B-S_NP_NP_NNS
" " B-O O-NP
encoding B-O B-VP_VBG
octamer-binding B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
cloned B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Some B-O B-S_NP_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
referred B-O B-VP_VBN
to B-O B-PP_TO
" " B-O B-NP_O-PP
as B-O B-PP_IN
OTF-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
are B-O B-VP_VBP
lymphoid B-O B-NP_JJ
specific B-O B-JJ
" " B-O O-NP
, B-O B-COMMA
whereas B-O B-SBAR_IN
at B-O B-S_NP_NP_NP_QP_IN
least B-O B-JJS
one B-O B-CD
" " B-O O-QP
other B-O B-JJ
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
possibly B-O B-ADVP_RB
" " B-O O-ADVP
more B-O B-NP_JJR
" " B-O B-NP_O-NP
" " B-O O-NP
( B-O B-PRN_LRB
referred B-O B-VP_VBN
to B-O B-PP_TO
" " B-O B-NP_O-PP
as B-O B-PP_IN
OTF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-PRN
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
found B-O B-VP_VBN
ubiquitously B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
all B-O B-NP_DT
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
exact B-O B-JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
different B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
directing B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
tissue-specific B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immunoglobulin B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
unclear B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
two B-O B-NP_NP_CD
human B-O B-NP_JJ
pre-B-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contain B-O B-S_NP_VP_VP_VBP
" " B-O B-NP_NP_PP_O-VP
yet B-O B-CC
still B-O B-RB
express B-O B-VP_VP_VBP
and B-O B-NP_ADVP_CC
efficiently B-O B-ADVP_RB
" " B-O O-ADVP
transcribe B-O B-VP_VBP
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Addition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
highly B-O B-ADJP_RB
enriched B-O B-JJ
" " B-O O-ADJP
preparation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
OTF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
made B-O B-VP_VBN
from B-O B-NP_PP_PP_IN
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
or B-O B-CC
from B-O B-PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
stimulated B-O B-VP_VBD
in B-O B-NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
immunoglobulin B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
OFT-1 B-O B-NP_NN
" " B-O O-NP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
approximately B-O B-NP_NP_RB
the B-O B-DT
same B-O B-JJ
transactivation B-O B-NN
ability B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
OTF-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
normalized B-O B-S_NP_VP_VBN
for B-O B-NP_PP_IN
binding B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
OTF-1 B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
without B-O B-PP_IN
OTF-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
sufficient B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
OTF-2 B-O B-S_NP_NP_NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Perceived B-O B-NP_NP_NP_NP_VBN
social B-O B-JJ
support B-O B-NN
" " B-O O-NP
and B-O B-CC
tumor B-O B-NP_NP_NN
estrogen/progesterone B-O B-NP_JJ
receptor B-O B-NN
" " B-O O-NP
status B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
as B-O B-PP_IN
predictors B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
natural B-O B-NP_NP_NP_JJ
killer B-O B-NN
cell B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
breast B-O B-NP_NN
cancer B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
This B-O B-S_S_NP_DT
report B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
concerned B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
prediction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
natural B-O B-NP_NP_JJ
activity B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
All B-O B-S_NP_DT
baseline B-O B-NP_NN
interview B-O B-NN
" " B-O O-NP
and B-O B-CC
testing B-O B-NP_NN
data B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
obtained B-O B-VP_VBN
either B-O B-NP_UCP_CC
just B-O B-SBAR_RB
before B-O B-IN
patients B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
discharged B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-UCP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
or B-O B-CC
at B-O B-PP_IN
their B-O B-NP_NP_PRPP
first B-O B-JJ
outpatient B-O B-JJ
visit B-O B-NN
" " B-O O-NP
, B-O B-COMMA
within B-O B-PP_IN
two B-O B-NP_NP_CD
weeks B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
discharge B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
major B-O B-JJ
interest B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
project B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_NP_DT
predictive B-O B-JJ
value B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
perceived B-O B-NP_VBN
social B-O B-JJ
support B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
as B-O B-PP_IN
a B-O B-NP_DT
potential B-O B-JJ
"""" B-O B-LQT
stress B-O B-NN
"""" B-O B-RQT
buffer B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
related B-O B-VP_VBN
to B-O B-NP_PP_TO
NK B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
main B-O B-JJ
model B-O B-NN
" " B-O O-NP
reported B-O B-VP_VBN
here B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
significant B-O B-JJ
amount B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NK B-O B-NP_NN
activity B-O B-NN
variance B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
explained B-O B-VP_VBN
by B-O B-NP_PP_IN
five B-O B-NP_CD
variables B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Higher B-O B-S_S_NP_JJR
NK B-O B-NN
activity B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
predicted B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-UCP_NP_NP_DT
perception B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
perceived B-O B-NP_NP_VBN
social B-O B-JJ
support B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
estrogen B-O B-NP_ADJP_NN
receptor-negative B-O B-JJ
" " B-O O-ADJP
tumor B-O B-NN
status B-O B-NN
" " B-O O-NP
, B-O B-COMMA
having B-O B-S_NP_VP_VBG
" " B-O B-NP_PP_O-S
, B-O B-COMMA
and B-O B-CC
actively B-O B-S_ADVP_RB
" " B-O O-ADVP
seeking B-O B-NP_VP_VBG
" " B-O B-NP_PP_O-S
" " B-O O-UCP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
R2 B-O B-NP_NP_NP_NN
" " B-O O-NP
= B-O B-ADJP_JJ
0.33 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
, B-O B-COMMA
F B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
5 B-O B-QP_CD
, B-O B-COMMA
55 B-O B-CD
" " B-O O-QP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
= B-O B-ADJP_JJ
5.5 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
, B-O B-COMMA
p B-O B-NP_NP_NN
" " B-O O-NP
less B-O B-ADJP_JJR
than B-O B-PP_IN
0.0004 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
  
Findings B-O B-S_NP_NNS
" " B-O O-NP
are B-O B-VP_VBP
discussed B-O B-VP_VBN
in B-O B-NP_PP_IN
terms B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
host B-O B-NP_NP_NP_NN
interaction B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Tax-independent B-O B-NP_NP_NP_JJ
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
multiple B-O B-NP_JJ
cellular B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
Tax-response B-O B-NP_NP_JJ
element B-O B-NN
DNA B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HTLV-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
human B-O B-NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
I B-O B-CD
( B-O B-LRB
HTLV-I B-O B-NN
) B-O B-RRB
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
contains B-O B-VP_VBZ
three B-O B-NP_NP_CD
copies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
imperfect B-O B-NP_NP_JJ
repeats B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
21-base B-O B-JJ
pair B-O B-NN
sequence B-O B-NN
" " B-O O-NP
designated B-O B-VP_VBN
" " B-O B-NP_ADVP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
separated B-O B-VP_VBN
" " B-O B-NP_O-VP
four B-O B-NP_CD
nuclear B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_SBAR_O-NP
from B-O B-PP_IN
C81-66-45 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_DT
HTLV-I B-O B-NP_NN
immortalized B-O B-JJ
Tax-expressing B-O B-VBG
human B-O B-JJ
T-lymphocyte B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
Salahuddin B-O B-NP_NP_NNP
et B-O B-FW
al. B-O B-FW
" " B-O O-NP
, B-O B-COMMA
1983 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
, B-O B-COMMA
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
interact B-O B-S_NP_VP_VBP
with B-O B-PP_IN
the B-O B-NP_DT
TRE-DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
none B-O B-SBAR_WHNP_NP_NN
" " B-O O-NP
of B-O B-WHPP_IN
which B-O B-WHPP_WDT
" " B-O O-WHPP
" " B-O O-WHPP
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
identical B-O B-ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_DT
Tax-protein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
proteins B-O B-NNS
" " B-O O-NP
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
have B-O B-VP_VBP
molecular B-O B-NP_NP_JJ
weights B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
about B-O B-NP_NP_QP_RB
32 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
, B-O B-COMMA
36 B-O B-NP_QP_CD
to B-O B-TO
42 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
, B-O B-COMMA
50 B-O B-NP_CD
" " B-O B-NP_O-NP
and B-O B-CC
110 B-O B-NP_CD
" " B-O B-NP_O-NP
kD B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Four B-O B-S_NP_CD
different B-O B-JJ
methods B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
identify B-O B-VP_VB
the B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
First B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
from B-O B-PP_IN
different B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
three B-O B-NP_NP_NP_CD
" " B-O O-NP
or B-O B-CC
all B-O B-NP_DT
four B-O B-CD
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
nuclear B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
specifically B-O B-ADJP_RB
" " B-O O-ADJP
cross-linked B-O B-VP_VBN
by B-O B-NP_PP_IN
UV B-O B-NP_NN
irradiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
radioactively B-O B-ADJP_RB
labeled B-O B-VBN
" " B-O O-ADJP
TRE-DNA B-O B-NP_NN
fragment B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Second B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
TRE-DNA B-O B-NP_NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
sedimented B-O B-VP_VBD
through B-O B-PP_IN
a B-O B-NP_DT
glycerol B-O B-NN
density B-O B-NN
gradient B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
rates B-O B-NP_NP_NNS
" " B-O O-NP
corresponding B-O B-VP_VBG
to B-O B-PP_TO
proteins B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Third B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
only B-O B-NP_RB
the B-O B-DT
50 B-O B-NP_CD
kD B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
retained B-O B-VP_VBN
on B-O B-NP_PP_IN
a B-O B-NP_DT
biotinylated B-O B-VBN
DNA-streptavidin B-O B-NN
matrix B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
DNA B-O B-NN
fragment B-O B-NN
" " B-O O-NP
contained B-O B-VP_VBD
the B-O B-NP_DT
TRE-DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Fourth B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
extensive B-O B-NP_NP_JJ
purification B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
several B-O B-NP_NP_JJ
cycles B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
TRE-DNA B-O B-NP_JJ
affinity B-O B-NN
chromatography B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
the B-O B-NP_NP_DT
32 B-O B-NP_CD
" " B-O B-NP_O-NP
, B-O B-COMMA
36 B-O B-NP_QP_CD
to B-O B-TO
42 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
and B-O B-CC
110 B-O B-NP_CD
" " B-O B-NP_O-NP
kD B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
to B-O B-PP_TO
less B-O B-ADJP_JJR
extent B-O B-NP_NN
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-PP
the B-O B-NP_DT
50 B-O B-NP_CD
kD B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_CD
abundant B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
75 B-O B-NP_NP_CD
" " B-O B-NP_O-NP
and B-O B-CC
80 B-O B-NP_CD
" " B-O B-NP_O-NP
kD B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
competed B-O B-VP_VBN
out B-O B-PRT_RP
" " B-O O-PRT
by B-O B-NP_PP_IN
poly[d(I-C)] B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
all B-O B-NP_DT
reactions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
cAMP-response B-O B-NP_JJ
element B-O B-NN
" " B-O O-NP
CRE B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
TGACGTCA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
present B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_DT
21 B-O B-NP_CD
base-pair B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
essential B-O B-ADJP_JJ
for B-O B-PP_IN
specific B-O B-NP_JJ
protein-TRE-DNA B-O B-JJ
interactions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
because B-O B-SBAR_IN
mutation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
two B-O B-CD
G B-O B-NN
's B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
destroys B-O B-VP_VBZ
this B-O B-NP_DT
complex B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
result B-O B-NN
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
cAMP B-O B-NP_NN
response B-O B-NN
element B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
CREB B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
and B-O B-CC
in B-O B-PP_IN
" " B-O B-S_NP_NP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Megakaryocytic B-O B-S_S_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
erythrocytic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
lineages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
share B-O B-VP_VBP
specific B-O B-NP_JJ
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Erythroid-specific B-O B-S_S_NP_NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O B-VP_O-NP
contain B-O B-VP_VBP
binding B-O B-NP_NP_VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
NF-E1 B-O B-NP_NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
called B-O B-VP_VP_ADVP_VBN
; B-O B-S_COLON
" " B-O B-NP_NP_ADVP_O-VP
) B-O B-RRB
" " B-O O-PRN
, B-O B-COMMA
the B-O B-NP_NP_DT
principal B-O B-JJ
DNA-binding B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
NF-E1 B-O B-S_NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
seems B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
restricted B-O B-VP_JJ
to B-O B-NP_PP_TO
the B-O B-NP_DT
erythrocytic B-O B-NP_JJ
lineage B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_S_NP_DT
closely B-O B-NP_ADJP_RB
related B-O B-JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
if B-O B-CONJP_IN
not B-O B-RB
" " B-O O-CONJP
identical B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
) B-O B-RRB
" " B-O O-PRN
protein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
found B-O B-VP_VBN
in B-O B-NP_PP_IN
both B-O B-NP_CC
a B-O B-NP_DT
human B-O B-NP_JJ
megakaryocytic B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
purified B-O B-NP_VBN
human B-O B-JJ
megakaryocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
it B-O B-S_NP_PRP
binds B-O B-VP_VBZ
to B-O B-PP_TO
promoter B-O B-NP_NP_NN
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_CD
megakaryocytic-specific B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_NP_DT
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
and B-O B-CC
partial B-O B-NP_JJ
proteolysis B-O B-NN
profile B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
indistinguishable B-O B-ADJP_JJ
from B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
erythroid B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
also B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
NF-E1 B-O B-NP_NN
messenger B-O B-NN
RNA B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_DT
same B-O B-JJ
size B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_CC
the B-O B-DT
megakaryocytic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
erythroid B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
point B-O B-NP_NP_NN
mutations B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
abolish B-O B-S_NP_VP_VBP
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-E1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
result B-O B-VP_VBP
in B-O B-PP_IN
a B-O B-NP_NP_DT
70 B-O B-ADJP_CD
% B-O B-NN
" " B-O O-ADJP
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
megakaryocytic-specific B-O B-NP_JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
find B-O B-VP_VBP
that B-O B-SBAR_IN
NF-E2 B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
another B-O B-NP_NP_DT
trans-acting B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
erythrocytic B-O B-NP_JJ
lineage B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
present B-O B-ADJP_JJ
in B-O B-PP_IN
megakaryocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transcriptional B-O B-S_NP_NP_JJ
effects B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_DT
lineages B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
might B-O B-VP_MD
then B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
mediated B-O B-VP_VBN
in B-O B-NP_PP_IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
same B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
trans-acting B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
data B-O B-NNS
" " B-O O-NP
strengthen B-O B-VP_VP_VBP
the B-O B-NP_NP_DT
idea B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
close B-O B-JJ
association B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
erythrocytic B-O B-JJ
" " B-O B-NP_O-NP
and B-O B-CC
the B-O B-NP_DT
megakaryocytic B-O B-JJ
" " B-O B-NP_O-NP
lineages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
could B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
explain B-O B-VP_VB
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
markers B-O B-NP_NP_NNS
" " B-O O-NP
specific B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_NP_NP_DT
new B-O B-JJ
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
leucine B-O B-NP_NN
zipper B-O B-NN
class B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
proteins B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
the B-O B-NP_DT
HLA B-O B-NP_NN
DR B-O B-NN
alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Several B-O B-S_S_NP_NP_JJ
mutants B-O B-NNS
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
transformed B-O B-NP_VBN
human B-O B-JJ
B B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
defective B-O B-ADJP_JJ
in B-O B-PP_IN
expressing B-O B-S_NP_VP_VBG
major B-O B-NP_JJ
histocompatibility B-O B-NN
complex B-O B-NN
( B-O B-LRB
MHC B-O B-NN
) B-O B-RRB
class B-O B-NN
II B-O B-CD
genes B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
failure B-O B-NN
to B-O B-S_NP_VP_TO
express B-O B-VP_VB
a B-O B-NP_DT
class B-O B-NP_NN
II B-O B-CD
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
at B-O B-NP_QP_IN
least B-O B-JJS
one B-O B-CD
" " B-O O-QP
such B-O B-JJ
mutant B-O B-NP_JJ
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
mapped B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
X B-O B-NN
box B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
conserved B-O B-NP_VBN
transcriptional B-O B-JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
complementary B-O B-NP_JJ
DNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
encoding B-O B-VP_VBG
a B-O B-NP_NP_NP_DT
DNA-binding B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
human B-O B-NP_NP_JJ
X B-O B-NN
box B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
hXBP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
whose B-O B-SBAR_WHNP_WPP
target B-O B-NN
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
the B-O B-NP_NP_DT
and B-O B-NP_CC
the B-O B-NP_DT
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
has B-O B-VP_VBZ
now B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
cloned B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_DT
complementary B-O B-NP_JJ
DNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
encoded B-O B-VP_VBD
a B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
structural B-O B-NP_NP_JJ
similarities B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
c-jun B-O B-NP_NN
proto-oncogene B-O B-NN
product B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
its B-O B-S_NP_PRPP
target B-O B-NN
sequence B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
closely B-O B-ADJP_RB
related B-O B-JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
palindromic B-O B-NP_JJ
target B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Mutation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
hXBP-1 B-O B-NP_NN
DNA B-O B-NN
target B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
decreased B-O B-VP_VBD
DR B-O B-NP_NP_NN
alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
hXBP-1 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
acts B-O B-VP_VBZ
as B-O B-PP_IN
a B-O B-NP_DT
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Quantitative B-O B-NP_NP_NP_NP_JJ
immunohistochemical B-O B-JJ
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mononuclear B-O B-NP_JJ
infiltrates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
breast B-O B-NP_NN
carcinomas B-O B-NNS
" " B-O O-NP
" " B-O O-PP
-- B-O B-COLON
" " B-O O-NP
correlation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
tumour B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Inflammatory B-O B-S_S_NP_JJ
infiltrates B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
analysed B-O B-VP_VBN
in B-O B-NP_PP_IN
tissue B-O B-NP_NP_NN
sections B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
76 B-O B-NP_CD
breast B-O B-NN
carcinomas B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_PP_IN
counting B-O B-S_NP_VP_VBG
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
by B-O B-PP_IN
measuring B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
These B-O B-S_NP_DT
parameters B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
nuclear B-O B-NP_NP_NP_JJ
grade B-O B-NN
" " B-O O-NP
and B-O B-CC
biochemically B-O B-NP_ADJP_RB
determined B-O B-VBN
" " B-O O-ADJP
hormone B-O B-NN
receptor B-O B-NN
status B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
known B-O B-NP_NP_JJ
markers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
tumour B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_S_NP_DT
direct B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
between B-O B-NP_PP_IN
the B-O B-NP_NP_DT
extent B-O B-NN
of B-O B-PP_IN
inflammation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
nuclear B-O B-NP_NP_JJ
grade B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_NP_ADJP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
an B-O B-S_NP_DT
inverse B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
inflammation B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
oestrogen B-O B-NP_NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
positivity B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-NP_NP_NN
" " B-O O-NP
less B-O B-ADJP_JJR
" " B-O B-PP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
inflammation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
progesterone B-O B-NP_NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
positivity B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-NP_NP_NN
" " B-O O-NP
less B-O B-ADJP_JJR
" " B-O B-PP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
percentage B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
OKT8+ B-O B-NP_JJ
suppressor/cytotoxic B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBD
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
inflammation B-O B-NN
" " B-O O-NP
expanded B-O B-VP_VBD
from B-O B-PP_IN
scanty B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
moderate B-O B-NP_NP_JJ
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_NP_ADJP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
diameter B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
PCVs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBD
with B-O B-PP_IN
increasing B-O B-NP_NP_VBG
inflammatory B-O B-JJ
infiltrate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-NP_NP_NN
" " B-O O-NP
less B-O B-ADJP_JJR
than B-O B-PP_IN
0.02 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_DT
direct B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
exists B-O B-VP_VBZ
between B-O B-PP_IN
the B-O B-NP_NP_NP_DT
diameter B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
PCVs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
both B-O B-NP_NP_CC
the B-O B-DT
percentage B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
( B-O B-NP_PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
Leu-7+ B-O B-JJ
( B-O B-NP_PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_NP_DT
novel B-O B-JJ
T-cell B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
recognizes B-O B-S_NP_VP_VBZ
a B-O B-NP_DT
palindromic B-O B-NP_JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
negative B-O B-NP_JJ
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Two B-O B-S_S_NP_NP_CD
major B-O B-NP_JJ
protein-binding B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_NP_DT
negative B-O B-NP_JJ
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
One B-O B-S_NP_NP_CD
" " B-O O-NP
( B-O B-PRN_LRB
site B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
contained B-O B-VP_VP_VBD
a B-O B-NP_NP_DT
palindromic B-O B-NP_JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
homology B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
steroid/thyroid B-O B-NP_NN
hormone B-O B-NN
response B-O B-NN
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
but B-O B-CC
was B-O B-VP_VBD
distinct B-O B-ADJP_JJ
from B-O B-PP_IN
previously B-O B-NP_NP_ADJP_RB
described B-O B-VBN
" " B-O O-ADJP
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
class B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
novel B-O B-JJ
T-cell B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
recognized B-O B-VP_VP_VBD
the B-O B-NP_NP_DT
palindromic B-O B-NP_JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
within B-O B-PP_IN
site B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
also B-O B-ADVP_RB
" " B-O O-ADVP
bound B-O B-VP_VBD
estrogen- B-O B-NP_NP_NN
" " B-O B-NP_NP_O-NP
or B-O B-CC
thyroid B-O B-NP_NN
hormone-response B-O B-NN
" " B-O B-NP_O-NP
elements B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
lower B-O B-NP_JJR
affinity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
7-base-pair B-O B-JJ
mutation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
site B-O B-NP_NN
B B-O B-NN
palindrome B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
destroyed B-O B-S_NP_VP_VBD
protein B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
increased B-O B-NP_NP_VBN
expression B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_NP_DT
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Epstein-Barr B-O B-S_S_NP_JJ
virus B-O B-NN
nuclear B-O B-JJ
antigen B-O B-NN
2 B-O B-CD
" " B-O O-NP
transactivates B-O B-VP_VBZ
latent B-O B-NP_NP_JJ
membrane B-O B-NN
protein B-O B-NN
" " B-O O-NP
LMP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Several B-O B-S_S_NP_NP_JJ
lines B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
evidence B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
compatible B-O B-ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_DT
hypothesis B-O B-NN
that B-O B-SBAR_IN
affects B-O B-S_NP_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
now B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
the B-O B-NP_DT
following B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LST_LRB
i B-O B-LS
) B-O B-RRB
" " B-O O-LST
Acute B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
transfection B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
EBNA-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
under B-O B-PP_IN
control B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
simian B-O B-NP_NP_JJ
virus B-O B-NN
40 B-O B-CD
" " B-O O-NP
or B-O B-CC
Moloney B-O B-NP_NN
murine B-O B-JJ
leukemia B-O B-NN
virus B-O B-NN
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
increased B-O B-NP_NP_VBN
LMP1 B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
P3HR-1-infected B-O B-NP_NP_JJ
Burkitt B-O B-NN
's B-O B-POS
lymphoma B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
P3HR-1 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
or B-O B-CC
Daudi B-O B-NP_NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LST_LRB
ii B-O B-LS
) B-O B-RRB
" " B-O O-LST
Transfection B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
EBNA-LP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
had B-O B-VP_VP_VBD
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
LMP1 B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
did B-O B-VP_VBD
not B-O B-RB
act B-O B-VP_VB
synergistically B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
EBNA-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
to B-O B-S_NP_VP_TO
affect B-O B-VP_VB
LMP1 B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LST_LRB
iii B-O B-LS
) B-O B-RRB
" " B-O O-LST
LMP1 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Daudi B-O B-NP_NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
P3HR-1-infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
controlled B-O B-VP_VBN
at B-O B-NP_PP_IN
the B-O B-NP_DT
mRNA B-O B-NP_NN
" " B-O O-NP
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
EBNA-2 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Daudi B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBD
LMP1 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LST_LRB
iv B-O B-LS
) B-O B-RRB
" " B-O O-LST
No B-O B-NP_DT
other B-O B-JJ
EBV B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
required B-O B-VP_VBN
for B-O B-NP_PP_IN
EBNA-2 B-O B-NP_NP_NP_NN
" " B-O O-NP
transactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LMP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
since B-O B-SBAR_IN
cotransfection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
recombinant B-O B-NP_NP_JJ
EBNA-2 B-O B-NN
expression B-O B-NN
vectors B-O B-NNS
" " B-O O-NP
and B-O B-CC
genomic B-O B-NP_JJ
LMP1 B-O B-NP_NN
DNA B-O B-NN
fragments B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
enhanced B-O B-VP_VBD
LMP1 B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
EBV-negative B-O B-NP_JJ
B-lymphoma B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
BJAB B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Louckes B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
BL30 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LST_LRB
v B-O B-LS
) B-O B-RRB
" " B-O O-LST
An B-O B-NP_DT
EBNA-2-responsive B-O B-NP_JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
within B-O B-NP_PP_IN
the B-O B-NP_DT
-512 B-O B-NP_CD
to B-O B-TO
+40 B-O B-CD
LMP1 B-O B-NN
DNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
since B-O B-SBAR_IN
this B-O B-S_NP_NP_DT
DNA B-O B-NN
" " B-O O-NP
linked B-O B-VP_VBN
to B-O B-NP_PP_TO
a B-O B-NP_DT
chloramphenicol B-O B-NP_NN
acetyltransferase B-O B-NN
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
transactivated B-O B-VP_VBN
by B-O B-NP_PP_IN
cotransfection B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LST_LRB
vi B-O B-LS
) B-O B-RRB
" " B-O O-LST
The B-O B-NP_DT
EBV B-O B-NN
type B-O B-NN
2 B-O B-CD
EBNA-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
transactivated B-O B-VP_VBD
LMP1 B-O B-NP_NP_NN
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
the B-O B-NP_DT
EBV B-O B-NP_NN
type B-O B-NN
1 B-O B-CD
EBNA-2 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LST_LRB
vii B-O B-LS
) B-O B-RRB
" " B-O O-LST
Two B-O B-NP_NP_CD
deletions B-O B-NNS
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_DT
EBNA-2 B-O B-NP_NN
" " B-O O-NP
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
rendered B-O B-S_NP_VP_VBD
EBV B-O B-S_NP_NN
transformation B-O B-NN
" " B-O O-NP
incompetent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
transactivate B-O B-VP_VB
LMP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
whereas B-O B-SBAR_IN
a B-O B-S_NP_DT
transformation-competent B-O B-NP_JJ
EBNA-2 B-O B-NN
deletion B-O B-NN
mutant B-O B-NN
" " B-O O-NP
" " B-O O-NP
did B-O B-VP_VBD
transactivate B-O B-VP_VB
LMP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LMP1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
a B-O B-NP_NP_DT
potent B-O B-JJ
effector B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B-lymphocyte B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
can B-O B-VP_MD
act B-O B-VP_VB
synergistically B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
EBNA-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
cellular B-O B-NP_JJ
CD23 B-O B-NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
EBNA-2 B-O B-NP_NP_NP_NN
" " B-O O-NP
transactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LMP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
amplifies B-O B-VP_VP_VBZ
the B-O B-NP_NP_DT
biological B-O B-JJ
impact B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
EBNA-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
underscores B-O B-VP_VBZ
its B-O B-NP_PRPP
central B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
EBV-induced B-O B-NP_JJ
growth B-O B-NN
transformation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Protein B-O B-S_S_NP_NN
kinase B-O B-NN
inhibitor B-O B-NN
H-7 B-O B-NN
" " B-O O-NP
blocks B-O B-VP_VBZ
accumulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
unspliced B-O B-NP_NP_JJ
mRNA B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
I B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Rex B-O B-S_S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
post-transcriptional B-O B-NP_JJ
regulator B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
I B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-I B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
accumulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Rex B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
phosphoprotein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
found B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
cell B-O B-NN
nucleolus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
whose B-O B-SBAR_WHNP_WPP
function B-O B-NN
" " B-O O-WHNP
may B-O B-S_NP_VP_MD
be B-O B-VP_VB
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
phosphorylation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
Rex B-O B-NP_NP_NN
" " B-O O-NP
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
using B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
protein B-O B-NN
kinase B-O B-NN
inhibitor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
H-7 B-O B-NP_NP_NN
" " B-O O-NP
[ B-O B-PRN_LRB
] B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
HTLV-I B-O B-NP_NN
infected B-O B-JJ
human B-O B-JJ
T-cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
H-7 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
blocked B-O B-VP_VBD
specifically B-O B-ADVP_RB
" " B-O O-ADVP
accumulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
unspliced B-O B-NP_JJ
gag-pol B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
resulting B-O B-S_NP_VP_VBG
in B-O B-PP_IN
the B-O B-NP_NP_DT
decreased B-O B-VBN
Gag B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
synthesis B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
corresponds B-O B-S_NP_VP_VBZ
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
other B-O B-NP_JJ
viral B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
cellular B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
products B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
not B-O B-RB
been B-O B-VP_VBN
influenced B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Rex B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_NP_DT
viral B-O B-JJ
RNA B-O B-NN
partition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HTLV-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Mononuclear B-O B-NP_NP_NP_NP_NP_JJ
leukocyte B-O B-NN
" " B-O O-NP
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
binding B-O B-NP_NN
characteristics B-O B-NNS
" " B-O O-NP
and B-O B-CC
down-regulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
major B-O B-NP_JJ
depression B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Some B-O B-S_S_S_NP_NP_DT
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
major B-O B-NP_NP_JJ
depressive B-O B-JJ
disorder B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MDD B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VP_VBP
elevated B-O B-NP_JJ
plasma B-O B-NN
cortisol B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
show B-O B-VP_VBP
failure B-O B-NP_NN
to B-O B-S_NP_VP_TO
suppress B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
yet B-O B-CC
they B-O B-S_NP_PRP
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
have B-O B-VP_VB
Cushingoid B-O B-NP_JJ
features B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
study B-O B-VP_VB
whether B-O B-SBAR_IN
this B-O B-S_NP_DT
" " B-O O-NP
represents B-O B-VP_VBZ
resistance B-O B-NP_NP_NP_PRN_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
[3H]-DEX-binding B-O B-S_NP_JJ
assays B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
measure B-O B-VP_VB
, B-O B-COMMA
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_NP_DT
and B-O B-NP_NP_NP_PRN_CC
" " B-O B-NP_NP_PRN_O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_S_NP_DT
receptor B-O B-NN
abnormalities B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
MDD B-O B-NN
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
thus B-O B-S_ADVP_RB
" " B-O O-ADVP
any B-O B-NP_NP_DT
cellular B-O B-JJ
defect B-O B-NN
" " B-O O-NP
leading B-O B-VP_VBG
to B-O B-PP_TO
a B-O B-NP_NP_DT
lack B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
responsiveness B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
MDD B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
if B-O B-FRAG_SBAR_IN
present B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-SBAR
" " B-O O-FRAG
, B-O B-COMMA
probably B-O B-ADVP_RB
" " B-O O-ADVP
lies B-O B-VP_VBZ
beyond B-O B-PP_IN
the B-O B-NP_DT
initial B-O B-JJ
receptor B-O B-NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
DEX B-O B-S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
1.0 B-O B-NP_NP_CD
mg B-O B-NN
" " B-O O-NP
orally B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
administered B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
study B-O B-VP_VB
in B-O B-NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
GC B-O B-NN
receptor B-O B-NN
down-regulation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Compared B-O B-S_PP_VBN
to B-O B-PP_TO
the B-O B-NP_DT
control B-O B-JJ
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
fewer B-O B-NP_JJR
depressed B-O B-JJ
subjects B-O B-NNS
" " B-O O-NP
down-regulated B-O B-VP_VBD
Bmax B-O B-NP_NN
" " B-O O-NP
after B-O B-PP_IN
DEX B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
paired B-O B-NP_JJ
t-test B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
Bmax B-O B-NP_NN
" " B-O O-NP
decreased B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_PP_IN
the B-O B-NP_DT
control B-O B-JJ
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
the B-O B-NP_DT
depressed B-O B-JJ
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Receptor B-O B-S_NP_NP_NN
number B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
control B-O B-JJ
day B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
correlate B-O B-VP_VB
significantly B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
the B-O B-NP_NP_NP_NP_DT
degree B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
receptor B-O B-NP_NN
down-regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
severity B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
depression B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
or B-O B-CC
cortisol B-O B-NP_NN
concentrations B-O B-NNS
" " B-O O-NP
" " B-O O-NP
across B-O B-PP_IN
all B-O B-NP_PDT
the B-O B-DT
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_S_NP_DT
results B-O B-NNS
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
lend B-O B-VP_VB
support B-O B-NP_NN
" " B-O O-NP
to B-O B-PP_TO
previous B-O B-NP_NP_JJ
reports B-O B-NNS
" " B-O O-NP
suggesting B-O B-VP_VBG
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
they B-O B-S_NP_PRP
" " B-O O-NP
emphasize B-O B-VP_VBP
the B-O B-NP_NP_DT
importance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
considering B-O B-S_NP_VP_VBG
receptor B-O B-NP_NN
studies B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
in B-O B-SBAR_IN
order B-O B-NN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
[ B-O B-PRN_PRN_LRB
The B-O B-NP_NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hydrocortisone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
chemotactic B-O B-JJ
migration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-PRN
  
Random B-O B-S_S_NP_NP_NP_NP_JJ
migration B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RM B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
chemotactic B-O B-NP_NP_JJ
migration B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ChtM B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
yeast B-O B-NP_NN
activated B-O B-JJ
serum B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
studied B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
modified B-O B-VBN
Boyden B-O B-NN
chamber B-O B-NN
method B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Both B-O B-S_NP_CC
RM B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
ChtM B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
showed B-O B-VP_VBD
circadian B-O B-NP_JJ
rhythm B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Leukocytes B-O B-S_NP_NNS
" " B-O O-NP
migrated B-O B-VP_VBD
most B-O B-ADVP_RBS
rapidly B-O B-RB
" " B-O O-ADVP
at B-O B-PP_IN
night B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
difference B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
peak B-O B-NP_NP_NN
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
0 B-O B-NP_CD
: B-O B-COLON
00 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
trough B-O B-NP_NP_NN
values B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
8 B-O B-NP_CD
: B-O B-COLON
00 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
RM B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
ChtM B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
significant B-O B-ADJP_JJ
statistically B-O B-ADVP_RB
" " B-O O-ADVP
( B-O B-PRN_LRB
P B-O B-NP_NP_NN
" " B-O O-NP
less B-O B-ADJP_JJR
than B-O B-PP_IN
0.01 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
ChtM B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
hydrocortisone B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
F B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
physiological B-O B-NP_NP_JJ
concentration B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
mol/L B-O B-NP_QP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
and B-O B-UCP_ADJP_CC
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
much B-O B-ADJP_ADVP_RB
more B-O B-RBR
" " B-O O-ADVP
evident B-O B-JJ
with B-O B-PP_IN
higher B-O B-NP_NP_JJR
dose B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
more B-O B-NP_QP_JJR
than B-O B-IN
10(-5) B-O B-CD
" " B-O O-QP
mol/L B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
reversed B-O B-VP_VBN
by B-O B-NP_PP_IN
RU38486 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
only B-O B-ADVP_RB
partially B-O B-RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
suggested B-O B-VP_VBN
that B-O B-SBAR_SBAR_IN
glucocorticoids B-O B-S_NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
GC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
its B-O B-COMP_S_NP_NP_PRPP
inhibitory B-O B-JJ
action B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
ChtM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
physiological B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
pharmacological B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
concentration B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
GC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
low B-O B-NP_NP_JJ
affinity B-O B-NN
specific B-O B-JJ
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_NP_DT
56-59-kilodalton B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
identified B-O B-VP_VBN
in B-O B-NP_PP_IN
untransformed B-O B-NP_JJ
steroid B-O B-NN
receptor B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
unique B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
exists B-O B-S_NP_VP_VBZ
in B-O B-PP_IN
cytosol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_S_S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
previously B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
shown B-O B-VP_VBN
that B-O B-SBAR_IN
contain B-O B-S_NP_NP_PP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
[ B-O B-PRN_LRB
Tai B-O B-NP_NP_NP_NNP
, B-O B-COMMA
P.K. B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
Maeda B-O B-NP_NNP
, B-O B-COMMA
Y. B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
Nakao B-O B-NP_NNP
, B-O B-COMMA
K. B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
Wakim B-O B-NP_NNP
, B-O B-COMMA
N.G. B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
Duhring B-O B-NP_NNP
, B-O B-COMMA
J.L. B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
& B-O B-CC
Faber B-O B-NP_NNP
, B-O B-COMMA
L.E. B-O B-NNP
" " B-O O-NP
" " B-O O-NP
( B-O B-NP_PRN_LRB
1986 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
Biochemistry B-O B-NP_NNP
25 B-O B-CD
, B-O B-COMMA
5269-5275 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
work B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
monoclonal B-O B-NP_JJ
antibody B-O B-NN
KN B-O B-NN
382/EC1 B-O B-NN
" " B-O O-NP
" " B-O O-NP
raised B-O B-VP_VBN
against B-O B-NP_PP_IN
the B-O B-NP_DT
rabbit B-O B-NP_NN
59-kDa B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
reacts B-O B-VP_VBZ
with B-O B-PP_PP_IN
9S B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
with B-O B-IN
4S B-O B-NP_NN
salt-transformed B-O B-JJ
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
human B-O B-JJ
protein B-O B-NN
" " B-O O-NP
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
EC1 B-O B-NP_NN
antibody B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
56-kDa B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
p56 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
moderate B-O B-NP_JJ
abundance B-O B-NN
" " B-O O-NP
" " B-O O-PP
located B-O B-ADJP_JJ
predominantly B-O B-PP_ADVP_RB
" " B-O O-ADVP
in B-O B-IN
the B-O B-NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
by B-O B-PP_IN
indirect B-O B-NP_JJ
immunofluorescence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
are B-O B-VP_VBP
at B-O B-NP_NP_QP_IN
least B-O B-JJS
six B-O B-CD
" " B-O O-QP
isomorphs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
p56 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
two-dimensional B-O B-NP_JJ
gel B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
N-Terminal B-O B-S_NP_NP_JJ
sequencing B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
20 B-O B-NP_CD
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
shows B-O B-VP_VBZ
that B-O B-SBAR_IN
p56 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
unique B-O B-NP_JJ
human B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
p56 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
immunoadsorbed B-O B-VP_VBN
from B-O B-NP_PP_IN
IM-9 B-O B-NP_NP_NN
cell B-O B-NN
" " B-O O-NP
cytosol B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
both B-O B-S_NP_CC
the B-O B-DT
70- B-O B-NP_CD
" " B-O B-NP_NP_O-NP
and B-O B-CC
90-kDa B-O B-NP_JJ
" " B-O B-NP_O-NP
heat B-O B-NP_NN
shock B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
coadsorbed B-O B-VP_VBN
in B-O B-NP_PP_IN
an B-O B-NP_DT
immune-specific B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Neither B-O B-S_NP_DT
heat B-O B-NP_NN
shock B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
reacts B-O B-VP_VBZ
directly B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
the B-O B-NP_DT
EC1 B-O B-NP_NN
antibody B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_IN
p56 B-O B-S_NP_NN
" " B-O O-NP
exists B-O B-VP_VBZ
in B-O B-PP_IN
cytosol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_NP_DT
higher B-O B-JJR
order B-O B-NN
complex B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
, B-O B-NP_NP_COMMA
" " B-O B-SBAR_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Detection B-O B-NP_NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
non-erythroid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
of B-O B-PP_IN
a B-O B-NP_NP_DT
factor B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
binding B-O B-NN
characteristics B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_NP_NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
erythroid B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
erythroid B-O B-NP_NP_JJ
factor-1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EF1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
critical B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
erythroid-specific B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
factor B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
mobility B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
sequence-specific B-O B-NP_JJ
DNA-binding B-O B-JJ
characteristics B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
EF1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
low B-O B-NP_JJ
abundance B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_NP_DT
wide B-O B-JJ
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
non-erythroid B-O B-NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
is B-O B-VP_VP_VBZ
the B-O B-NP_NP_DT
first B-O B-JJ
report B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
EF1-like B-O B-JJ
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
non-erythroid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
indicates B-O B-VP_VBZ
that B-O B-SBAR_IN
this B-O B-S_NP_DT
factor B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
play B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cell B-O B-NP_NP_NP_NP_NP_NN
type B-O B-NN
specificity B-O B-NN
" " B-O O-NP
and B-O B-CC
activation B-O B-NP_NN
requirements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
NFAT-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
nuclear B-O B-NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
determined B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_NP_DT
new B-O B-JJ
method B-O B-NN
" " B-O O-NP
using B-O B-VP_VBG
transgenic B-O B-NP_JJ
mice B-O B-NNS
" " B-O O-NP
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Nuclear B-O B-S_S_NP_NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
T-cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
NFAT-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
considered B-O B-VP_VBN
" " B-O B-S_NP_VP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
developed B-O B-VP_VBN
a B-O B-NP_NP_DT
system B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHNP_S_NP_VP_TO
monitor B-O B-VP_VB
" " B-O B-NP_NP_PP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
system B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
based B-O B-VP_VBN
on B-O B-NP_PP_IN
the B-O B-NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
oligomerized B-O B-JJ
NFAT-1 B-O B-NN
binding B-O B-NN
motif B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
report B-O B-NN
" " B-O O-NP
represents B-O B-VP_VBZ
the B-O B-NP_DT
first B-O B-JJ
demonstration B-O B-NN
that B-O B-SBAR_IN
a B-O B-S_NP_DT
multimerized B-O B-JJ
short B-O B-JJ
binding B-O B-VBG
motif B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
function B-O B-VP_VB
appropriately B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
transgenic B-O B-NP_JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NFAT-1 B-O B-S_NP_NN
activity B-O B-NN
" " B-O O-NP
had B-O B-VP_VBD
previously B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
thought B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
confined B-O B-VP_VBN
to B-O B-NP_PP_TO
upon B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
targeting B-O B-S_NP_VP_VBG
NFAT-1-dependent B-O B-NP_NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
transgenic B-O B-NP_JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
discovered B-O B-VP_VBD
new B-O B-NP_NP_JJ
sites B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
NFAT-1 B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Besides B-O B-S_PP_IN
in B-O B-PP_IN
T-lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
NFAT-1 B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
could B-O B-VP_VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
T-lymphocyte-depleted B-O B-NP_NP_JJ
spleen B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
purified B-O B-NP_VBN
B-lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
requires B-O B-VP_VBZ
agents B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
both B-O B-S_NP_CC
release B-O B-VP_VP_VBP
intracellular B-O B-NP_JJ
calcium B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
activate B-O B-VP_VBP
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
difference B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
time B-O B-NN
course B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
appearance B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NFAT-1 B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
between B-O B-PP_IN
T-lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
non-T-lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
revealed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Constitutive B-O B-S_S_NP_JJ
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
small B-O B-JJ
population B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
some B-O B-S_NP_DT
mice B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
developed B-O B-VP_VBN
skin B-O B-NP_NN
lesions B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
tissue B-O B-NN
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NFAT-1 B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resembles B-O B-VP_VBZ
the B-O B-NP_NP_DT
expression B-O B-NN
pattern B-O B-NN
" " B-O O-NP
described B-O B-VP_VBN
for B-O B-NP_PP_IN
HIV-LTR/tat B-O B-NP_NN
transgenic B-O B-JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
Vogel B-O B-NP_NP_NP_NP_NNP
, B-O B-COMMA
J. B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
Hinrichs B-O B-NP_NNP
, B-O B-COMMA
S. B-O B-NNP
H. B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
Reynolds B-O B-NP_NNP
, B-O B-COMMA
R. B-O B-NNP
K. B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
Luciw B-O B-NP_NNP
, B-O B-COMMA
P. B-O B-NNP
A. B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Jay B-O B-NP_NNP
, B-O B-COMMA
G. B-O B-NNP
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
1988 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
Nature B-O B-NP_NP_NNP
335 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
606-611 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_NP_DT
similarity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
fact B-O B-NN
that B-O B-SBAR_IN
NFAT-1 B-O B-S_NP_NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
" " B-O B-S_NP_VP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
suggest B-O B-VP_VBP
a B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
NFAT-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
dermal B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-LTR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_NP_DT
internal B-O B-JJ
methionine B-O B-NN
codons B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
II B-O B-CD
rex B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
required B-O B-VP_VBN
for B-O B-NP_PP_IN
p24rex B-O B-NP_NP_NN
production B-O B-NN
" " B-O O-NP
or B-O B-CC
virus B-O B-NP_NN
replication B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
transformation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Human B-O B-S_S_NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
types B-O B-NNS
I B-O B-NP_NP_CD
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-I B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
II B-O B-NP_NP_CD
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-II B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
two B-O B-NP_NP_NP_CD
nonstructural B-O B-JJ
trans-acting B-O B-JJ
regulatory B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
tax B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
rex B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
located B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_NP_DT
3' B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
viral B-O B-JJ
genome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
tax B-O B-NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-I B-O B-NP_NP_NN
p40tax B-O B-NN
" " B-O O-NP
and B-O B-CC
HTLV-II B-O B-NP_NN
p37tax B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
activator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
viral B-O B-JJ
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
rex B-O B-NN
gene B-O B-NN
" " B-O O-NP
encodes B-O B-VP_VBZ
two B-O B-NP_NP_CD
protein B-O B-NN
products B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
p27rex/p21rex B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
p26rex/p24rex B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
HTLV-I B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
HTLV-II B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Rex B-O B-S_NP_NN
" " B-O O-NP
acts B-O B-VP_VBZ
posttranscriptionally B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-S_NP_VP_TO
facilitate B-O B-VP_VB
accumulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Previous B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
first B-O B-JJ
ATG B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
rex B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
critical B-O B-ADJP_JJ
for B-O B-PP_IN
Rex B-O B-NP_NN
production B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
function B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
importance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
internal B-O B-JJ
ATGs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
Rex B-O B-NP_NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
known B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
mutagenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HTLV-I B-O B-NN
rex B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
provided B-O B-VP_VBN
indirect B-O B-NP_NP_JJ
evidence B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
suggests B-O B-S_NP_VP_VBZ
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
using B-O B-S_NP_VP_VBG
an B-O B-NP_NP_DT
infectious B-O B-JJ
molecular B-O B-JJ
clone B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HTLV-II B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
importance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
internal B-O B-JJ
ATGs B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
rex B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
Rex B-O B-NP_NN
protein B-O B-NN
production B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
function B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
p24rex B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HTLV-II B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
initiated B-O B-VP_VBN
at B-O B-NP_PP_IN
an B-O B-NP_DT
internal B-O B-JJ
AUG B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_DT
internal B-O B-JJ
methionine B-O B-NN
codons B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
crucial B-O B-ADJP_JJ
to B-O B-PP_TO
and B-O B-NP_NP_CC
, B-O B-COMMA
, B-O B-ADVP_COMMA
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Interferon B-O B-S_S_NP_NN
" " B-O O-NP
affects B-O B-VP_VBZ
nuclear B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
clinically B-O B-NP_ADJP_RB
sensitive B-O B-JJ
" " B-O O-ADJP
chronic B-O B-JJ
myelogenous B-O B-JJ
leukemia B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Cytoplasmic B-O B-S_S_NP_NP_JJ
protein B-O B-NN
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
chronic B-O B-NP_JJ
myelogenous B-O B-JJ
leukemia B-O B-NN
( B-O B-LRB
CML B-O B-NN
) B-O B-RRB
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contained B-O B-VP_VBD
an B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
altered B-O B-S_NP_VP_VBD
the B-O B-NP_NP_DT
electrophoretic B-O B-JJ
mobility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Exposure B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CML B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-VP_TO
IFN-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
diminished B-O B-VP_VBD
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CML B-O B-NN
cytoplasmic B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
these B-O B-NP_DT
nuclear B-O B-JJ
protein-DNA B-O B-JJ
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
clinical B-O B-NP_NP_JJ
responsiveness B-O B-NN
" " B-O O-NP
to B-O B-VP_TO
IFN-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlated B-O B-VP_VBD
with B-O B-PP_IN
the B-O B-NP_NP_DT
sensitivity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
IFN-induced B-O B-JJ
change B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
electrophoretic B-O B-JJ
mobility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
protein-DNA B-O B-JJ
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IFN-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
CML B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
linked B-O B-VP_VBN
to B-O B-NP_VP_TO
" " B-O B-NP_NP_SBAR_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-PRN_PRN_LRB
Glucocorticoid B-O B-NP_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
mononuclear B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
polymorphonuclear B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
leucocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
changes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
yang-deficiency B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-PRN
  
It B-O B-S_S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
that B-O B-SBAR_IN
, B-O B-COMMA
in B-O B-S_PP_IN
former B-O B-NP_JJ
works B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
glucocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
were B-O B-VP_VBD
decreased B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
work B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-S_S_NP_DT
mixed B-O B-JJ
leucocytes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
further B-O B-ADVP_RB
" " B-O O-ADVP
separated B-O B-VP_VBN
into B-O B-NP_PP_IN
mononuclear B-O B-NP_NP_NP_JJ
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
and B-O B-CC
polymorphonuclear B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
leucocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
GCR B-O B-S_NP_NN
" " B-O O-NP
were B-O B-VP_VBD
determined B-O B-VP_VBN
in B-O B-NP_PP_IN
each B-O B-NP_NP_DT
part B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
leucocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
GCR B-O B-S_NP_NP_NN
" " B-O O-NP
on B-O B-PP_IN
MNL B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
PML B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
6 B-O B-NP_CD
Yang B-O B-NN
deficient B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
3473 B-O B-NP_NP_QP_CD
+/- B-O B-CC
413 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
and B-O B-CC
4433 B-O B-NP_QP_CD
+/- B-O B-CC
651 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
sites/cell B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
respectively B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
statistically B-O B-ADVP_RB
significant B-O B-JJ
from B-O B-PP_IN
the B-O B-NP_DT
normal B-O B-JJ
control B-O B-JJ
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
4462 B-O B-NP_NP_NP_QP_CD
+/- B-O B-CC
962 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
and B-O B-CC
5622 B-O B-NP_QP_CD
+/- B-O B-CC
782 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
sites/cell B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
respectively B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
P B-O B-NP_NP_NN
" " B-O O-NP
less B-O B-ADJP_JJR
than B-O B-PP_IN
0.05 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
GCR B-O B-S_S_NP_NP_NN
" " B-O O-NP
on B-O B-PP_IN
MNL B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
PML B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
mixed B-O B-NP_JJ
leucocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
5 B-O B-NP_CD
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
determined B-O B-VP_VBN
simultaneously B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
all B-O B-S_NP_DT
" " B-O O-NP
lowered B-O B-VP_VBD
from B-O B-PP_IN
the B-O B-NP_DT
control B-O B-JJ
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
3369 B-O B-NP_NP_QP_CD
+/- B-O B-CC
370 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
, B-O B-COMMA
4986 B-O B-NP_QP_CD
+/- B-O B-CC
419 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
and B-O B-CC
4524 B-O B-NP_QP_CD
+/- B-O B-CC
852 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
sites/cell B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
respectively B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
with B-O B-PP_IN
the B-O B-NP_NP_NP_DT
lowest B-O B-JJS
GCR B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
MNL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
highest B-O B-NP_NP_ADJP_JJS
" " B-O O-ADJP
" " B-O B-NP_O-NP
on B-O B-PP_IN
PML B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
NF-kappa B-O B-NP_NP_NP_NN
B B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
inducible B-O B-NP_NP_JJ
transcriptional B-O B-NP_JJ
activator B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
granulocyte-macrophage B-O B-NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
gene B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
the B-O B-NP_DT
granulocyte-macrophage B-O B-NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GM-CSF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
induced B-O B-VP_VBN
upon B-O B-NP_PP_PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
upon B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
same B-O B-JJ
agents B-O B-NNS
" " B-O O-NP
induce B-O B-VP_VBP
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
interleukin-2 B-O B-NP_NN
receptor B-O B-NN
alpha-chain B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
interleukin-2 B-O B-NP_NN
" " B-O B-NP_O-NP
genes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
depending B-O B-PP_VBG
on B-O B-PP_IN
promoter B-O B-NP_NP_NN
elements B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bind B-O B-S_NP_VP_VBP
" " B-O B-NP_NP_PRN_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
tested B-O B-VP_VBD
the B-O B-NP_DT
possibility B-O B-NN
that B-O B-SBAR_IN
the B-O B-S_NP_DT
GM-CSF B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_S_NP_NP_DT
recent B-O B-JJ
functional B-O B-JJ
analysis B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
Miyatake B-O B-NP_NP_NNP
et B-O B-FW
al. B-O B-FW
" " B-O O-NP
( B-O B-PRN_LRB
S. B-O B-NP_NP_NP_NNP
Miyatake B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
M. B-O B-NP_NNP
Seiki B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
M. B-O B-NP_NNP
Yoshida B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
K. B-O B-NP_NNP
Arai B-O B-NNP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
Mol. B-O B-NP_NNP
Cell. B-O B-NNP
Biol. B-O B-NNP
8 B-O B-CD
" " B-O O-NP
: B-O B-COLON
5581-5587 B-O B-NP_CD
" " B-O O-NP
, B-O B-COMMA
1988 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
described B-O B-VP_VBD
a B-O B-NP_NP_DT
short B-O B-NP_JJ
promoter B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
GM-CSF B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
conferred B-O B-S_NP_VP_VBD
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
no B-O B-S_NP_DT
NF-kappa B-O B-NP_NN
B-binding B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
showed B-O B-VP_VBD
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_PP_IN
purified B-O B-NP_VBN
human B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
of B-O B-PP_IN
the B-O B-NP_NP_DT
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
activated B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
to B-O B-PP_TO
an B-O B-NP_NP_DT
oligonucleotide B-O B-NN
" " B-O O-NP
comprising B-O B-VP_VBG
the B-O B-NP_NP_DT
responsible B-O B-NP_ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_SBAR_IN
shown B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
methylation B-O B-NN
interference B-O B-NN
analysis B-O B-NN
" " B-O O-NP
and B-O B-CC
oligonucleotide B-O B-NP_NN
competition B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
purified B-O B-S_NP_VBN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
binds B-O B-VP_VBZ
at B-O B-PP_IN
positions B-O B-NP_NP_NP_NNS
-82 B-O B-CD
to B-O B-TO
-91 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
GGGAACTACC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GM-CSF B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
an B-O B-NP_NP_DT
affinity B-O B-NN
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
" " B-O B-SBAR_WHPP_S_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_CD
kappa B-O B-NP_NN
B-like B-O B-JJ
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
at B-O B-PP_IN
positions B-O B-NP_NP_NNS
-98 B-O B-CD
to B-O B-TO
-108 B-O B-CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GM-CSF B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
recognized B-O B-VP_VBN
but B-O B-NP_CC
with B-O B-PP_IN
much B-O B-NP_ADJP_JJ
lower B-O B-JJR
" " B-O O-ADJP
affinities B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
data B-O B-NNS
" " B-O O-NP
provide B-O B-VP_VBP
strong B-O B-NP_JJ
evidence B-O B-NN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GM-CSF B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
following B-O B-PP_VBG
T-cell B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Octamer B-O B-NP_NP_NP_NN
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
cell B-O B-NP_NN
type-specificity B-O B-NN
of B-O B-IN
immunoglobulin B-O B-NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Antibodies B-O B-S_S_NP_NNS
" " B-O O-NP
are B-O B-VP_VBP
produced B-O B-VP_VBN
exclusively B-O B-NP_PP_ADVP_RB
" " B-O O-ADVP
in B-O B-IN
B B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
antibody-encoding B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
immunoglobulin B-O B-NP_NN
( B-O B-LRB
Ig B-O B-NN
) B-O B-RRB
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
restricted B-O B-VP_JJ
to B-O B-NP_PP_TO
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
octamer B-O B-NP_NN
sequence B-O B-NN
" " B-O O-NP
ATGCAAAT B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
present B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_NP_NP_DT
promoter B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
enhancer B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
Ig B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
plays B-O B-VP_VBZ
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
its B-O B-NP_PRPP
tissue-specific B-O B-JJ
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
sequence B-O B-NP_NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
so-called B-O B-JJ
octamer B-O B-NP_NN
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
" " B-O B-NP_NP_NP_NP_O-NP
or B-O B-CC
OTF B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
Oct-1 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
present B-O B-ADJP_JJ
in B-O B-PP_IN
all B-O B-NP_NP_DT
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
analyzed B-O B-VP_VBN
so B-O B-NP_ADVP_RB
far B-O B-RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
whereas B-O B-SBAR_IN
Oct-2A B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
Oct-2B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
found B-O B-VP_VBN
mainly B-O B-NP_PP_ADVP_RB
" " B-O O-ADVP
in B-O B-IN
B B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_DT
three B-O B-CD
proteins B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
the B-O B-NP_DT
same B-O B-JJ
sequence B-O B-NP_NN
specificity B-O B-NN
" " B-O O-NP
and B-O B-CC
binding B-O B-NP_NN
affinity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
appears B-O B-VP_VBZ
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_NP_DT
B B-O B-NN
cell-specific B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Ig B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
at B-O B-NP_PP_ADVP_IN
least B-O B-JJS
" " B-O O-ADVP
in B-O B-IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
cell B-O B-NP_NN
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
there B-O B-S_NP_EX
" " B-O O-NP
are B-O B-VP_VBP
both B-O B-NP_CC
quantitative B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
qualitative B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
differences B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
between B-O B-PP_IN
" " B-O B-NP_NP_NP_NP_O-NP
and B-O B-CC
Oct-2 B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recently B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
a B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_JJ
octamer B-O B-NP_NN
factor B-O B-NN
variants B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Many B-O B-S_NP_NP_JJ
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_VP_MD
be B-O B-VP_VB
created B-O B-VP_VBN
by B-O B-NP_PP_IN
alternative B-O B-NP_NP_JJ
splicing B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
may B-O B-VP_MD
serve B-O B-VP_VB
a B-O B-NP_DT
specific B-O B-JJ
function B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
fine B-O B-JJ
tuning B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
ETS1 B-O B-S_S_NP_NN
" " B-O O-NP
transactivates B-O B-VP_VBZ
the B-O B-NP_NP_DT
human B-O B-NP_JJ
GM-CSF B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Activation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
helper B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
coordinate B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Granulocyte-macrophage B-O B-S_NP_NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GM-CSF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
one B-O B-NP_NP_CD
such B-O B-JJ
cytokine B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
whose B-O B-SBAR_WHNP_WPP
increased B-O B-VBN
expression B-O B-NN
" " B-O O-WHNP
results B-O B-S_NP_VP_VBZ
partly B-O B-PP_ADVP_RB
" " B-O O-ADVP
from B-O B-IN
increases B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cis-acting B-O B-S_NP_NP_JJ
elements B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
NF B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
AP-1 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
ETS-like B-O B-NP_JJ
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O B-SBAR_O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
identified B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
promoter B-O B-NN
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GM-CSF B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
important B-O B-ADJP_JJ
for B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
activity B-O B-NN
" " B-O O-NP
following B-O B-PP_VBG
stimulation B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
ETS B-O B-NP_NN
family B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O B-PP_O-NP
are B-O B-VP_VBP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
including B-O B-PP_VBG
ETS1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
ELF1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
describe B-O B-VP_VBP
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
interact B-O B-VP_VB
with B-O B-PP_IN
, B-O B-NP_NP_NP_PRN_COMMA
located B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Exogenous B-O B-S_NP_NP_JJ
ETS1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
ELF1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
can B-O B-VP_MD
transactivate B-O B-VP_VB
GM-CSF B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
through B-O B-PP_IN
the B-O B-NP_DT
GM5 B-O B-NP_NN
" " B-O O-NP
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
a B-O B-NP_DT
PMA B-O B-NN
/ionomycin B-O B-NN
dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Other B-O B-S_NP_NP_ADJP_JJ
unidentified B-O B-JJ
" " B-O O-ADJP
ETS-like B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
are B-O B-VP_VBP
also B-O B-ADVP_RB
" " B-O O-ADVP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
binding B-O B-S_NP_VP_VBG
GM5 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
core B-O B-NN
ETS B-O B-NP_NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
-GGAA- B-O B-NP_NN
to B-O B-TO
-GGAT- B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
prevents B-O B-VP_VBZ
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ETS-like B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
exception B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ETS1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
GM-CSF B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
modified B-O B-VP_VBN
in B-O B-NP_PP_IN
this B-O B-NP_DT
way B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
ETS1 B-O B-ADJP_NP_NN
" " B-O O-NP
specific B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
fully B-O B-ADJP_RB
responsive B-O B-JJ
to B-O B-PP_TO
PMA B-O B-NP_NN
/ionomycin B-O B-NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
addition B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
ETS1 B-O B-NP_NP_NP_NN
" " B-O O-NP
transactivation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Together B-O B-S_ADVP_RB
" " B-O O-ADVP
these B-O B-NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
ETS1 B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_DT
murine B-O B-JJ
BCL6 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
activated B-O B-NP_VBN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
an B-O B-NP_DT
immediate B-O B-NP_JJ
early B-O B-JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
chromosomal B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
involving B-O B-VP_VBG
3q27 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
often B-O B-ADVP_RB
" " B-O O-ADVP
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_NP_JJ
B-cell B-O B-NN
lymphomas B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
especially B-O B-ADVP_RB
" " B-O O-ADVP
diffuse B-O B-NP_NP_JJ
lymphomas B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_DT
large-cell B-O B-JJ
component B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
BCL6 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_NP_DT
chromosomal B-O B-JJ
breakpoint B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
lymphomas B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
cloned B-O B-VP_VBD
the B-O B-NP_DT
murine B-O B-NP_JJ
BCL6 B-O B-NN
( B-O B-LRB
mBCL6 B-O B-NN
) B-O B-RRB
cDNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
muscle B-O B-NP_NN
cDNA B-O B-NN
library B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
using B-O B-S_NP_VP_VBG
the B-O B-NP_DT
human B-O B-NP_JJ
BCL6 B-O B-NN
( B-O B-LRB
hBCL6 B-O B-NN
) B-O B-RRB
cDNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_DT
probe B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
predicted B-O B-VBN
amino B-O B-NN
acid B-O B-NN
sequence B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
95 B-O B-ADJP_NP_CD
% B-O B-NN
" " B-O O-NP
identical B-O B-JJ
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
hBCL6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
contains B-O B-VP_VBZ
six B-O B-NP_NP_NP_CD
repeats B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Kruppel-like B-O B-NP_JJ
zinc-finger B-O B-JJ
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
completely B-O B-ADJP_RB
identical B-O B-JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_DT
BCL6 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
well B-O B-ADVP_RB
" " B-O O-ADVP
conserved B-O B-VP_VBN
between B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
mBCL6 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
ubiquitously B-O B-ADVP_RB
" " B-O O-ADVP
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
adult B-O B-NP_NP_JJ
mouse B-O B-NN
tissues B-O B-NNS
" " B-O O-NP
including B-O B-PP_VBG
lymphatic B-O B-NP_JJ
organs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
activated B-O B-VP_VBN
with B-O B-NP_PP_IN
phorbol B-O B-NP_NP_NN
ester B-O B-NN
" " B-O O-NP
and B-O B-CC
Ca2+ B-O B-NP_NN
ionophore B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
30 B-O B-NP_NP_CD
min B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
induction B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_DT
protein B-O B-NN
synthesis B-O B-NN
inhibitor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
cycloheximide B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
BCL6 B-O B-S_NP_NN
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
activated B-O B-NP_VBN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
an B-O B-NP_DT
immediate B-O B-JJ
early B-O B-JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Bik B-O B-S_S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
novel B-O B-JJ
death-inducing B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
shares B-O B-VP_VP_VBZ
a B-O B-NP_DT
distinct B-O B-JJ
sequence B-O B-NN
motif B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
Bcl-2 B-O B-NP_NN
family B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
interacts B-O B-VP_VBZ
with B-O B-PP_IN
viral B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
cellular B-O B-NP_JJ
survival-promoting B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
survival-promoting B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
Bcl-2 B-O B-NP_NN
family B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
proteins B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
modulated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
a B-O B-NP_NP_NP_DT
novel B-O B-JJ
cellular B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
Bik B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
interacts B-O B-S_NP_VP_VBZ
with B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-CONJP_NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
transient B-O B-NP_JJ
transfection B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
Bik B-O B-NP_NN
" " B-O O-NP
promotes B-O B-VP_VBZ
cell B-O B-NP_NN
death B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
manner B-O B-NN
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
Bax B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Bak B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
death-promoting B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Bik B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
suppressed B-O B-VP_VBN
by B-O B-NP_PP_IN
coexpression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_NP_NP_O-NP
, B-O B-COMMA
" " B-O B-NP_NP_NP_O-NP
, B-O B-COMMA
" " B-O B-NP_NP_NP_O-NP
and B-O B-CC
" " B-O B-NP_NP_NP_O-NP
proteins B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
Bik B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
While B-O B-S_SBAR_IN
Bik B-O B-S_NP_NP_NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
show B-O B-VP_VB
overt B-O B-NP_NP_JJ
homology B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_NP_ADJP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-NP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
it B-O B-S_NP_PRP
" " B-O O-NP
does B-O B-VP_VBZ
share B-O B-VP_VB
a B-O B-NP_DT
9 B-O B-NP_NP_CD
amino B-O B-NP_NN
acid B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
BH3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O B-SBAR_O-NP
with B-O B-PP_IN
Bax B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Bak B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
may B-O B-S_NP_VP_MD
be B-O B-VP_VB
a B-O B-NP_NP_DT
critical B-O B-JJ
determinant B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Tissue-specific B-O B-NP_NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
rabbit B-O B-NP_JJ
15-lipoxygenase B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
erythroid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
a B-O B-NP_DT
transcriptional B-O B-NP_JJ
silencer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
15-lipoxygenase B-O B-NP_NN
( B-O B-LRB
lox B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_DT
tissue-specific B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
predominantly B-O B-PP_PP_ADVP_RB
" " B-O O-ADVP
in B-O B-IN
erythroid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
also B-O B-PP_RB
in B-O B-IN
airway B-O B-NP_NP_NN
epithelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
eosinophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
in B-O B-PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
5' B-O B-NP_JJ
flanking B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
15-lox B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contains B-O B-VP_VBZ
sequences B-O B-NP_NP_NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
down-regulate B-O B-S_NP_VP_VBP
" " B-O B-NP_PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
element B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
characteristics B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
transcriptional B-O B-NP_JJ
' B-O B-LQT
silencer B-O B-NN
' B-O B-RQT
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
since B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
functions B-O B-VP_VBZ
in B-O B-PP_IN
both B-O B-NP_DT
orientations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
main B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
silencer B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
mapped B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
first B-O B-JJ
900 B-O B-CD
bp B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
5' B-O B-NP_NP_JJ
flanking B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_S_NP_DT
binding B-O B-NP_VBG
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
similar B-O B-NP_JJ
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
multiple B-O B-S_NP_NP_JJ
copies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
confer B-O B-VP_VBP
tissue-specific B-O B-NP_JJ
down-regulation B-O B-NN
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
attached B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
a B-O B-NP_DT
minimal B-O B-NP_JJ
lox B-O B-NN
promoter B-O B-NN
fragment B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
5' B-O B-NP_JJ
flanking B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
contains B-O B-VP_VBZ
a B-O B-NP_NP_DT
cluster B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
three B-O B-NP_CD
binding B-O B-NP_VBG
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
the B-O B-NP_NP_DT
GATA B-O B-NP_NN
family B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Coexpression B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NP_NN
B B-O B-NN
/Rel B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
Sp1 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
1-induced B-O B-JJ
, B-O B-COMMA
dendritic B-O B-JJ
cell-T-cell B-O B-NN
syncytia B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Productive B-O B-S_S_NP_NP_JJ
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
typically B-O B-ADVP_RB
" " B-O O-ADVP
requires B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_DT
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
be B-O B-VP_VB
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_NP_DT
requirement B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
attributed B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
, B-O B-NP_COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recently B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
found B-O B-VP_VBN
that B-O B-SBAR_IN
vigorous B-O B-S_NP_NP_JJ
replication B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
takes B-O B-VP_VBZ
place B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
nonactivated B-O B-NP_JJ
memory B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
syncytium B-O B-NP_NP_NN
formation B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
syncytia B-O B-NNS
" " B-O O-NP
lack B-O B-VP_VBP
activated B-O B-NP_VBN
cells B-O B-NNS
" " B-O O-NP
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
expression B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
Sp1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
, B-O B-COMMA
therefore B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
analyzed B-O B-VP_VBN
in B-O B-NP_PP_IN
isolated B-O B-NP_NP_VBN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
DCs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
humans B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
mice B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
used B-O B-VP_VBN
immunolabeling B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Western B-O B-NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
" " B-O O-NP
and B-O B-CC
supershift B-O B-NP_NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
T B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
lack B-O B-VP_VP_VBP
active B-O B-NP_JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
but B-O B-CC
express B-O B-VP_VBP
Sp1 B-O B-NP_NN
" " B-O O-NP
as B-O B-SBAR_IN
expected B-O B-S_NP_VP_VBN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DCs B-O B-S_NP_NNS
" " B-O O-NP
express B-O B-VP_VBP
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
all B-O B-NP_DT
known B-O B-JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
Rel B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
with B-O B-PP_IN
activity B-O B-S_NP_NN
" " B-O O-NP
residing B-O B-VP_VBG
primarily B-O B-PP_ADVP_RB
" " B-O O-ADVP
within B-O B-IN
RelB B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p50 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
DCs B-O B-NP_NNS
" " B-O O-NP
lack B-O B-VP_VBP
Sp1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
may B-O B-S_NP_VP_MD
explain B-O B-VP_VB
the B-O B-NP_NP_DT
failure B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Coexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
Sp1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurs B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_DT
heterologous B-O B-NP_JJ
DC-T-cell B-O B-NN
syncytia B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
HIV-1-induced B-O B-NP_JJ
cell B-O B-NN
fusion B-O B-NN
" " B-O O-NP
brings B-O B-VP_VBZ
together B-O B-ADVP_RB
" " B-O O-ADVP
factors B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
upregulate B-O B-S_NP_VP_VBP
virus B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
DCs B-O B-S_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
memory B-O B-NP_NN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
frequently B-O B-ADVP_RB
" " B-O O-ADVP
traffic B-O B-VP_VBP
together B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-ADVP_FW
situ B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
these B-O B-S_NP_DT
unusual B-O B-JJ
heterologous B-O B-NP_JJ
syncytia B-O B-NN
" " B-O O-NP
" " B-O O-NP
could B-O B-VP_MD
develop B-O B-VP_VP_VB
in B-O B-PP_IN
infected B-O B-NP_JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
lead B-O B-VP_VB
to B-O B-PP_TO
chronic B-O B-NP_NP_JJ
HIV-1 B-O B-NN
replication B-O B-NN
" " B-O O-NP
without B-O B-PP_IN
ostensible B-O B-NP_JJ
immune B-O B-JJ
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Down-regulation B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NP_NN
B B-O B-NN
protein B-O B-NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
activated B-O B-NP_VBN
human B-O B-JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
1,25-dihydroxyvitamin B-O B-NP_NN
D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
[ B-O B-S_LRB
published B-O B-NP_VBN
erratum B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
in B-O B-PP_IN
Proc B-O B-NP_NP_NNP
Natl B-O B-NNP
Acad B-O B-NNP
Sci B-O B-NNP
U B-O B-NNP
S B-O B-NNP
A B-O B-NNP
" " B-O O-NP
1996 B-O B-NP_CD
Jan B-O B-NNP
9 B-O B-CD
" " B-O O-NP
; B-O B-COLON
93 B-O B-NP_CD
( B-O B-LRB
1 B-O B-CD
) B-O B-RRB
" " B-O O-NP
: B-O B-COLON
524 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1,25-dihydroxyvitamin B-O B-NP_NP_NP_NN
D3 B-O B-NN
" " B-O O-NP
[ B-O B-PRN_LRB
1,25(OH)2)D3 B-O B-NP_NN
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
steroid B-O B-NN
hormone B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
immunomodulating B-O B-NP_NN
properties B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
on B-O B-PP_IN
nuclear B-O B-NP_NP_NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
examined B-O B-VP_VBN
in B-O B-NP_PP_IN
in B-O B-NP_FW
vitro B-O B-FW
activated B-O B-VBN
normal B-O B-JJ
human B-O B-JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
Western B-O B-NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Over B-O B-S_PP_IN
a B-O B-NP_NP_DT
72-hr B-O B-JJ
period B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
50-kDa B-O B-NP_NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
its B-O B-NP_NP_PRPP
precursor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
p105 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
increased B-O B-VP_VBN
progressively B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
cells B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
activated B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
mature B-O B-JJ
protein B-O B-NN
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
its B-O B-NP_PRPP
precursor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
decreased B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
hormone B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
demonstrable B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_DT
cytosolic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
nuclear B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
compartments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
it B-O B-S_NP_PRP
" " B-O O-NP
required B-O B-VP_VP_VBD
between B-O B-PP_IN
4 B-O B-NP_QP_CD
and B-O B-CC
8 B-O B-CD
" " B-O O-QP
hr B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
was B-O B-VP_VBD
specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
as B-O B-SBAR_IN
25-hydroxyvitamin B-O B-S_NP_NP_NN
D3 B-O B-NN
" " B-O O-NP
and B-O B-CC
24,25-dihydroxyvitamin B-O B-NP_NN
D3 B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
ineffective B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Besides B-O B-S_PP_IN
p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
decreased B-O B-VP_VBD
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
another B-O B-NP_NP_DT
NF-kappa B-O B-NP_NN
B B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
namely B-O B-ADVP_RB
" " B-O O-ADVP
c-rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
decreased B-O B-VP_VBD
the B-O B-NP_NP_DT
abundance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
specific B-O B-NP_JJ
DNA-protein B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
formed B-O B-VP_VBN
upon B-O B-NP_PP_IN
incubation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
with B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Jurkat B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
transiently B-O B-VP_ADVP_RB
" " B-O O-ADVP
transfected B-O B-VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
containing B-O B-NP_VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
observations B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VP_VBP
directly B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
there B-O B-S_NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
de B-O B-NP_NP_ADJP_FW
novo B-O B-FW
" " B-O O-ADJP
synthesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
during B-O B-PP_IN
human B-O B-NP_JJ
lymphocyte B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
this B-O B-S_NP_DT
process B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
hormonally B-O B-ADVP_RB
" " B-O O-ADVP
regulated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Staphylococcal B-O B-S_S_NP_JJ
enterotoxins B-O B-NNS
" " B-O O-NP
modulate B-O B-VP_VBP
interleukin B-O B-NP_NP_NP_NN
2 B-O B-CD
receptor B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
and B-O B-CC
ligand-induced B-O B-NP_NP_JJ
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
" " B-O B-NP_NP_PRN_O-NP
and B-O B-CC
signal B-O B-NP_NP_NN
transducers B-O B-NNS
and B-O B-CC
activators B-O B-NNS
of B-O B-IN
transcription B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Staphylococcal B-O B-S_S_NP_NP_JJ
enterotoxins B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
SE B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
stimulate B-O B-VP_VP_VBP
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
expressing B-O B-VP_VBG
the B-O B-NP_DT
appropriate B-O B-JJ
variable B-O B-NP_JJ
region B-O B-NN
beta B-O B-NN
chain B-O B-NN
of B-O B-IN
( B-O B-LRB
V B-O B-NN
beta B-O B-NN
) B-O B-RRB
T-cell B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
have B-O B-VP_VBP
been B-O B-VP_VBN
implicated B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
pathogenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Depending B-O B-S_PP_VBG
on B-O B-PP_IN
costimulatory B-O B-NP_JJ
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
SE B-O B-NP_NNS
" " B-O O-NP
induce B-O B-VP_VBP
either B-O B-NP_NP_CC
proliferation B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
anergy B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
SE B-O B-NP_NNS
" " B-O O-NP
can B-O B-VP_MD
induce B-O B-VP_VB
an B-O B-NP_NP_DT
interleukin-2 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
nonresponsive B-O B-JJ
state B-O B-NN
" " B-O O-NP
and B-O B-CC
apoptosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
SE B-O B-S_NP_NNS
" " B-O O-NP
induce B-O B-VP_VBP
dynamic B-O B-NP_NP_JJ
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
and B-O B-NP_NP_NP_PP_CC
" " B-O B-NP_NP_PP_NP_NP_PRN_O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
antigen-specific B-O B-JJ
CD4+ B-O B-JJ
T-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
after B-O B-PP_IN
4 B-O B-NP_NP_CD
hr B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
exposure B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
SEA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
SEB B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-S_S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2R B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
down-regulated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
IL-2R B-O B-S_NP_NN
gamma B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
slightly B-O B-ADVP_RB
" " B-O O-ADVP
up-regulated B-O B-VP_VBN
" " B-O B-NP_O-VP
, B-O B-COMMA
while B-O B-SBAR_IN
IL-2R B-O B-S_NP_NN
alpha B-O B-NN
" " B-O O-NP
remained B-O B-VP_VBD
largely B-O B-ADJP_RB
unaffected B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
composition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2Rs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL-2-induced B-O B-NP_NP_JJ
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
parallel B-O B-NP_JJ
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
IL-2-driven B-O B-NP_JJ
proliferation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
significantly B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_S_PP_IN
16 B-O B-NP_NP_CD
hr B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
exposure B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
SE B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2R B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
remained B-O B-VP_VBD
low B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
while B-O B-SBAR_IN
that B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
IL2R B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
and B-O B-CC
IL2R B-O B-NP_NN
gamma B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
further B-O B-ADVP_RB
" " B-O O-ADVP
up-regulated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
ligand-induced B-O B-S_NP_NP_JJ
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Jak3 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Stat B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
partly B-O B-ADVP_RB
" " B-O O-ADVP
normalized B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Yet B-O B-S_RB
, B-O B-COMMA
IL-2-driven B-O B-NP_JJ
proliferation B-O B-NN
" " B-O O-NP
remained B-O B-VP_VBD
profoundly B-O B-VP_ADVP_RB
" " B-O O-ADVP
inhibited B-O B-JJ
" " B-O B-NP_O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
signaling B-O B-S_NP_NP_NN
events B-O B-NNS
" " B-O O-NP
other B-O B-CONJP_JJ
than B-O B-IN
" " B-O O-CONJP
Jak3/Stat B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
had B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
changed B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
conclusion B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
our B-O B-NP_PRPP
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
SE B-O B-S_NP_NNS
" " B-O O-NP
can B-O B-VP_MD
modulate B-O B-VP_VB
expression B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
" " B-O B-NP_NP_VP_O-NP
in B-O B-PP_IN
CD4+ B-O B-NP_JJ
T-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Mutation B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Jak3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_NP_DT
patient B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
SCID B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
essential B-O B-NP_NP_JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Jak3 B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
lymphoid B-O B-NP_JJ
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Males B-O B-S_S_NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
X-linked B-O B-NP_NP_JJ
severe B-O B-JJ
combined B-O B-JJ
immunodeficiency B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
XSCID B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
defects B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
common B-O B-JJ
cytokine B-O B-NP_NN
receptor B-O B-NN
gamma B-O B-NN
chain B-O B-NN
( B-O B-LRB
gamma B-O B-NN
c B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
encodes B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
Janus B-O B-NP_NP_NN
family B-O B-NN
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
Jak3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
only B-O B-JJ
signaling B-O B-VBG
molecule B-O B-NN
" " B-O O-NP
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
so B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
hypothesized B-O B-VP_VBN
that B-O B-SBAR_IN
might B-O B-S_NP_NP_PP_VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
girl B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
immunological B-O B-NP_NP_JJ
features B-O B-NNS
" " B-O O-NP
indistinguishable B-O B-ADJP_JJ
from B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
XSCID B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
therefore B-O B-ADVP_RB
" " B-O O-ADVP
selected B-O B-VP_VBN
for B-O B-NP_PP_IN
analysis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_NP_DT
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
( B-O B-LRB
EBV B-O B-NN
) B-O B-RRB
-transformed B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
her B-O B-NP_PRPP
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
had B-O B-VP_VP_VP_VBD
normal B-O B-NP_JJ
gamma B-O B-NP_NN
c B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
but B-O B-CC
lacked B-O B-VP_VBD
Jak3 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
had B-O B-VP_VBD
greatly B-O B-NP_ADJP_RB
diminished B-O B-VBN
" " B-O O-ADJP
Jak3 B-O B-NP_NN
messenger B-O B-NN
RNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Sequencing B-O B-S_S_NP_NN
" " B-O O-NP
revealed B-O B-VP_VBD
a B-O B-NP_NP_DT
different B-O B-JJ
mutation B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
each B-O B-NP_DT
allele B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
a B-O B-NP_NP_DT
single B-O B-JJ
nucleotide B-O B-NN
insertion B-O B-NN
" " B-O O-NP
resulting B-O B-VP_VBG
in B-O B-PP_IN
a B-O B-NP_NP_NP_NP_DT
frame B-O B-NN
shift B-O B-NN
" " B-O O-NP
and B-O B-CC
premature B-O B-NP_JJ
termination B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
Jak3 B-O B-NP_NN
JH4 B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
nonsense B-O B-JJ
mutation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
Jak3 B-O B-NP_NN
" " B-O O-NP
JH2 B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
lack B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Jak3 B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlated B-O B-VP_VBD
with B-O B-PP_IN
impaired B-O B-NP_JJ
B B-O B-NN
cell B-O B-NN
signaling B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-SBAR_IN
demonstrated B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
inability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
observations B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_NP_DT
functions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
gamma B-O B-NP_NN
c B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
Jak3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
Jak3 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
lymphoid B-O B-NP_JJ
and B-O B-NP_CC
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Inhibition B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
dexamethasone B-O B-NP_NP_NN
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
human B-O B-NP_JJ
glucocorticoid B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
New B-O B-NP_NN
World B-O B-NN
primate B-O B-JJ
cell B-O B-NN
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
To B-O B-S_S_S_NP_VP_TO
determine B-O B-VP_VB
if B-O B-SBAR_IN
New B-O B-S_NP_NN
World B-O B-NN
primates B-O B-NNS
" " B-O O-NP
express B-O B-VP_VBP
" " B-O B-NP_NP_SBAR_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
[3H]dexamethasone B-O B-NP_NP_NN
binding B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cytosol B-O B-NP_NP_NN
" " B-O O-NP
prepared B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_O-VP
, B-O B-COMMA
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
B95-8 B-O B-S_NP_NN
cytosol B-O B-NN
" " B-O O-NP
inhibited B-O B-VP_VBD
specific B-O B-NP_NP_JJ
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
[3H]dexamethasone B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-NP_NP_NN
" " B-O O-NP
< B-O B-ADJP_JJR
0.01 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
mixed B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
cytosol B-O B-NP_NP_NN
" " B-O O-NP
prepared B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
inhibitory B-O B-JJ
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
heat B-O B-ADJP_ADJP_NN
labile B-O B-JJ
" " B-O O-ADJP
and B-O B-CC
trypsin B-O B-ADJP_NP_NN
" " B-O O-NP
sensitive B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Peak B-O B-S_NP_JJ
inhibitory B-O B-JJ
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
150-200 B-O B-ADJP_QP_CD
" " B-O O-QP
kd B-O B-NN
" " B-O O-ADJP
fractions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
Sephacryl B-O B-NP_NN
G-200 B-O B-NN
ultrafiltration B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Scatchard B-O B-S_NP_NP_NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
[3H]dexamethasone B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
using B-O B-VP_VBG
mixed B-O B-NP_JJ
cytosol B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
showed B-O B-VP_VBD
a B-O B-NP_DT
diminished B-O B-VBN
GR B-O B-NP_NN
" " B-O O-NP
apparent B-O B-JJ
binding B-O B-NN
affinity B-O B-NN
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
HL B-O B-NP_NN
cytosol B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Kinetic B-O B-S_NP_NP_JJ
studies B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
mixed B-O B-NP_JJ
cytosol B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
B95-8 B-O B-S_NP_NN
cytosol B-O B-NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
affect B-O B-VP_VB
the B-O B-NP_NP_DT
apparent B-O B-JJ
dissociation B-O B-NN
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
[3H]dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
B95-8 B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
contain B-O B-VP_VBP
a B-O B-NP_NP_DT
competitive B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
prevents B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Costimulation B-O B-NP_NP_NP_NN
requirement B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
AP-1 B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
transcription B-O B-NN
factor B-O B-NN
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VBZ
T-cell B-O B-NP_NP_NP_NN
" " B-O O-NP
costimulation B-O B-NN
" " B-O O-NP
delivered B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
TCR B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
auxiliary B-O B-NP_JJ
receptor B-O B-NN
CD28 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Several B-O B-S_NP_JJ
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
participate B-O B-VP_VBP
in B-O B-PP_IN
IL-2 B-O B-NP_NP_NP_NN
" " B-O O-NP
promoter B-O B-NN
activation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
among B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
are B-O B-SINV_VP_VBP
AP-1-like B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-SINV
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Protein B-O B-S_S_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
two B-O B-CD
factors B-O B-NNS
" " B-O B-S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
( B-O B-S_S_LST_LRB
1 B-O B-LS
) B-O B-RRB
" " B-O O-LST
it B-O B-NP_PRP
" " B-O O-NP
induces B-O B-VP_VBZ
the B-O B-NP_NP_DT
transactivating B-O B-NN
capacity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
AP-1 B-O B-NP_NP_NN
protein B-O B-NN
" " B-O O-NP
c-Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
and B-O B-CC
( B-O B-S_LST_LRB
2 B-O B-LS
) B-O B-RRB
" " B-O O-LST
it B-O B-NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
release B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
, B-O B-COMMA
from B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
allowing B-O B-S_NP_VP_VBG
translocation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
latter B-O B-JJ
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
recently B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
both B-O B-S_NP_DT
phosphorylation B-O B-NN
processes B-O B-NNS
" " B-O O-NP
require B-O B-VP_VBP
T-cell B-O B-NP_NN
costimulation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
kinetics B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
two B-O B-CD
phosphorylation B-O B-NN
events B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
essentially B-O B-ADJP_RB
similar B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
According B-O B-S_PP_VBG
to B-O B-PP_TO
our B-O B-NP_PRPP
results B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
kinases B-O B-NNS
" " B-O O-NP
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_DT
two B-O B-CD
processes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
are B-O B-VP_VBP
distinct B-O B-NP_JJ
entities B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Whereas B-O B-S_SBAR_IN
TPCK B-O B-S_NP_NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
phosphorylation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
, B-O B-COMMA
consequently B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
it B-O B-S_NP_PRP
" " B-O O-NP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
enhances B-O B-VP_VBZ
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
JNK B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
MAP B-O B-NP_NP_NN
kinase-related B-O B-JJ
kinase B-O B-NN
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
, B-O B-COMMA
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
propose B-O B-VP_VBP
the B-O B-NP_NP_DT
activation B-O B-NN
scheme B-O B-NN
" " B-O O-NP
presented B-O B-VP_VBN
in B-O B-NP_PP_IN
FIGURE B-O B-NP_NN
3 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
for B-O B-PP_IN
T-cell B-O B-NP_NN
costimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Costimulation B-O B-S_NP_NN
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
signaling B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
leads B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Integration B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
signals B-O B-NNS
" " B-O O-NP
generated B-O B-VP_VBN
by B-O B-NP_PP_IN
TCR B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
CD28 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
engagement B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurs B-O B-VP_VBZ
along B-O B-PP_IN
this B-O B-NP_NP_DT
pathway B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
then B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
bifurcates B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
are B-O B-VP_VBP
currently B-O B-ADVP_RB
" " B-O O-ADVP
engaged B-O B-VP_VBN
in B-O B-NP_PP_IN
defining B-O B-S_NP_VP_VBG
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
two B-O B-CD
signals B-O B-NNS
" " B-O O-NP
integrate B-O B-VP_VBP
" " B-O B-PP_ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Chromosomal B-O B-NP_NP_NP_JJ
localization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_NP_CD
KOX B-O B-NP_NN
zinc B-O B-NN
finger B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
chromosome B-O B-NP_NP_NN
bands B-O B-NNS
" " B-O O-NP
7q21-q22 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Human B-O B-S_S_NP_NP_JJ
cDNAs B-O B-NNS
" " B-O O-NP
encoding B-O B-VP_VBG
Kruppel-type B-O B-NP_NP_JJ
zinc B-O B-NN
finger B-O B-NN
domains B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
designated B-O B-VP_VBN
KOX B-O B-S_NP_NP_NN
1-32 B-O B-CD
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
cloned B-O B-VP_VBN
from B-O B-NP_PP_IN
human B-O B-NP_JJ
T B-O B-NN
lymphocyte B-O B-NN
cell B-O B-NN
line B-O B-NN
libraries B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
the B-O B-NP_NP_DT
regional B-O B-JJ
localizations B-O B-NNS
" " B-O O-NP
by B-O B-PP_IN
in B-O B-NP_NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
KOX B-O B-NP_NP_NP_NN
18 B-O B-CD
" " B-O O-NP
and B-O B-CC
KOX B-O B-NP_NN
25 B-O B-CD
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
chromosome B-O B-NP_NN
bands B-O B-NNS
7q21q22 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Pulse-field B-O B-S_NP_NP_NP_JJ
gel B-O B-NN
electrophoresis B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PFGE B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
analysis B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
these B-O B-S_NP_DT
genes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
physically B-O B-ADVP_RB
" " B-O O-ADVP
located B-O B-ADJP_JJ
within B-O B-PP_IN
a B-O B-NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
genes B-O B-NNS
" " B-O O-NP
KOX B-O B-NP_NP_NN
4 B-O B-CD
" " B-O O-NP
and B-O B-CC
KOX B-O B-NP_NN
9 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
mapped B-O B-VP_VBN
on B-O B-NP_PP_IN
chromosome B-O B-NP_NN
8q24 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
located B-O B-ADJP_JJ
within B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
From B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
previous B-O B-NP_JJ
" " B-O B-NP_O-NP
data B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
eighteen B-O B-NP_CD
different B-O B-JJ
KOX B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
located B-O B-ADJP_JJ
at B-O B-NP_ADVP_IN
least B-O B-JJS
" " B-O O-ADVP
two B-O B-NP_NP_CD
" " B-O O-NP
by B-O B-PP_IN
two B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
within B-O B-PP_IN
nine B-O B-NP_NP_CD
DNA B-O B-NP_NN
fragments B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
200 B-O B-NP_QP_CD
to B-O B-TO
580 B-O B-CD
" " B-O O-QP
kb B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Expression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
chemokine B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
BLR2/EBI1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
specifically B-O B-ADVP_RB
" " B-O O-ADVP
transactivated B-O B-VP_VBN
by B-O B-NP_PP_IN
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
nuclear B-O B-JJ
antigen B-O B-NN
2 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_S_PP_IN
our B-O B-NP_NP_PRPP
attempt B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
identify B-O B-VP_VB
chemokine B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
used B-O B-VP_VBD
RT-PCR B-O B-NP_NP_NN
" " B-O O-NP
resulting B-O B-VP_VBG
in B-O B-PP_IN
the B-O B-NP_NP_DT
isolation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
protein B-O B-NN
" " B-O O-NP
shows B-O B-VP_VP_VBZ
significant B-O B-NP_NP_JJ
sequence B-O B-NN
similarities B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
G-protein B-O B-NP_NN
coupled B-O B-JJ
chemokine B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
turned B-O B-VP_VBD
out B-O B-PRT_RP
" " B-O O-PRT
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
identical B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_DT
" " B-O B-ADJP_NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
BLR2 B-O B-S_NP_NN
mRNA B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
highly B-O B-ADVP_RB
" " B-O O-ADVP
stimulated B-O B-VP_VBN
in B-O B-NP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
BLR2-specific B-O B-S_NP_JJ
mRNA B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
all B-O B-NP_DT
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
positive B-O B-JJ
B B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
transcription B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
BLR2 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
specifically B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
negative B-O B-JJ
BL B-O B-NN
41 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
via B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
an B-O B-NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
BLR2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
migration B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
activated B-O B-NP_VBN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
viral B-O B-NP_JJ
pathogenesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cupric B-O B-S_S_NP_JJ
ion B-O B-NN
" " B-O O-NP
blocks B-O B-VP_VBZ
NF B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
through B-O B-PP_IN
inhibiting B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
signal-induced B-O B-JJ
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_S_NP_NP_DT
transcription B-O B-NP_NP_NN
factor B-O B-NN
" " B-O O-NP
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
regulates B-O B-S_NP_VP_VBZ
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
sequestered B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_NP_DT
complex B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
an B-O B-NP_DT
inhibitory B-O B-NP_JJ
protein B-O B-NN
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Various B-O B-S_NP_JJ
extracellular B-O B-JJ
signals B-O B-NNS
" " B-O O-NP
induce B-O B-VP_VBP
phosphorylation B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
rapid B-O B-NP_JJ
degradation B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-S_NP_VP_TO
release B-O B-VP_VB
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cu2+ B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
inhibit B-O B-VP_VB
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deoxycholate B-O B-S_NP_NP_NN
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
cytoplasmic B-O B-JJ
extract B-O B-NN
" " B-O O-NP
prepared B-O B-VP_VBN
from B-O B-NP_PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
by B-O B-NP_PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
the B-O B-NP_NP_DT
release B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
Cu2+ B-O B-S_NP_NN
" " B-O O-NP
interferes B-O B-VP_VBZ
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Neither B-O B-S_NP_NP_CC
phosphorylation B-O B-NP_NN
" " B-O O-NP
nor B-O B-CC
degradation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
upon B-O B-NP_PP_IN
TNF-alpha B-O B-NP_NP_NP_NN
" " B-O O-NP
stimulation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Cu2+ B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
Cu2+ B-O B-S_NP_NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
the B-O B-NP_NP_DT
release B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
blockade B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Interleukin-7 B-O B-S_S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
induce B-O B-VP_VB
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Jak B-O B-NP_NP_NN
1 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
Jak B-O B-NP_NN
3 B-O B-CD
" " B-O O-NP
and B-O B-CC
STAT B-O B-NP_NN
5 B-O B-CD
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
murine B-O B-NP_JJ
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Janus B-O B-NP_NP_NP_NN
protein B-O B-NN
tyrosine B-O B-NN
kinases B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
Jak B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
STAT B-O B-NP_NN
( B-O B-LRB
signal B-O B-NN
transducer B-O B-NN
and B-O B-CC
activator B-O B-NN
of B-O B-IN
transcription B-O B-NN
) B-O B-RRB
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
recently B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
linked B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
signal B-O B-NN
transduction B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_JJ
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
IL-7 B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
a B-O B-NP_NP_NP_DT
tyrosine B-O B-ADJP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
concomitantly B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
and B-O B-NP_CC
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
STAT B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
utilized B-O B-VP_VBN
by B-O B-NP_PP_IN
IL-7 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VP_VBD
identical B-O B-ADJP_JJ
to B-O B-PP_TO
those B-O B-NP_NP_DT
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
could B-O B-VP_MD
be B-O B-VP_VB
identified B-O B-VP_VBN
as B-O B-NP_PP_IN
various B-O B-NP_JJ
STAT B-O B-NP_NN
5 B-O B-CD
isoforms B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
Jak B-O B-NN
1 B-O B-NP_CD
" " B-O O-NP
and B-O B-CC
3 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
STAT B-O B-NP_NP_NN
5 B-O B-CD
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
correlated B-O B-VP_VBD
with B-O B-PP_IN
the B-O B-NP_NP_DT
growth-promoting B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
IL-7 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
this B-O B-S_NP_DT
signal B-O B-NN
transduction B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
play B-O B-VP_VB
a B-O B-NP_DT
key B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Lymphocyte B-O B-NP_NP_NP_NN
glucocorticoid B-O B-NN
receptor B-O B-NN
: B-O B-COLON
" " B-O O-NP
predictor B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
sertraline B-O B-NP_NP_NN
response B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
adolescent B-O B-NP_JJ
major B-O B-NP_NP_JJ
depressive B-O B-JJ
disorder B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Major B-O B-S_S_NP_NP_NP_JJ
depressive B-O B-JJ
disorder B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MDD B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
adolescents B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrates B-O B-VP_VBZ
resistance B-O B-NP_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
tricyclic B-O B-NP_JJ
antidepressants B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
absence B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
hypercortisolemia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
efficacy B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
serotonin B-O B-NP_NP_NN
reuptake B-O B-NN
inhibitors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
SRIs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
uncertain B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
response B-O B-S_NP_NN
predictors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
unavailable B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Abnormal B-O B-S_NP_NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
fast B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
feedback B-O B-NN
" " B-O O-NP
and B-O B-CC
negative B-O B-NP_JJ
feedback B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
hypothalamic-pituitary-adrenal B-O B-JJ
axis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
implicates B-O B-VP_VBZ
a B-O B-NP_DT
dampened B-O B-JJ
limbic-hippocampal B-O B-NP_NP_JJ
glucocorticoid B-O B-NN
type B-O B-NN
II B-O B-CD
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GCII B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
hypothesized B-O B-VP_VBD
that B-O B-SBAR_IN
lymphocyte B-O B-S_NP_NN
GCII B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
altered B-O B-VP_VBN
in B-O B-NP_PP_IN
adolescent B-O B-NP_JJ
MDD B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
could B-O B-VP_MD
serve B-O B-VP_VB
as B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
an B-O B-NP_DT
open-label B-O B-JJ
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
adolescents B-O B-NP_NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
n B-O B-NP_NP_NN
" " B-O O-NP
= B-O B-ADJP_JJ
20 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
meeting B-O B-VP_VBG
DSM-III-R B-O B-NP_NP_NN
criteria B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
MDD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
showed B-O B-VP_VBD
baseline B-O B-NP_NP_NP_NN
lymphocyte B-O B-NP_NN
GCII B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
per B-O B-PP_IN
cell B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
sites/cell B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
values B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
793 B-O B-NP_NP_CD
+/- B-O B-CC
106 B-O B-CD
" " B-O O-NP
versus B-O B-CC
2 B-O B-NP_NP_NP_CD
, B-O B-COMMA
563 B-O B-CD
+/- B-O B-CC
499 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
+/- B-O B-NP_CC
SEM B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
for B-O B-PP_IN
( B-O B-NP_NP_NP_PRN_PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
GCII B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
bimodally B-O B-ADVP_RB
" " B-O O-ADVP
distributed B-O B-VP_VBN
, B-O B-NP_COMMA
with B-O B-PP_IN
SRI B-O B-S_NP_NN
responders B-O B-NNS
" " B-O O-NP
differing B-O B-VP_VBG
from B-O B-PP_IN
nonresponders B-O B-NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
GCII B-O B-S_NP_NN
" " B-O O-NP
accurately B-O B-ADVP_RB
" " B-O O-ADVP
classified B-O B-VP_VBD
90 B-O B-NP_NP_NP_CD
percent B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
sertraline B-O B-NP_NN
responders B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
80 B-O B-NP_NP_CD
percent B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nonresponders B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Only B-O B-S_NP_RB
SRI B-O B-NN
responders B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
GCII B-O B-NP_NP_NP_NN
" " B-O O-NP
sites/cell B-O B-NNS
" " B-O O-NP
upregulated B-O B-VP_VBN
after B-O B-NP_PP_IN
6 B-O B-NP_NP_CD
weeks B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
treatment B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
( B-O B-PRN_LRB
t B-O B-NP_NP_NP_NN
" " B-O O-NP
= B-O B-ADJP_JJ
2.1 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
, B-O B-COMMA
df B-O B-NP_NP_NN
" " B-O O-NP
= B-O B-ADJP_JJ
10 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
; B-O B-COLON
p B-O B-NP_NP_NN
" " B-O O-NP
< B-O B-ADJP_JJR
.05 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Salicylates B-O B-S_S_NP_NNS
" " B-O O-NP
inhibit B-O B-VP_VBP
lipopolysaccharide-induced B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
transcriptional B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
tissue B-O B-NN
factor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Binding B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
plasma B-O B-NP_NN
Factor B-O B-NN
VII/VIIa B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
tissue B-O B-NP_NN
factor B-O B-NN
( B-O B-LRB
TF B-O B-NN
) B-O B-RRB
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
initiates B-O B-VP_VBZ
the B-O B-NP_DT
coagulation B-O B-NP_NN
protease B-O B-NN
" " B-O O-NP
cascades B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
TF B-O B-S_NP_NP_NN
expression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
circulating B-O B-NP_VBG
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
thrombotic B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
inflammatory B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
complications B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
diseases B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transcriptional B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
TF B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
monocytic B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
exposed B-O B-VP_VBN
to B-O B-NP_PP_TO
bacterial B-O B-NP_NP_JJ
lipopolysaccharide B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
LPS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-Rel B-O B-NP_NN
/p65 B-O B-NN
heterodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_NP_DT
kappa B-O B-NP_NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_NP_DT
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
anti-inflammatory B-O B-NP_JJ
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
known B-O B-VP_VBN
as B-O B-NP_PP_IN
the B-O B-NP_DT
salicylates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
inhibited B-O B-VP_VBD
LPS B-O B-NP_NP_NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
TF B-O B-NP_NP_NN
gene B-O B-NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
monocytic B-O B-NP_JJ
THP-1 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
at B-O B-PP_IN
clinically B-O B-NP_ADJP_RB
relevant B-O B-JJ
" " B-O O-ADJP
doses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
sodium B-O B-NP_NN
salicylate B-O B-NN
" " B-O O-NP
blocked B-O B-VP_VBD
the B-O B-NP_NP_DT
LPS-induced B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
proteolytic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
degradation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
prevented B-O B-S_NP_VP_VBD
the B-O B-NP_NP_DT
nuclear B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Rel B-O B-NP_NN
/p65 B-O B-NN
heterodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
two B-O B-NP_NP_CD
other B-O B-JJ
nonsteroidal B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
anti-inflammatory B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
drugs B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
ibuprofen B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
indomethacin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
inhibit B-O B-VP_VB
LPS B-O B-NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TF B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
salicylates B-O B-S_NP_NNS
" " B-O O-NP
inhibited B-O B-VP_VBD
LPS B-O B-NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
preventing B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
clinical B-O B-JJ
benefits B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
salicylates B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_NP_JJ
diseases B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
atherosclerosis B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
rheumatoid B-O B-NP_NN
arthritis B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
related B-O B-ADJP_JJ
to B-O B-PP_TO
their B-O B-NP_PRPP
ability B-O B-NN
to B-O B-S_NP_VP_TO
reduce B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Oncogenicity B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
papillomavirus- B-O B-NP_ADJP_NN
" " B-O O-ADJP
" " B-O B-ADJP_NP_O-NP
or B-O B-CC
adenovirus-transformed B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
resistance B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
lysis B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
natural B-O B-NP_JJ
killer B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
reasons B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
dissimilar B-O B-JJ
oncogenicities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_NP_JJ
adenoviruses B-O B-NNS
" " B-O O-NP
and B-O B-CC
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
humans B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VP_VBP
unknown B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
but B-O B-CC
may B-O B-VP_MD
relate B-O B-VP_VB
to B-O B-PP_TO
differences B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_S_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
As B-O B-S_PP_IN
one B-O B-NP_NP_CD
test B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
hypothesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
compared B-O B-VP_VBD
the B-O B-NP_NP_DT
abilities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
E1A- B-O B-NP_NP_ADJP_ADJP_ADJP_NN
" " B-O B-ADJP_O-ADJP
and B-O B-CC
E7-expressing B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
human B-O B-ADJP_JJ
fibroblastic B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O B-NP_O-NP
or B-O B-CC
keratinocyte-derived B-O B-NP_ADJP_JJ
human B-O B-JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
selectively B-O B-ADVP_RB
" " B-O O-ADVP
killed B-O B-VP_VBN
by B-O B-NP_PP_IN
either B-O B-NP_CC
or B-O B-NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cells B-O B-S_NP_NP_NNS
" " B-O O-NP
expressing B-O B-VP_VBG
the B-O B-NP_DT
E1A B-O B-NP_NN
oncoprotein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
selectively B-O B-ADVP_RB
" " B-O O-ADVP
killed B-O B-VP_VBN
by B-O B-NP_PP_IN
unstimulated B-O B-NP_JJ
NK B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
while B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
same B-O B-JJ
parental B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
but B-O B-CC
expressing B-O B-NP_NP_VP_VBG
the B-O B-NP_DT
" " B-O B-NP_NP_PRN_NP_O-NP
or B-O B-CC
HPV-18 B-O B-NP_NN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
resistant B-O B-ADJP_JJ
to B-O B-PP_TO
NK B-O B-NP_NN
cell B-O B-NN
lysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IFN-activated B-O B-NP_JJ
NK B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_PP_TO
selectively B-O B-ADVP_RB
" " B-O O-ADVP
kill B-O B-VP_VB
virally B-O B-NP_RB
transformed B-O B-VBN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-PP
" " B-O O-S
" " B-O O-NP
depends B-O B-VP_VBZ
on B-O B-PP_IN
IFN B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
's B-O B-POS
" " B-O O-NP
ability B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
resistance B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_CONJP_NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
E1A B-O B-S_NP_NN
" " B-O O-NP
blocked B-O B-VP_VBD
IFN B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
's B-O B-POS
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytolytic B-O B-NP_JJ
resistance B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
resulting B-O B-S_NP_VP_VBG
in B-O B-PP_IN
the B-O B-NP_NP_DT
selective B-O B-JJ
lysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
adenovirus-transformed B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
IFN-activated B-O B-NP_JJ
NK B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
extent B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IFN-induced B-O B-NP_NP_JJ
NK B-O B-NN
cell B-O B-NN
killing B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E1A-expressing B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VP_VBD
proportional B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E1A B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
correlated B-O B-VP_VBN
with B-O B-PP_IN
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E1A B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
block B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
E7 B-O B-NP_NN
" " B-O O-NP
blocked B-O B-VP_VBD
neither B-O B-NP_CC
IFN-stimulated B-O B-NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
nor B-O B-CC
IFN B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
's B-O B-POS
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytolytic B-O B-NP_JJ
resistance B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
thereby B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
precluding B-O B-VP_VBG
the B-O B-NP_NP_DT
selective B-O B-JJ
lysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HPV-transformed B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
IFN-activated B-O B-NP_JJ
NK B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
conclusion B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
E1A B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
marks B-O B-VP_VBZ
cells B-O B-NP_NNS
" " B-O O-NP
for B-O B-PP_IN
destruction B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
the B-O B-NP_DT
host B-O B-NN
NK B-O B-NP_NN
cell B-O B-NN
" " B-O O-NP
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
whereas B-O B-SBAR_IN
the B-O B-S_NP_DT
E7 B-O B-NP_NN
oncoprotein B-O B-NN
" " B-O O-NP
" " B-O O-NP
lacks B-O B-VP_VBZ
this B-O B-NP_DT
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
CIITA B-O B-S_S_NP_NN
" " B-O O-NP
activates B-O B-VP_VBZ
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
mouse B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_S_S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
long B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
a B-O B-NP_DT
puzzle B-O B-NN
that B-O B-SBAR_IN
MHC B-O B-S_NP_NN
class B-O B-NN
II B-O B-CD
molecules B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
this B-O B-S_NP_DT
expression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
believed B-O B-VP_VBN
to B-O B-S_NP_VP_TO
play B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Recently B-O B-S_ADVP_RB
" " B-O O-ADVP
the B-O B-NP_NP_DT
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
transactivator B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
CIITA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
reported B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
a B-O B-NP_NP_DT
for B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
human B-O B-S_NP_NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
expressing B-O B-VP_VBG
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
have B-O B-VP_VBP
CIITA B-O B-NP_NP_NN
" " B-O O-NP
transcripts B-O B-NNS
" " B-O O-NP
while B-O B-SBAR_IN
MHC B-O B-S_NP_NN
class B-O B-NN
II-negative B-O B-JJ
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
mouse B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
mouse B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
reconstituted B-O B-VP_VBN
upon B-O B-NP_PP_IN
transfection B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
CIITA B-O B-NN
cDNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CIITA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
explains B-O B-VP_VBZ
the B-O B-NP_NP_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
or B-O B-CC
" " B-O B-NP_NP_PP_O-NP
of B-O B-PP_IN
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_ADJP_NP_O-NP
and B-O B-CC
mouse B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Identification B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha-associated B-O B-JJ
protein B-O B-NN
kinase B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
human B-O B-NP_JJ
monocytic B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
determination B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_NP_PRPP
phosphorylation B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Nuclear B-O B-S_S_NP_NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
stored B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
an B-O B-NP_DT
inactive B-O B-JJ
form B-O B-NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
interaction B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
a B-O B-NP_NP_NP_DT
rapid B-O B-JJ
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
presumed B-O B-VP_VBN
" " B-O B-S_NP_VP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
recently B-O B-ADVP_RB
" " B-O O-ADVP
reported B-O B-VP_VBN
the B-O B-NP_NP_DT
establishment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
lipopolysaccharide B-O B-ADJP_NN
( B-O B-LRB
LPS B-O B-NN
) B-O B-RRB
-dependent B-O B-JJ
cell-free B-O B-JJ
" " B-O O-ADJP
activation B-O B-NN
system B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
association B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
a B-O B-NP_NP_NP_DT
kinase B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
cell B-O B-NP_NP_NN
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
specifically B-O B-S_NP_VP_ADVP_RB
" " B-O O-ADVP
binds B-O B-VP_VBZ
" " B-O B-NP_O-VP
and B-O B-CC
phosphorylates B-O B-VP_VBZ
" " B-O B-NP_O-VP
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LPS B-O B-S_NP_NN
stimulation B-O B-NN
" " B-O O-NP
transiently B-O B-ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VBD
the B-O B-NP_NP_DT
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
alpha-bound B-O B-JJ
kinase B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
THP-1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutational B-O B-S_NP_NP_NP_JJ
analyses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
competition B-O B-NP_NP_NN
experiments B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
synthetic B-O B-JJ
peptides B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
identified B-O B-VP_VBD
major B-O B-NP_JJ
phosphorylation B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
by B-O B-PP_IN
the B-O B-NP_DT
bound B-O B-VBN
kinase B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
Ser B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
Thr B-O B-NP_NN
" " B-O B-NP_O-NP
residues B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
C-terminal B-O B-NP_JJ
acidic B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
peptide B-O B-NN
, B-O B-COMMA
" " B-O O-NP
corresponding B-O B-S_NP_VP_VBG
to B-O B-PP_TO
the B-O B-NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
blocked B-O B-VP_VBD
the B-O B-NP_NP_DT
LPS-induced B-O B-JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
inducible B-O B-NP_NP_JJ
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
endogenous B-O B-NP_JJ
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
cell-free B-O B-JJ
system B-O B-NN
" " B-O O-NP
using B-O B-VP_VBG
THP-1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
bound B-O B-NP_JJ
kinase B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
signaling B-O B-NN
pathway B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
by B-O B-PP_IN
inducing B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Triggering B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
interleukin-6 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
interferon-gamma B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
tumor B-O B-NP_NN
necrosis B-O B-NN
factor-alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involves B-O B-VP_VBZ
cooperation B-O B-NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
interferon B-O B-NP_NP_NP_NN
regulatory B-O B-JJ
factor-1 B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
, B-O B-COMMA
NF B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
Sp1 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VP_VBD
the B-O B-NP_NP_DT
molecular B-O B-JJ
basis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
synergistic B-O B-JJ
induction B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
compared B-O B-VP_VBD
it B-O B-NP_PRP
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
basis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Functional B-O B-S_NP_NP_JJ
studies B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
IL-6 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
three B-O B-S_NP_CD
regions B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
the B-O B-NP_NP_DT
targets B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
and/or B-O B-NP_NP_CC
action B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
whereas B-O B-SBAR_IN
only B-O B-S_NP_NP_RB
one B-O B-CD
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
seemed B-O B-VP_VBD
" " B-O B-S_NP_VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
three B-O B-CD
regions B-O B-NNS
" " B-O O-NP
concerned B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
are B-O B-VP_VBP
" " B-O B-NP_O-VP
" " B-O O-S
: B-O B-COLON
1 B-O B-NP_NP_LST_LS
) B-O B-RRB
" " B-O O-LST
a B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
-73 B-O B-NP_QP_CD
and B-O B-CC
-36 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
the B-O B-NP_NP_DT
minimal B-O B-NP_JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
inducible B-O B-ADJP_JJ
by B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
; B-O B-COLON
2 B-O B-NP_LST_LS
) B-O B-RRB
" " B-O O-LST
an B-O B-NP_NP_DT
element B-O B-NN
" " B-O O-NP
located B-O B-ADJP_JJ
between B-O B-PP_IN
-181 B-O B-NP_QP_CD
and B-O B-CC
-73 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
appeared B-O B-S_NP_VP_VBD
to B-O B-S_NP_VP_TO
regulate B-O B-VP_VB
" " B-O B-NP_ADVP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
; B-O B-COLON
and B-O B-CC
3 B-O B-NP_LST_LS
) B-O B-RRB
" " B-O O-LST
a B-O B-NP_NP_DT
distal B-O B-NP_JJ
element B-O B-NN
upstream B-O B-JJ
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
-224 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
inducible B-O B-ADJP_JJ
by B-O B-PP_IN
" " B-O B-NP_NP_ADVP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
LPS B-O B-S_NP_NN
signaling B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
involve B-O B-VP_VB
NF B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
the B-O B-NP_DT
p50 B-O B-NP_NN
/p65 B-O B-NN
heterodimers B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Synergistic B-O B-S_NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-6 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
IFN-gamma B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
TNF-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
involved B-O B-VP_VBD
cooperation B-O B-NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
IRF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
p65 B-O B-NN
homodimers B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
with B-O B-PP_IN
concomitant B-O B-NP_NP_JJ
removal B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
negative B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
present B-O B-NP_ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
removal B-O B-NN
" " B-O O-NP
occurred B-O B-VP_VBD
by B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
constitutive B-O B-NP_JJ
Sp1 B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
whose B-O B-SBAR_WHNP_WPP
increased B-O B-NP_VBN
and B-O B-NP_CC
" " B-O B-NP_O-WHNP
were B-O B-S_NP_VP_VBD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
balance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NP_NN
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_NP_NP_NP_DT
signal B-O B-NN
transducer B-O B-NN
" " B-O O-NP
and B-O B-CC
activator B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
STAT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
transcription B-O B-NN
factor B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
cytokines B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
inflammatory B-O B-NP_JJ
synovial B-O B-JJ
fluids B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_S_NP_NP_DT
balance B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
type B-O B-NP_NN
1 B-O B-NP_CD
" " B-O B-NP_O-NP
and B-O B-CC
2 B-O B-NP_CD
" " B-O B-NP_O-NP
T B-O B-NP_NN
helper B-O B-NN
cell B-O B-NN
cytokine B-O B-NP_NN
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
plays B-O B-VP_VBZ
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
several B-O B-NP_NP_JJ
animal B-O B-JJ
models B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
autoimmunity B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
skewed B-O B-S_NP_NP_JJ
patterns B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
described B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_JJ
inflammatory B-O B-JJ
diseases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Many B-O B-S_NP_JJ
cytokines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
activate B-O B-VP_VBP
signal B-O B-NP_NN
transducer B-O B-NN
and B-O B-CC
activation B-O B-NN
of B-O B-IN
transcription B-O B-NN
( B-O B-LRB
STAT B-O B-NN
) B-O B-RRB
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
, B-O B-S_COMMA
in B-O B-PP_IN
turn B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
activate B-O B-NP_VP_VBP
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
inflammatory B-O B-NP_JJ
effector B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
used B-O B-VP_VBD
mononuclear B-O B-NP_NP_JJ
cell B-O B-NN
priming B-O B-NN
cultures B-O B-NNS
" " B-O O-NP
and B-O B-CC
inflammatory B-O B-NP_NP_NP_JJ
synovial B-O B-JJ
fluids B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
SFs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
arthritis B-O B-NP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
to B-O B-S_NP_VP_TO
examine B-O B-VP_VB
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
production B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
activity B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
an B-O B-NP_DT
inflammatory B-O B-JJ
synovial B-O B-JJ
microenvironment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Exposure B-O B-S_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
SFs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
priming B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
an B-O B-NP_NP_DT
81 B-O B-ADJP_CD
% B-O B-NN
" " B-O O-ADJP
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interferon B-O B-NP_NP_NP_NN
( B-O B-LRB
IFN B-O B-NN
) B-O B-RRB
-gamma B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
interleukin B-O B-NP_NP_NN
( B-O B-LRB
IL B-O B-NN
) B-O B-RRB
4 B-O B-CD
" " B-O O-NP
" " B-O B-NP_O-NP
, B-O B-COMMA
production B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
effector B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
generated B-O B-VP_VBN
in B-O B-NP_PP_IN
priming B-O B-NP_JJ
cultures B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
SF B-O B-S_S_NP_NN
suppression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
IL-4 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-10 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
reversed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_DT
dominant B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
exogenous B-O B-NP_JJ
IL-12 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
SFs B-O B-S_S_NP_NNS
" " B-O O-NP
blocked B-O B-VP_VBD
the B-O B-NP_NP_DT
sustained B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
factor B-O B-NN
Stat1 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
Stat3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
during B-O B-PP_IN
the B-O B-NP_DT
priming B-O B-NN
period B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
Stat1 B-O B-S_NP_NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
differentially B-O B-ADVP_RB
" " B-O O-ADVP
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
cytokines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
parallel B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
their B-O B-NP_PRPP
" " B-O B-NP_ADJP_NP_O-NP
or B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Active B-O B-S_NP_NP_JJ
Stat3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
Stat1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
inflamed B-O B-NP_JJ
joints B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
a B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
altered B-O B-NP_NP_JJ
balance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Stat1 B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
Stat3 B-O B-NP_NN
" " B-O B-NP_O-NP
transcriptional B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NP_NN
cell B-O B-NN
" " B-O O-NP
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
the B-O B-NP_NP_DT
pathogenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
inflammatory B-O B-NP_JJ
synovitis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Anti-immunoglobulin B-O B-S_S_NP_NN
M B-O B-NN
" " B-O O-NP
activates B-O B-VP_VBZ
nuclear B-O B-NP_NP_JJ
calcium B-O B-NN
/calmodulin-dependent B-O B-JJ
protein B-O B-NN
kinase B-O B-NN
II B-O B-CD
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_S_NP_NP_PRP
" " B-O O-NP
and B-O B-CC
others B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_DT
nuclear B-O B-NP_NP_JJ
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
Ets-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
phosphorylated B-O B-VP_VBN
in B-O B-NP_PP_IN
after B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
As B-O B-S_SBAR_IN
this B-O B-S_NP_DT
phosphorylation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
independent B-O B-ADJP_JJ
of B-O B-PP_IN
protein B-O B-NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
tested B-O B-VP_VBD
whether B-O B-SBAR_IN
a B-O B-S_NP_DT
calcium B-O B-NP_NP_NN
/calmodulin-dependent B-O B-JJ
protein B-O B-NN
kinase B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CaM B-O B-NP_NN
kinase B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
might B-O B-VP_MD
phosphorylate B-O B-VP_VB
the B-O B-NP_DT
Ets-1 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
after B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
dephosphorylated B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Ets-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
to B-O B-PP_TO
chromatin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_DT
operative B-O B-NP_JJ
kinase B-O B-NN
" " B-O O-NP
" " B-O O-NP
should B-O B-VP_MD
be B-O B-VP_VB
detectable B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
prepared B-O B-VP_VBD
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
two B-O B-NP_NP_CD
human B-O B-NP_JJ
B B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
increased B-O B-S_NP_VBN
calcium B-O B-ADJP_ADJP_ADJP_NN
levels B-O B-NNS
" " B-O O-NP
correlated B-O B-VP_VBD
with B-O B-PP_IN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activity B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CaM B-O B-NP_NN
kinases B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
determined B-O B-VP_VBN
" " B-O B-NP_O-VP
using B-O B-S_NP_VP_VBG
a B-O B-NP_DT
synthetic B-O B-JJ
peptide B-O B-NN
substrate B-O B-NN
" " B-O O-NP
both B-O B-PP_CC
in B-O B-IN
the B-O B-NP_DT
absence B-O B-NP_NN
" " B-O B-PP_O-NP
and B-O B-CC
presence B-O B-NP_NN
" " B-O B-PP_O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
specific B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Stimulation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
anti-IgM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
led B-O B-VP_VBD
to B-O B-PP_TO
increased B-O B-NP_NP_VBN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
nuclear B-O B-NP_JJ
kinase B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
this B-O B-S_NP_DT
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
reduced B-O B-VP_VBN
by B-O B-NP_PP_IN
10 B-O B-NP_ADJP_CD
microM B-O B-NN
" " B-O O-ADJP
KN-62 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Kinase B-O B-S_NP_NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
reduced B-O B-VP_VBN
in B-O B-NP_PP_IN
lysates B-O B-NP_NP_NNS
" " B-O O-NP
preadsorbed B-O B-VP_VBN
using B-O B-NP_S_NP_VP_VBG
" " B-O B-NP_NP_ADJP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two-dimensional B-O B-S_NP_NP_JJ
phosphopeptide B-O B-NN
maps B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Ets-1 B-O B-NP_NN
" " B-O O-NP
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
incubated B-O B-VP_VBN
with B-O B-NP_PP_IN
ionomycin B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
anti-IgM B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contained B-O B-VP_VBD
two B-O B-NP_NP_CD
unique B-O B-JJ
phosphopeptides B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
absent B-O B-ADJP_JJ
in B-O B-PP_IN
untreated B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Incubation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
isolated B-O B-NP_VBN
Ets-1 B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
purified B-O B-NP_VBN
CaM B-O B-NP_NN
kinase B-O B-NN
II B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
produced B-O B-VP_VBD
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
peptides B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
migrated B-O B-S_NP_VP_VBD
identically B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
a B-O B-NP_NP_DT
model B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
signal B-O B-NP_NP_NN
transduction B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
the B-O B-NP_NP_DT
antigen B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_DT
lymphotoxin B-O B-NN
promoter B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
stimulated B-O B-VP_VBN
by B-O B-NP_PP_IN
HTLV-I B-O B-NP_NP_NN
tax B-O B-NN
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
T-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
HTLV-I B-O B-NN
transcriptional B-O B-JJ
activator B-O B-NN
tax B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
gain B-O B-VP_VB
insight B-O B-NP_NP_NN
" " B-O O-NP
into B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tax-expressing B-O B-S_NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
produce B-O B-VP_VBP
LT B-O B-NP_NN
biologic B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_NP_DT
LT B-O B-NP_NP_NN
promoter B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
LT-293 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
CAT B-O B-NN
construct B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contained B-O B-S_NP_VP_VBD
an B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
was B-O B-VP_VBD
active B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
the B-O B-NP_NP_DT
LT-producing B-O B-JJ
C81-66-45 B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contains B-O B-S_NP_VP_VP_VBZ
defective B-O B-NP_JJ
HTLV-I B-O B-NN
" " B-O O-NP
" " B-O O-VP
but B-O B-CC
expresses B-O B-VP_VBZ
tax B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
observation B-O B-NN
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
mutated B-O B-VBN
LT-kappa B-O B-NN
B B-O B-NN
construct B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
M1-CAT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
inactive B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
C81-66-45 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
confirmed B-O B-VP_VBD
the B-O B-NP_NP_DT
importance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
LT B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tax B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
transfected B-O B-VP_VBN
into B-O B-NP_PP_IN
HTLV-I-negative B-O B-NP_JJ
human B-O B-JJ
T-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Jurkat B-O B-S_NP_NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
stably B-O B-VP_ADVP_RB
" " B-O O-ADVP
expressing B-O B-VBG
tax B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
contained B-O B-VP_VBD
elevated B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
directly B-O B-S_NP_VP_ADVP_RB
" " B-O O-ADVP
bound B-O B-VBD
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tax B-O B-S_NP_NP_NN
" " B-O O-NP
co-transfected B-O B-VP_VBN
with B-O B-NP_PP_IN
reporter B-O B-NP_NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
maximally B-O B-VP_VP_ADVP_RB
" " B-O O-ADVP
activated B-O B-VBD
HTLV-I-LTR-CAT B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
kappa B-O B-NP_NN
B-fos-CAT B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
also B-O B-RB
activated B-O B-VP_VBD
LT-293 B-O B-NP_NN
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_DT
lesser B-O B-JJR
extent B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
JM B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
tax B-O B-NP_NN
" " B-O O-NP
induced B-O B-VP_JJ
LT-293 B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
two- B-O B-NP_NP_CD
" " B-O B-NP_O-NP
to B-O B-TO
four-fold B-O B-NP_JJ
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
though B-O B-SBAR_IN
there B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
M1-CAT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
LT-293 B-O B-NP_NN
CAT B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
mirrored B-O B-VP_VBD
the B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
LT B-O B-NP_NN
biologic B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
seen B-O B-VP_VBN
under B-O B-NP_PP_IN
these B-O B-NP_DT
conditions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_NP_DT
studies B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
first B-O B-JJ
" " B-O O-NP
to B-O B-SBAR_WHNP_S_NP_VP_TO
demonstrate B-O B-VP_VB
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
over B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
HTLV-I B-O B-S_NP_NN
tax B-O B-NN
" " B-O O-NP
causes B-O B-VP_VBZ
low-level B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
endogenous B-O B-NP_JJ
LT B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
LT B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
at B-O B-PP_PP_ADVP_IN
least B-O B-JJS
" " B-O O-ADVP
in B-O B-IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
through B-O B-IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
tyrosine B-O B-NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
and B-O B-CC
T-cell B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
vanadate B-O B-NP_NP_NN
peroxide B-O B-NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
tyrosine B-O B-NN
phosphatases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Rapid B-O B-S_NP_NP_JJ
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
key B-O B-NP_JJ
cellular B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
crucial B-O B-JJ
event B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
transduction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activation B-O B-NP_NN
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
T-lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
regulatory B-O B-JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NP_NN
tyrosine B-O B-NN
phosphatases B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
PTPases B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
this B-O B-NP_DT
process B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
explored B-O B-VP_VBN
by B-O B-NP_PP_IN
studying B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Pervanadate B-O B-S_NP_NN
" " B-O O-NP
induced B-O B-VP_VBD
activation B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
tyrosine B-O B-NN
kinases B-O B-NNS
lck B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
fyn B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
4- B-O B-NP_NP_QP_CD
and B-O B-CC
3-fold B-O B-JJ
" " B-O O-QP
" " B-O O-NP
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
dramatic B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
tyrosine B-O B-NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cellular B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
notably B-O B-NP_RB
phospholipase B-O B-NN
C B-O B-NN
gamma B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_PP_IN
this B-O B-NP_DT
event B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
a B-O B-NP_NP_DT
rise B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
intracellular B-O B-NP_JJ
Ca2+ B-O B-NN
concentration B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
corresponding B-O B-VP_VBG
to B-O B-PP_TO
an B-O B-NP_DT
influx B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
required B-O B-VP_VP_VBD
surface B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD45 B-O B-NN
PTPase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
was B-O B-VP_VBD
not B-O B-RB
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
CD45-deficient B-O B-NP_NP_JJ
variants B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
the B-O B-NP_DT
CD45-negative B-O B-JJ
variant B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
pervanadate B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
tyrosine B-O B-NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
globally B-O B-ADVP_RB
" " B-O O-ADVP
decreased B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
some B-O B-S_NP_DT
phosphorylated B-O B-VBN
substrates B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
specifically B-O B-ADVP_RB
" " B-O O-ADVP
missing B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Pervanadate B-O B-S_NP_NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
stimulated B-O B-VP_VBD
transcription B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
c-fos B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
accumulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_PRPP
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
several B-O B-NP_NP_JJ
other B-O B-JJ
hallmarks B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
T-lymphocyte B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
such B-O B-PP_JJ
as B-O B-IN
surface B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
CD69 B-O B-NN
antigen B-O B-NN
" " B-O O-NP
and B-O B-CC
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Pervanadate B-O B-S_NP_NN
" " B-O O-NP
synergized B-O B-VP_VBD
with B-O B-PP_IN
signals B-O B-NP_NP_NNS
" " B-O O-NP
delivered B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
T-cell B-O B-NP_NN
antigen B-O B-NN
receptor B-O B-NN
engagement B-O B-NN
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
by B-O B-PP_IN
a B-O B-NP_DT
phorbol B-O B-NN
ester B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
interleukin B-O B-NP_NN
2 B-O B-CD
production B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Pervanadate B-O B-S_NP_NN
" " B-O O-NP
activated B-O B-VP_VBD
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_IN
shown B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
thus B-O B-ADVP_RB
" " B-O O-ADVP
conclude B-O B-VP_VBP
that B-O B-SBAR_IN
PTPases B-O B-S_NP_NNS
" " B-O O-NP
play B-O B-VP_VBP
a B-O B-NP_DT
crucial B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
negative B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
tyrosine B-O B-NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appears B-O B-VP_VBZ
sufficient B-O B-ADJP_JJ
per B-O B-ADVP_FW
se B-O B-FW
" " B-O O-ADVP
to B-O B-S_NP_VP_TO
initiate B-O B-VP_VB
a B-O B-NP_DT
complete B-O B-JJ
activation B-O B-NN
programme B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
rel B-O B-S_NP_NN
" " B-O O-NP
Is B-O B-VP_VBZ
rapidly B-O B-VP_ADVP_RB
" " B-O O-ADVP
tyrosine-phosphorylated B-O B-JJ
following B-O B-NP_PP_VBG
granulocyte-colony B-O B-NP_NP_JJ
stimulating B-O B-NN
factor B-O B-NN
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
neutrophils B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
neutrophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
granulocyte-colony B-O B-NP_NP_JJ
stimulating B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
G-CSF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
an B-O B-NP_NP_DT
enhanced B-O B-VBN
respiratory B-O B-JJ
burst B-O B-NN
" " B-O O-NP
, B-O B-COMMA
prolonged B-O B-NP_JJ
survival B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
increased B-O B-NP_VBN
tumor B-O B-NN
cell B-O B-NN
killing B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
G-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
binding B-O B-NP_NP_VBG
" " B-O O-NP
to B-O B-PP_TO
specific B-O B-NP_UCP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
high B-O B-NP_JJ
affinity B-O B-NN
" " B-O O-NP
" " B-O O-UCP
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
G-CSF B-O B-S_S_NP_NN
receptors B-O B-NNS
" " B-O O-NP
lack B-O B-VP_VBP
intrinsic B-O B-NP_JJ
tyrosine B-O B-NN
kinase B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_DT
rapid B-O B-JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tyrosine B-O B-NP_NN
kinase B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Antiphosphotyrosine B-O B-S_NP_NP_JJ
immunoblots B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
whole B-O B-NP_NP_JJ
cell B-O B-NN
lysates B-O B-NNS
" " B-O O-NP
prepared B-O B-VP_VBN
from B-O B-NP_PP_IN
neutrophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
G-CSF B-O B-NN
" " B-O O-NP
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
induces B-O B-VP_VBZ
prominent B-O B-NP_NP_JJ
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
monospecific B-O B-NP_JJ
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
the B-O B-NP_DT
80-kDa B-O B-JJ
tyrosine-phosphorylated B-O B-JJ
protein B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
p80c-rel B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-NP_NP_VP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tyrosine B-O B-NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p80c-rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
unique B-O B-ADJP_JJ
to B-O B-PP_TO
G-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
in B-O B-SBAR_IN
that B-O B-IN
granulocyte-macrophage B-O B-S_NP_NP_JJ
colony B-O B-NN
stimulating B-O B-NN
factor B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
also B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
stimulates B-O B-VP_VP_VBZ
and B-O B-NP_CC
induces B-O B-VP_VBZ
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
result B-O B-VP_VB
in B-O B-PP_IN
tyrosine B-O B-NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
consequences B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
p80c-rel B-O B-NP_NN
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
yet B-O B-ADVP_RB
" " B-O O-ADVP
known B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
however B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
tyrosine-phosphorylated B-O B-NP_JJ
p80c-rel B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
capable B-O B-ADJP_JJ
of B-O B-PP_IN
binding B-O B-S_NP_VP_VBG
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
G-CSF B-O B-S_NP_NN
stimulation B-O B-NN
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
amount B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
one B-O B-S_NP_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
first B-O B-JJ
biochemical B-O B-JJ
events B-O B-NNS
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
occurs B-O B-S_NP_VP_VBZ
" " B-O B-PP_PP_O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
leads B-O B-VP_VBZ
directly B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
the B-O B-NP_NP_DT
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p80c-rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
G-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
directly B-O B-VP_ADVP_RB
" " B-O O-ADVP
transduce B-O B-VB
a B-O B-NP_DT
signal B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Thrombin B-O B-S_S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
thrombin B-O B-NP_NN
receptor B-O B-NN
agonist B-O B-NN
peptide B-O B-NN
" " B-O O-NP
" " B-O O-NP
induce B-O B-VP_VP_VBP
early B-O B-NP_NP_JJ
events B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
synergize B-O B-VP_VBP
with B-O B-PP_IN
TCR B-O B-NP_NP_NN
cross-linking B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
CD69 B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
and B-O B-CC
interleukin B-O B-NP_NN
2 B-O B-CD
production B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Thrombin B-O B-S_S_NP_NP_NN
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
T B-O B-NN
leukemic B-O B-JJ
cell B-O B-NN
line B-O B-NN
Jurkat B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induced B-O B-VP_VBD
a B-O B-NP_DT
transient B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
[Ca2+]i B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Proteolytic B-O B-S_NP_NP_JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
enzyme B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
required B-O B-VP_VBN
for B-O B-NP_PP_IN
this B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
since B-O B-SBAR_IN
diisopropyl B-O B-S_NP_NN
fluorophosphate-thrombin B-O B-NN
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
increase B-O B-VP_VB
[Ca2+]i B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
hirudin B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
anti-thrombin B-O B-NP_NN
III B-O B-CD
" " B-O O-NP
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_DT
thrombin-induced B-O B-JJ
[Ca2+]i B-O B-NN
rise B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_S_NP_NP_NP_DT
synthetic B-O B-JJ
thrombin B-O B-NP_NP_NN
receptor B-O B-NN
agonist B-O B-NN
peptide B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TRP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
7 B-O B-NP_CD
residues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
SFLLRNP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
as B-O B-ADJP_ADVP_RB
" " B-O O-ADVP
effective B-O B-JJ
" " B-O O-ADJP
as B-O B-PP_IN
thrombin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
[Ca2+]i B-O B-NP_NN
mobilization B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
both B-O B-S_NP_DT
agonists B-O B-NNS
" " B-O O-NP
induced B-O B-VP_VBD
Ca2+ B-O B-NP_NN
release B-O B-NN
" " B-O O-NP
exclusively B-O B-ADVP_RB
" " B-O O-ADVP
from B-O B-PP_IN
internal B-O B-NP_JJ
stores B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Thrombin B-O B-S_NP_NN
" " B-O O-NP
stimulated B-O B-VP_VBD
tyrosine B-O B-NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
molecular B-O B-NP_JJ
mass B-O B-NN
40 B-O B-NP_CD
" " B-O B-NP_O-NP
, B-O B-COMMA
42 B-O B-NP_CD
" " B-O B-NP_O-NP
, B-O B-COMMA
70 B-O B-NP_CD
" " B-O B-NP_O-NP
, B-O B-COMMA
120 B-O B-NP_CD
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
130 B-O B-NP_CD
" " B-O B-NP_O-NP
kDa B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_DT
good B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
thrombin-induced B-O B-NP_NP_NP_JJ
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
latter B-O B-JJ
three B-O B-CD
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
Ca2+ B-O B-NP_NN
mobilization B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thrombin B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
TRP B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
caused B-O B-VP_VBD
translocation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
cytosol B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
plasma B-O B-NN
membrane B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_PP_IN
a B-O B-NP_NP_DT
likely B-O B-JJ
consequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
events B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
thrombin B-O B-NP_NN
" " B-O O-NP
activated B-O B-VP_VBD
the B-O B-NP_DT
nuclear B-O B-JJ
factor B-O B-NN
NF-kB B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Several B-O B-S_NP_NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
hematopoietic B-O B-NP_JJ
origin B-O B-NN
" " B-O O-NP
" " B-O O-PP
including B-O B-PP_VBG
the B-O B-NP_NP_DT
leukemic B-O B-JJ
T B-O B-NN
cell B-O B-NN
line B-O B-NN
HPB.ALL B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
erythroleukemic B-O B-JJ
cell B-O B-NN
line B-O B-NN
K562 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
responsive B-O B-ADJP_JJ
to B-O B-PP_TO
thrombin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
whereas B-O B-SBAR_IN
others B-O B-S_NP_NNS
such B-O B-PP_JJ
as B-O B-IN
THP1 B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
myelomonocytic B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
BL2 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
Burkitt B-O B-NN
lymphoma B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
refractory B-O B-ADJP_JJ
to B-O B-PP_TO
thrombin B-O B-NP_NP_NN
" " B-O B-NP_O-NP
or B-O B-CC
TRP B-O B-NP_NN
" " B-O B-NP_O-NP
stimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
magnitude B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
thrombin B-O B-NN
response B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
different B-O B-JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
paralleled B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
thrombin B-O B-NN
receptor B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
a B-O B-NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
led B-O B-VP_VBD
to B-O B-PP_PP_TO
a B-O B-NP_NP_DT
dramatic B-O B-JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
and B-O B-CC
to B-O B-PP_TO
a B-O B-NP_NP_DT
concomitant B-O B-JJ
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
thrombin B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
TRP B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
enhanced B-O B-VP_VBD
CD69 B-O B-NP_NP_NP_NN
expression B-O B-NN
" " B-O O-NP
and B-O B-CC
interleukin B-O B-NP_NN
2 B-O B-CD
production B-O B-NN
" " B-O O-NP
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
highlight B-O B-VP_VBP
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
thrombin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
potential B-O B-JJ
regulator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
lymphocyte B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_DT
interleukin-8 B-O B-NP_NN
AP-1 B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
kappa B-O B-NP_NN
B-like B-O B-JJ
" " B-O B-NP_O-NP
sites B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
genetic B-O B-NP_NP_JJ
end B-O B-NN
targets B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
FK506-sensitive B-O B-NP_NP_JJ
pathway B-O B-NN
" " B-O O-NP
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
calcium B-O B-NP_NN
mobilization B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
FK506 B-O B-S_S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_DT
immunosuppressant B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
inhibits B-O B-VP_VBZ
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
that B-O B-SBAR_IN
FK506 B-O B-S_NP_NN
" " B-O O-NP
suppressed B-O B-VP_VBD
the B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
deleted B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
mutated B-O B-NP_VBN
" " B-O B-NP_O-NP
analysis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-8 B-O B-NN
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
AP-1 B-O B-NN
and B-O B-CC
kappa B-O B-NN
B-like B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
as B-O B-NP_PP_IN
the B-O B-NP_NP_DT
responsive B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
PMA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
ionomycin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
FK506 B-O B-S_NP_NN
" " B-O O-NP
suppressed B-O B-VP_VBD
the B-O B-NP_NP_NP_DT
transcriptions B-O B-NNS
" " B-O O-NP
through B-O B-PP_IN
the B-O B-NP_NP_DT
AP-1 B-O B-NN
" " B-O O-NP
or B-O B-CC
kappa B-O B-NP_NN
B-like B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
PMA B-O B-NP_NN
plus B-O B-CC
Ca(2+)-mobilizing B-O B-NP_NN
agents B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
those B-O B-NP_NP_DT
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
Ca(2+)-independent B-O B-NP_NN
stimuli B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
gel B-O B-NP_NN
retardation B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
FK506 B-O B-NP_NN
" " B-O O-NP
had B-O B-VP_VBD
little B-O B-NP_JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
AP-1 B-O B-NN
site B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PMA/ionomycin-induced B-O B-NP_NP_JJ
nuclear B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
FK506 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
EGTA B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
Ca2+ B-O B-NP_NN
chelator B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
similarly B-O B-ADVP_RB
" " B-O O-ADVP
affected B-O B-VP_VBD
the B-O B-NP_NP_DT
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
kappa B-O B-NP_NP_NN
B-like B-O B-JJ
site B-O B-NN
binding B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
not B-O B-RB
recognized B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
confirmed B-O B-VP_VBD
the B-O B-NP_DT
previous B-O B-JJ
report B-O B-NN
that B-O B-SBAR_IN
FK506 B-O B-S_NP_NN
" " B-O O-NP
suppressed B-O B-VP_VBD
the B-O B-NP_NP_DT
PMA/ionomycin-induced B-O B-JJ
activation B-O B-NN
" " B-O O-NP
through B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
not B-O B-S_NP_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
the B-O B-NP_NP_DT
reported B-O B-VBN
IL-2 B-O B-NP_NN
NF-AT B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
NFIL-2A B-O B-NP_NN
" " B-O B-NP_O-NP
sites B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
Ig B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
the B-O B-NP_NP_DT
IL-8 B-O B-NP_NP_NN
" " B-O O-NP
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
kappa B-O B-NP_NN
B-like B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
terminals B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
FK506-sensitive B-O B-NP_NP_JJ
pathway B-O B-NN
" " B-O O-NP
involving B-O B-VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Retinoic B-O B-S_S_NP_NP_ADJP_JJ
acid-induced B-O B-JJ
" " B-O O-ADJP
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD38 B-O B-NP_NN
antigen B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
myeloid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
retinoic B-O B-NP_JJ
acid B-O B-NN
receptor-alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
CD38 B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
leukocyte B-O B-NN
differentiation B-O B-NN
antigen B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
has B-O B-S_NP_VP_VBZ
been B-O B-VP_VBN
thought B-O B-VP_VBN
" " B-O B-S_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
myeloid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
CD38 B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
during B-O B-NP_PP_IN
early B-O B-NP_NP_JJ
stages B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Virtually B-O B-S_NP_RB
no B-O B-DT
information B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
available B-O B-ADJP_JJ
on B-O B-PP_IN
regulation B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
functions B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
CD38 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recently B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
reported B-O B-VP_VBD
that B-O B-SBAR_IN
all-trans-retinoic B-O B-S_NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ATRA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
potent B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
highly B-O B-ADJP_RB
specific B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
inducer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD38 B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
ATRA-induced B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD38 B-O B-NP_NP_NN
antigen B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
myeloid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
retinoic B-O B-NP_NP_JJ
acid-alpha B-O B-NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
ATRA B-O B-S_NP_NN
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
CD38 B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
mutant B-O B-JJ
subclone B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Retroviral B-O B-S_NP_NP_JJ
vector-mediated B-O B-JJ
transduction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
RA B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RAR B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
this B-O B-NP_DT
HL-60R B-O B-NN
subclone B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
completely B-O B-ADVP_RB
" " B-O O-ADVP
restored B-O B-VP_VBD
the B-O B-NP_NP_DT
sensitivity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
ATRA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
terms B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
their B-O B-NP_PRPP
ability B-O B-NN
to B-O B-S_NP_VP_TO
express B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
CD38 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
inducible B-O B-ADJP_JJ
by B-O B-PP_IN
ATRA B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
HL-60R B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
transfected B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD38 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
acute B-O B-NP_NP_ADJP_JJ
promyelocytic B-O B-JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
acute B-O B-NP_ADJP_JJ
myeloblastic B-O B-JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
leukemia B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
independent B-O B-ADJP_JJ
of B-O B-PP_IN
ATRA-induced B-O B-NP_JJ
cytodifferentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Following B-O B-S_PP_VBG
culture B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
ATRA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
increased B-O B-NP_VBN
CD38 B-O B-NN
protein B-O B-NN
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
normal B-O B-NP_JJ
CD34+ B-O B-JJ
bone B-O B-NN
marrow B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-PP_RB
on B-O B-IN
normal B-O B-NP_JJ
circulating B-O B-VBG
granulocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
From B-O B-S_PP_IN
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_IN
CD38 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
ATRA B-O B-ADJP_NN
inducible B-O B-JJ
in B-O B-PP_IN
myeloid B-O B-NP_NP_JJ
leukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
normal B-O B-NP_JJ
CD34+ B-O B-JJ
bone B-O B-NN
marrow B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
independent B-O B-ADJP_JJ
of B-O B-PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
RAR B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HL-60 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
similar B-O B-JJ
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
RAR B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
CD38 B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
other B-O B-NP_JJ
hematopoietic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Comparison B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
retinoic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
and B-O B-CC
phorbol B-O B-NP_NN
myristate B-O B-NN
acetate B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-PP_IN
inducers B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
monocytic B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Several B-O B-S_S_NP_NP_JJ
human B-O B-JJ
myeloid B-O B-JJ
leukemia B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
growing B-O B-VP_VBG
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
induced B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
to B-O B-S_NP_VP_TO
differentiate B-O B-VP_VB
to B-O B-PP_TO
more B-O B-NP_ADJP_RBR
mature B-O B-JJ
" " B-O O-ADJP
monocyte/macrophage-like B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
cells B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
THP-1 B-O B-NN
myeloid B-O B-JJ
leukemia B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
acquire B-O B-VP_VBP
macrophage-like B-O B-NP_JJ
characteristics B-O B-NNS
" " B-O O-NP
after B-O B-PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
all-trans B-O B-NP_ADJP_JJ
" " B-O O-ADJP
retinoic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
analyze B-O B-VP_VB
the B-O B-NP_NP_DT
signal B-O B-NN
transduction B-O B-NN
mechanisms B-O B-NNS
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
first B-O B-ADVP_RB
" " B-O O-ADVP
compared B-O B-VP_VBD
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
PMA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
RA B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
effectively B-O B-ADVP_RB
" " B-O O-ADVP
down-regulated B-O B-VP_VBD
c-myc B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
, B-O B-COMMA
while B-O B-SBAR_IN
c-myb B-O B-S_NP_NN
expression B-O B-NN
" " B-O O-NP
decreased B-O B-VP_VBD
only B-O B-PP_ADVP_RB
" " B-O O-ADVP
after B-O B-IN
PMA B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
beta B-O B-NP_NP_NN
2-integrin B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
CD11a B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
CD11b B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
clearly B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBN
after B-O B-NP_PP_IN
both B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
treatments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Their B-O B-S_S_NP_NP_PRPP
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
src-family B-O B-NN
tyrosine B-O B-NN
kinase B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
different B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
hck B-O B-S_S_NP_NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
similarly B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
these B-O B-NP_DT
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
but B-O B-CC
lyn B-O B-S_NP_NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
stronger B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
and B-O B-CC
more B-O B-ADJP_RBR
rapid B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
after B-O B-PP_IN
RA B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
RA B-O B-S_NP_NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VBD
lyn B-O B-NP_NN
mRNA B-O B-NN
production B-O B-NN
" " B-O O-NP
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
HL-60 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lyn B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
common B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
examine B-O B-VP_VB
whether B-O B-SBAR_IN
the B-O B-S_NP_DT
AP-1 B-O B-NN
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
THP-1 B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
transiently B-O B-ADVP_RB
" " B-O O-ADVP
transfected B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
chloramphenicol B-O B-NN
acetyl B-O B-NN
transferase B-O B-NN
( B-O B-LRB
CAT B-O B-NN
) B-O B-RRB
-reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
5 B-O B-NP_NP_CD
copies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
RA B-O B-NP_NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
induce B-O B-VP_VB
any B-O B-NP_NP_DT
CAT B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
thus B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
suggesting B-O B-VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
RA-induced B-O B-JJ
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
described B-O B-VP_VBN
above B-O B-NP_ADVP_IN
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Antigenic B-O B-NP_NP_NP_JJ
specificities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
CD4+ B-O B-JJ
T-cell B-O B-NN
clones B-O B-NNS
" " B-O O-NP
recovered B-O B-VP_VBD
from B-O B-NP_PP_IN
recurrent B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
genital B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
herpes B-O B-NN
simplex B-O B-JJ
virus B-O B-NN
type B-O B-NN
2 B-O B-CD
lesions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Lesions B-O B-S_S_NP_NP_NNS
" " B-O O-NP
resulting B-O B-VP_VBG
from B-O B-PP_IN
recurrent B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
genital B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
herpes B-O B-NP_NP_NN
simplex B-O B-JJ
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HSV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
infiltration B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD4+ B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
the B-O B-NP_NP_DT
antigenic B-O B-JJ
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
47 B-O B-NP_NP_CD
HSV-specific B-O B-JJ
CD4+ B-O B-JJ
T-cell B-O B-NN
clones B-O B-NNS
" " B-O O-NP
recovered B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Clones B-O B-S_NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
proliferative B-O B-NP_NP_JJ
responses B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
or B-O B-NP_NP_NP_NP_NP_PRN_CC
gD B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
HSV-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
or B-O B-CC
purified B-O B-NP_NP_VBN
natural B-O B-JJ
gC B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HSV-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
comprised B-O B-VP_VBD
a B-O B-NP_NP_DT
minority B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
total B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HSV-specific B-O B-NP_NP_JJ
clones B-O B-NNS
" " B-O O-NP
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
gC2- B-O B-NP_NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
gD2-specific B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
CD4+ B-O B-NP_JJ
clones B-O B-NNS
" " B-O O-NP
" " B-O O-NP
had B-O B-VP_VBD
cytotoxic B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
approximate B-O B-JJ
locations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
HSV-2 B-O B-NN
genes B-O B-NNS
" " B-O O-NP
encoding B-O B-VP_VBG
HSV-2 B-O B-NP_NN
type-specific B-O B-JJ
CD4+ B-O B-JJ
antigens B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VP_VBP
been B-O B-VP_VBN
determined B-O B-VP_VBN
by B-O B-NP_PP_IN
using B-O B-S_NP_VP_VBG
HSV-1 B-O B-NP_NN
x B-O B-NN
HSV-2 B-O B-NN
intertypic B-O B-JJ
recombinant B-O B-JJ
virus B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
include B-O B-VP_VBP
the B-O B-NP_NP_DT
approximate B-O B-JJ
map B-O B-NN
regions B-O B-NNS
" " B-O O-NP
0.30 B-O B-NP_NP_QP_CD
to B-O B-TO
0.46 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
, B-O B-COMMA
0.59 B-O B-NP_QP_CD
to B-O B-TO
0.67 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
, B-O B-COMMA
0.67 B-O B-NP_QP_CD
to B-O B-TO
0.73 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
0.82 B-O B-NP_QP_CD
to B-O B-TO
1.0 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
units B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
antigenic B-O B-JJ
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
HLA B-O B-NN
DQ2-restricted B-O B-JJ
, B-O B-COMMA
HSV-2 B-O B-NN
type-specific B-O B-JJ
T-cell B-O B-NN
clone B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
mapped B-O B-VP_VBN
to B-O B-NP_PP_TO
amino B-O B-NP_NP_NN
acids B-O B-NNS
425 B-O B-CD
to B-O B-TO
444 B-O B-CD
" " B-O O-NP
of B-O B-PP_IN
VP16 B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HSV-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
sequential B-O B-NP_NP_JJ
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
intertypic B-O B-JJ
recombinant B-O B-JJ
virus B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Each B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
remaining B-O B-VBG
four B-O B-CD
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
yielded B-O B-VP_VBD
at B-O B-NP_QP_IN
least B-O B-JJS
one B-O B-CD
" " B-O O-QP
type-specific B-O B-NP_NP_JJ
T-cell B-O B-NN
clone B-O B-NN
" " B-O O-NP
reactive B-O B-ADJP_JJ
with B-O B-PP_IN
an B-O B-NP_NP_DT
HSV-2 B-O B-NN
epitope B-O B-NN
" " B-O O-NP
mapping B-O B-VP_VBG
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
antigenic B-O B-JJ
specificities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
lesion-derived B-O B-NP_JJ
CD4+ B-O B-JJ
T-cell B-O B-NN
clones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VP_VBP
quite B-O B-ADJP_RB
diverse B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
include B-O B-VP_VBP
at B-O B-NP_QP_IN
least B-O B-JJS
10 B-O B-CD
" " B-O O-QP
epitopes B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_NP_NP_JJ
T-cell B-O B-NN
clones B-O B-NNS
" " B-O O-NP
reactive B-O B-ADJP_JJ
with B-O B-PP_IN
gC B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
VP16 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
are B-O B-VP_VBP
reported B-O B-VP_VBN
here B-O B-NP_ADVP_RB
" " B-O O-ADVP
for B-O B-PP_IN
the B-O B-NP_DT
first B-O B-JJ
time B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Sp1 B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
critical B-O B-JJ
factor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
monocytic B-O B-ADJP_JJ
specific B-O B-JJ
" " B-O O-ADJP
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
CD14 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
CD14 B-O B-S_S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
membrane B-O B-NN
glycoprotein B-O B-NN
" " B-O O-NP
expressed B-O B-VP_VBN
specifically B-O B-NP_ADVP_RB
" " B-O O-ADVP
on B-O B-PP_IN
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
its B-O B-S_NP_PRPP
expression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
markedly B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBN
during B-O B-NP_PP_IN
the B-O B-NP_NP_DT
process B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
monocyte B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_SBAR_IN
order B-O B-NN
to B-O B-S_NP_VP_TO
study B-O B-VP_VB
CD14 B-O B-NP_NN
gene B-O B-NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_DT
human B-O B-JJ
CD14 B-O B-NN
gene B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
cloned B-O B-VP_VBN
from B-O B-NP_PP_IN
a B-O B-NP_DT
partial B-O B-JJ
EcoRI B-O B-NN
digested B-O B-JJ
chromosome B-O B-NN
5 B-O B-CD
library B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
5.5-kilobase B-O B-JJ
genomic B-O B-JJ
clone B-O B-NN
" " B-O O-NP
contained B-O B-VP_VBD
the B-O B-NP_NP_DT
full-length B-O B-JJ
CD14 B-O B-NN
coding B-O B-NN
sequence B-O B-NN
" " B-O O-NP
and B-O B-CC
4.2 B-O B-NP_CD
kilobases B-O B-NNS
of B-O B-IN
5'-upstream B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
major B-O B-JJ
" " B-O B-NP_O-NP
and B-O B-CC
one B-O B-NP_CD
minor B-O B-JJ
" " B-O B-NP_O-NP
transcription B-O B-NP_NN
start B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
101 B-O B-NP_ADVP_NP_CD
and B-O B-CC
130 B-O B-CD
base B-O B-NN
pairs B-O B-NNS
( B-O B-LRB
bp B-O B-NN
) B-O B-RRB
" " B-O O-NP
upstream B-O B-RB
" " B-O B-PP_O-ADVP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
from B-O B-PP_IN
the B-O B-NP_DT
protein B-O B-NN
translation B-O B-NN
start B-O B-NN
ATG B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
DNA B-O B-NN
fragment B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
128 B-O B-NP_CD
bp B-O B-NN
of B-O B-IN
upstream B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
had B-O B-VP_VBD
strong B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
monocyte-specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
CD14 B-O B-NP_NP_NN
positive B-O B-JJ
monocytic B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
Mono B-O B-NP_NN
Mac B-O B-NN
6 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
as B-O B-SBAR_IN
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
" " B-O B-NP_NP_NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Four B-O B-S_NP_NP_CD
regions B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
DNA B-O B-NN
fragment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
interact B-O B-VP_VBP
with B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
Sp1 B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
bound B-O B-VP_VBD
to B-O B-PP_TO
three B-O B-NP_NP_CD
different B-O B-JJ
regions B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
CD14 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
major B-O B-JJ
Sp1 B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
-110 B-O B-NP_CD
bp B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
decreased B-O B-VP_VBD
tissue-specific B-O B-NP_JJ
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
these B-O B-S_NP_NP_DT
results B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
together B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
transactivation B-O B-NP_NN
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
Sp1 B-O B-S_NP_NN
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
critical B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
tissue-specific B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
CD14 B-O B-S_NP_NN
Sp1 B-O B-NN
site B-O B-NN
oligonucleotides B-O B-NNS
" " B-O O-NP
bound B-O B-VP_VBD
preferentially B-O B-PP_ADVP_RB
" " B-O O-ADVP
to B-O B-TO
a B-O B-NP_NP_DT
105-kDa B-O B-JJ
Sp1 B-O B-NN
species B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
present B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_O-ADJP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
" " B-O B-SBAR_O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Inhibition B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
extracellular B-O B-NP_NP_JJ
matrix B-O B-NN
protein B-O B-NN
" " B-O O-NP
tenascin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Tenascin B-O B-S_S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
TN B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
extracellular B-O B-JJ
matrix B-O B-NN
protein B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VP_VBZ
expressed B-O B-VP_VBN
" " B-O B-NP_ADVP_PP_O-VP
, B-O B-COMMA
but B-O B-CC
reappears B-O B-VP_VBZ
at B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
soluble B-O B-S_NP_JJ
TN B-O B-NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
proliferation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TN B-O B-S_S_NP_NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
inhibits B-O B-VP_VBZ
proliferation B-O B-NP_NP_NN
" " B-O O-NP
driven B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
alpha B-O B-NP_NN
CD3/IL-2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
by B-O B-PP_IN
phorbol B-O B-NP_NN
ester/IL-2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
prevents B-O B-VP_VBZ
high B-O B-NP_NP_JJ
level B-O B-NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2R B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TN B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
culture B-O B-NP_NN
medium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
does B-O B-VP_VP_VBZ
not B-O B-RB
detectably B-O B-ADVP_RB
" " B-O O-ADVP
alter B-O B-VP_VB
the B-O B-NP_NP_DT
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tyrosine B-O B-NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
resulting B-O B-VP_VBG
from B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
at B-O B-PP_IN
later B-O B-NP_JJR
time B-O B-NN
points B-O B-NNS
" " B-O O-NP
" " B-O O-PP
prevents B-O B-VP_VBZ
the B-O B-NP_NP_DT
appearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
functional B-O B-NP_JJ
NF-AT1 B-O B-NN
transcription B-O B-NN
factor B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
are B-O B-VP_VP_VBP
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_NP_DT
postulated B-O B-VBN
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
TN B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_NP_DT
natural B-O B-JJ
antagonist B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
T B-O B-S_NP_NP_NN
cell B-O B-NN
responses B-O B-NNS
" " B-O O-NP
occurring B-O B-VP_VBG
at B-O B-PP_IN
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-VP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
influenced B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Tolerance B-O B-S_S_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
lipopolysaccharide B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involves B-O B-VP_VBZ
mobilization B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
predominance B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
p50 B-O B-NP_NN
homodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Stimulation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_NP_JJ
monocytic B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
Mono B-O B-NP_NN
Mac B-O B-NN
6 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
lipopolysaccharide B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
LPS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
rapid B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
transient B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokines B-O B-NP_NP_NNS
" " B-O O-NP
like B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
such B-O B-S_NP_JJ
cells B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
precultured B-O B-VP_VBN
for B-O B-NP_PP_IN
2 B-O B-NP_CD
days B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_NP_DT
low B-O B-JJ
dose B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
20 B-O B-NP_CD
ng/ml B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
followed B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
expression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TNF B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
minimal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
i.e. B-O B-PP_FW
" " B-O O-PP
the B-O B-S_NP_DT
cells B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
tolerant B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
nuclear B-O B-NP_JJ
run-on B-O B-JJ
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
such B-O B-NP_JJ
tolerant B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
only B-O B-NP_NP_RB
a B-O B-DT
low B-O B-JJ
degree B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
tolerance B-O B-S_NP_NN
" " B-O O-NP
operates B-O B-VP_VBZ
at B-O B-UCP_PP_IN
" " B-O B-NP_O-PP
or B-O B-CC
upstream B-O B-ADVP_RB
" " B-O B-PP_O-UCP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
CD14 B-O B-NN
LPS B-O B-NN
receptor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
up-regulated B-O B-VP_VP_VBN
( B-O B-NP_PRN_LRB
not B-O B-RB
down-regulated B-O B-VP_VBN
" " B-O B-NP_O-VP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
in B-O B-PP_IN
tolerant B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
LPS B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
, B-O B-COMMA
in B-O B-PP_IN
fact B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
still B-O B-ADVP_RB
" " B-O O-ADVP
lead B-O B-VP_VB
to B-O B-PP_TO
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
tolerant B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
as B-O B-SBAR_IN
evidenced B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
mobilization B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Resolution B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
gel B-O B-NP_NN
shift B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
shows B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
binding B-O B-VBG
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
mobilized B-O B-VP_VBN
in B-O B-NP_PP_IN
naive B-O B-NP_JJ
Mono B-O B-NN
Mac B-O B-NN
6 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
consists B-O B-VP_VBZ
mainly B-O B-ADVP_RB
" " B-O O-ADVP
of B-O B-PP_IN
p50-p65 B-O B-NP_NN
heterodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
while B-O B-SBAR_IN
in B-O B-S_PP_IN
tolerant B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
p50 B-O B-NN
homodimer B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
predominant B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
p50 B-O B-NP_NN
homodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
coincides B-O B-VP_VBZ
with B-O B-PP_IN
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
p105 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggestive B-O B-ADVP_JJ
of B-O B-PP_IN
a B-O B-NP_NP_DT
transcriptional B-O B-JJ
up-regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Reporter B-O B-S_NP_NN
gene B-O B-NN
analysis B-O B-NN
" " B-O O-NP
reveals B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
NF-kappa B-O B-NN
B B-O B-NN
complex B-O B-NN
" " B-O O-NP
mobilized B-O B-VP_VBN
in B-O B-NP_PP_IN
tolerant B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
functionally B-O B-ADJP_RB
inactive B-O B-JJ
in B-O B-PP_IN
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_ADVP_JJ
to B-O B-PP_TO
Mono B-O B-NP_NN
Mac B-O B-NN
6 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
, B-O B-COMMA
primary B-O B-S_NP_JJ
blood B-O B-NN
monocytes B-O B-NNS
, B-O B-COMMA
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
precultured B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
low B-O B-JJ
dose B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
also B-O B-ADVP_RB
" " B-O O-ADVP
become B-O B-VP_VP_VP_VBP
tolerant B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
produce B-O B-VP_VBP
little B-O B-NP_JJ
TNF B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
after B-O B-PP_IN
LPS B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
tolerant B-O B-JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
up-regulate B-O B-VP_VBP
CD14 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
they B-O B-S_NP_PRP
" " B-O O-NP
mobilize B-O B-VP_VBP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
predominance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p50 B-O B-NP_NN
homodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O B-NP_O-VP
" " B-O O-S
, B-O B-COMMA
these B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
tolerance B-O B-S_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
determined B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
HLA-DR- B-O B-NP_NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
CD33+ B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
CD56+ B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
CD16- B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
myeloid/natural B-O B-NP_JJ
killer B-O B-NN
cell B-O B-NN
acute B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
: B-O B-COLON
" " B-O O-NP
a B-O B-NP_NP_NP_DT
previously B-O B-ADJP_RB
unrecognized B-O B-JJ
" " B-O O-ADJP
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
acute B-O B-NP_JJ
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
potentially B-O B-ADJP_RB
misdiagnosed B-O B-JJ
as B-O B-PP_IN
French-American-British B-O B-NP_ADJP_JJ
acute B-O B-JJ
myeloid B-O B-JJ
" " B-O O-ADJP
leukemia-M3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
[ B-O B-S_LRB
see B-O B-NP_VP_VB
comments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
characterized B-O B-VP_VBN
" " B-O B-NP_O-VP
a B-O B-NP_NP_DT
previously B-O B-ADJP_RB
unrecognized B-O B-JJ
" " B-O O-ADJP
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
acute B-O B-NP_JJ
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
shares B-O B-S_NP_VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
From B-O B-S_S_PP_IN
a B-O B-NP_NP_DT
consecutive B-O B-JJ
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
350 B-O B-NP_NP_CD
cases B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
adult B-O B-NP_ADJP_JJ
" " B-O O-ADJP
de B-O B-ADJP_FW
novo B-O B-FW
" " B-O O-ADJP
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
identified B-O B-VP_VBD
20 B-O B-NP_NP_CD
cases B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
6 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_DT
unique B-O B-JJ
immunophenotype B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
CD33+ B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
CD56+ B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
CD11a+ B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
CD13lo B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
CD15lo B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
CD34+/- B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
HLA-DR- B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
CD16- B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
Multicolor B-O B-S_NP_JJ
flow B-O B-NN
cytometric B-O B-JJ
assays B-O B-NNS
" " B-O O-NP
confirmed B-O B-VP_VBD
the B-O B-NP_NP_DT
coexpression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
myeloid B-O B-NP_NP_JJ
( B-O B-LRB
CD33 B-O B-NN
, B-O B-COMMA
CD13 B-O B-NN
, B-O B-COMMA
CD15 B-O B-NN
) B-O B-RRB
" " B-O B-NP_O-NP
and B-O B-CC
NK B-O B-NP_NN
cell-associated B-O B-JJ
( B-O B-LRB
CD56 B-O B-NN
) B-O B-RRB
" " B-O B-NP_O-NP
antigens B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
each B-O B-NP_DT
case B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
whereas B-O B-SBAR_IN
reverse B-O B-S_NP_NP_NP_NN
transcription B-O B-NN
polymerase B-O B-NN
chain B-O B-NN
reaction B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RT-PCR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
assays B-O B-NNS
" " B-O O-NP
confirmed B-O B-VP_VBD
the B-O B-NP_NP_DT
identity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD56 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
leukemic B-O B-NP_JJ
blasts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
two B-O B-S_NP_CD
cases B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VBD
CD4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
no B-O B-S_S_NP_DT
case B-O B-NN
" " B-O O-NP
expressed B-O B-VP_VBD
CD2 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
CD3 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
CD8 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
no B-O B-S_NP_DT
case B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
clonal B-O B-NP_NP_JJ
rearrangement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
encoding B-O B-VP_VBG
" " B-O B-NP_NP_PRN_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Leukemic B-O B-S_S_NP_NP_JJ
blasts B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
majority B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cases B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
shared B-O B-VP_VBD
unique B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
morphologic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
features B-O B-NNS
" " B-O B-SBAR_O-NP
( B-O B-PRN_LRB
deeply B-O B-NP_NP_ADJP_RB
invaginated B-O B-JJ
nuclear B-O B-JJ
" " B-O O-ADJP
membranes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
scant B-O B-NP_NP_JJ
cytoplasm B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
fine B-O B-NP_JJ
azurophilic B-O B-JJ
granularity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
finely B-O B-NP_NP_ADJP_RB
granular B-O B-JJ
" " B-O O-ADJP
Sudan B-O B-NN
black B-O B-JJ
B B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
myeloperoxidase B-O B-NP_NN
" " B-O B-NP_O-NP
cytochemical B-O B-NP_JJ
reactivity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
remarkably B-O B-ADJP_RB
similar B-O B-JJ
to B-O B-PP_TO
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-S
; B-O B-COLON
particularly B-O B-NP_ADVP_RB
" " B-O O-ADVP
the B-O B-NP_DT
microgranular B-O B-JJ
variant B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
FAB B-O B-NP_NN
AML-M3v B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
all B-O B-S_S_NP_DT
20 B-O B-CD
cases B-O B-NNS
" " B-O O-NP
lacked B-O B-VP_VBD
the B-O B-NP_DT
t(15;17) B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
17 B-O B-S_NP_NP_CD
cases B-O B-NNS
" " B-O O-NP
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
lacked B-O B-VP_VBD
the B-O B-NP_DT
promyelocytic/retinoic B-O B-JJ
acid B-O B-NN
receptor B-O B-NN
alpha B-O B-NN
( B-O B-LRB
RAR B-O B-NN
alpha B-O B-NN
) B-O B-RRB
fusion B-O B-NN
transcript B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
RT-PCR B-O B-NP_NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-S
; B-O B-COLON
12 B-O B-S_NP_CD
cases B-O B-NNS
" " B-O O-NP
had B-O B-VP_VBD
46,XX B-O B-NP_NP_NN
" " B-O B-NP_O-NP
or B-O B-CC
46,XY B-O B-NP_NN
" " B-O B-NP_O-NP
karyotypes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
whereas B-O B-SBAR_IN
2 B-O B-S_NP_CD
cases B-O B-NNS
" " B-O B-NP_O-NP
had B-O B-VP_VBD
abnormalities B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
chromosome B-O B-NP_NN
17q B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
1 B-O B-NP_NP_NP_CD
" " B-O O-NP
with B-O B-PP_IN
del(17)(q25) B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
other B-O B-JJ
" " B-O O-NP
with B-O B-PP_IN
t(11;17)(q23;q21) B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
promyelocytic B-O B-JJ
leukemia B-O B-NN
zinc B-O B-NN
finger/RAR B-O B-NN
alpha B-O B-NN
fusion B-O B-NN
transcript B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_NP_NP_NP_DT
cases B-O B-NNS
" " B-O O-NP
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
( B-O B-PRN_LRB
6/20 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
the B-O B-NP_NP_DT
case B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
t(11;17) B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
differentiate B-O B-VP_VB
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
these B-O B-S_NP_DT
cases B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
account B-O B-VP_VB
for B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Four B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
6 B-O B-NP_NP_CD
cases B-O B-NNS
" " B-O O-NP
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
functional B-O B-NP_JJ
NK B-O B-NN
cell-mediated B-O B-JJ
cytotoxicity B-O B-NN
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
relationship B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
these B-O B-NP_NP_DT
unique B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_ADJP_NP_O-NP
, B-O B-COMMA
" " B-O B-NP_ADJP_NP_O-NP
, B-O B-COMMA
" " B-O B-NP_ADJP_NP_O-NP
acute B-O B-NP_JJ
leukemias B-O B-NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
normal B-O B-NP_JJ
CD56+ B-O B-JJ
, B-O B-COMMA
CD16- B-O B-JJ
NK B-O B-NN
precursor B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
a B-O B-NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
panning B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
multiparameter B-O B-NP_NN
flow B-O B-NN
cytometric B-O B-JJ
sorting B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
identified B-O B-VP_VBD
a B-O B-NP_DT
normal B-O B-ADJP_JJ
" " B-O O-ADJP
CD56+ B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
CD33+ B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
CD16- B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O O-NP
counterpart B-O B-NP_NN
cell B-O B-NN
" " B-O O-NP
" " B-O O-NP
at B-O B-PP_IN
a B-O B-NP_NP_DT
frequency B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1 B-O B-NP_ADJP_QP_CD
% B-O B-NN
to B-O B-TO
2 B-O B-CD
% B-O B-NN
" " B-O O-QP
" " B-O O-ADJP
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
peripheral B-O B-JJ
blood B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
healthy B-O B-NP_JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_S_NP_PRPP
studies B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
this B-O B-S_NP_NP_DT
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
acute B-O B-NP_JJ
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
arise B-O B-VP_VB
from B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
thus B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
the B-O B-NP_DT
designation B-O B-NN
myeloid/NK B-O B-JJ
acute B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Recognition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
new B-O B-JJ
leukemic B-O B-JJ
entity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
will B-O B-VP_MD
be B-O B-VP_VB
important B-O B-ADJP_JJ
in B-O B-PP_IN
distinguishing B-O B-S_NP_VP_VBG
these B-O B-NP_DT
ATRA-nonresponsive B-O B-JJ
cases B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
APL B-O B-NP_ADJP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Evidence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
a B-O B-NP_NP_DT
trans-acting B-O B-JJ
activator B-O B-NN
function B-O B-NN
" " B-O O-NP
regulating B-O B-VP_VBG
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
CD5 B-O B-NN
antigen B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Interspecies B-O B-S_NP_JJ
somatic B-O B-JJ
cell B-O B-NN
hybrids B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
generated B-O B-VP_VBN
by B-O B-NP_PP_IN
fusing B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
mouse B-O B-NN
T-lymphoma B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
BW5147 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
with B-O B-PP_IN
normal B-O B-NP_JJ
human B-O B-JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
different B-O B-NP_NP_JJ
stages B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thymocytes B-O B-S_NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
activated B-O B-NP_VBN
peripheral B-O B-JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
an B-O B-NP_DT
activated B-O B-VBN
T-cell B-O B-NN
clone B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
as B-O B-NP_PP_IN
human B-O B-NP_JJ
partners B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
three B-O B-NP_CD
independent B-O B-JJ
fusions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Irrespective B-O B-S_PP_JJ
of B-O B-IN
the B-O B-NP_NP_DT
human B-O B-JJ
cell B-O B-NN
partner B-O B-NN
" " B-O O-NP
used B-O B-VP_VBN
for B-O B-NP_PP_IN
fusion B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_NP_DT
certain B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hybrids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
lost B-O B-VP_VBD
CD5 B-O B-NP_NN
surface B-O B-NN
expression B-O B-NN
" " B-O O-NP
over B-O B-PP_IN
a B-O B-NP_NP_DT
period B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
time B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
culture B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_DT
phenotype B-O B-UCP_NP_NN
" " B-O O-NP
and B-O B-CC
genetic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-UCP
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
lack B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD5 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
due B-O B-PP_JJ
neither B-O B-PP_CC
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
nor B-O B-CC
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
loss B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD5 B-O B-NP_NN
surface B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlated B-O B-VP_VBD
with B-O B-PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_JJ
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
these B-O B-S_NP_DT
hybrids B-O B-NNS
" " B-O O-NP
preferentially B-O B-ADVP_RB
" " B-O O-ADVP
segregate B-O B-VP_VBP
human B-O B-NP_JJ
chromosomes B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
the B-O B-NP_NP_DT
existence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
non-syntenic B-O B-JJ
trans-active B-O B-JJ
locus B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
loci B-O B-NP_NNS
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-NP
positively B-O B-VP_ADVP_RB
" " B-O O-ADVP
controlling B-O B-VBG
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
CD5 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Alpha-tocopherol B-O B-S_S_NP_NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
agonist-induced B-O B-NP_NP_JJ
monocytic B-O B-JJ
cell B-O B-NN
adhesion B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
cultured B-O B-NP_VBN
human B-O B-JJ
endothelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Antioxidants B-O B-S_S_S_NP_NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
proposed B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
however B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
underlying B-O B-VP_VBG
their B-O B-NP_PRPP
beneficial B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
poorly B-O B-ADVP_RB
" " B-O O-ADVP
understood B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
alpha-tocopherol B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
alpha-tcp B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
one B-O B-NP_NP_CD
cellular B-O B-JJ
event B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
atherosclerotic B-O B-NP_NP_JJ
plaque B-O B-NN
development B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_S_NP_JJ
umbilical B-O B-JJ
vein B-O B-NN
ECs B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
pretreated B-O B-VP_VBN
with B-O B-NP_PP_IN
alpha-tcp B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
before B-O B-PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
known B-O B-NP_NP_JJ
agonists B-O B-NNS
" " B-O B-NP_O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
IL-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
10 B-O B-NP_CD
ng/ml B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
LPS B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
10 B-O B-NP_CD
ng/ml B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
thrombin B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
30 B-O B-NP_CD
U/ml B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
PMA B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
10 B-O B-NP_CD
nM B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
Agonist-induced B-O B-S_NP_NP_JJ
monocytic B-O B-JJ
cell B-O B-NN
adhesion B-O B-NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
basal B-O B-NP_JJ
adhesion B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_DT
time- B-O B-NP_NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
concentration-dependent B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
manner B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
alpha-tcp B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
IC50 B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
alpha-tcp B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
an B-O B-NP_DT
IL-1-induced B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
45 B-O B-NP_CD
microM B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
inhibition B-O B-NN
" " B-O O-NP
correlated B-O B-VP_VBD
with B-O B-PP_IN
a B-O B-NP_NP_NP_DT
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
steady B-O B-NP_JJ
state B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
of B-O B-PP_IN
E-selectin B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
cell B-O B-NP_NP_NN
surface B-O B-NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E-selectin B-O B-NP_NP_NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Probucol B-O B-S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
50 B-O B-NP_CD
microM B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
N-acetylcysteine B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
20 B-O B-NP_CD
mM B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
agonist-induced B-O B-NP_JJ
monocytic B-O B-JJ
cell B-O B-NN
adhesion B-O B-NN
" " B-O O-NP
; B-O B-COLON
whereas B-O B-SBAR_IN
, B-O B-COMMA
several B-O B-S_NP_ADJP_JJ
other B-O B-JJ
" " B-O O-ADJP
antioxidants B-O B-NNS
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
significant B-O B-JJ
effect B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Protein B-O B-S_NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PKC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
appear B-O B-VP_VB
to B-O B-S_NP_VP_TO
play B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
alpha-tcp B-O B-NN
effect B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
since B-O B-SBAR_IN
no B-O B-S_NP_NP_DT
suppression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
substrates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NP_NP_NN
factor B-O B-NN
" " B-O O-NP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
reported B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
necessary B-O B-ADJP_ADJP_JJ
" " B-O B-PP_O-ADJP
but B-O B-CC
not B-O B-ADJP_RB
sufficient B-O B-JJ
" " B-O B-PP_O-ADJP
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Electrophoretic B-O B-S_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
show B-O B-VP_VB
an B-O B-NP_NP_DT
alpha-tcp-induced B-O B-JJ
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
of B-O B-PP_IN
this B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
cytokine B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
hypothesized B-O B-VP_VBN
that B-O B-SBAR_IN
alpha-tcp B-O B-S_NP_NN
" " B-O O-NP
acts B-O B-VP_VBZ
as B-O B-PP_IN
an B-O B-NP_DT
anti-atherosclerotic B-O B-JJ
molecule B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
point B-O B-VP_VBP
to B-O B-PP_TO
a B-O B-NP_NP_DT
novel B-O B-JJ
alternative B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
alpha-tcp B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Inhibition B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
myeloid B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
redox B-O B-NP_NP_NN
changes B-O B-NNS
" " B-O O-NP
induced B-O B-VP_VBN
through B-O B-NP_PP_IN
glutathione B-O B-NP_NN
depletion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
redox B-O B-NP_NN
changes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
on B-O B-PP_IN
the B-O B-NP_NP_DT
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
glutathione-depleting B-O B-JJ
agent B-O B-NN
diethyl B-O B-NN
maleate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
DEM B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
prevented B-O B-VP_VBD
the B-O B-NP_NP_DT
development B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
differentiated B-O B-NP_VBN
features B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
phorbol B-O B-NP_NN
esters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
including B-O B-PP_VBG
adherence B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
plastic B-O B-NP_JJ
surfaces B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
repression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
myeloperoxidase B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
CD34 B-O B-NP_NN
" " B-O B-NP_O-NP
genes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
DEM B-O B-NP_NN
" " B-O O-NP
abolished B-O B-VP_VBD
phorbol B-O B-NP_NP_NN
12-myristate B-O B-NN
13-acetate-induced B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
AP-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Egr-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
due B-O B-ADJP_JJ
, B-O B-COMMA
, B-O B-PP_COMMA
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Upregulation B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
bcl-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
Epstein-Barr B-O B-NP_NP_JJ
virus B-O B-NN
latent B-O B-JJ
membrane B-O B-NN
protein B-O B-NN
" " B-O O-NP
LMP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
a B-O B-NP_NP_DT
B-cell-specific B-O B-JJ
response B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
delayed B-O B-VP_VBN
" " B-O B-NP_O-VP
relative B-O B-ADVP_JJ
to B-O B-PP_PP_TO
and B-O B-NP_CC
to B-O B-PP_TO
" " B-O B-NP_O-PP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
An B-O B-S_S_S_NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Epstein-Barr B-O B-NP_NP_JJ
virus B-O B-NN
latent B-O B-JJ
membrane B-O B-NN
protein B-O B-NN
" " B-O O-NP
LMP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
enhance B-O B-VP_VB
the B-O B-NP_NP_DT
survival B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
through B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
was B-O B-VP_VBD
first B-O B-ADVP_RB
" " B-O O-ADVP
suggested B-O B-VP_VBN
by B-O B-NP_PP_IN
experiments B-O B-NP_NP_NNS
" " B-O O-NP
involving B-O B-VP_VBG
and B-O B-NP_NP_CC
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
S.Henderson B-O B-NP_NP_NP_NNP
" " B-O O-NP
, B-O B-COMMA
M. B-O B-NP_NNP
Rowe B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
C.Gregory B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
F.Wang B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
E.Kieff B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
A.Rickinson B-O B-NP_NNP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
Cell B-O B-NP_NNP
65 B-O B-CD
" " B-O O-NP
: B-O B-COLON
1107-1115 B-O B-NP_CD
" " B-O O-NP
, B-O B-COMMA
1991 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
it B-O B-NP_NP_PRP
" " B-O O-NP
" " B-O B-S_O-NP
was B-O B-VP_VBD
not B-O B-RB
possible B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
ascertain B-O B-VP_VB
whether B-O B-SBAR_IN
Bcl-2 B-O B-S_NP_NN
upregulation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
or B-O B-NP_NP_CC
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
reexamined B-O B-VP_VBD
this B-O B-NP_DT
issue B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
using B-O B-S_NP_VP_VBG
two B-O B-NP_NP_CD
approaches B-O B-ADJP_ADJP_ADJP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
activation B-O B-S_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
upregulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NP_NP_NN
adhesion B-O B-NN
molecule B-O B-NN
" " B-O O-NP
ICAM-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
as B-O B-NP_PP_IN
early B-O B-NP_NP_JJ
indices B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
LMP1 B-O B-NP_NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
first B-O B-JJ
approach B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
stable B-O B-NP_NP_JJ
clones B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_NP_CD
B-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
carrying B-O B-VP_VBG
an B-O B-NP_DT
LMP1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
under B-O B-PP_IN
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
inducible B-O B-JJ
metallothionein B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
induced B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
express B-O B-VP_VB
LMP1 B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
all B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NK-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
upregulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ICAM-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
occurred B-O B-VP_VP_VBD
within B-O B-PP_IN
24 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
were B-O B-VP_VBD
followed B-O B-VP_VBN
at B-O B-NP_PP_IN
48 B-O B-NP_QP_CD
to B-O B-TO
72 B-O B-CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
upregulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Bcl-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
second B-O B-JJ
approach B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
tested B-O B-VP_VBD
the B-O B-NP_NP_DT
generality B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
phenomenon B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
transiently B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
expressing B-O B-VP_VBG
LMP1 B-O B-NP_NN
" " B-O O-NP
from B-O B-PP_IN
a B-O B-NP_NP_DT
promoter B-O B-ADJP_ADJP_ADVP_ADJP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_S_NP_NP_DT
six B-O B-CD
B-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
showed B-O B-VP_VBD
NF-kappa B-O B-NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
LMP1 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
this B-O B-S_NP_DT
" " B-O O-NP
was B-O B-VP_VBD
followed B-O B-VP_VBN
in B-O B-NP_PP_IN
five B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
six B-O B-NP_CD
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ICAM-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Bcl-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
same B-O B-JJ
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
all B-O B-NP_DT
three B-O B-CD
non-B-cell B-O B-JJ
lines B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
and B-O B-CC
ICAM-1 B-O B-NP_NN
upregulation B-O B-NN
" " B-O O-NP
but B-O B-CC
never B-O B-ADVP_RB
" " B-O O-ADVP
any B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
upon B-O B-PP_IN
Bcl-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
conclude B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
Bcl-2 B-O B-S_NP_NN
upregulation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
part B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
but B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
cell B-O B-ADJP_NN
type B-O B-NN
specific B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
data B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
whilst B-O B-S_SBAR_IN
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
other B-O B-S_NP_JJ
cell-specific B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
required B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
to B-O B-S_NP_VP_TO
effect B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
CD14-mediated B-O B-S_S_NP_NP_JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
factor-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
lipopolysaccharide B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
require B-O B-VP_VB
tyrosine B-O B-NP_NN
kinase B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
During B-O B-S_S_PP_IN
the B-O B-NP_NP_DT
course B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
serious B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
bacterial B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
infections B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
lipopolysaccharide B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
LPS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
believed B-O B-VP_VBN
to B-O B-S_NP_VP_TO
interact B-O B-VP_VB
with B-O B-PP_IN
macrophage B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
resulting B-O B-S_NP_VP_VBG
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
CD14 B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
glycosylphosphatidylinositol-linked B-O B-JJ
antigen B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
functions B-O B-VP_VBZ
as B-O B-PP_IN
an B-O B-NP_DT
LPS B-O B-NN
signaling B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
critical B-O B-JJ
issue B-O B-NN
" " B-O O-NP
concerns B-O B-VP_VBZ
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
CD14 B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
has B-O B-S_NP_VP_VBZ
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
transduces B-O B-VP_VBZ
its B-O B-NP_PRPP
signal B-O B-NN
" " B-O O-NP
following B-O B-PP_VBG
LPS B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recently B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
investigators B-O B-NP_NNS
" " B-O O-NP
have B-O B-VP_VBP
hypothesized B-O B-VP_VBN
that B-O B-SBAR_IN
CD14-mediated B-O B-S_NP_JJ
signaling B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
effected B-O B-VP_VBN
through B-O B-NP_PP_IN
a B-O B-NP_DT
receptor-associated B-O B-JJ
" " B-O B-NP_O-PP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Wild-type B-O B-S_NP_JJ
Chinese B-O B-JJ
hamster B-O B-NN
ovary B-O B-NN
( B-O B-LRB
CHO B-O B-NN
) B-O B-RRB
-K1 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
endotoxin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
to B-O B-S_NP_VP_TO
release B-O B-VP_VB
arachidonate B-O B-NP_NN
" " B-O O-NP
following B-O B-PP_VBG
transfection B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
human B-O B-NP_JJ
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_NP_JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytosolic B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LPS-inducible B-O B-NP_JJ
responses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
sought B-O B-VP_VBD
to B-O B-S_NP_VP_VP_TO
determine B-O B-VP_VB
if B-O B-SBAR_IN
this B-O B-S_NP_DT
pathway B-O B-NN
" " B-O O-NP
were B-O B-VP_VBD
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
to B-O B-VP_TO
elucidate B-O B-VP_VB
the B-O B-NP_NP_DT
relationship B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
CD14 B-O B-NN
receptor B-O B-NN
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LPS-stimulated B-O B-S_NP_NP_JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
CHO/CD14 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resembled B-O B-VP_VBD
the B-O B-NP_NP_DT
same B-O B-JJ
response B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
murine B-O B-NP_NP_NN
macrophage-like B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
RAW B-O B-NP_NN
264.7 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Protein B-O B-S_NP_NP_NP_NN
synthesis B-O B-NN
inhibitors B-O B-NNS
" " B-O O-NP
and B-O B-CC
corticosteroids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
suppress B-O B-S_NP_VP_VBP
arachidonate B-O B-NP_NP_NN
release B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
synthesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
proinflammatory B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
translocation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
CHO/CD14 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
RAW B-O B-NP_NN
264.7 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
demonstrating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NN
B B-O B-NN
translocation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_DT
early B-O B-JJ
event B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
TK B-O B-S_NP_NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
consistently B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBN
by B-O B-NP_PP_IN
immunoblotting B-O B-NP_NP_VBG
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
activated B-O B-NP_VBN
RAW B-O B-NN
264.7 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
LPS-induced B-O B-S_NP_JJ
phosphotyrosine B-O B-NN
residues B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
observed B-O B-VP_VBN
from B-O B-NP_PP_IN
similarly B-O B-NP_ADJP_RB
treated B-O B-VBN
" " B-O O-ADJP
CHO/CD14 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
TK B-O B-NN
inhibitors B-O B-NNS
" " B-O O-NP
herbimycin B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
and B-O B-CC
genistein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
inhibit B-O B-VP_VB
translocation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
CHO/CD14 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
RAW B-O B-NP_NN
264.7 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
although B-O B-SBAR_IN
both B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibited B-O B-VP_VBD
LPS-induced B-O B-NP_JJ
TK B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
RAW B-O B-NP_NN
264.7 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
imply B-O B-VP_VBP
that B-O B-SBAR_IN
TK B-O B-S_NP_NN
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
obligatory B-O B-ADJP_JJ
" " B-O O-ADJP
for B-O B-SBAR_WHNP_IN
CD14-mediated B-O B-S_NP_JJ
signal B-O B-JJ
transduction B-O B-NN
" " B-O O-NP
to B-O B-VP_TO
occur B-O B-VP_VB
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD14 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
monocytic B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
with B-O B-NP_PP_IN
1 B-O B-NP_CD
alpha,25-dihydroxyvitamin B-O B-NN
D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
CD14 B-O B-S_S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
monocyte/macrophage B-O B-NN
receptor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_NP_DT
complex B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
LPS B-O B-NP_NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
differentiation B-O B-NN
marker B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
monocyte/macrophage B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
analyzed B-O B-VP_VBN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD14 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
1 B-O B-NP_CD
alpha,25-dihydroxyvitamin B-O B-NN
D3 B-O B-NN
( B-O B-LRB
VitD3 B-O B-NN
) B-O B-RRB
-induced B-O B-JJ
monocytic B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
FACS B-O B-NP_NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
Northern B-O B-NP_NN
blotting B-O B-NN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
nuclear B-O B-NP_JJ
run-on B-O B-JJ
" " B-O B-NP_O-NP
analyses B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_NP_DT
up-regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD14 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
monocytic B-O B-NP_JJ
cell B-O B-NN
maturation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
mainly B-O B-NP_ADVP_RB
" " B-O O-ADVP
at B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
new B-O B-S_NP_JJ
protein B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
recently B-O B-ADVP_RB
" " B-O O-ADVP
cloned B-O B-VP_VP_VBN
the B-O B-NP_DT
CD14 B-O B-NN
5' B-O B-JJ
upstream B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
demonstrated B-O B-VP_VBD
its B-O B-NP_PRPP
tissue-specific B-O B-JJ
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
stable B-O B-NP_NP_JJ
transfection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
monocytoid B-O B-JJ
U937 B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_DT
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
deletion B-O B-NP_NP_NN
mutants B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
bp B-O B-S_NP_NN
-128 B-O B-CD
to B-O B-TO
-70 B-O B-CD
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
critical B-O B-JJ
region B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
region B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
two B-O B-NP_NP_CD
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
Sp1 B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
3-bp B-O B-JJ
mutation B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_DT
distal B-O B-JJ
Sp1-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
not B-O B-VP_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
eliminates B-O B-VP_VBZ
Sp1 B-O B-NP_NN
interaction B-O B-NN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
abolishes B-O B-VP_VBZ
most B-O B-NP_NP_JJS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
VitD3 B-O B-NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD14 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Electrophoretic B-O B-S_NP_JJ
mobility B-O B-NN
shift B-O B-NN
analysis B-O B-NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
detect B-O B-VP_VB
a B-O B-NP_NP_DT
direct B-O B-JJ
interaction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD14 B-O B-NN
distal B-O B-JJ
Sp1-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_NP_DT
vitamin B-O B-NN
D3 B-O B-NN
receptor B-O B-NN
" " B-O O-NP
and B-O B-CC
its B-O B-NP_NP_PRPP
partner B-O B-NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
retinoid B-O B-NN
X B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VP_VBP
that B-O B-SBAR_IN
VitD3 B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
CD14 B-O B-NP_NN
" " B-O O-NP
indirectly B-O B-ADVP_RB
" " B-O O-ADVP
through B-O B-PP_IN
some B-O B-NP_DT
intermediary B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
suggest B-O B-VP_VBP
a B-O B-NP_NP_DT
critical B-O B-JJ
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
Sp1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
this B-O B-NP_DT
process B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Calcium B-O B-NP_NP_NP_NN
signalling B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_DT
cyclophilin B-O B-NN
B-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
immunosuppressant B-O B-JJ
drug B-O B-NN
" " B-O O-NP
cyclosporin B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-NP
blocks B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
calcium-dependent B-O B-JJ
signal B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
T-cell B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
normally B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
leads B-O B-VP_VBZ
to B-O B-PP_TO
T-cell B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
bound B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
cyclophilin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
cyclosporin B-O B-S_NP_NN
A B-O B-NN
" " B-O O-NP
binds B-O B-VP_VP_VBZ
" " B-O B-NP_O-VP
and B-O B-CC
inactivates B-O B-VP_VBZ
" " B-O B-NP_O-VP
the B-O B-NP_DT
key B-O B-JJ
signalling B-O B-NN
intermediate B-O B-JJ
calcineurin B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
identify B-O B-VP_VB
potential B-O B-NP_NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
cellular B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
homologues B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
cyclosporin B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
might B-O B-S_NP_VP_MD
regulate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
cloned B-O B-VP_VBN
human B-O B-NP_NP_JJ
genes B-O B-NNS
" " B-O O-NP
encoding B-O B-VP_VBG
cyclophilin B-O B-NP_NN
B-binding-proteins B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
using B-O B-S_NP_VP_VBG
the B-O B-NP_DT
yeast B-O B-NN
two-hybrid B-O B-JJ
system B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_CD
gene B-O B-NN
product B-O B-NN
, B-O B-COMMA
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
overexpressed B-O B-S_NP_VP_VBN
in B-O B-NP_PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
specifically B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBD
transcription B-O B-NP_NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
interleukin-2 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
by B-O B-PP_IN
activating B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
T-cell-specific B-O B-JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
NF-AT B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NF-IL2A B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
termed B-O B-VP_VBN
calcium-signal B-O B-S_NP_NP_NP_JJ
modulating B-O B-NN
cyclophilin B-O B-NN
ligand B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CAML B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
acts B-O B-VP_VBZ
downstream B-O B-ADVP_ADVP_RB
of B-O B-PP_IN
the B-O B-NP_DT
TCR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
and B-O B-CC
upstream B-O B-ADVP_RB
of B-O B-PP_IN
calcineurin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-ADVP
by B-O B-PP_IN
causing B-O B-S_NP_VP_VBG
an B-O B-NP_NP_DT
influx B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
calcium B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CAML B-O B-S_NP_NN
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
a B-O B-NP_NP_DT
new B-O B-JJ
participant B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
calcium-signal B-O B-JJ
transduction B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
implicating B-O B-S_NP_VP_VBG
cyclophilin B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
calcium B-O B-NP_NN
signalling B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
even B-O B-PP_ADVP_RB
" " B-O O-ADVP
in B-O B-IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cyclosporin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Antioxidants B-O B-S_S_NP_NNS
" " B-O O-NP
inhibit B-O B-VP_VBP
monocyte B-O B-NP_NN
adhesion B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
suppressing B-O B-S_NP_VP_VBG
nuclear B-O B-NP_NP_JJ
factor-kappa B-O B-NN
B B-O B-NN
mobilization B-O B-NN
" " B-O O-NP
and B-O B-CC
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Cell B-O B-S_S_NP_NP_NN
adhesion B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
endothelial B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
stimulated B-O B-NP_NP_VBN
by B-O B-IN
tumor B-O B-NN
necrosis B-O B-NN
factor-alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TNF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
due B-O B-ADJP_JJ
to B-O B-PP_TO
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
surface B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
such B-O B-PP_JJ
as B-O B-IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
antioxidant B-O B-JJ
pyrrolidine B-O B-NP_NP_NN
dithiocarbamate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PDTC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
inhibits B-O B-VP_VBZ
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
factor-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
kappa B-O B-S_NP_NN
B B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
present B-O B-ADJP_JJ
in B-O B-PP_IN
VCAM-1 B-O B-NP_NN
and B-O B-CC
intercellular B-O B-JJ
adhesion B-O B-NN
molecule-1 B-O B-NN
( B-O B-LRB
ICAM-1 B-O B-NN
) B-O B-RRB
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
used B-O B-VP_VBD
PDTC B-O B-NP_NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
study B-O B-VP_VB
the B-O B-NP_NP_DT
regulatory B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
PDTC B-O B-S_NP_NP_NN
" " B-O B-NP_O-NP
or B-O B-CC
N-acetylcysteine B-O B-NP_NN
" " B-O B-NP_O-NP
dose B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
dependently B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBD
TNF-induced B-O B-NP_NP_NP_JJ
VCAM-1 B-O B-NN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
ICAM-1 B-O B-NP_NP_NN
surface B-O B-NN
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
also B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
human B-O B-NP_JJ
umbilical B-O B-JJ
arterial B-O B-JJ
endothelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
mRNA B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
by B-O B-PP_PP_IN
70 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
100 B-O B-NP_CD
mumol/L B-O B-NN
PDTC B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
) B-O B-RRB
" " B-O O-PRN
in B-O B-PP_IN
HUVECs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
as B-O B-SBAR_IN
assessed B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
flow B-O B-NP_NP_NN
cytometry B-O B-NN
" " B-O O-NP
and B-O B-CC
polymerase B-O B-NP_NN
chain B-O B-NN
reaction B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Gel-shift B-O B-S_NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HUVECs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
PDTC B-O B-S_NP_NN
" " B-O O-NP
prevented B-O B-VP_VBD
NF-kappa B-O B-NP_NN
B B-O B-NN
mobilization B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
TNF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
HUVECs B-O B-S_S_NP_NNS
" " B-O O-NP
released B-O B-VP_VBD
superoxide B-O B-NP_NN
anions B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
TNF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
H2O2 B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
VCAM-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
PDTC B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
act B-O B-VP_VB
as B-O B-PP_IN
a B-O B-NP_DT
radical B-O B-JJ
scavenger B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
ICAM-1 B-O B-S_NP_NN
induction B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
unaffected B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
inhibitors B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
NADPH B-O B-NP_NP_NP_NN
oxidase B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
apocynin B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
or B-O B-CC
cytochrome B-O B-NP_NP_NN
P-450 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
SKF525a B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suppressed B-O B-VP_VBD
VCAM-1 B-O B-NP_NN
induction B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
TNF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
revealing B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
several B-O B-S_NP_JJ
radical-generating B-O B-JJ
systems B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
involved B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
PDTC B-O B-S_S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
apocynin B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
SKF525a B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
decreased B-O B-VP_VBD
adhesion B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
monocytic B-O B-NP_JJ
U937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
TNF-treated B-O B-NP_VBN
HUVECs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
by B-O B-PP_PP_IN
75 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
100 B-O B-NP_CD
mumol/L B-O B-NN
PDTC B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
  
Inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
anti-VCAM-1 B-O B-NP_NP_JJ
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
1G11 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
U937 B-O B-S_S_NP_NN
adhesion B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
VCAM-1 B-O B-ADJP_NN
dependent B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
suppression B-O B-S_NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
antioxidants B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
due B-O B-ADJP_JJ
to B-O B-PP_TO
reduced B-O B-NP_VBN
VCAM-1 B-O B-NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
Inducible B-O B-S_S_NP_NP_JJ
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
c-fos B-O B-NN
serum B-O B-NN
response B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_DT
phosphotyrosine-containing B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_DT
proto-oncogene B-O B-NP_NN
c-fos B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
immediate-early B-O B-NP_JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
first B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
transcribed B-O B-VP_VBN
after B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Fos B-O B-S_NP_NN
expression B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
a B-O B-NP_NP_DT
pivotal B-O B-JJ
event B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
converting B-O B-S_NP_VP_VBG
ligand-receptor B-O B-NP_NP_JJ
interactions B-O B-NNS
" " B-O O-NP
at B-O B-PP_IN
" " B-O B-NP_O-NP
into B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
serum B-O B-NP_NP_NN
response B-O B-NN
element B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
SRE B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
c-fos B-O B-NP_NN
regulatory B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
participates B-O B-VP_VBZ
in B-O B-PP_IN
induction B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_PP_IN
various B-O B-NP_JJ
growth B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
by B-O B-PP_IN
phorbol B-O B-NP_NP_NN
esters B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
subsequent B-O B-NP_NP_JJ
squelching B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
an B-O B-S_NP_DT
inducible B-O B-ADJP_JJ
" " B-O O-ADJP
protein B-O B-NP_NP_NN
complex B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Band B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
binds B-O B-VP_VP_VBZ
to B-O B-PP_TO
SRE B-O B-NP_NN
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
10 B-O B-NP_NP_CD
min B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
becomes B-O B-VP_VBZ
nondetectable B-O B-ADJP_JJ
by B-O B-PP_IN
60 B-O B-NP_CD
min B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Band B-O B-S_NP_NN
A B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
the B-O B-NP_NP_DT
serum B-O B-NP_NN
response B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
plus B-O B-CC
additional B-O B-NP_JJ
factor B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
protein B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
phosphorylated B-O B-VP_VBN
on B-O B-NP_PP_IN
a B-O B-NP_NP_DT
tyrosine B-O B-NN
residue B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
suppresses B-O B-VP_VBZ
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Band B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
SRE B-O B-NP_NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Upon B-O B-S_PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
this B-O B-S_S_NP_DT
protein B-O B-NN
" " B-O O-NP
no B-O B-ADVP_RB
longer B-O B-RBR
" " B-O O-ADVP
prevents B-O B-VP_VBZ
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
Band B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
suppression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
binding B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
restored B-O B-VP_VBN
within B-O B-NP_PP_IN
30 B-O B-NP_CD
min B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
phosphorylated B-O B-VBN
tyrosine B-O B-NN
residue B-O B-NN
" " B-O O-NP
itself B-O B-NP_PRP
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
important B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_DT
protein-protein B-O B-JJ
interaction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
MHC B-O B-NP_NP_NP_NP_NP_NN
class B-O B-NN
II B-O B-CD
" " B-O O-NP
signaling B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
B-cell B-O B-NP_NP_NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
[ B-O B-S_LRB
see B-O B-NP_VP_VB
comments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
cognate B-O B-JJ
interaction B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
antigen-presenting B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
APCs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
major B-O B-NP_JJ
histocompatibility B-O B-NN
complex B-O B-NN
( B-O B-LRB
MHC B-O B-NN
) B-O B-RRB
class B-O B-NN
II B-O B-CD
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_DT
delivery B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activation B-O B-NP_NN
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
APC B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
These B-O B-S_NP_DT
signals B-O B-NNS
" " B-O O-NP
contribute B-O B-VP_VP_VBP
to B-O B-PP_TO
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
co-stimulatory B-O B-NP_NP_JJ
activity B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
APCs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
have B-O B-VP_VBP
important B-O B-NP_NP_JJ
consequences B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
cell B-O B-NP_NN
effector B-O B-NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
MHC B-O B-S_NP_NP_NN
class B-O B-NN
II B-O B-CD
" " B-O O-NP
molecules B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
serve B-O B-VP_VBP
as B-O B-PP_IN
receptors B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
B-cell B-O B-NP_NP_NP_NN
" " B-O O-NP
stimulation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
microbial B-O B-NP_JJ
superantigens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
review B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
Paul B-O B-NP_NP_NN
Scholl B-O B-NN
" " B-O O-NP
and B-O B-CC
Raif B-O B-NP_NN
Geha B-O B-NN
" " B-O O-NP
" " B-O O-NP
discuss B-O B-VP_VP_VBP
recent B-O B-NP_NP_JJ
advances B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
our B-O B-NP_NP_PRPP
understanding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mechanisms B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
analyse B-O B-VP_VBP
their B-O B-NP_NP_PRPP
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
B-cell B-O B-NP_NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Steel B-O B-S_S_NP_NN
factor B-O B-NN
" " B-O O-NP
affects B-O B-VP_VBZ
SCL B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
normal B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
erythroid B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Steel B-O B-S_S_S_NP_NN
factor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
growth B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
controls B-O B-S_NP_VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
SCL B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
also B-O B-ADVP_RB
" " B-O O-ADVP
known B-O B-VP_VBN
as B-O B-NP_PP_IN
Tcl-5 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
Tal-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
erythropoiesis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
the B-O B-NP_NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
SCL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
proliferation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
burst-forming B-O B-JJ
unit-erythroid B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Steel B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
SCL B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
proliferating B-O B-NP_VBG
erythroid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
BFU-E-derived B-O B-S_NP_JJ
colonies B-O B-NNS
" " B-O O-NP
increase B-O B-VP_VBP
progressively B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
size B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
cell B-O B-NP_NP_NN
number B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
from B-O B-PP_PP_IN
day B-O B-NP_NN
7 B-O B-CD
" " B-O O-NP
" " B-O B-PP_O-PP
to B-O B-PP_TO
day B-O B-NP_NN
14 B-O B-CD
" " B-O O-NP
" " B-O B-PP_O-PP
of B-O B-PP_IN
culture B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
with B-O B-PP_IN
the B-O B-NP_NP_NP_NP_DT
greatest B-O B-JJS
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
colony B-O B-NP_NN
size B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
10-fold B-O B-NP_JJ
expansion B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
occurring B-O B-VP_VBG
between B-O B-PP_IN
day B-O B-NP_NP_NN
7 B-O B-CD
" " B-O O-NP
and B-O B-CC
day B-O B-NP_NN
10 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
SCL B-O B-S_NP_NP_NP_NN
protein B-O B-NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
BFU-E-derived B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
highest B-O B-UCP_ADJP_JJS
in B-O B-PP_IN
day B-O B-NP_NN
7 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
and B-O B-CC
decreased B-O B-VP_VBD
progressively B-O B-NP_ADVP_RB
" " B-O O-ADVP
from B-O B-PP_PP_IN
day B-O B-NP_NN
7 B-O B-CD
" " B-O O-NP
" " B-O B-PP_O-PP
to B-O B-PP_TO
day B-O B-NP_NN
14 B-O B-CD
" " B-O O-NP
" " B-O B-PP_O-PP
of B-O B-PP_IN
culture B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-UCP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
an B-O B-NP_NP_DT
association B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
SCL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
erythroid B-O B-NP_JJ
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
SCL B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
decrease B-O B-VP_VB
significantly B-O B-ADVP_RB
" " B-O O-ADVP
between B-O B-PP_IN
day B-O B-NP_NP_NN
7 B-O B-CD
" " B-O B-NP_O-NP
and B-O B-CC
day B-O B-NP_NN
14 B-O B-CD
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
posttranscriptional B-O B-S_NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
largely B-O B-ADJP_RB
responsible B-O B-JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
SCL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Steel B-O B-NP_NN
factor-induced B-O B-JJ
erythroid B-O B-JJ
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
then B-O B-ADVP_RB
" " B-O O-ADVP
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
BFU-E-derived B-O B-NP_NP_JJ
colonies B-O B-NNS
" " B-O O-NP
cultured B-O B-VP_VBN
with B-O B-NP_PP_IN
Steel B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
colony B-O B-NP_NN
size B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBN
compared B-O B-NP_PP_VBN
to B-O B-PP_TO
control B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
day B-O B-NP_NP_NP_NN
7 B-O B-CD
" " B-O B-NP_O-NP
and B-O B-CC
day B-O B-NP_NN
10 B-O B-CD
" " B-O B-NP_O-NP
erythroid B-O B-NP_JJ
precursors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
cultured B-O B-VP_VBN
with B-O B-NP_PP_IN
Steel B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
SCL B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
increased B-O B-VP_VBN
significantly B-O B-NP_ADVP_RB
" " B-O O-ADVP
compared B-O B-PP_VBN
to B-O B-PP_TO
control B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
SCL B-O B-NP_NP_NP_NN
" " B-O O-NP
protein B-O B-NN
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
early B-O B-NP_NP_JJ
erythroid B-O B-NP_JJ
precursors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
stimulated B-O B-VP_VBD
with B-O B-NP_PP_IN
Steel B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggests B-O B-VP_VBZ
one B-O B-NP_NP_CD
mechanism B-O B-NN
" " B-O O-NP
through B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
Steel B-O B-S_NP_NN
factor B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
enhance B-O B-VP_VB
proliferation B-O B-NP_ADJP_ADJP_ADJP_NN
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
SCL B-O B-S_NP_NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
assessed B-O B-VP_VBN
by B-O B-NP_PP_IN
Northern B-O B-NP_NN
blot B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
day B-O B-NP_NN
7 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
increase B-O B-VP_VB
significantly B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
Steel B-O B-NP_NP_NN
factor B-O B-NN
" " B-O O-NP
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
posttranscriptional B-O B-S_NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
important B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cross-linking B-O B-S_S_NP_NP_JJ
CD40 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
activates B-O B-VP_VBZ
nuclear B-O B-NP_JJ
factor-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_DT
B B-O B-NP_NN
cell-associated B-O B-JJ
surface B-O B-NN
molecule B-O B-NN
CD40 B-O B-NN
" " B-O O-NP
" " B-O O-NP
functions B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
regulate B-O B-VP_VB
B B-O B-NP_NN
cell B-O B-NN
responses B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Cross-linking B-O B-S_NP_NP_JJ
CD40 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
lead B-O B-VP_VB
to B-O B-PP_PP_TO
homotypic B-O B-NP_NP_JJ
cell B-O B-NN
adhesion B-O B-NN
" " B-O O-NP
, B-O B-COMMA
IL-6 B-O B-NP_NP_NN
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
, B-O B-COMMA
in B-O B-PP_IN
combination B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
cytokines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
to B-O B-PP_TO
Ig B-O B-NP_NN
isotype B-O B-NN
switching B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tyrosine B-O B-S_NP_NN
kinase B-O B-NN
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
increased B-O B-VP_VBN
shortly B-O B-NP_ADVP_RB
" " B-O O-ADVP
after B-O B-PP_IN
engagement B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Little B-O B-S_NP_JJ
" " B-O B-PP_O-NP
is B-O B-VP_VBZ
known B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
about B-O B-PP_IN
how B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_NP_DT
very B-O B-ADJP_RB
early B-O B-JJ
" " B-O O-ADJP
events B-O B-NNS
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
CD40 B-O B-NP_NP_NN
" " B-O O-NP
cross-linking B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
link B-O B-VP_VBP
to B-O B-PP_TO
cellular B-O B-NP_JJ
responses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
nuclear B-O B-S_NP_NP_JJ
factor B-O B-NN
( B-O B-LRB
NF B-O B-NN
) B-O B-RRB
-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B-like B-O B-JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
activated B-O B-VP_VBN
after B-O B-NP_PP_IN
cross-linking B-O B-NP_NP_JJ
and B-O B-NP_PP_PP_CC
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
activation B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
rapid B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
a B-O B-NP_DT
tyrosine B-O B-NN
kinase-dependent B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
complexes B-O B-NNS
" " B-O O-NP
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
contain B-O B-VP_VBP
p50 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p65 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
RelA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
c-Rel B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
most B-O B-ADVP_RBS
likely B-O B-RB
" " B-O O-ADVP
other B-O B-NP_JJ
components B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
using B-O B-S_NP_VP_VBG
transient B-O B-NP_JJ
transfection B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
cross-linking B-O B-S_NP_JJ
CD40 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
supports B-O B-VP_VBZ
NF-kappa B-O B-NP_NN
B-dependent B-O B-JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
define B-O B-VP_VP_VBP
the B-O B-NP_DT
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
system B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
an B-O B-NP_NP_DT
intermediate B-O B-JJ
event B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
CD40 B-O B-NP_NP_NN
" " B-O O-NP
signaling B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
CD40 B-O B-NP_NN
" " B-O O-NP
pathway B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
influence B-O B-VP_VB
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
with B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
consensus B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Separation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
oxidant-initiated B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
redox-regulated B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
steps B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
signal B-O B-NN
transduction B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Studies B-O B-S_S_NP_NP_NNS
" " B-O O-NP
presented B-O B-VP_VBN
here B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
overall B-O B-S_NP_JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
signal B-O B-NN
transduction B-O B-NN
" " B-O O-NP
begins B-O B-VP_VBZ
with B-O B-PP_IN
" " B-O B-NP_NP_NP_PP_SBAR_WHPP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
These B-O B-S_NP_DT
initial B-O B-JJ
pathways B-O B-NNS
" " B-O O-NP
culminate B-O B-VP_VBP
in B-O B-PP_IN
a B-O B-NP_NP_DT
common B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
through B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
all B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
stimulating B-O B-VBG
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
ultimately B-O B-ADVP_RB
" " B-O O-ADVP
signal B-O B-VP_VBP
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
distinguish B-O B-VP_VBP
the B-O B-NP_DT
stimuli-specific B-O B-JJ
pathways B-O B-NNS
" " B-O O-NP
by B-O B-PP_IN
showing B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_DT
oxidative B-O B-JJ
stimuli B-O B-NNS
" " B-O O-NP
trigger B-O B-VP_VBP
activation B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
, B-O B-NP_COMMA
whereas B-O B-SBAR_IN
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
the B-O B-NP_DT
common B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
the B-O B-NP_NP_DT
simplest B-O B-JJS
way B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
accounting B-O B-S_NP_VP_NN
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
include B-O B-VP_VBP
a B-O B-NP_DT
redox-regulatory B-O B-JJ
mechanism B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
common B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
account B-O B-VP_VB
for B-O B-PP_IN
the B-O B-NP_NP_DT
redox B-O B-ADJP_NN
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
we B-O B-S_NP_PRP
" " B-O O-NP
put B-O B-VP_VBP
tyrosine B-O B-NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
common B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
showing B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
is B-O B-S_NP_NP_PRN_VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_SBAR_IN
internal B-O B-S_NP_NP_JJ
sites B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
oxidant B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
since B-O B-SBAR_IN
tyrosine B-O B-S_NP_NP_NN
kinase B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
phosphatase B-O B-NP_NN
" " B-O B-NP_O-NP
activities B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
, B-O B-COMMA
these B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
intracellular B-O B-S_NP_JJ
redox B-O B-NN
status B-O B-NN
" " B-O O-NP
controls B-O B-VP_VBZ
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
regulating B-O B-S_NP_VP_VBG
" " B-O B-NP_PP_O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Interleukin-2 B-O B-S_S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
tyrosine B-O B-NP_NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
and B-O B-CC
nuclear B-O B-NP_JJ
translocation B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
stat3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
An B-O B-S_S_NP_NP_DT
early B-O B-RB
biochemical B-O B-JJ
event B-O B-NN
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
T B-O B-NP_NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
through B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
tyrosine B-O B-NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_JJ
intracellular B-O B-JJ
substrates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
exact B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
IL-2 B-O B-S_NP_NN
" " B-O O-NP
regulates B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
different B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
presently B-O B-ADVP_RB
" " B-O O-ADVP
unknown B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
through B-O B-PP_IN
the B-O B-NP_DT
IL-2R B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induced B-O B-VP_JJ
tyrosine B-O B-NP_NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
and B-O B-CC
subsequent B-O B-NP_JJ
nuclear B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
stat3 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
stat1 B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
tyrosine B-O B-ADJP_NN
phosphorylated B-O B-JJ
after B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
ligation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
whereas B-O B-SBAR_IN
tyrosine-phosphorylated B-O B-S_NP_NP_JJ
stat1 B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
91 B-O B-NP_NP_CD
" " B-O B-NP_O-NP
and B-O B-CC
84 B-O B-NP_CD
" " B-O B-NP_O-NP
kDa B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
were B-O B-VP_VBD
translocated B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
following B-O B-PP_NN
treatment B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Apart B-O B-S_ADJP_RB
from B-O B-PP_IN
stat3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
another B-O B-NP_DT
cytoplasmic B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
tyrosine B-O B-UCP_ADJP_NN
phosphorylated B-O B-JJ
" " B-O O-ADJP
and B-O B-CC
subsequently B-O B-ADVP_RB
" " B-O O-ADVP
translocated B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
protein B-O B-NN
" " B-O O-NP
had B-O B-VP_VP_VBD
an B-O B-NP_NP_DT
apparent B-O B-JJ
molecular B-O B-JJ
mass B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
84 B-O B-NP_CD
kDa B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
was B-O B-VP_VBD
not B-O B-RB
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
stat3 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
stat1 B-O B-NP_NN
mAb B-O B-NN
" " B-O O-NP
or B-O B-CC
antisera B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
IL-2 B-O B-S_S_NP_NN
" " B-O O-NP
induced B-O B-JJ
nuclear B-O B-NP_NP_JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
84 B-O B-NP_CD
kDa B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-S
and B-O B-CC
stat3 B-O B-S_NP_NN
" " B-O O-NP
followed B-O B-VP_VBD
identical B-O B-NP_JJ
kinetics B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
p84 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
candidate B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
a B-O B-NP_NP_DT
new B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
yet B-O B-RB
undefined B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
, B-O B-COMMA
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
STAT B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-UCP_SBAR_DT
IL-2 B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
and B-O B-NP_NP_NP_CC
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-UCP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Induction B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ICAM-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
LFA-3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
Tax1 B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
mechanism B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
down-regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ICAM-1 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
LFA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
adult-T-cell-leukemia B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
undertaken B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
determine B-O B-VP_VB
the B-O B-NP_NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
TaxI B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_NP_DT
human B-O B-NP_JJ
T-cell B-O B-NN
line B-O B-NN
Jurkat B-O B-NN
" " B-O O-NP
" " B-O O-NP
carrying B-O B-VP_VBG
the B-O B-NP_DT
TaxI B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
under B-O B-PP_IN
the B-O B-NP_DT
metallothionein B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
led B-O B-VP_VBD
to B-O B-PP_TO
increases B-O B-NP_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
mRNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
surface B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ICAM-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LFA-3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
TaxI B-O B-NP_NP_NN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VP_VBD
, B-O B-COMMA
on B-O B-PP_IN
the B-O B-NP_DT
other B-O B-JJ
hand B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
relatively B-O B-ADJP_ADVP_RB
" " B-O O-ADVP
slow B-O B-ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
weak B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
might B-O B-VP_MD
be B-O B-VP_VB
indirect B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transactivation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
ICAM-I B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
TaxI B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
further B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
by B-O B-NP_PP_IN
co-transfection B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
CAT B-O B-NP_NN
reporter B-O B-NN
construct B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_NP_NP_DT
and B-O B-NP_CC
a B-O B-NP_DT
" " B-O B-NP_O-NP
expressing B-O B-VP_VBG
TaxI B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
down-regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ICAM-I B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
LFA-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
4 B-O B-NP_CD
ATL B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
next B-O B-ADVP_RB
" " B-O O-ADVP
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
ICAM-I B-O B-S_S_NP_NN
mRNA B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
quite B-O B-ADJP_RB
low B-O B-JJ
in B-O B-PP_IN
MT-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
no B-O B-S_NP_DT
genomic B-O B-JJ
changes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
CAT B-O B-NP_NN
reporter B-O B-NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
ICAM-I B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
inactive B-O B-ADJP_JJ
in B-O B-PP_IN
MT-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
combined B-O B-NP_NP_JJ
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
MT-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
5-azacytidine B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IFN-gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induced B-O B-VP_VBD
re-expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ICAM-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Collectively B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
( B-O B-NP_NP_LRB
a B-O B-DT
) B-O B-RRB
transcriptional B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
necessary B-O B-ADJP_JJ
for B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ICAM-I B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
repressed B-O B-VP_VBN
in B-O B-NP_PP_IN
MT-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
DNA B-O B-NP_NN
methylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Three B-O B-S_NP_NP_CD
other B-O B-JJ
ATL B-O B-NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
TL-OmI B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
H582 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
HuT102 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
little B-O B-NP_JJ
mRNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
( B-O B-NP_PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
H582 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
HuT102 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
negative B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_DT
LFA-I B-O B-NP_NN
alpha B-O B-NN
chain B-O B-NN
( B-O B-LRB
CDIIa B-O B-NN
) B-O B-RRB
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_S_NP_DT
genomic B-O B-JJ
changes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
a B-O B-S_NP_NP_DT
CAT B-O B-NP_NN
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
CD18 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
inactive B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_NP_DT
3 B-O B-CD
" " B-O O-NP
of B-O B-PP_IN
them B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
again B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
suggesting B-O B-VP_VBG
lack B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
( B-O B-NP_NP_LRB
a B-O B-DT
) B-O B-RRB
transcriptional B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
necessary B-O B-ADJP_JJ
for B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Transcription-independent B-O B-NP_NP_NP_NP_JJ
turnover B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
monocyte B-O B-NP_NN
adherence B-O B-NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
implications B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
a B-O B-NP_NP_DT
translational B-O B-JJ
component B-O B-NN
" " B-O O-NP
regulating B-O B-VP_VBG
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha/MAD-3 B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
identified B-O B-VP_VBD
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha/MAD-3 B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
an B-O B-NP_NP_DT
immediate-early B-O B-NP_JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
expressed B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Within B-O B-S_PP_IN
5 B-O B-NP_NP_CD
min B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
monocyte B-O B-NP_NN
adhesion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
markedly B-O B-ADVP_RB
" " B-O O-ADVP
diminished B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
but B-O B-CC
is B-O B-VP_VBZ
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
replaced B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_DT
cycloheximide-sensitive B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
20 B-O B-NP_CD
min B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Accompanying B-O B-SINV_VP_VBG
the B-O B-NP_NP_DT
rapid B-O B-JJ
turnover B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
is B-O B-VP_VBZ
" " B-O B-VP_O-VP
simultaneous B-O B-NP_NP_JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B-related B-O B-JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
nuclei B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
adhered B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-SINV
  
The B-O B-S_NP_DT
demonstration B-O B-NN
that B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
regulate B-O B-VP_VB
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha/MAD-3 B-O B-NN
gene B-O B-NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
other B-O B-NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
rapid B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
steady-state B-O B-NP_JJ
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha/MAD-3 B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
we B-O B-SBAR_WHNP_S_NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
within B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
would B-O B-VP_MD
result B-O B-VP_VB
from B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B-dependent B-O B-JJ
transcriptional B-O B-JJ
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
run-on B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
analyses B-O B-NNS
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
, B-O B-S_COMMA
instead B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
while B-O B-SBAR_IN
several B-O B-S_NP_NP_JJ
immediate-early B-O B-NP_JJ
cytokine B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
such B-O B-PP_JJ
as B-O B-IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
transcriptionally B-O B-ADVP_RB
" " B-O O-ADVP
activated B-O B-VP_VBN
during B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha/MAD-3 B-O B-NN
gene B-O B-NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
remained B-O B-VP_VBD
constant B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
adherence-dependent B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha/MAD-3 B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
not B-O B-RB
a B-O B-NP_NP_DT
consequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mRNA B-O B-NP_NP_NN
" " B-O O-NP
stabilization B-O B-NN
events B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
while B-O B-SBAR_IN
increases B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_CC
IL-1 B-O B-NP_NN
beta B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha/MAD-3 B-O B-NN
mRNA B-O B-NN
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
nuclei B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
adherent B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
cytoplasmic B-O B-S_NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
IL-1 B-O B-NP_NN
beta B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBN
during B-O B-PP_IN
adherence B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
whereas B-O B-SBAR_IN
those B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha/MAD-3 B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
our B-O B-S_NP_PRPP
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
two B-O B-S_NP_CD
interactive B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
regulate B-O B-VP_VBP
monocytic B-O B-NP_NP_JJ
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
alpha/MAD-3 B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
that B-O B-SBAR_IN
adherent B-O B-S_NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
regulate B-O B-VP_VBP
nuclear B-O B-NP_NP_JJ
processing B-O B-NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
or B-O B-CC
decay B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha/MAD-3 B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
thereby B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
increasing B-O B-VP_VBG
mRNA B-O B-NP_NN
levels B-O B-NNS
" " B-O O-NP
without B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
since B-O B-SBAR_IN
inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
accumulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha/MAD-3 B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
without B-O B-PP_IN
stimulating B-O B-S_NP_VP_VBG
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha/MAD-3 B-O B-NN
gene B-O B-NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
low B-O B-S_NP_NP_JJ
cytoplasmic B-O B-JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha/MAD-3 B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
maintained B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_DT
translation-dependent B-O B-JJ
degradation B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
E2F-1 B-O B-S_S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
cyclin-like B-O B-NP_JJ
DNA B-O B-NN
repair B-O B-NN
enzyme B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
uracil-DNA B-O B-NP_NN
glycosylase B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
provide B-O B-VP_VBP
evidence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
an B-O B-NP_NP_DT
autoregulatory B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
cell B-O B-NP_NN
cycle-dependent B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
E2F-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
regulates B-O B-VP_VBZ
the B-O B-NP_NP_DT
cyclin-like B-O B-JJ
species B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
DNA B-O B-NP_NP_NN
repair B-O B-NN
enzyme B-O B-NN
" " B-O O-NP
uracil-DNA B-O B-NP_NN
glycosylase B-O B-NN
( B-O B-LRB
UDG B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
osteosarcoma B-O B-NN
( B-O B-LRB
Saos-2 B-O B-NN
) B-O B-RRB
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
, B-O B-COMMA
through B-O B-PP_IN
the B-O B-NP_NP_DT
deletion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
UDG B-O B-NN
promoter B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
that B-O B-SBAR_IN
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
E2F-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
activates B-O B-VP_VBZ
the B-O B-NP_DT
UDG B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
through B-O B-PP_IN
several B-O B-NP_JJ
E2F B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
major B-O B-NP_JJ
putative B-O B-JJ
downstream B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
E2F B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
located B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_DT
first B-O B-NP_JJ
exon B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
" " B-O O-NP
serves B-O B-VP_VBZ
as B-O B-PP_IN
a B-O B-NP_NP_DT
target B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
E2F-1/DP1 B-O B-NP_NP_NP_NN
complex B-O B-NN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
provide B-O B-VP_VBP
evidence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
functional B-O B-JJ
relationship B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
cyclin-like B-O B-NP_JJ
UDG B-O B-NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
E2F B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
High B-O B-S_NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
UDG B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_DT
transient B-O B-JJ
transfection B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
result B-O B-VP_VBP
in B-O B-PP_IN
the B-O B-NP_NP_DT
down-regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
activity B-O B-NN
" " B-O O-NP
through B-O B-PP_IN
elements B-O B-NP_NP_NNS
" " B-O O-NP
specific B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Overexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
UDG B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Saos B-O B-NP_NN
2 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
to B-O B-S_NP_VP_TO
delay B-O B-VP_VP_VB
growth B-O B-NP_NN
" " B-O O-NP
late B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
G1 B-O B-NP_NN
phase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
transiently B-O B-ADVP_RB
" " B-O O-ADVP
arrest B-O B-VP_VB
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
hypothetical B-O B-JJ
model B-O B-NN
" " B-O O-NP
integrates B-O B-VP_VBZ
one B-O B-NP_NP_CD
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
repair B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
cell B-O B-NN
cycle B-O B-NN
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
likely B-O B-ADVP_RB
" " B-O O-ADVP
through B-O B-PP_IN
E2F B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
implicates B-O B-VP_VBZ
E2F B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
multifunctional B-O B-JJ
target B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
proteins B-O B-NP_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
enzymes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
possibly B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
responsive B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Aspirin B-O B-S_S_NP_NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
nuclear B-O B-NP_NP_NP_NP_JJ
factor-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
mobilization B-O B-NN
" " B-O O-NP
and B-O B-CC
monocyte B-O B-NP_NN
adhesion B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
stimulated B-O B-NP_VBN
human B-O B-JJ
endothelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
BACKGROUND B-O B-NP_NP_NN
: B-O B-COLON
" " B-O O-NP
The B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
vascular B-O B-NP_NP_NP_JJ
cell B-O B-NN
adhesion B-O B-NN
molecule-1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
VCAM-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
E-selectin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor-alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TNF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
mobilization B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_NP_NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
Since B-O B-S_SBAR_IN
salicylates B-O B-S_NP_NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
reported B-O B-VP_VBN
to B-O B-S_NP_VP_TO
inhibit B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
a B-O B-NP_NP_DT
potential B-O B-JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
acetylsalicylate B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
aspirin B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
umbilical B-O B-JJ
vein B-O B-NN
endothelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
HUVECs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
METHODS B-O B-NP_NP_NP_NNS
" " B-O O-NP
AND B-O B-CC
RESULTS B-O B-NP_NNS
: B-O B-COLON
" " B-O O-NP
" " B-O O-NP
Gel-shift B-O B-S_NP_JJ
analyses B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
dose-dependent B-O B-NP_NP_JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TNF-induced B-O B-NP_JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
mobilization B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
aspirin B-O B-NP_NP_NN
" " B-O O-NP
at B-O B-PP_IN
concentrations B-O B-NP_NP_NNS
" " B-O O-NP
ranging B-O B-VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
  
Induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
VCAM-1 B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
E-selectin B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
surface B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
TNF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
dose-dependently B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBN
by B-O B-NP_PP_IN
aspirin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
over B-O B-PP_IN
the B-O B-NP_DT
same B-O B-JJ
range B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
while B-O B-SBAR_IN
induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
intercellular B-O B-NP_NP_JJ
adhesion B-O B-NN
molecule-1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ICAM-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
hardly B-O B-ADVP_RB
" " B-O O-ADVP
affected B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Aspirin B-O B-S_NP_NN
" " B-O O-NP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
prevent B-O B-VP_VB
VCAM-1 B-O B-NP_NP_NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
since B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
dose-dependently B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
VCAM-1 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
TNF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_PP_IN
a B-O B-NP_DT
functional B-O B-JJ
consequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
adhesion B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
U937 B-O B-NP_NN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
TNF-stimulated B-O B-NP_JJ
HUVECs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
markedly B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBN
by B-O B-NP_PP_IN
aspirin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
due B-O B-PP_JJ
to B-O B-TO
suppression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
VCAM-1 B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
E-selectin B-O B-NP_NP_NN
" " B-O B-NP_O-NP
upregulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
aspirin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
related B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cyclooxygenase B-O B-NP_NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
since B-O B-SBAR_IN
indomethacin B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
ineffective B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CONCLUSIONS B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
Our B-O B-S_NP_PRPP
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
aspirin B-O B-S_NP_NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
mobilization B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
, B-O B-NP_NP_PP_COMMA
and B-O B-CC
subsequent B-O B-NP_JJ
monocyte B-O B-NN
adhesion B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
thereby B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
providing B-O B-VP_VBG
an B-O B-NP_NP_DT
additional B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
therapeutic B-O B-NP_NP_JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
Growth B-O B-NP_NP_NP_NP_NN
regulation B-O B-NN
" " B-O O-NP
and B-O B-CC
cellular B-O B-NP_JJ
changes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
during B-O B-PP_IN
differentiation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
prostatic B-O B-JJ
cancer B-O B-NN
LNCaP B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-SBAR_IN
induced B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
T B-O B-NP_NN
lymphocyte B-O B-JJ
-conditioned B-O B-JJ
medium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Human B-O B-S_S_NP_NP_JJ
prostatic B-O B-JJ
epithelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
an B-O B-NP_DT
androgen-dependent B-O B-NP_JJ
LNCaP B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
in B-O B-NP_PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
derived B-O B-NP_NP_NP_PRN_VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Addition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
caused B-O B-VP_VBD
a B-O B-NP_NP_DT
greater B-O B-ADJP_QP_JJR
than B-O B-IN
70 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-ADJP
reduction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
cell B-O B-NP_NP_NN
counting B-O B-NN
" " B-O O-NP
and B-O B-CC
cell B-O B-NP_NN
cycle B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_S_NP_DT
cells B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
G1 B-O B-NP_NN
phase B-O B-NN
arrest B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_DT
clonogenicity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
reduced B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
growth-modulating B-O B-JJ
effect B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
dose-dependent B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
not B-O B-RB
due B-O B-ADJP_JJ
to B-O B-PP_TO
cell B-O B-NP_NN
lysis B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
apoptosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
androgen B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
androgen B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
approximately B-O B-NP_ADJP_QP_RB
50 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-ADJP
reduction B-O B-NN
" " B-O O-NP
, B-O B-COMMA
underlining B-O B-S_NP_VP_VBG
a B-O B-NP_DT
proliferation B-O B-NN
reduction B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
prostate-specific B-O B-NP_NP_JJ
antigen B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PSA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
downregulated B-O B-VP_VBN
to B-O B-NP_PP_TO
approximately B-O B-NP_QP_RB
75 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
the B-O B-NP_DT
process B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cell B-O B-S_NP_NN
morphology B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
dendritic B-O B-NP_NP_JJ
processes B-O B-NNS
" " B-O O-NP
extending B-O B-VP_VBG
from B-O B-PP_IN
cytoplasm B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
other B-O B-NP_JJ
neuroendocrine B-O B-NP_JJ
cell B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
characteristics B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_JJ
cytoskeleton B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
intracellular B-O B-NP_JJ
" " B-O B-NP_O-NP
proteins B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBD
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
by B-O B-NP_PP_PP_IN
immunostaining B-O B-NP_NP_NN
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
and B-O B-CC
by B-O B-PP_IN
ELISA B-O B-NP_NN
procedures B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
" " B-O O-NP
included B-O B-VP_VBD
vimentin B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
correlating B-O B-VP_VBG
to B-O B-PP_TO
cell B-O B-NP_NN
shape B-O B-NN
changes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
cytokeratins B-O B-NP_NP_NNS
8 B-O B-NP_CD
" " B-O O-NP
and B-O B-CC
18 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
differentiated B-O B-NP_NP_VBN
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
prostate B-O B-NP_NN
epithelia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
neuron-specific B-O B-NP_NP_NP_JJ
enolase B-O B-NN
" " B-O O-NP
and B-O B-CC
serotonin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
neuroendocrine B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
From B-O B-S_PP_IN
these B-O B-NP_DT
cellular B-O B-JJ
changes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
can B-O B-VP_MD
infer B-O B-VP_VB
that B-O B-SBAR_IN
the B-O B-S_NP_DT
cell B-O B-NN
growth B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
modulated B-O B-VP_VBN
along B-O B-NP_PP_IN
with B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activated B-O B-S_NP_VBN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
demonstrated B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
important B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
growth B-O B-NP_NN
modulator B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VP_VBD
semipurified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
and B-O B-CC
had B-O B-VP_VBD
an B-O B-NP_NP_DT
estimated B-O B-VBN
molecular B-O B-JJ
weight B-O B-NN
" " B-O O-NP
13,000 B-O B-NP_QP_CD
to B-O B-TO
24,000 B-O B-CD
" " B-O O-QP
Da B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
determined B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
distinct B-O B-ADJP_JJ
from B-O B-PP_IN
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
interaction B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
lymphoid B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
prostatic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
growth B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
development B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
described B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Monocyte B-O B-S_S_NP_NP_NN
tethering B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
P-selectin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
regulates B-O B-VP_VBZ
monocyte B-O B-NP_NP_NP_NN
chemotactic B-O B-JJ
protein-1 B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor-alpha B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
secretion B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Signal B-O B-NP_NP_NP_NN
integration B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
translocation B-O B-NN
" " B-O O-NP
" " B-O O-NP
[ B-O B-S_LRB
see B-O B-NP_VP_VB
comments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-NP
  
Adhesion B-O B-S_S_NP_NP_NN
molecules B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
tether B-O B-S_NP_VP_VBP
circulating B-O B-NP_VBG
leukocytes B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
endothelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
may B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
transduce B-O B-VP_VP_VB
" " B-O B-NP_O-VP
or B-O B-CC
modulate B-O B-VP_VB
" " B-O B-NP_O-VP
outside-in B-O B-NP_NP_JJ
signals B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
cellular B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
providing B-O B-S_NP_VP_VBG
an B-O B-NP_DT
initial B-O B-JJ
regulatory B-O B-JJ
point B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
inflammatory B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Adhesion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
P-selectin B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
most B-O B-ADJP_ADVP_RBS
rapidly B-O B-RB
" " B-O O-ADVP
expressed B-O B-VBN
" " B-O O-ADJP
endothelial B-O B-NP_JJ
tethering B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
increased B-O B-VP_VBD
the B-O B-NP_NP_DT
secretion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
monocyte B-O B-NP_NP_NP_NN
chemotactic B-O B-JJ
protein-1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MCP-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor-alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TNF-alpha B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
leukocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
they B-O B-S_NP_PRP
" " B-O O-NP
were B-O B-VP_VBD
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
platelet-activating B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Increased B-O B-S_NP_VBN
cytokine B-O B-NN
secretion B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
specifically B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
G1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
anti-P-selectin B-O B-NP_JJ
mAb B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
prevents B-O B-S_NP_VP_VBZ
" " B-O B-NP_PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
tethering B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
P-selectin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VBD
nuclear B-O B-NP_NP_JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_NP_JJ
factor-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
P-selectin B-O B-S_NP_NN
, B-O B-COMMA
" " B-O O-NP
through B-O B-PP_IN
its B-O B-NP_NP_PRPP
ligands B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
may B-O B-VP_MD
locally B-O B-ADVP_RB
" " B-O O-ADVP
regulate B-O B-VP_VB
cytokine B-O B-NP_NP_NN
" " B-O O-NP
secretion B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
inflamed B-O B-NP_JJ
tissues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Danazol B-O B-S_S_NP_NN
" " B-O O-NP
decreases B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
estrogen B-O B-NP_NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
1. B-O B-S_LST_LS
" " B-O O-LST
Administration B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
danazol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
over B-O B-NP_QP_IN
one B-O B-CD
" " B-O O-QP
month B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reduced B-O B-VP_VBD
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
estrogen B-O B-NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ER B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
its B-O B-NP_PRPP
mRNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-PP_TO
approximately B-O B-NP_RB
50 B-O B-NP_CD
" " B-O B-NP_O-NP
and B-O B-CC
20 B-O B-NP_CD
" " B-O B-NP_O-NP
% B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
2. B-O B-S_LST_LS
" " B-O O-LST
Danazol B-O B-NP_NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
alter B-O B-VP_VB
the B-O B-NP_NP_DT
degradation B-O B-NN
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ER B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
3. B-O B-S_LST_LS
" " B-O O-LST
Danazol B-O B-NP_NN
" " B-O O-NP
decreased B-O B-VP_VBD
the B-O B-NP_NP_DT
transcription B-O B-NN
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ER B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-PP_TO
approximately B-O B-NP_QP_RB
50 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_DT
run-on B-O B-JJ
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
4. B-O B-S_LST_LS
" " B-O O-LST
Danazol B-O B-NP_NN
" " B-O O-NP
may B-O B-VP_MD
release B-O B-VP_VB
estrogen B-O B-NP_NN
predominance B-O B-NN
" " B-O O-NP
via B-O B-PP_IN
the B-O B-NP_NP_DT
reduction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
ER B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
leads B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
reduction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cross-linking B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD30 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
HIV B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
chronically B-O B-NP_ADJP_RB
infected B-O B-JJ
" " B-O O-ADJP
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
CD30 B-O B-S_S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TNF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
receptor B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
constitutively B-O B-NP_ADVP_RB
" " B-O O-ADVP
on B-O B-PP_IN
the B-O B-NP_NP_DT
surface B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
human B-O B-JJ
T B-O B-NN
cell B-O B-NN
line B-O B-NN
ACH-2 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
cross-linking B-O B-S_S_NP_VP_JJ
CD30 B-O B-NP_NN
" " B-O O-NP
with B-O B-PP_IN
an B-O B-NP_NP_DT
anti-CD30-specific B-O B-JJ
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
results B-O B-VP_VBZ
in B-O B-PP_IN
HIV B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CD30 B-O B-S_S_NP_NP_NN
" " B-O O-NP
cross-linking B-O B-NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
alter B-O B-VP_VB
proliferation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ACH-2 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
endogenous B-O B-NP_JJ
TNF B-O B-NP_NN
alpha/beta B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
cross-linking B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD30 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
NF-kappa B-O B-NP_NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
and B-O B-CC
enhanced B-O B-NP_VBN
HIV B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
CD30-CD30L B-O B-NP_JJ
interactions B-O B-NNS
" " B-O O-NP
mediate B-O B-VP_VBP
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
a B-O B-NP_NP_DT
kappa B-O B-NN
B-dependent B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
independent B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
mechanism B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
important B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
, B-O B-NP_NP_ADJP_NP_COMMA
in B-O B-PP_ADVP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Integrin-mediated B-O B-NP_NP_NP_NP_JJ
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
and B-O B-CC
cytokine B-O B-NP_NP_NN
" " B-O O-NP
message B-O B-NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
A B-O B-NP_NP_DT
possible B-O B-JJ
signaling B-O B-NN
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
Syk B-O B-NP_NN
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Activation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cytoplasmic B-O B-NP_JJ
tyrosine B-O B-NN
kinases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
important B-O B-JJ
aspect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
signal B-O B-NP_NP_NN
transduction B-O B-NN
" " B-O O-NP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
integrins B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
monocytic B-O B-JJ
cell B-O B-NN
line B-O B-NN
THP-1 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
either B-O B-NP_CC
integrin-dependent B-O B-NP_NP_JJ
cell B-O B-NN
adhesion B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
fibronectin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
or B-O B-CC
ligation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
beta B-O B-NP_NN
1 B-O B-CD
integrins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
antibodies B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
causes B-O B-VP_VBZ
a B-O B-NP_NP_DT
rapid B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
intense B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_NP_CD
sets B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
proteins B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
about B-O B-NP_RB
and B-O B-NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
integrin B-O B-NP_NP_NN
" " B-O O-NP
ligation B-O B-NN
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_PP_TO
nuclear B-O B-NP_NP_JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
and B-O B-NP_CC
p65 B-O B-NP_NN
subunits B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
to B-O B-PP_TO
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
reporter B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
driven B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
containing B-O B-NP_VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
to B-O B-PP_TO
increased B-O B-NP_NP_VBN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
mRNAs B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
tyrosine B-O B-NN
kinase B-O B-NN
inhibitors B-O B-NNS
" " B-O O-NP
genistein B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
herbimycin B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
block B-O B-VP_VBP
both B-O B-NP_CC
integrin-mediated B-O B-NP_JJ
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
and B-O B-CC
increases B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
IL-1 B-O B-NP_NP_NN
beta B-O B-NN
" " B-O O-NP
message B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
causal B-O B-JJ
relationship B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_DT
two B-O B-CD
events B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
components B-O B-NNS
" " B-O O-NP
tyrosine B-O B-VP_NN
phosphorylated B-O B-VBN
subsequent B-O B-NP_ADJP_JJ
to B-O B-PP_TO
cell B-O B-NP_NN
adhesion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-NP
include B-O B-VP_VBP
paxillin B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
pp125FAK B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_DT
SH2 B-O B-NP_NN
domain B-O B-NN
containing B-O B-VBG
tyrosine B-O B-NN
kinase B-O B-NN
Syk B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
integrin B-O B-NP_NP_NP_NN
" " B-O O-NP
ligation B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
antibodies B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
tyrosine B-O B-NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_PP_IN
Syk B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
of B-O B-IN
FAK B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
paxillin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
adhering B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
pre-treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
cytochalasin B-O B-NP_NN
D B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suppresses B-O B-VP_VBZ
tyrosine B-O B-NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_PP_IN
FAK B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
paxillin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
of B-O B-IN
Syk B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
while B-O B-SBAR_IN
IL-1 B-O B-S_NP_NP_NN
beta B-O B-NN
" " B-O O-NP
message B-O B-NN
induction B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
unaffected B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
observations B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
Syk B-O B-NP_NN
" " B-O O-NP
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
an B-O B-NP_NP_DT
important B-O B-JJ
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_PP_COMMA
" " B-O B-VP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_S_NP_DT
Ah B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
recognizes B-O B-VP_VBZ
DNA B-O B-NP_NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
B B-O B-NP_NP_NN
cell B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
BSAP B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
a B-O B-NP_NP_DT
possible B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
dioxin-mediated B-O B-NP_NP_JJ
alteration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD19 B-O B-NP_NP_NP_NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
2,3,7,8-tetrachlorodibenzo-p-dioxin B-O B-S_S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
TCDD B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
inhibits B-O B-VP_VBZ
murine B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
human B-O B-NP_JJ
" " B-O B-NP_O-NP
B B-O B-NP_NN
lymphocyte B-O B-NN
immunoglobulin B-O B-NN
production B-O B-NN
" " B-O O-NP
" " B-O O-NP
through B-O B-PP_IN
an B-O B-NP_DT
unknown B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_NP_DT
study B-O B-NN
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TCDD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD19 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_DT
human B-O B-NP_JJ
B B-O B-NN
lymphocyte B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
TCDD B-O B-S_NP_NN
treatment B-O B-NN
" " B-O O-NP
decreased B-O B-VP_VBD
steady B-O B-NP_NP_JJ
state B-O B-NN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
CD19 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
67 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
IM-9 B-O B-NP_NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
a B-O B-NP_DT
gel B-O B-NN
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
identified B-O B-VP_VBD
a B-O B-NP_NP_DT
DNA-binding B-O B-NP_NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
IM-9 B-O B-NP_NN
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
by B-O B-S_NP_PP_IN
several B-O B-NP_JJ
criteria B-O B-NNS
" " B-O O-NP
" " B-O O-PP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
Ah B-O B-NP_NN
receptor B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
recognized B-O B-VP_VBD
a B-O B-NP_NP_DT
DNA B-O B-NP_NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
B B-O B-NP_NP_NP_NN
cell B-O B-NN
lineage-specific B-O B-JJ
activator B-O B-NN
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
BSAP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
promoter B-O B-NP_NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
similar B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
AhR B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
could B-O B-VP_MD
interfere B-O B-VP_VB
with B-O B-PP_IN
BSAP-stimulated B-O B-NP_JJ
CD19 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
competition B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Nitric B-O B-S_S_NP_JJ
oxide B-O B-NN
" " B-O O-NP
decreases B-O B-VP_VBZ
cytokine-induced B-O B-NP_JJ
endothelial B-O B-JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Nitric B-O B-S_NP_JJ
oxide B-O B-NN
" " B-O O-NP
selectively B-O B-ADVP_RB
" " B-O O-ADVP
reduces B-O B-VP_VBZ
endothelial B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
adhesion B-O B-NP_NP_NN
molecules B-O B-NNS
" " B-O O-NP
and B-O B-CC
proinflammatory B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_S_NP_VP_TO
test B-O B-VP_VB
the B-O B-NP_DT
hypothesis B-O B-NN
that B-O B-SBAR_IN
limits B-O B-S_NP_NP_PRN_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
treated B-O B-VP_VP_VBD
cytokine-stimulated B-O B-NP_JJ
human B-O B-JJ
saphenous B-O B-JJ
vein B-O B-NN
endothelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
several B-O B-NP_JJ
NO B-O B-NN
donors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
assessed B-O B-VP_VBD
their B-O B-NP_NP_PRPP
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
inducible B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
a B-O B-NP_DT
concentration-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
NO B-O B-NP_NN
" " B-O O-NP
inhibited B-O B-VP_VBD
interleukin B-O B-NP_NP_NN
( B-O B-LRB
IL B-O B-NN
) B-O B-RRB
-1 B-O B-CD
" " B-O O-NP
alpha-stimulated B-O B-JJ
VCAM-1 B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
35-55 B-O B-NP_QP_CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
cell B-O B-NP_NP_NN
surface B-O B-NN
enzyme B-O B-NN
immunoassays B-O B-NNS
" " B-O O-NP
and B-O B-CC
flow B-O B-NP_NN
cytometry B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
inhibition B-O B-NN
" " B-O O-NP
was B-O B-VP_VP_VBD
paralleled B-O B-VP_VBN
by B-O B-NP_PP_IN
reduced B-O B-NP_NP_VBN
monocyte B-O B-NN
adhesion B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
endothelial B-O B-NP_JJ
monolayers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
nonstatic B-O B-NP_JJ
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
was B-O B-VP_VBD
unaffected B-O B-ADJP_JJ
by B-O B-PP_IN
cGMP B-O B-NP_NN
analogues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
was B-O B-VP_VBD
quantitatively B-O B-ADJP_RB
similar B-O B-JJ
after B-O B-PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
either B-O B-NP_CC
IL-1 B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
, B-O B-COMMA
IL-1 B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
, B-O B-COMMA
IL-4 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
, B-O B-NP_NP_PRN_COMMA
or B-O B-CC
bacterial B-O B-NP_JJ
lipopolysaccharide B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NO B-O B-S_NP_NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
decreased B-O B-VP_VBD
the B-O B-NP_NP_DT
endothelial B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_NP_NP_JJ
leukocyte B-O B-NP_NN
adhesion B-O B-NN
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
E-selectin B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
to B-O B-PP_TO
, B-O B-NP_COMMA
intercellular B-O B-NP_JJ
adhesion B-O B-NN
molecule-1 B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
secretable B-O B-NP_NP_JJ
cytokines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
IL-6 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-8 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
endogenous B-O B-NP_JJ
NO B-O B-NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
L-N-monomethyl-arginine B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
VCAM-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
did B-O B-VP_VBD
not B-O B-RB
augment B-O B-VP_VB
cytokine-induced B-O B-NP_JJ
VCAM-1 B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_NP_JJ
run-on B-O B-JJ
assays B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
transfection B-O B-NP_NP_NN
studies B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
various B-O B-NP_JJ
VCAM-1 B-O B-NP_NN
promoter B-O B-NN
reporter B-O B-NN
gene B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
NO B-O B-S_NP_NN
" " B-O O-NP
represses B-O B-VP_VBZ
VCAM-1 B-O B-NP_NP_NN
" " B-O O-NP
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
, B-O B-COMMA
in B-O B-PP_IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
by B-O B-PP_IN
inhibiting B-O B-S_NP_VP_VBG
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
that B-O B-SBAR_IN
NO B-O B-S_NP_NN
's B-O B-POS
ability B-O B-NN
to B-O B-S_NP_VP_TO
limit B-O B-VP_VP_VB
and B-O B-NP_CC
inhibit B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
may B-O B-VP_MD
contribute B-O B-VP_VB
to B-O B-PP_TO
some B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Distinct B-O B-S_S_NP_JJ
signaling B-O B-NN
properties B-O B-NNS
" " B-O O-NP
identify B-O B-VP_VBP
functionally B-O B-NP_ADJP_RB
different B-O B-JJ
" " B-O O-ADJP
CD4 B-O B-NP_NN
epitopes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_DT
CD4 B-O B-NP_NN
coreceptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
interacts B-O B-VP_VP_VBZ
with B-O B-PP_IN
non-polymorphic B-O B-NP_NP_JJ
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
major B-O B-NP_NP_JJ
histocompatibility B-O B-NN
complex B-O B-NN
class B-O B-NN
II B-O B-CD
molecules B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
contributes B-O B-VP_VBZ
to B-O B-PP_TO
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD4 B-O B-NP_NP_NN
" " B-O O-NP
triggering B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
activating B-O B-NN
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
lymphoma B-O B-NN
model B-O B-NN
" " B-O O-NP
using B-O B-VP_VBG
monoclonal B-O B-NP_NP_NP_JJ
antibodies B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
CD4 B-O B-S_NP_NP_NN
" " B-O O-NP
triggering B-O B-NN
" " B-O O-NP
delivers B-O B-VP_VBZ
signals B-O B-NP_NP_NNS
" " B-O O-NP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Whereas B-O B-S_SBAR_IN
different B-O B-S_NP_ADJP_JJ
" " B-O O-ADJP
anti-CD4 B-O B-NP_JJ
mAb B-O B-NN
" " B-O O-NP
or B-O B-CC
HIV-1 B-O B-NP_NN
gp120 B-O B-NN
" " B-O O-NP
" " B-O O-NP
could B-O B-VP_MD
all B-O B-ADVP_DT
" " B-O O-ADVP
trigger B-O B-VP_VB
activation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_NP_O-PP
" " B-O O-NP
and B-O B-CC
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-SBAR_O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
they B-O B-S_NP_PRP
" " B-O O-NP
differed B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
their B-O B-NP_PRPP
ability B-O B-NN
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Lack B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
full B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_VP_MD
be B-O B-VP_VB
correlated B-O B-VP_VBN
to B-O B-NP_PP_TO
a B-O B-NP_DT
dramatically B-O B-ADJP_RB
reduced B-O B-VBN
" " B-O O-ADJP
capacity B-O B-NN
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
could B-O B-VP_MD
be B-O B-VP_VB
complemented B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_DT
calcium B-O B-NN
ionophore B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
identify B-O B-VP_VBP
functionally B-O B-NP_NP_ADJP_RB
distinct B-O B-JJ
" " B-O O-ADJP
epitopes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
CD4 B-O B-NP_NN
coreceptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
and B-O B-NP_NP_NP_PP_CC
calcium B-O B-NP_NN
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Lipopolysaccharide-induced B-O B-S_S_NP_JJ
E-selectin B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
requires B-O B-VP_VP_VBZ
continuous B-O B-NP_NP_JJ
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
bactericidal/permeability-increasing B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Endothelial B-O B-S_S_NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
by B-O B-NP_PP_IN
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
express B-O B-VP_VBP
E-selectin B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
plays B-O B-S_NP_VP_VBZ
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
E-selectin B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
induced B-O B-VP_VBN
within B-O B-NP_PP_IN
1-2 B-O B-NP_QP_CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
peaks B-O B-VP_VBZ
at B-O B-PP_IN
4-6 B-O B-NP_QP_CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
gradually B-O B-ADVP_RB
" " B-O O-ADVP
returns B-O B-VP_VBZ
to B-O B-PP_TO
basal B-O B-NP_JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
24 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
rBPI21 B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
recombinant B-O B-NP_JJ
N-terminal B-O B-JJ
fragment B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
bactericidal/permeability-increasing B-O B-JJ
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
BPI B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
inhibited B-O B-VP_VBD
LPS-induced B-O B-NP_JJ
E-selectin B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
added B-O B-S_NP_VP_VBN
at B-O B-NP_PP_PP_IN
the B-O B-NP_NP_DT
same B-O B-JJ
time B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
up B-O B-PP_NP_QP_IN
to B-O B-TO
6 B-O B-CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
after B-O B-IN
" " B-O B-NP_O-PP
, B-O B-COMMA
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Delayed B-O B-S_NP_NP_VBN
administration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
rBPI21 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
affected B-O B-VP_VBD
LPS-mediated B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
nuclear B-O B-NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_NP_QP_CD
to B-O B-TO
4 B-O B-CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
following B-O B-PP_VBG
LPS B-O B-NP_NP_NN
addition B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
endothelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
already B-O B-ADVP_RB
" " B-O O-ADVP
activated B-O B-VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
addition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
rBPI21 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
marked B-O B-NP_NP_JJ
reduction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
detectable B-O B-ADJP_JJ
at B-O B-PP_IN
4 B-O B-NP_QP_CD
or B-O B-CC
6 B-O B-CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
endothelial B-O B-S_S_NP_JJ
activation B-O B-NN
" " B-O O-NP
requires B-O B-VP_VBZ
continuous B-O B-NP_NP_JJ
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
rBPI21 B-O B-S_NP_NN
" " B-O O-NP
acts B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
reverse B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Does B-O B-SQ_SQ_VBZ
thyroidectomy B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
radioactive B-O B-NP_JJ
iodine B-O B-NN
therapy B-O B-NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
antithyroid B-O B-NP_JJ
drug B-O B-NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-NP
alter B-O B-VP_VB
reactivity B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NNS
' B-O B-POS
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
epitopes B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
thyrotropin B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
autoimmune B-O B-NP_JJ
thyroid B-O B-NN
diseases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
? B-O B-PERIOD
" " B-O O-SQ
" " B-O O-SQ
  
The B-O B-S_S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
treatment B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
thyroid B-O B-NP_NP_NN
antibody B-O B-NN
production B-O B-NN
" " B-O O-NP
and B-O B-CC
T B-O B-NP_NP_NN
cell B-O B-NN
reactivity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
thyroid B-O B-NP_NN
antigens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
in B-O B-NP_PP_IN
15 B-O B-NP_NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
before B-O B-PP_PP_IN
" " B-O B-NP_O-PP
and B-O B-CC
after B-O B-PP_IN
" " B-O B-NP_O-PP
thyroidectomy B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
19 B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
GD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
before B-O B-PP_PP_IN
" " B-O B-NP_O-PP
and B-O B-CC
after B-O B-PP_IN
" " B-O B-NP_O-PP
therapy B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
9 B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
maintained B-O B-VP_VBD
euthyroid B-O B-NP_ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Twenty B-O B-S_NP_NP_CD
subjects B-O B-NNS
" " B-O O-NP
matched B-O B-ADJP_JJ
for B-O B-PP_IN
age B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
sex B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
without B-O B-PP_IN
known B-O B-NP_JJ
thyroid B-O B-NN
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
served B-O B-VP_VBD
as B-O B-PP_IN
controls B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
GD B-O B-NP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
responses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
peripheral B-O B-NP_NP_NP_JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
PBMC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
TSH B-O B-NP_NN
receptor B-O B-NN
( B-O B-LRB
TSHR B-O B-NN
) B-O B-RRB
-specific B-O B-JJ
T B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
recombinant B-O B-NP_NP_JJ
human B-O B-JJ
TSHR B-O B-NN
extracellular B-O B-JJ
domain B-O B-NN
" " B-O O-NP
, B-O B-COMMA
thyroglobulin B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
TSHR B-O B-NP_NP_NN
" " B-O O-NP
peptides B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
on B-O B-NP_UCP_PP_IN
the B-O B-NP_NP_NP_DT
day B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
( B-O B-PRN_LRB
day B-O B-NP_NN
0 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
also B-O B-ADVP_RB
" " B-O O-ADVP
6-8 B-O B-NP_NP_NP_QP_CD
" " B-O O-QP
weeks B-O B-NNS
" " B-O O-NP
and B-O B-CC
3-6 B-O B-NP_QP_CD
" " B-O O-QP
months B-O B-NNS
" " B-O O-NP
" " B-O O-NP
thereafter B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Reactivity B-O B-S_NP_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
TSHR B-O B-NP_NP_NN
" " B-O O-NP
peptides B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
before B-O B-PP_IN
surgery B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VP_VBD
heterogeneous B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
spanned B-O B-VP_VBD
the B-O B-NP_DT
entire B-O B-JJ
extracellular B-O B-NP_JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Six B-O B-S_PP_NP_QP_CD
to B-O B-TO
8 B-O B-CD
" " B-O O-QP
weeks B-O B-NNS
" " B-O O-NP
after B-O B-IN
subtotal B-O B-NP_JJ
thyroidectomy B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
' B-O B-POS
PBMC B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
responding B-O B-VP_VBG
to B-O B-PP_TO
any B-O B-NP_DT
peptide B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
average B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
recognized B-O B-NP_VBN
peptides B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
decreased B-O B-VP_VBD
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
further B-O B-JJ
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
T B-O B-NN
cell B-O B-NN
reactivity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
TSHR B-O B-NP_NP_NN
" " B-O O-NP
peptides B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-NP_VP_VBN
3-6 B-O B-PP_NP_QP_CD
" " B-O O-QP
months B-O B-NNS
" " B-O O-NP
after B-O B-IN
surgery B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
responses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
PBMC B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
Graves B-O B-NP_NP_NN
' B-O B-POS
patients B-O B-NNS
" " B-O O-NP
before B-O B-PP_IN
RAI B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
less B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
presurgical B-O B-JJ
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Six B-O B-S_PP_NP_QP_CD
to B-O B-TO
8 B-O B-CD
" " B-O O-QP
weeks B-O B-NNS
" " B-O O-NP
after B-O B-IN
RAI B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
responding B-O B-VP_VBG
to B-O B-PP_TO
any B-O B-NP_DT
peptide B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
average B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
recognized B-O B-NP_VBN
peptides B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
increased B-O B-VP_VBD
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Three B-O B-S_PP_NP_QP_CD
to B-O B-TO
6 B-O B-CD
" " B-O O-QP
months B-O B-NNS
" " B-O O-NP
after B-O B-IN
RAI B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
T B-O B-NP_NP_NN
cell B-O B-NN
responses B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
TSHR B-O B-NP_NP_NN
" " B-O O-NP
peptides B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
less B-O B-ADJP_ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
those B-O B-NP_DT
6-8 B-O B-NP_QP_CD
" " B-O O-QP
weeks B-O B-NNS
" " B-O O-NP
after B-O B-PP_IN
RAI B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
but B-O B-CC
still B-O B-ADJP_ADJP_RB
higher B-O B-JJR
" " B-O O-ADJP
than B-O B-PP_IN
the B-O B-NP_NP_DT
values B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
day B-O B-NP_NN
0 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Responses B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
PBMC B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
GD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
maintained B-O B-VP_VBD
euthyroid B-O B-NP_ADJP_JJ
on B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
lower B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
before B-O B-PP_IN
surgery B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
RAI B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
reactivity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
different B-O B-NP_JJ
groups B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reflected B-O B-VP_VBD
a B-O B-NP_NP_DT
pattern B-O B-NN
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
PBMC B-O B-NP_NP_NN
" " B-O O-NP
after B-O B-PP_IN
treatment B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TSHR B-O B-S_NP_NP_NP_NN
antibody B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
microsomal B-O B-NP_NP_JJ
antibody B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
decreased B-O B-VP_VP_VBD
after B-O B-PP_IN
surgery B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
increased B-O B-VP_VBD
after B-O B-PP_IN
RAI B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
difference B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
recognized B-O B-NP_NP_VBN
peptides B-O B-NNS
" " B-O O-NP
by B-O B-PP_IN
patients B-O B-NP_NP_NNS
' B-O B-POS
before B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
reflect B-O B-VP_VB
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
long B-O B-NP_NP_NP_JJ
term B-O B-NN
therapy B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
ATD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
vs. B-O B-CC
the B-O B-NP_NP_DT
shorter B-O B-JJR
period B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
decreased B-O B-VBN
T B-O B-NN
cell B-O B-NN
reactivity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
thyroid B-O B-NP_NN
antigens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
thyroidectomy B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
the B-O B-NP_NP_DT
result B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
removal B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
or B-O B-CC
redistribution B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
suppressor-inducer B-O B-NP_JJ
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
increased B-O B-VBN
T B-O B-NN
cell B-O B-NN
response B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
RAI B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
probably B-O B-ADVP_RB
" " B-O O-ADVP
epitope B-O B-UCP_ADJP_NN
specific B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
rather B-O B-CONJP_RB
than B-O B-IN
" " B-O O-CONJP
a B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
whole B-O B-JJ
TSHR B-O B-NP_NN
" " B-O O-NP
molecule B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Synchronous B-O B-S_S_NP_NP_JJ
recognition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
peptides B-O B-NP_NNS
158-176 B-O B-NP_CD
" " B-O O-NP
and B-O B-CC
248-263 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
important B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_NP_DT
development B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_NP_DT
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
recognition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
an B-O B-NP_NP_NP_DT
early B-O B-JJ
sign B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immune B-O B-NP_JJ
remission B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
predictor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
euthyroidism B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
IL-10 B-O B-S_S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
the B-O B-NP_NP_NP_DT
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tyk2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Jak1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
differential B-O B-JJ
assembly B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
STAT1 B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
and B-O B-CC
STAT3 B-O B-NP_NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
IL-10 B-O B-S_S_NP_NN
" " B-O O-NP
affects B-O B-VP_VBZ
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
by B-O B-PP_IN
driving B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
progression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immune B-O B-NP_JJ
responsiveness B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
such B-O B-SBAR_IN
that B-O B-IN
Th2 B-O B-S_NP_NN
lymphocyte-mediated B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
predominate B-O B-VP_VBP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
in B-O B-S_PP_IN
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
IL-10 B-O B-NP_NN
" " B-O O-NP
stimulates B-O B-VP_VBZ
tyrosine B-O B-NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_NP_CC
, B-O B-NP_COMMA
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
in B-O B-PP_IN
a B-O B-NP_DT
differential B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
such B-O B-SBAR_IN
that B-O B-IN
the B-O B-S_NP_NP_DT
relative B-O B-JJ
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
varies B-O B-VP_VBZ
between B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
monocytes B-O B-NP_NNS
" " B-O O-NP
express B-O B-VP_VBP
a B-O B-NP_NP_DT
novel B-O B-JJ
IL-10-stimulated B-O B-NP_JJ
STAT B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
an B-O B-NP_NP_DT
M(r) B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
70 B-O B-NP_CD
kDa B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VP_VBZ
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
but B-O B-CC
is B-O B-VP_VBZ
not B-O B-RB
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IL-10 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_DT
ligand-induced B-O B-JJ
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tyk2 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
Jak1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
Jak2 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
Jak3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Selective B-O B-S_NP_NP_JJ
modulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immune B-O B-NP_JJ
responsiveness B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
IL-10 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
result B-O B-VP_VB
in B-O B-PP_IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
the B-O B-NP_NP_DT
differential B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
STAT B-O B-NP_NN
protein B-O B-NN
pairs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Costimulation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
CD4+ B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
LFA-3 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
B7 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induce B-O B-VP_VBP
distinct B-O B-NP_JJ
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
AP-1 B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
earlier B-O B-ADVP_RBR
" " B-O O-ADVP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
CD4+ B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
distinct B-O B-NP_JJ
profiles B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
now B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
B7 B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
LFA-3 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
costimulated B-O B-VP_VBD
IL-2 B-O B-NP_NP_NP_NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
and B-O B-CC
mRNA B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
CD4+ B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Maximal B-O B-S_NP_NP_JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
recorded B-O B-VP_VBN
with B-O B-NP_PP_IN
CHO-DR/B7/LFA-3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
cooperative B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B7 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
LFA-3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
the B-O B-NP_DT
transcriptional B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Gel-shift B-O B-S_NP_JJ
analysis B-O B-NN
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD4+ B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
CHO-DR B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
staphylococcal B-O B-NP_JJ
enterotoxin B-O B-NN
A B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
sufficient B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-SBAR_IN
induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
required B-O B-VP_VBD
costimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LFA-3 B-O B-S_NP_NN
" " B-O O-NP
induced B-O B-VP_VP_VBD
moderate B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
did B-O B-VP_VBD
not B-O B-RB
influence B-O B-VP_VB
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
while B-O B-SBAR_IN
B7 B-O B-S_NP_NP_NN
" " B-O O-NP
costimulation B-O B-NN
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBD
both B-O B-NP_CC
AP-1 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
substantially B-O B-NP_ADJP_RB
enhanced B-O B-VBN
" " B-O O-ADJP
NF-kappa B-O B-NP_NN
B B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
CHO-DR/B7/LFA-3 B-O B-NP_NN
triple B-O B-JJ
transfectant B-O B-NN
" " B-O O-NP
" " B-O O-NP
induced B-O B-VP_VBD
a B-O B-NP_NP_DT
further B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
AP-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
binding B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
compared B-O B-PP_VBN
with B-O B-PP_IN
the B-O B-NP_DT
double B-O B-NP_JJ
transfectants B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Oct-1 B-O B-NP_NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
remained B-O B-VP_VBD
similar B-O B-ADJP_JJ
in B-O B-PP_IN
all B-O B-NP_DT
samples B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Super-shift B-O B-S_NP_JJ
analysis B-O B-NN
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
NF-kappa B-O B-NP_NN
B B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
costimulated B-O B-NP_VBN
CD4+ B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contained B-O B-VP_VBD
large B-O B-NP_NP_NP_JJ
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
substantial B-O B-NP_NP_JJ
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
marginal B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
c-Rel B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
AP-1 B-O B-NP_NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
contained B-O B-VP_VBD
c-Jun B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Jun-D B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Fra-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CC
marginal B-O B-NP_NP_JJ
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Jun-B B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-Fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
distinct B-O B-NP_NP_JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
B7 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
LFA-3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
costimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
" " B-O O-NP
may B-O B-VP_MD
partly B-O B-ADVP_RB
" " B-O O-ADVP
account B-O B-VP_VB
for B-O B-PP_IN
the B-O B-NP_NP_DT
differential B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
B7 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
LFA-3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
costimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Interleukin B-O B-S_S_NP_NN
2 B-O B-CD
signaling B-O B-NN
" " B-O O-NP
involves B-O B-VP_VBZ
the B-O B-NP_NP_DT
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Stat B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
One B-O B-S_S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
most B-O B-ADJP_RBS
important B-O B-JJ
" " B-O O-ADJP
cytokines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
immune B-O B-NP_JJ
response B-O B-NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
interleukin B-O B-NP_NP_NP_NN
2 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
potent B-O B-JJ
activator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
proliferation B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
function B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
the B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
propagated B-O B-VP_VBN
within B-O B-NP_PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
understood B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
While B-O B-S_SBAR_IN
the B-O B-S_NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
its B-O B-NP_PRPP
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
recently B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
lead B-O B-VP_VB
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
subsequent B-O B-S_NP_NP_NP_JJ
steps B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
signaling B-O B-NN
pathway B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
lead B-O B-S_NP_VP_VBP
to B-O B-PP_TO
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
had B-O B-VP_VBD
not B-O B-RB
been B-O B-VP_VBN
characterized B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
many B-O B-S_NP_NP_JJ
cytokines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
activate B-O B-S_NP_VP_VBP
Jak B-O B-NP_NN
kinases B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
lead B-O B-VP_VBP
to B-O B-PP_TO
the B-O B-NP_NP_DT
tyrosine B-O B-NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
and B-O B-CC
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
members B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
trigger B-O B-VP_VB
Stat B-O B-NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
was B-O B-VP_VBD
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Exposure B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_PP_IN
activated B-O B-NP_VBN
human B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
of B-O B-PP_IN
a B-O B-NP_NP_DT
natural B-O B-NP_JJ
killer B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
NKL B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
to B-O B-PP_TO
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_PP_IN
Stat1 B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
, B-O B-COMMA
Stat1 B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Stat3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
of B-O B-PP_IN
two B-O B-NP_NP_CD
Stat-related B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
p94 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
p95 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
p94 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
p95 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
share B-O B-VP_VP_VBP
homology B-O B-NP_NN
" " B-O O-NP
with B-O B-PP_IN
Stat1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_PP_IN
the B-O B-NP_DT
phosphorylation B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
the B-O B-NP_DT
Src B-O B-NP_NN
homology B-O B-NN
2 B-O B-CD
( B-O B-LRB
SH2 B-O B-NN
) B-O B-RRB
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
otherwise B-O B-ADVP_RB
" " B-O O-ADVP
are B-O B-VP_VBP
immunologically B-O B-ADJP_RB
distinct B-O B-JJ
from B-O B-PP_IN
Stat1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
Stat B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_VP_TO
translocate B-O B-VP_VB
to B-O B-PP_TO
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
to B-O B-VP_TO
bind B-O B-VP_VB
to B-O B-PP_TO
a B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
a B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
IL-2 B-O B-S_NP_NP_NN
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
its B-O B-NP_PRPP
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
may B-O B-VP_MD
activate B-O B-VP_VB
specific B-O B-NP_NP_JJ
genes B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
" " B-O B-NP_PP_PP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
granulocyte-macrophage B-O B-NP_NP_NP_NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
E-selectin B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
endothelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
cyclosporin B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
T-cell B-O B-NP_NP_NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
NFAT B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Nuclear B-O B-S_S_NP_NP_JJ
factor B-O B-NN
of B-O B-IN
activated B-O B-VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
NFAT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
originally B-O B-ADVP_RB
" " B-O O-ADVP
described B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_NP_DT
T-cell-specific B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
athat B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
and B-O B-S_NP_VP_VP_CC
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
As B-O B-S_SBAR_IN
we B-O B-S_NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
that B-O B-SBAR_IN
activated B-O B-S_NP_VBN
endothelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBD
NFAT B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
tested B-O B-VP_VBD
the B-O B-NP_NP_DT
antiinflammatory B-O B-JJ
properties B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
CsA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
endothelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Significantly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
CsA B-O B-NP_NN
" " B-O O-NP
completely B-O B-ADVP_RB
" " B-O O-ADVP
suppressed B-O B-VP_VP_VBD
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFAT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
endothelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
inhibited B-O B-VP_VBD
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
granulocyte-macrophage B-O B-NP_NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
( B-O B-LRB
GM-CSF B-O B-NN
) B-O B-RRB
gene B-O B-NN
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
use B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
60 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CsA B-O B-S_NP_NN
" " B-O O-NP
similarly B-O B-ADVP_RB
" " B-O O-ADVP
mediated B-O B-VP_VBD
a B-O B-NP_NP_DT
reduction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
up B-O B-PP_NP_QP_RB
to B-O B-TO
65 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
in B-O B-PP_IN
GM-CSF B-O B-NP_NP_NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
protein B-O B-NP_NN
" " B-O B-NP_O-NP
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
activated B-O B-NP_VBN
endothelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CsA B-O B-S_NP_NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
suppressed B-O B-VP_VBD
E-selectin B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
vascular B-O B-NP_NP_NP_JJ
cell B-O B-NN
adhesion B-O B-NN
molecule-1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
VCAM-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O B-NP_O-NP
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
endothelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
even B-O B-SBAR_RB
though B-O B-IN
the B-O B-S_NP_DT
E-selectin B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
rather B-O B-CONJP_RB
than B-O B-IN
" " B-O O-CONJP
NFAT B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Hence B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
induction B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NP_NN
surface B-O B-NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
leukocyte B-O B-NP_NN
adhesion B-O B-NN
molecule B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
tumor B-O B-NP_NN
necrosis B-O B-NN
factor B-O B-NN
( B-O B-LRB
TNF B-O B-NN
) B-O B-RRB
-alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
reduced B-O B-VP_VBN
by B-O B-NP_PP_IN
40 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CsA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
this B-O B-S_NP_DT
" " B-O O-NP
was B-O B-VP_VBD
reflected B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
decrease B-O B-ADJP_QP_NN
" " B-O O-NP
in B-O B-PP_IN
adhesion B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
CsA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
endothelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
detected B-O B-VP_VBN
at B-O B-NP_PP_IN
the B-O B-NP_DT
chromatin B-O B-NP_NN
" " B-O O-NP
structure B-O B-NN
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
as B-O B-SBAR_IN
DNasel B-O B-S_NP_NP_NN
hypersensitive B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
within B-O B-PP_IN
both B-O B-NP_CC
the B-O B-NP_DT
GM-CSF B-O B-NP_NN
" " B-O O-NP
enhancer B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
E-selectin B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
suppressed B-O B-VP_VBN
by B-O B-NP_PP_IN
CsA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
represents B-O B-VP_VP_VBZ
the B-O B-NP_NP_DT
first B-O B-JJ
report B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFAT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
endothelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
suggests B-O B-VP_VBZ
mechanisms B-O B-NP_NP_NNS
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
CsA B-O B-S_NP_NN
" " B-O O-NP
could B-O B-VP_MD
function B-O B-VP_VB
" " B-O B-PP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-WHPP
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Direct B-O B-NP_NP_NP_NP_JJ
demonstration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFATp B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
dephosphorylation B-O B-NN
" " B-O O-NP
and B-O B-CC
nuclear B-O B-NP_JJ
localization B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
activated B-O B-NP_VBN
HT-2 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
using B-O B-S_NP_VP_VBG
a B-O B-NP_DT
specific B-O B-JJ
NFATp B-O B-NP_NN
polyclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Nuclear B-O B-S_S_S_NP_NP_JJ
factor B-O B-NN
of B-O B-IN
activated B-O B-VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
NFAT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
regulates B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
NFAT B-O B-S_NP_NP_NN
" " B-O O-NP
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
stimulated B-O B-VP_VBN
following B-O B-NP_PP_VBG
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Several B-O B-S_NP_NP_JJ
lines B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
evidence B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
suggested B-O B-VP_VBN
that B-O B-SBAR_IN
NFAT B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
substrate B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
a B-O B-NP_NP_DT
polyclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
murine B-O B-NP_JJ
NFATp B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
Western B-O B-S_NP_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
various B-O B-NP_JJ
mouse B-O B-NN
tissues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
110-130-kDa B-O B-ADJP_JJ
" " B-O O-ADJP
NFATp B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
highly B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
immunoprecipitated B-O B-NP_NP_VBN
NFATp B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
untreated B-O B-NP_JJ
HT-2 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
calcineurin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
the B-O B-NP_NP_DT
dephosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFATp B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
demonstrating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
NFATp B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
substrate B-O B-ADJP_NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NFATp B-O B-S_NP_NP_NN
" " B-O O-NP
immunoprecipitated B-O B-VP_VBN
from B-O B-NP_PP_IN
32P-labeled B-O B-NP_JJ
HT-2 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
migrated B-O B-VP_VBD
as B-O B-PP_IN
an B-O B-NP_NP_DT
approximately B-O B-ADJP_RB
120-kDa B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
localized B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
ionomycin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_NP_DT
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
molecular B-O B-JJ
weight B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFATp B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
32P B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
consistent B-O B-ADVP_JJ
with B-O B-PP_IN
NFATp B-O B-NP_NP_NN
" " B-O O-NP
dephosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
dephosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFATp B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
localization B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
nuclear B-O B-JJ
fraction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
events B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
preincubation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
FK506 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
calcineurin B-O B-NP_NN
" " B-O O-NP
inhibitor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
consistent B-O B-ADVP_JJ
with B-O B-PP_IN
the B-O B-NP_DT
hypothesis B-O B-NN
that B-O B-SBAR_IN
NFATp B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Temperature-induced B-O B-NP_NP_NP_JJ
down-regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
mononuclear B-O B-JJ
leucocyte B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
sepsis B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
septic B-O B-NP_JJ
shock B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
OBJECTIVE B-O B-NP_NP_NN
: B-O B-COLON
" " B-O O-NP
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
hypothalamic-pituitary-adrenal B-O B-JJ
axis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
of B-O B-PP_IN
vital B-O B-NP_JJ
importance B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
critical B-O B-NP_JJ
illness B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
studied B-O B-VP_VBN
the B-O B-NP_NP_DT
adaptive B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
occur B-O B-S_NP_VP_VBP
at B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DESIGN B-O B-NP_NP_NN
: B-O B-COLON
" " B-O O-NP
The B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
hypercortisolaemia B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
hyperthermia B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
cellular B-O B-NP_JJ
composition B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
number B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
per B-O B-PP_IN
cell B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
their B-O B-NP_PRPP
affinity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
evaluated B-O B-VP_VBN
, B-O B-NP_COMMA
both B-O B-ADVP_CC
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
and B-O B-CC
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
mononuclear B-O B-JJ
leucocytes B-O B-NNS
" " B-O O-NP
of B-O B-PP_PP_IN
control B-O B-NP_JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
  
SUBJECTS B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
Fifteen B-O B-S_NP_NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
age B-O B-NP_NN
25-79 B-O B-QP_CD
" " B-O O-QP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
with B-O B-PP_IN
sepsis B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
septic B-O B-NP_JJ
shock B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
who B-O B-SBAR_WHNP_WP
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
admitted B-O B-VP_VBN
to B-O B-NP_PP_TO
an B-O B-NP_DT
intensive B-O B-JJ
care B-O B-NN
unit B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
were B-O B-VP_VBD
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
control B-O B-JJ
group B-O B-NN
" " B-O O-NP
consisted B-O B-VP_VBD
of B-O B-PP_IN
24 B-O B-NP_CD
healthy B-O B-JJ
laboratory B-O B-NN
employees B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
MEASUREMENTS B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
The B-O B-S_NP_NP_DT
binding B-O B-NP_NN
capacity B-O B-NN
" " B-O O-NP
and B-O B-CC
affinity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
measured B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
compared B-O B-VP_VBN
to B-O B-NP_PP_TO
clinical B-O B-NP_NP_JJ
data B-O B-NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
plasma B-O B-NN
cortisol B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
  
RESULTS B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
Hypercortisolaemia B-O B-S_NP_NN
, B-O B-COMMA
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
, B-O B-COMMA
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_NP_DT
decreased B-O B-VBN
affinity B-O B-NN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_DT
decreased B-O B-VBN
binding B-O B-NN
capacity B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
  
In B-O B-S_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
, B-O B-COMMA
hyperthermia B-O B-NP_NP_NN
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
variations B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
cellular B-O B-JJ
composition B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
influence B-O B-VP_VB
the B-O B-NP_DT
glucocorticoid B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_NP_DT
change B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
receptors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
per B-O B-PP_IN
cell B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-SBAR_IN
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
healthy B-O B-NP_JJ
controls B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
a B-O B-NP_NP_DT
decreased B-O B-VBN
affinity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_NP_DT
weak B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
but B-O B-CC
significant B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
negative B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-ADJP
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
body B-O B-NP_NP_NN
temperature B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
patient B-O B-NN
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_NP_DT
relation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
circulating B-O B-NP_NP_VBG
cortisol B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
and B-O B-CC
glucocorticoid B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
affinity B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
number B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CONCLUSIONS B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
There B-O B-S_NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
no B-O B-NP_NP_DT
obvious B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
plasma B-O B-NP_NP_NN
cortisol B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
in B-O B-ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_NP_DT
decreased B-O B-VBN
affinity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
together B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
the B-O B-NP_NP_DT
negative B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
hyperthermia B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
hypothalamic-pituitary-adrenal B-O B-S_NP_NP_JJ
axis B-O B-NN
activation B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
critical B-O B-NP_JJ
illness B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
peripheral B-O B-NP_NP_JJ
adaptation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Signalling B-O B-NP_NP_NP_NN
" " B-O O-NP
via B-O B-PP_IN
CD28 B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
naive B-O B-JJ
neonatal B-O B-JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Accessory B-O B-S_S_NP_JJ
molecules B-O B-NNS
" " B-O O-NP
play B-O B-VP_VBP
a B-O B-NP_DT
crucial B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
development B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
T B-O B-NN
cell B-O B-NN
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
antigenic B-O B-NP_JJ
challenge B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD28 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
modulating B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
T B-O B-ADJP_NN
cell B-O B-NN
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
compare B-O B-VP_VB
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD28 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
neonatal B-O B-S_NP_NP_NP_JJ
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
adult B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
pair B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mitogenic B-O B-NP_JJ
anti-CD2 B-O B-JJ
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NP_NN
" " B-O B-NP_O-NP
or B-O B-CC
absence B-O B-NP_NN
" " B-O B-NP_O-NP
" " B-O O-NP
of B-O B-PP_IN
anti-CD28 B-O B-NP_JJ
MoAb B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
With B-O B-S_PP_IN
anti-CD2 B-O B-NP_NP_NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
neonatal B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
proliferated B-O B-VP_VP_VBD
slightly B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
but B-O B-CC
produced B-O B-VP_VBD
no B-O B-NP_DT
detectable B-O B-JJ
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
whereas B-O B-SBAR_IN
adult B-O B-S_NP_JJ
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
proliferated B-O B-VP_VBD
vigorously B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
with B-O B-PP_IN
significant B-O B-NP_JJ
IL-2 B-O B-NP_NN
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Costimulation B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
anti-CD28 B-O B-NP_JJ
MoAb B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
greatly B-O B-ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VBD
the B-O B-NP_NP_DT
proliferative B-O B-JJ
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
neonatal B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-PP_TO
levels B-O B-NP_NP_NNS
" " B-O O-NP
equivalent B-O B-ADJP_JJ
to B-O B-PP_TO
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
adult B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
whereas B-O B-SBAR_IN
adult B-O B-S_NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
only B-O B-NP_ADJP_RB
slight B-O B-JJ
" " B-O O-ADJP
increases B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
IL-2 B-O B-S_NP_NP_NN
" " B-O O-NP
secretion B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
increased B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
anti-CD28 B-O B-NP_JJ
MoAb B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
neonatal B-O B-S_NP_NP_JJ
T B-O B-NN
cell B-O B-NN
" " B-O O-NP
IL-2 B-O B-NP_NN
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
remained B-O B-VP_VBD
lower B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
in B-O B-NP_NP_PP_IN
adults B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
enhancement B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
neonates B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
similar B-O B-ADJP_JJ
to B-O B-PP_TO
adult B-O B-NP_JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Anti-CD28 B-O B-S_NP_JJ
MoAb B-O B-NN
costimulation B-O B-NN
" " B-O O-NP
increased B-O B-VP_VBD
NF B-O B-NP_NP_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
neonates B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
albeit B-O B-PP_IN
to B-O B-PP_TO
levels B-O B-NP_NP_NNS
" " B-O O-NP
lower B-O B-ADJP_JJR
than B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
cellular B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
governing B-O B-VP_VBG
the B-O B-NP_NP_DT
diminished B-O B-VBN
proliferative B-O B-JJ
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
neonatal B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
anti-CD2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
may B-O B-VP_MD
therefore B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
due B-O B-ADJP_JJ
to B-O B-PP_TO
decreased B-O B-NP_NP_VBN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
, B-O B-COMMA
reduced B-O B-NP_VBN
IL-2 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
and B-O B-CC
deficient B-O B-NP_JJ
IL-2 B-O B-NP_NN
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
anti-CD28 B-O B-S_NP_NP_JJ
MoAb B-O B-NN
" " B-O O-NP
costimulation B-O B-NN
" " B-O O-NP
enhances B-O B-VP_VBZ
all B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
above B-O B-JJ
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
NF B-O B-S_NP_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
IL-2 B-O B-NP_NN
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
remain B-O B-VP_VBP
lower B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
in B-O B-NP_NP_PP_IN
adults B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
need B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
further B-O B-NP_NP_JJ
activation B-O B-NN
requirements B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Evidence B-O B-NP_NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
normal B-O B-NP_NP_NP_JJ
vitamin B-O B-NP_NN
D B-O B-NN
receptor B-O B-NN
messenger B-O B-NN
ribonucleic B-O B-JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
genotype B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
absorptive B-O B-NP_JJ
hypercalciuria B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Absorptive B-O B-S_S_NP_NP_JJ
hypercalciuria B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
a B-O B-NP_DT
stone-forming B-O B-JJ
condition B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
gut B-O B-NP_NP_NP_NP_NN
hyperabsorption B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
hypercalciuria B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
reduced B-O B-NP_VBN
bone B-O B-NN
density B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Inasmuch B-O B-S_SBAR_RB
as B-O B-IN
these B-O B-S_NP_DT
features B-O B-NNS
" " B-O O-NP
implicate B-O B-VP_VBP
enhanced B-O B-NP_NP_VBN
calcitriol B-O B-NN
action B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
gut B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
bone B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
analyzed B-O B-VP_VBD
the B-O B-NP_DT
vitamin B-O B-NP_NN
D B-O B-NN
receptor B-O B-NN
( B-O B-LRB
VDR B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
to B-O B-S_NP_VP_TO
ascertain B-O B-VP_VB
whether B-O B-SBAR_IN
marks B-O B-S_NP_NP_PP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
compared B-O B-VP_VBN
the B-O B-NP_NP_DT
frequency B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_NP_DT
restriction B-O B-NP_NN
fragment B-O B-NN
length B-O B-NN
polymorphism B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
Bsm B-O B-NP_NN
I B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_NP_DT
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
33 B-O B-NP_CD
patients B-O B-ADJP_ADJP_ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
36 B-O B-NP_CD
control B-O B-ADJP_ADJP_ADJP_JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_DT
difference B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
distribution B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
VDR B-O B-NP_NN
" " B-O O-NP
alleles B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
patient B-O B-NN
population B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
compared B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
normal B-O B-JJ
population B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
coding B-O B-VBG
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
VDR B-O B-NP_NN
messenger B-O B-NN
RNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
normal B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
both B-O B-NP_NP_CC
analysis B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
chemical B-O B-NP_JJ
mismatch B-O B-NN
cleavage B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-NP_NP_DT
basis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
enhanced B-O B-VBN
intestinal B-O B-JJ
calcium B-O B-NN
absorption B-O B-NN
" " B-O O-NP
invariably B-O B-VP_ADVP_RB
" " B-O O-ADVP
seen B-O B-VBN
in B-O B-NP_PP_IN
absorptive B-O B-NP_JJ
hypercalciuria B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
and B-O B-CC
attendant B-O B-NP_NP_JJ
symptoms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
disorder B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VP_VBP
not B-O B-RB
attributable B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
are B-O B-VP_VBP
not B-O B-RB
linked B-O B-VP_VBN
to B-O B-NP_PP_TO
a B-O B-NP_DT
common B-O B-JJ
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Up-regulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
high-affinity B-O B-NP_JJ
dehydroepiandrosterone B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
dehydroepiandrosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
activated B-O B-NP_VBN
human B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Although B-O B-S_S_SBAR_IN
evidence B-O B-S_NP_NN
" " B-O O-NP
indicates B-O B-VP_VBZ
that B-O B-SBAR_IN
dehydroepiandrosterone B-O B-S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
exerts B-O B-VP_VBZ
effects B-O B-NP_ADJP_NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
its B-O B-S_NP_NP_PRPP
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
remains B-O B-VP_VBZ
unknown B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
DHEA B-O B-S_NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
using B-O B-S_S_NP_VP_VBG
a B-O B-NP_DT
whole-cell B-O B-JJ
binding B-O B-NN
assay B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
human B-O B-NP_JJ
T B-O B-NN
lymphoid B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
PEER B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
revealing B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
single B-O B-JJ
class B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
was B-O B-VP_VBD
greatly B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O B-SBAR_WHADVP_S_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Bound B-O B-S_NP_VBN
[3H]DHEA B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
displaced B-O B-ADJP_JJ
sensitively B-O B-PP_PP_ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
DHEA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
secondarily B-O B-ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
dihydrotestosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
effectively B-O B-ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
other B-O B-NP_NP_JJ
steroids B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
DHEA B-O B-NP_NN
sulfate B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
not B-O B-VP_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
indicate B-O B-VP_VBP
the B-O B-NP_NP_DT
existence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
DHEA B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
T B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
become B-O B-VP_VBP
susceptible B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
during B-O B-PP_IN
the B-O B-NP_NP_DT
process B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
and B-O B-CC
cytokine B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
myeloid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
/Rel B-O B-NN
" " B-O O-NP
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
CD4+ B-O B-S_S_NP_NP_JJ
macrophages B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
tissues B-O B-NP_NP_NP_NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
lung B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
skin B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
lymph B-O B-NP_NN
nodes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
promyelocytic B-O B-NP_NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
bone B-O B-NP_NN
marrow B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
peripheral B-O B-NP_JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
serve B-O B-VP_VBP
as B-O B-PP_IN
important B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
targets B-O B-NP_NNS
" " B-O O-NP
and B-O B-CC
reservoirs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
human B-O B-NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
HIV-1-infected B-O B-S_NP_JJ
myeloid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
often B-O B-ADVP_RB
" " B-O O-ADVP
diminished B-O B-VP_VBN
in B-O B-NP_PP_IN
their B-O B-NP_NP_PRPP
ability B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
participate B-O B-VP_VB
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HIV-1 B-O B-S_NP_NP_NN
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
myeloid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
lead B-O B-VP_VB
to B-O B-PP_TO
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
surface B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
increase B-O B-S_NP_VP_VBP
" " B-O B-NP_NP_PP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Enhancement B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
related B-O B-ADJP_JJ
in B-O B-PP_IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
increased B-O B-NP_NP_VBN
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cellular B-O B-NP_NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
binds B-O B-VP_VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
HIV-1 B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
long B-O B-NP_JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
contributes B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
inducibility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
multiple B-O B-NP_JJ
activating B-O B-VBG
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Phosphorylation B-O B-S_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
degradation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cytoplasmic B-O B-NP_NP_JJ
inhibitor B-O B-NN
" " B-O O-NP
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
crucial B-O B-NP_NP_JJ
regulatory B-O B-JJ
events B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
N- B-O B-NP_NP_NN
" " B-O B-NP_NP_O-NP
and B-O B-CC
C-terminal B-O B-NP_JJ
" " B-O B-NP_O-NP
residues B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
inducer-mediated B-O B-NP_JJ
degradation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Chronic B-O B-S_NP_NP_JJ
HIV-1 B-O B-NN
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
myeloid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VP_VBZ
to B-O B-PP_TO
constitutive B-O B-NP_JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
provides B-O B-VP_VBZ
an B-O B-NP_NP_DT
intranuclear B-O B-JJ
environment B-O B-NN
" " B-O O-NP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
perpetuating B-O B-S_NP_VP_VBG
HIV-1 B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Increased B-O B-S_NP_NP_VBN
intracellular B-O B-JJ
stores B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
latent B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
result B-O B-VP_VB
in B-O B-PP_IN
rapid B-O B-NP_NP_JJ
inducibility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B-dependent B-O B-JJ
cytokine B-O B-NP_NN
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
secondary B-O B-NP_ADJP_JJ
" " B-O O-ADJP
pathogenic B-O B-NP_JJ
infections B-O B-NNS
" " B-O O-NP
or B-O B-CC
antigenic B-O B-NP_JJ
challenge B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
cytokine B-O B-NP_NP_NN
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
rapidly B-O B-UCP_VP_ADVP_RB
" " B-O O-ADVP
induced B-O B-VBN
" " B-O B-NP_O-VP
, B-O B-COMMA
enhanced B-O B-VP_VBN
" " B-O B-NP_O-VP
, B-O B-COMMA
and B-O B-CC
sustained B-O B-ADJP_JJ
over B-O B-PP_RP
prolonged B-O B-NP_JJ
periods B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
in B-O B-PP_IN
HIV-1-infected B-O B-NP_JJ
myeloid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
compared B-O B-PP_VBN
with B-O B-PP_IN
uninfected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Elevated B-O B-S_NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_JJ
inflammatory B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
sera B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1-infected B-O B-NP_JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Secretion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
myeloid B-O B-NP_JJ
cell-derived B-O B-JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
both B-O B-VP_CC
increase B-O B-VP_VB
virus B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
contribute B-O B-VP_VB
to B-O B-PP_TO
AIDS-associated B-O B-NP_JJ
disorders B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_NP_DT
DNA-binding B-O B-JJ
properties B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_NP_CD
heat B-O B-NN
shock B-O B-NN
factors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
HSF1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
HSF3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
avian B-O B-NP_JJ
erythroblast B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
HD6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Avian B-O B-S_S_NP_JJ
cells B-O B-NNS
" " B-O O-NP
express B-O B-VP_VBP
three B-O B-NP_NP_CD
heat B-O B-NP_NN
shock B-O B-NN
transcription B-O B-NN
factor B-O B-NN
( B-O B-LRB
HSF B-O B-NN
) B-O B-RRB
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
corresponding B-O B-VP_VBG
to B-O B-PP_TO
a B-O B-NP_NP_DT
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
homologs B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
biochemical B-O B-NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
cell B-O B-NP_NN
biological B-O B-JJ
" " B-O B-NP_O-NP
properties B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
HSFs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reveals B-O B-VP_VBZ
that B-O B-SBAR_IN
HSF3 B-O B-S_NP_NN
" " B-O O-NP
has B-O B-VP_VP_VBZ
properties B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
yet B-O B-ADVP_RB
" " B-O O-ADVP
has B-O B-VP_VBZ
features B-O B-NP_NP_NNS
" " B-O O-NP
which B-O B-WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
" " B-O B-ADJP_O-S
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HSF3 B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
erythroblast B-O B-NP_NN
cell B-O B-NN
line B-O B-NN
HD6 B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
lymphoblast B-O B-NP_NN
cell B-O B-NN
line B-O B-NN
MSB B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
embryo B-O B-NP_NN
fibroblasts B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
yet B-O B-S_ADVP_RB
" " B-O O-ADVP
its B-O B-NP_PRPP
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
induced B-O B-VP_VBN
only B-O B-NP_ADVP_RB
" " B-O O-ADVP
upon B-O B-PP_IN
exposure B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HD6 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
heat B-O B-NP_NN
shock B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Acquisition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HSF3 B-O B-NP_NP_NN
" " B-O O-NP
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
HD6 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
oligomerization B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
a B-O B-NP_DT
non-DNA-binding B-O B-NP_JJ
dimer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_DT
DNA-binding B-O B-NP_JJ
trimer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
whereas B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
heat B-O B-NP_NN
shock B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
HSF1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
oligomerization B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
inert B-O B-NP_JJ
monomer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_DT
DNA-binding B-O B-NP_JJ
trimer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HSF3 B-O B-NP_NP_NN
" " B-O O-NP
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
delayed B-O B-VP_VBN
compared B-O B-NP_PP_VBN
with B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
HSF1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_SBAR_IN
occurs B-O B-S_NP_VP_VBZ
for B-O B-PP_IN
HSF1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
heat B-O B-S_NP_NN
shock B-O B-NN
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HSF3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
HSF B-O B-S_NP_NN
" " B-O O-NP
exhibits B-O B-VP_VBZ
the B-O B-NP_NP_DT
properties B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
transcriptional B-O B-NP_JJ
activator B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_SBAR_IN
judged B-O B-S_NP_VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_NP_DT
stimulatory B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
as B-O B-SBAR_IN
independently B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
assayed B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
reveal B-O B-VP_VBP
that B-O B-SBAR_IN
HSF3 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
negatively B-O B-ADVP_RB
" " B-O O-ADVP
regulated B-O B-VP_VBN
in B-O B-NP_PP_IN
avian B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
acquires B-O B-VP_VBZ
DNA-binding B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
certain B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_IN
heat B-O B-NP_NN
shock B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
N- B-O B-S_S_NP_NN
and B-O B-CC
C-terminal B-O B-JJ
sequences B-O B-NNS
" " B-O O-NP
control B-O B-VP_VBP
degradation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
MAD3/I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
inducers B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
activity B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
proteolytic B-O B-JJ
degradation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
inhibitory B-O B-NP_NP_JJ
protein B-O B-NN
" " B-O O-NP
MAD3/I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
extracellular B-O B-NP_JJ
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
prerequisite B-O B-JJ
step B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NP_NP_NN
factor B-O B-NN
" " B-O O-NP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
stable B-O B-NP_NP_JJ
transfectants B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
mouse B-O B-NP_NN
70Z/3 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
shows B-O B-VP_VBZ
that B-O B-SBAR_IN
, B-O B-COMMA
as B-O B-PP_IN
for B-O B-PP_IN
the B-O B-NP_DT
endogenous B-O B-JJ
murine B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
exogenous B-O B-S_NP_JJ
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
degraded B-O B-VP_VBN
in B-O B-NP_PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
pretreatment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
proteasome B-O B-NP_NP_NP_JJ
" " B-O O-NP
inhibitor B-O B-NN
" " B-O O-NP
N-Ac-Leu-Leu-norleucinal B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibits B-O B-VP_VP_VBZ
this B-O B-NP_DT
ligand-induced B-O B-JJ
degradation B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
, B-O B-COMMA
in B-O B-PP_IN
agreement B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
previous B-O B-NP_JJ
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
stabilizes B-O B-VP_VBZ
a B-O B-NP_NP_DT
hyperphosphorylated B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
expressing B-O B-S_NP_VP_VBG
mutant B-O B-NP_NP_JJ
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
cell B-O B-NP_NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
delineate B-O B-VP_VB
the B-O B-NP_NP_DT
sequences B-O B-NNS
" " B-O O-NP
responsible B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
deletion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
C B-O B-NP_NN
terminus B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
molecule B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
up B-O B-PP_RB
to B-O B-TO
amino B-O B-NP_NN
acid B-O B-NN
279 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
abolishes B-O B-VP_VP_VBZ
constitutive B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
but B-O B-CC
not B-O B-NP_ADJP_RB
ligand-inducible B-O B-JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
phosphorylation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
inhibits B-O B-VP_VBZ
ligand-inducible B-O B-NP_JJ
degradation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_NP_JJ
analysis B-O B-NN
" " B-O O-NP
reveals B-O B-VP_VBZ
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_NP_DT
inducible B-O B-JJ
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
maps B-O B-VP_VBZ
to B-O B-PP_TO
two B-O B-NP_NP_CD
serines B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
( B-O B-NP_PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
mutation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_DT
residue B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
sufficient B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
abolish B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
, B-O B-COMMA
whereas B-O B-SBAR_IN
both B-O B-S_NP_DT
residues B-O B-NNS
must B-O B-VP_MD
be B-O B-VP_VB
mutated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
to B-O B-S_NP_VP_TO
abolish B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
A B-O B-NP_NP_NP_DT
central B-O B-JJ
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
a B-O B-NP_NP_DT
single B-O B-NP_JJ
c-Myb B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
thymic B-O B-NP_JJ
locus B-O B-NN
control B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Locus B-O B-S_S_NP_NP_NN
control B-O B-NN
regions B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
LCRs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
are B-O B-VP_VBP
powerful B-O B-NP_NP_JJ
assemblies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
cis B-O B-NP_NP_JJ
elements B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
organize B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_NP_NP_NP_DT
2.3-kb B-O B-NP_JJ
LCR B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
adenosine B-O B-NN
deaminase B-O B-NN
( B-O B-LRB
ADA B-O B-NN
) B-O B-RRB
gene B-O B-NN
first B-O B-JJ
intron B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
controls B-O B-S_NP_VP_VBZ
expression B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
thymocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
composed B-O B-VP_VBN
of B-O B-NP_PP_IN
a B-O B-NP_NP_NP_DT
200-bp B-O B-NP_JJ
enhancer B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
extended B-O B-NP_JJ
flanking B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
facilitate B-O B-S_NP_VP_VBP
activation B-O B-NP_NN
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Prior B-O B-S_NP_RB
analyses B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_DT
enhancer B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_NP_DT
28-bp B-O B-NP_JJ
core B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
local B-O B-NP_ADJP_JJ
adjacent B-O B-JJ
augmentative B-O B-JJ
" " B-O O-ADJP
cis B-O B-NP_JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
now B-O B-ADVP_RB
" " B-O O-ADVP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
core B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_DT
single B-O B-JJ
critical B-O B-JJ
c-Myb B-O B-NP_NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
both B-O B-NP_CC
transiently B-O B-NP_RB
cotransfected B-O B-VBN
human B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
stable B-O B-NP_JJ
chromatin-integrated B-O B-NP_JJ
yeast B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
c-Myb B-O B-NP_NN
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
transactivated B-O B-VP_VBD
reporter B-O B-NP_NP_NN
constructs B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contained B-O B-S_NP_VP_VBD
polymerized B-O B-NP_JJ
core B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
c-Myb B-O B-S_NP_NN
protein B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
strongly B-O B-ADJP_RB
evident B-O B-JJ
in B-O B-PP_IN
T B-O B-NP_NP_NN
lymphoblasts B-O B-NNS
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
the B-O B-S_NP_DT
enhancer B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VP_VBD
and B-O B-ADJP_CC
was B-O B-VP_VBD
" " B-O B-ADJP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Fetal B-O B-S_NP_JJ
murine B-O B-NN
thymus B-O B-NN
" " B-O O-NP
exhibited B-O B-VP_VBD
a B-O B-NP_NP_DT
striking B-O B-JJ
concordance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
endogenous B-O B-NP_JJ
c-myb B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
that B-O B-NP_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
mouse B-O B-NP_NN
ADA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
human B-O B-NP_JJ
ADA B-O B-NN
LCR-directed B-O B-JJ
transgene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Point B-O B-S_NP_NP_NN
mutation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
c-Myb B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_DT
intact B-O B-JJ
2.3-kb B-O B-NP_JJ
LCR B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
severely B-O B-ADVP_RB
" " B-O O-ADVP
attenuated B-O B-VP_VBD
enhancer B-O B-NP_NP_NP_NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
transfections B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
LCR B-O B-NP_NP_NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
transgenic B-O B-NP_JJ
thymocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Within B-O B-S_PP_IN
the B-O B-NP_NP_DT
context B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
complex B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
LCR B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
c-Myb B-O B-NP_NN
" " B-O O-NP
can B-O B-VP_MD
act B-O B-VP_VB
as B-O B-PP_IN
an B-O B-NP_NP_DT
organizer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
thymocyte-specific B-O B-NP_NP_JJ
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
via B-O B-PP_IN
a B-O B-NP_DT
single B-O B-JJ
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcriptional B-O B-NP_NP_NP_NP_JJ
repression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
interleukin-2 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
vitamin B-O B-NP_NN
D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
direct B-O B-NP_NP_JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFATp B-O B-NP_NP_NN
/AP-1 B-O B-NN
complex B-O B-JJ
" " B-O O-NP
formation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
a B-O B-NP_DT
nuclear B-O B-NP_JJ
hormone B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
T-lymphocyte B-O B-S_S_NP_NN
proliferation B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
suppressed B-O B-VP_VBN
by B-O B-NP_PP_IN
1,25-dihydroxyvitamin B-O B-NP_NP_NN
D3 B-O B-NN
[ B-O B-LRB
1,25(OH)2D3 B-O B-NN
] B-O B-RRB
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
active B-O B-JJ
metabolite B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
1,25(OH)2D3-mediated B-O B-S_NP_NP_JJ
repression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
cycloheximide B-O B-ADJP_NN
resistant B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
examined B-O B-VP_VBD
vitamin B-O B-NP_NP_NN
D3-mediated B-O B-JJ
repression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
IL-2 B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_PP_IN
cotransfecting B-O B-S_NP_VP_VBG
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
promoter B-O B-NN
/reporter B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
and B-O B-CC
a B-O B-NP_DT
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
and B-O B-CC
by B-O B-PP_IN
DNA B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
delineated B-O B-VP_VBD
an B-O B-NP_NP_DT
element B-O B-NN
" " B-O O-NP
conferring B-O B-VP_VBG
both B-O B-NP_NP_CC
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
the B-O B-NP_NP_NP_DT
receptor B-O B-NN
" " B-O O-NP
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
" " B-O O-NP
and B-O B-CC
1,25(OH)2D3-mediated B-O B-NP_NP_JJ
repression B-O B-NN
" " B-O O-NP
in B-O B-ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_NP_DT
short B-O B-JJ
40-bp B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
encompassing B-O B-VP_VBG
, B-O B-NP_NP_NP_COMMA
, B-O B-NP_COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
VDR B-O B-S_S_NP_NN
DNA-binding B-O B-JJ
mutants B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
unable B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
either B-O B-VP_RB
bind B-O B-VP_VB
to B-O B-PP_TO
" " B-O B-NP_ADVP_O-VP
or B-O B-CC
repress B-O B-VP_VB
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
the B-O B-S_NP_NP_DT
VDR B-O B-NP_NN
DNA-binding B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
" " B-O O-NP
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
bound B-O B-VP_VP_VBD
the B-O B-NP_DT
element B-O B-NN
" " B-O O-NP
" " B-O O-VP
but B-O B-CC
also B-O B-ADVP_RB
" " B-O O-ADVP
could B-O B-VP_MD
not B-O B-RB
repress B-O B-VP_VB
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
DNA B-O B-S_NP_NP_NN
binding B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
VDR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
necessary B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
but B-O B-CC
not B-O B-ADJP_RB
sufficient B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
mediate B-O B-VP_VB
repression B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
combining B-O B-S_NP_VP_VBG
partially B-O B-NP_RB
purified B-O B-VBN
proteins B-O B-NNS
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
the B-O B-NP_NP_DT
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
bound B-O B-VBN
NFATp B-O B-NP_NN
/AP-1-DNA B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_IN
inclusion B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
VDR B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
VDR-retinoid B-O B-NP_NN
X B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Order B-O B-S_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-NP_O-NP
and B-O B-CC
off-rate B-O B-NP_JJ
" " B-O B-NP_O-NP
experiments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
VDR-retinoid B-O B-NP_NN
X B-O B-NN
receptor B-O B-NN
heterodimer B-O B-NN
" " B-O O-NP
" " B-O O-NP
blocks B-O B-VP_VP_VBZ
NFATp B-O B-NP_NP_NN
/AP-1 B-O B-NN
complex B-O B-NN
" " B-O O-NP
formation B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
then B-O B-ADVP_RB
" " B-O O-ADVP
stably B-O B-ADVP_RB
" " B-O O-ADVP
associates B-O B-VP_VBZ
with B-O B-PP_IN
the B-O B-NP_DT
NF-AT-1 B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
direct B-O B-JJ
inhibition B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
a B-O B-NP_NP_DT
nuclear B-O B-JJ
hormone B-O B-NN
receptor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
activators B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
provide B-O B-VP_VB
a B-O B-NP_NP_DT
mechanistic B-O B-JJ
explanation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
how B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
vitamin B-O B-S_NP_NN
derivatives B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
act B-O B-VP_VB
" " B-O B-PP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
PU.1 B-O B-S_S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
Spi-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
C/EBP B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
regulate B-O B-VP_VBP
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
granulocyte-macrophage B-O B-NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
receptor B-O B-NN
alpha B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Growth B-O B-S_S_NP_NN
factor B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
play B-O B-VP_VBP
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
hematopoiesis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_SBAR_IN
order B-O B-NN
to B-O B-S_NP_VP_TO
further B-O B-ADVP_RB
" " B-O O-ADVP
understand B-O B-VP_VB
the B-O B-NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
directing B-O B-VP_VBG
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
initiated B-O B-VP_VBD
a B-O B-NP_NP_DT
study B-O B-NN
" " B-O O-NP
investigating B-O B-VP_VBG
the B-O B-NP_NP_DT
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
activating B-O B-VP_VBG
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
human B-O B-NP_JJ
GM-CSF B-O B-NN
receptor B-O B-NN
alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
directs B-O B-VP_VBZ
reporter B-O B-NP_NP_NN
gene B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
tissue-specific B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
myelomonocytic B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
GM-CSF B-O B-NP_NN
receptor B-O B-NN
alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
contains B-O B-VP_VBZ
an B-O B-NP_NP_DT
important B-O B-JJ
functional B-O B-JJ
site B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
positions B-O B-NP_NNS
-53 B-O B-QP_CD
and B-O B-CC
-41 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-SBAR_IN
identified B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
deletion B-O B-NP_NP_NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
reporter B-O B-NP_NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
myeloid B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
B B-O B-NP_NN
cell B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
PU.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
binds B-O B-VP_VBZ
specifically B-O B-PP_ADVP_RB
" " B-O O-ADVP
to B-O B-TO
this B-O B-NP_DT
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
CCAAT B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
located B-O B-ADJP_JJ
upstream B-O B-ADVP_RB
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADVP
" " B-O O-ADJP
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
positive-negative B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
C/EBP B-O B-S_NP_NN
alpha B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
major B-O B-JJ
CCAAT/enhancer-binding B-O B-NP_NP_JJ
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
C/EBP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
form B-O B-NN
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
this B-O B-NP_DT
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Point B-O B-S_NP_NP_NN
mutations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_NP_CC
the B-O B-NP_DT
PU.1 B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
or B-O B-CC
the B-O B-NP_DT
C/EBP B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
abolish B-O B-S_NP_VP_VBP
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
result B-O B-VP_VBP
in B-O B-PP_IN
a B-O B-NP_NP_DT
significant B-O B-JJ
decrease B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GM-CSF B-O B-NP_NP_NN
receptor B-O B-NN
alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
myelomonocytic B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
only B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
in B-O B-S_PP_IN
myeloid B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
B B-O B-NP_NN
" " B-O B-NP_O-NP
cell B-O B-NP_NN
extracts B-O B-VBZ
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
PU.1 B-O B-NP_NN
" " B-O O-NP
forms B-O B-VP_VBZ
a B-O B-NP_NP_DT
novel B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
specific B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
more B-O B-ADJP_RBR
slowly B-O B-RB
migrating B-O B-VBG
" " B-O O-ADJP
" " B-O O-ADJP
complex B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PU-SF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
binding B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_NP_ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
first B-O B-JJ
demonstration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
specific B-O B-JJ
interaction B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
PU.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
a B-O B-NP_DT
myeloid B-O B-NP_JJ
PU.1 B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
novel B-O B-JJ
complex B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
distinct B-O B-ADJP_JJ
from B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
described B-O B-VP_VBN
previously B-O B-NP_ADVP_RB
" " B-O O-ADVP
as B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
can B-O B-VP_MD
be B-O B-VP_VB
formed B-O B-VP_VBN
by B-O B-NP_PP_IN
addition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
PU.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-UCP_SBAR_IN
the B-O B-S_NP_DT
PU-SF B-O B-NP_NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
sites B-O B-NP_NP_NP_NNS
" " B-O O-NP
found B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
its B-O B-COMP_S_NP_PRPP
formation B-O B-NN
" " B-O O-NP
requires B-O B-VP_VBZ
an B-O B-NP_NP_DT
intact B-O B-JJ
PU.1 B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
adjacent B-O B-ADJP_JJ
to B-O B-PP_TO
a B-O B-NP_DT
single-stranded B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
PU.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
nonmyeloid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
activate B-O B-VP_VB
the B-O B-NP_DT
GM-CSF B-O B-NP_NN
receptor B-O B-NN
alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
amino-terminal B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
PU.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_PP_IN
a B-O B-NP_NP_DT
failure B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
form B-O B-VP_VB
the B-O B-NP_DT
complex B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
a B-O B-NP_NP_DT
concomitant B-O B-JJ
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transactivation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
formation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
is B-O B-VP_VBZ
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
C/EBP B-O B-S_NP_NN
alpha B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
active B-O B-VP_JJ
the B-O B-NP_DT
GM-CSF B-O B-NP_NN
receptor B-O B-NN
alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
nonmyeloid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
400 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
An B-O B-S_S_NP_DT
interferon-gamma B-O B-NP_NN
activation B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
mediates B-O B-VP_VBZ
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IgG B-O B-NP_NN
Fc B-O B-NN
receptor B-O B-NN
type B-O B-NN
IC B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
interferon-gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Expression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IgG B-O B-NP_NP_NN
Fc B-O B-NN
receptor B-O B-NN
type B-O B-NN
I B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
Fc B-O B-NP_NN
gamma B-O B-NN
RI B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
myeloid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
dramatically B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBN
by B-O B-NP_PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
interferon-gamma B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
that B-O B-SBAR_IN
Fc B-O B-S_NP_NP_NP_NN
gamma B-O B-NN
RI B-O B-NN
" " B-O O-NP
transcript B-O B-NN
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
monoblast-like B-O B-NP_JJ
U937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VP_VBD
elevated B-O B-VP_VBN
within B-O B-NP_PP_IN
3 B-O B-NP_CD
hr B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
peaked B-O B-VP_VBD
12 B-O B-PP_NP_CD
hr B-O B-NN
" " B-O O-NP
after B-O B-IN
exposure B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
U937 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
IFN-gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
9 B-O B-NP_CD
hr B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cycloheximide B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
led B-O B-VP_VBD
to B-O B-PP_TO
super-induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Fc B-O B-NP_NP_NN
gamma B-O B-NN
RI B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_JJ
run-on B-O B-JJ
analysis B-O B-NN
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Fc B-O B-NP_NP_NN
gamma B-O B-NN
RI B-O B-NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
increased B-O B-VP_VBN
by B-O B-NP_PP_IN
IFN-gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Genomic B-O B-S_NP_NP_JJ
sequence B-O B-NN
" " B-O O-NP
upstream B-O B-ADVP_JJ
of B-O B-PP_IN
the B-O B-NP_DT
Fc B-O B-NP_NN
gamma B-O B-NN
RIC B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-NP
was B-O B-VP_VBD
cloned B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
subjected B-O B-VP_VBN
to B-O B-NP_PP_TO
primer B-O B-NP_NP_NN
extension B-O B-NN
analysis B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
demonstrated B-O B-S_NP_VP_VBD
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transient B-O B-S_NP_NP_JJ
transfections B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
CAT B-O B-NP_NP_NN
reporter B-O B-NN
gene B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
containing B-O B-VP_VBG
various B-O B-NP_JJ
Fc B-O B-NP_NN
gamma B-O B-NN
RIC B-O B-NN
promoter B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_SBAR_IN
a B-O B-S_NP_NP_DT
20-bp B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
surrounding B-O B-VP_VBG
the B-O B-NP_NP_DT
( B-O B-NP_PRN_LRB
) B-O B-QP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
capable B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
an B-O B-S_NP_DT
IFN-gamma B-O B-NP_NP_NN
responsive B-O B-JJ
element B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GIRE B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
present B-O B-ADJP_JJ
within B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
17-bp B-O B-NP_JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
between B-O B-PP_IN
positions B-O B-NP_NNS
-51 B-O B-QP_CD
and B-O B-CC
-35 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
conferred B-O B-VP_VBD
IFN-gamma B-O B-NP_NP_NN
" " B-O O-NP
responsiveness B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
a B-O B-NP_DT
heterologous B-O B-NP_JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Double-stranded B-O B-S_NP_NP_JJ
GIRE B-O B-NN
sequence B-O B-NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
a B-O B-NP_DT
scrambled B-O B-NP_VBN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
specifically B-O B-ADVP_RB
" " B-O O-ADVP
bound B-O B-VP_VBN
by B-O B-NP_PP_IN
nuclear B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
IFN-gamma B-O B-NP_NN
treated B-O B-JJ
U937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Gel B-O B-S_NP_NN
shift B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
STAT1 B-O B-NP_NN
alpha B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
bound B-O B-VP_VBD
to B-O B-PP_TO
the B-O B-NP_DT
Fc B-O B-NP_NN
gamma B-O B-NN
RIC B-O B-NN
GIRE B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
Fc B-O B-NP_NN
gamma B-O B-NN
RIC B-O B-NN
GIRE B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
homologous B-O B-ADJP_JJ
to B-O B-PP_PP_TO
the B-O B-NP_NP_DT
IFN-gamma B-O B-NP_NP_NN
activation B-O B-NN
sequence B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
guanylate B-O B-NP_NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
to B-O B-PP_TO
X B-O B-NP_NP_NN
box B-O B-NN
elements B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
class B-O B-NP_NN
II B-O B-CD
MHC B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
transcriptional B-O B-S_NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Fc B-O B-NP_NN
gamma B-O B-NN
RIC B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
IFN-gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involves B-O B-VP_VBZ
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
STAT1 B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_NP_DT
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Immunosuppression B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
[ B-O B-S_LRB
see B-O B-NP_VP_VB
comments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-NP
" " B-O O-NP
  
Glucocorticoids B-O B-S_S_NP_NNS
" " B-O O-NP
are B-O B-VP_VBP
among B-O B-PP_IN
the B-O B-NP_DT
most B-O B-ADJP_RBS
potent B-O B-JJ
" " B-O O-ADJP
anti-inflammatory B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
immunosuppressive B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
They B-O B-S_S_NP_PRP
" " B-O O-NP
inhibit B-O B-VP_VBP
synthesis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_PP_IN
almost B-O B-NP_ADJP_RB
all B-O B-DT
known B-O B-JJ
" " B-O O-ADJP
cytokines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
of B-O B-PP_IN
several B-O B-NP_NP_JJ
cell B-O B-NP_NN
surface B-O B-NN
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-NP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
the B-O B-S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
underlying B-O B-VP_VBG
this B-O B-NP_DT
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
unclear B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
it B-O B-NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
shown B-O B-VP_VBN
that B-O B-SBAR_IN
glucocorticoids B-O B-S_NP_NNS
" " B-O O-NP
are B-O B-VP_VBP
potent B-O B-NP_NP_JJ
inhibitors B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
mice B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
cultured B-O B-NP_VBN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
inhibition B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
alpha B-O B-NN
inhibitory B-O B-JJ
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
activates B-O B-VP_VBZ
many B-O B-NP_JJ
immunoregulatory B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
pro-inflammatory B-O B-NP_JJ
stimuli B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_PRPP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
a B-O B-NP_NP_DT
major B-O B-JJ
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
anti-inflammatory B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Pathogenesis B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
atherosclerosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
earliest B-O B-JJS
lesion B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
development B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
atherosclerotic B-O B-JJ
plaque B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_DT
fatty B-O B-JJ
streak B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_NP_DT
chronic B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
inflammatory B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
reaction B-O B-NN
" " B-O O-NP
results B-O B-VP_VBZ
from B-O B-PP_IN
a B-O B-NP_NP_DT
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
events B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
begins B-O B-S_NP_VP_VBZ
with B-O B-PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
trapped B-O B-VBN
LDL B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
seeded B-O B-VP_VBN
with B-O B-NP_PP_IN
oxidative B-O B-NP_NP_JJ
species B-O B-NNS
" " B-O O-NP
released B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
overlying B-O B-VBG
endothelium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
lipid B-O B-S_NP_NN
oxidation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
initiated B-O B-VP_VBN
within B-O B-NP_PP_IN
the B-O B-NP_DT
LDL B-O B-NN
particle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Some B-O B-S_NP_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
lipids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
result B-O B-S_NP_VP_VBP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
lead B-O B-VP_VBP
to B-O B-PP_TO
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFkB-like B-O B-NP_NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
cause B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
At B-O B-S_NP_QP_IN
least B-O B-JJS
1 B-O B-CD
" " B-O O-QP
major B-O B-NP_JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
modulates B-O B-VP_VBZ
the B-O B-NP_NP_NP_DT
oxidation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LDL B-O B-NP_NN
lipids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and/or B-O B-CC
the B-O B-NP_NP_DT
biologic B-O B-JJ
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
these B-O B-NP_DT
lipids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
inverse B-O B-JJ
relation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
high B-O B-NP_NP_NP_JJ
density B-O B-NN
lipoprotein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HDL B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
atherosclerotic B-O B-NP_JJ
events B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
in B-O B-PP_IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
be B-O B-VP_VB
due B-O B-ADJP_JJ
to B-O B-PP_TO
enzymes B-O B-NP_NP_NNS
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
HDL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
destroy B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
HMG-I B-O B-S_S_S_NP_NN
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
GATA B-O B-NP_NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
implications B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
an B-O B-NP_DT
HPFH B-O B-NN
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
nuclear B-O B-NP_NP_JJ
protein B-O B-NN
" " B-O O-NP
HMG-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
human B-O B-NP_JJ
gamma-globin B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
find B-O B-VP_VBP
that B-O B-SBAR_IN
HMG-I B-O B-S_NP_NN
" " B-O O-NP
binds B-O B-VP_VBZ
preferentially B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
the B-O B-NP_NP_DT
more B-O B-JJR
3' B-O B-JJ
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
this B-O B-S_NP_DT
paired B-O B-JJ
motif B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
bound B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
erythroid B-O B-NP_JJ
factor B-O B-NN
GATA-1 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_S_NP_NP_NP_DT
naturally B-O B-ADJP_RB
occurring B-O B-VBG
" " B-O O-ADJP
mutation B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
-175 B-O B-NP_CD
T-C B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
area B-O B-NN
" " B-O O-NP
" " B-O O-PP
bound B-O B-VP_VBN
by B-O B-NP_PP_IN
HMG-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
overexpression B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
gamma-globin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
adult B-O B-NP_NP_JJ
red B-O B-JJ
blood B-O B-NN
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
up-regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
gamma-globin B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
in B-O B-NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
expression B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
HMG-I B-O B-S_NP_NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
bind B-O B-VP_VB
to B-O B-PP_TO
this B-O B-NP_DT
mutant B-O B-NP_JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
survey B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GATA B-O B-NP_NP_NN
motifs B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
other B-O B-NP_JJ
globin B-O B-NP_NN
cis-elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrates B-O B-VP_VBZ
HMG-I B-O B-NP_NP_NP_NN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
most B-O B-NP_NP_JJS
" " B-O O-NP
of B-O B-PP_IN
them B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_S_NP_DT
findings B-O B-NNS
" " B-O O-NP
implicate B-O B-VP_VBP
HMG-I B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
HPFH B-O B-NP_NN
" " B-O O-NP
phenotype B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
we B-O B-S_NP_PRP
" " B-O O-NP
speculate B-O B-VP_VBP
that B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
may B-O B-VP_MD
participate B-O B-VP_VB
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Expression B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
nucleoside B-O B-NP_NN
diphosphate B-O B-NN
kinase B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
skin B-O B-NN
cancers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
an B-O B-NP_DT
immunohistochemical B-O B-JJ
study B-O B-NN
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Expression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
nucleoside B-O B-NP_NP_NN
diphosphate B-O B-NN
( B-O B-LRB
NDP B-O B-NN
) B-O B-RRB
kinase B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
homologous B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
inversely B-O B-ADVP_RB
" " B-O O-ADVP
associated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
relationship B-O B-NN
" " B-O O-NP
remains B-O B-VP_VBZ
controversial B-O B-ADJP_JJ
according B-O B-PP_VBG
to B-O B-PP_TO
the B-O B-NP_DT
tumor B-O B-NP_NN
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
and B-O B-CC
experimental B-O B-NP_JJ
system B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
with B-O B-PP_IN
conflicting B-O B-NP_NP_VBG
results B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
different B-O B-NP_JJ
research B-O B-NN
groups B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_SBAR_IN
order B-O B-NN
to B-O B-S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
NDP B-O B-S_NP_NP_NN
kinase B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
serves B-O B-VP_VBZ
as B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
assessed B-O B-VP_VBD
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
NDP B-O B-NP_NP_NP_NN
kinase B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
9 B-O B-NP_NP_CD
, B-O B-NP_COMMA
26 B-O B-NP_CD
, B-O B-NP_COMMA
and B-O B-CC
25 B-O B-NP_CD
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
using B-O B-S_NP_VP_VBG
immunohistochemistry B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NDP B-O B-NP_NN
kinase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
intense B-O B-ADJP_JJ
in B-O B-PP_IN
KA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
SCC B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
compared B-O B-PP_VBN
with B-O B-PP_IN
BCC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
difference B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NDP B-O B-NP_NP_NN
kinase B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
between B-O B-PP_IN
KA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
SCC B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
statistically B-O B-ADJP_RB
significant B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
And B-O B-S_CC
there B-O B-NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_NP_DT
statistically B-O B-ADJP_RB
significant B-O B-JJ
" " B-O O-ADJP
difference B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
NDP B-O B-NP_NP_NN
kinase B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
between B-O B-PP_IN
SCC B-O B-NP_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
metastasis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
SCC B-O B-NP_NP_NN
" " B-O O-NP
without B-O B-PP_IN
metastasis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
contradict B-O B-VP_VBP
the B-O B-NP_NP_DT
hypothesis B-O B-NN
" " B-O O-NP
concerning B-O B-PP_VBG
the B-O B-NP_NP_DT
possible B-O B-JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nm23 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_NP_DT
metastatic B-O B-JJ
suppressor B-O B-NN
gene B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
skin B-O B-NN
cancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
overexpression B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
various B-O B-NP_JJ
tumor B-O B-NP_NN
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
its B-O B-NP_NP_PRPP
biological B-O B-JJ
significance B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cutaneous B-O B-NP_JJ
carcinogenesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
remain B-O B-VP_VB
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
determined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cloning B-O B-S_S_NP_VP_VBG
a B-O B-NP_DT
cDNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
human B-O B-NP_NP_JJ
NK/T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
codes B-O B-S_NP_VP_VBZ
for B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_S_NP_DT
cDNA B-O B-NP_NP_NN
clone B-O B-NN
" " B-O O-NP
, B-O B-COMMA
B4-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
a B-O B-NP_DT
natural B-O B-NP_JJ
killer B-O B-NN
( B-O B-LRB
NK B-O B-NN
) B-O B-RRB
minus B-O B-CC
T B-O B-NN
cell B-O B-NN
subtractive B-O B-JJ
library B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
B4-2 B-O B-NP_NN
" " B-O O-NP
clone B-O B-NN
" " B-O O-NP
coded B-O B-VP_VBD
for B-O B-PP_IN
an B-O B-NP_NP_DT
mRNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
2061 B-O B-NP_NP_CD
bp B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
length B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
encodes B-O B-VP_VBZ
a B-O B-NP_NP_DT
deduced B-O B-VBN
327 B-O B-NP_CD
aa B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
calculated B-O B-VBN
molecular B-O B-JJ
mass B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
35.2 B-O B-NP_CD
kDa B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Searching B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
B4-2 B-O B-NP_NP_NN
DNA B-O B-NN
" " B-O O-NP
and B-O B-CC
protein B-O B-NP_NN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
against B-O B-PP_IN
various B-O B-NP_JJ
databases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
no B-O B-NP_NP_DT
high B-O B-JJ
homology B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
other B-O B-NP_JJ
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
B4-2 B-O B-NP_NN
" " B-O O-NP
has B-O B-VP_VP_VBZ
an B-O B-NP_NP_DT
unusually B-O B-ADJP_RB
high B-O B-JJ
" " B-O O-ADJP
proline B-O B-NN
content B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
13 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
contains B-O B-VP_VBZ
a B-O B-NP_DT
putative B-O B-JJ
nuclear B-O B-NP_JJ
targeting B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
has B-O B-VP_VBZ
several B-O B-NP_NP_JJ
SPXX B-O B-NP_NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
frequently B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
stretches B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
prolines B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
B4-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
closely B-O B-ADVP_RB
" " B-O O-ADVP
resembles B-O B-VP_VBZ
the B-O B-NP_NP_DT
ligand B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
proteins B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
SH3 B-O B-NP_NN
domains B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_NP_NN
hybridization B-O B-NN
data B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
B4-2 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
not B-O B-RB
a B-O B-NP_DT
lymphoid B-O B-NP_JJ
specific B-O B-JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
expressed B-O B-UCP_VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
and B-O B-CC
also B-O B-ADVP_RB
" " B-O O-ADVP
transcribed B-O B-UCP_VP_ADVP_VBN
" " B-O B-NP_O-VP
or B-O B-CC
absent B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
" " B-O B-NP_O-UCP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
polyclonal B-O B-JJ
antiserum B-O B-NN
" " B-O O-NP
raised B-O B-VP_VBN
against B-O B-NP_PP_IN
recombinant B-O B-NP_JJ
B4-2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
recognizes B-O B-VP_VBZ
a B-O B-NP_DT
32-34 B-O B-NP_CD
kDa B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
IFN-gamma B-O B-S_S_NP_NP_NP_NN
" " B-O O-NP
priming B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
enhances B-O B-VP_VBZ
LPS-induced B-O B-NP_JJ
TNF B-O B-NP_NN
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
augmenting B-O B-S_NP_VP_VBG
both B-O B-NP_CC
transcription B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
MRNA B-O B-NP_NN
stability B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
monocytes/macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
bacterial B-O B-NP_NP_JJ
endotoxin B-O B-NN
" " B-O O-NP
or B-O B-CC
lipopolysaccharide B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
critical B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
highly B-O B-ADJP_RB
regulated B-O B-VBN
" " B-O O-ADJP
" " B-O O-ADJP
host B-O B-NN
defence B-O B-NN
response B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
augmentation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LPS B-O B-NP_NN
responses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
interferon B-O B-NP_NP_NN
gamma B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IFN-gamma B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
referred B-O B-VP_VBN
to B-O B-PP_TO
" " B-O B-NP_O-PP
as B-O B-PP_IN
priming B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
well B-O B-ADVP_RB
" " B-O O-ADVP
established B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
mechanism B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
priming B-O B-S_NP_NN
" " B-O O-NP
occurs B-O B-VP_VBZ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
poorly B-O B-ADVP_RB
" " B-O O-ADVP
defined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
tumour B-O B-NP_NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TNF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_DT
model B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
experiments B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
designed B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
analyse B-O B-VP_VB
in B-O B-PP_IN
detail B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
priming B-O B-NN
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Priming B-O B-S_NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
IFN-gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
primarily B-O B-ADVP_RB
" " B-O O-ADVP
manifested B-O B-VP_VBN
at B-O B-NP_PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TNF B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
accumulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IFN-gamma B-O B-S_NP_NP_NN
" " B-O O-NP
pre-treatment B-O B-NN
" " B-O O-NP
affected B-O B-VP_VBD
the B-O B-NP_NP_NP_DT
magnitude B-O B-NN
" " B-O O-NP
rather B-O B-CONJP_RB
than B-O B-IN
" " B-O O-CONJP
the B-O B-NP_DT
sensitivity B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
LPS B-O B-NN
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Priming B-O B-S_S_NP_NN
" " B-O O-NP
occurred B-O B-VP_VBD
after B-O B-PP_IN
several B-O B-NP_NP_JJ
hours B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
treatment B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_DT
primed B-O B-JJ
state B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
either B-O B-NP_CC
IFN-gamma B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
GM-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
M-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Primed B-O B-S_NP_VBN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
transcribed B-O B-VP_VBD
TNF B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
a B-O B-NP_NP_DT
higher B-O B-JJR
rate B-O B-NN
" " B-O O-NP
than B-O B-PP_IN
freshly B-O B-NP_ADJP_RB
isolated B-O B-VBN
" " B-O O-ADJP
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
increased B-O B-VBN
transcriptional B-O B-JJ
rate B-O B-NN
" " B-O O-NP
correlated B-O B-VP_VBD
with B-O B-PP_IN
a B-O B-NP_NP_DT
marked B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
nuclear B-O B-NP_NP_NP_JJ
factor-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
electrophoretic B-O B-NP_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
using B-O B-VP_VBG
a B-O B-NP_DT
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_DT
additional B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
significant B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
finding B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
than B-O B-SBAR_IN
TNF B-O B-S_NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
primed B-O B-NP_VBN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
much B-O B-ADJP_ADJP_ADJP_ADVP_RB
more B-O B-RBR
" " B-O O-ADVP
stable B-O B-JJ
" " B-O O-ADJP
than B-O B-PP_IN
in B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-ADJP
( B-O B-PRN_LRB
T1/2 B-O B-S_NP_NN
" " B-O O-NP
increased B-O B-VP_VBN
" " B-O B-NP_O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Consistent B-O B-S_ADVP_JJ
with B-O B-PP_IN
the B-O B-NP_DT
increased B-O B-VBN
mRNA B-O B-NP_NN
" " B-O O-NP
stability B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-S_NP_NP_DT
duration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mRNA B-O B-NP_NP_NN
" " B-O O-NP
accumulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
longer B-O B-ADJP_RBR
following B-O B-PP_VBG
LPS B-O B-NP_NP_NN
stimulation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
primed B-O B-NP_VBN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
in B-O B-PP_IN
addition B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
being B-O B-S_NP_VP_VBG
of B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
primed B-O B-NP_NP_VBN
" " B-O B-NP_O-NP
and B-O B-CC
unprimed B-O B-NP_JJ
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
possessed B-O B-VP_VBD
a B-O B-NP_NP_DT
differential B-O B-JJ
sensitivity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
kinase B-O B-NN
inhibitor B-O B-NN
H-89 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
H-89 B-O B-S_NP_NN
" " B-O O-NP
substantially B-O B-VP_ADVP_RB
" " B-O O-ADVP
suppressed B-O B-VP_VBD
LPS-induced B-O B-NP_NP_JJ
TNF B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
accumulation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
unprimed B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
had B-O B-VP_VBD
no B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
primed B-O B-NP_VBN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
following B-O B-PP_VBG
LPS B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
The B-O B-S_S_NP_DT
myeloid B-O B-NP_NP_JJ
zinc B-O B-NN
finger B-O B-NN
gene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
MZF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
regulates B-O B-VP_VBZ
the B-O B-NP_DT
CD34 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
MZF-1 B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
C2H2 B-O B-NP_NN
zinc B-O B-NN
finger B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
encoding B-O B-VP_VBG
a B-O B-NP_NP_DT
putative B-O B-NP_JJ
transcriptional B-O B-JJ
regulator B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
myeloid B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
MZF-1 B-O B-NP_NN
" " B-O O-NP
protein B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
13 B-O B-NP_NP_CD
C2H2 B-O B-NP_NN
zinc B-O B-NN
fingers B-O B-NNS
" " B-O O-NP
" " B-O O-NP
arranged B-O B-VP_VBN
in B-O B-NP_PP_IN
bipartite B-O B-NP_NP_JJ
DNA B-O B-NP_NN
binding B-O B-NN
domains B-O B-NNS
" " B-O O-NP
" " B-O O-NP
containing B-O B-VP_VBG
and B-O B-NP_NP_NP_PP_CC
, B-O B-COMMA
in B-O B-PP_IN
, B-O B-NP_COMMA
" " B-O B-NP_NP_PP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
previously B-O B-ADVP_RB
" " B-O O-ADVP
identified B-O B-VP_VBD
the B-O B-NP_NP_DT
DNA B-O B-NP_NN
consensus B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
two B-O B-CD
DNA B-O B-NP_NN
binding B-O B-NN
domains B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
assess B-O B-VP_VB
the B-O B-NP_NP_DT
transcription B-O B-NN
regulatory B-O B-JJ
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
MZF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
the B-O B-S_NP_DT
full-length B-O B-JJ
MZF-1 B-O B-NP_NN
" " B-O O-NP
coding B-O B-NN
region B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
fused B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
DNA B-O B-NP_NN
binding B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
yeast B-O B-NP_NN
transactivator B-O B-NN
GAL4 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
expression B-O B-NN
vector B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
cotransfected B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
chloramphenicol B-O B-NP_NN
acetyl B-O B-NN
transferase B-O B-NN
( B-O B-LRB
CAT B-O B-NN
) B-O B-RRB
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
containing B-O B-NP_VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
NIH B-O B-NP_NP_NN
3T3 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
293 B-O B-NP_CD
" " B-O O-NP
, B-O B-COMMA
K562 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Jurkat B-O B-NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
MZF-1 B-O B-S_NP_NN
" " B-O O-NP
represses B-O B-VP_VBZ
CAT B-O B-NP_NP_NN
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
via B-O B-PP_IN
GAL4 B-O B-NP_NP_NP_NN
" " B-O O-NP
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
nonhematopoietic B-O B-NP_NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
NIH B-O B-NP_NP_NN
3T3 B-O B-NN
" " B-O O-NP
and B-O B-CC
293 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
MZF-1 B-O B-NP_NN
" " B-O O-NP
activates B-O B-VP_VBZ
CAT B-O B-NP_NP_NP_NN
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
hematopoietic B-O B-NP_NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
K562 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Jurkat B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
MZF-1 B-O B-NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
present B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_NP_DT
promoters B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_NP_JJ
genes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
expressed B-O B-VP_VBN
during B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
including B-O B-PP_VBG
the B-O B-NP_DT
CD34 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
MZF-1 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
transcriptional B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
physiologically B-O B-NP_RB
relevant B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
assessed B-O B-VP_VBN
in B-O B-NP_PP_IN
both B-O B-NP_CC
hematopoietic B-O B-NP_ADJP_NP_JJ
" " B-O O-NP
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
nonhematopoietic B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recombinant B-O B-S_NP_JJ
MZF-1 B-O B-NN
protein B-O B-NN
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
binds B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
consensus B-O B-NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
CD34 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
mobility B-O B-NP_NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
MZF-1 B-O B-S_NP_NP_NN
" " B-O O-NP
expression B-O B-NN
vectors B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
cotransfected B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
luciferase B-O B-NP_NN
reporter B-O B-NN
plasmids B-O B-NNS
" " B-O O-NP
" " B-O O-NP
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
CD34 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
both B-O B-NP_CC
nonhematopoietic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
hematopoietic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_PP_IN
with B-O B-PP_IN
the B-O B-NP_DT
heterologous B-O B-JJ
DNA B-O B-NP_NN
binding B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
MZF-1 B-O B-NP_NN
" " B-O O-NP
represses B-O B-VP_VP_VBZ
reporter B-O B-NP_NP_NP_NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
nonhematopoietic B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
activates B-O B-VP_VBZ
expression B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
hematopoietic B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD34 B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
hematopoietic B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
intact B-O B-NP_JJ
MZF-1 B-O B-NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
cell B-O B-NN
type-specific B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD34 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
MZF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggests B-O B-VP_VBZ
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tissue-specific B-O B-NP_NP_NP_JJ
regulators/adapters B-O B-NNS
" " B-O O-NP
or B-O B-CC
differential B-O B-NP_JJ
MZF-1 B-O B-NP_NN
" " B-O O-NP
modifications B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
determine B-O B-S_NP_VP_VBP
transcriptional B-O B-NP_NP_JJ
regulatory B-O B-JJ
function B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_DT
human B-O B-NP_JJ
TCF-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
encodes B-O B-VP_VBZ
a B-O B-NP_NP_DT
nuclear B-O B-NP_JJ
DNA-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
uniquely B-O B-VP_ADVP_RB
" " B-O O-ADVP
expressed B-O B-VBN
in B-O B-NP_PP_IN
normal B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
neoplastic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
T-lineage B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_DT
TCF-1 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
encodes B-O B-VP_VBZ
a B-O B-NP_NP_DT
putative B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
affinity B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
a B-O B-NP_NP_DT
sequence B-O B-NN
motif B-O B-NN
" " B-O O-NP
occurring B-O B-VP_VBG
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
TCF-1 B-O B-S_NP_NN
mRNA B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
originally B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_DT
T B-O B-NN
cell-specific B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
expression B-O B-NP_NN
" " B-O O-NP
reportedly B-O B-ADVP_RB
" " B-O O-ADVP
occurs B-O B-VP_VBZ
in B-O B-PP_IN
multiple B-O B-NP_JJ
nonlymphoid B-O B-JJ
tissues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
murine B-O B-NP_JJ
embryogenesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
now B-O B-ADVP_RB
" " B-O O-ADVP
raised B-O B-VP_VBN
a B-O B-NP_DT
monoclonal B-O B-NP_JJ
antibody B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
to B-O B-S_NP_VP_TO
document B-O B-VP_VB
expression B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
biochemistry B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
TCF-1 B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_SBAR_IN
expected B-O B-S_NP_VP_VBN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_DT
TCF-1 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
detectable B-O B-ADJP_JJ
only B-O B-PP_ADVP_RB
" " B-O O-ADVP
in B-O B-IN
cell B-O B-NP_NN
lines B-O B-NNS
of B-O B-IN
T B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Its B-O B-S_NP_PRPP
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
always B-O B-ADVP_RB
" " B-O O-ADVP
restricted B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Immunohistochemistry B-O B-S_NP_NP_NN
" " B-O O-NP
on B-O B-PP_IN
a B-O B-NP_NP_DT
panel B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
tissues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
TCF-1 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
exclusively B-O B-NP_PP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
thymocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Western B-O B-S_NP_NN
blotting B-O B-NN
" " B-O O-NP
yielded B-O B-VP_VBD
a B-O B-NP_NP_DT
set B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
bands B-O B-NP_NP_NNS
" " B-O O-NP
ranging B-O B-VP_VBG
from B-O B-PP_IN
25 B-O B-NP_CD
kD B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
55 B-O B-NP_CD
kD B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
resulting B-O B-S_NP_VP_VBG
from B-O B-PP_IN
extensive B-O B-NP_JJ
alternative B-O B-JJ
splicing B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
TCF-1 B-O B-NP_NN
" " B-O O-NP
protein B-O B-NN
" " B-O O-NP
was B-O B-VP_VP_VBD
detectable B-O B-ADJP_JJ
in B-O B-PP_IN
all B-O B-NP_NP_DT
samples B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
set B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
was B-O B-VP_VBD
absent B-O B-ADJP_JJ
from B-O B-PP_IN
a B-O B-NP_NP_DT
large B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_JJ
hematologic B-O B-NP_JJ
neoplasms B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_S_NP_DT
observations B-O B-NNS
" " B-O O-NP
imply B-O B-VP_VBP
a B-O B-NP_NP_DT
T B-O B-NN
cell-specific B-O B-JJ
function B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
TCF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
a B-O B-NP_NP_DT
notion B-O B-NN
" " B-O O-NP
corroborated B-O B-VP_VBN
by B-O B-NP_PP_IN
recent B-O B-NP_NP_JJ
observations B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
Tcf-1 B-O B-NP_NN
knock-out B-O B-JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
nuclear B-O B-S_NP_JJ
TCF-1 B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
serve B-O B-VP_VB
as B-O B-PP_IN
a B-O B-NP_DT
pan-T-lineage B-O B-JJ
marker B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
diagnosis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Constitutive B-O B-NP_NP_NP_JJ
overexpression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
L-selectin B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
fresh B-O B-NP_NP_JJ
leukemic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
adult B-O B-NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
can B-O B-S_NP_VP_MD
be B-O B-VP_VB
transactivated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
L-selectin B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_NP_DT
adhesion B-O B-NN
molecule B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
selectin B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
mediates B-O B-S_NP_VP_VBZ
the B-O B-NP_NP_DT
initial B-O B-JJ
step B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Upon B-O B-S_PP_IN
cellular B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
L-selectin B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
downregulated B-O B-VP_VBN
at B-O B-NP_PP_IN
both B-O B-NP_CC
the B-O B-DT
protein B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
mRNA B-O B-NP_NN
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
understand B-O B-VP_VB
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
leukemic B-O B-NP_NP_NP_JJ
cell B-O B-NN
" " B-O O-NP
infiltration B-O B-NN
" " B-O O-NP
into B-O B-PP_IN
organs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
studied B-O B-VP_VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
regulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
L-selectin B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
fresh B-O B-NP_NP_JJ
leukemic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
L-selectin B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
human B-O B-NP_NP_JJ
T-cell B-O B-NN
lymphotropic B-O B-JJ
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
( B-O B-LRB
HTLV-1 B-O B-NN
) B-O B-RRB
Tax B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Flow B-O B-S_NP_NN
cytometry B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
L-selectin B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
expressed B-O B-VP_VBN
on B-O B-NP_PP_IN
fresh B-O B-NP_NP_JJ
along B-O B-NP_CONJP_IN
with B-O B-IN
" " B-O O-CONJP
other B-O B-NP_JJ
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_SBAR_IN
ATL B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
overexpressed B-O B-VP_VBD
that B-O B-NP_DT
L-selectin B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_DT
level B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
aberrantly B-O B-ADVP_RB
" " B-O O-ADVP
upregulated B-O B-VP_VBN
after B-O B-NP_PP_IN
PMA B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Studies B-O B-S_NP_NP_NNS
" " B-O O-NP
using B-O B-VP_VBG
in B-O B-NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
showed B-O B-VP_VBD
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
L-selectin B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
infiltrating B-O B-VBG
leukemic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
liver B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_CD
ATL B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Intravenous B-O B-S_NP_NP_JJ
injection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
rat B-O B-NP_NN
T-cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
overexpresses B-O B-S_NP_VP_VBZ
L-selectin B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
increased B-O B-NP_VBN
organ B-O B-NN
infiltration B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Tax B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
JPX9 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
about B-O B-NP_NP_ADJP_RB
a B-O B-DT
twofold B-O B-JJ
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
mRNA B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
levels B-O B-NNS
" " B-O O-NP
compared B-O B-PP_VBN
with B-O B-PP_IN
the B-O B-NP_DT
basal B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Chloramphenicol B-O B-S_NP_NP_NP_NP_NN
acetyltransferase B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CAT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
assay B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
transient B-O B-NP_JJ
cotransfection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
about B-O B-NP_NP_ADJP_RB
a B-O B-DT
fivefold B-O B-JJ
" " B-O O-ADJP
transactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
L-selectin B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
Tax B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
serum B-O B-NN
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
shed B-O B-NN
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
L-selectin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O B-PRN_O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBN
in B-O B-NP_PP_IN
ATL B-O B-NP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
mean B-O B-NP_NP_NN
+/- B-O B-CC
SD B-O B-NN
" " B-O O-NP
, B-O B-COMMA
4,215.4 B-O B-NP_QP_CD
+/- B-O B-CC
4,111 B-O B-CD
" " B-O O-QP
ng/mL B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
compared B-O B-PP_VBN
with B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
asymptomatic B-O B-NP_NP_JJ
carriers B-O B-NNS
" " B-O O-NP
and B-O B-CC
healthy B-O B-NP_JJ
blood B-O B-NN
donors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
mean B-O B-NP_NP_NN
+/- B-O B-CC
SD B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-NP_NP_CC
, B-O B-NP_COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
ATL B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
overexpress B-O B-VP_VBP
the B-O B-NP_NP_DT
L-selectin B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
can B-O B-S_NP_VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
overexpression B-O B-NN
" " B-O O-NP
of B-O B-PP_PP_IN
L-selectin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
of B-O B-PP_IN
inflammatory B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
by B-O B-PP_IN
ATL B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
provide B-O B-VP_VB
a B-O B-NP_NP_DT
basis B-O B-NN
" " B-O O-NP
for B-O B-SBAR_WHADVP_IN
ATL B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
to B-O B-VP_TO
attach B-O B-VP_VB
the B-O B-NP_DT
vascular B-O B-JJ
endothelium B-O B-NN
" " B-O O-NP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
leading B-O B-S_NP_VP_VBG
to B-O B-PP_TO
transmigration B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
organ B-O B-NP_NN
infitration B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_NP_DT
DNA B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
steroid B-O B-NP_NN
binding B-O B-NN
domains B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
altered B-O B-VP_VBN
in B-O B-NP_PP_IN
mononuclear B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
treated B-O B-NP_VBN
CLL B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
aim B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
to B-O B-S_NP_VP_TO
investigate B-O B-VP_VB
whether B-O B-SBAR_IN
could B-O B-S_NP_NP_PP_VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
receptor B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
tested B-O B-VP_VBN
immunocytochemically B-O B-NP_UCP_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
steroid B-O B-NP_NN
binding B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
by B-O B-PP_IN
a B-O B-NP_NP_NP_DT
mutation B-O B-NN
screening B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-S_NP_VP_RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
receptor-cDNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
receptor B-O B-NN
concentration B-O B-NN
, B-O B-COMMA
" " B-O O-NP
as B-O B-SBAR_IN
measured B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
staining B-O B-UCP_S_NP_VP_VBG
" " B-O O-VP
" " B-O O-S
and B-O B-CC
steroid B-O B-NP_NN
binding B-O B-NN
test B-O B-NN
" " B-O O-NP
" " B-O O-UCP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
varied B-O B-VP_VP_VBD
considerably B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
but B-O B-CC
showed B-O B-VP_VBD
no B-O B-NP_NP_DT
clear B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
clinical B-O B-NP_JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
a B-O B-NP_NP_DT
highly B-O B-ADJP_RB
sensitive B-O B-JJ
" " B-O O-ADJP
mutation B-O B-NN
screening B-O B-NN
assay B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
DNA- B-O B-NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
the B-O B-NP_DT
steroid-binding B-O B-JJ
" " B-O B-NP_O-NP
region B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
none B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
treated B-O B-VBN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
any B-O B-NP_DT
mutation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
is B-O B-VP_VBZ
not B-O B-RB
altered B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
one B-O B-NP_NP_CD
individual B-O B-NN
" " B-O O-NP
who B-O B-SBAR_WHNP_WP
" " B-O O-WHNP
had B-O B-S_NP_VP_VBD
not B-O B-RB
been B-O B-VP_VBN
treated B-O B-VP_VBN
before B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
a B-O B-NP_DT
silent B-O B-JJ
mutation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
in B-O B-NP_PP_IN
one B-O B-NP_CD
receptor B-O B-NN
allele B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
mechanisms B-O B-S_NP_NP_NNS
" " B-O O-NP
other B-O B-CONJP_JJ
than B-O B-IN
" " B-O O-CONJP
altered B-O B-NP_NP_JJ
ligand B-O B-NN
" " B-O O-NP
or B-O B-CC
DNA B-O B-NP_NP_NN
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
conclusion B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
discussed B-O B-VP_VBN
in B-O B-NP_PP_IN
relation B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_DT
normal B-O B-JJ
cell B-O B-NN
cycle B-O B-NN
activation B-O B-NN
program B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
exploited B-O B-VP_VBN
during B-O B-NP_PP_IN
the B-O B-NP_NP_DT
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
quiescent B-O B-NP_JJ
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
B B-O B-S_S_NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
peripheral B-O B-JJ
circulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
maintained B-O B-ADJP_JJ
in B-O B-PP_IN
a B-O B-NP_DT
non-proliferative B-O B-JJ
state B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Antigen B-O B-S_NP_NN
recognition B-O B-NN
" " B-O O-NP
stimulates B-O B-VP_VBZ
limited B-O B-NP_JJ
proliferation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
whereas B-O B-SBAR_IN
infection B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
Epstein-Barr B-O B-NP_NP_JJ
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EBV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
continual B-O B-NP_NP_NP_JJ
proliferation B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
outgrowth B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
immortal B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
it B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
not B-O B-RB
clear B-O B-ADJP_JJ
" " B-O O-ADJP
at B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
point B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-WHNP
" " B-O O-WHPP
the B-O B-S_NP_DT
peripheral B-O B-NP_JJ
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
arrested B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
characterized B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_JJ
cell B-O B-NP_NN
cycle-associated B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
quiescent B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
stimulated B-O B-NP_VBN
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
four B-O B-NP_NP_CD
cell B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
cdc-2 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
cyclin B-O B-NP_NN
E B-O B-NN
" " B-O O-NP
, B-O B-COMMA
CD23 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
cyclin B-O B-NP_NN
D2 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
up-regulated B-O B-VP_VBN
approximately B-O B-NP_NP_RB
100-fold B-O B-RB
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
result B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
these B-O B-S_NP_DT
genes B-O B-NNS
" " B-O O-NP
play B-O B-VP_VBP
a B-O B-NP_DT
positive B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cell B-O B-NP_NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
this B-O B-S_NP_DT
regulatory B-O B-JJ
switch B-O B-NN
" " B-O O-NP
contributes B-O B-VP_VBZ
to B-O B-PP_TO
controlling B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Transient B-O B-S_NP_NP_JJ
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
quiescent B-O B-NP_JJ
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
either B-O B-NP_CC
a B-O B-NP_NP_DT
cocktail B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
anti-CD40 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
anti-IgM B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
IL4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
EBV B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_DT
rapid B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
same B-O B-JJ
four B-O B-CD
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
, B-O B-S_COMMA
after B-O B-PP_IN
infection B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
EBV B-O B-NP_NN
" " B-O O-NP
exploits B-O B-VP_VBZ
the B-O B-NP_NP_DT
normal B-O B-JJ
program B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
BCL-6 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
molecular B-O B-JJ
pathogenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B-cell B-O B-NP_NN
lymphoma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
results B-O B-NNS
" " B-O O-NP
presented B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
identify B-O B-VP_VBP
the B-O B-NP_NP_DT
first B-O B-JJ
genetic B-O B-JJ
lesion B-O B-NN
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
DLCL B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
most B-O B-ADJP_RBS
clinically B-O B-RB
relevant B-O B-JJ
" " B-O O-ADJP
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NHL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
no B-O B-S_NP_NP_DT
proof B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-NP
yet B-O B-ADVP_RB
" " B-O O-ADVP
exists B-O B-VP_VBZ
of B-O B-PP_IN
a B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
these B-O B-NP_DT
lesions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
DLCL B-O B-NP_NN
pathogenesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-NP_NP_NP_DT
feature B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
BCL-6 B-O B-NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
its B-O B-NP_NP_PRPP
specific B-O B-JJ
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_NP_DT
clustering B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lesions B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
disrupting B-O B-VP_VBG
its B-O B-NP_PRPP
regulatory B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
deregulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
BCL-6 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
contribute B-O B-VP_VB
to B-O B-PP_TO
DLCL B-O B-NP_NN
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
more B-O B-ADJP_RBR
precise B-O B-JJ
" " B-O O-ADJP
definition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
BCL-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
normal B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
neoplastic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
B-cell B-O B-NN
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
goal B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ongoing B-O B-NP_NP_JJ
study B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transgenic B-O B-NP_NP_JJ
mice B-O B-NNS
" " B-O O-NP
engineered B-O B-VP_VBN
" " B-O B-NP_S_NP_VP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NN
to B-O B-TO
contributing B-O B-S_NP_VP_VBG
to B-O B-PP_TO
the B-O B-NP_NP_DT
understanding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DLCL B-O B-NP_NN
pathogenesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
identification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
BCL-6 B-O B-NP_NN
lesions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
have B-O B-VP_VB
relevant B-O B-NP_JJ
clinical B-O B-JJ
implications B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DLCL B-O B-S_NP_NN
" " B-O O-NP
represent B-O B-VP_VBP
a B-O B-NP_NP_DT
heterogeneous B-O B-JJ
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
neoplasms B-O B-NP_NP_NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
treated B-O B-VP_VBN
" " B-O B-NP_ADVP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
Schneider B-O B-NP_NP_NP_NNP
" " B-O O-NP
et B-O B-ADVP_FW
al. B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
1990 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
fact B-O B-NN
that B-O B-SBAR_IN
BCL-6 B-O B-S_NP_NN
rearrangements B-O B-NNS
" " B-O O-NP
identify B-O B-VP_VBP
and B-O B-NP_NP_ADJP_ADVP_ADVP_CC
distinct B-O B-ADVP_JJ
" " B-O O-ADJP
subsets B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
DLCL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
these B-O B-S_NP_DT
lesions B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
useful B-O B-ADJP_JJ
" " B-O O-ADJP
as B-O B-PP_IN
markers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
selection B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
based B-O B-NP_PP_VBN
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
BCL-6 B-O B-NN
rearrangements B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
identify B-O B-VP_VP_VP_VB
" " B-O B-NP_O-VP
and B-O B-CC
monitor B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-VP
the B-O B-NP_DT
malignant B-O B-JJ
clone B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
sensitive B-O B-NP_JJ
PCR-based B-O B-JJ
techniques B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
clinical B-O B-S_NP_JJ
remission B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
significant B-O B-JJ
fraction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
these B-O B-NP_DT
markers B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
serve B-O B-VP_VB
as B-O B-PP_IN
critical B-O B-NP_NP_JJ
tools B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
sensitive B-O B-NP_NP_NP_JJ
monitoring B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
early B-O B-NP_NP_JJ
diagnosis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
Gribben B-O B-NP_NP_NP_NNP
" " B-O O-NP
et B-O B-ADVP_FW
al. B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
1993 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Prolactin B-O B-S_S_NP_NP_NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
interleukin-2 B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
signal B-O B-VP_VBP
through B-O B-PP_IN
a B-O B-NP_DT
MGF-STAT5-like B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
cell B-O B-NN
surface B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
PRL B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
interleukin-2 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VP_VBP
structurally B-O B-ADJP_RB
distinct B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
share B-O B-VP_VBP
regulatory B-O B-NP_NP_JJ
tasks B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
They B-O B-S_NP_PRP
" " B-O O-NP
can B-O B-VP_MD
stimulate B-O B-VP_VP_VB
proliferation B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
activate B-O B-VP_VB
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
over-lapping B-O B-NP_NP_JJ
sets B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PRL B-O B-S_NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
IL-2 B-O B-NP_NN
" " B-O B-NP_O-NP
receptor B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
both B-O B-DT
linked B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
Jak/Stat B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
signal B-O B-NP_NN
transducer B-O B-NN
and B-O B-CC
activator B-O B-NN
of B-O B-IN
transcription B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PRL B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
Stat B-O B-NP_NP_NN
proteins B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
different B-O B-NP_JJ
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
specificities B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
reactivities B-O B-NNS
" " B-O O-NP
toward B-O B-PP_IN
Stat-specific B-O B-NP_JJ
antisera B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_NP_DT
mol B-O B-NN
wt B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2- B-O B-NP_NP_NP_NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
PRL-induced B-O B-NP_JJ
DNA-binding B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
Nb2 B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
C196 B-O B-NP_NN
" " B-O B-NP_O-NP
T B-O B-NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
investigated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
comparison B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
Stat B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
interferon-gamma B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
PRL B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
IL-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
T47D B-O B-NP_NN
mammary B-O B-JJ
tumor B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
made B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
these B-O B-S_NP_DT
parameters B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
indistinguishable B-O B-ADJP_JJ
for B-O B-PP_IN
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
closely B-O B-ADJP_RB
related B-O B-JJ
to B-O B-PP_TO
mammary B-O B-NP_JJ
gland B-O B-NN
factor-Stat5 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
is B-O B-VP_VBZ
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
activated B-O B-VP_VBN
upon B-O B-NP_PP_IN
interaction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
PRL B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
their B-O B-NP_PRPP
respective B-O B-JJ
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
second B-O B-JJ
protein B-O B-NN
" " B-O O-NP
related B-O B-ADJP_JJ
to B-O B-PP_TO
Stat1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
emphasize B-O B-VP_VP_VBP
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PRL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_NP_DT
regulator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
immune B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
Stat B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
mammary B-O B-NP_NP_JJ
gland B-O B-NN
factor-Stat5 B-O B-NN
" " B-O O-NP
and B-O B-CC
" " B-O B-NP_NP_NP_O-NP
" " B-O O-NP
" " B-O O-NP
play B-O B-VP_VBP
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
during B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
CD30 B-O B-S_S_NP_NP_NN
" " B-O O-NP
ligation B-O B-NN
" " B-O O-NP
induces B-O B-VP_VBZ
nuclear B-O B-NP_NP_JJ
factor-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
CD30 B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
recently B-O B-ADJP_RB
described B-O B-VBN
" " B-O O-ADJP
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
tumor B-O B-NP_NN
necrosis B-O B-NN
factor/nerve B-O B-NN
growth B-O B-NN
factor B-O B-NN
receptor B-O B-NN
superfamily B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
following B-O B-S_PP_VBG
incubation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
L540 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_NP_DT
and B-O B-NP_NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
two B-O B-NP_CD
nuclear B-O B-NP_JJ
factor B-O B-NN
( B-O B-LRB
NF B-O B-NN
) B-O B-RRB
-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
DNA B-O B-NN
binding B-O B-NN
activities B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
mAb B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
towards B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
rapid B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
as B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
occurred B-O B-VP_VP_VBD
within B-O B-PP_IN
20 B-O B-NP_CD
min B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
was B-O B-VP_VBD
sustained B-O B-ADJP_JJ
for B-O B-PP_IN
h B-O B-NP_QP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
comparison B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
an B-O B-NP_DT
isotype-matched B-O B-NP_JJ
antibody B-O B-NN
" " B-O O-NP
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
human B-O B-NP_NP_JJ
T B-O B-NN
helper B-O B-NN
( B-O B-LRB
Th B-O B-NN
) B-O B-RRB
clones B-O B-NNS
" " B-O O-NP
functionally B-O B-VP_ADVP_RB
" " B-O O-ADVP
characterized B-O B-VBN
as B-O B-NP_PP_IN
being B-O B-S_NP_VP_VBG
of B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
extent B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD30-mediated B-O B-NP_JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlated B-O B-VP_VBD
with B-O B-PP_IN
the B-O B-NP_NP_DT
proportion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD30+ B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
all B-O B-NP_NP_DT
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
investigated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
NF-kappa B-O B-NP_NN
B B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
induced B-O B-VP_VBN
following B-O B-NP_PP_VBG
CD30 B-O B-NP_NP_NN
" " B-O O-NP
engagement B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
contain B-O B-VP_VB
p50 B-O B-NP_NP_NN
NF-kappa B-O B-NN
B1 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
p65 B-O B-NP_NN
RelA B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
possibly B-O B-NP_ADVP_RB
" " B-O O-ADVP
other B-O B-JJ
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Collectively B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
our B-O B-NP_PRPP
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
nuclear B-O B-S_NP_NP_JJ
translocation B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
rank B-O B-VP_NN
among B-O B-PP_IN
the B-O B-NP_NP_DT
short-term B-O B-JJ
cellular B-O B-JJ
responses B-O B-NNS
" " B-O O-NP
elicited B-O B-VP_VBD
following B-O B-NP_PP_VBG
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
